cell_line_id,drug_id,response
KMS-26,136227924,1.9705002365993127
PSN1,135421197,2.7573404072547327
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
TOV-112D,11494412,0.1754795194968993
CJM [Human melanoma],135659046,3.6050904853036703
SJSA-1,100016,7.674645652371816
HGC-27,11494412,-1.4088898855213312
BT 422,71751553,4.340972602813402
HCC44,135984461,3.9649295662301585
JURL-MK1,9926054,0.5883612269898851
786-O,selumetinib-vorinostat (8-1 mol-mol),3.923964737864286
C2BBe1,1566236,2.772139102612497
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
SNU-601,11152667,-3.2024778673902254
Aska-SS,9868037,4.2121131114727435
EoL-1,11404337,-2.4489617476913432
NU-DUL-1,3854666,-0.2985589643704558
SNU-1272,3854666,4.252561459564198
NCI-H1395,54618305,4.493399620925908
TTC-709,JQ-1-carboplatin (1-1 mol-mol),1.695991072597723
OAW28,10296883,4.314409366833216
SNU-182,9911463,2.9412810978967867
HCC2108,12003241,-1.7779849182593923
AU565,10322450,3.206832643999438
TT,9926054,1.79906613528668
NCI-H2029,4705,3.1961427877566173
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
SNU-213,135984461,4.435605101205859
Hs 611.T,9926054,1.8280926290746755
LS513,JQ-1-carboplatin (1-1 mol-mol),4.102727759059396
KE-37,9868037,1.7348034211084984
NCI-H1105,11494412,1.05624549663504
KG-1-C,11152667,0.3070141898417881
SF295,54618771,1.9072877365394525
Caov-3,9915743,1.9155459693646115
BT 359,10296883,4.315166062972002
RL95-2,selumetinib-vorinostat (8-1 mol-mol),-0.5511800242944189
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
U-BLC1,10322450,3.651002961479182
GCT,1566236,1.4105252742075816
786-O,71751553,5.395169035424641
LAMA-84,54618771,0.5560134201720579
Daoy,9911463,4.106155174248402
HH [Human lymphoma],9911463,2.7803451597373887
BICR 31,9884685,0.303781088019613
OPM-2,136227331,3.7431952210756014
5637,11404337,-1.271939426582808
KP-2,1566236,3.613978345797679
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
JeKo-1,100016,6.219930850058466
HuCC-T1,3465537,1.6578684986062462
DEL,44241473,5.648282571710881
EJM,135421197,1.4211538659692204
LCLC-103H,11404337,0.85397290991948
PE/CA-PJ41 (clone D2),24771867,3.741688569493883
NCO2,54618305,3.6684730669441152
SNU-201,3854666,4.676040623574546
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
BT 504,11494412,1.1419728911910534
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
CHP-126,selumetinib-GDC-0941 (4-1 mol-mol),3.8559663060343
NU-DUL-1,9915743,-0.5036069794958961
HCC1428,135984461,5.872132902333047
K029AX,selumetinib-vorinostat (8-1 mol-mol),1.1162865494323109
MDST8,11404337,0.5498361952050128
HCC44,JQ-1-carboplatin (1-1 mol-mol),-0.5327946699204261
647V,selumetinib-vorinostat (8-1 mol-mol),2.3605187203171987
HuH-6,11152667,-2.162019568572356
NCI-H1650,12003241,-2.181878019620055
TUHR10TKB,9884685,2.5502093698496004
SF268,135984461,5.451116229998117
PE/CA-PJ49,11152667,-0.7755260151132314
Panc 05.04,9915743,-0.1908442283292951
KYSE-150,9911463,4.274881584609526
CJM [Human melanoma],9935249,3.667632457160335
HCC4006,24771867,0.3651432577667053
Hs 944.T,65628,3.908889176196175
JHH-2,JQ-1-carboplatin (1-1 mol-mol),3.497557537915234
SK-N-BE(2),2742550,3.013955161893337
SNU-626,54618771,3.903853524129119
NCI-H1944,selumetinib-GDC-0941 (4-1 mol-mol),0.8132454381958738
JJN-3,71751553,4.601473128898884
Kelly,100016,6.527674974645037
SNU-886,selumetinib-vorinostat (8-1 mol-mol),0.3326918028445991
OAW42,9915743,3.0067264030666907
RT-112,11404337,0.3024597530600803
Hs 852.T,selumetinib-vorinostat (8-1 mol-mol),2.3684973893680024
Karpas-422,6918638,-0.9922508328121828
SK-N-MC,9915743,0.8828684389930763
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
ONS-76,100016,6.019166856387977
LC-1/sq-SF,selumetinib-vorinostat (8-1 mol-mol),3.9506285089296513
TE-11,65628,5.742213297143678
FU-OV-1,73707386,2.8924737769549633
Yamato-SS,6918638,0.9950789040001992
F-36P,11152667,-1.3463503839028206
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
HCT 8,9884685,1.0209967056986369
QGP-1,11152667,0.9572583178254478
KMH-2,54618305,4.158753389755641
SNU-16,135984461,3.245976227672491
L3.3,10296883,4.354494828099719
SW579,2742550,3.4497897909573223
SK-CO-1,3854666,3.8596661393399927
KG-1-C,9915743,2.9302265350196315
Namalwa,9911463,2.7572577056870022
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
IGR-37,2746,2.835708308282215
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
BT 428,6918638,-0.3537388396166394
SNU-8,9911463,4.350153434001515
Peer,49836020,4.240424721025454
RPMI-8402,54618305,4.0465755097564555
BT 286,49836020,4.709879888093613
DU145,2742550,4.5042202840437975
BT 482,54618771,0.8626033669866102
PK-45H,1566236,1.9523523516451644
OE21,10296883,3.8232218432120058
MIA PaCa-2,135659046,3.7193443303471727
Hs 611.T,12003241,-4.3632527403619425
SJSA-1,136227924,3.1619398784526176
NCI-H2126,9935249,3.58501111788995
JHUEM-1,54618771,0.4332987252464321
NCI-H1623,1566236,4.077529389730835
HT-1376,10296883,4.451130716286632
SNU-8,100016,6.375529183181613
OVCAR-8,135421197,1.5864277094483568
U-251MG,9926054,2.2647834350690483
NCI-H2106,JQ-1-carboplatin (1-1 mol-mol),3.821123323467481
OCUM-1,49836020,-0.6781383792077297
SNU-886,3465537,4.952996907212378
NCI-H460,136227924,3.925006850615035
HPB-ALL,10322450,3.7687188105178206
PC-14,4378219,5.64918445258186
Granta-519,65628,2.6603144373939154
KALS-1,136227331,4.320673828023345
PE/CA-PJ49,11404337,0.0513303948007028
EB1,10296883,2.8926613623150685
TUHR14TKB,selumetinib-vorinostat (8-1 mol-mol),2.7160873557760024
BL-70,9911463,2.445001964287348
SF268,135659046,3.3969248782419608
Ri-1,9935249,2.110817780838048
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
BT 440,1566236,1.7318288618334623
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
SW1088,2742550,4.360123495040072
AML-193,JQ-1-carboplatin (1-1 mol-mol),0.2220532745153866
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
SCC-4,135421197,1.85399046640426
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
A-253,4705,3.938906906816397
NCI-H1734,24771867,2.031566489860908
GI-1,9935249,3.04250008924813
BT 428,24771867,1.0803852417882902
MOLM-13,100016,3.967621300341963
Mel Ho,11152667,0.8252449561031235
OAW28,71751553,5.303505748888211
COLO 668,4705,2.9161430559961588
NCI-H1435,11152667,-0.3527509280063574
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
BT 224,71751553,4.407976562424278
HEC-151,54618771,1.151174886462992
SK-HEP-1,3854666,3.0622551399292264
U266B1,76446078,4.191822515620462
NCI-H2106,11404337,-0.0060242090595341
JHH-1,71751553,4.253382088977832
NCI-H1581,11152667,-0.3315014668198749
8-MG-BA,11152667,0.13632020716098
TUHR4TKB,54618771,1.114218379650299
AGS,3854666,3.591609764349203
TUHR10TKB,2742550,3.0161349099279033
AML-193,9884685,0.1171363640105301
HCC95,12003241,-0.8735704800502477
CW-2,9935249,2.613016499199886
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
MIA PaCa-2,2742550,3.852651019611259
SUP-T11,54618305,4.5643588933895956
OE21,24771867,2.4466208199603185
SW48,54618771,0.2213541125267267
LC-1/sq-SF,11152667,0.2715714825449515
COLO 680N,selumetinib-GDC-0941 (4-1 mol-mol),2.523373252620712
OVSAHO,11404337,0.0344009814781069
MKN74,1566236,3.387752601691297
OCI-Ly10,9926054,1.7793271735454907
A2780,2746,1.939184711313242
K-562,100016,4.034095210213227
COLO 668,12003241,0.007541298710802
A3/Kawakami,3854666,0.4749804241070199
IM95,2746,2.7432811533123247
NCI-H522,11404337,-1.4542746262182442
TUHR10TKB,9868037,2.493221827195661
ME-1 [Human leukemia],selumetinib-GDC-0941 (4-1 mol-mol),0.4788349760990721
HGC-27,76446078,4.616529709663479
SNU-C2A,selumetinib-vorinostat (8-1 mol-mol),2.556346033839852
YD-10B,selumetinib-GDC-0941 (4-1 mol-mol),-2.4124074693543887
NCI-H441,100016,5.015174861435744
DND-41,9926054,1.3861019613196697
J82,9926054,1.9182596726219543
COLO 680N,9915743,3.1865022811794006
SK-UT-1,100016,6.311695779547894
JHH-5,9884685,3.4124778347887106
MOLT-13,selumetinib-GDC-0941 (4-1 mol-mol),0.648080768379065
IM95,selumetinib-vorinostat (8-1 mol-mol),1.7782724211956276
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
COV362,3465537,2.7023896432001733
SW48,9911463,3.374803590447597
COLO 680N,54618771,3.898900204814355
JHH-1,24771867,2.827706239342005
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
COR-L51,135984461,4.507897023169623
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
A2780,9911463,2.7303797257759235
ZR-75-1,3854666,3.378187889004693
COR-L51,11494412,-0.9719928446177656
Karpas-620,9926054,3.72255119036043
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525
Pfeiffer,100016,6.236222400968574
MOLT-3,2742550,3.4970391665192175
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
DND-41,2742550,2.4562180323562326
HLF,9915743,2.207816370136927
SNU-626,49836020,-1.879821731308555
JVM-3,9915743,-1.1278742890902858
SNU-899,3854666,4.196460373735126
SUP-HD1,11494412,0.2707492633532761
BT 159,9935249,2.6944472929674226
HCC1419,1566236,3.0079823710753923
KMS-26,selumetinib-vorinostat (8-1 mol-mol),-0.8161988345197432
NCI-H520,6918638,-0.4821268163650811
OCI-Ly3,136227924,2.2750950031645885
HEC-108,54618771,2.78064765565191
KMS-18,54618771,-1.0350203667424809
SF539,71751553,4.845342915681748
HL-60,71751553,4.3254524029405275
SUIT-2,136227924,3.4861054974924133
M-07e,9911463,2.8967882241025995
KMH-2,9911463,2.975818602931934
TOV-112D,100016,6.758334848108728
BFTC-905,135421197,2.6921264103177
SK-OV-3,3854666,3.321518045263264
F-36P,40482356,5.08817235841337
RMG-I,54618305,4.556986541858906
JHOC-5,12003241,-1.1087899100302334
BT 504,9926054,1.7523750045888775
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182
786-O,12003241,0.5866804436375384
PK-45H,54618771,1.4553505750064293
HCC1395,9911463,3.7308184139789855
COV434,3854666,0.915604279747924
Aska-SS,100016,5.454856815374324
NCI-H1838,11152667,0.4729099226601252
JHOM-1,71751553,4.814264639455068
SNU-626,9911463,4.505405872194439
HT-1080,135421197,1.6974023477762936
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
KP-N-SI9s,135984461,3.392026045664003
Ki-JK,12003241,-1.478318359413444
BT 271,10322450,5.076233079663244
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
SNU-601,136227924,3.114119824082727
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
BT 239,4378219,1.0499899367803716
ONS-76,3854666,0.984876663182433
DB,2742550,2.8913384743373536
NCI-H1755,9935249,3.3261262266034577
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
JHUEM-1,135659046,3.513270809180088
DMS 114,10322450,4.614293219898761
MEC-1,2742550,3.1493999603639526
HCC78,11152667,-0.3255847419940918
TE 617.T,49836020,3.775264114601375
MKN7,selumetinib-GDC-0941 (4-1 mol-mol),2.574249068911848
DU145,1566236,3.495730163617442
NOMO-1,135398744,6.340708200805823
BT 112,54618771,1.3381626551406447
GA-10,11152667,-3.274266411551672
NCI-H1373,9911463,3.627616196356772
A-375,44241473,4.458361896268554
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
NH-6,4705,3.0039103568475674
Karpas-422,12003241,0.4573968210074843
KYSE-150,selumetinib-GDC-0941 (4-1 mol-mol),2.603924706865474
AsPC-1,3854666,3.565227366628202
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
OVSAHO,135984461,5.613445307833131
FTC-133,9935249,4.194644265855045
SNU-216,6918638,0.1724072866575592
NH-6,136227924,2.082013315983653
LK-2,10296883,4.228835920762888
PK-1,54618771,1.395529069214854
647V,9926054,1.756736719694015
MKN1,2742550,4.9827202282235685
OCI-M1,71751553,4.386393852068909
SK-N-FI,11494412,-0.1872095873392484
BICR 22,49836020,2.6142262300183305
MM1.S,2746,1.322857724988492
SNU-1033,135421197,1.1443309651958211
NCI-H2081,6918638,-1.1409095287475362
JHUEM-1,136227924,2.224041693066133
769-P,12003241,-0.850847726914325
8305C,11152667,-0.8944679868957458
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
HGC-27,24771867,-2.6696273898106653
LC-1/sq-SF,24771867,4.4914426511219645
UM-UC-3,11404337,0.461237449604962
NCI-H2141,11404337,-1.2716473405568056
HCC38,11404337,0.6997124930449434
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
AU565,3854666,0.9438607721687704
JHUEM-1,2746,3.5357921784869775
TE-15,6918638,-0.5881050446638335
NCI-H2029,10296883,4.228313124120171
Karpas-299,9868037,2.0515454012978176
PL-21,135421197,1.4240798978799187
SW1710,135398744,7.400823424142947
SNU-685,54618771,0.6420391462722509
SUIT-2,11404337,0.4217329969696077
LOU-NH91,9935249,4.429052878520747
B-CPAP,2742550,3.2183332694531677
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
DMS 114,9926054,1.677325946401266
HCC2279,selumetinib-vorinostat (8-1 mol-mol),3.4821596775534167
Hs 888.T,9935249,3.2466052266925822
TE 617.T,4705,0.0619159999462867
SNU-C4,135421197,3.0670219235957914
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
RPMI-7951,650361,3.986097803134267
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
IPC-298,10296883,3.818121747972668
AsPC-1,135984461,3.722049898583642
OCI-AML-3,136227924,1.3599145322416812
CAL-33,71751553,4.914654901307642
MKN74,9935249,3.3607171533797127
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
A-498,11404337,2.25955984981305
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615
NU-DUL-1,4705,2.4106173006018268
KMS-34,9884685,-1.7176410454877906
NCI-H2106,2742550,3.343740248931034
G-292 clone A141B1,12003241,-1.351842997684689
A-375,135398744,6.486116496095493
K-562,11494412,-0.907204058397288
OUMS-23,9911463,3.126412201053572
23132/87,3854666,1.2924616930846544
CJM [Human melanoma],1566236,1.8000677209088238
SNU-869,11404337,1.139832869567116
MOLT-13,10296883,2.8313852072501966
KMRC-1,1566236,3.0378094444517645
HSC-3,54618771,0.6642536113718133
A-375,65628,4.4466647793828855
CAL-29,9915743,0.4542192657776882
OVCAR-5,9911463,3.385912841679363
YD-8,11404337,-1.7651477779753342
SK-ES-1,49836020,6.460464214010888
253J,12003241,-2.2004462353623775
CAL-54,24771867,2.8343015730904333
JVM-2,12003241,-4.468160768320854
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
HGC-27,9926054,1.079439551544522
Reh,selumetinib-GDC-0941 (4-1 mol-mol),2.2162895945823093
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
KMS-27,9935249,2.590998934095406
Aska-SS,11152667,-1.72297256980761
UO-31,JQ-1-carboplatin (1-1 mol-mol),1.475282337781019
Kelly,135421197,1.3669012525071198
HT-1376,44241473,5.995086046187869
OV7,selumetinib-vorinostat (8-1 mol-mol),3.5480660941155424
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
H-STS,3854666,0.1561624900748555
TE-5,10322450,3.7882454446327087
Hs 940.T,9911463,3.592326868154122
BICR 56,11152667,0.0702266217115395
LS123,11152667,-1.6976083930995145
NCI-H1693,1566236,1.8540342250412096
T-47D,selumetinib-GDC-0941 (4-1 mol-mol),3.2531063352612697
Hs 888.T,selumetinib-GDC-0941 (4-1 mol-mol),2.8983060042425484
NCI-H1435,135398744,6.3008870427516115
NCI-H2444,54618771,3.319337103675071
OVCAR-4,135984461,4.697392944988172
SK-N-DZ,9915743,0.9921777316804312
T24,3854666,1.9739653742964731
KMS-27,24771867,-2.8070025091368054
A101D,11494412,3.85328566830266
SNU-46,9926054,2.489766142928295
SNU-738,11152667,-1.159018364842496
BT 228,136227924,3.2498510190278314
SK-ES-1,9884685,-0.8929254514041229
HCC15,9911463,3.642862209488471
BT 428,76446078,5.6455430214390985
NMC-G1,136227924,2.469359539544405
NB1,135421197,1.388835024026268
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
M-07e,selumetinib-vorinostat (8-1 mol-mol),1.3971239600856724
LS1034,10322450,3.783129685700755
Caov-3,135398744,6.775001868991772
NCI-H1155,9868037,2.157837609238264
COLO 680N,9911463,4.286168198207007
L-363,11152667,-4.496955803562482
ST486,6918638,-1.4802112864016868
SK-N-BE(2),100016,5.117046374692038
SNU-685,6918638,-0.5860605595397334
NCI-H2023,54618305,4.354066699280693
RPMI-8226,2746,1.5846721201375709
TOV-112D,9911463,4.387944714861712
BICR 18,11494412,1.6811938858482085
NCI-H2087,49836020,4.38375865979883
KYO-1,135984461,2.714539808295769
KP-N-SI9s,9926054,1.6199423536774489
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
SNU-840,9926054,2.11865142604258
BT 428,JQ-1-carboplatin (1-1 mol-mol),-0.3144310627215171
OVCAR-8,24779724,5.1657808765026285
UO-31,6918638,1.142003131035845
DND-41,49836020,1.1250375058635431
BT 232,3854666,3.559831057180391
Hs 895.T,168313307,4.455541417323381
NCI-H1792,12003241,-0.2343490439085071
Panc 03.27,54618771,0.0634128871766815
CHP-126,73707386,2.56011600138591
NCI-H526,9935249,3.1967186299160466
HEC-1-B,12003241,-1.9447585975595445
NCI-H1915,2742550,4.073446103573009
NCI-H1869,6918638,1.090174259453097
BT 164,65628,2.969610614929698
EPLC-272H,24771867,-0.0308080580709378
AsPC-1,9935249,3.639166614114404
CAL-33,24771867,1.1853509154782378
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
SNU-387,12003241,-1.416188991629313
COR-L47,11494412,0.8798748860776965
LN-18,selumetinib-GDC-0941 (4-1 mol-mol),2.471662791203074
MHH-NB-11,11404337,-1.8746153403956665
KM12,2746,3.7112872132085686
TF-1,selumetinib-vorinostat (8-1 mol-mol),0.2373450390299108
KYSE-140,54618771,1.7180424995817132
SCaBER,9915743,-1.392407899834092
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
RS4;11,24771867,-2.987365187851434
BT 328,71751553,4.608962030519419
THP-1,73707386,3.039946481349438
CAL-120,9884685,3.43304722885063
KYSE-180,11404337,-0.9460930401604244
SK-MEL-1,12003241,-1.7363712573149035
HEC-151,100016,5.913951457428463
SNU-C1,9926054,1.821636344159182
PK-1,11494412,1.9575571881437173
NCI-H1105,4705,1.2739510490449024
SK-MEL-28,selumetinib-vorinostat (8-1 mol-mol),1.183939454839272
KYSE-520,3854666,2.9600275476239957
JHUEM-1,6918638,0.9428418212694492
AML-193,40482356,5.132384685555445
IA-LM,9911463,2.6703246121465436
Calu-1,12003241,-0.3445186674692038
IGR-1,135421197,2.0618404907412473
TE 617.T,selumetinib-vorinostat (8-1 mol-mol),2.763602035928325
Calu-3,9915743,-3.447731776127472
TOV-112D,135421197,1.1317975787010155
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188
MOLT-13,136227924,1.9107910741830303
MOLT-13,9915743,-0.4312567007691435
697,24771867,-2.828263941354031
GOS-3,1566236,2.0611902912111013
ST486,2746,0.9238009694882156
PLC/PRF/5,2742550,3.829662269991737
SUP-M2,11494412,-1.6860756358527853
TUHR14TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.1009270469043897
RD,9884685,0.0829186100181427
UACC-257,11494412,4.416808575611809
HCC1428,9926054,2.453077305759455
HEC-251,100016,6.174926130166858
SW1710,10322450,4.1954905662020305
TUHR4TKB,4378219,2.5141922863349064
Namalwa,135659046,3.012855120581617
2004,11404337,-1.336940767900643
OS-RC-2,selumetinib-vorinostat (8-1 mol-mol),3.5044283188137504
SNU-213,12003241,-1.127561281071067
Capan-2,24779724,5.003902097193099
A2058,10296883,3.853282697194753
LK-2,9935249,3.1585878787064803
SW1990,54618305,4.718025842071016
BHY,11404337,-1.9155741795554864
WM88,9915743,1.087537207724937
COR-L51,12003241,-0.3418570343381517
253J-BV,24771867,4.50937218032254
SYO-1,4378219,4.4322210427254545
KMBC-2,selumetinib-vorinostat (8-1 mol-mol),1.67831087866627
TE-1,49836020,4.425156685624386
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
Hs 611.T,4378219,1.8492709684076516
K-562,6918638,0.0740833242167517
ST486,3854666,0.1902738125367225
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
T3M-10,44241473,4.67958167886788
SNU-C2A,9911463,4.1542386249666094
NCI-H647,11494412,2.106693333692888
TCCSUP,9911463,4.056352676279941
LCLC-97TM1,4378219,2.0431586025336332
KALS-1,1566236,2.244162575984816
LNCaP clone FGC,9911463,2.657029606210989
Hs 294T,9884685,0.4800605925029185
AN3-CA,40482356,5.1223591742849415
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
MFE-296,9935249,2.6093075530400864
KMS-26,11404337,-1.1990569021181443
BICR 31,3854666,2.26793763186435
CAL-29,3854666,2.71198320496625
KMS-18,9868037,2.273728459676758
M059K,135984461,3.9567991778438247
TYK-nu,JQ-1-carboplatin (1-1 mol-mol),2.875539349540035
KE-97,9915743,-0.9585907230635954
Karpas-422,9911463,4.381699719624804
HLF,54618771,-0.5261928492303469
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
8505C,selumetinib-vorinostat (8-1 mol-mol),1.1149126375147471
WM115,24771867,3.628628048718056
KE-97,2742550,4.218678752457228
CA46,54618771,1.203400154931592
NCI-H647,9935249,3.357508970290888
NCI-H1755,selumetinib-vorinostat (8-1 mol-mol),2.43902185104056
MOLP-8,3854666,0.8063321236158104
MOLM-6,2742550,3.618071762117163
BT 333,11152667,1.6479441253937606
WT2-iPS,2742550,4.265208753416965
AsPC-1,4705,5.582464580618905
RD,65628,4.606255765609253
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
CAL-54,12003241,-2.3491200847554103
NCI-H1581,100016,6.5572943300427795
LS1034,4705,2.791572248963506
JM-1,9935249,0.9666917954448688
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
NB1,9935249,3.348619595020339
SNU-449,54618771,0.9697829427454708
HCC1428,135421197,1.8247359563067895
COLO 800,9915743,1.5977279916979588
SW1990,54618771,1.819696432191247
JHH-5,6918638,1.17562922333198
BT 231,136227924,3.1954768658582378
NCI-H1299,65628,5.181040397435313
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
NALM-6,73707386,2.2984921556780704
CAL-27,2746,3.342989034660484
NCI-H1573,54618771,0.5890663299030774
VMRC-RCW,100016,5.733604538717687
Becker,11494412,0.142625338466196
A3/Kawakami,10296883,3.880092254870085
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
DMS 454,2742550,3.819348213912809
CAL-33,135398744,6.573384587063474
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
HCC4006,9911463,4.4581598628848385
OCI-Ly3,49836020,4.868556688555981
SNU-398,12003241,3.2060207303790924
H-STS,9911463,3.056276034663577
Rh30,9884685,-0.1007455789627698
TE-14,JQ-1-carboplatin (1-1 mol-mol),0.3658378251951246
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
RKN,65628,4.337575078598336
NCI-H2087,4378219,1.8758721744956532
NCI-H1563,4705,2.6238012803038124
CL-11,9935249,5.287545766743186
NU-DUL-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.5711505169578749
M059K,9926054,1.7795727491270252
EB1,6918638,-0.9960989613224034
PSN1,11494412,1.2145566639626413
JHUEM-7,12003241,-3.5765771521887246
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
NCI-H2122,135421197,1.54063176818906
HOP-62,136227924,3.3249367186884564
T24,10296883,4.197604631060403
NCI-H1838,9935249,3.7675840247786248
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125
SNU-668,11152667,-1.5637713827568929
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
NCI-H1838,10322450,3.614692228512862
HT-144,9911463,4.304760863766968
Yamato-SS,136227924,3.1022512927874444
L-363,73707386,2.44874868394157
HCC366,9926054,2.0580421664352513
SNU-738,3465537,3.666758159287323
Hs 746.T,4378219,1.9535167500354071
KNS-62,selumetinib-vorinostat (8-1 mol-mol),2.7265872970297917
COR-L88,11404337,0.6108297700178786
SaOS-2,2746,3.4161371679978436
GP2d,11494412,0.0345645894259447
SNU-601,selumetinib-GDC-0941 (4-1 mol-mol),-0.2622654032095929
SW620,9926054,2.9151394622237823
Tm87-16,9868037,4.7880424925648715
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
JHUEM-3,2746,2.584117066729092
IGR-1,selumetinib-vorinostat (8-1 mol-mol),1.2502749786155671
TE-9,135984461,4.389815989870175
EN,10296883,4.0657206853664345
TYK-nu,650361,3.673575203480575
HCC2218,9884685,-1.464365341774582
SNU-1079,54618771,-1.146333378136814
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194
PF-382,73707386,2.646630293561946
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
NCI-H1092,10296883,3.8260798051213376
BL-70,135421197,0.854508793534898
HuNS1,11152667,-1.226453597215441
SNU-C2A,9915743,0.5240422710487646
NCI-H1915,11494412,3.124487070451525
OCI-Ly10,10296883,3.528234094962338
Panc 10.05,6918638,1.3073335951613236
HCC1428,4705,3.7350108144218983
U2OS,selumetinib-vorinostat (8-1 mol-mol),2.2777992346093945
NCI-H1650,10296883,4.859498077632093
SK-MM-2,1566236,0.3685804031223497
UACC-257,9915743,3.2321822894615546
COV362,9884685,-0.0915196949765083
SNU-503,135659046,5.578031724761291
IGR-37,4705,3.0869599188409658
NCI-H2342,9915743,3.0177583918562303
A-673,6918638,-0.1443248090306654
BT-16,1566236,4.246582335480924
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
SK-MEL-1,9868037,2.6521511264174493
NCI-H1651,selumetinib-GDC-0941 (4-1 mol-mol),2.159962931758626
DMS 53,3854666,0.9054182301635644
LS411N,9935249,3.5378716054356927
MKN74,6918638,1.410948460236771
BICR 56,1566236,3.6638637762846993
TC-71,65628,3.786909553172794
SCaBER,4705,0.4436742600385659
HLF,2746,3.261638353143838
HEC-6,JQ-1-carboplatin (1-1 mol-mol),1.897969075910313
KHM-1B,54639665,4.391144139421017
L-428,selumetinib-GDC-0941 (4-1 mol-mol),3.762194755166614
AsPC-1,136227924,3.2025742465891938
CMK,11404337,1.5948104345564638
SUP-HD1,JQ-1-carboplatin (1-1 mol-mol),1.2897139290826176
A-498,11494412,3.741733086313002
BT 187,10322450,6.076847615310279
JHH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.61874119121482
SCC-9,9926054,1.898935947612019
COLO 684,9884685,-2.257049363366989
SK-MEL-3,24771867,3.8427008859182625
NCI-H520,135659046,3.9949277821053704
NCI-H2286,135984461,2.8625340358152247
BT 286,135421197,2.331823163871174
Hs 729.T,9911463,4.317623145839552
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
L-428,11404337,-1.5944494988953837
OVTOKO,100016,8.078720974707625
Panc 03.27,71751553,4.542100190957626
ECC10,24771867,-2.5080909522055785
NCI-H1299,3854666,3.0957339105974766
NCI-H2170,6918638,0.3062237011393727
SK-N-FI,54618771,1.4169008036751305
A4/Fukuda,11494412,-1.359408079628026
647V,11152667,-0.9997029322393228
Rh41,73707386,2.6001924678488684
AsPC-1,11404337,0.3809720735493328
RS4;11,9884685,-0.8130311792767286
DBTRG-05MG,selumetinib-GDC-0941 (4-1 mol-mol),1.9211216865971592
SNU-C1,44241473,4.563213794647544
HT-55,4705,2.5986536735617833
CA46,11152667,-1.1506421067609531
KMS-11,12003241,-2.8887213513956147
MeWo,135421197,1.5459550604441452
BT 422,135421197,2.465319301073433
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
RKN,1566236,1.687441004968786
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
KLE,54618305,4.289261640342655
NCI-H1734,9935249,3.3895147226281037
SNU-685,selumetinib-GDC-0941 (4-1 mol-mol),4.064777169332982
VMRC-LCD,136227924,2.9641387298533868
DMS 454,10296883,3.765531757081873
NCI-H1651,9926054,1.9046490097522224
BT 239,9935249,0.5202539451214898
OAW42,11404337,-0.3833970130425348
Hs 940.T,135659046,5.2418708204303615
SNU-C1,54618305,4.256785506246939
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
SNU-16,24779724,4.843312236489717
Namalwa,10322450,3.877307531453308
FU-OV-1,9884685,-0.2158788705773567
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
CAL-33,4705,1.086643830288211
NCI-H1650,11404337,0.7802522611526345
Pfeiffer,11404337,-3.375841294616924
BT 187,1566236,2.9307051706234986
HEC-265,3854666,1.062389994601968
NCI-H2106,9911463,3.3350071984194356
SNU-398,selumetinib-vorinostat (8-1 mol-mol),2.491417659337193
L-540,73707386,3.020953643715912
NCI-H1694,136227924,2.5297757130143887
CMK,9911463,3.4147490124520075
OE19,11152667,0.6464409394196118
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926
VCaP,4705,2.864443182344748
ESS-1,9911463,4.377027533841143
KE-37,9915743,-1.0787732351752954
NCI-H520,9884685,-1.9980015448993624
CW-2,54639665,-0.4017445704850298
SK-N-DZ,1566236,1.6850106257935773
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338
TE-15,9884685,1.0908801329755264
PaTu 8988s,24771867,5.513171941040546
RT-4,9915743,2.2914033994891847
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
HCC4006,9926054,1.7314546414063618
KMS-11,24771867,-1.3705876893517872
RVH-421,135659046,3.595946771540715
PK-1,9915743,1.3307464414908754
LXF 289,9926054,2.043368643335034
SNU-387,11152667,-0.6652185187285166
Hs 746.T,2742550,4.150215272270972
CAMA-1,11404337,0.4907502800478153
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
BICR 31,1566236,4.637821170940002
U-CH1,1566236,1.8876808469756592
Hs 822.T,24771867,4.696467905411859
COV434,JQ-1-carboplatin (1-1 mol-mol),2.068766497655691
TE-5,3465537,2.4658323956499526
HCC1143,11152667,-1.9901975183751028
BICR 6,136227924,2.7894508880651485
OC 314,11494412,-1.4137176616387894
U-251MG,3465537,2.0313719983720633
SUIT-2,136227924,3.4861054974924133
PSN1,selumetinib-GDC-0941 (4-1 mol-mol),0.7617880642657375
Panc 02.03,9926054,1.881153725115377
BT 359,2746,3.6241977126009206
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
JVM-3,11152667,-1.88724585820006
SNU-1105,12003241,-1.0789157776023728
OVTOKO,JQ-1-carboplatin (1-1 mol-mol),3.861822916435348
CL-11,4705,3.0893529529673347
PE/CA-PJ34 (clone C12),1566236,1.827252089315036
SK-BR-3,65628,3.766479538164496
SCaBER,100016,6.423492154596734
Kuramochi,9926054,1.9908985756300632
SK-N-DZ,3854666,0.4650532665078188
YH-13,12003241,-0.7443010060517422
U-CH1,3854666,3.825404484943735
COLO 792,9884685,-0.452379287079953
G-401,9884685,-1.463173781220529
UACC-257,4705,3.5446001139477197
SF126,4378219,3.4604158552319824
SW1417,54618305,5.216526082263956
HCC2279,11152667,0.2450924496054455
UACC-812,9915743,-6.921665690083625
JM-1,10322450,2.576608882705072
OCI-AML-3,135984461,4.624808466912499
CA46,100016,3.773189878640827
CAL-78,9911463,4.373353120464338
42-MG-BA,40482356,5.136900518735085
HuH-6,9935249,3.1892050642519756
Rh30,135421197,2.937313489864044
HOS,11404337,-1.3499027331466464
REC-1,12003241,3.6312404592907614
HCC2218,1566236,1.7509931914659491
RKN,9911463,4.114615883902867
HCC2218,9911463,3.007199101123831
TT2609-C02,11152667,0.559349969972072
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
AML-193,135421197,0.7876033807150744
G-292 clone A141B1,135398744,6.65861915049708
NCO2,9884685,1.5735117508455894
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
LS123,2742550,5.908804831704125
HEC-1-B,selumetinib-vorinostat (8-1 mol-mol),2.5148214875762687
HEC-251,9935249,3.6457865673090097
SNU-478,selumetinib-vorinostat (8-1 mol-mol),0.1819467823622978
BICR 6,9935249,3.132544852482652
WM983B,1566236,4.024003638692175
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
F-36P,136227924,2.476842028434826
HuP-T3,4705,2.7233440783632608
Lu-65,JQ-1-carboplatin (1-1 mol-mol),1.9478415319376168
DMS 53,JQ-1-carboplatin (1-1 mol-mol),-0.3265365150884423
HCC38,11494412,0.4416317556150596
RVH-421,71751553,4.673213631952434
BFTC-905,12003241,-0.5086689742708943
COLO 829,selumetinib-vorinostat (8-1 mol-mol),0.6653479490850627
HCC44,24771867,0.19594120930994
BT 330,2746,4.080308483434876
23132/87,136227924,2.929197271565677
Malme-3M,3465537,2.4992243131735656
Lu-65,2746,3.448286012693329
EHEB,135421197,1.2947733633872678
NCI-H647,3854666,2.4207197319409595
PF-382,9926054,1.6899693166343082
SK-N-DZ,selumetinib-GDC-0941 (4-1 mol-mol),1.1652159438027232
HSC-4,2742550,4.46855499399167
Panc 08.13,11494412,2.7627448463572177
SF539,2742550,3.134990737020823
EJM,selumetinib-vorinostat (8-1 mol-mol),1.9565276246961512
SK-N-SH,11404337,-0.9981993214283256
CGTH-W-1,JQ-1-carboplatin (1-1 mol-mol),2.382639318925406
NH-6,135659046,3.541103193914359
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
DMS 454,3854666,-1.2678102747277342
HPB-ALL,100016,7.357554409535215
HuH-1,9915743,2.131122478495969
Hs 944.T,9884685,2.467648358367301
SYO-1,71751553,4.299871511856913
NCI-H1703,JQ-1-carboplatin (1-1 mol-mol),1.5748995560231345
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
SH-10-TC,10296883,4.6565479517394355
TTC-709,6918638,1.4201492579902153
PC-14,54618305,4.281679623383799
HCC95,selumetinib-vorinostat (8-1 mol-mol),3.641120192013373
Hs 888.Lu,11152667,-0.35178931009223
WM88,10296883,3.749160769987803
NCI-H322,100016,6.362238943247445
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
WM983B,selumetinib-vorinostat (8-1 mol-mol),-1.7225741889279806
HCC1588,9926054,1.7105432403142011
IM95,11494412,0.4524692193792306
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
KM12,54618771,2.3555448487565247
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
M-07e,4378219,4.605552786777074
MG-63,4705,3.9801982101515825
KMS-11,135984461,2.862381632910091
JM-1,11152667,-1.617053586455527
LCLC-97TM1,3854666,0.8191923722369518
SUP-B15,49836020,5.289684304949365
PaTu 8988t,9911463,4.367264855700764
RS4;11,2742550,3.863093603163464
JHUEM-3,9915743,-0.9592300023642776
JHH-1,135421197,1.7316230199472116
FaDu,9935249,3.0876333613815623
SNU-119,135421197,4.049091304293704
C2BBe1,9915743,2.975671813944452
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
RPMI-8226,24771867,-0.4837782228963089
T3M-10,2746,5.219719103110665
Ci-1,2742550,3.4067893087019785
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
TE-15,135421197,1.6096072932868513
Hs 611.T,2742550,3.744335328422511
HEC-265,49836020,-5.012817345393805
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
SNU-503,6918638,0.4427810712385108
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
M-07e,JQ-1-carboplatin (1-1 mol-mol),-0.796008398970337
NCI-H716,135398744,6.457168364956761
SNU-886,11152667,-0.5084903707284607
EKVX,9935249,2.6667854349625566
BT 416,JQ-1-carboplatin (1-1 mol-mol),0.4698269492624847
RD,11404337,-1.7858539381850014
COLO 201,100016,6.515418099212221
253J,10322450,3.648031599175377
TC-71,1566236,1.8045860018031188
HMC-1-8,12003241,-0.3368702938294806
TE-15,10322450,3.2140192626835313
KALS-1,2742550,5.776257078576174
EFO-27,11152667,1.7712187839859168
NCI-H460,1566236,4.3513012021592505
HeLa,9915743,4.03760238390019
BICR 6,9911463,4.323874314228029
NCI-H522,10296883,3.751667506317718
Ri-1,12003241,-5.9425936829646435
SNU-1272,selumetinib-vorinostat (8-1 mol-mol),4.048227486527485
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
Capan-1,135659046,4.622208259682843
TTC-709,11404337,-1.0402819998142765
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
CAL-12T,54618771,2.0833735357091077
NALM-6,10322450,2.9761732504638103
SUP-HD1,44241473,5.893628301047623
NCI-H1184,135421197,-1.5924558307630432
SNB-75,3854666,4.127790081674319
MCAS,4378219,2.0291292173835993
RKO,9915743,2.8851858618766957
SNB-75,9935249,3.3000208836374245
HuG1-N,135398744,6.4115232793077235
KMS-18,9915743,2.162276720334097
Ki-JK,11404337,-1.0273669041089517
Hs 852.T,54618305,4.90334205576894
NCI-H2170,selumetinib-GDC-0941 (4-1 mol-mol),2.2424418004959654
Ci-1,135659046,3.670902573768625
SNU-1214,54618771,-0.4857643216446591
OV56,selumetinib-vorinostat (8-1 mol-mol),4.726313652324262
NCI-H1975,9915743,-3.928107410623461
Karpas-299,135984461,4.585524824228754
BT 482,135421197,2.625315115733885
M-07e,100016,5.065678373530031
HCC1569,JQ-1-carboplatin (1-1 mol-mol),1.570304655964314
OCI-Ly19,9935249,-0.0089677509466631
EJM,9926054,1.7534790705740089
BT 232,selumetinib-vorinostat (8-1 mol-mol),2.9524508630620554
SNU-738,12003241,0.0747510600230264
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
HEL,136227924,2.725456875957553
Hs 611.T,24771867,0.1006087367285268
Peer,3854666,0.4917924912491418
NCI-H647,4378219,6.350983381036
DU145,9911463,4.064467262158392
WM266-4,9935249,2.973624182923004
JM-1,9884685,0.5602575931973728
CGTH-W-1,49836020,5.717814266829885
647V,9935249,3.25283943928746
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
NCI-H1915,3465537,2.421496271137385
MeWo,11494412,0.7893375124921355
Panc 03.27,11494412,0.9108991016924464
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
HT-1376,100016,4.270787672820572
NCI-H2452,4378219,4.095695943124218
LS123,3854666,4.134120711084662
SW579,135421197,1.841394745286318
Kelly,73707386,3.676841116050576
Karpas-299,4378219,1.8476477170643033
KMS-18,54639665,4.4302920956465055
Calu-3,76446078,4.226816856102675
COR-L51,135659046,3.365467483108773
BxPC-3,11404337,-0.6361724208993981
NCI-H1563,selumetinib-vorinostat (8-1 mol-mol),4.426949691687728
BT 224,135421197,2.656676342588309
LN-229,44487872,4.461552485906766
UM-UC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.321826526721954
MEC-1,3465537,1.2385420929167623
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
SNU-668,9926054,1.9494933006011008
OCI-AML-2,9911463,2.4773286761058992
NCI-H1573,12003241,0.8925202340822594
L3.3,3854666,3.761529361474975
MOTN-1,9926054,1.7711575511093696
ZR-75-1,2746,4.074441390340067
TE-11,2746,3.705466590750396
SK-MEL-1,JQ-1-carboplatin (1-1 mol-mol),3.273117082595556
253J-BV,2742550,2.542605823634484
HDLM-2,9926054,1.2404831446966105
NCI-H1703,100016,6.215140096774371
ES-2,135398744,8.06870751291861
JHH-6,11404337,1.87275396496971
OV-90,54618771,1.0119398680970997
OCI-AML-3,4705,3.3295764443297475
B-CPAP,4378219,2.1409307713074353
FTC-133,135398744,6.510037604259866
HCT 8,selumetinib-GDC-0941 (4-1 mol-mol),2.0495496026415307
ESS-1,100016,6.502595194480242
KE-37,135421197,0.0656333668327355
Pfeiffer,11152667,-5.003109172861117
253J-BV,3854666,1.39668141347677
HEC-265,JQ-1-carboplatin (1-1 mol-mol),0.3590363949507987
NCI-H647,11404337,-0.2592601702494094
SH-10-TC,9911463,4.344994867688331
HCC1438,4705,3.126117336231009
HD-MY-Z,54618771,0.9859939173589182
LK-2,4705,3.2443649801870382
NCI-H1703,135984461,4.378199750715437
Raji,11152667,-1.6469558196734089
SUP-HD1,9915743,0.8948687265051912
NCI-H1339,11404337,0.2277853658172252
LOX-IMVI,6918638,-0.3729962449079992
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
NUGC-4,3854666,3.7030088458950914
Toledo,1566236,1.5557950289614797
Mino,100016,3.8828597807205023
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
TALL-1 [Human adult T-ALL],9884685,0.4782618464268887
HCC1500,11152667,3.4439033763408644
GaMG,4705,3.2307282924763845
BT 444,24779724,4.4459296914982565
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
TALL-1 [Human adult T-ALL],JQ-1-carboplatin (1-1 mol-mol),-0.5352778858852548
COLO 741,9915743,3.842124253309565
SNU-407,selumetinib-vorinostat (8-1 mol-mol),0.751458580891734
SNU-216,11494412,1.6343036804588515
HT,11404337,-1.0705366474134053
A-253,135984461,4.591715883678831
M059K,71751553,4.748260141833626
OCI-Ly19,12003241,-2.2360327877915545
NCI-H716,9915743,1.329215193121519
NCI-H1155,3854666,0.3602876365703957
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
COLO 668,100016,7.809114037996309
SNU-5,9935249,3.5189415375312696
SF539,11152667,-2.173581814614824
HuT 78,9935249,1.327110293574704
KP-N-YN,136227924,3.0572578369433376
SNU-449,54618305,4.668068655096509
SNU-503,12003241,-0.772187364196845
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
NCI-H2085,12003241,-2.8100927731995924
SU-DHL-1,10322450,2.9485372728674473
GDM-1,11404337,-0.1697685825330185
HL-60,12003241,-0.948434817183572
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
VMRC-RCZ,11152667,0.1024224557486136
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SNU-119,11404337,-0.1265251374759644
KMS-21-BM,11152667,-1.593157926365923
KYSE-30,11404337,-1.4511722042502642
HT,selumetinib-vorinostat (8-1 mol-mol),2.368663443065234
DU4475,6918638,-1.1708823120268763
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
KP-2,4705,3.822790950107379
NCI-H650,selumetinib-GDC-0941 (4-1 mol-mol),1.2489714260088474
Hs 852.T,2746,1.815262794144644
HuP-T4,24771867,1.5723502348856364
SK-N-SH,71751553,4.86546041028893
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776
JeKo-1,4705,3.398339905986335
SNU-1,135421197,1.7958722609417297
HCT 15,54618771,1.4400117592771968
LoVo,135421197,2.0078610802467307
NCI-H1339,9911463,4.3916675652750925
DB,JQ-1-carboplatin (1-1 mol-mol),-0.32501810171376
IMR-32,135984461,1.157056096731398
KYSE-520,136227924,3.1208401396418592
MM1.S,selumetinib-vorinostat (8-1 mol-mol),1.8050138059594567
SUP-T1,100016,6.229647258472745
HCC1588,12003241,-0.4884151161938169
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
BT 245,9884685,1.0158676742482895
JHH-5,selumetinib-GDC-0941 (4-1 mol-mol),1.0650507170556407
OE19,135421197,2.291572889832539
NCI-H2452,54618771,2.226699645078912
5637,135984461,2.794564016216432
OCI-Ly10,selumetinib-GDC-0941 (4-1 mol-mol),1.0181444461611715
TE 617.T,6918638,0.5415631808582457
KE-97,54639665,4.464069438264846
HMC-1-8,JQ-1-carboplatin (1-1 mol-mol),2.246629703835433
Hs 578Bst,71751553,5.4091919490870435
RD,54618771,0.0144347314731342
RERF-LC-MS,9926054,1.8051014319834384
NCI-H2170,100016,6.477443817994488
MDA-MB-435S,selumetinib-vorinostat (8-1 mol-mol),2.4592117826855193
BT 422,24779724,4.448897225717868
42-MG-BA,9935249,2.8954336270636576
OCI-M1,9911463,3.27082780782835
Pfeiffer,9911463,2.288637526190458
COLO 668,24771867,4.589409157390178
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
Hep 3B2.1-7,9915743,1.8474397407384695
HLF,6918638,1.351490313619424
Lu-99,2742550,4.2970950808030715
SW1573,9926054,3.1618263718643513
HSC-4,24779724,5.454925638847944
BT 504,54618305,4.42433904701444
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
KMS-34,54618771,-0.7533215739464646
CAL-62,100016,6.567555445612565
MDA-MB-157,4378219,2.6716514190617104
SNU-C1,selumetinib-GDC-0941 (4-1 mol-mol),-7.034120569721028
BV-173,JQ-1-carboplatin (1-1 mol-mol),-0.3456077598653477
NCI-H1792,135421197,1.9377775784144329
L-363,9911463,3.9565669957446423
NCI-H28,2742550,3.992303917650692
Mel Ho,selumetinib-GDC-0941 (4-1 mol-mol),-1.3923525506877812
KMS-34,2742550,2.8353380812727416
RPMI-6666,9926054,1.733679521146624
HuH-28,49836020,4.5831032591173635
Capan-1,9926054,1.8783300658857656
NCI-H1703,12003241,-1.7949432370006393
HeLa,12003241,1.4760559160729645
CAL-78,9884685,-1.1065576377776678
HCC78,135421197,2.5201678114483683
JHH-1,11494412,1.1358911008605377
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706
COLO 668,4378219,2.009703963358555
ME-1 [Human leukemia],54618771,1.2979456738996673
COV434,9926054,1.0674163383843658
HEC-265,135421197,3.07473850340402
SNU-1041,11152667,-0.085013189644464
HCC15,76446078,6.244123044550032
MKN74,650361,3.7860453637514953
DK-MG,1566236,1.8656983972525785
UACC-257,4378219,2.6274874430103208
JMSU-1,9935249,2.904229608980848
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
SNU-C5,135659046,3.5746931112208853
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
HGC-27,135421197,0.8927042884556606
KO52,9926054,1.7676529122170044
23132/87,9935249,3.409197898421799
IMR-32,71751553,0.2380209164457374
SU-DHL-1,49836020,5.336381428124731
PE/CA-PJ49,9911463,4.148173895384107
ChaGo-K-1,1566236,2.038584840253616
SNU-C4,6918638,1.4968948752394289
CCF-STTG1,10296883,4.282837475963798
42-MG-BA,2742550,4.771377551035741
EKVX,135659046,3.5210765242905304
RCH-ACV,24771867,-2.4514427268817633
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
MOTN-1,3854666,0.5699425367736352
SUP-HD1,1566236,0.9887534979431616
TE-14,4705,1.5857323028822543
REC-1,10296883,4.285765558435674
HEC-1-B,135421197,1.3262919275478138
A-204,1566236,1.9335732426445524
SK-N-BE(2),135398744,6.372852995200929
NCI-H1573,selumetinib-GDC-0941 (4-1 mol-mol),-0.038011367109904
HCT 8,9935249,3.19275811412893
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
CAL-148,100016,6.461133409351435
NCI-H841,9884685,0.3344171331513928
Lu-65,11152667,-1.8224670022620897
EHEB,135984461,4.428627188495882
TF-1,9926054,1.8165915475907757
TE-15,11404337,-0.7391616924820064
RCH-ACV,100016,4.052738843081589
KYM-1,3854666,0.6296388431851128
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
TYK-nu,2742550,3.415381611681683
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
COLO 792,2746,4.014850740160219
5637,selumetinib-vorinostat (8-1 mol-mol),2.341102350030954
SNU-1033,65628,4.326862310201289
CJM [Human melanoma],selumetinib-GDC-0941 (4-1 mol-mol),2.04616975422909
KP-N-YN,54618771,4.352699986589353
CFPAC-1,11152667,-0.7440904943214312
PE/CA-PJ41 (clone D2),65628,4.385016080496858
NCI-H2085,9935249,3.511786264079395
NCI-H2030,100016,6.672614959068411
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
WM88,71751553,5.868796186292424
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
PaTu 8988s,2742550,4.064177152940504
SK-MES-1,49836020,5.814503877703118
BT-549,12003241,-0.9663956127583828
HOP-62,9884685,0.5036019018396981
5637,54618771,0.8259357118151949
NCI-H1373,11152667,0.0475707209909377
AN3-CA,9915743,2.510213815091878
BT-474,selumetinib-vorinostat (8-1 mol-mol),2.752458488334215
COLO 678,selumetinib-GDC-0941 (4-1 mol-mol),0.6470701140991139
LK-2,9911463,3.718268646522675
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
SNU-1076,selumetinib-GDC-0941 (4-1 mol-mol),-0.5128697942190128
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
TE-11,12003241,-1.4991757511197057
SW1271,54618771,-0.1319273231055389
TE-14,1566236,3.7463982876900177
CAL-27,11152667,-1.1570264921906133
GA-10,135984461,1.4208058611129633
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
NCI-H2009,9935249,4.414461781647313
SW1088,54618771,1.1113850453219438
NCI-H1339,11152667,-1.000017899668529
GP2d,9915743,-1.6456174019811347
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
COR-L279,9884685,-1.0321126972364183
KYSE-150,9926054,2.2758457773041645
Raji,3854666,1.2627673053798778
Caki-1,3854666,3.843299414220747
FaDu,1566236,1.9343580286240425
GSS,100016,3.718199006522657
Hs 746.T,71751553,4.777780100201024
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
NCI-H1581,135421197,1.183263993717128
Hs 746.T,11404337,-0.7817772551225204
G-292 clone A141B1,9884685,-1.2189697169963245
HuG1-N,4705,3.1646359507228623
KMRC-20,9926054,2.16526453404653
RPMI-7951,4378219,1.8029418546764064
TE-14,9935249,3.117284410933106
IPC-298,12003241,-0.6695697613758284
SJSA-1,2746,5.233978868985217
JVM-3,2742550,3.0127935695747023
MIA PaCa-2,9926054,1.823118001934022
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
SW948,135984461,4.375312800732864
COLO 320,11404337,-1.0914685328703808
GaMG,3854666,1.9172841085475143
NB1,selumetinib-vorinostat (8-1 mol-mol),2.4657686582204255
AML-193,100016,3.9854178308912074
Karpas-422,71751553,4.158262906049952
NU-DHL-1,9935249,0.0276338554577939
IM95,76446078,4.158274021550121
SNU-16,136227331,3.664519264936635
Sq-1,24771867,3.131914604322549
OCI-Ly19,24771867,-2.0931519719269094
LK-2,2746,3.266884411488981
TE-4,selumetinib-GDC-0941 (4-1 mol-mol),0.9436267923396215
KE-97,selumetinib-GDC-0941 (4-1 mol-mol),2.3217302036143295
DLD-1,11404337,-0.813522825038391
A-375,selumetinib-vorinostat (8-1 mol-mol),1.9790131702817335
Panc 03.27,9884685,1.4792691761795522
Karpas-620,9911463,4.471669059123084
COR-L51,9926054,1.8572799108466955
BC-3C,9915743,1.1334859275806484
RS4;11,9868037,1.846875847822728
KMS-26,54618305,4.443948888927761
IGR-37,9884685,1.000968603362932
MDA-MB-468,9884685,0.4433272557303077
LCLC-103H,135421197,1.2256317024766628
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
SW982,selumetinib-vorinostat (8-1 mol-mol),2.9958400585589926
DV-90,650361,4.027920817519659
SNU-81,44494148,1.061827805146114
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
EFE-184,9926054,2.5194211419802723
Namalwa,100016,3.934978584241161
YD-38,100016,6.21667674155364
TE 441.T,JQ-1-carboplatin (1-1 mol-mol),3.6275074638677465
EJM,49836020,4.362565190709962
MKN7,10296883,4.147888797827488
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
Granta-519,9915743,0.9460784198503543
YD-8,9911463,3.690343271752708
SUP-T1,24771867,-1.7526538791604511
NCI-H69,135421197,1.0126694729048382
CAS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.9599714674157864
ChaGo-K-1,9911463,3.7968497419655094
MKN1,3854666,3.3252090270596777
AGS,65628,4.4065157996976945
LAMA-84,3854666,0.7757174142172463
LAMA-84,selumetinib-vorinostat (8-1 mol-mol),0.1963960485996854
COV362,24779724,4.394288527377943
A-549,100016,7.181380121169662
EJM,11494412,-0.937899289743814
MPP 89,selumetinib-GDC-0941 (4-1 mol-mol),2.3167615576876734
OV-90,71751553,4.590877608444182
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
C2BBe1,2742550,3.0977711517053153
COV362,4705,3.5601253805360975
SUP-M2,12003241,0.982076040273681
UM-UC-3,24771867,3.926917338822868
SF268,9926054,1.8343424406702535
SU-DHL-1,135984461,1.9491307161872016
HL-60,135421197,1.9226353151764572
IA-LM,6918638,0.61198230609435
DU145,135659046,3.5568052359419604
SET-2,12003241,-1.37504024910663
HCC2279,54618771,-0.3569311345677481
KYSE-140,135421197,1.0055598212916683
HEC-151,4378219,2.401235967325108
Peer,136227924,2.1160969435978303
VCaP,9911463,3.952912743808643
CA46,6918638,-2.155597959241919
697,9884685,-1.5792659034584708
CMK,9935249,0.8813974275498553
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815
L-363,10296883,3.350566136289887
Hep 3B2.1-7,9935249,3.6352240530651008
HeLa,11494412,0.2354090887840819
OC 314,2746,3.4168775378472893
TE-15,54618771,1.8265153099983404
NCI-H1184,9915743,0.6883439734891695
AsPC-1,136227924,3.2025742465891938
SNU-1066,9935249,5.759446428936507
K029AX,9926054,1.886633217948548
JHH-1,2742550,4.071570054771418
KP-2,2746,4.5923372847517765
BT-549,71751553,4.2471267374516435
SCC-25,selumetinib-vorinostat (8-1 mol-mol),1.0923234996305136
KNS-62,2746,3.88205889014037
PE/CA-PJ41 (clone D2),10296883,4.236451814997899
KMS-34,JQ-1-carboplatin (1-1 mol-mol),-0.8418856206446907
NCI-H1563,JQ-1-carboplatin (1-1 mol-mol),4.5120553214981625
NCI-H2052,100016,6.8923960055757805
NCI-H1651,9911463,4.060056657134865
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
BT 172,9926054,1.8062475080252252
TE-6,9884685,1.4847603304489934
NCC-StC-K140,100016,6.431860837963816
HuNS1,3854666,0.1228986912397878
NCI-H2444,9926054,0.9505376631945008
CAL-54,71751553,3.8387639169926326
CAL-27,JQ-1-carboplatin (1-1 mol-mol),1.5591369487847715
PC-14,3854666,0.2934048653754776
WSU-DLCL2,135984461,1.5451272149334774
Pfeiffer,1566236,0.9583867480822434
A-204,4705,2.732319737517574
NCI-H1563,11404337,1.575154147256652
KMRC-20,54618771,1.1098897337437623
Hs 294T,10322450,5.012803504486345
AU565,71751553,3.982904849419344
Hs 766T,65628,4.740759619513126
OE19,135984461,5.542264217224972
NCI-H446,135984461,1.479932164265367
MDA-MB-157,11152667,0.7570225590856333
HCC1954,73707386,2.4821792049497824
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
RCC10RGB,9911463,4.415558893727306
NCI-H1385,1566236,1.8640603152545463
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
8505C,9915743,3.019446627889447
L-363,3854666,1.384061455726828
SK-MM-2,2746,0.987120657113426
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193
BV-173,100016,4.070459829867503
MOLT-16,9935249,1.302591205382856
TTC-709,9868037,3.9116830012775816
SUP-T1,135984461,2.153486266323967
A-253,selumetinib-GDC-0941 (4-1 mol-mol),2.2204781544732284
KMS-27,44241473,4.927559459703403
NCI-H23,135984461,4.675725917601218
WT2-iPS,12003241,-2.3723982156624057
OUMS-23,JQ-1-carboplatin (1-1 mol-mol),4.676027552287151
HEY A8,selumetinib-GDC-0941 (4-1 mol-mol),1.3817126396854498
SNU-1079,135421197,1.0783376836912564
Hs 729.T,11404337,-0.1228627032694511
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
A-204,JQ-1-carboplatin (1-1 mol-mol),0.2793211134785925
SYO-1,9915743,2.525873666544599
MOLM-6,JQ-1-carboplatin (1-1 mol-mol),0.2604997389910982
NCI-H889,selumetinib-vorinostat (8-1 mol-mol),2.358779197358101
BT-20,100016,6.680150665921765
KNS-60,135659046,3.5033473079997273
SF539,54618771,0.9520052550930058
JHH-5,11404337,-1.7016316561461169
SF539,selumetinib-vorinostat (8-1 mol-mol),3.0121970622277248
CJM [Human melanoma],6918638,1.423162618874033
JeKo-1,9884685,1.0765625898866802
SNU-61,9926054,1.8929452670989917
MHH-CALL-3,65628,0.4360080488789846
HCC1438,11404337,0.7174449174884908
HuP-T4,54618771,-0.0993332629416019
JHOS-2,3854666,3.9223909271833546
SK-LMS-1,54618305,4.344599681263995
RVH-421,12003241,-1.8374248826372317
OCI-Ly10,65628,4.9673691925811685
EFO-21,135984461,3.9887102664802807
KP-4,3854666,1.6469581431730445
OCI-Ly3,6918638,-1.72449157217465
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
MOLM-13,4378219,1.3750720877022855
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
HEC-1-B,11152667,-1.21106376639031
SNU-449,9935249,2.650976699885872
TCC-Pan2,selumetinib-GDC-0941 (4-1 mol-mol),0.1470991216405226
HT-55,12003241,-0.758438477023311
Kasumi-2,71751553,4.151047970892257
HCC1395,3854666,1.6089767843252074
NCI-H524,11404337,-1.0230582740337757
A2780,9884685,-1.5939943621043984
TALL-1 [Human adult T-ALL],9868037,2.0698659893863884
SK-MEL-5,9935249,4.115682360197781
JK-1,JQ-1-carboplatin (1-1 mol-mol),0.4843297170939055
8505C,135421197,0.9629586989681284
Ci-1,11494412,0.5037895866991277
SK-BR-3,49836020,6.022467534114696
CCK-81,9935249,2.2164809803205703
UM-UC-1,135659046,3.598030387266929
769-P,9935249,3.642920837160134
JHH-4,9915743,1.3813494338537873
NCI-H1373,100016,4.430083600999957
JL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.640014576160969
BT 248,4705,2.6318547262793386
SW1710,9926054,2.792354936189826
SNU-182,11404337,-2.4504456684550475
SK-ES-1,71751553,4.362311909689851
EPLC-272H,135984461,4.356023711246228
BT 231,54618771,0.7922646437361874
SCaBER,9911463,4.265148583814743
T84,9935249,1.8419022966508296
YH-13,9915743,2.529803461221303
BT 231,135421197,1.0763175924586934
TE-6,2746,2.631645333531432
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
TE-8,135984461,3.955481797487968
Mino,9911463,2.4278795242831253
Yamato-SS,9884685,-1.879911266317303
BT 330,3854666,1.6927657875958029
COV644,3854666,1.1187746024873992
SK-BR-3,9926054,1.6318008391907537
SK-MEL-3,4705,2.152547921158096
NCI-H647,9926054,1.878907234482811
Panc 05.04,3854666,4.206759252182565
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
NCI-H226,9935249,4.613737226682963
NCI-H2170,9911463,3.949150680542003
WM793,11404337,-0.7690985454206903
NCI-N87,65628,4.009039012864223
YD-10B,135421197,0.9932980294986136
LS123,selumetinib-vorinostat (8-1 mol-mol),1.989623849791832
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
22Rv1,10322450,3.5094460128480987
RD,135421197,3.4107276707770864
B-CPAP,9911463,3.799628401356715
OVCAR-8,24771867,3.789669548956352
OCI-M1,100016,6.862784368685653
MFE-296,6918638,1.6270992147424843
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
ESS-1,54618771,1.2318880484657342
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951
NCI-H929,100016,3.8135603062591
THP-1,136227924,2.5094113505430737
ECC10,9884685,-0.6725691061854394
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
KMS-27,12003241,-0.3161890721272481
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
BT 498,135421197,2.801881228152874
MDA-MB-468,9915743,-0.4692748619853074
U266B1,9911463,4.2942847065196394
SUP-B15,selumetinib-vorinostat (8-1 mol-mol),0.2663315428977156
LC-1/sq-SF,11404337,-0.155620091081562
RERF-LC-MS,135984461,4.284403636339015
Peer,4378219,1.9350365007690764
BT 440,49836020,4.914023334980662
NCI-H2444,11404337,-1.49307136407969
BT 428,11152667,-0.1216773247617757
SCC-9,3854666,1.6335835525169635
Karpas-620,100016,5.312019885835398
OVK18,100016,6.632788488948234
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
PE/CA-PJ34 (clone C12),24771867,1.6845259930692984
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
23132/87,100016,5.572734576179291
RS4;11,135984461,1.068681958562837
NCI-H1915,71751553,4.285363115702843
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
2004,JQ-1-carboplatin (1-1 mol-mol),0.7466571410916254
CMK,6918638,-1.0640278448730467
A101D,9911463,4.385774367797012
NCI-H1299,selumetinib-vorinostat (8-1 mol-mol),3.816207733314422
HT-55,9911463,3.2790943482968986
HCC1419,12003241,0.329008083865116
TE 441.T,24779724,4.334447186977638
RD,3854666,0.8250746000487614
RKN,73707386,3.296207724675486
SW620,65628,4.413668799796276
SNG-M,selumetinib-GDC-0941 (4-1 mol-mol),2.713078980516464
MIA PaCa-2,136227924,2.1731844460154743
F-36P,6918638,-0.9703997893287856
CAS-1,3465537,2.4572660302658607
OCI-AML-3,1566236,1.4852754357905558
D283 Med,100016,3.728925578699804
Hs 822.T,135659046,5.0235627389760715
NCI-H1341,65628,3.962003306488367
SK-N-SH,65628,2.1902058343213655
SCaBER,1566236,1.7257780630033532
NCI-H1703,49836020,-2.068142260286603
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
HCT 8,JQ-1-carboplatin (1-1 mol-mol),1.4638248293100051
RS4;11,9935249,2.6128847525207735
TT2609-C02,135659046,5.602741752641771
KCL-22,9935249,3.2284716714967296
IGROV-1,135398744,6.402844237905131
KHM-1B,135984461,4.335909278526869
SNU-61,2742550,3.576212598776706
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
IM95,JQ-1-carboplatin (1-1 mol-mol),0.9463817139870012
SNU-182,73707386,2.6235662481878146
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
RD,100016,6.5954800872388155
NCI-H2171,1566236,1.862945078393334
SK-N-BE(2),11152667,0.2196247397695578
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
MFE-296,selumetinib-GDC-0941 (4-1 mol-mol),2.628937371578258
Karpas-422,54618771,1.0964695949683176
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
SK-ES-1,2746,2.7060210922441463
SNU-16,2742550,1.6766119862774724
Capan-1,JQ-1-carboplatin (1-1 mol-mol),2.2044130423038477
DMS 114,1566236,2.6045957348634956
SF268,3854666,1.8198409399657236
KYM-1,6918638,-0.4482897804277287
BT 340,9884685,2.0684109733399323
HEY A8,2746,3.567367579370524
Hs 683,65628,4.4952708080724495
IMR-32,54618771,0.9755251255632068
TE-6,135659046,3.478655108369394
KMRC-1,71751553,4.436686890494674
EBC-1,54618771,0.4501558342724816
BT 179,11494412,1.90608905728386
HCC1588,9911463,3.721403474338108
Rh30,136227331,4.257101028878693
HT-55,selumetinib-GDC-0941 (4-1 mol-mol),0.6831799344698409
JM-1,11494412,0.2153546786296628
OCI-Ly10,100016,6.418038918193145
WM88,9884685,-1.1119542466113133
A2780,4378219,4.7769256594107254
Mono-Mac-6,9868037,1.4226493594623044
SNU-840,54618771,2.041373861449483
NCI-H2052,9935249,4.043899917200753
PC-14,11152667,-3.213893550122198
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
SNU-423,9926054,1.7894708985292902
CAL-51,135659046,3.6035863494873137
NCI-H1184,54618771,1.2504018594222124
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JHH-4,11494412,-0.1349570760111059
DMS 114,3854666,0.9964134582157976
MIA PaCa-2,1566236,1.8703719885196528
SW1710,4378219,2.1785919207097515
NCI-H2052,11152667,-1.5494246316581135
MG-63,2746,4.323476175039674
Hs 888.T,135659046,3.9979664612811354
IGR-1,11494412,0.7039835706972326
SH-4,9911463,2.562813688525255
HuG1-N,100016,5.877444193140431
NCI-H2452,11404337,-0.3859535574072682
CAL-120,11404337,0.6916203737378318
L3.3,9926054,1.9335911906728165
KNS-62,9911463,4.346358947523489
COR-L105,24771867,3.297975412837562
SK-N-MC,9911463,2.6824462579046755
HCC202,11152667,-0.7446049793504876
MFE-296,4378219,4.638360133516321
HeLa,9926054,1.7615972318293558
DEL,10322450,3.0359282026720575
SNU-C5,2742550,4.034700516109946
Aska-SS,11404337,-0.8839501993376483
TCCSUP,100016,6.5110410318476575
SNU-478,24771867,3.5020514370718976
KYSE-140,136227924,3.3753020930843065
NCI-H1184,9926054,1.8119934997453773
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
OE19,selumetinib-vorinostat (8-1 mol-mol),4.06149932522275
PANC-1,4705,3.930019058376023
BT 239,9868037,2.51635002205042
PLC/PRF/5,11494412,2.4031877451972754
HCC1937,11404337,1.0839462166923302
L-363,12003241,0.3787290467646389
SW579,49836020,3.73786460957764
TYK-nu,10296883,3.5391236676051583
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
SK-LMS-1,12003241,-1.0710207153229787
HCC1195,11152667,0.1400980443335025
ALL-SIL,136227924,2.439460537978413
JeKo-1,54618771,0.9651230591785864
2004,selumetinib-GDC-0941 (4-1 mol-mol),4.378845407517423
MCAS,9884685,0.0580097672331096
RVH-421,9926054,1.6904251361057423
AN3-CA,11152667,-0.493921351954846
SK-N-BE(2),9926054,2.2939851330117413
HH [Human lymphoma],9915743,0.3869476104558722
SEM,135421197,0.5141119166667375
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017
NCI-H929,135421197,1.062377968485951
2004,136227924,1.8982400348113204
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
A-253,9884685,2.3107926636693907
NUGC-4,2742550,4.776949321673274
BT 333,11404337,-0.8508015694655927
Hs 895.T,4705,4.1293689798575794
GA-10,2746,0.7729221646050856
DU4475,9884685,-0.0580970001953044
ONCO-DG-1,135984461,4.389696319058022
ECC10,44241473,3.708077266510813
PaTu 8902,4705,3.6244040622068256
HEL 92.1.7,6918638,-1.1828451874252928
RL,100016,6.4335673885856135
LNCaP clone FGC,71751553,4.050545611826545
NCI-H460,136227924,3.925006850615035
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
Hs 611.T,2746,3.500782789021053
SNU-738,3854666,2.877216929749153
BL-70,9926054,1.763509439822291
EHEB,73707386,3.258970186799186
HCC2108,44241473,4.848973928948178
KMS-12-BM,135984461,1.7287315424792562
SF126,JQ-1-carboplatin (1-1 mol-mol),5.083897711074173
NCI-H2228,9926054,2.036678685605589
COLO 800,11152667,-1.2200838930089684
TM-31,6918638,1.2377309655221411
BT 239,12003241,-1.4894008844853184
NCI-H1975,selumetinib-GDC-0941 (4-1 mol-mol),-2.1756384403206326
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
TCC-Pan2,54618305,5.007378723744469
AGS,136227924,3.766909782373439
VM-CUB-1,selumetinib-vorinostat (8-1 mol-mol),2.483062987600528
LP-1,54618771,-0.0349126371834358
MJ,6918638,-0.2004138762975409
RPMI-8402,12003241,-0.4088888603650127
KG-1-C,JQ-1-carboplatin (1-1 mol-mol),1.591651516557658
A2780,3465537,2.6217509140821247
NCI-H1666,100016,7.086863626956854
TE-14,9911463,3.9221721376636816
CAL-27,11404337,-0.0180137116406381
NCI-H747,10322450,3.8486702496060463
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
SNU-478,44241473,4.778030052940461
SNU-685,2746,3.0176644885418056
TE-11,selumetinib-vorinostat (8-1 mol-mol),3.801977692651704
OCI-Ly19,49836020,4.441664761754026
SW1417,12003241,-2.0835943723769184
HCC202,11404337,1.6013031156862827
A3/Kawakami,6918638,-1.1948916865846906
OE19,selumetinib-GDC-0941 (4-1 mol-mol),2.914512652837311
SNU-1079,12003241,-2.81102043929997
OAW42,2742550,3.9256565797202776
SH-10-TC,12003241,1.4218324467353134
SNU-175,12003241,-1.252002444372071
NCI-H1944,2746,3.2082243372495354
KCL-22,9926054,1.5140986246434818
U266B1,11404337,-0.4739361104309206
Ci-1,2746,3.190931407467591
EJM,135659046,3.4058346184663693
KMS-34,selumetinib-GDC-0941 (4-1 mol-mol),0.0635053645557878
SW1710,135984461,3.1161178091197863
TE-4,selumetinib-vorinostat (8-1 mol-mol),1.7429676419494515
647V,11494412,0.9980508040818752
COV644,9911463,4.1377396171756144
MOLP-2,2746,2.18726921703514
LNCaP clone FGC,54618305,4.126133237949938
SNU-61,3854666,2.8565665342705735
HuP-T3,9926054,1.9266750805140576
SK-LU-1,4705,2.465937162773369
Panc 05.04,9935249,5.19537836182522
HCC4006,9935249,3.1496211616534273
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
OUMS-23,100016,6.512546818056364
EM-2,9868037,1.5238018435010934
CAL-51,2742550,4.689941422286605
BT 232,54618305,4.404663674911541
BT 444,11494412,4.738516696174284
GMS-10,10296883,4.265684683390355
HEC-59,3854666,1.7819501596078249
CAL-85-1,6918638,0.0860999805829631
Calu-1,71751553,5.536345694277309
BT 224,136227924,4.003699925469014
NCI-H28,selumetinib-GDC-0941 (4-1 mol-mol),0.00452428337889
253J,54618771,1.0062396076481863
OCI-AML-5,6918638,-0.9986415463571308
FaDu,24771867,3.891837806285879
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
KMS-20,3854666,0.6836854926820529
SU-DHL-8,9926054,1.545172236486763
NCI-H322,9926054,1.834077312686318
WM983B,3854666,2.4188126448912075
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
LOU-NH91,4705,2.8449970854381945
SW1353,3854666,1.0037118421292317
NCI-H1650,selumetinib-vorinostat (8-1 mol-mol),3.5739205665134466
786-O,2746,3.398389202890904
L-540,3854666,0.4369037772014328
SK-MEL-30,135421197,2.8284209456564025
BT 224,135398744,6.495060752655371
NCI-H2170,1566236,4.07378736868643
MKN7,54618771,2.9720813941878577
VMRC-RCZ,44241473,4.422908170779659
Hs 944.T,24771867,3.5803086410292946
HEC-151,24771867,2.9837344862982
BICR 18,JQ-1-carboplatin (1-1 mol-mol),0.3768377986008463
COLO 680N,136227924,3.1124323049819003
NCI-H211,11404337,-2.184886204882766
GDM-1,9911463,2.550889213910243
NCI-H929,9935249,2.217272904882535
MG-63,11152667,0.9825777114082088
ChaGo-K-1,2746,5.131732167485152
M-07e,11494412,-0.4352811650560824
ES-2,11152667,-1.0665874566143538
SaOS-2,11494412,0.4895123820960489
BT 330,11404337,-0.3310722205999429
BT 145,136227924,2.723434550490864
SK-N-BE(2),selumetinib-vorinostat (8-1 mol-mol),-0.8893758646967648
GDM-1,135421197,1.3394592190633656
SW1417,10296883,4.30591793322403
KYSE-180,9868037,4.629723429656334
KMS-21-BM,54618305,4.311138878515908
DMS 53,136227924,2.35473496791988
Hs 746.T,12003241,0.0057336203254279
U-251MG,71751553,5.496604209232847
CL-11,24771867,-2.7207930611795947
HSC-3,3854666,1.1819322162410355
NB4,9911463,3.3051650807142514
PL-21,9915743,0.5916230612831309
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777
MKN74,54618771,1.3558742291917982
Panc 05.04,54618305,4.5822328451886465
SNU-1214,54618305,4.749041864711717
GI-1,3854666,0.8777053912165353
NCI-H2452,54618305,4.302077073898344
U266B1,9915743,0.5964925492166065
KYSE-30,9868037,3.995382741587693
Hs 895.T,2742550,3.795003582218494
A2058,3854666,0.7864755506685932
RCH-ACV,12003241,-2.009657794147886
JHH-2,1566236,1.6731430194844064
WSU-DLCL2,136227924,1.92257757824623
BT 359,3465537,3.812701654960202
LCLC-97TM1,24771867,-3.13973757551719
HCC95,selumetinib-GDC-0941 (4-1 mol-mol),2.25370960012268
LP-1,10296883,3.461993801411865
NCI-H226,24771867,3.3987400752778796
REC-1,54639665,4.455967355102018
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152
SW579,24771867,2.994488835936143
FTC-238,135984461,5.145147478477925
JHH-5,136227331,4.11271540989167
U-BLC1,JQ-1-carboplatin (1-1 mol-mol),2.2972315497002156
Panc 08.13,9911463,3.6396018844852662
J82,100016,6.509431143115434
PE/CA-PJ41 (clone D2),11494412,6.141663454426873
SK-ES-1,54618771,0.5955874337790977
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
LOU-NH91,3854666,2.9087049696787544
DU145,4705,5.59514886378127
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
JM-1,54639665,5.005029028557516
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
PL-21,1566236,1.5934473154308642
KO52,3465537,1.4492421646178062
OCI-Ly10,11404337,-0.1929706540387932
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
MSTO-211H,11152667,-3.5300772231011703
HCC1833,54618771,1.9776792637653005
NU-DUL-1,44241473,4.321628030898983
NCI-H2029,44241473,5.023939479874606
VM-CUB-1,9926054,1.9231906197166304
A-549,9911463,3.875766071211208
DB,135398744,6.337933152850909
PE/CA-PJ49,54618305,4.991417436766986
JK-1,11404337,-1.9979584162277513
NALM-6,54618771,-1.340027714929621
OVK18,10296883,4.168587177693041
MKN1,54618771,0.4952124443033494
Panc 10.05,71751553,4.352315782049923
SNG-M,3854666,1.233762120612781
NCI-H1838,selumetinib-GDC-0941 (4-1 mol-mol),2.2361071015638445
KYSE-410,24771867,2.1573021034498705
ALL-SIL,9884685,1.523019065964201
SNU-5,selumetinib-vorinostat (8-1 mol-mol),2.3569567628578176
KYSE-520,11404337,-0.584711234415048
SNU-1214,11404337,-1.0088442164692528
SNU-C5,4378219,4.855364260132724
Capan-1,71751553,4.749042559112668
Panc 05.04,135421197,1.7241772934352249
MPP 89,10296883,4.223562446240864
SW620,44241473,4.205130781095435
HCC2218,selumetinib-vorinostat (8-1 mol-mol),2.1332099474977455
SNU-16,24771867,-3.0730578189683926
Ci-1,24771867,3.487893985217422
NCI-H322,selumetinib-vorinostat (8-1 mol-mol),3.8122623010454264
SNU-620,136227924,2.4539673197881444
Detroit 562,9915743,0.7221649172673843
OCUM-1,9926054,1.1512095062885492
RPMI-7951,136227924,2.219680452566263
SK-LU-1,1566236,3.629821638142186
TT2609-C02,136227331,4.484463069653878
LAMA-84,9911463,3.2110209522938247
NCI-H1573,9915743,0.8618655163621424
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
BT-12,54618771,-0.2566375632021986
P31/FUJ,10322450,3.023071845081992
KM12,10322450,3.9627058318193495
SNU-1076,135421197,2.6867393428940107
NCI-H2029,11404337,0.5042736669587571
NCI-H28,24771867,-3.083159059508336
AML-193,12003241,-1.5379973109398848
HCC1395,135984461,4.308264403922993
Capan-1,11404337,1.6610188182670238
LS1034,9926054,1.864667676562072
OCI-Ly3,11494412,0.0579198080364928
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
Hs 683,4705,2.6530339386806476
NCI-H889,11404337,-0.9688065890654572
HEL 92.1.7,3854666,0.8338262840039316
HCT 15,2746,3.234164073098613
PaTu 8902,1566236,3.6887913704860535
Capan-2,54618771,-0.253287331081348
TE-9,selumetinib-vorinostat (8-1 mol-mol),3.686792839648975
A-375,100016,6.005492870785018
IPC-298,100016,6.58023685235314
KYSE-450,9915743,1.0249516523129705
NCI-H23,136227924,2.7523480468192254
BT 228,11494412,2.9985974737490557
CCF-STTG1,6918638,2.2635117256438835
NCI-H1793,135421197,3.9424142241593145
DB,135659046,3.355027747328138
SK-MEL-28,4705,3.074639735007158
KYSE-150,135421197,2.7515172040532687
MDA-MB-361,9868037,3.9951939200325057
ME-1 [Human leukemia],9935249,2.5760324068309455
IGR-1,9884685,1.9069100613698544
L-428,11494412,0.039932037975066
JHOC-5,9926054,1.8776072884950488
HCC4006,3465537,3.3364041305290004
SK-MEL-31,10296883,4.185495056611244
SK-MEL-2,11404337,0.550817025493175
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
SNU-1076,12003241,-1.173823716137647
NCI-H446,12003241,-2.472170144252885
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
COV362,6918638,2.636273495865165
BT 320,9926054,4.941319925063275
BT 340,9935249,2.1443978497861504
A-204,135984461,5.548637311180796
PE/CA-PJ49,2746,2.1917494925150653
COLO 699,selumetinib-GDC-0941 (4-1 mol-mol),0.865445033104183
SW1417,9915743,0.7399869758043424
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
HT,73707386,3.008918492813066
SH-4,12003241,-2.3432697923698083
Yamato-SS,71751553,4.380711104717213
TALL-1 [Human adult T-ALL],24771867,-2.6335751833715686
EKVX,9911463,3.45817686520516
EKVX,10296883,4.140951610899391
SK-MES-1,9926054,1.7676300515090215
CML-T1,2742550,2.9758871773228366
DMS 79,JQ-1-carboplatin (1-1 mol-mol),2.1232478586327215
NCI-H358,4378219,1.998179918266641
OCI-Ly10,11494412,1.3336698369044977
P3HR-1,JQ-1-carboplatin (1-1 mol-mol),0.4067249254374854
HT-1197,44241473,5.299907151085159
JK-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404611397538406
A-253,3465537,3.175691347672769
SW48,9926054,0.5681768331785455
253J-BV,44487872,4.358270003385931
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
GP2d,6918638,-1.154935446775354
HCC1438,9911463,4.347213742956148
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
NCI-H1869,136227924,3.4575085361719955
PK-59,9926054,1.7891376671835462
COV362,11404337,0.8285013906094965
HCC1419,10322450,4.752947220118952
BT-20,11404337,0.6443596092093807
KMS-27,9915743,0.5712823893171636
SR,1566236,1.8681155468369743
DB,9884685,0.0125098764631308
Daudi,71751553,3.830487233171358
Mono-Mac-6,9915743,0.3878185063656593
SNU-478,3854666,1.0704157798123697
TE-10,selumetinib-GDC-0941 (4-1 mol-mol),2.2597459184044593
RVH-421,11494412,2.857089619011577
RS4;11,selumetinib-vorinostat (8-1 mol-mol),2.060931955458443
JK-1,12003241,-7.790720782549377
SNU-840,11404337,1.1450615228869434
YKG-1,135421197,3.1079510852519343
GaMG,12003241,-1.1621616673389346
BT-474,2746,-1.392865413318883
DU145,135421197,3.2080942542888056
M-07e,24779724,5.840780932705825
OCI-AML-2,10296883,2.8220982332294615
BT 340,11404337,-1.0592377517699567
THP-1,54618305,4.264664624638681
HCC1419,9884685,-0.6707632508921959
BT 245,135659046,4.182181998244751
BCP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.866380650613888
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
TCCSUP,11152667,-1.0569561728619483
UO-31,selumetinib-vorinostat (8-1 mol-mol),1.996213021898257
CL-11,4378219,2.320508377861677
ECC12,11404337,1.5850993718639097
Aska-SS,2746,3.0488180575917463
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
OV56,4705,5.529436174824006
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
EJM,11404337,-0.4702991542329423
DK-MG,9926054,2.480223353364803
SW579,1566236,3.6379170014502393
MKN45,selumetinib-vorinostat (8-1 mol-mol),5.20778496027016
BT 440,24771867,2.4871048199114187
DK-MG,24771867,2.7893278421667302
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
DV-90,136227331,3.915454108317936
SW1710,44241473,5.2024115124735655
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
G-401,44241473,4.28251451131172
CAL-33,9915743,-0.5523572938486134
Daudi,9911463,2.4252044126403915
HCC1937,3854666,4.439967963275119
A-172,2746,3.137938137682863
KO52,71751553,4.277873961450632
8505C,11152667,0.3800662842278975
BICR 6,11494412,-0.0780471229924908
IGR-37,6918638,0.9669989882697694
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
F-36P,9935249,1.4854738782819463
SF539,24779724,4.8810531030455415
VCaP,135659046,3.61578581295777
BT 164,9926054,1.7569954478000085
JJN-3,9926054,1.1995633611794354
P3HR-1,24771867,6.000161608388154
HCC1833,135984461,4.342714287426043
MES-SA,selumetinib-GDC-0941 (4-1 mol-mol),2.335158862320408
VMRC-RCW,9935249,3.8871203544868935
HEY A8,9915743,1.8632242051136063
NCI-H2172,11404337,1.861894071580906
NCI-H1793,71751553,4.881121266496761
SCaBER,12003241,-1.3613478880946173
SNU-213,3854666,3.663424826303367
Hs 294T,100016,6.337209257885702
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
REC-1,73707386,2.7839275654473243
LAMA-84,11404337,0.2635139900443839
EC-GI-10,9884685,1.441134902570653
COLO 792,selumetinib-GDC-0941 (4-1 mol-mol),-1.2874205422493403
SK-ES-1,9868037,1.8051819394038728
HCC44,12003241,-2.184153343310603
OAW42,24771867,3.645967625884045
RERF-LC-A1,54618771,2.031168626063029
PLC/PRF/5,71751553,4.875285495081073
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
A-375,100016,6.005492870785018
RMG-I,4378219,1.8712171640968256
KMS-12-BM,selumetinib-vorinostat (8-1 mol-mol),2.1031452809096827
KMRC-3,11152667,0.0454830194586134
BCP-1,6918638,-1.8466999206036412
TOV-112D,9926054,1.7834686388264986
T24,11494412,1.5431599577117932
Peer,9935249,1.2377857726534496
BHY,4378219,1.895122052558388
SCC-4,2746,2.994805038812276
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
T84,65628,6.475428256450229
HCC1428,JQ-1-carboplatin (1-1 mol-mol),1.63516660368819
Hs 578T,9915743,0.6778530093725601
BT 245,4705,2.436380122563236
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
SU-DHL-10,9915743,0.9308124359278332
A-172,11152667,0.1923956558568524
OE21,135421197,1.5054570422138
Caki-1,10296883,4.233557259626662
KMS-20,11404337,-1.24048912938788
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
DB,10296883,3.486914708564097
THP-1,9926054,1.7604592205221938
786-O,selumetinib-GDC-0941 (4-1 mol-mol),2.324696492331355
WM115,1566236,3.8332358430398847
KMRC-20,24771867,3.994101826039686
SEM,9911463,3.141152403249145
SF126,2742550,4.653066114574705
EB1,54618771,-0.3915386993254522
SK-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4310498502666769
KYSE-410,2746,3.332005025730893
G-292 clone A141B1,3854666,1.01270133207083
SNU-C2A,136227924,3.0438027551295352
TE-4,JQ-1-carboplatin (1-1 mol-mol),-0.4679949874900955
ECC12,135421197,3.3964396494270357
Ci-1,9915743,3.2992367606729496
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
YD-38,135421197,2.8276318584619022
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
SNU-16,44241473,4.16197590499851
SUP-M2,9935249,-1.4542663708308443
RL,40482356,5.164569658316409
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
PE/CA-PJ49,135659046,3.5549002552522175
RERF-LC-A1,136227924,2.978723056085531
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
NCI-H1792,100016,5.097619126157972
HCC1500,4705,3.1720127097688073
T3M-10,6918638,0.3791169249150829
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
A4/Fukuda,11404337,-2.650657466190433
HCC2218,9935249,-1.250761387060799
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187
OCUM-1,11404337,-0.1568634600047591
KE-97,100016,5.841816758085698
HCC2218,3854666,2.216625580917516
HEC-151,9911463,4.0043305736729105
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
Kasumi-1,9911463,2.7183571819341776
Panc 03.27,11152667,-1.218178075757916
HMC-1-8,9911463,4.100955658112126
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
CW-2,11404337,-0.6368156397090832
NCI-H810,135659046,3.1719200378755055
NCI-H446,9935249,2.952195847832737
TE-8,selumetinib-GDC-0941 (4-1 mol-mol),2.5154311677987575
Mono-Mac-1,11404337,-0.2219879905670924
NCI-H1755,11152667,-0.8607954113291786
SNU-1,11404337,-1.6591941972461035
SCC-25,9915743,-2.46733650734929
LUDLU-1,10322450,1.9625689447261536
COR-L105,2742550,3.8597521863519257
COLO 320,54618305,4.811274582545649
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
PE/CA-PJ49,9915743,0.4153900299925456
OVSAHO,9935249,3.7943989352895975
HT-144,71751553,4.953969663873573
BT 187,44241473,5.585577122491378
HEC-1-A,136227924,3.4085098693584603
BL-70,65628,3.443552461432303
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918
A-172,71751553,5.172716040481698
SUP-HD1,12003241,0.3285815834035863
NCI-H2106,3854666,2.945318189575744
G-292 clone A141B1,24771867,2.630505680123509
K029AX,selumetinib-GDC-0941 (4-1 mol-mol),-0.0187548496270864
SF268,650361,5.434454407952264
COLO 678,JQ-1-carboplatin (1-1 mol-mol),3.427094237994177
DAN-G,9911463,4.055561075678672
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
EPLC-272H,9911463,4.277104632869788
HCC15,9868037,2.5640614102548556
BHY,9884685,0.3882857047327643
SNU-387,2742550,5.0042131108814
G-402,JQ-1-carboplatin (1-1 mol-mol),0.5216010908440976
EB1,12003241,-4.025525342770554
GP2d,9911463,3.4287638364332333
Hs 578Bst,11494412,4.466651990011993
NCI-H358,9926054,2.488331292072961
SK-UT-1,65628,4.642853879953485
SW1990,4705,4.395682074596428
OVCAR-8,49836020,4.475611867400311
B-CPAP,9935249,3.6331972825505474
TE-8,73707386,3.752182289773797
Rh41,49836020,4.456584836146854
Karpas-620,11404337,-0.9098676733651666
COLO 668,6918638,-0.3397215553853323
SW948,4705,1.720002028261835
SNU-8,11404337,-0.4750422228003279
EFO-21,selumetinib-GDC-0941 (4-1 mol-mol),2.070102563498296
PE/CA-PJ15,11152667,-0.7034244137409247
NCI-H2029,11494412,1.7688671482320395
OE33,9911463,4.318006925608157
HT-1080,selumetinib-vorinostat (8-1 mol-mol),2.4518233128508418
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
KYM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.885650004060589
F-36P,3854666,-0.4499689748762866
EPLC-272H,3854666,2.0784340754619826
COLO 741,11404337,-0.2468832755936964
SK-N-BE(2),71751553,3.75245641553736
U266B1,12003241,-0.5113173834247196
OVSAHO,11152667,2.3243832570578236
NCI-H747,11494412,1.949841115292288
Fu97,4705,3.9554938740337096
SNU-308,54618771,1.0411941789938453
NCC-StC-K140,2746,2.399339405510586
BL-70,10322450,2.4597869877226004
NALM-6,9926054,1.499716705925791
EKVX,40482356,5.121234776382939
Hs 746.T,1566236,1.9781542235751777
HCC1806,2742550,4.245484328514533
BFTC-909,4378219,4.497242068417329
ST486,11404337,-3.35080317485283
SCC-9,4378219,1.9931327421657885
EFO-21,selumetinib-vorinostat (8-1 mol-mol),2.792209112341651
JK-1,9935249,2.3641418741396527
HPB-ALL,9935249,1.7527438967861384
SK-N-MC,11152667,-1.1821735930174364
KP-4,9868037,2.659555107849518
Lu-99,135421197,1.2736591779946078
LOX-IMVI,10296883,4.016923639720429
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266
CJM [Human melanoma],selumetinib-vorinostat (8-1 mol-mol),4.115485086300489
CAL-62,2742550,4.603848898842044
K-562,136227924,2.737847329779252
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
BV-173,136227924,2.1412277594985816
SUP-T1,11152667,-3.1666536530692477
BT 231,11152667,1.8482025461380396
NCI-H1793,135659046,3.4932365475314837
HEC-1-B,11404337,0.5872322910444284
TCC-Pan2,9926054,2.315773971229038
SNU-182,9884685,-1.6897357849624497
SUP-T1,54639665,5.160624619206478
JJN-3,9935249,1.5049332115943086
SK-BR-3,JQ-1-carboplatin (1-1 mol-mol),3.127240758828175
SNB-75,1566236,4.191791620259989
KYSE-30,1566236,3.7632160201104186
SNU-201,selumetinib-vorinostat (8-1 mol-mol),2.4684445780418023
NCI-H1395,11404337,2.1973197619817832
NCI-H446,100016,4.920277084242614
EFO-21,54618305,4.527789159608335
BEN,11152667,1.5571390714565738
PC-14,9868037,2.5861209247826644
SK-MEL-30,9911463,3.9366573262978473
BV-173,10322450,3.6127329477753327
WM115,9911463,2.5241618652619007
ONCO-DG-1,12003241,-0.5849918543503058
OVK18,3854666,2.1766896267890816
786-O,9884685,1.3533328898647403
GA-10,3854666,-0.056575285481401
CAL-148,54618771,-0.772242663626429
DMS 53,135984461,4.182249903339298
CGTH-W-1,54618305,6.0196010994102815
OCI-Ly10,3465537,1.265089065733374
KYSE-70,12003241,-1.4257688129039825
SK-HEP-1,12003241,-1.7510835313415607
Hs 746.T,selumetinib-vorinostat (8-1 mol-mol),2.6877277725717357
MFE-296,11152667,-1.49874727462349
CML-T1,9884685,1.1136090650670494
SK-MES-1,6918638,0.2897648687563215
SNU-410,11404337,1.1102019570699369
EBC-1,9926054,1.6543051302548544
KMS-20,10296883,2.054648014794474
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
PaTu 8902,3854666,4.137852419807088
Jurkat,12003241,-1.1785607025510931
BxPC-3,3854666,3.4835595653471167
SYO-1,11152667,-1.8766382672810296
BT 172,10322450,4.417951286359916
NU-DHL-1,11404337,-3.826325924415509
TT2609-C02,11404337,0.8244882242749442
Fu97,3854666,1.01101706440742
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
NCI-H2171,6918638,-1.5146784294865197
SNU-46,11404337,0.6593840830544361
NCI-H1915,9915743,0.3571601745148741
Hs 729.T,11152667,-0.1585094610562804
Sq-1,selumetinib-GDC-0941 (4-1 mol-mol),2.237150148829387
A2058,JQ-1-carboplatin (1-1 mol-mol),3.692426829341752
NCI-H520,136227331,4.183046250285636
SW1783,11404337,0.7381457579106708
MOTN-1,100016,6.2802968176710445
NCI-H1792,11404337,0.0016171974821283
SNU-1214,136227924,2.9720785133706213
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
A-673,11152667,-2.304412849002376
TE-4,54618771,0.5260278074732754
BFTC-909,54618771,2.8225313881877545
BT 248,3465537,1.7130202551321618
NCI-H2122,136227924,3.797810316623325
HCT 15,135984461,4.216464874302124
KP-2,9884685,3.910318291012164
F-36P,1566236,1.4994309826223562
Daoy,4378219,1.7857229539302837
UO-31,4705,2.423149562470716
MPP 89,2742550,3.993555422023738
KYSE-410,12003241,-2.1155115062785805
Ku812,135421197,1.6654017400601815
HuG1-N,9884685,3.387846210164392
A-375,12003241,-1.2978704743837648
BT 422,9884685,0.8498641278856381
P12-Ichikawa,selumetinib-GDC-0941 (4-1 mol-mol),1.616010765024319
Hep-G2,135421197,1.3335693407455125
CAL-120,9915743,1.5300357462743028
RPMI-8402,9884685,1.0462032171352182
Hs 839.T,9926054,1.9387188117771836
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
IGR-39,selumetinib-GDC-0941 (4-1 mol-mol),2.3690668734503415
CAL-51,65628,4.560195683913681
KE-39,9911463,3.415693188275342
CA46,24771867,-0.8036362931877258
P3HR-1,selumetinib-vorinostat (8-1 mol-mol),2.8609164673310907
BT 228,9911463,2.83539892477779
SKM-1,9868037,0.7505046314280106
BT-549,1566236,1.7296376770428397
KYSE-510,11404337,0.4094464488051804
Hs 578Bst,9868037,5.270219324127126
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
MKN74,9915743,1.5544684592006026
JJN-3,selumetinib-vorinostat (8-1 mol-mol),2.2771818627598224
C2BBe1,24771867,5.583922819049353
JVM-3,9884685,-0.7569385790622597
HCC1438,3854666,0.7940091935117004
BT 112,9911463,2.5169416957375015
SW1353,12003241,-1.0641088251163675
ChaGo-K-1,11152667,-0.0716632534971208
PK-59,73707386,3.024684722161558
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
P3HR-1,24771867,6.000161608388154
EoL-1,2746,-0.0046206936254649
OAW42,selumetinib-vorinostat (8-1 mol-mol),4.452734121336326
EPLC-272H,54618771,2.195123762717199
BT 359,selumetinib-GDC-0941 (4-1 mol-mol),2.125695165959512
HEY A8,24779724,4.871747298777593
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
TCCSUP,54618771,0.6448534643306117
Rh30,24771867,1.970629031249306
NCI-H226,11404337,0.9721595611674808
SNB-75,9868037,4.435778123125775
KE-39,44487872,4.457727251314366
KMS-27,65628,3.4273380344864233
LMSU,9884685,1.8441382051797008
HPAF-II,9935249,3.710504446936883
RD,2746,3.2035817097570334
KMBC-2,11152667,1.3012621029988305
ES-2,54618771,2.1434167327207954
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
HT-1080,11404337,0.3572929158559362
IGR-37,136227924,2.9944260233382667
NCI-H2106,selumetinib-GDC-0941 (4-1 mol-mol),2.731448809919849
SF539,136227331,3.3252279599925085
LOX-IMVI,54618771,-0.8031507578309087
Hs 611.T,11494412,-0.0466996238947274
Hep 3B2.1-7,54618771,-0.219926675598239
Caov-3,24779724,4.476615145928651
HSC-2,4378219,3.018305397905356
HCC1500,9884685,1.9086372211674376
DEL,65628,3.2716270578205866
LOU-NH91,135659046,3.4412725013745336
SF268,11152667,-0.399676086943417
NCI-H2342,10296883,4.213291341725321
NCI-H1693,100016,7.64063251702684
NCI-H1915,54618305,4.271520986839047
NCI-H2029,71751553,4.3547337585188615
SNU-61,136227924,2.341371828887226
DMS 273,71751553,4.31191978803821
JHUEM-3,9911463,3.690046931710037
SCC-9,135421197,2.7056920215811293
NCI-H358,9935249,4.705375933570609
IGROV-1,9915743,-0.4757488934941289
GSS,54618771,-0.6166501734641827
CADO-ES1,9911463,2.9400550809567454
PF-382,11152667,-1.8592814828562831
SNU-216,JQ-1-carboplatin (1-1 mol-mol),3.8633664512106622
OCI-M1,3854666,0.1062277305509749
CCF-STTG1,11152667,0.6516582666822289
L-428,4705,3.188037531722373
SW1990,3854666,4.405402240089115
CAS-1,selumetinib-vorinostat (8-1 mol-mol),2.584768719119857
Mel JuSo,12003241,-0.8749256028494242
SK-ES-1,3854666,0.6093716991358727
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
LS1034,10296883,3.964188114120739
SNU-685,11494412,1.6566722740686777
JHUEM-1,2742550,3.845716488362213
COLO 320,11494412,1.2110746429620267
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
COLO 684,11404337,-0.4632176529743375
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
Mino,24771867,-3.235629712313572
Hs 895.T,54618305,6.468585963277805
VCaP,6918638,-1.0588034112716072
LAMA-84,24771867,0.8191710106808141
BICR 31,11152667,-0.7818812516610519
BT 248,135659046,3.5168747963796636
HEC-6,136227924,2.983713037764577
NCI-H1105,135421197,0.5397494538103206
TTC-709,54618771,0.1325833030612315
KNS-42,3465537,5.419781734929303
NCI-H2342,3854666,3.3105988533108777
NCI-H1299,9935249,3.5547957097116143
BT 245,24771867,5.283841994129179
LK-2,11404337,-2.7548250863089367
RKN,4378219,1.9905206425028277
RKO,9926054,1.883626680074333
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
HCT 8,24771867,4.100479674555145
T3M-10,JQ-1-carboplatin (1-1 mol-mol),3.984166000628971
JHH-5,135421197,0.9598662644879212
KALS-1,24771867,3.000627523181766
HCC1395,12003241,-2.06138866466857
KMS-27,11404337,-1.6812910673716006
YD-15,100016,6.01418803247364
NCI-H1563,100016,6.550294719377214
EHEB,4378219,1.3108988632273402
NCI-H2030,54618305,5.554359715807879
LAMA-84,selumetinib-GDC-0941 (4-1 mol-mol),-0.0298835136014615
LOX-IMVI,9926054,1.7031980960413209
CML-T1,136227924,1.8923919385229255
DV-90,selumetinib-vorinostat (8-1 mol-mol),0.2763091288197432
BT 179,9911463,3.927482199479875
OVK18,9884685,-0.4598005872394062
RPMI-6666,11152667,-2.0860196323814697
ACHN,9911463,3.895747404778365
HT-1197,9911463,2.9411019344315217
JHUEM-1,24771867,2.37978547366131
Karpas-422,3854666,1.0831762818043358
NCI-H2030,135421197,3.075513669205883
HCC1569,76446078,4.152765512716805
HCC1428,6918638,-0.4708375932365498
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
TE-8,54618771,2.0990725036496123
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
T24,44241473,5.44472522879021
TE-15,9911463,3.694434531668693
AsPC-1,4705,5.582464580618905
SNU-601,9884685,1.2283568058466754
SNU-719,135421197,0.9792842920964928
JHUEM-1,10296883,3.9346694694253657
RPMI-8226,9935249,2.1777849990691025
MKN74,11404337,-0.8129110599609928
KO52,54618771,1.4631554759036511
HCC2108,54618305,4.9170237432018435
MIA PaCa-2,11152667,-2.2461765608848663
SK-N-AS,24771867,2.5012979508837696
SKM-1,54618771,0.6725959366795358
DMS 454,9884685,0.3984651636391856
EC-GI-10,11404337,-0.7610557200028516
KYSE-150,selumetinib-vorinostat (8-1 mol-mol),3.39838636509464
GCT,11152667,0.2440943178190859
ACHN,71751553,4.44708282710721
8505C,24771867,2.985510614993711
PL-21,12003241,-0.83006256212438
SW620,2746,3.8356655866874414
DMS 273,6918638,-0.6329393875591668
RS4;11,24779724,4.696874238166559
HCC366,3854666,0.9176175755914344
NCI-H1694,9915743,-0.097259817128113
SK-MEL-3,9915743,2.9768628838576037
DMS 454,10322450,3.6931379827732664
A-549,136227924,3.1395144761786486
NCI-H1339,selumetinib-vorinostat (8-1 mol-mol),3.4752897958657245
HEL,100016,4.260371486080393
COR-L95,11404337,0.1032061359669597
FU-OV-1,10296883,4.259179003182187
HCC44,9884685,-1.326885873359785
COLO 792,9915743,1.202162575993562
BT 224,9911463,3.280505090907216
NUGC-3,44241473,5.180110957285132
IPC-298,3854666,3.3185631134579667
SK-N-MC,JQ-1-carboplatin (1-1 mol-mol),0.7192818040209301
BT 239,9884685,-0.9552991343653138
UM-UC-1,1566236,3.49642764256864
HEC-59,54618771,1.4246899684638197
BT 224,54618771,1.0609387834532893
SF268,100016,6.377468220379779
Calu-3,10322450,4.307462921709786
MCF-7,135984461,4.749341125159992
SK-N-AS,JQ-1-carboplatin (1-1 mol-mol),2.0637783416612767
SW1088,11404337,0.4126276779889334
NCI-H1355,9915743,1.7324952444054351
FTC-238,12003241,-0.6060695245587711
BT 248,44241473,4.372252470027867
YD-10B,selumetinib-vorinostat (8-1 mol-mol),-1.870978615949193
Namalwa,11152667,-1.2838817681822148
L-363,9868037,2.573634031756044
HT-29,135421197,2.624845390114819
HOP-62,100016,6.313498249886369
OE33,136227924,2.987067512543954
HPAC,54618771,1.6074763393424083
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
KMS-20,54618771,0.3177440488164709
Hs 611.T,6918638,0.1647262246694485
LOX-IMVI,135398744,6.429324407359154
RVH-421,4378219,2.8224165620069366
SNG-M,9915743,0.6282873859108726
YH-13,2746,3.803826628530811
MDA-MB-157,3854666,0.668628762558335
OCI-M1,9926054,1.747333325747777
NCI-H1092,135421197,1.379439810077043
Hs 729.T,54618771,1.7662519209313146
DEL,9915743,3.429632007483548
Hep-G2,136227924,2.2133800896817304
NCI-H1341,11404337,-1.9361621115679644
KLE,54618771,1.0287660425791825
UM-UC-1,135421197,1.1725143747551234
NCI-H661,9935249,3.279757521015836
LOX-IMVI,44241473,5.900540062527418
MDA-MB-361,3854666,3.1830071535055593
RERF-LC-Ad2,2746,5.029161088145208
A3/Kawakami,71751553,4.362373152095837
Daudi,10322450,2.3131627402631905
OCI-Ly19,2746,2.185882112946918
OCI-M1,6918638,-0.7125786973139969
AML-193,11152667,-3.2233662083382297
KMRC-1,9911463,4.4126092990485395
RMG-I,4705,2.197778207097114
A-204,135421197,1.5277781833550137
KMRC-2,54618771,2.1629104463678335
IGR-1,11152667,0.1543834410514462
ACHN,2746,3.5458826569709587
SK-N-BE(2),65628,3.4369981362561703
SNU-620,9911463,2.718235223469864
A-673,9935249,0.595201632659186
JVM-2,9915743,-2.5513470723309095
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
KMRC-1,135421197,2.781168744821282
NCI-H522,11152667,0.761836671652074
T24,100016,6.183675550900896
OV7,9911463,4.355611595134673
Peer,9868037,0.9246335266521049
NUGC-4,9935249,3.5425573545623847
SUP-B15,10322450,4.034364888516056
A2780,3854666,-0.0414990172822217
NCI-H211,9868037,1.83710145053469
OCI-AML-3,135421197,1.1151677608997974
SW1271,9915743,1.6128868969613257
42-MG-BA,11152667,-0.8745465289807025
AU565,9935249,2.085801217703038
Hs 940.T,11152667,-0.0455223883696226
HSC-4,11404337,-0.2351979780524762
BT 482,4378219,1.8753816161654864
COLO 320,selumetinib-GDC-0941 (4-1 mol-mol),1.1921670353492264
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
DU145,1566236,3.495730163617442
KP-N-SI9s,selumetinib-GDC-0941 (4-1 mol-mol),1.114910325038949
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
TE-4,136227924,2.9171247501964945
Peer,11404337,-1.6679589887046322
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
RD-ES,12003241,-1.2305184687153958
KYSE-410,9926054,2.1669765108653483
SW1088,9884685,0.5024488647997187
SW1990,11152667,-1.371942963553871
SK-MM-2,9911463,2.140550040440612
RKO,3854666,1.2691133577357363
BT 172,6918638,2.2314251276093415
NCI-N87,54618771,0.8863121899707505
YAPC,9926054,1.8358643335634888
BT 248,76446078,4.2307608716074565
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
AU565,3465537,1.0667310492419344
KMS-12-BM,9911463,2.0749809508981256
CA46,11494412,-0.1540181126177876
8-MG-BA,2746,3.598296066021755
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
JHH-4,selumetinib-GDC-0941 (4-1 mol-mol),1.975979663923368
GCT,2746,3.501463189612396
SNU-1,100016,5.685360721271126
Malme-3M,JQ-1-carboplatin (1-1 mol-mol),-0.4541728562567664
CAL-54,11152667,-1.096063440720087
RVH-421,44241473,5.136778235878817
SK-N-DZ,24771867,-1.974627449601504
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
P31/FUJ,9915743,-0.8907797257006451
RERF-LC-MS,9884685,0.4531053665233772
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
AML-193,2746,2.0410312997302698
Jurkat,136227924,2.4803602069258712
A-549,9926054,1.8971220341716168
KMS-11,135421197,1.6070380180755417
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
REC-1,9868037,0.961521370423606
HDQ-P1,11404337,1.6870707002815033
GDM-1,135398744,6.258827934702185
WM88,11152667,-0.5209926910891152
HeLa,9911463,4.222129751403694
RPMI-6666,100016,5.822007631719843
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
SNU-840,4378219,4.702756727484071
ACC-MESO-1,135421197,1.1131712845559925
SU-DHL-8,4705,3.58469118843627
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
EJM,12003241,0.5402616975347148
Caki-1,71751553,5.630510939066582
NCI-H1792,9926054,2.787600202110533
DOV13,2742550,3.93484873738036
U-BLC1,3465537,1.550402791454292
Rh41,3854666,0.4955024650837225
BICR 6,9915743,0.967897294058306
BT 145,100016,5.857999875396141
NCI-H1355,9926054,1.8192914468713284
D283 Med,1566236,1.5114731538286772
WM88,selumetinib-vorinostat (8-1 mol-mol),-2.7855359401178825
NCI-N87,100016,7.118039999797619
SK-N-MC,11404337,-1.4271046508781242
C2BBe1,49836020,4.36863555932656
AsPC-1,12003241,0.1897400127907629
BT 359,6918638,2.662687063562674
NCI-H1869,136227924,3.4575085361719955
TCC-Pan2,11404337,0.04940510816565
EFM-192A,54618771,1.407035681084211
DMS 273,9915743,1.912374780622189
SNU-216,9868037,3.645721485009989
YD-10B,54618305,4.478486027530094
CCK-81,44241473,4.40170200206355
BT 440,11494412,3.9335430982852406
TE-5,136227924,2.0128832307516715
P12-Ichikawa,selumetinib-vorinostat (8-1 mol-mol),1.6236889428800614
CHP-126,136227924,2.2251507312000576
BICR 6,54618771,1.779612133300688
ONCO-DG-1,11152667,-0.5484669385829071
JHUEM-2,11152667,-0.7431230896020583
SNU-601,2746,3.467999192841188
SNU-410,9911463,3.9048002645235536
OCI-Ly10,6918638,-0.7396222686177214
COV434,9935249,0.9840385733400504
JHOS-2,65628,4.369428236265807
Calu-1,9935249,4.740703039266813
Aska-SS,1566236,2.835493117782545
KYSE-520,11494412,3.6154468143610825
BT 145,9915743,0.579862863836084
LMSU,selumetinib-vorinostat (8-1 mol-mol),4.672884739471154
TE-5,9915743,-0.2115886110471379
SIG-M5,65628,3.9627714833655383
NCI-H1581,selumetinib-vorinostat (8-1 mol-mol),2.561236854042443
MOLT-16,1566236,0.8818560395757914
HCC95,11152667,-0.1847959805543043
SNU-C4,9926054,1.7359691760271532
CA46,3465537,3.345448990020783
NCI-H2110,49836020,-1.7351781152481929
VMRC-LCD,11152667,-1.4796067866772968
TE-15,9926054,1.8189889434505215
DMS 114,100016,6.89872652787532
MFE-296,9926054,1.7629319837489352
HOS,2742550,4.342501392061334
Capan-2,9926054,1.7295951578081552
KMS-21-BM,135421197,0.9217420053482288
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
BT 231,selumetinib-vorinostat (8-1 mol-mol),2.946498999717448
DV-90,44241473,3.8644802815039
SCaBER,11152667,0.3321813903171761
BT 504,24771867,5.715295997283281
NCI-H661,136227924,2.7818959309662183
BT-474,12003241,-0.1629967020972257
NH-6,9915743,0.850347452828082
MDA-MB-231,9926054,2.3849554736036613
OUMS-23,3854666,3.3522693308519234
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585
HCC1428,selumetinib-vorinostat (8-1 mol-mol),2.4982790214648087
LS180,49836020,0.6204023867713871
BICR 18,11404337,0.2486496925996474
BT 187,selumetinib-GDC-0941 (4-1 mol-mol),2.194213096235158
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
SF126,9935249,3.7437112279707185
Calu-6,3854666,0.8971542674673161
SW579,10296883,3.762097839369787
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
HT,9884685,-1.5332342214712364
Caki-1,4378219,4.6268402826489705
SNU-475,1566236,3.929799458774806
KG-1-C,10322450,5.451010729371517
Hs 294T,selumetinib-vorinostat (8-1 mol-mol),0.6984578471361444
PE/CA-PJ15,4378219,3.8751704694952753
5637,65628,4.2797556217083965
SNU-449,3854666,3.254678167809475
LP-1,9926054,1.657631549896095
T24,2742550,4.322768033358217
SH-4,1566236,1.7518917759818655
MV4-11,44487872,4.715588525495155
A3/Kawakami,11494412,-0.0217688682403614
MDA-MB-453,4378219,1.7417226469020404
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
Lu-99,selumetinib-GDC-0941 (4-1 mol-mol),1.1181366334842004
Kuramochi,selumetinib-GDC-0941 (4-1 mol-mol),1.9620820620986936
JM-1,54618305,4.117087010604098
DMS 454,selumetinib-GDC-0941 (4-1 mol-mol),0.8231378505894382
HuP-T4,selumetinib-GDC-0941 (4-1 mol-mol),-0.95779192570868
SNU-761,136227924,3.0890701215325085
IGR-39,9926054,2.0144252699344176
BT 228,4705,2.9776742374727436
PE/CA-PJ41 (clone D2),3465537,3.306521730536944
EKVX,2742550,3.9948619425475607
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
PSN1,44487872,4.3354690925814
G-402,24771867,2.0085455844967384
ESS-1,6918638,0.5362706870956574
SW1573,11404337,-1.3449252751203844
LCLC-97TM1,9911463,3.937478558519083
Lu-99,selumetinib-vorinostat (8-1 mol-mol),2.3440066330762415
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
HCC2108,11152667,0.6161783395316693
HCT 8,selumetinib-vorinostat (8-1 mol-mol),2.4555192201587044
GSS,9884685,-0.174857877617277
NCI-H1155,11152667,-0.9195037787444386
Becker,44241473,5.200691051735636
MKN74,2746,3.2220393473660973
OCI-M1,136227924,3.580987744477365
KMS-34,selumetinib-vorinostat (8-1 mol-mol),2.1105569395835975
KMRC-1,2746,4.901784458568857
MHH-CALL-4,100016,6.461754156645112
A-172,6918638,1.3272545759191037
A4/Fukuda,9915743,-0.3554458205966057
SNU-449,135984461,4.468051833024593
SNU-719,9915743,1.2257458937302947
Ki-JK,9884685,-1.9228761538828023
NCI-H23,54618305,4.28685943340946
KE-39,135984461,4.3782777468955745
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
COR-L51,11404337,-0.9884929367070868
KYSE-520,6918638,1.4732887931926149
DMS 114,65628,5.583930702955729
HeLa,11152667,-1.1066196767080478
RMG-I,9915743,0.3310978387400572
647V,4705,2.7300428943650044
NCI-H2170,135984461,4.266034929534041
BT 139,9926054,3.0317650629280717
BT 131,1566236,1.8547694675327384
P12-Ichikawa,24771867,-2.9489496906527597
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
HEC-108,9926054,2.177226179063823
SK-ES-1,10296883,3.792538750425496
M-07e,6918638,-1.343658816703153
GSS,selumetinib-vorinostat (8-1 mol-mol),1.884936814348228
SHP-77,9935249,3.258969461214577
Panc 03.27,135984461,6.251236630594111
NUGC-4,9911463,3.797597719438973
Panc 03.27,9935249,4.091964927593618
MOLM-6,100016,5.4880920806856865
OCI-AML-2,12003241,-1.1091047572975106
SNU-C1,JQ-1-carboplatin (1-1 mol-mol),1.0012449564207797
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577
HEC-251,selumetinib-GDC-0941 (4-1 mol-mol),3.2910402284708757
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356
OVCAR-8,100016,5.760214455598188
Sq-1,4378219,2.0889665427207
HSC-4,11152667,-1.532358108136572
KYSE-450,11404337,-0.7664225185438103
MDA-MB-415,6918638,0.6587420657172316
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
NCI-H1693,4378219,4.743522930459692
L-363,54618771,-0.4858237315579012
ACHN,3854666,3.401003067580889
HCC1438,6918638,1.5215576875890318
RPMI-6666,71751553,4.036502684153802
Hs 940.T,9868037,4.608468279286332
SNG-M,11404337,-0.7896933791605669
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
U-251MG,2746,3.594174971863172
KMS-26,73707386,2.0283413542396365
HuP-T4,2746,3.1090463727506257
AU565,6918638,0.3564513775218086
DU4475,2746,1.2992930311917237
PF-382,100016,3.957595275699552
EKVX,11152667,1.24553116907644
Panc 04.03,10296883,4.422301293811254
TE 617.T,1566236,1.7943954235614814
NCI-H2452,1566236,3.5735792412039022
SK-LU-1,9926054,2.124586219371247
BICR 22,135421197,2.0438055763788556
BT 145,54618305,4.4037541633391735
HEC-1-A,2746,3.527816775331282
COLO 800,54618771,0.8952139014407665
MDA-MB-468,65628,4.048602457586348
HSC-2,71751553,4.4976955122650155
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
A2780,12003241,-2.743381978251489
SCC-9,54639665,4.512228528266098
Yamato-SS,selumetinib-GDC-0941 (4-1 mol-mol),-1.5672740621691217
U-937,10296883,3.442205161599926
EHEB,65628,3.796785261187004
KATO III,6918638,0.282003219023021
OCI-AML-3,6918638,-1.4001290252615282
NCI-H2170,10296883,3.9799076581526855
SNU-719,3854666,4.073079265106613
TOV-112D,11152667,0.4642176888088713
COLO 678,71751553,4.243067893374363
IGR-1,10296883,3.2349676961668083
LNCaP clone FGC,9884685,-0.2879888364865913
KP-4,12003241,-0.2003950722684058
COR-L95,135659046,3.614564650544248
SNU-16,54618305,3.809629362468688
OCI-M1,JQ-1-carboplatin (1-1 mol-mol),0.7435952415619963
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
CCK-81,4378219,2.0196703808348406
PC-3,136227331,4.235931729378205
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
Ri-1,65628,2.1586840271379732
SCC-9,136227924,3.721677265331546
NCI-H23,135421197,1.340316450445973
GaMG,3465537,2.957023403681719
Granta-519,4705,3.4024179319436483
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
NCI-H1339,9926054,1.7994324687191725
PSN1,9935249,3.2197582498789696
NCI-H322,9915743,-1.5185613747470492
KNS-62,136227331,4.203841276745653
GB-1,9915743,1.6867043056533375
EC-GI-10,71751553,4.470484975486233
SNU-878,9935249,3.2749809298171457
SK-MEL-5,JQ-1-carboplatin (1-1 mol-mol),5.709362170357264
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
IGROV-1,4378219,2.016502068118561
COLO 205,selumetinib-vorinostat (8-1 mol-mol),0.3968296952392246
LS513,selumetinib-GDC-0941 (4-1 mol-mol),-1.1553983681711826
T98G,3854666,3.005982982811289
KYSE-180,2742550,4.361413861886047
Ri-1,9911463,2.719411575193649
BL-70,11404337,-3.370287818653298
MOTN-1,4705,3.315167180619075
MSTO-211H,65628,3.7458295220001
EFO-27,9926054,1.857839666788878
ChaGo-K-1,4378219,2.361959907819356
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
NCI-H1734,11152667,-1.987198033015952
PaTu 8988s,9915743,-0.0886276947358788
SH-10-TC,9926054,2.8749564288273604
YD-8,4705,3.8146154447521146
SNU-1066,135984461,4.396874081929567
NCI-H146,4378219,1.8118272794434884
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
HDQ-P1,11152667,-0.6891382364348575
M-07e,24771867,-2.7746773188378815
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776
LOX-IMVI,135398744,6.429324407359154
MOLT-16,11404337,-3.721146983736032
HD-MY-Z,6918638,0.9232072898358828
TE-14,54618771,0.7402705360744307
G-361,9935249,2.9804954875301024
LAMA-84,2742550,4.382990016000107
HH [Human lymphoma],9926054,1.7922289040675246
BDCM,24779724,4.545897019972193
HCC15,11404337,-0.219975280966356
HT-1197,24779724,4.378865216004622
BT 224,24771867,5.942467272277205
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
BICR 22,10322450,4.612637955736889
NCI-H520,4705,3.58444135118044
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
LAMA-84,11152667,-1.6044591200200753
YD-8,4378219,2.399532986422255
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
KMRC-1,54618771,0.2036698487849761
NCI-H2405,11404337,0.6998100573495162
HuNS1,1566236,1.8236827924794037
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
MDA-MB-231,49836020,-4.061290256388782
DMS 53,9915743,0.9976254394471727
KMS-12-BM,11404337,-1.6165924780935808
ACC-MESO-1,54618771,0.8381740730227087
CML-T1,9935249,2.5956918222650507
T3M-10,54618305,4.952668323160926
PE/CA-PJ49,10322450,5.083749464761158
LS513,9935249,3.2653924263768643
BCP-1,54618771,1.535577379039456
HT-55,24771867,3.3798705449652333
CL-11,9915743,1.17704113749316
Hs 888.Lu,71751553,4.295902830369434
Caki-2,9926054,1.76147282411668
SNU-1033,4378219,1.9830509373994671
BICR 6,135984461,4.397394430442058
NCI-H841,54618305,4.564886723812773
SK-N-BE(2),selumetinib-GDC-0941 (4-1 mol-mol),-2.409093744965772
BT 328,9926054,3.720062864226824
OC 314,9868037,3.4198698834926553
TALL-1 [Human adult T-ALL],44241473,4.683565999090002
SW579,9915743,0.8612316643696222
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157
SUP-T11,9935249,2.2122809051591417
Hs 611.T,JQ-1-carboplatin (1-1 mol-mol),1.233772265287216
NCI-H1693,JQ-1-carboplatin (1-1 mol-mol),-1.0867749942115603
KMS-26,10322450,3.1640442596906104
BT 145,9935249,1.8068162159792407
KE-39,3854666,4.449857131704124
OVCAR-4,2746,3.8556050114326506
L-428,9884685,0.1797779674831695
A-253,9935249,3.057139117762592
HEC-1-A,11404337,0.0023043827287881
TF-1,136227924,2.8858592548660766
JHUEM-3,11152667,-2.492971610615099
KYSE-30,135421197,1.7734254693963984
KALS-1,2746,4.252891034132703
RERF-LC-A1,135398744,8.259619126952485
NCI-H520,selumetinib-GDC-0941 (4-1 mol-mol),1.617810838341725
RERF-LC-A1,11404337,-0.8149390042058701
HPB-ALL,4705,3.3035953851942548
COLO 800,9911463,4.009510973901368
ZR-75-30,9926054,1.848847204207402
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567
NCI-H1651,6918638,0.1812573070199931
G-292 clone A141B1,9911463,4.73582688224515
NCI-H1339,135421197,3.8934160378835054
TC-71,4705,3.1245427089592757
BL-70,24771867,-2.753771697014839
CA46,12003241,-2.799565618947511
NCI-H1573,9926054,1.726764013189345
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
HuP-T4,49836020,4.250504685299003
L-1236,3854666,3.4070343749706784
BT 440,9911463,3.153626294049379
IST-Mes1,9911463,4.127098730346426
MOLM-6,10296883,2.5763077662070195
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188
SNU-738,selumetinib-GDC-0941 (4-1 mol-mol),2.490499311064832
RS4;11,49836020,6.257665529441248
HCC202,9926054,2.1190704993467917
SNU-478,10322450,3.5512522353536515
SW982,12003241,-0.7831418604360746
WM983B,135421197,2.3980917008752725
BT 416,135984461,1.873658392465374
HOP-92,135984461,4.9526709086531415
JHUEM-2,73707386,2.660139253253633
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
Raji,54618771,-0.1378575615243227
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
FU-OV-1,11404337,-0.2130364442314083
WM88,2742550,4.1257519283830595
SH-4,selumetinib-vorinostat (8-1 mol-mol),0.851484479163358
KMS-20,4378219,1.896511565907232
C2BBe1,9926054,1.888966029374552
DU145,24771867,3.0403814394567283
BICR 31,136227924,2.8140968842668923
GMS-10,135421197,1.564647859858216
ChaGo-K-1,136227924,2.8574479872364247
HuH-28,9926054,2.302050382507772
NCI-H1105,JQ-1-carboplatin (1-1 mol-mol),2.500241308426971
SW620,24779724,4.4273355019775265
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
OVCAR-4,selumetinib-GDC-0941 (4-1 mol-mol),3.050941054620586
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
SU-DHL-1,9868037,1.568771805047012
SK-OV-3,49836020,-5.2191550029019025
MHH-ES-1,65628,3.443367883229779
YKG-1,9935249,4.562558251006297
SNU-1066,65628,4.413733003264305
WM266-4,3854666,2.447764610666349
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
MOLP-8,10322450,4.082153801594249
HT-144,3854666,2.3799435938580076
NU-DHL-1,10296883,3.6667794076879594
OV56,71751553,4.820824732580885
TC-71,JQ-1-carboplatin (1-1 mol-mol),2.9266133797401617
NCI-H1299,11152667,0.5765175859368963
TE-10,12003241,-0.2960597839275556
HCC1438,JQ-1-carboplatin (1-1 mol-mol),6.275002785263112
RL,71751553,4.25993021394767
T24,2746,3.727610415765059
NCI-H226,11152667,2.5295492164700977
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
HOP-62,136227331,3.5608481617611165
HCC2108,136227924,3.562843531024723
GOS-3,9935249,3.5788705539521315
BDCM,135421197,0.954440132345953
TE-9,136227924,3.0742454984310825
BT 330,9926054,2.1336209959126253
SNU-869,71751553,5.7810883558309465
OAW28,9911463,4.007690751229585
L-363,2746,2.0484035065398007
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
LAMA-84,9926054,1.7519699359088703
HT-1080,1566236,3.9096687939469135
BT 159,selumetinib-vorinostat (8-1 mol-mol),2.758617104178697
CMK,12003241,0.0052049395185332
A101D,49836020,-1.073011415975237
CL-11,2746,2.4152572914027366
CA46,1566236,0.9666867201201066
KMS-20,54618305,3.8048007259852543
KE-39,136227331,5.536038659908766
ONCO-DG-1,3854666,0.637439715699951
KMS-18,65628,5.193689022316172
253J,9868037,1.5770762651025676
HCC1438,9884685,0.8398898245443017
KMS-28BM,1566236,-0.3708562680621429
A-549,24771867,2.4933733383815206
HEC-251,11404337,-0.8985576004471967
JHH-4,11404337,-2.717621679177181
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
A-549,136227924,3.1395144761786486
BT 112,10296883,3.9999728699442607
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
SNU-869,9911463,4.356989154503334
JM-1,10296883,2.092198976716966
NU-DUL-1,1566236,0.5337861668433016
NCI-H1915,11404337,-0.6754401964347063
NU-DHL-1,11152667,-2.1433741052472493
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
Daudi,54639665,4.383406013207389
CAMA-1,54618771,-0.4577950074396519
UACC-257,2742550,4.012288915291852
HuH-1,1566236,4.12950114237624
SNU-840,9884685,2.581610284096353
DK-MG,6918638,0.8133882736108148
HuH-1,71751553,4.274429516830916
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
OC 314,9926054,1.7783261777640869
Hs 934.T,9884685,-0.7666789770957926
JHH-4,4378219,2.033392408216237
KCL-22,9868037,2.068563427073688
U-BLC1,136227924,2.288895160726179
QGP-1,135421197,1.134586890713183
EJM,135984461,5.02990169097732
DND-41,11494412,0.7707126282349229
OV56,135398744,6.336681474599488
HuCC-T1,4378219,1.7187737313992542
KMRC-2,3854666,3.8888485200781377
PE/CA-PJ41 (clone D2),9884685,0.9202237029017308
AsPC-1,2742550,5.133078791264603
TTC-709,2746,3.375818132682937
SNU-620,54618305,4.1885361455168155
NCI-H526,100016,5.298819017471169
COLO 668,135659046,3.450093755240726
J82,12003241,-0.1407716325694316
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
BT 482,9926054,2.2206643781764184
BICR 56,100016,6.239283130221144
HCC1937,44241473,5.82408790758293
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
SNU-886,24771867,1.589817907725939
EN,71751553,4.851604891017641
DU145,2742550,4.5042202840437975
OE19,9911463,4.190839758314233
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
Hs 940.T,9884685,0.681854393088184
Kuramochi,9911463,3.7010026849827087
BT 482,9935249,2.8918115184774305
BT 416,9935249,0.9588167986090808
GaMG,54618771,-0.7184169257406299
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
OE19,9915743,-1.6834349992839135
RCH-ACV,9926054,1.6841422831368045
NCI-H358,selumetinib-GDC-0941 (4-1 mol-mol),-1.5970203411339507
BT 333,1566236,2.7290285893433173
A-204,44241473,4.646558487223065
NCI-H211,73707386,2.5869092574593413
UACC-257,selumetinib-GDC-0941 (4-1 mol-mol),-0.8117172075049729
NCI-H1651,9935249,3.236864659614126
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
YD-38,136227924,2.6123275605059075
GI-1,JQ-1-carboplatin (1-1 mol-mol),0.4755278036860928
BICR 22,11494412,0.8036857209518554
A-549,54618771,0.0374822867627876
EBC-1,11404337,-0.1600536834306797
NCI-H650,selumetinib-vorinostat (8-1 mol-mol),2.643357651704564
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
NCI-H1693,9926054,2.0729608249560436
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
U-251MG,136227924,4.317491880233533
NU-DHL-1,3465537,0.9340526955418934
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
VCaP,selumetinib-GDC-0941 (4-1 mol-mol),1.6951262679306962
HD-MY-Z,65628,4.144650294210182
BT-474,71751553,4.578203440139317
NCI-H2052,135421197,2.7850999570051003
JHH-6,selumetinib-vorinostat (8-1 mol-mol),4.827316742876486
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
HT-1197,6918638,1.042258659945556
SK-MEL-30,11152667,1.317956981050057
NCI-H647,10322450,4.351576478086524
KM12,3854666,2.1035139353174372
NCI-H146,24771867,1.252264036368602
Detroit 562,65628,4.413660609351981
SNU-16,4705,2.028758835255635
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
YKG-1,9911463,4.439291278473792
BICR 22,9911463,4.403388511465592
SU-DHL-1,54618305,4.34503505735179
SNG-M,4378219,2.1715928837627185
HSC-2,135659046,3.2324626300653465
HCC15,11152667,0.1037945221143532
Calu-6,selumetinib-GDC-0941 (4-1 mol-mol),1.8439594255895029
TE-5,11404337,-1.6640351718537505
NCI-H1341,9915743,0.2650285979263042
SET-2,135659046,3.4006834919950006
Daoy,24771867,3.1474812172720625
GOS-3,11152667,0.5000513857969126
JHOC-5,73707386,5.104699893328899
MCF-7,selumetinib-GDC-0941 (4-1 mol-mol),1.646510277694018
NCI-H841,3854666,0.1332516295685137
MFE-319,9935249,3.387887066953814
GMS-10,65628,4.321252297896726
NCI-H661,4705,2.5155315968978127
JHH-2,11404337,-0.6360298022443034
NCI-H522,71751553,5.137300136027492
Hs 934.T,12003241,-1.701018905102148
NCI-H647,2742550,3.61263816541944
Hs 578T,3854666,0.9314111663705392
NCI-H446,selumetinib-GDC-0941 (4-1 mol-mol),2.0638797586373263
MCAS,24771867,2.4778802536032045
NCI-H747,135659046,3.644022415013725
NCI-H2029,3854666,1.065457939049436
HCC95,54618771,0.2896337021071054
TALL-1 [Human adult T-ALL],11152667,-3.0141291554787655
HCC2935,3465537,2.564859835808272
MDA-MB-453,3854666,1.8999840682298523
HEC-6,100016,5.931518422248653
NCI-H841,135984461,4.323824309438455
ACC-MESO-1,54618305,4.946353791859653
CAL-62,11404337,0.5781549927115224
SYO-1,9935249,3.6195972707875255
F-36P,selumetinib-vorinostat (8-1 mol-mol),0.7634512600897306
HPAC,9935249,3.1967144578068294
HCC1500,11404337,-1.1638452247583002
SCaBER,11494412,0.3138504125122266
SK-N-DZ,9926054,1.7056763451018535
BT 286,11152667,1.278732358262165
SU-DHL-8,9884685,0.5394241302496563
HCC-56,selumetinib-GDC-0941 (4-1 mol-mol),-0.1385009392783674
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
CAL-148,selumetinib-vorinostat (8-1 mol-mol),2.102120604451704
BT 359,4378219,1.954860036671166
NCI-H460,11404337,1.7201854837770862
DU4475,9926054,1.608890542810364
SNG-M,selumetinib-vorinostat (8-1 mol-mol),3.700323618975828
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
Ki-JK,9868037,1.5525844066111418
Hep 3B2.1-7,9911463,3.814987656182777
YKG-1,1566236,3.4432239781359577
NCI-H1838,9926054,1.7507639405240023
IPC-298,54639665,4.406895640456026
NCI-H2444,selumetinib-vorinostat (8-1 mol-mol),3.1032732552944293
RCH-ACV,2742550,3.694340545440027
NCI-H647,136227924,2.9483035397305164
WM115,11494412,2.975341542339242
OE33,9884685,-1.0024057051138902
NCI-H209,9884685,0.4313294242687383
NCI-H2170,9915743,-4.0730094679521125
BT 147,9911463,2.928240500663929
ChaGo-K-1,11404337,1.1508536619225571
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
RVH-421,9884685,0.9486635523553502
KMS-21-BM,JQ-1-carboplatin (1-1 mol-mol),-1.6939988291679535
HCC1195,1566236,1.8667850509646169
MDA-MB-415,9926054,2.772494701182559
KMRC-20,9911463,4.198821616328526
SNU-869,54618771,1.00410575890065
JK-1,2746,0.8600907908975023
MOLM-6,9935249,2.359977585309934
HSC-2,1566236,1.667339069930402
Rh18,9911463,3.04547091228865
BT 416,9884685,0.6464924018321844
WM266-4,2742550,3.9652001129463863
NCI-H929,11404337,-0.6691193705825791
KE-97,24771867,-2.300360212734288
Hs 578T,71751553,3.352664213062509
MKN7,11404337,0.0072923391755458
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
Rh18,11152667,0.4315995494314446
Yamato-SS,9911463,4.3796041086014
BT 139,12003241,-0.7824976089919207
CMK,9926054,1.7941257572629667
YD-8,2742550,3.780440690417096
Hep 3B2.1-7,135421197,0.863862977673099
KPL-1,3465537,2.5185436279370896
WT2-iPS,65628,3.328166240276732
SUP-T11,3854666,0.4319450798488521
HEC-1-A,9911463,3.802015322835987
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
NCI-H196,11152667,-0.3084820466732423
HCC1428,10322450,3.77316482135935
U-87MG ATCC,11404337,1.6069036214157395
TCC-Pan2,9911463,4.063376197709276
NCI-H2029,2746,2.486824956560061
TE 617.T,11152667,-1.0765284818833325
KMS-34,44241473,3.849012372493151
NCI-H1869,12003241,-1.5114527115730307
IST-Mes1,136227924,2.313131576565863
TF-1,2746,2.294459830990238
HCC2935,9868037,3.914000615600812
IM95,12003241,-0.6158272527459553
A-549,54618771,0.0374822867627876
SUP-M2,1566236,0.979539411092358
NCI-H838,6918638,0.9107836938551492
COLO 800,6918638,0.9384820746097428
KG-1-C,selumetinib-GDC-0941 (4-1 mol-mol),0.970562535367186
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
NCI-H460,100016,5.855223104671776
SK-MEL-5,135421197,1.8346447693413537
FTC-133,24771867,3.849205905915908
BT-474,136227924,2.4914554847870187
CW-2,1566236,1.6101300904143996
YD-10B,9911463,3.649905942597577
CAL-33,9884685,-0.0221160143719173
BT 139,9868037,3.9588523345635376
Lu-99,JQ-1-carboplatin (1-1 mol-mol),0.8870442725111318
ST486,135421197,0.3717374472748143
L-428,10322450,3.383753825926629
PE/CA-PJ34 (clone C12),2746,3.651379195242312
UACC-62,6918638,0.9187226840984998
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
COLO 684,10296883,4.095510288741906
BT 216,4378219,2.787992245384894
UO-31,10322450,3.2206425207996268
AML-193,135659046,2.987496818828137
MKN74,136227331,4.503917554589063
LS123,54618305,5.7379544122052275
NCI-H196,9884685,-0.0340951711946578
NCC-StC-K140,3854666,-0.5733064353695863
ECC12,9911463,4.410460667736256
G-402,100016,6.451749665500501
CHP-212,9884685,-1.3335734130600392
MV4-11,9926054,1.3518163817603386
KYSE-410,135659046,3.770855239455897
BT 416,24771867,1.406096437509098
C2BBe1,135421197,0.6239864918667269
NCI-H1355,136227924,5.68794295830134
KYSE-140,12003241,-0.6057431237522657
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
BT 359,11152667,1.623883380648874
KMRC-20,11152667,-0.0779110822248748
SK-MEL-5,10296883,3.4956550108222775
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
CAL-78,10296883,4.297149072748996
SNU-119,24771867,2.6075976586492624
RERF-LC-A1,JQ-1-carboplatin (1-1 mol-mol),5.6290359475230725
SK-OV-3,12003241,-1.2313805329375749
HD-MY-Z,9911463,3.453159994393753
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
HCC1428,1566236,5.933889412294908
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
42-MG-BA,6918638,1.602058040932412
KNS-81,4378219,5.370896913967785
CAL-85-1,135421197,1.4377656539975323
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
HEC-1-B,9935249,3.3979686302548413
LK-2,JQ-1-carboplatin (1-1 mol-mol),4.1358496368308035
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
HCC1500,10296883,3.843895309810077
SNU-1077,136227924,3.612132735883527
ES-2,54618305,5.3150029072751375
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
LUDLU-1,12003241,-0.5957791848083803
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
Tm87-16,3854666,2.16285781044172
LK-2,selumetinib-GDC-0941 (4-1 mol-mol),2.476952398707666
SK-ES-1,selumetinib-vorinostat (8-1 mol-mol),2.305244767377923
MPP 89,24771867,3.702458281662236
HCC95,9911463,3.4166261837623098
NCI-H889,54618771,1.1876594721233993
AU565,11152667,-0.8659767610796402
NCI-H1838,11404337,-0.072819025932654
SNU-C2A,10322450,3.700200592981039
SNU-407,selumetinib-GDC-0941 (4-1 mol-mol),0.3272948267945177
VMRC-RCW,73707386,3.661601615077718
OE21,11404337,-3.0833954848691234
HuP-T4,9915743,-1.7741648598156543
NCI-H647,12003241,-2.504495302724225
BT-20,24771867,2.695530760477261
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
SK-N-FI,selumetinib-GDC-0941 (4-1 mol-mol),0.5932957788770222
DU145,65628,4.2291081704038325
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
Li-7,12003241,-1.919504874807884
NCI-H211,selumetinib-vorinostat (8-1 mol-mol),1.6355902662267163
SNU-840,24771867,3.757295517919868
DMS 454,11494412,-0.2610081451364712
A-549,3465537,3.857188765779011
OVSAHO,54618771,1.1645898575055549
MKN7,9911463,4.336260113916537
Malme-3M,4705,3.370041144877098
HuT 78,3465537,2.3062408835575923
YKG-1,2746,3.802533592415727
HT-144,135659046,3.3516643492898477
BT 179,1566236,1.8409261490305735
NCI-H2286,54618305,-3.3822182041905813
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
SYO-1,10296883,4.0687623186484005
TALL-1 [Human adult T-ALL],9911463,3.188580812335009
NCI-H1651,3854666,1.3633084002246365
JHH-5,selumetinib-vorinostat (8-1 mol-mol),1.604008416934301
Caov-3,9926054,2.84814467099178
HEC-6,9911463,4.040117768715498
MDA-MB-361,4378219,1.8946086979260963
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
NCI-H1092,65628,3.8308798172666183
HEC-151,9915743,1.4580340601681427
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
MKN7,4705,2.6628082775423865
H-STS,6918638,-0.6396360846494638
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
BT 248,6918638,2.3802175448525844
Hs 683,10322450,2.9588176453624766
L-428,3854666,0.4436949042034823
JMSU-1,2742550,3.14564169590764
COV644,54618771,0.8361295238713768
COR-L51,4705,3.639553791730093
WM88,2746,2.5770363002684555
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
MDA-MB-453,11152667,-1.4808178636693017
HuG1-N,44241473,4.611352443081476
SNU-1,54618305,4.180407236417695
NCI-H2228,2742550,6.139111772417892
HCC38,selumetinib-vorinostat (8-1 mol-mol),3.9868927828285594
LNCaP clone FGC,6918638,-0.3198952238594262
TT2609-C02,12003241,-1.0431647024866548
DOV13,12003241,2.698298225737835
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
G-361,135984461,4.251520371382919
SYO-1,65628,3.525115275598551
DB,135421197,1.3227021747573118
Hs 611.T,selumetinib-vorinostat (8-1 mol-mol),2.75896517659524
NCI-H358,100016,4.0854531303861155
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
Raji,11404337,2.5048803156599586
MJ,9915743,1.766638415426978
MCF-7,9911463,4.323534340426757
SNU-899,11404337,-0.8978205339796733
PSN1,71751553,4.565522907457272
SNU-886,135398744,6.3424886084429435
SNU-1,71751553,4.430518042504184
NCI-H1944,4705,2.455781593710475
NCI-H1339,9915743,3.628924415446368
OCI-Ly19,9884685,-0.3928365240686269
Karpas-299,9926054,1.611454190499719
Panc 10.05,9884685,0.9993318997912782
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
BICR 31,2746,4.041774334142006
OV7,9935249,0.7087225870012266
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
NCI-H2052,54639665,-0.9573654652535992
HEL 92.1.7,10296883,3.579285339073021
BT 147,54618305,4.434824757436184
SUP-T11,9926054,1.9086268061731997
NUGC-3,3854666,1.9021354568285025
HPAC,selumetinib-vorinostat (8-1 mol-mol),1.7368980324290706
SK-MES-1,9911463,3.432548166775373
EFE-184,24771867,3.9170571214290737
BT 498,3854666,4.451868649055675
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
G-401,12003241,-2.103305079214356
SNU-410,135984461,4.232022058920155
HCC2218,JQ-1-carboplatin (1-1 mol-mol),4.076746377800596
A3/Kawakami,4705,2.957663936707348
KNS-60,11152667,-1.945489843618092
BT 330,6918638,2.094290704712354
EFO-21,2746,3.739979027331037
NCI-H520,10296883,3.906496007421639
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
NCI-H1693,6918638,0.9296427342900364
HCC-56,9935249,3.344973391088982
IM95,1566236,3.9242016220149623
CAMA-1,135421197,1.145586441403014
TE-4,2742550,3.8546929103430174
MJ,24771867,-4.046707231281286
EM-2,9911463,2.8916487141843974
SUP-HD1,9911463,3.4202590539145836
U-87MG ATCC,135421197,3.5274943050860874
HGC-27,44241473,4.2298295038521525
SNU-1066,selumetinib-GDC-0941 (4-1 mol-mol),1.622393970628324
CMK,JQ-1-carboplatin (1-1 mol-mol),-0.2458956642529063
NCI-H2081,135659046,2.9715500062667455
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
Karpas-620,136227924,3.0310478312116467
OCI-Ly3,135421197,2.144739759882478
NCI-H1915,10322450,3.706063293985689
LCLC-103H,9911463,4.367340887441101
HCC78,65628,4.210557288257803
NCI-H1105,2746,0.8615179559982858
WT2-iPS,44241473,4.309840654423109
KNS-62,54618771,0.989715202363148
NCI-H446,9926054,1.7959327761623658
OCI-Ly10,4378219,4.465100210934848
SNU-407,10322450,3.446523216641638
Kasumi-1,JQ-1-carboplatin (1-1 mol-mol),-1.0248552118786003
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
FaDu,24779724,4.73773020769498
HCC1500,2746,2.6069735713089006
PK-1,135421197,2.4270856926792947
HCC44,10322450,3.2615133519838775
GOS-3,136227924,2.1351760440562533
OPM-2,10296883,2.7550650350156474
NCI-H1581,9868037,1.2648285588909711
MEC-1,11494412,0.0986564081761275
SNU-601,12003241,-1.174156148938379
NCI-H2405,9926054,1.7306933863874645
SK-MEL-3,1566236,2.444556915654436
Raji,9915743,1.7375595717981451
PaTu 8988t,12003241,-0.7673639150441187
LNCaP clone FGC,10296883,3.861229612453215
A-375,135984461,4.563596493696721
IGR-37,9926054,1.73801540894826
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
NCI-H1092,54618771,1.961811722948082
SKM-1,9935249,2.0831236560196147
HOS,12003241,-0.4852200240623472
KYO-1,12003241,-5.7976599099380595
HOP-92,2746,3.1946789045133217
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
BT 179,24771867,3.9403629989947513
KNS-42,1566236,2.4771574284534417
GI-1,24771867,4.465773987443069
NCI-H23,6918638,-0.9097469315005928
MOTN-1,2746,1.1076991402099114
SNU-C1,135398744,6.35894151615267
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
SNU-1272,9911463,4.2598402664697685
BFTC-905,9915743,1.39772044573247
Ci-1,JQ-1-carboplatin (1-1 mol-mol),1.531401836561634
NCI-H1792,9935249,4.999628575749727
Panc 05.04,9911463,4.206171655784268
L-363,3465537,1.4710509677174886
Hs 766T,4378219,4.55690081129731
IGR-37,9911463,4.34930148495989
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
RMG-I,73707386,3.131829712185126
23132/87,11404337,0.4022152079144664
SK-LMS-1,4705,3.2417588485362554
HCC-56,11152667,-0.9440233104098088
SK-MM-2,9926054,1.3112248924199803
BT-16,JQ-1-carboplatin (1-1 mol-mol),4.438873165062089
KMS-18,11404337,-2.191729984555339
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
SNU-466,3854666,1.364536343751292
K029AX,12003241,-1.6892437749493532
Hs 940.T,selumetinib-GDC-0941 (4-1 mol-mol),2.512556445742238
SNU-1041,136227924,4.256354114890169
TUHR4TKB,9926054,1.808622022375876
A3/Kawakami,135659046,2.928957386337573
HCT 116,selumetinib-vorinostat (8-1 mol-mol),2.362007276438713
Rh18,4378219,2.2189060331704753
Hs 578T,54618771,1.0464366040522988
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
SNU-1076,24771867,1.5529030715563172
Capan-1,12003241,-1.403867722449874
LP-1,2742550,1.8998426324012776
U-118MG,3854666,2.832586657113328
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
HT-1080,135659046,3.530042119705326
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
HMCB,12003241,-2.4987094510650834
L-363,JQ-1-carboplatin (1-1 mol-mol),0.6579201637920293
HCC1954,4378219,1.71348935546315
HT115,135421197,2.47112158690729
NCI-H508,54618771,1.4622256000794474
MOLT-13,135421197,0.8546862359015375
NCI-H2106,selumetinib-vorinostat (8-1 mol-mol),2.254760596846594
SNU-8,9884685,1.4758258715385455
SK-MEL-28,10296883,3.852008110979885
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
LUDLU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.599632203402907
NCI-H1623,135421197,3.7764453326534855
OE21,3854666,0.7782353690934734
CGTH-W-1,9926054,2.1439424725815814
CAL-12T,12003241,-2.021983796416415
NCI-H2087,100016,6.366125554898137
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
ACHN,135984461,1.8041050140456245
SNU-C4,selumetinib-vorinostat (8-1 mol-mol),3.654514117080656
SNU-387,10296883,4.167941134769786
ONS-76,65628,4.406189432641036
SF539,12003241,-2.026733754371074
VMRC-LCD,2746,2.492181384222375
NCI-H2030,9926054,2.071654789099982
DU4475,135659046,2.7286473029025675
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
NCI-H1838,9868037,3.6730401154480767
KALS-1,9935249,3.898562329613611
KP-N-SI9s,12003241,-1.3670670210068214
TC-71,11494412,0.2670168299570634
Daoy,100016,6.878604021612681
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
PK-59,11152667,-0.441675469971464
OVCAR-5,4705,3.2119011926923378
SCaBER,10296883,4.146798449581147
HuH-6,selumetinib-vorinostat (8-1 mol-mol),2.590919017707307
B-CPAP,24771867,2.555650366496606
SK-N-SH,24771867,-4.618722010839445
JHUEM-3,9926054,2.0122307954459004
PE/CA-PJ49,4705,3.0123221957178017
Hs 729.T,135659046,4.671594069025629
LS180,11404337,-0.0678179476465551
MeWo,2746,2.380002507942182
JHUEM-1,4378219,1.963327649705112
JHUEM-7,3854666,0.7941739350816123
COLO 320,4705,2.552881427676556
SNU-478,65628,4.317035065954759
MHH-CALL-4,10296883,2.742921338749494
KE-97,135421197,1.12759931417641
Hs 852.T,9915743,-0.5396545081507467
Lu-65,1566236,3.455735123137807
TUHR10TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.6041094312427258
HEC-1-B,9926054,2.0295913011539173
HCT 15,9915743,0.5336080219876301
MOLM-13,54618771,-0.6841479707721928
RVH-421,135421197,2.7493093312166534
DMS 454,1566236,1.2742388106012354
COR-L88,11494412,1.2749755816381174
Calu-3,9884685,3.111229867397832
EFO-21,9926054,1.8086504581736744
SCC-25,9926054,1.6689856093207305
TALL-1 [Human adult T-ALL],4378219,2.06393200152422
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
KNS-62,136227924,3.1878911405001236
MDA-MB-157,2746,2.873003215594031
BEN,JQ-1-carboplatin (1-1 mol-mol),1.5811982122787027
BT-474,10322450,2.780600319023071
A-375,9926054,2.393426871996004
NCI-H211,2742550,2.7483286250684573
NCI-H1734,12003241,-3.2634619258307644
NCI-H2106,136227924,2.8262070038466955
BT 164,1566236,1.750997539979922
LMSU,2746,4.6094970791668315
JMSU-1,44241473,4.90665244064813
NCI-H2405,136227924,3.1304062683146747
RPMI-8402,49836020,4.366358527241826
PE/CA-PJ15,135984461,4.416241968173964
DAN-G,11152667,-0.8681633456195671
BT 139,11404337,0.9723364970795382
HuH-28,3854666,3.680446535502344
SW1417,24771867,4.044728857973512
MM1.S,3854666,1.277087835200556
TE-8,3854666,0.6254057025947416
Hs 940.T,54618771,0.7106983337265675
JHUEM-1,selumetinib-vorinostat (8-1 mol-mol),2.3736389824492035
NUGC-4,selumetinib-vorinostat (8-1 mol-mol),-1.0651550460583663
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
G-402,10322450,4.125946909240017
LP-1,4705,3.1959395550133247
SNU-C4,9915743,0.291849772396667
SF539,135984461,4.130188481564332
COLO 201,9935249,3.74717966542248
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
TE-6,136227331,4.078918341903366
BxPC-3,9926054,1.7603137158224154
NCI-H2171,2746,1.1013983502046127
MG-63,71751553,6.373877555127259
HMCB,1566236,1.7394312384979265
SK-MEL-24,selumetinib-GDC-0941 (4-1 mol-mol),-1.728607730118346
JHH-5,100016,5.964491744827364
AGS,9868037,3.4891422873048046
NCI-H2009,54618771,-0.2233577251443086
TOV-112D,4705,3.678495004677763
NCI-H2030,76446078,5.365957574929404
SUP-T1,11404337,-1.5860390885647615
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
SNU-1,4378219,2.100880152298618
CHP-126,65628,2.6111837286845243
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
BT 416,3465537,2.504203056087228
SNU-410,4378219,2.0638699890675047
SW579,12003241,-1.7693862144500747
P-STS,2746,1.4034499567898922
SR,selumetinib-GDC-0941 (4-1 mol-mol),2.945554798995567
NCI-H1915,4705,3.3172772088085307
KM12,11404337,0.0188417949264162
L-1236,11404337,0.7595432314307335
BT 172,135659046,3.5133066038104355
CAL-62,9911463,4.371192134502622
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
HCC1500,1566236,1.5057997400762737
SK-UT-1,11494412,1.7393092296584682
CAL-54,100016,6.472919480601912
BT-12,1566236,1.8346698509370287
JM-1,1566236,0.6280103536338946
DBTRG-05MG,12003241,-1.7775035610862775
U-BLC1,6918638,0.4166229945457058
BT 286,2746,4.414216796759687
NCI-H196,54618771,3.538687286650074
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
NCI-H929,73707386,0.8452841513210776
PF-382,135984461,1.6582229573318208
ONCO-DG-1,JQ-1-carboplatin (1-1 mol-mol),2.9184611678719667
MDA-MB-468,9926054,1.8087827398846443
AsPC-1,54618771,1.0442216511349782
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
KMRC-1,3854666,2.659759078644905
HCC827,73707386,5.245993299227604
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
Calu-1,24771867,0.8970625753815772
MOLT-3,9935249,-1.737643818642649
NCI-H838,2746,3.438518103958065
CL-11,73707386,2.162351861308678
8-MG-BA,135421197,2.5937417683499526
EM-2,10322450,3.0285960061439865
CFPAC-1,136227924,3.3404294087361883
KMRC-2,4378219,1.94428185531496
SNU-16,9935249,0.7935481401053108
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
HCC1428,54618771,4.504577297987602
Karpas-620,40482356,6.62895086010946
P31/FUJ,9926054,1.2698752833949425
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
KYSE-450,6918638,1.5500469019976144
GA-10,11404337,-3.9267202398834167
JHOM-1,selumetinib-vorinostat (8-1 mol-mol),4.561392642602074
HuNS1,54618305,4.275761416742284
BHT-101,selumetinib-vorinostat (8-1 mol-mol),0.3729037272415222
CCK-81,3854666,1.9040688936241612
NCI-H526,136227924,1.9152739000663332
WM115,9915743,2.6223908273409515
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
YD-10B,9915743,-4.675964091727352
BT 416,3854666,-0.8392418796175438
SK-MEL-3,10322450,3.9048135305000624
NCI-H2110,54618771,2.4596551535175504
SW620,12003241,-2.6864351641930155
KMS-34,9868037,1.4276182493949865
253J-BV,136227924,2.6085874458601066
SW1710,selumetinib-GDC-0941 (4-1 mol-mol),2.8555583802472277
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
NCI-H1734,9915743,-1.4157060227107183
SW579,11404337,-1.5327232138346547
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155
NCI-H2291,12003241,-0.3481975958318299
NMC-G1,12003241,-0.7597442114064075
EHEB,11152667,-1.348021466254982
PaTu 8988t,136227924,2.49705731140334
PC-14,136227924,3.162840410264972
CMK,11494412,-0.0667901955813207
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
HT-1080,9926054,1.8253134121716592
DU145,selumetinib-vorinostat (8-1 mol-mol),2.4809592604092305
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
RPMI-7951,11152667,-2.388321573678012
KM12,11152667,-4.273444919213735
G-361,2746,2.496090432084752
KATO III,54618771,1.8555498660455492
HLF,135984461,4.657471192071366
TM-31,9935249,3.1549341902639054
WM1799,9926054,2.0873998071095685
MDA-MB-415,9911463,3.632692855147505
ECC12,9926054,2.4969836568853507
NCI-H1623,9911463,3.95788841498078
MIA PaCa-2,JQ-1-carboplatin (1-1 mol-mol),-0.0764118739989751
MKN45,54618771,1.1504604366979514
BT 139,9911463,2.810742843963801
NCI-H441,54618771,2.015817613413058
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
OE21,9926054,1.7334869398194368
SK-N-SH,136227924,2.487245372945198
Panc 10.05,9911463,3.4870522809555653
253J-BV,9915743,1.703363927754684
SNU-213,44241473,4.380911531659556
CAL-51,9935249,3.84795648434564
TE-6,10322450,4.821445801682838
HOP-62,24779724,5.1203173517940135
JHUEM-2,9911463,2.885358490635734
COLO 792,135421197,2.064004994537627
NCI-H2052,11404337,-0.3501167429878626
HCC-56,11404337,1.7100052482003292
HT-1080,71751553,4.199253292607991
SK-UT-1,1566236,1.7242203991960865
SNU-398,2746,3.3199250937792866
GSU,135421197,3.362120533278017
SF295,100016,6.949657377166824
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
Karpas-620,73707386,2.2664961291067995
Kelly,10296883,3.2053414181421265
HCC1954,9935249,3.6133875865094063
IMR-32,11404337,-2.700681379951113
NCI-H1092,1566236,1.754245151236072
KALS-1,136227924,3.4972882997363257
KMS-26,11152667,-2.145052290186052
KE-39,44241473,4.750329858029805
Hs 294T,11152667,-0.3503938468733086
HeLa,54618771,0.9271666044907572
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
HPB-ALL,9926054,1.8714976527379283
NCI-H2029,11152667,0.9806383957372796
Panc 08.13,24771867,3.629736438956928
HCC2218,4378219,3.99128981890596
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
P12-Ichikawa,JQ-1-carboplatin (1-1 mol-mol),-0.0557948647984977
HPAC,11152667,-1.496468536370371
CL-11,10296883,4.178438273202507
Hs 895.T,4378219,2.6067013065770324
UM-UC-1,9884685,0.3158725560360218
OPM-2,3854666,0.6659331794855328
AU565,1566236,1.7493429265082687
2004,54618771,0.1677615799091476
NCI-H647,9911463,4.264902637756033
HuP-T3,9884685,1.9355517940144655
NCI-H2030,54618771,3.292263250244386
A4/Fukuda,135421197,1.440002399326734
SNU-601,9911463,3.648706440193743
MOLP-8,135421197,1.7506124789909805
FTC-133,65628,4.302527639906617
J82,4705,3.746320789135998
BHT-101,9911463,4.450414123842211
CAL-85-1,49836020,1.7789600466695898
MKN74,selumetinib-vorinostat (8-1 mol-mol),2.9891343546894267
ZR-75-30,9915743,-8.763917050030939
HCC1833,12003241,-0.598038454038546
HT-144,11404337,-2.6736353860165054
OV7,6918638,1.9769978883441133
ME-1 [Human leukemia],135421197,1.4857901642413922
MKN74,135421197,1.917095385489804
MCAS,12003241,0.5308085719616568
SJSA-1,54618771,0.8793199356074002
HCC1419,54618771,0.889402864117146
HEC-59,135421197,2.778714880666289
BT-20,3465537,4.429607875792749
MDA-MB-468,1566236,1.4532799362924351
PF-382,44241473,4.707549872781651
HCC1395,9935249,3.722590461759625
Hs 888.T,49836020,6.084092385452033
MDA-MB-453,11494412,1.83607541398336
G-401,4378219,4.593157039926137
SNU-8,135984461,1.5881449503105405
NCI-H146,24779724,4.32606530761132
HCC4006,4705,-0.7694526877641281
TUHR4TKB,3854666,3.4631850286996717
OCI-AML-3,4378219,2.020771339620158
KMS-21-BM,12003241,-1.038159466289584
BT 440,2742550,3.3908982659384668
JL-1,11404337,1.0856357490679192
HCC1395,54618771,2.360286103240852
Panc 02.03,24771867,4.320948526904658
Calu-6,44487872,4.552226004376926
OVTOKO,11404337,0.3114289672372418
NCI-H520,12003241,-2.710304641181941
HCT 15,9911463,2.535565798999095
A-204,6918638,0.7578791197634218
DoHH2,73707386,-1.3802336356597755
NU-DUL-1,9911463,2.736663650607352
Hs 888.T,54618771,0.4236563431262232
Mel JuSo,24771867,4.169559856435605
GCT,JQ-1-carboplatin (1-1 mol-mol),4.70217217207532
CHP-212,2746,0.548553476305332
SNU-489,3854666,2.987559743136252
VM-CUB-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2001367648558769
CA46,9911463,2.565133854881976
KCL-22,11404337,-1.0119839618424291
BT 359,136227331,5.057853288307873
BT 359,10322450,5.961347508750194
AGS,JQ-1-carboplatin (1-1 mol-mol),3.380502968435776
Kelly,selumetinib-vorinostat (8-1 mol-mol),2.3555800551092356
BICR 6,10296883,4.111164180583034
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
NCI-H2110,11404337,1.6337523371229576
HSC-4,136227924,4.2199200707906845
NCI-H2141,2742550,3.0407478548544544
JM-1,44487872,4.651129481786086
TE-5,100016,6.463093527046919
KO52,3854666,-0.4105607896605044
TCCSUP,3854666,3.617075113283279
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
Namalwa,2746,1.3872498592399898
A-375,135421197,1.9818816716343688
NCI-H1694,9868037,2.26987701984991
T84,2742550,3.5016652738458456
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
BT 333,4705,3.363159057665455
KMRC-2,9911463,4.365671191059928
SK-UT-1,9911463,4.1504947350424315
EB1,9915743,-0.0076946910500104
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
SNU-475,54618771,1.821628813352334
TE 617.T,10322450,3.863383234066746
KU-19-19,136227924,3.1447471190609217
BT 330,4378219,1.6055397762494217
AML-193,24779724,5.0401581340070205
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934
SNU-1,10296883,3.7174122839678336
SK-N-FI,12003241,-1.9986022359494329
HEL,11404337,-0.835651629585067
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
HCC1954,11152667,-1.3224396298390433
T-47D,11404337,0.5836773446504185
OS-RC-2,9915743,1.7303629724196847
NCI-H1694,40482356,5.080253872971327
NU-DUL-1,54618771,-1.656554068738758
Panc 03.27,24771867,3.0819012538089106
EM-2,136227924,2.1746228564853864
HOP-92,24771867,2.2961333191414703
Hs 746.T,9935249,2.8365347377791954
Hs 940.T,49836020,0.3433567165193816
PK-1,9911463,3.7695460947373784
BCP-1,9884685,-1.059831110427225
JJN-3,135398744,6.34309809291168
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
Capan-2,10296883,4.260435559241064
NCI-H841,4705,3.1864652961877917
HSC-4,135421197,2.1482643592466495
Sq-1,9915743,-0.0182413792869356
NCI-H2052,12003241,-1.5616837194527835
8-MG-BA,3854666,3.167803657238392
SNU-475,selumetinib-vorinostat (8-1 mol-mol),4.539590497188421
BT 498,11404337,1.4735257645837956
UO-31,3854666,1.8037632230339509
MDA-MB-435S,9915743,4.554328214645058
AsPC-1,11494412,3.580103428724827
AML-193,9926054,0.8292500331421907
BT 232,1566236,2.96800449677677
A-253,2746,3.706033536924258
SYO-1,9868037,3.815139234423316
JHOM-1,4705,3.029937408009012
DU4475,JQ-1-carboplatin (1-1 mol-mol),0.3822189062446061
RCH-ACV,4705,2.8616908433941495
NCI-H1184,selumetinib-vorinostat (8-1 mol-mol),2.335103631077057
CW-2,135421197,1.1852786816312322
SNU-C1,2742550,3.130102864096647
JHH-2,12003241,-2.42929005443543
JHOM-1,24771867,3.1231526081627794
C2BBe1,selumetinib-vorinostat (8-1 mol-mol),2.2327261845522774
SU-DHL-1,3465537,3.713885766889003
BL-70,1566236,1.7416130953011706
LS513,135984461,3.023375368580486
PK-59,54618771,0.2590305123117813
BT 330,10322450,4.515837789997584
KMS-20,136227924,2.296093636743899
A-498,168313307,4.423397924448837
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
UACC-257,10296883,3.905415192758359
Karpas-422,11404337,-0.752603119365503
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
BT 444,4705,3.933248870863524
NCI-H1581,2742550,2.98284330301107
BT 164,2746,3.0448887101441793
NCI-H1581,9926054,1.914442948452832
SNU-C1,135421197,0.9147895752646428
IGROV-1,12003241,-2.0122972114546904
IPC-298,9935249,3.634833619141818
JK-1,4705,2.217809938793497
BT 159,6918638,2.114216253864974
NCI-H1435,9926054,1.8918877697265553
PLC/PRF/5,11404337,0.67614932520098
SNU-626,76446078,4.013389722449539
BT 147,136227924,1.9245142249128984
LCLC-97TM1,10322450,3.85878970197106
MIA PaCa-2,11494412,0.4238198089736678
HCT 15,12003241,-0.9489590343068364
HCC1428,12003241,3.752026929973328
SK-MM-2,135984461,1.4318073157862956
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
Panc 10.05,10296883,3.775390801263641
BT 444,136227331,4.190644654212499
Ri-1,9915743,-1.2170005610109595
PE/CA-PJ34 (clone C12),9935249,1.3468495063678572
Lu-99,9911463,4.284576210673527
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
Sq-1,selumetinib-vorinostat (8-1 mol-mol),2.350813570544066
NCI-H1092,11404337,-0.107357005094737
YD-10B,9884685,-1.5803668389078624
RL,4705,3.6746067243503857
U-251MG,135659046,4.3313031112664095
OV7,JQ-1-carboplatin (1-1 mol-mol),4.300342052298617
NCI-H1793,44241473,4.659845459348694
BT 139,10296883,4.347610797549644
NCI-H1092,76446078,4.704982368459853
HCC4006,135659046,3.6436381784680494
KYSE-150,9868037,4.171183799285216
RD,9911463,4.091242805100522
COR-L88,100016,6.409850176158066
VM-CUB-1,54618305,5.052147862407373
HD-MY-Z,12003241,-2.342795911905131
HCC1143,49836020,2.702530837822698
GSU,JQ-1-carboplatin (1-1 mol-mol),3.56440629696987
8505C,135398744,7.128245503588914
PF-382,12003241,-3.7051147214471114
RT-112,12003241,-0.7712914992257113
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
LS123,40482356,5.031986777400032
BT 231,100016,7.4946101776766385
HuP-T4,135398744,7.1369518257480475
CAL-29,136227924,2.032112399542908
Sq-1,2746,3.2736389846426532
SK-N-MC,1566236,1.1445008025862364
NB4,12003241,-0.9132683604987908
MOLM-6,73707386,1.8712602450547513
SW1353,JQ-1-carboplatin (1-1 mol-mol),2.2379049663986437
NCI-H889,3854666,0.6908596149728301
SNU-5,4378219,2.540466175995709
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
SCC-25,1566236,1.5434275794698058
MFE-319,selumetinib-vorinostat (8-1 mol-mol),2.3643464051369483
ES-2,9915743,3.6243790068274384
2004,11152667,-2.5450594943975986
Hs 578T,12003241,-1.9219753364875385
KYSE-150,71751553,4.3455313830128635
Kuramochi,136227924,3.2782581577037964
LOX-IMVI,9915743,1.7866984805438202
TE-15,100016,6.263488161224716
NCI-H1299,9911463,4.155040762407167
HT-29,selumetinib-vorinostat (8-1 mol-mol),2.6415975495156596
TE-10,54618771,1.2495537185307453
SU-DHL-8,135421197,1.0706680615676138
CJM [Human melanoma],71751553,4.441871884843961
ZR-75-1,9926054,2.043336248210882
NCI-H2170,24779724,5.385987309009065
SUP-M2,54618305,3.727120428172907
Daudi,136227924,1.3476403322374937
Calu-3,9926054,2.517272987008367
TE-5,11152667,-0.0661782736435693
SUP-T11,9884685,-1.4007483875875175
NCI-H1869,6918638,1.090174259453097
SUP-T1,2746,1.6864160186054145
SNU-308,9911463,4.030831002886429
NCI-H2029,65628,4.268303683940135
WM266-4,1566236,1.7711273273174748
TE-14,100016,6.976624848230786
Peer,54639665,4.400120880800027
RL95-2,73707386,3.467916185047665
KE-39,3465537,4.350124533164427
TC-71,10296883,3.4863812877107176
HCC-56,12003241,-1.1028800957118954
MES-SA,135659046,3.2856375054871436
NCI-H2126,9926054,2.0707718665056456
K-562,9911463,2.5078915917546336
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
PLC/PRF/5,54618305,4.300403954013755
ST486,JQ-1-carboplatin (1-1 mol-mol),-0.3320701641895573
KNS-42,3854666,2.658975673692566
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
YAPC,3854666,3.60977300269674
PK-59,10296883,3.535365595306604
OAW28,11152667,0.0990704789630026
MEC-1,65628,3.8656059442846664
SK-CO-1,11404337,-0.5084033800481932
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
EoL-1,136227924,1.175653355009707
NCI-H1355,selumetinib-GDC-0941 (4-1 mol-mol),2.7709082983519564
RVH-421,JQ-1-carboplatin (1-1 mol-mol),4.487330987841125
BxPC-3,9911463,3.950256717526944
HEC-59,9935249,3.547828303095583
COV362,JQ-1-carboplatin (1-1 mol-mol),5.952007792704957
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
RPMI-7951,9915743,0.6767769344324703
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
NCI-H1573,selumetinib-vorinostat (8-1 mol-mol),1.3032639466540858
CHP-212,9926054,1.886787046066781
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
BT 172,11404337,-1.2975012169581652
LS513,11404337,-0.9008701596149395
LS513,9915743,-0.1928520394279614
SNU-1079,24771867,0.8441166398955187
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
KYM-1,11404337,-1.4539042664575286
NCI-H2085,11152667,-1.1434648476401426
BT 145,4378219,1.994615742890751
NCI-H1092,11494412,2.17753949415027
BC-3C,9911463,4.117920402638588
SW1990,136227924,4.2742525725591864
SK-MEL-2,6918638,1.2677051834629418
A-172,1566236,2.7054654358022345
A-204,24771867,1.8197648192043092
WM793,9926054,1.9861694749243135
JHUEM-2,11404337,-1.101426517745614
NUGC-3,135421197,1.602671962705462
EM-2,9935249,2.516925866453196
KYSE-510,9868037,3.781080992935668
LUDLU-1,135659046,3.627701709010381
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
JJN-3,11152667,-1.6047644991927048
NCI-H1568,1566236,1.6523344134899465
NCI-H2172,650361,3.904571472219665
Hs 746.T,3854666,2.6045097457620465
COLO 792,4705,2.7626450241642355
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
JHOC-5,54618771,0.913993677886488
RERF-LC-Ad2,3854666,2.675858231607706
COLO 320,1566236,1.500506254136779
JJN-3,136227924,1.2624051766932831
SK-MEL-24,10322450,6.176718296792277
RMG-I,11404337,0.6551142499064945
COR-L51,9911463,3.8563370562199286
GA-10,JQ-1-carboplatin (1-1 mol-mol),-0.7456185194400317
SCC-25,9911463,3.418657228936731
HCC1428,9911463,4.299453342074575
HGC-27,9915743,-0.5179385932122726
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
Aska-SS,11494412,1.6723137258667875
KNS-62,71751553,4.396119226436637
HCC1395,11404337,-0.1331965245654414
HCC1438,11494412,0.0406589697755076
RD,selumetinib-GDC-0941 (4-1 mol-mol),0.4291937329067764
NCI-H838,54618771,3.458197236352402
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
BT 159,11404337,0.5861575458896715
RKO,10296883,4.075814636405189
NCI-H1299,9926054,1.7323284970245385
T3M-10,4705,2.7923170944145643
DV-90,9915743,0.0761455851411662
NCI-H2023,9915743,3.985285977542264
PSN1,9926054,1.7845816919346065
MES-SA,3854666,1.035679794156088
Panc 10.05,selumetinib-GDC-0941 (4-1 mol-mol),-0.0838909853180393
HT-144,9915743,2.253768741240734
KYSE-150,6918638,1.3155627931216132
Capan-2,selumetinib-vorinostat (8-1 mol-mol),3.1590069051625544
NCI-H2081,54618771,1.045855982244366
SHP-77,9926054,1.3761087450643723
JJN-3,11404337,-1.3886118473033382
BT 504,12003241,-1.3815102310326015
NCI-H520,54618771,1.0653077757718592
SW982,44241473,4.190288950747636
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
T98G,24771867,3.67849039634948
SHP-77,selumetinib-GDC-0941 (4-1 mol-mol),3.697439866327475
U-118MG,selumetinib-GDC-0941 (4-1 mol-mol),2.998678120294993
SK-MES-1,2742550,3.2236302544154354
F-36P,9868037,2.720274888315988
RERF-LC-A1,9911463,3.9529854896489782
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
VMRC-RCZ,1566236,3.0269814676241924
JHOS-2,2746,4.554227628602608
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
PF-382,9915743,0.1930622386086079
RERF-LC-Ad2,12003241,0.07971757119013
EB1,135659046,2.7495616978120543
NALM-6,3854666,0.6417754224123796
NCI-N87,12003241,-2.470820657410725
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
NCO2,44241473,4.08733028399539
TE-14,2742550,4.106621802038204
KE-97,11404337,-2.252102327608571
COLO 668,3854666,0.8964487913111397
NCI-H2444,3465537,3.061978524719414
T-47D,9935249,3.0203001978251236
KMS-18,2742550,3.49349515314962
SK-N-SH,10296883,3.689781558622769
ZR-75-30,2746,3.4802316913865563
DMS 114,12003241,-1.1763340491850245
SNU-719,11404337,-0.3522965671167558
GOS-3,135421197,1.697146176044067
SNU-410,9868037,3.710526937668442
AML-193,11404337,0.8563534093329411
LoVo,73707386,4.416344333605744
BICR 6,4705,4.392083823551742
NCI-H1944,71751553,4.042430534033758
NCO2,100016,5.1199760357582385
Capan-2,11404337,0.168585594733678
MDST8,10296883,3.644541291105843
HEC-1-B,100016,7.817681002018073
P3HR-1,11404337,-1.4937921094684845
2004,136227331,4.391518238587266
SNU-668,9935249,3.727070375636441
BT 145,4705,0.7034961776372417
BT 231,65628,6.2549230990110605
BICR 31,4705,2.7587837218207194
BT 340,4378219,1.592905473917639
CMK,11152667,-1.0104545212357872
NCI-H810,JQ-1-carboplatin (1-1 mol-mol),0.4173048947939034
BV-173,4705,2.8039060927559505
M059K,9935249,3.033672108656433
Hs 578Bst,9911463,4.212238001895026
Hs 936.T,10296883,3.997542153042743
HPB-ALL,JQ-1-carboplatin (1-1 mol-mol),1.026609404352011
OCI-Ly19,selumetinib-GDC-0941 (4-1 mol-mol),-1.7363769217481064
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
OVCAR-5,3465537,1.473355824395234
YKG-1,54618305,4.389332697073838
BT 164,JQ-1-carboplatin (1-1 mol-mol),4.081532753647648
HSC-2,9935249,3.203277250045846
OPM-2,12003241,-2.9738714531294232
SNU-46,135421197,1.3377995260402369
KMS-21-BM,9868037,1.4447274996214214
HCT 15,9926054,1.8634175733293992
PaTu 8902,136227924,3.2072125986231117
ST486,9926054,1.8361941441765457
NCI-H838,12003241,-1.6819169768090954
COV362,9926054,1.902525685415388
SNU-620,9926054,1.6234040218368857
Rh18,49836020,4.886485383707075
YAPC,9935249,3.6850704434892823
M059K,selumetinib-vorinostat (8-1 mol-mol),2.381985012022912
AML-193,3854666,-0.1541161036359395
EJM,71751553,6.47545049455161
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
EKVX,selumetinib-GDC-0941 (4-1 mol-mol),0.6299385991814179
NCI-H1793,9868037,4.171600355487511
COLO 668,54618771,1.2538028479070895
HLF,selumetinib-GDC-0941 (4-1 mol-mol),3.676368121214341
SNU-1,9911463,2.449424301931946
T3M-10,9911463,3.745237338298436
OCI-AML-3,9915743,0.4173420308342337
BT 179,6918638,1.1141974557977532
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974
LP-1,2746,1.409450400710279
NCI-H2030,11404337,0.8105383061900018
HCC1833,4378219,1.832290560559543
HT115,65628,4.396008028218786
BT 231,6918638,3.0604187031451437
KMH-2,24771867,-0.8834131311064513
Hs 294T,2746,2.985563453462856
KMS-11,10296883,3.3073702256130693
KYSE-70,9915743,1.2522553618909642
EB1,2746,1.806357780632162
RL,135659046,3.5403288851191927
HCC1419,71751553,5.3223316013448985
HDQ-P1,135421197,5.294865947723562
HT115,11152667,0.332844259056983
CAL-85-1,2746,3.013278075815884
COLO 792,6918638,1.1737976996738528
GMS-10,54618771,2.907722210856396
HEL,135984461,1.7610482730169696
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
TT2609-C02,2746,4.994680494565545
8505C,2742550,3.800445536913175
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
LS411N,11404337,-0.9351547419605356
P-STS,JQ-1-carboplatin (1-1 mol-mol),0.9856003461730172
MG-63,135421197,2.3239487693953627
IMR-32,100016,6.43791059275997
U266B1,9935249,2.70146726971407
RERF-LC-Ad2,100016,6.703705933143471
HCC1569,9884685,-0.2540549319759735
A-673,9911463,3.7053308577681583
NCI-H2052,54618771,-0.8339738497532683
SNU-201,9911463,4.2984017961299035
SNU-5,54618771,-0.9797108545959382
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
BT 286,65628,3.2626686935167544
22Rv1,3854666,1.9155449359846033
Panc 08.13,9926054,1.852191503455224
OC 314,135421197,2.0874935264790646
MDA-MB-435S,2746,3.2936917461422426
TE 441.T,49836020,3.964912597269393
BT 231,9915743,1.2683297871302317
Capan-2,1566236,2.8956582475218906
WM983B,9911463,4.352284884356164
LCLC-97TM1,1566236,1.804143498427706
UACC-62,3465537,3.3991522699600023
PC-14,54618771,1.2873092129984136
HCC1588,9935249,3.204556215826443
SNU-685,11404337,-1.4693578983295623
CAL-51,3854666,1.1494535123186709
PF-382,135421197,0.9667662585436329
WM983B,24771867,3.973677625635561
BL-41,135659046,2.671916295491686
COLO 699,4378219,2.1456768560783903
NCI-H358,9915743,-2.527498846949541
HEC-1-A,9926054,1.9825174619243453
KE-37,73707386,2.4219901291478214
SCC-4,3854666,0.8904264801390891
NCI-H1105,24771867,4.13290217676728
Caki-1,9911463,4.3928078257810785
CAL-78,24771867,1.367783184529445
HT-1197,71751553,5.426785505505591
SNU-449,100016,6.350050439021361
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
SK-MEL-1,11152667,1.128621157478479
JHH-1,selumetinib-GDC-0941 (4-1 mol-mol),2.043129184310282
Namalwa,10296883,3.754455655563699
OVCAR-4,JQ-1-carboplatin (1-1 mol-mol),1.400504619073484
BT 498,JQ-1-carboplatin (1-1 mol-mol),6.0311872836348535
HEC-151,JQ-1-carboplatin (1-1 mol-mol),1.2344499659819954
Hs 944.T,JQ-1-carboplatin (1-1 mol-mol),2.5361847784795715
CFPAC-1,135421197,3.4833112622431357
NCI-H1299,11404337,0.8410914432786373
ONS-76,9884685,2.079600161824297
YD-8,650361,3.8896393800715297
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
CML-T1,54618771,0.285641515878807
MKN7,9935249,3.2048024238983825
HT-55,54639665,4.445414545651382
KNS-62,10296883,4.284329668268845
NCI-H1184,4705,5.16871662983158
PK-1,54618305,4.508738372274147
KPL-1,9915743,2.2588912198208595
A-673,136227924,1.815433973878695
SK-N-AS,100016,6.379811774246359
NCI-H508,136227331,4.38758043299591
EFM-192A,54639665,5.165933724638737
BICR 56,9926054,1.8423418764912696
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
UACC-62,136227924,3.255935919058072
PK-45H,11152667,0.2417737455305368
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
SNU-245,11404337,1.1841340979823434
NCI-H23,9915743,1.0695073587250767
NCI-H650,12003241,-0.6460655528270789
HEY A8,11152667,-0.054665065354644
UM-UC-3,9884685,3.162644039126796
M059K,136227924,2.883059674155944
DEL,76446078,4.337482958652243
Hs 936.T,JQ-1-carboplatin (1-1 mol-mol),2.819300005463285
NCI-H1869,9911463,4.397307517913515
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866
KYSE-520,71751553,4.200829163158519
SNU-685,12003241,-1.0976198055590074
PL-21,9911463,3.159423653145491
NCI-H1395,11152667,2.8212920431399597
IMR-32,9911463,2.6287307610589172
KMS-28BM,4378219,2.6845619036231416
HCC2935,54618771,0.7337310107674532
BT 172,4378219,2.062438348929965
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
KM12,9884685,0.5350123780883383
SCaBER,selumetinib-vorinostat (8-1 mol-mol),0.862558649966769
MHH-ES-1,11404337,-1.1882712301989995
BT 131,11404337,-0.6302190073571774
SNU-16,12003241,-4.948615651726049
8305C,54618771,0.5083809192665402
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
RCC10RGB,6918638,2.235907203261483
SBC-5,3854666,0.5257720708282073
SaOS-2,24771867,1.911103494547597
Hs 578T,JQ-1-carboplatin (1-1 mol-mol),1.3034632234881312
BT 286,2742550,3.3943072978834277
ACHN,65628,4.557904719615972
KPL-1,135421197,3.0565693123686617
COR-L88,9915743,2.6531314221419704
NCI-H2196,9884685,-0.5196236885071903
JHH-6,4378219,4.006238945465007
COLO 320,3854666,1.7292178275601346
NMC-G1,76446078,4.114622797464651
Caki-2,6918638,1.5363275788764994
NCI-H1666,11152667,-0.2091625365803616
BT 416,136227331,3.8203373209104425
5637,9911463,3.863072039147436
CL-11,10322450,3.8898071669578
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
UM-UC-1,9926054,1.7733389617998403
HuH-6,24771867,3.3872458893316177
KE-97,10322450,3.096998499841668
SK-HEP-1,4378219,1.9889575503272792
Panc 03.27,3854666,1.0969733528715877
Capan-2,3854666,3.9240543200315026
G-292 clone A141B1,54618771,3.663374867416664
JM-1,4705,3.374089362448498
L-363,1566236,1.639224714587579
LS1034,11404337,-0.6299919233148044
BT 320,4378219,1.7610425663146678
COV644,4378219,1.933437464253687
MOLM-6,11152667,-3.090915690268157
HCC2218,6918638,-0.2279728548913661
COV644,9926054,1.7976744262803612
SW1417,11404337,-1.4535869227082985
NCI-H1666,10296883,3.734666163240881
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
BICR 31,65628,4.368112552275168
NCI-H841,65628,4.282861178298196
NCI-H211,135421197,0.3603373283624291
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
SNU-478,12003241,-2.4220393479516025
SNU-1214,9935249,2.745312094811984
MHH-NB-11,12003241,-1.5354599516868075
YAPC,11152667,0.3482753398657929
BT 112,3854666,0.1986005618410543
Namalwa,6918638,-1.4599496749108598
Calu-6,73707386,3.776758288702592
A2058,9911463,4.395992822531059
SUP-T1,9915743,0.2147589739019727
Ci-1,135421197,1.276790754576014
KU-19-19,65628,4.405271017285275
NCI-H1944,65628,5.0529725090595985
Malme-3M,11152667,3.7755207733410647
SNU-182,9926054,1.7680094082282705
42-MG-BA,44241473,5.680175730129261
SNU-61,1566236,1.9599867850180668
Calu-6,24771867,3.261055977205879
CAL-33,2742550,3.386545431599898
KMRC-2,135659046,5.230232657074779
NCI-H446,650361,5.808661894862166
COLO 205,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404403717614667
MOLM-6,65628,3.2313618395358645
TTC-709,9911463,3.2608867997672935
HCC44,135421197,1.110305691716081
HuP-T4,4705,0.794216535307181
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
HH [Human lymphoma],9935249,1.1534572137581305
BT-20,71751553,4.468530583756154
BT 112,12003241,0.1954695576836523
A-673,12003241,-2.2168793422392103
COR-L95,9935249,2.976260244275784
CAL-51,24771867,-0.5018492111736887
Hs 940.T,2742550,3.5735358604768837
ESS-1,9884685,0.689834242395422
MSTO-211H,9926054,1.9546831701161536
DMS 273,54639665,4.46621146803559
SU-DHL-1,44241473,4.633491620971472
CAL-78,11152667,-0.6927221356851716
PE/CA-PJ15,54618771,-1.2856394778285385
NCI-H322,selumetinib-GDC-0941 (4-1 mol-mol),1.023926311645034
SNU-201,54618771,1.5381558224082674
BHT-101,12003241,-0.6402723165837827
VMRC-LCD,11494412,0.3498055732572009
HuCC-T1,9935249,3.5788863262421216
SNU-738,135421197,2.9898433759416396
COV644,12003241,0.3541041054737522
NCI-H2286,9915743,0.0711668307778549
EB1,11404337,-3.430704628521276
CAL-54,54618305,4.3484536151131135
SNU-407,12003241,-0.5168922712641052
LNCaP clone FGC,11404337,0.2192821981043099
786-O,10296883,4.604694854621938
JeKo-1,selumetinib-vorinostat (8-1 mol-mol),2.4453871376323955
MCAS,100016,6.4909883414165135
Malme-3M,selumetinib-vorinostat (8-1 mol-mol),-1.6232213829827038
JHOC-5,selumetinib-vorinostat (8-1 mol-mol),2.458385145545893
KMS-34,135984461,4.175936368885124
VMRC-LCD,3854666,0.6115412380814026
EC-GI-10,100016,6.57909581265972
253J,24771867,3.5292843254473514
NCI-H838,136227924,3.210993191129446
TUHR14TKB,9911463,3.7384474172031976
NCI-H838,100016,5.521581837907123
Hs 944.T,1566236,3.0882237799515297
BT 131,9884685,0.9627724880969004
PK-59,4378219,2.005391198678221
Karpas-299,10296883,3.126285958642229
PK-59,12003241,-0.8874443449539482
SNU-449,2746,3.928036011173348
Li-7,65628,4.354303680077222
DMS 454,54618771,0.8095302292114137
SK-MM-2,11152667,-1.4514217856008986
NU-DHL-1,1566236,-0.7944323454419335
BT-549,2746,3.8188337512891137
A-549,2746,4.106748757541722
SK-N-AS,11494412,-0.8691510414375381
CAL-51,54618771,0.0049145289548569
NB4,135421197,1.336242233620032
IGROV-1,9935249,3.330117761231163
NCI-H69,12003241,2.7316245717871572
HCC1171,4378219,4.634976218235682
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
ChaGo-K-1,54618305,4.246058769958448
SIG-M5,selumetinib-vorinostat (8-1 mol-mol),-2.7749557072637083
SNU-423,54618771,0.8845738276291084
769-P,11404337,1.353529745525745
GSS,11404337,-1.198572034455594
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842
BICR 22,135984461,4.376718251500639
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
MPP 89,3854666,2.9002727572082705
SNU-685,65628,4.307858928134081
CAL-51,24771867,-0.5018492111736887
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
RT-4,54618771,0.6660630053371256
RL95-2,54618771,0.9471315050617304
NCI-H1568,10296883,3.9462373745058863
HCC1588,73707386,4.063531908987796
ESS-1,9915743,1.8900363437156489
MOLP-8,71751553,4.257415338539138
WT2-iPS,100016,6.129452507999119
SR,9911463,3.2455364597382075
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
DU4475,54618771,1.1300821286191531
J82,136227924,3.3108045260668564
NCI-H747,2746,2.5698832282909665
OCI-Ly3,10322450,2.4111759735163316
SW1710,24771867,3.1471121529063546
NCI-H2023,135421197,2.5449046355332436
DBTRG-05MG,54618771,1.322739647725507
NCI-H841,135659046,3.31199371059189
Kuramochi,2742550,3.727558787016432
CAS-1,3854666,3.1720263873322194
JJN-3,65628,4.557976519589219
SNU-869,9935249,3.216155235234016
SK-N-FI,9911463,4.1976793255914275
253J,11404337,0.3224352985838272
SW620,54618771,1.1689155284524844
U-251MG,9935249,3.268808759101635
DU145,11404337,1.4411442495527176
YD-8,10296883,4.26925641885348
SNU-201,11152667,1.3436502466257625
LN-229,65628,4.462977906883874
Fu97,10296883,3.8261692245769776
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
HCC1419,135659046,5.048116193224175
NCI-H1651,24779724,5.019172728435523
SNU-216,1566236,1.785015766563616
22Rv1,135984461,3.7893154959585735
NCI-H841,selumetinib-vorinostat (8-1 mol-mol),3.748508447954211
SNU-81,3854666,0.9917295007006844
RKN,12003241,-0.3350096455718494
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
SNU-119,136227924,3.0573258202750253
Rh18,54618771,1.0178435523811953
MOLP-8,54618771,0.2679151571300236
VMRC-LCD,71751553,5.332417713766258
OVTOKO,12003241,-1.0973416897014734
HCC366,JQ-1-carboplatin (1-1 mol-mol),1.2821420815948563
GA-10,11494412,-0.8165208112665053
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
42-MG-BA,11494412,1.955126057661204
SU.86.86,10296883,4.023388867710504
NCI-H1435,1566236,1.899438674459205
BT 359,9911463,3.139748899568744
BT 444,54618305,4.416023109657525
SUP-M2,6918638,-1.8081420223018785
Mono-Mac-6,10296883,5.539962555703235
ES-2,2742550,5.454114961101578
SNU-C4,11404337,1.6015292344690046
HT-1080,9911463,3.8798634306890105
MKN74,3854666,2.1744767713942905
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
NCI-H1568,71751553,3.6437596116554887
SUP-T1,selumetinib-vorinostat (8-1 mol-mol),2.3626230933029375
HEC-1-A,100016,7.347183870003149
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
SNU-761,2746,2.9250609675985917
WSU-DLCL2,2742550,3.021872637867583
SNU-61,9911463,3.407728451470452
NCI-H661,135421197,1.0600684669241136
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
BT 416,44241473,4.372636562751848
PLC/PRF/5,10322450,3.983384699735352
CAL-27,10296883,4.057207739356728
KYSE-410,3854666,3.296773212929304
SCC-25,4705,0.8659317696448142
HCC1588,JQ-1-carboplatin (1-1 mol-mol),4.871781854862913
OAW42,4705,4.623217521868117
Capan-2,136227924,3.162135891621308
NCI-H1793,54618771,0.9383287956329432
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
JK-1,9884685,0.0147881533582394
SK-MEL-3,11494412,3.62103205508352
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
OCI-Ly19,100016,6.584850236816641
BT 359,11404337,-0.8986671728734847
WM983B,4705,3.3375940959152244
GaMG,11152667,0.163513537406371
HCC44,65628,4.349401919276432
BT 428,54618771,1.9125909448822425
SNU-213,54618305,4.384098644621688
Hs 852.T,65628,4.460884218370228
HOS,3854666,2.0706469924501474
MKN74,9915743,1.5544684592006026
NCI-H2009,9911463,4.220122302208283
Lu-65,135659046,2.9879940161565206
LS411N,9911463,4.267700407985282
BICR 56,12003241,-1.3308187474558526
RT-112,54618305,-4.692727933409511
Hs 766T,6918638,1.6874780240509222
Karpas-299,44241473,4.75946350296733
NCI-H508,10296883,3.4644363543099312
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
SH-4,9915743,0.7789394097193199
HEC-251,54618771,0.8830858807964597
SNU-398,11152667,-0.7435304087318404
KATO III,11494412,3.9284377774184063
DND-41,135984461,3.0712550622908643
HGC-27,9935249,1.1253542566009878
786-O,136227924,4.54082640186513
P-STS,54639665,4.398592450418463
Lu-99,9926054,1.653362823410905
JIMT-1,12003241,-0.563362100663344
Daoy,65628,3.6949596991690976
JHH-2,71751553,4.333509260153597
ZR-75-30,12003241,0.0052055629667129
HCC95,11404337,-1.0962465907307095
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
TE-1,11152667,-1.3085145016086972
NCI-H1339,9884685,1.174532924558328
EFE-184,73707386,3.690171940356052
KYO-1,11404337,-0.4735869494306794
Kasumi-2,24779724,5.733659143451784
SF268,71751553,4.591733155494545
NCI-H2452,136227924,3.4253193575490695
BCP-1,9935249,-1.7748725818635605
KALS-1,11152667,-0.748944464329897
CJM [Human melanoma],2742550,3.845461183394304
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
COLO 684,54618771,1.417005870587021
JHUEM-2,9915743,-0.2350251959157376
A-253,selumetinib-vorinostat (8-1 mol-mol),3.961861986632096
SIG-M5,10322450,3.963755242230549
JHOM-1,11494412,-1.2826925438789665
CAL-27,6918638,0.7140007001592554
THP-1,135984461,4.301295147002072
JMSU-1,11404337,-0.9331464485977649
JIMT-1,54618771,0.8201229283888136
NU-DHL-1,11494412,-1.1621345375437304
2004,9926054,1.8081714609693849
MDA-MB-231,11152667,-0.1909288238816012
SNU-761,11404337,-2.3232289106427695
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
BT 271,9915743,1.1851402962233049
BT 131,selumetinib-vorinostat (8-1 mol-mol),2.183277043085374
CCF-STTG1,11404337,1.400188980811807
MeWo,136227331,4.002976901142853
Malme-3M,6918638,1.0970595783496475
EPLC-272H,3465537,1.4196473327996324
A4/Fukuda,6918638,-1.9449982869755031
Pfeiffer,11494412,-1.5298938903732595
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
BT 340,135421197,2.5749512763200824
HT-1197,1566236,1.7604501004419797
KYSE-450,1566236,2.943712788473633
KMS-28BM,2746,1.511503840028706
HT-1376,4378219,2.0379523360126988
NCI-H2029,9911463,2.565034474609612
BT 172,9884685,1.398754184455955
TYK-nu,44241473,5.146122796829407
Rh30,9915743,1.5349254277578692
RERF-LC-A1,selumetinib-vorinostat (8-1 mol-mol),2.1105956202148346
BT 224,9915743,3.066397544250084
OCI-Ly3,135398744,6.408015135669225
Kasumi-1,9915743,0.5863959367393617
HOP-92,9926054,1.661169949591577
SR,11152667,-1.901425979751036
CGTH-W-1,9911463,4.280692853658182
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
LCLC-97TM1,11404337,-1.4043223473519348
SNU-1272,54618771,3.136436186338116
NCI-H889,9868037,2.7171029486851683
A-204,selumetinib-GDC-0941 (4-1 mol-mol),0.2553877558733737
A2780,54618305,3.781380565087532
NCI-H1666,135421197,0.9962315776177934
GOS-3,44241473,4.447421169667303
COV434,136227924,1.351853150285656
CAL-27,9915743,-3.4733954540635015
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
SNU-685,11152667,0.0876165729015351
HLF,54639665,4.499757528178239
NCI-H2196,135659046,3.3895978567837073
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
EC-GI-10,selumetinib-vorinostat (8-1 mol-mol),3.7752462789918697
DoHH2,44241473,1.658659764082314
J82,1566236,4.508340274654256
Granta-519,9884685,-0.5481626961732873
NCI-H1435,135421197,1.75045264737253
NU-DHL-1,12003241,-2.4677988287748915
THP-1,9884685,-1.0718495276637905
BT 416,54618305,4.383399525094827
SW1990,10296883,4.2503704087411025
42-MG-BA,135421197,1.023186017239741
UACC-62,9915743,3.9206443408409455
786-O,6918638,1.6864492481746118
MV4-11,selumetinib-vorinostat (8-1 mol-mol),-0.5147725533384067
NCI-H526,selumetinib-vorinostat (8-1 mol-mol),2.4769440770126514
NCI-H2141,9911463,2.830365569007881
U266B1,11494412,-0.8114470542074865
Rh18,selumetinib-GDC-0941 (4-1 mol-mol),2.126634875194983
SUIT-2,9935249,5.647291906272881
NCI-H2085,9926054,3.027383511126382
HCC2279,9915743,1.7630274974109628
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
SNU-182,650361,3.213355032316707
Hs 888.Lu,100016,7.863224005148367
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
SNU-423,135421197,3.0122188559971725
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
BT 422,11404337,-0.0607028130466723
DMS 114,11152667,0.949918299372712
HCC1937,136227924,3.58866664774513
EJM,9915743,0.880814312418276
SUP-T11,9911463,3.242593830976794
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
SNU-1196,9935249,3.6469845299154726
Rh30,2746,3.242991400457772
KMBC-2,1566236,2.626882312986064
KPL-1,11404337,1.240920910385959
BT 271,65628,3.445867348348474
Calu-1,9911463,4.35367590047306
RCH-ACV,11152667,-4.538548761334481
Hs 683,6918638,0.9726484186750864
SNU-46,9911463,4.271059077765821
HT-144,54618771,1.2488424909624232
NCI-H520,10296883,3.906496007421639
PK-1,9926054,1.83429012816666
WM115,3465537,1.2344570371137795
HCC1438,12003241,-0.2782249625748692
Karpas-299,9915743,0.0717302917443794
COLO 829,11152667,-0.2700014399675054
BT 444,1566236,3.080515728465438
MDA-MB-231,2746,3.4899061229386965
KMBC-2,24771867,3.814811761513654
DEL,JQ-1-carboplatin (1-1 mol-mol),1.3960837973555382
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
PC-3,1566236,2.121156143550011
TE-15,135659046,3.5275305939343884
JJN-3,24771867,-2.735783524205991
SW579,136227924,2.120211379000796
HOP-62,24771867,2.21478649865432
Hs 578T,49836020,0.6847429303234678
NCI-H2009,136227924,2.9896301065010933
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
SNU-119,9915743,-0.9461018440857424
697,3854666,0.199250665245893
RPMI-8226,135421197,1.9475796731003323
L3.3,24771867,2.302026780280536
G-401,135421197,1.4306754302223277
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
EB1,1566236,0.9429423424199086
B-CPAP,136227924,3.258845757188781
GA-10,9935249,-0.4353694549259401
SH-4,76446078,5.514694328865145
CAL-29,11404337,-0.7991299862488138
LS180,9935249,3.57280690269837
HGC-27,136227924,2.541882907814414
ES-2,12003241,0.0508402342945085
COR-L105,11494412,3.277457630260471
TALL-1 [Human adult T-ALL],selumetinib-vorinostat (8-1 mol-mol),1.1410654288760709
ONS-76,12003241,-1.3579895274230906
NOMO-1,11404337,-0.1001889231988697
P-STS,11494412,1.4773274535809604
NCI-H526,9911463,4.043981545768548
LP-1,JQ-1-carboplatin (1-1 mol-mol),-0.8126599405302602
SU-DHL-8,24771867,-2.866707404485274
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
BT 245,71751553,4.246004451264995
Pfeiffer,4378219,2.098537677255867
BC-3C,6918638,1.5868731043226476
NCI-H446,136227924,3.5012378178100487
RD,11152667,0.3513258141441123
WSU-DLCL2,135421197,1.3366887647242718
697,135421197,-0.0099062080038934
Karpas-299,selumetinib-GDC-0941 (4-1 mol-mol),2.273668184734746
TE-11,71751553,4.171165547166187
ZR-75-30,54618771,0.9428020193636316
T-47D,9911463,4.083486296646728
SNU-478,JQ-1-carboplatin (1-1 mol-mol),1.5753140485557118
MOLP-8,9884685,-1.6145757941110517
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978
TE-1,11404337,-0.7530649857442655
NCI-H1355,3854666,0.7237353710481594
K-562,71751553,5.367911183247371
SK-N-SH,11494412,-1.1686339817034832
SNU-407,54618771,0.7273608158174886
SNU-46,selumetinib-vorinostat (8-1 mol-mol),3.202126820201843
BHY,49836020,5.6544174202433855
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
SNU-1076,2742550,3.052127271141954
KP-N-SI9s,10296883,3.538113469874099
RMG-I,135984461,4.206545511526054
DMS 53,135421197,0.687232619284389
HCC1195,9935249,4.027609315345556
NCI-H747,9868037,3.413430732582287
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
BT 112,135421197,2.023572470173789
MOTN-1,12003241,-0.0935669928398487
RPMI-7951,JQ-1-carboplatin (1-1 mol-mol),3.054924141826928
Peer,73707386,2.3378342217205015
OUMS-23,2742550,2.4373114846272586
HEC-151,10296883,3.675956149700743
BT 239,3854666,0.6020621099838442
BT 428,135659046,3.573763038343519
SF268,12003241,-2.0418893916572243
Ishikawa (Heraklio) 02 ER-,11152667,-0.2897968836684769
A-375,9911463,4.039687099931349
NCI-H69,selumetinib-vorinostat (8-1 mol-mol),2.400954503336172
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316
NCI-H1435,54618771,-0.0103086846499203
SNU-886,54618771,-0.5899639628082597
786-O,44241473,4.872123237666425
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
VCaP,135421197,0.8808099569732696
MPP 89,9911463,4.3763364691928786
DU4475,11494412,-0.2036500518736227
Kasumi-1,11494412,0.3722538658063193
HSC-4,9926054,2.0278633205902468
KP-4,135421197,2.59268452027494
HD-MY-Z,2746,3.1927944542914393
KP-4,100016,6.84348879863886
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
Capan-2,135421197,1.2802517101193276
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
HGC-27,135659046,3.397555397732454
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
HOP-62,12003241,-2.147728480634193
T24,65628,4.261975471430199
NCI-H647,100016,4.3873613110575045
KYSE-30,9911463,3.831121744516391
NCI-H2081,9911463,2.5760332235225016
KNS-62,4705,4.3663723212199885
KMRC-20,9915743,2.261900740642606
SK-MES-1,10322450,4.30384017318748
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
SR,3854666,0.7752570600014472
BT 333,9868037,4.601052403948759
LS180,12003241,-0.6460664270988897
SNU-C1,1566236,1.8241631606910471
Mel JuSo,135659046,5.566553580989515
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
UM-UC-3,54618771,3.8430059461326658
HEC-6,54618771,0.3851736338204913
LS180,9915743,2.834892961755663
Panc 08.13,selumetinib-vorinostat (8-1 mol-mol),2.1234456199276193
JHH-1,136227924,2.990976056622349
KMS-20,9884685,-0.8480553066997102
P3HR-1,9884685,0.0475249216128984
T24,135421197,1.5767187843599464
TUHR10TKB,9911463,3.273764915717201
NCI-H146,9926054,1.7480459470636802
Sq-1,3465537,3.0778623896650386
HOP-92,1566236,3.231225690393918
NCI-H747,3465537,1.8944570595405523
BT 359,selumetinib-vorinostat (8-1 mol-mol),2.781469406851911
SU-DHL-10,9935249,2.725812831825159
OE33,71751553,4.3154384433130355
MOLM-13,73707386,2.881964792667641
HGC-27,JQ-1-carboplatin (1-1 mol-mol),1.0978980363153934
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
EFO-27,6918638,-0.5643283195590469
BT 145,6918638,0.0582257419032156
NCI-H929,54639665,4.443848049019438
BT 333,136227924,4.6219554593863075
HT-1080,10296883,4.176429034595713
DMS 454,9911463,3.0407786288723475
KP-3,100016,6.07483479536675
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
RERF-LC-Ad1,11152667,0.5366755842825199
A-375,135421197,1.9818816716343688
EHEB,11404337,0.0364567319098325
IMR-32,65628,1.73184881776237
NCI-H1915,9884685,4.1818915574686395
NCI-H1755,73707386,2.6822536013595895
SW1116,4705,0.6661703449380979
NCI-H211,3854666,0.5598756025462432
KMRC-2,9884685,0.9059778924037538
KCL-22,100016,3.971728515649248
LMSU,10296883,4.275438301361486
VMRC-RCZ,24771867,2.777198455073447
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
HCC-56,10296883,4.321936359264917
SW1116,10322450,3.761194873514236
BT 245,4378219,2.684006607069923
BT 286,9926054,2.06315076189255
ZR-75-30,3854666,2.361916002626113
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
CA46,10322450,2.6264913036213606
KM12,10296883,3.701493082192586
Hs 611.T,71751553,2.589968262099222
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
NH-6,650361,3.794392223759619
Hs 578Bst,24771867,2.454142587048227
MFE-319,4378219,4.392527987141838
NCI-H1092,6918638,-0.0011423595466388
MCAS,54618771,1.3372810495752594
HT,3465537,3.9314731876792695
DMS 454,4705,3.5434056229110498
BT 271,11404337,-1.9578148063056395
KYSE-510,100016,5.186546688011686
KP-2,3854666,3.6631158292147226
HLF,136227924,2.390310427445978
NCI-H526,54618771,1.0633322876543316
Pfeiffer,65628,4.184862068239767
IGR-37,2742550,3.8549971974634465
SK-LU-1,selumetinib-vorinostat (8-1 mol-mol),3.1775151004152327
Daudi,9926054,1.7776420054693636
BHT-101,selumetinib-GDC-0941 (4-1 mol-mol),-0.4263486280129431
SNU-503,54618771,1.215393479173298
Hs 944.T,9868037,2.6864916829697703
SK-N-FI,1566236,1.4625632666872723
KP-3,54618305,4.754928976610576
SNU-C1,selumetinib-vorinostat (8-1 mol-mol),-2.612030699102198
Kasumi-2,9911463,3.4999156831259524
A3/Kawakami,2746,0.9859280265710952
NCI-H1869,selumetinib-vorinostat (8-1 mol-mol),2.952305626055488
Hs 888.T,9884685,1.2229455399044955
LUDLU-1,9884685,1.2694311551040651
Caov-3,1566236,2.912009247754364
Hs 766T,136227924,2.630952750368734
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
KCL-22,11152667,-1.7149450247190612
MOLP-2,54618771,0.3344993744663657
F-36P,9915743,0.3844593263484804
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
RL95-2,JQ-1-carboplatin (1-1 mol-mol),1.5011912902975624
LK-2,9915743,2.752054960797746
KNS-62,9935249,5.766503523403454
EFO-21,71751553,5.137367529423648
EPLC-272H,1566236,2.3537284633634763
NCI-H522,3854666,0.0482767863302698
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209
COV644,9884685,0.7515598041461382
COLO 205,136227924,2.4867417586096416
8505C,100016,6.577733697234268
EC-GI-10,4705,0.5713397420594433
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
WM266-4,135421197,2.204314792506349
SK-LMS-1,11152667,1.335730322583835
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
NCI-H2081,65628,3.78371199726488
DU145,6918638,0.5820093502251232
TALL-1 [Human adult T-ALL],2742550,2.976976720806849
TE-9,135421197,3.747020112935066
KNS-60,136227924,2.463930704521007
Ki-JK,73707386,2.487291163163647
SNU-61,54618771,-0.470226071786205
SCC-4,1566236,1.7714297882501675
PC-3,9884685,-0.023104430972579
D283 Med,11494412,-0.6782080211757803
GB-1,BRD-K16130065,4.42493590422296
TE 617.T,54639665,4.38998607843506
HEC-1-B,3854666,3.528509684945124
G-292 clone A141B1,65628,4.8871250703785805
L-428,135421197,0.7073965487557408
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
Karpas-620,selumetinib-GDC-0941 (4-1 mol-mol),4.598341067647778
CJM [Human melanoma],3854666,0.9164819663884698
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
LN-229,54618771,1.209787731976597
NCI-H1838,12003241,-1.140669133543194
BV-173,135421197,1.3396067648225152
IGR-37,54618771,0.3967957480696406
SNU-1196,11404337,0.8236083262137488
SNU-1,JQ-1-carboplatin (1-1 mol-mol),-0.7235204219761906
OVCAR-8,11152667,-1.64737502837339
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
253J,9926054,1.3748639406347178
CW-2,3854666,2.8676785339047512
NALM-6,24771867,-3.636827932093219
RERF-LC-Ad2,11152667,0.7033188335171204
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
MOLP-2,10296883,2.8483200317166935
JVM-3,11404337,-0.5913580396426641
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
SNU-466,11404337,-0.8937710860512643
HEC-1-A,136227331,4.058497716463453
ONCO-DG-1,9884685,0.4243352102423045
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
NCI-H211,JQ-1-carboplatin (1-1 mol-mol),-0.6701581797936323
EFO-21,9884685,3.376545063394627
BT 271,4705,1.1408708850439713
Capan-2,6918638,1.8511012185183664
HEC-151,11404337,-0.8422867477352739
BT-16,11494412,1.7201073702019167
IA-LM,1566236,2.064855820915055
COLO 792,9926054,1.6988024802785178
L-540,135421197,1.2106932508822246
TE-15,3854666,-0.2434846174212646
T24,71751553,4.424735740051958
IPC-298,1566236,1.913696221898385
U-251MG,1566236,3.4645251762745506
RL,11404337,-1.4009299024824362
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
Rh30,54618771,1.1038289315266856
COLO 678,2742550,4.164672443152451
SNU-C1,4705,2.5587329567228414
Hs 683,1566236,3.857796471842603
TE 617.T,135421197,0.8388775868881587
BT-20,12003241,1.693784137841815
F-36P,54618771,0.2911241423131909
NU-DHL-1,9911463,3.294428726772871
NUGC-4,JQ-1-carboplatin (1-1 mol-mol),-0.8477062663812829
PL-21,11152667,-4.55142163084927
CAL-51,11152667,-1.203722258692511
COV434,2742550,2.924605049724598
COLO 829,11404337,0.9914366451901834
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
BT 340,1566236,2.190598640135625
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
KALS-1,11404337,0.5593043385497104
OAW42,4378219,2.256269324004719
Panc 03.27,4378219,1.942503579680026
GOS-3,71751553,4.284016393111424
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
NOMO-1,136227924,2.5449106490851263
HuH-1,JQ-1-carboplatin (1-1 mol-mol),3.110129386511311
Hs 934.T,4378219,1.698654753435016
RERF-LC-Ad2,selumetinib-vorinostat (8-1 mol-mol),3.1653662861701157
Ku812,54618305,3.744773275517672
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
PE/CA-PJ15,10322450,4.3579745096101075
HCC38,12003241,1.828137629090711
EFO-27,2746,3.149760082978987
NCI-H1385,JQ-1-carboplatin (1-1 mol-mol),2.259608589109217
LAMA-84,9868037,1.3276253526445787
SNU-869,2746,3.873911314544542
SNG-M,10322450,3.801998973988302
BT 145,9911463,3.096023169309247
SK-N-SH,135984461,4.272548278190685
BICR 22,11152667,-1.8276171650012312
KE-97,12003241,-1.757079073884842
THP-1,65628,3.276100390761181
GSS,11152667,-1.6427216501784565
HCC1569,9911463,3.793678704328586
KYSE-140,11404337,-0.0921040105213257
SJSA-1,4705,2.8709767105947974
Tm87-16,54618771,0.1838114986679219
CAL-78,11404337,0.3095011123947553
Calu-6,136227331,4.4599645259954555
GB-1,54618305,4.728305083790762
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
COLO 680N,selumetinib-vorinostat (8-1 mol-mol),2.406461894687131
BT 147,9935249,1.8557182731997623
NCI-H520,11404337,-0.911000559838952
IGR-37,10296883,3.844591108282479
HD-MY-Z,11494412,0.5861901428023402
UO-31,11152667,-0.0094884527945568
SUP-HD1,136227924,3.4836971225000735
BT 422,54618771,0.9695029183446764
BICR 18,12003241,0.2549770836209779
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
SNU-503,2746,2.787173124084262
KM12,12003241,1.1245278791827416
ESS-1,24771867,2.6208219680257328
NCI-H1299,54618771,0.5506920644788533
MEC-1,11404337,-2.8975071038846023
ME-1 [Human leukemia],136227924,3.8385097232305103
SNU-46,100016,6.6556000707540095
BEN,9915743,3.139870035792778
NALM-6,9915743,-0.4248933620675649
A-375,44241473,4.458361896268554
P-STS,6918638,-1.1348204820090546
BT 216,49836020,1.982286397666987
CAL-85-1,12003241,-1.401340141763049
LCLC-103H,selumetinib-vorinostat (8-1 mol-mol),2.6611498366022763
Lu-99,4378219,4.35466252691
Yamato-SS,135421197,2.276835379752713
RMG-I,650361,3.81864593195537
NCI-H2106,135421197,0.6471538236638695
COV434,54618771,-1.0404001935191405
WM88,44241473,4.4226922807314395
YD-8,9884685,0.4288602362117117
TC-71,100016,6.681443396825605
HEC-151,10322450,3.547902209799766
8-MG-BA,10296883,4.312011375690635
BT 145,2746,2.646861409473543
NCI-H1694,6918638,-0.6027220987996394
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936
Hep-G2,4705,3.661377424610174
NCI-H526,12003241,1.2765702668014436
BT 333,136227331,5.5959520749391904
SK-UT-1,136227924,4.460190875137593
JM-1,40482356,5.622716652052393
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
Capan-2,11152667,-0.1737244436389105
G-292 clone A141B1,11404337,1.6382299378859118
DK-MG,135984461,4.5873435094388215
PE/CA-PJ15,12003241,-2.2005242909151668
NCI-H2087,selumetinib-vorinostat (8-1 mol-mol),-3.329133987399838
HCC1419,11152667,2.886444938310032
G-292 clone A141B1,1566236,1.5411770521873664
ES-2,100016,6.579379467241575
OVCAR-5,1566236,3.333028869896027
CHP-126,9935249,4.007708055794919
RPMI-8402,73707386,2.4280869468438446
OC 314,136227331,3.341110019421027
VMRC-LCD,selumetinib-vorinostat (8-1 mol-mol),2.297585943130406
MOR/CPR,136227924,3.350851412370925
647V,71751553,4.528566632695141
SNU-886,10322450,3.968731934637612
DB,54618305,3.8621754509529262
BC-3C,9935249,3.143232042704622
EKVX,1566236,3.271748104536343
HOS,2746,3.590009491278375
BT 245,10296883,3.705541909006873
NCI-H1385,12003241,1.7057998630948272
CAL-85-1,9911463,3.700883327445061
CHP-212,135659046,3.126756855928974
TE-5,71751553,4.947583204218297
LK-2,9926054,1.788707651887683
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
PaTu 8988s,3465537,1.2834975763885186
SNU-308,9926054,1.9749915644839853
F-36P,135421197,1.230502256000523
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
RCC10RGB,9935249,3.9754060705766943
EFO-21,24771867,3.9696173415950406
SNU-899,12003241,-1.150293591999144
Rh30,3854666,3.1387459352284752
NCI-H747,135421197,1.1053174645352293
KNS-81,9868037,4.212770476057123
Ki-JK,9915743,-0.1988023014574486
A3/Kawakami,135984461,3.954538611976779
CAL-54,selumetinib-GDC-0941 (4-1 mol-mol),0.8998815087239347
JHUEM-3,136227924,3.0400208358424243
SNU-C1,11404337,-1.600990625985275
SCaBER,9926054,1.794532433131724
KE-39,6918638,0.3873788369468276
GOS-3,9911463,4.370946765627494
NCI-H1563,135659046,3.636669670188891
MeWo,9915743,1.4031179966359888
CCK-81,12003241,-0.505625792514721
OVCAR-5,100016,6.797399029850292
A-204,54618771,0.0789139316749608
SET-2,54618305,3.97030944643435
HOS,54618771,1.216646065025966
SK-MEL-24,2746,3.4655100940792254
DU145,11494412,1.9147313694004515
SNU-1,3854666,2.125271252141142
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
KE-39,24771867,5.944751904846296
DAN-G,135984461,4.367213077467543
PE/CA-PJ15,135659046,3.5653102065107176
KE-97,3854666,-0.4981384374359918
ESS-1,selumetinib-vorinostat (8-1 mol-mol),3.369239403980627
KNS-60,10296883,3.392658915268081
NCI-H2087,4705,3.3747422843456185
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
SNU-387,135659046,3.67285635575436
HEC-1-A,4705,4.084299527202415
WT2-iPS,9915743,3.010959085060511
MIA PaCa-2,9915743,0.7812754347673511
SNU-1214,9926054,3.9057313084396656
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
PC-14,9911463,4.053685719227892
L-428,54618771,0.5974116891557107
ACC-MESO-1,4378219,4.550142070750771
CAL-85-1,11404337,-0.674659950000608
K029AX,135398744,6.420759462552213
MES-SA,71751553,4.3664020443524105
SNU-1196,selumetinib-vorinostat (8-1 mol-mol),2.510516391643449
LUDLU-1,11152667,-1.2221544436007594
Sq-1,10322450,4.325633425734601
NCI-H647,3465537,2.923785800971271
NCI-H841,11404337,-0.1615181645680822
HEY A8,24771867,3.727653041957821
Rh41,2742550,2.9632635418115916
SK-MEL-2,4378219,3.1510075145048644
NCI-H1339,100016,8.285361450373896
KMRC-20,12003241,-0.2043728031762648
U-BLC1,54618771,-0.2094086487307373
NCI-H2452,4705,3.641149380662554
SH-10-TC,11152667,-0.1352620924138639
NCI-H2196,49836020,4.894055204627393
Hs 839.T,44487872,4.36119514235804
KU-19-19,54618771,0.4920305765445359
G-292 clone A141B1,4705,3.730177058269135
BL-70,135984461,4.106594232964942
P31/FUJ,9935249,2.700947453739227
JHUEM-2,135984461,4.241514174817559
NCI-H2110,2746,2.5947990205927405
DV-90,JQ-1-carboplatin (1-1 mol-mol),-0.681487288410465
HCC1833,49836020,-1.119955366422227
SNU-601,135659046,3.8023044437748417
BT 440,6918638,3.62148033116424
TOV-21G,6918638,1.3242301911997263
SNU-C5,9911463,3.786526891589904
DMS 53,54618771,0.8665759166845977
COV644,2746,2.991747419191786
IA-LM,9926054,3.212619063516659
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
SU-DHL-1,3854666,0.5155348387571919
SaOS-2,9868037,3.691858985861763
BC-3C,3854666,3.3854560486679053
WM266-4,9884685,-0.0947823690174165
DU4475,2742550,2.301558915295113
IST-Mes1,3854666,2.0681561223579075
BT 216,9911463,3.0589370422001494
MIA PaCa-2,9911463,3.5885490135085663
DU4475,10322450,2.3984430458592385
CAL-54,4378219,2.005799653589018
SNU-8,12003241,-0.8120802877527198
OPM-2,65628,4.597670741376445
BC-3C,10296883,3.936118595707102
CAL-85-1,4705,1.851642821697695
UO-31,135421197,2.4256878664158443
LS1034,1566236,1.869812205803379
HCT 8,4705,3.304717107003546
BT 239,54618771,0.6858691475419959
SK-ES-1,100016,7.4795645853927475
CAL-54,11494412,1.9724294528675907
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
MDA-MB-468,3854666,0.819847867381648
SK-MEL-3,2746,3.317338205228237
NCI-H522,54618305,4.230012053256092
SNU-601,71751553,5.5964452561972955
SU.86.86,24771867,3.5741931056159535
Hs 683,135659046,3.747937151940255
SNU-1076,selumetinib-vorinostat (8-1 mol-mol),1.2031584211744453
SNU-1,24779724,6.404579548662128
AM-38,11404337,-0.5610335090567212
ECC10,2742550,3.033123572020692
NCI-H2029,10322450,2.79312710605276
HT-1197,9884685,0.7490718797514191
YH-13,10296883,4.196539709790054
Rh18,9935249,2.794389835248646
KE-37,3854666,0.6473006828434584
Ci-1,4378219,4.468680704450462
RCH-ACV,73707386,2.164720549147375
EB1,65628,2.3225973087067255
OCI-AML-3,10322450,2.261433742122515
KYSE-450,10296883,4.225795837642371
TT2609-C02,6918638,0.9374667365701628
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
CAL-148,9884685,-1.3771109426757842
CJM [Human melanoma],11494412,0.950200915557512
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
KMS-12-BM,2742550,3.02175924738708
NH-6,6918638,-1.4454078829022647
Hs 888.T,4705,3.9900399475264887
T98G,12003241,-0.2247982599387034
Aska-SS,49836020,4.404663805549638
253J-BV,54618771,0.8699065308229518
NCI-H2081,1566236,1.4725524820150873
JL-1,10296883,4.327951566443025
639V,9911463,4.4419540135561
DU145,selumetinib-vorinostat (8-1 mol-mol),2.4809592604092305
SaOS-2,9884685,-0.6485333929619777
NCI-H2228,9884685,1.6616453832187148
COLO 684,9915743,1.4008131015785188
SNU-869,1566236,3.315368037807328
SNU-1196,selumetinib-GDC-0941 (4-1 mol-mol),2.312847943895299
NCI-H889,9915743,1.0430914945054055
JK-1,10296883,2.2916856247126263
KYSE-140,9911463,3.6059267318888817
BV-173,9884685,-0.0886667703066502
KMRC-3,136227924,3.033903598858876
HEC-59,54618305,4.716446309240821
KP-4,11404337,0.6488423054091234
HuCC-T1,11404337,-0.917560199382238
ME-1 [Human leukemia],135398744,6.466274911980868
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
SF539,9868037,3.16067122997076
BT 159,135421197,3.0775929354078926
COLO 684,selumetinib-vorinostat (8-1 mol-mol),2.6955916888531304
T24,9935249,4.082261815978772
SNU-C5,11404337,-0.8246866486472284
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
SK-MM-2,10296883,1.2028909628230222
Rh18,10322450,3.5568914493716712
PK-45H,9915743,1.737886794631877
NCI-H1869,11494412,4.466275600700225
BT 139,9935249,2.9068190210975975
SUP-T1,9884685,-0.9230730282342138
LCLC-97TM1,11152667,-1.9849905525936635
BT 271,135421197,1.2817550115075582
NCI-N87,135421197,1.227136310912881
NH-6,selumetinib-GDC-0941 (4-1 mol-mol),1.9246197081776155
KNS-62,2742550,4.248627568743254
SK-BR-3,6918638,-0.1564610837276475
BV-173,2742550,3.230844784705435
TE-14,10322450,4.592810153102171
CW-2,135984461,4.848993009779452
KMS-27,9868037,2.1445614612253614
A3/Kawakami,2742550,3.663536756053575
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
SU-DHL-8,9915743,1.1928625100006218
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
A-549,11404337,-0.2898707579606809
Hs 888.Lu,49836020,4.832752015410737
U-937,12003241,1.6522375422653783
Li-7,4378219,3.4797271844256072
HCC1395,135421197,5.533531628940142
COV644,1566236,1.8684526207467456
NCI-H1395,135984461,4.376761136039875
UM-UC-1,selumetinib-vorinostat (8-1 mol-mol),1.0639259134064845
KMS-21-BM,9926054,0.3453207317075127
SNU-489,24771867,3.721234676775179
Panc 04.03,11494412,3.764008563191269
TYK-nu,9884685,1.973055967006664
TE-5,4705,3.380562740986189
CAL-51,135421197,1.6266864976107616
OVCAR-5,9915743,0.3174164391419692
L3.3,2746,3.431089753490113
CJM [Human melanoma],4705,3.52697616396543
SJSA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9428552640575236
BT 440,9926054,3.075570735220903
JeKo-1,135421197,1.3904667144592064
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
KNS-42,6918638,2.1232444554437926
NCI-H1693,11494412,1.8422349416207413
FU-OV-1,9915743,0.5010130642537969
MDA-MB-361,54618771,0.6906132618662956
P-STS,3854666,1.06404979900826
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
NCI-H1355,24779724,5.688705326978688
CCF-STTG1,9911463,4.668972921835481
NCI-H1703,9926054,1.7378583933423122
DK-MG,2746,3.5429718490608924
HuT 78,11494412,0.3707002136667609
THP-1,12003241,-0.95805458474302
JHUEM-2,24771867,-3.419304338864635
NCI-H2286,11152667,-1.5906920747470763
TE-5,24771867,2.979973697247953
JL-1,136227924,2.288232757655929
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
U-87MG ATCC,44241473,6.113073255710961
COR-L51,11152667,-0.8150408073965146
TALL-1 [Human adult T-ALL],4705,3.508136996580395
ONCO-DG-1,24771867,3.0522327251107857
NCI-H1563,136227331,3.8731399869875167
Hs 944.T,9915743,1.2530099192350108
TF-1,11404337,0.9992321487738164
JM-1,2746,0.8560843341026924
Hs 683,9915743,1.4986187440690526
SU-DHL-10,11404337,-3.1168849698273404
NCO2,9915743,0.6795436219303662
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
EPLC-272H,selumetinib-GDC-0941 (4-1 mol-mol),-0.4942695564653549
NCI-H526,24771867,-3.604007946770568
SK-BR-3,11494412,0.3073008464211634
NCI-H2342,54618771,3.373010202836016
Rh41,135421197,0.890799382686484
SF295,11404337,1.1305596027792637
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752
U-BLC1,135984461,1.880488153301068
KNS-60,selumetinib-vorinostat (8-1 mol-mol),1.8359205903687537
SNU-1076,11404337,0.2265563836106352
ONCO-DG-1,9868037,1.829035514218224
JHUEM-1,9911463,4.030543660927087
HMC-1-8,100016,5.583587343649554
CAS-1,9935249,3.6183368085181553
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
Malme-3M,49836020,-0.4276181558524726
GOS-3,49836020,5.837697611269413
EKVX,135421197,0.902433297386992
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
HuNS1,9884685,1.7669935378589272
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
KYSE-30,65628,6.48911885956441
PLC/PRF/5,54618771,1.111508720136614
BT 139,135421197,2.718205377140928
DMS 273,9911463,3.7655644930376257
NCI-H358,136227924,2.8821870791202873
NCI-H1341,selumetinib-vorinostat (8-1 mol-mol),2.1937405592406884
BT 139,9915743,2.3473723766604833
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
MDA-MB-361,100016,6.5281042722822145
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
SW620,135984461,4.297796341732351
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
HCT 15,44241473,4.386230722611718
U-118MG,11404337,-0.8562943449328914
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
COR-L95,54618771,1.9587299059916856
JMSU-1,54618771,0.1163446167769653
SK-ES-1,9926054,1.5618900800676432
BT 498,136227331,4.544114350665722
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
KALS-1,3854666,1.8076760580597435
COLO 684,11152667,-1.1782172222202727
NCI-H2110,54618305,4.481600360500252
Kasumi-2,65628,2.2018759133614987
SKM-1,2746,1.6032420730880204
VM-CUB-1,11152667,-1.0333830736737548
SNU-398,9911463,3.388057866137583
U-251MG,9868037,3.950547423154838
697,1566236,0.6800074813339387
NCI-H520,11152667,-0.8111617843564765
EBC-1,2746,2.5031802936730547
JHOM-1,54618771,2.421101396642466
SNU-466,selumetinib-vorinostat (8-1 mol-mol),2.658498622478202
EM-2,135421197,1.083301811797457
RPMI-6666,9884685,-0.1073884108825948
Hs 688(A).T,9868037,5.465863970600614
JK-1,9926054,1.218283183105194
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
EoL-1,71751553,1.891736650896905
SNU-16,11404337,-2.6898366893784997
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
HCT 8,135421197,1.352992198121239
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
GA-10,54618305,3.7110732839259257
IPC-298,selumetinib-GDC-0941 (4-1 mol-mol),-1.1184200059628775
LUDLU-1,54618305,4.859130009384722
MHH-ES-1,9915743,1.9071670198037491
IMR-32,136227924,2.2103917598606326
Hs 294T,2742550,3.9124130314345456
Lu-65,136227924,3.620246561182502
JMSU-1,JQ-1-carboplatin (1-1 mol-mol),2.6355388254924517
NCI-H2452,650361,3.725817753027947
NCI-H2110,selumetinib-vorinostat (8-1 mol-mol),2.8227636055377565
BT 504,135421197,2.466290644112219
YD-38,selumetinib-vorinostat (8-1 mol-mol),0.9831282675647876
WT2-iPS,54618771,5.206944426983613
SNU-478,135421197,1.3858416930524595
CAL-120,9911463,4.415772964133076
Mel JuSo,9935249,3.4919970972717618
Ki-JK,9935249,1.493918091847371
COR-L95,136227924,2.879022500990784
SNU-387,76446078,4.211576246962701
NCI-H358,2742550,3.487810889438015
Caki-1,136227924,3.8203162456228417
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
PaTu 8988t,6918638,2.256433939948275
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
SR,2746,2.1071904113131392
MEC-1,100016,3.995806762220144
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
KO52,54618305,4.665930774043992
HCT 116,135421197,1.1800274219002476
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
VCaP,selumetinib-vorinostat (8-1 mol-mol),2.423309917251552
OS-RC-2,11152667,0.1323387245454607
NCI-H1703,9884685,-1.4744603676906212
COV362,selumetinib-vorinostat (8-1 mol-mol),4.6626475289843965
BT 232,9911463,3.3781399253099256
HuP-T3,11152667,0.3145958176635
CFPAC-1,selumetinib-vorinostat (8-1 mol-mol),3.6214251657468406
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324
Tm87-16,10296883,3.860781577822318
JMSU-1,10322450,3.467232689574709
BT 444,9868037,4.354992099001343
KNS-60,1566236,1.8846845687083928
SNU-C1,9915743,1.8965789747873807
NCI-H2405,11152667,-1.3641856896039837
KE-37,9911463,3.0387406165945383
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
VMRC-RCZ,135984461,4.612343951091238
NCI-H2110,11494412,1.0397098548542971
SK-OV-3,11404337,1.4011927232423718
MOLT-16,JQ-1-carboplatin (1-1 mol-mol),0.2899951204011434
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
HCC2935,6918638,1.4896193076974535
SW1417,44241473,4.393892655885035
NB4,9915743,0.5883941664739625
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
NCI-H747,10296883,1.2461857502958518
Hs 578Bst,135659046,3.7214456124706543
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
JVM-2,selumetinib-GDC-0941 (4-1 mol-mol),-4.259839678662807
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
HT-144,3465537,2.6376255723865865
NCI-H520,selumetinib-vorinostat (8-1 mol-mol),2.5250196264642835
ACC-MESO-1,76446078,4.183302819310867
HOP-92,selumetinib-vorinostat (8-1 mol-mol),2.322415007077192
BT 232,54618771,0.7442415190466014
SK-MEL-24,JQ-1-carboplatin (1-1 mol-mol),2.7809090892182744
AU565,9911463,3.1332064122278687
EN,9915743,1.169812706824078
COR-L47,3465537,2.8794248279849217
KMBC-2,12003241,-0.070536665370705
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
MKN45,44241473,5.298245790871059
IA-LM,135421197,2.370501142960713
HT-55,9915743,-1.6854357534662117
BT 131,selumetinib-GDC-0941 (4-1 mol-mol),2.219067508706083
BT-549,44241473,4.976602861760902
NCI-H1435,4378219,2.0416140380077445
CAL-54,65628,4.404642425429288
BT 112,9915743,1.837502115717176
HLF,9911463,4.995203426264865
KMS-34,65628,2.7326154382917607
G-292 clone A141B1,selumetinib-vorinostat (8-1 mol-mol),4.366985302501173
OCI-Ly3,3854666,0.4334929140420765
CJM [Human melanoma],2746,4.510121301862787
SU-DHL-10,12003241,2.591682900303347
MeWo,JQ-1-carboplatin (1-1 mol-mol),2.4504069963497463
Mono-Mac-1,54618305,4.078084902520956
HCC-56,135984461,4.583376296349448
CHP-126,3854666,-0.1747092469759535
IMR-32,12003241,0.5902035807991148
HDLM-2,11404337,-0.3778039113995139
L-363,9926054,1.3998682481230786
CAS-1,11152667,-0.3875255691229622
KMS-20,24779724,4.331285550613222
COV362,selumetinib-GDC-0941 (4-1 mol-mol),2.9953812620195066
TC-71,9911463,4.31174852976799
2004,135421197,1.2984734830690137
KNS-81,4705,2.5413050318058596
TTC-709,10296883,3.6532150982477503
SNU-8,11152667,-0.943436801192986
P31/FUJ,49836020,4.674155414221834
KG-1-C,40482356,5.553861999999367
Ku812,49836020,4.574644913995472
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
MOLT-3,54618771,-0.579298933394039
NH-6,11152667,-1.25503210276294
HCC1588,11404337,-1.2064927748047265
HCC44,9868037,1.8192522790953956
Fu97,JQ-1-carboplatin (1-1 mol-mol),0.0288153653540589
BL-70,2742550,3.282580596685524
NCI-H1869,11152667,0.433153558661154
Karpas-299,12003241,-0.4647539333721411
Calu-3,11404337,-1.5161569407168425
BT 328,9911463,3.726223215474182
OCI-AML-5,54618771,0.4264677614075425
EHEB,100016,6.596024177667571
HEC-151,3854666,1.712269153838878
NH-6,12003241,-1.8219752869317325
U-BLC1,49836020,5.6845894274854585
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
G-402,44241473,5.089469136956295
RKN,135984461,0.6080422026652917
NCI-H2228,11152667,-1.3256620017520957
Panc 05.04,11152667,0.5937527047443664
HCC4006,135984461,1.8301833848087097
ACHN,10296883,4.360085471718373
TE-11,9884685,1.1318911845628066
NCI-H727,11404337,0.8145711342672778
NCI-H520,9935249,3.10400998228373
DU145,10322450,6.851968050616261
Pfeiffer,135659046,2.6558992288544725
COLO 684,2742550,3.773525644725552
769-P,135421197,1.1178294524098082
OCI-Ly3,4378219,1.9762350833474704
NCI-H1184,24771867,-3.092988191409792
Kuramochi,135984461,4.688112275810485
TE-15,1566236,3.006173949892504
HCT 116,selumetinib-GDC-0941 (4-1 mol-mol),2.1704161349367506
22Rv1,54618771,1.0786787609274302
SIG-M5,10296883,3.681364440246351
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
MKN45,135421197,1.3599393151619537
HCC2218,9868037,3.0911136075501253
Detroit 562,135421197,1.0926229563125225
KMH-2,selumetinib-vorinostat (8-1 mol-mol),2.389760502831543
UACC-257,54618771,0.929112305561946
CHP-126,9915743,1.430510462525058
SKM-1,9926054,1.2950133266657913
FTC-238,3854666,0.5562513966266507
NCI-H838,4378219,1.995234768102148
NCI-H1184,9935249,3.235256645331142
SNU-869,selumetinib-GDC-0941 (4-1 mol-mol),1.3245686314727811
DU145,4705,5.59514886378127
Daudi,9884685,-1.7998414591903729
EN,54639665,4.409810078244538
WM88,3854666,1.7326705708463876
NCI-H2171,24771867,-2.6220866978549444
CHP-126,135984461,6.03528386391008
Panc 10.05,136227924,2.25248962667623
OCI-AML-5,135659046,3.671994608621507
SNU-738,11404337,1.0077192926024503
GCT,54618771,1.7991225479555093
SK-MES-1,11404337,-1.915365805563204
SUIT-2,11152667,1.417612600480328
NOMO-1,9884685,0.4754269892492985
HEY A8,12003241,-2.767500133031125
MOLM-13,135421197,0.945680487717708
Ri-1,73707386,2.473234427573793
MDA-MB-453,54618771,-0.4179555738274852
NCI-H660,135659046,3.42543751190604
NCI-H1155,11404337,-0.9864413542688488
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
MDA-MB-157,6918638,0.523436976846598
SNU-478,54618771,0.1182109485114638
JHOS-2,9915743,3.2140989729370273
T3M-10,12003241,-1.1759997048612671
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
OVISE,24771867,1.656692666128474
Peer,24771867,-3.750350300069915
BT 147,24771867,4.731741962550589
HCC827,11404337,-0.5987268990428054
SK-N-DZ,65628,4.220030116054574
EBC-1,12003241,0.7952037321943549
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
LS180,44487872,4.564049669792266
Ku812,73707386,3.1917387110464666
HT-1197,135984461,4.813315019512045
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
NUGC-3,9926054,1.9670154065403471
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
JVM-3,136227924,1.9937281150641608
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
TE 617.T,54618305,4.435147460279245
BT 422,9868037,4.234688123695473
HuP-T3,24771867,4.228511460696379
MHH-CALL-3,100016,3.61949081353442
PE/CA-PJ49,24771867,1.9864075317158347
SU-DHL-10,3854666,1.8889758804883152
ZR-75-1,9935249,3.721021315564273
BICR 6,135421197,2.188693589086808
A-498,3854666,2.914304878080617
LUDLU-1,3465537,3.523806799822874
KMS-20,135984461,4.215331371407202
LNCaP clone FGC,135659046,3.5330322853898957
RPMI-6666,49836020,4.712616665171358
RPMI-6666,65628,3.838300823801096
T24,4378219,2.0200519870106137
NALM-6,12003241,-1.6085171342218008
MFE-319,11494412,1.4507368814002106
RS4;11,12003241,-1.5224166820052676
G-402,1566236,1.655640146211604
HCC1171,selumetinib-vorinostat (8-1 mol-mol),3.9661582718602273
NCI-H1693,12003241,-2.0700110042259072
JVM-3,selumetinib-GDC-0941 (4-1 mol-mol),1.8327445847214063
AN3-CA,24771867,0.3006367782170145
J82,6918638,1.767532826285683
TE-1,44241473,4.358299140015943
KMS-21-BM,9915743,0.1101239094873029
OV7,3854666,3.3865666364071223
HEL 92.1.7,65628,4.01135306171132
NCI-H841,6918638,0.9604631046268464
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
NCI-H2342,9926054,1.8673615783954545
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
MFE-319,2742550,4.226299136306918
NCI-H2009,12003241,-1.6852069192913937
NCI-H2170,135659046,3.716321979563838
DMS 114,selumetinib-vorinostat (8-1 mol-mol),3.139820854284445
SK-N-DZ,135421197,1.275457172430967
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
COR-L105,9884685,2.6443959528770167
Hs 294T,1566236,1.721437690472421
HCC-56,selumetinib-vorinostat (8-1 mol-mol),0.9567492072878072
SK-MEL-31,73707386,4.231736662554632
Hs 688(A).T,135659046,5.661695633132947
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
BT 112,4378219,2.0035787751838057
NCI-H1435,12003241,-2.5624704178121274
TE-5,9911463,3.65954938557894
COV362,11152667,-1.7293670609022522
HLF,44487872,4.498501289677035
PC-3,9911463,4.050651586625943
NCI-H1915,2746,2.498380618372834
KNS-42,54618771,1.5414231722108478
FaDu,10296883,4.258019240847728
IST-Mes1,6918638,1.4350648787515894
ALL-SIL,11404337,-1.8413362349398936
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
KYSE-450,9911463,4.540289012412596
BT 172,selumetinib-GDC-0941 (4-1 mol-mol),1.268434466812915
EHEB,54618771,1.2042140049426533
NCI-H2030,136227924,3.923759704530775
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724
NCI-H2170,4705,1.2718117604923076
Detroit 562,11404337,-0.2286733429262966
COR-L88,11152667,0.0655209576586565
Calu-6,54618771,1.0169937306444143
SNU-C2A,JQ-1-carboplatin (1-1 mol-mol),1.666650905200112
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
Tm87-16,11152667,-0.8154575220171274
P3HR-1,1566236,2.3415442579386987
PE/CA-PJ41 (clone D2),6918638,0.5938730898283403
BICR 31,9926054,1.721382648019371
T-47D,11152667,2.977233468307929
IPC-298,selumetinib-vorinostat (8-1 mol-mol),-1.8986379893326115
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
NCI-H2170,9935249,3.196642717423438
YD-38,9911463,4.143159410614896
SNU-C2A,3854666,1.1286378609784615
KMS-20,6918638,-0.8366604804869239
COLO 792,1566236,1.718125081191272
CML-T1,11404337,-1.4571467715346416
Lu-65,11404337,-0.485331944829254
SNU-61,12003241,0.1572719330395487
DU4475,136227924,1.4993153773488237
CL-11,9926054,1.919128241871703
SK-HEP-1,54618771,0.9570801540222316
SNU-1,11152667,-1.0568577120834788
A4/Fukuda,9926054,1.7963505717751411
NALM-6,135984461,1.4298238990327978
BT 330,9935249,0.442722317267438
J82,9884685,1.6283766678303309
COLO 320,9935249,2.096184530518157
TUHR14TKB,12003241,-2.6792741920200815
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
NCI-H1373,11404337,0.111453942184986
NCI-H810,136227924,1.6901408020045232
UACC-62,54618771,1.116169218616572
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
WM266-4,54618771,1.3867437118908044
KE-39,9935249,3.082096285966509
HCC1937,9911463,4.268340075854012
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
SNU-475,71751553,4.845221607036342
NCI-H841,4378219,2.103528892197762
SW620,9911463,4.067252618204241
HCC1833,9868037,3.329588957496932
HCC1438,11152667,0.8769169282292807
BHY,9935249,4.74012310047911
HEL,65628,4.10911337005638
SCaBER,54618771,2.268737587506627
NCI-H2126,selumetinib-vorinostat (8-1 mol-mol),2.6137904318766707
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
EoL-1,9915743,-0.0181598036434267
DB,100016,4.066938426663746
MCF-7,11152667,1.662528672458487
SH-10-TC,24771867,4.350364270890339
P31/FUJ,3854666,0.6136756098719494
GCT,4378219,2.302786449967914
JHUEM-1,3854666,0.8383851323648895
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
LOX-IMVI,65628,4.323385700869822
MFE-296,9911463,3.764855426656665
NCI-H1563,135984461,5.495757685430573
F-36P,135398744,6.4039586130062505
SK-ES-1,6918638,0.0671447143005349
BT-474,9915743,-4.144721850714229
Tm87-16,11404337,-0.2481919010875855
KYSE-70,54618771,1.1170424016733127
IST-Mes1,11494412,3.57589790392084
AsPC-1,11152667,-0.9426796832875202
BT 340,11152667,1.694199353559282
PE/CA-PJ15,1566236,2.6409505588349353
NCI-H2085,9915743,0.6026125220601625
RCH-ACV,10322450,3.427971439759819
MOLT-16,12003241,-1.273061825596023
NCI-H2228,2746,2.5336872635274226
U-118MG,9926054,1.9994289810495935
NCI-H1395,4378219,4.7590684323615635
TE-9,selumetinib-GDC-0941 (4-1 mol-mol),2.552175387754049
SK-N-MC,135984461,4.087273122460901
HuG1-N,11404337,-0.1697567004462442
A2780,24771867,-2.9740519428749055
NCI-H2228,selumetinib-vorinostat (8-1 mol-mol),2.242438507763082
K029AX,11152667,1.6125860914830858
NCI-H2122,3854666,2.0598225653016424
GI-1,9926054,1.7357819318992778
BHY,2742550,3.1680059679217476
A-375,10296883,4.364928139092641
HT115,12003241,-0.6699503648785873
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
CAL-51,3854666,1.1494535123186709
SNU-869,selumetinib-vorinostat (8-1 mol-mol),3.0867433449606123
SW982,6918638,1.6388429790879695
NCI-H2444,9868037,3.8466322726518256
SYO-1,3854666,0.8909773661164561
KMRC-3,9935249,3.2900979171549865
NCI-H1339,2742550,4.5254309197539735
CAL-12T,135421197,3.5670485271085868
OCI-AML-2,11152667,-3.2738296049895266
Panc 08.13,1566236,1.9309412684643408
NCI-H889,4378219,1.855018762119449
AML-193,9915743,-1.3116324914766342
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
A101D,136227924,2.7929516463081123
SW1271,11404337,-3.6050810245472382
SNU-489,54618771,1.3505446494743896
TUHR10TKB,selumetinib-vorinostat (8-1 mol-mol),2.947823569031478
BT 172,24771867,3.765062995461094
NCI-H1944,JQ-1-carboplatin (1-1 mol-mol),2.139349165329713
CAL-148,11404337,0.0721234409222233
SJSA-1,9926054,1.739207886020936
HuT 78,135984461,1.9427901339992903
NCI-H322,11494412,1.1348066706862836
HCC38,100016,6.688694515924342
OVK18,1566236,1.7808365706100535
BT-20,135659046,3.529178166961368
JHH-5,9935249,1.9754654494080983
GSU,selumetinib-GDC-0941 (4-1 mol-mol),-0.0301350261262937
FaDu,3854666,2.490372797251813
LUDLU-1,9915743,0.4461040293600573
MOLT-16,2742550,2.806612523905755
SNU-601,9915743,5.263014958216545
EPLC-272H,135421197,1.5481264659951517
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
BT-474,6918638,-0.8202779774932777
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
HD-MY-Z,4705,3.2851682687360735
Peer,100016,3.808596484759728
OAW28,10296883,4.314409366833216
T-47D,100016,6.980531714745858
MOLM-13,65628,2.9573007313246924
PE/CA-PJ49,54618771,0.7503164660158113
PE/CA-PJ49,9926054,1.8069972619127008
THP-1,4705,2.9352513647716836
SK-LU-1,44241473,4.4527088326385345
Kasumi-2,54618305,4.391643278203803
Daoy,11152667,0.0005739166010448
SU-DHL-10,JQ-1-carboplatin (1-1 mol-mol),-0.069963148884663
23132/87,65628,4.231237876491767
JVM-3,24771867,-3.3516521445042944
HD-MY-Z,9884685,1.0880914261328605
NCI-H1793,9926054,5.214680491004607
DBTRG-05MG,9926054,3.4438340523747955
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
TYK-nu,4378219,2.031818628243507
FU-OV-1,136227924,3.2834953568281597
KCL-22,54618305,4.906689630190886
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
MOLT-3,71751553,4.490864363539756
IMR-32,9926054,1.7425604419011955
TE 617.T,9935249,2.123679604144266
A3/Kawakami,12003241,0.0304416634107028
DMS 273,135984461,4.327877942465965
5637,selumetinib-GDC-0941 (4-1 mol-mol),0.4079577317339777
SCC-4,9911463,4.04011035485065
HuG1-N,9911463,3.1610800611840366
SW1271,136227331,4.376300443457216
LS123,9935249,2.027322446683245
DU4475,9911463,2.219274285034518
NCI-H747,selumetinib-vorinostat (8-1 mol-mol),-1.4900573400803985
Hs 294T,4705,3.364751346281281
KE-39,9868037,3.621529869698051
COLO 684,136227924,2.900562305918871
KYSE-150,11494412,2.89214249755195
SK-MEL-3,71751553,5.266797753387062
NCI-H322,135421197,2.22865477281611
SUP-HD1,24771867,1.9244489801737297
JHH-5,11494412,0.4405846778714341
DOV13,10322450,3.678402258814296
SF268,10296883,3.944693282925585
KYO-1,9868037,1.678802312904593
MPP 89,71751553,5.281111904460767
ONCO-DG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.679099331983427
BT 482,1566236,2.665611750333292
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
PE/CA-PJ15,65628,4.3455180568825025
PC-3,100016,6.704789318152335
BT 228,10322450,4.52310265932876
SF126,9868037,3.6473603445619
EoL-1,9884685,-2.267367014131727
SNU-620,24779724,-2.929464717918514
U-251MG,54618771,1.0937916825211575
UM-UC-1,JQ-1-carboplatin (1-1 mol-mol),1.521072888434132
NCI-H520,9911463,3.6961325383043007
KO52,135659046,3.503950077041595
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
RVH-421,9911463,4.042729397827981
NCI-H716,71751553,4.800404342202104
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
SUP-B15,JQ-1-carboplatin (1-1 mol-mol),0.3674762383240116
Rh30,135398744,6.322590827161508
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
BICR 16,136227924,2.8848408076895393
TUHR10TKB,135659046,3.511153588074704
BT 440,9868037,4.283687628506758
HuNS1,12003241,-0.810335190638815
SYO-1,76446078,4.2356641390920196
KMS-34,3854666,-0.3155498127279236
NCI-H520,9884685,-1.9980015448993624
AML-193,71751553,5.520545246875898
LOX-IMVI,9911463,3.8715849180913633
NCI-H1666,11404337,-2.6853606173229125
639V,24771867,4.010198205289502
NCI-H1395,6918638,1.485308761584704
SW1353,11152667,0.6062945809493967
Mono-Mac-6,11404337,-0.9088442855658504
HCC4006,2742550,5.021230654357048
SNU-216,54618771,-0.3617470583099299
NU-DHL-1,135398744,6.409233084142903
BT 333,54618771,1.0971803659169013
HT-29,11404337,-0.847378289342427
OAW28,3854666,2.969576020962734
MHH-CALL-3,10296883,3.858328954118167
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
KM12,1566236,3.3530659738635333
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
TUHR4TKB,9915743,2.327900585898517
COLO 800,11404337,0.0903366557424785
Caki-1,11404337,2.102506471634507
NCI-H2030,11152667,0.1486125355085492
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
HuH-6,73707386,2.841389478245076
SUP-M2,100016,3.7473632933772394
TE-10,selumetinib-vorinostat (8-1 mol-mol),3.4900763661530907
SJSA-1,1566236,3.0284015213116415
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532
HuH-28,136227924,3.512267666844948
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
NCI-H2110,11152667,-0.5579192362236717
SNU-449,9926054,1.9385314164963827
L3.3,11152667,-1.6552573738209355
TM-31,11152667,-0.2010667394462257
HSC-2,4705,1.5590916600613702
MHH-CALL-4,9868037,2.145138443959549
HOP-62,40482356,5.176244995623167
U-BLC1,11152667,-2.158849665870786
HD-MY-Z,71751553,4.240197659195247
KMS-26,9884685,-2.486464178547567
G-292 clone A141B1,71751553,4.310232300400396
SK-N-BE(2),9868037,2.6667298506556447
TC-71,2746,3.085188483378043
NCI-H2342,6918638,1.2820873150212615
VMRC-RCW,2746,4.068142110971067
LC-1/sq-SF,2746,4.189437324423252
Pfeiffer,9926054,1.762205807051045
RPMI-8226,9884685,-0.1879223006811967
DAN-G,9915743,1.9935074421825545
COR-L88,135421197,1.3679822518227
NCI-H23,3854666,0.0313541683344203
IGROV-1,2746,2.8413672686351212
COR-L88,2746,1.355169672755057
LP-1,10322450,2.4863509324995827
RVH-421,10296883,3.51018214130791
SW1990,9935249,3.469784483732877
SW1088,3854666,3.18484653745333
HuCC-T1,2742550,3.2517227525139565
Hs 888.T,3465537,2.708625352273053
NCI-H522,9935249,3.002706281912375
COLO 829,9926054,1.880005790170633
HCC-56,54618771,1.0985960691001735
HT-144,12003241,-2.1434131709855215
HCC78,100016,6.366939598030235
HGC-27,11152667,-1.849804730861495
NCI-H716,11494412,1.1252717992801926
NCI-H647,54618305,4.3213835050384315
BV-173,2746,1.3543374496057554
A-375,4705,2.938448414109293
Hs 822.T,54618771,1.097463284906687
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
NCI-H716,54618305,4.001171648016114
HCT 15,selumetinib-vorinostat (8-1 mol-mol),3.789257313413483
HCC1806,selumetinib-GDC-0941 (4-1 mol-mol),2.757254827906479
RPMI-8402,9915743,0.1468401173271679
SNU-308,selumetinib-vorinostat (8-1 mol-mol),3.2167042029880264
JHOM-1,2746,3.154925992332872
CFPAC-1,JQ-1-carboplatin (1-1 mol-mol),2.3512621109850897
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937
HuT 78,10322450,2.3335862951913726
SNU-46,3854666,3.3615805544302133
Ci-1,1566236,1.8797102720685392
SW579,11152667,-2.578295959963482
WM793,10296883,3.657255931485473
D283 Med,selumetinib-vorinostat (8-1 mol-mol),2.011575118738352
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
BT 147,9868037,4.310170196853697
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
SNU-C1,10322450,2.683977813165255
K029AX,135421197,2.4286138926915175
KMM-1,9911463,3.7881854047287113
NCI-H1092,9884685,5.208907292159036
HT-1080,4705,3.343447730900498
NCI-H28,49836020,4.481045778865963
EKVX,9884685,0.0650856407845384
RVH-421,6918638,1.0964005679710755
NCI-H2023,9911463,3.271912940774434
NU-DUL-1,9926054,1.630316493703293
LP-1,12003241,-0.1215623944522291
SNU-685,3854666,2.1125077744933
COLO 699,136227924,2.9902058739506385
NCI-H2141,6918638,0.0318107940340185
KP-N-YN,71751553,4.417015018221096
TE-8,4705,2.806711792876773
HCC1438,9868037,4.0008009235248005
MPP 89,54618771,3.5839559613282916
LUDLU-1,3854666,1.3097190271987702
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
EFE-184,3465537,3.1407639622077395
SK-MES-1,selumetinib-vorinostat (8-1 mol-mol),2.706535329304162
Hs 839.T,4378219,1.94956437740926
COLO 668,11494412,0.7802380816103417
BT 179,11152667,-0.2700470764101368
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
NMC-G1,11404337,-0.1784694384642232
2004,4705,2.464885912287897
P12-Ichikawa,65628,3.061584325032845
Mino,6918638,-1.9893642721575304
HEC-6,44241473,4.793739409575418
SK-N-AS,9915743,0.9630784924267336
Hs 578T,2742550,3.5663140561815525
LS411N,49836020,4.501659667614969
DND-41,JQ-1-carboplatin (1-1 mol-mol),-0.1344797725296377
LOX-IMVI,11404337,-0.9085197853802874
BT 228,9935249,2.295715399425516
ONS-76,9926054,2.5108803232151304
DBTRG-05MG,selumetinib-vorinostat (8-1 mol-mol),3.184987086723066
Panc 03.27,11404337,-0.4411804077325879
BT 416,4378219,1.879572994125315
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
PE/CA-PJ49,1566236,1.7621483938715563
BCP-1,11404337,-1.851006569506268
NCI-H650,54618771,-0.8168884104410387
BT 147,135398744,6.518001641470466
BxPC-3,49836020,-2.380895293574403
SU-DHL-10,selumetinib-GDC-0941 (4-1 mol-mol),2.1131040208605576
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
NCI-H1092,3854666,1.7831562708521254
COV644,11494412,1.744559483625179
EBC-1,135421197,2.252820006275089
U-CH1,12003241,2.634808409336574
SK-MEL-31,10322450,4.01395205895819
GCT,selumetinib-GDC-0941 (4-1 mol-mol),2.439679750854635
A-172,10296883,3.776077319077153
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
SH-10-TC,9935249,3.302172172490518
SU-DHL-8,65628,2.7455564974118283
MES-SA,1566236,1.8383207711013103
NCI-H1339,JQ-1-carboplatin (1-1 mol-mol),3.0025540987138326
HEC-1-A,9884685,0.2654955927517619
PaTu 8988s,4705,3.38811272412219
OCI-AML-2,9915743,0.8292990074766823
M-07e,11152667,-2.997128010914285
BT-474,11404337,1.3863676230346815
OE33,9915743,2.242004758711727
RERF-LC-Ad1,9911463,4.614184078770455
AsPC-1,9911463,3.4970941612274693
HuG1-N,71751553,4.683774656749965
CHP-212,9935249,1.3663209076830405
PL-21,24771867,2.814856917473943
Caki-2,9911463,4.333503624350426
P3HR-1,9868037,3.788082301181329
SW579,136227331,4.609326652979714
LoVo,9935249,1.1872155844887071
BICR 18,selumetinib-GDC-0941 (4-1 mol-mol),2.10893562893339
BCP-1,9926054,1.6337686711618178
MOLT-13,9911463,3.0690071291401626
EM-2,24771867,-3.6193575560618063
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
T3M-10,11494412,3.4512689265696936
BT 271,9884685,0.6655753843685114
LXF 289,4705,5.10311909598278
OVCAR-8,9911463,4.194046142536917
Hep-G2,11152667,-0.2869645192447481
NCI-H1341,54618305,3.7343593679242417
SNU-685,100016,6.855109756647912
A101D,12003241,-1.0986495828587448
KP-4,9926054,2.5953636784587877
HCC366,selumetinib-GDC-0941 (4-1 mol-mol),2.581638032416284
Hs 294T,selumetinib-GDC-0941 (4-1 mol-mol),1.293217302318029
SK-ES-1,9911463,3.761079792155382
NCI-H1869,135984461,4.367577543921494
TE 617.T,2742550,3.402468402026986
KMS-18,selumetinib-GDC-0941 (4-1 mol-mol),2.1372948898179462
COLO 205,9926054,1.7915651258593497
DMS 454,12003241,-0.401739549188604
JL-1,54618771,3.703254873905745
LS1034,9935249,3.2731145220005753
SU-DHL-10,selumetinib-vorinostat (8-1 mol-mol),2.662660898832206
DAN-G,11494412,2.594711153246368
NCI-H522,9884685,0.1045560296672991
TT2609-C02,44241473,5.910804313192962
HCC2108,54618771,2.799542688239582
IGROV-1,135421197,1.96820638017286
SNU-886,9926054,2.2284003182480774
HT-1376,9911463,4.13018577448945
A-549,24771867,2.4933733383815206
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
LOX-IMVI,1566236,1.766970310435897
HOS,selumetinib-GDC-0941 (4-1 mol-mol),2.6717134852728264
RPMI-6666,135421197,1.415232327318222
Kasumi-1,6918638,-1.672437064714565
TUHR10TKB,1566236,3.1698186598160705
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
SUP-B15,6918638,-0.8049733622393979
BEN,BRD-K16130065,4.206876741952794
BT 286,135659046,3.5488699738704432
8305C,9915743,0.0007928276495739
T3M-10,71751553,4.991092560172867
T3M-10,11404337,0.3404159052495322
BDCM,12003241,-3.7863516552935415
HCT 8,10296883,4.100696094904368
F-36P,11494412,-1.3209854958695244
MOLT-13,9868037,1.8039325171319247
OVCAR-5,11494412,4.220003635064294
Panc 04.03,1566236,3.6247050899799698
SNU-1033,2746,3.071869125008986
KP-3,135984461,4.664901942241971
A-204,2746,2.3964881328568315
HCC827,3854666,0.8630947489226746
NCI-H660,3854666,3.03505528953488
OVSAHO,4378219,1.798410005071074
EJM,3854666,0.5770225844187807
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
OCI-AML-5,136227924,1.61818972770755
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
GSS,2742550,2.9505623218307298
SK-LMS-1,44241473,5.38031759835473
Hs 766T,71751553,4.306792933444251
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
HCC44,9926054,1.5614419320460398
HuT 78,54618305,4.369358935790669
OC 314,135659046,3.480860974794082
MeWo,11152667,-0.8999084829893459
DAN-G,2746,3.5284338969271265
YD-15,9915743,-2.405110430781952
U266B1,9926054,1.2913740580373996
BT 248,9884685,-0.279602051509792
BT 248,9935249,2.246614582121965
NCI-H1869,12003241,-1.5114527115730307
MCAS,11152667,-0.1014639738878534
Mino,selumetinib-vorinostat (8-1 mol-mol),1.4107779642854583
NCC-StC-K140,9935249,0.5138853084156294
UM-UC-3,136227331,3.94021080809034
ME-1 [Human leukemia],100016,5.540349228215307
Hs 888.T,6918638,2.9621316525739885
CAL-120,135398744,6.432645448228996
NCI-H1703,54618771,1.8200920979055903
VCaP,12003241,1.0138144203532238
PE/CA-PJ34 (clone C12),selumetinib-vorinostat (8-1 mol-mol),2.6799974676882883
BT 216,11404337,-0.0425915422639234
BT 147,12003241,0.4037100837513208
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
RVH-421,selumetinib-vorinostat (8-1 mol-mol),1.3960776963459798
KYSE-510,9935249,3.150721090572469
GDM-1,10322450,3.191264659365354
NCI-H1573,4378219,2.96389642020658
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
EoL-1,54639665,4.29545945108559
Rh18,44241473,4.9535314901781
SNU-1041,135421197,3.0593389422379293
HCC1954,2742550,3.203608466138423
OV7,9915743,1.7839177837721256
Calu-3,selumetinib-GDC-0941 (4-1 mol-mol),0.8119052170432226
NCI-H2106,73707386,2.2062547399893417
A-204,3854666,1.289524707021466
NCI-H1666,9884685,0.2740886740036458
JL-1,selumetinib-vorinostat (8-1 mol-mol),2.5961200479912714
MOLP-8,11494412,0.4734092912657368
NCI-H146,3854666,1.3221451848305394
OE21,2746,3.2562317048816363
WM115,135421197,2.9135607351561883
HSC-4,9911463,3.832706037448295
MKN45,9911463,4.632909886442526
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
SW1417,136227924,2.767989145735224
SNU-475,11404337,1.9630553602139893
PK-1,11404337,1.355004976466392
KP-2,3465537,3.946728673772689
RD,9915743,0.9845356275865762
HMCB,3854666,0.4980905922324143
SK-MEL-30,2746,2.9636242403288344
L3.3,135421197,2.5730452840447415
PSN1,135984461,4.283628399888077
LS123,73707386,1.910994196621481
GA-10,65628,2.41107724577683
TE 617.T,54618771,-2.3163435045847436
RERF-LC-A1,11152667,1.3803453308335734
SNB-75,9926054,1.9842991929062104
NH-6,71751553,4.4252117067676275
SNU-869,6918638,0.8592076478427688
TT2609-C02,3465537,3.455701552021007
NCI-H1581,54618771,2.0706230217486468
KMS-20,9915743,0.2569666585707142
Capan-1,6918638,0.6786915212188055
NCI-H1651,54618771,4.521553313874046
OVISE,135984461,1.6429740508824469
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
MOLT-16,selumetinib-GDC-0941 (4-1 mol-mol),2.290963052000247
Daoy,135421197,1.0307479494466607
HDLM-2,54618771,0.2228052898730796
COR-L105,135421197,1.9442341701951136
JeKo-1,9911463,3.294378834813148
SNU-C5,selumetinib-vorinostat (8-1 mol-mol),1.5322725159443586
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
Hep 3B2.1-7,11404337,0.0289427466491547
HCC1569,3854666,2.945082470894372
TCCSUP,11404337,-0.4859326706611666
YD-10B,11404337,-1.441259923990304
A3/Kawakami,40482356,5.618568759585912
GSU,9911463,4.305557619693962
Hs 578T,10296883,3.7096057485466223
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
KYM-1,100016,6.934049900113359
SNU-761,54618305,5.766464917094291
HuT 78,11404337,-1.1966282759274738
PLC/PRF/5,9935249,3.446956558470987
Aska-SS,9935249,3.1640243411747666
A4/Fukuda,11152667,-2.4230854517211977
HCT 15,6918638,1.0583340950733469
TF-1,4705,3.093952009928188
JHUEM-1,1566236,1.8042145554615676
UO-31,136227331,3.2031973353809833
A-253,6918638,0.9016181172742443
NCI-H1869,1566236,2.8728790566593747
NCI-H1755,10296883,4.225143740358611
8-MG-BA,6918638,1.6355353194414102
KG-1-C,9926054,3.438726286073136
HEL,12003241,-0.3954740832299299
SW1573,9911463,3.734935340044018
SK-MEL-3,54618771,0.906293998556286
BL-70,12003241,-2.1974938808167477
TF-1,selumetinib-GDC-0941 (4-1 mol-mol),1.467323615098958
A-549,135421197,2.4799819746704075
EB1,JQ-1-carboplatin (1-1 mol-mol),1.505411442976691
THP-1,9915743,0.7907463858245806
OVSAHO,136227924,3.9451154225840783
Sq-1,12003241,-0.6972908416742193
BT 416,2746,4.178903855653317
NUGC-4,9868037,2.67095726720747
HuH-6,9884685,0.3084855166914031
Kasumi-2,4705,3.579279614719375
TYK-nu,9926054,1.6864170114704335
TE-10,9911463,4.005414561442447
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
LOX-IMVI,100016,4.319089113839007
MV4-11,44241473,4.272766802808059
JHUEM-1,11494412,0.6922251980518859
NCI-H226,selumetinib-vorinostat (8-1 mol-mol),4.332500490297142
HuT 78,9915743,-0.3205464670121912
LS123,9884685,-0.4320326525483665
BT 245,3854666,0.2943168101858666
HCC827,9868037,2.0129298599097227
K-562,54618771,1.1969173800987956
RPMI-8402,selumetinib-vorinostat (8-1 mol-mol),2.302380796643318
SK-MEL-1,9935249,4.4226392340907825
HT-55,54618771,1.7226930749216656
DMS 454,9915743,0.9542388658928032
SW579,44241473,4.414006194660448
HuP-T3,40482356,5.071639396405957
BT 428,4705,1.6502431761366996
JHH-4,135984461,4.02642317281815
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
KMBC-2,9926054,2.0094384239747294
SK-N-FI,135984461,4.351093738178911
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125
IPC-298,44241473,4.459786307803648
U-937,selumetinib-vorinostat (8-1 mol-mol),2.4655202685324236
WM266-4,4378219,2.0058073239326095
KP-N-SI9s,135421197,1.130974840483334
IM95,3854666,2.5844605567324925
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
22Rv1,9884685,-1.1677338946675415
DoHH2,11152667,-2.4116880189602643
YD-15,11404337,-0.8850670977234124
NCI-H1105,selumetinib-vorinostat (8-1 mol-mol),1.804974840497553
SK-MM-2,12003241,0.4022958113963022
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
DMS 454,2746,1.9739977196857323
TE-6,10296883,3.6280455791463098
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
SF539,44241473,5.236379084530278
A-172,54618305,4.515283659977801
OCI-Ly19,54618771,-1.0348518015701054
RL,65628,4.074599228005119
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
Calu-6,9911463,3.814763109547714
DU145,54618305,4.450294310090801
KYSE-150,4378219,2.006668305797274
SYO-1,6918638,0.2602930891489552
U-BLC1,9884685,1.006082357042544
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
CHP-212,135421197,1.019713131092093
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
HuH-1,4705,4.381282786595648
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
SNU-1077,54618305,5.347093142592056
SNU-503,selumetinib-vorinostat (8-1 mol-mol),0.2887202036830235
EFO-27,71751553,4.378478985868248
U-118MG,12003241,-0.1852675851464418
SK-N-DZ,11152667,-1.5791240084386322
EFO-27,2742550,4.50908635993052
Mel JuSo,135421197,1.941691146031138
G-401,6918638,0.0373379560261908
HCC1143,9915743,0.7364353129897024
PK-1,3854666,3.537340048707808
HT-1080,12003241,-0.8718791582683669
SNU-16,10322450,2.297245339388599
SNU-449,9915743,1.6643053553641087
LN-18,selumetinib-vorinostat (8-1 mol-mol),2.5778552693541052
Ri-1,136227924,2.363884089308993
ChaGo-K-1,10296883,3.916138257208464
SK-MEL-24,10296883,3.9886960310238178
SW1783,44241473,6.157052132127655
EJM,2742550,4.0665181922374805
T3M-10,135659046,3.5498820327325875
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
HEL,135421197,2.810551353794614
BT 232,136227331,4.34663354921091
RT-4,9911463,3.5197462916355073
TALL-1 [Human adult T-ALL],9935249,2.492316336854245
Jurkat,3854666,0.1907683336293414
T3M-10,9915743,3.0037354208599996
NCI-H1666,4705,1.0065866231900624
YKG-1,2742550,5.856053185506653
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
BT 231,2742550,2.753337443391445
SNU-398,9935249,1.9793428162570832
SK-OV-3,73707386,3.7899266428434233
Becker,9926054,2.0290907819284283
NCI-H1395,4705,3.4784735381586183
DU145,4378219,2.506058441713071
MM1.S,1566236,0.950221343647725
KP-4,9935249,4.396743844440814
DoHH2,12003241,-3.729445034849217
BT 271,10296883,4.284017476819925
NU-DUL-1,9884685,-1.0623784374180658
BL-70,136227924,2.857298369944604
LMSU,71751553,4.583903358050372
NCI-H1563,6918638,2.248675960717125
CAL-51,9926054,2.2227862000004577
NCI-H1299,65628,5.181040397435313
PC-3,10322450,4.846357152814794
WM1799,12003241,-2.735191284404769
SNU-213,135421197,2.2792835673188687
WM1799,9915743,1.2587525193703504
SNU-1041,selumetinib-vorinostat (8-1 mol-mol),3.508880149625294
BT-474,JQ-1-carboplatin (1-1 mol-mol),5.214986891454346
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
LS513,12003241,-0.5342180043119649
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
G-402,9911463,3.624660620930307
HCC1806,136227924,2.6306602850580387
BT 416,1566236,1.637828038025737
DU145,4378219,2.506058441713071
COLO 699,11152667,-1.5476847653514505
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991
SNU-449,135421197,1.7191553190938056
OAW42,65628,4.461928912240859
UM-UC-1,2742550,3.314005121432249
JeKo-1,11494412,0.2725686605120115
JURL-MK1,12003241,-5.793080967465335
SCC-25,11404337,-1.9627814938837227
SNU-8,44241473,4.763385234005065
PL-21,10296883,3.1495852903666623
BT-20,54618305,4.294432746709741
ChaGo-K-1,71751553,4.486695284730435
BHY,9915743,-2.760312091830137
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
UACC-257,6918638,0.5878135089282499
253J-BV,135421197,3.2645583108657217
A4/Fukuda,100016,4.8831896191852096
SW1573,4705,3.887877577681455
KATO III,12003241,-4.840637368540689
HCC1569,9935249,3.5629865818868613
MV4-11,11404337,-1.0129181206141806
JHOM-1,44241473,5.0412575448771975
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
SF268,4705,3.336245866912317
NCI-H1869,11404337,1.2362831155289085
Hs 729.T,100016,6.726636381823557
TC-71,12003241,0.7010514965491693
Calu-6,100016,6.484915939204548
JHH-2,3854666,3.1841844959157277
NCI-H1435,selumetinib-GDC-0941 (4-1 mol-mol),1.0023239879000474
RL,135421197,1.8322990483714552
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
NCI-H1693,54618305,4.535108475988098
U-CH1,JQ-1-carboplatin (1-1 mol-mol),2.2916861581051062
Mel JuSo,10296883,4.305095904574399
SK-MEL-1,selumetinib-vorinostat (8-1 mol-mol),-1.3399286249767557
DMS 79,9926054,1.7240828255931135
CAL-85-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1820592337314743
BT 333,2742550,4.922305550414676
Hs 766T,1566236,3.04131244391702
KNS-81,1566236,3.2129969954763973
SNU-61,9935249,2.942554259952632
NCI-H1341,10296883,3.7188145345884407
TE 617.T,24771867,4.245459071859496
RT-112,selumetinib-vorinostat (8-1 mol-mol),2.1628521495611333
PC-3,135659046,4.742697246450577
BT 286,54618771,0.8427122634128117
HPAC,3854666,3.57580848834068
HCC1143,135984461,4.873829103860087
GMS-10,11404337,1.4547750638091848
Sq-1,44241473,5.83551022175152
CAL-29,49836020,4.434653881531219
PK-59,54618305,4.329681142974429
NMC-G1,24779724,4.225220713567242
SNU-869,100016,6.487538118719535
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
HCC1143,44241473,5.874360916813842
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
KMS-18,1566236,1.6034758875219752
KMRC-2,9926054,2.0216271093968263
Hs 944.T,9926054,2.091458056725466
SF126,12003241,-0.8562047407383144
HEC-1-A,2742550,3.858745606484426
SCC-9,9915743,1.0040050158500469
NCI-H196,49836020,1.0558785681395022
MDA-MB-231,selumetinib-GDC-0941 (4-1 mol-mol),2.1561447118873383
HT-55,135421197,1.3327520491863434
TM-31,10296883,4.091171590398709
HEC-1-A,9915743,1.9800038677829928
HEC-151,135421197,1.9024476201303135
Panc 10.05,JQ-1-carboplatin (1-1 mol-mol),5.298332174955392
MFE-319,44241473,5.487537752987347
MDA-MB-468,24771867,-1.511843430118938
MOLT-16,11152667,-3.3929002826964085
MES-SA,11152667,0.5364963747831863
HOP-62,6918638,0.8791129287698843
Panc 03.27,1566236,2.3499818808083064
PE/CA-PJ15,136227924,2.633948596133963
NCI-H2196,65628,4.307213942062808
GCT,9915743,0.92699998919311
RPMI-6666,54618771,0.781806189170932
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
A2780,11404337,-0.8981705286722745
NCI-H1339,24771867,3.8469201935046815
MOLP-8,1566236,0.7132031003128095
JMSU-1,11152667,-1.6700997143159322
MDA-MB-415,71751553,5.417271361950941
BT 359,135421197,1.2544226030548953
Hs 578T,650361,5.221503033244948
MOLT-16,136227924,1.8334417676190544
Pfeiffer,10296883,1.0462803777158507
EBC-1,24771867,-2.8964696394488123
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
SNU-1076,54618771,0.3413327758331145
Caki-1,135421197,2.421962136106705
JeKo-1,136227924,2.4041415853814687
JHOC-5,11152667,-0.9759245542637908
NCI-H1838,9911463,4.286629824505249
DV-90,9926054,1.8346982871797115
DOV13,selumetinib-vorinostat (8-1 mol-mol),4.285112015872766
NCI-H1105,9926054,1.86457745322678
CHP-212,11494412,-1.604846658421623
HCC1500,9911463,3.4774936591741703
K-562,12003241,-5.632155645383806
NCI-H520,135421197,1.6066426721545042
HSC-4,4705,3.95336427523857
HuH-6,3465537,0.6799951481772273
SNU-423,2746,3.5801912517104695
BT 504,1566236,1.844513919380763
WT2-iPS,3465537,3.265223297454724
SYO-1,54618305,4.368337519568372
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
NB4,136227924,2.0986844076590616
HEY A8,selumetinib-vorinostat (8-1 mol-mol),2.236859595097947
SJSA-1,12003241,-0.348535560110424
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
BHY,3854666,2.882550341834236
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566
SNU-1196,24771867,3.5344229530172084
NCI-H1395,11494412,4.0372714005300026
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546
COV362,2746,5.138153782003929
NCI-H2286,136227331,5.6980309243628
SNB-75,11494412,4.209755113489716
Namalwa,1566236,0.962108735319634
KMS-18,10296883,2.8324410966365985
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
CAL-85-1,136227924,2.9828253747888067
B-CPAP,135984461,1.7006873444468935
SET-2,10322450,3.4472789227229925
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382
Hs 940.T,10322450,5.493990907316365
T84,9884685,0.0950503112207011
Daudi,11404337,-3.064654238522792
KNS-62,9868037,4.116699778662341
KMS-20,11494412,0.3854055603119042
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
RS4;11,9926054,1.3996833727357625
TE-6,selumetinib-vorinostat (8-1 mol-mol),2.420365581709828
HEC-6,11404337,-0.461352025950454
SW579,11494412,0.7321590256226097
RPMI-8226,100016,4.270983790022636
SW982,54618771,0.7299689874898085
LN-18,136227924,2.6730717807576347
A2780,136227331,3.7351205807719863
MDA-MB-157,1566236,1.4232096904008935
NCI-H1339,12003241,0.6707609457385758
SNU-1,9915743,0.7760871972168086
SNU-475,9935249,4.4332882179625015
OAW28,6918638,0.0048657249331401
Panc 08.13,selumetinib-GDC-0941 (4-1 mol-mol),0.8396472898062124
MOLP-2,4705,2.8444901068578687
MM1.S,49836020,3.8296017324588942
ECC10,100016,5.627610035010204
A-549,1566236,4.271699172517002
NCI-H841,40482356,5.202318147086401
NCI-H1355,11152667,-1.9063918526279175
COLO 201,136227924,3.2878786819809105
SEM,9884685,1.4949119152013906
NB1,selumetinib-GDC-0941 (4-1 mol-mol),2.4185204185307527
OCI-AML-5,selumetinib-vorinostat (8-1 mol-mol),2.268725375318619
BT 131,2742550,4.391200704137665
ME-1 [Human leukemia],9868037,1.581753710265031
CCK-81,9915743,-3.5525770077735555
Hs 294T,54618771,1.144454520663973
CHP-212,JQ-1-carboplatin (1-1 mol-mol),-0.8333787356849307
SNU-489,2742550,6.440892359279651
MFE-319,9911463,4.372172899539541
Hs 940.T,1566236,4.326667730982519
BL-70,100016,3.880189960258483
JHH-4,54618771,-0.357256318884579
NCI-H1703,54618305,4.148207764421203
KYSE-70,135398744,6.338938630156892
G-402,3854666,1.4392948064524391
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
COR-L88,selumetinib-GDC-0941 (4-1 mol-mol),4.210918027029114
HCC4006,100016,6.421907923076987
B-CPAP,10322450,5.621210843033534
KMS-28BM,selumetinib-vorinostat (8-1 mol-mol),1.8148707559723616
GSS,3854666,0.8019328802169965
NCI-H1869,54618771,2.934235316942264
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
HOP-92,12003241,-2.2936384439521156
MKN7,24771867,3.454423301474028
SW1271,135659046,3.922158232881772
VMRC-RCZ,9926054,3.085597836740958
BT 482,136227924,3.374884803280594
42-MG-BA,12003241,-1.3085155086024562
MSTO-211H,9915743,-1.0722844498490078
WT2-iPS,2746,4.7130481819205015
DoHH2,selumetinib-vorinostat (8-1 mol-mol),1.073205965733501
A-549,3465537,3.857188765779011
HuH-6,54618305,4.039870782585062
DND-41,24771867,4.768925636280578
MDA-MB-415,11494412,3.530335819236776
SK-MEL-5,9911463,3.724914838124911
Kasumi-2,4378219,6.192429128955844
Mel JuSo,9926054,2.008818568190823
CW-2,selumetinib-vorinostat (8-1 mol-mol),1.834795520359669
CMK,10296883,3.7802056460582385
NCI-H747,136227331,4.187158203356049
TE-11,3854666,0.6923023078298671
HCT 8,11152667,1.9192978307377688
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
SIG-M5,71751553,4.293006286134242
SNU-668,54618771,1.3172714373164345
TT,9868037,3.136972915519422
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
YKG-1,9884685,-0.1545508204895388
SF539,9915743,0.9219479584552366
Rh30,selumetinib-vorinostat (8-1 mol-mol),2.333625325238172
KMRC-2,9915743,0.8631489276658242
SK-MES-1,11494412,1.2665104699184024
MFE-296,135421197,4.335521235356187
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
CML-T1,9915743,1.9836361869709076
SHP-77,11152667,0.6576554567365351
NCI-H1385,135984461,3.701163403463682
KMM-1,44241473,4.395866908951306
697,9935249,-1.5234929638841532
HCC95,9935249,3.710216243518792
SK-OV-3,54618771,2.5849230632376923
NCI-H1563,4378219,4.693951002207225
MeWo,9911463,3.6919226890378942
NCI-H1435,4705,4.767035431854917
A-375,1566236,1.7725511656695576
Ku812,9911463,3.2535027234043428
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
NCI-H2444,3854666,3.925544858785653
NALM-6,54618305,4.100743618247065
CHP-126,2746,1.549661784493303
SNU-8,9926054,2.0095672828148636
NCI-H1869,71751553,5.160002179984854
KE-39,9915743,-0.5446321163343049
NCI-H2087,2742550,3.773914514591571
SU-DHL-1,9915743,1.482861419138649
NCI-H647,24771867,2.439298815176434
JeKo-1,11404337,-1.0082771831534074
NCI-H292,9915743,-0.4817131806939655
YD-15,54618771,0.7976995145825885
JHH-6,6918638,2.94778128430583
RL,9915743,1.6730730266381315
KMH-2,136227924,2.758064098306969
Yamato-SS,24779724,-0.903549549711913
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
HCC4006,6918638,1.1355769823914148
HPAC,12003241,0.9185778330779416
NCI-H661,44241473,4.80522256986357
KE-39,9915743,-0.5446321163343049
JURL-MK1,11152667,-3.3450890935441713
CAL-62,12003241,-1.1507806931187785
P12-Ichikawa,9911463,3.30531247754742
SNU-8,54618771,-0.2346938322915562
KMS-20,3465537,0.9285591790497558
CHP-212,100016,6.525746829388361
M059K,2746,3.2617211369125383
SW948,54618771,1.4567685239775812
MOLT-13,9935249,1.2940380714229205
TUHR14TKB,71751553,6.485615082435111
SNU-C1,12003241,0.2452706417287593
ME-1 [Human leukemia],11404337,1.0093638821614643
QGP-1,54618771,1.891890541476157
U-937,2742550,3.439530464441688
COLO 320,selumetinib-vorinostat (8-1 mol-mol),2.1116908992228702
OCI-M1,135984461,1.8150878916625208
BT 145,3854666,0.0488390868227151
BT 232,9926054,2.340014679513304
KYO-1,3854666,0.614487001981186
IGROV-1,9926054,1.8111808945519428
SNU-119,54618771,1.6343524810724477
AGS,selumetinib-vorinostat (8-1 mol-mol),2.398857545176039
KP-2,54618771,1.1956106328766414
MDA-MB-468,49836020,3.927183487044253
OV-90,9926054,2.051582159797273
8505C,49836020,5.7227071797800235
A-204,11494412,0.8963449345422223
HCC1500,9915743,1.9340540182592263
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
Lu-65,9935249,3.101131829236005
COR-L95,24771867,5.320672645408192
MES-SA,2746,3.3783826340616243
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
PK-45H,10296883,4.020299525080379
BT 328,9868037,5.326885818831123
SNU-C5,10322450,3.582539499597872
GI-1,selumetinib-GDC-0941 (4-1 mol-mol),2.406121419892038
TE 617.T,11494412,-0.0865540584067903
PSN1,2746,4.086398996517882
8505C,3854666,1.9826671632672512
SW1990,12003241,-1.6004272332343192
NCI-H1975,49836020,-1.0893813245468835
SUP-B15,76446078,5.1983225752564435
KE-39,24771867,5.944751904846296
NCI-H2228,10322450,3.891754335699043
MOLP-2,11152667,-1.802656645325623
EFE-184,9915743,2.640815176926095
RERF-LC-A1,100016,6.9126876628990885
KMRC-2,11494412,6.4606307205450015
Lu-65,54618771,-0.448084270947246
HCC44,11404337,-1.974038980762408
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
NCI-H2444,11152667,-0.3751475326918679
NCI-H28,11152667,-0.8241097892639433
IGR-1,2746,1.8985150610888328
DK-MG,11494412,1.0754842837417289
OPM-2,136227924,1.7425170628423947
MM1.S,135421197,1.5136201913497214
ZR-75-30,1566236,2.802921383922552
DK-MG,54618771,1.0774373419981456
SNU-668,selumetinib-GDC-0941 (4-1 mol-mol),1.744810645163071
NOMO-1,135421197,1.2386186938920458
BT 179,136227924,3.760107948072088
A2780,9926054,1.5482217772077662
HCC2935,10296883,4.009305839829136
42-MG-BA,2746,3.593124420605687
SK-MEL-1,11404337,-0.7875528095472949
Hep-G2,12003241,-0.7040118985216451
BT 172,10296883,4.205503162843324
HH [Human lymphoma],3854666,0.2843191725884716
PC-14,2742550,4.050636111371891
Hs 578Bst,11152667,3.6587285726164183
KYSE-520,135398744,6.453499706252085
OV56,9926054,1.8437049272321575
IGR-1,selumetinib-GDC-0941 (4-1 mol-mol),0.2767905376035742
NCI-H2106,9935249,3.2299572797389096
Hs 766T,54618771,0.4813536193297115
A-375,54618771,0.2489032260565352
Malme-3M,selumetinib-GDC-0941 (4-1 mol-mol),-2.272222861013609
EKVX,9868037,3.7956253257863217
HT-144,135421197,3.272729024645835
Tm87-16,71751553,4.289418278764033
BT 216,11152667,1.8521130172934532
CGTH-W-1,11404337,-0.3355456944915889
KYM-1,4378219,1.8114134606342005
JHH-4,9926054,1.9011355280949385
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
MG-63,9884685,0.4591360322389684
PaTu 8902,136227331,5.567107594748722
SNU-601,9926054,1.5128291451092608
HEC-1-B,JQ-1-carboplatin (1-1 mol-mol),0.0800794652195035
COR-L95,10296883,4.074268886544182
Hs 888.Lu,9884685,1.1513032262047451
WM983B,76446078,5.309795973967175
YD-8,12003241,-1.7142863629727714
SW579,3465537,3.040854051366811
Ri-1,24771867,-1.201447409529902
COV434,65628,4.436950760352565
P31/FUJ,100016,5.4217002529902185
NCI-H2081,11152667,0.3314648978290519
GA-10,1566236,0.5449565889355672
SNU-387,4705,3.526786738032827
IM95,9884685,2.9986081253440644
BT 333,12003241,1.72597197998683
AN3-CA,9911463,3.862780684019093
OUMS-23,24771867,4.63193176489715
SNU-8,24771867,0.819050595072537
SYO-1,9926054,1.4051151618362918
DMS 114,9935249,2.684737393179628
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
BT 504,4705,3.101925484309532
MKN7,selumetinib-vorinostat (8-1 mol-mol),3.1856910692458102
DMS 79,65628,2.0742410834649316
COR-L95,3465537,1.5360689669151406
NCI-H2196,10296883,4.157958831010532
DV-90,135984461,4.374368296493772
RERF-LC-Ad2,9911463,4.319203395941844
WM983B,11152667,-1.3678163730800454
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
NCI-H1435,73707386,2.9005384628289517
K-562,4705,3.481256778033869
KMH-2,9935249,3.3935783727628426
HEL 92.1.7,136227924,2.7818707499809188
647V,100016,6.109475002217934
Capan-1,54618305,4.4097719000547135
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
SCC-4,9868037,1.8621190248013155
HT-144,1566236,1.744450606587017
U-937,9884685,0.5979635741027005
A-673,135659046,3.595490040408381
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
NCI-H23,9926054,1.8354921761885392
HCC1195,selumetinib-GDC-0941 (4-1 mol-mol),2.113355514825289
SNU-840,selumetinib-vorinostat (8-1 mol-mol),2.4340389670643345
ChaGo-K-1,selumetinib-vorinostat (8-1 mol-mol),2.615914600490853
BC-3C,135659046,3.4176936154501845
697,11404337,-3.514095221219387
U-937,65628,4.428967957842935
JHUEM-3,11494412,-0.7196564295735808
SK-N-AS,2742550,3.823682171563052
NCI-H1155,selumetinib-vorinostat (8-1 mol-mol),2.411327156163
Hs 822.T,9935249,3.3041930901497794
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
KP-2,10322450,5.99994747446592
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
SNU-869,136227924,3.0372027283613505
THP-1,3465537,1.1164105126480133
ECC10,11404337,0.1866316876880306
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
Hs 934.T,24771867,3.8609264544481903
KYSE-150,100016,4.009775484830176
FTC-238,9935249,2.9756911354849143
SK-MEL-1,49836020,3.8417397632517143
MFE-319,24771867,4.310253183233504
MIA PaCa-2,10322450,3.5979699373077585
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293
HMCB,136227924,3.0347930044007643
TE-11,9915743,-1.3132877910831091
BT 444,selumetinib-vorinostat (8-1 mol-mol),2.9884692374196744
KMS-28BM,136227924,3.12099798130619
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
KMS-27,49836020,5.305149991763679
SUIT-2,9935249,5.647291906272881
NCI-H2126,9911463,3.5992006521825317
KYO-1,1566236,1.52682449500088
Hs 944.T,135659046,3.5243934331701268
KE-97,136227924,2.279256150432482
HuG1-N,selumetinib-GDC-0941 (4-1 mol-mol),-3.3555719378633375
Mono-Mac-6,9884685,-0.179940591951051
PE/CA-PJ15,9915743,-1.4704662389348668
MKN74,9935249,3.3607171533797127
NCI-H211,3465537,0.5035689428238851
42-MG-BA,1566236,2.996441509240824
GA-10,selumetinib-vorinostat (8-1 mol-mol),1.5334838453135928
NCI-H1563,24771867,2.054733219014131
DAN-G,6918638,0.6024749153933902
KO52,11404337,0.1772123930911338
HT-144,6918638,0.3712139680778337
NALM-6,11404337,-2.6750966527549855
HMCB,9935249,3.1054191675254064
YD-38,54618771,0.1066197400708346
SNG-M,11152667,-0.3247836343382136
HuH-6,2746,2.1362629951594396
MHH-NB-11,9868037,2.6095173563675065
WM983B,2742550,4.170565550824284
KYSE-410,11152667,-0.1422079620328849
NCI-H1299,100016,6.953805951258825
Karpas-422,136227924,2.027369566350396
NCI-H522,44487872,5.4176039717063915
EB1,136227924,2.1314721571590876
SK-ES-1,4378219,1.996532834284689
SK-N-AS,9926054,1.80921327911472
HCT 15,100016,6.694419225032017
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
PaTu 8988s,135421197,1.1460063606701134
BT-12,6918638,1.843242029093903
RL,54618771,1.0204483724933282
PE/CA-PJ15,650361,5.890408316913619
WM793,135984461,3.5730556754970175
HT-144,9884685,0.7310557135267524
CHP-126,24771867,-2.7833200780426126
HCC2218,2746,2.1275689170875847
LNCaP clone FGC,135421197,1.5055395740527522
HCC1588,65628,4.850372204262946
COV434,9884685,-0.9978800737002462
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
GI-1,10296883,3.999407360262004
PK-45H,135421197,3.006684170238441
MG-63,135398744,6.808455799902383
SNU-449,11152667,1.3844218204303944
DMS 273,136227924,2.538513279360657
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
Fu97,selumetinib-vorinostat (8-1 mol-mol),1.744198071356546
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
KMS-28BM,135984461,2.268189755697481
SK-N-AS,9935249,1.6086220249478496
P12-Ichikawa,44241473,4.677620662686486
Hs 729.T,3854666,2.014688118884844
COR-L88,6918638,-0.7274407096817714
GI-1,54618771,0.7325470873707357
BT 320,136227331,4.5584663350036605
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
MES-SA,9926054,1.7710161106499946
Calu-6,1566236,3.730929510545656
COLO 668,71751553,4.5654463925913635
Hs 578T,1566236,1.5797547304061297
BICR 56,3854666,1.0101510025798168
NCI-H292,9868037,4.01216306257403
SCC-4,9884685,0.8808701095997418
HuT 78,2746,0.9832751477780014
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
NCI-H841,9915743,3.2736348589608606
BT 164,54618305,4.2947586907163275
Hs 895.T,10296883,4.2502082152330685
TE-15,136227924,4.530652264188515
KMS-12-BM,54618305,3.825029881117321
MeWo,44241473,4.73531947901582
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
T24,selumetinib-vorinostat (8-1 mol-mol),4.469268178928029
Panc 04.03,2746,3.3610494767062513
BT 139,54618771,0.6654274606551459
ACHN,54618771,1.0716775131315517
MCAS,11404337,-0.3191442981427469
SK-N-MC,2746,2.1914120575245373
NCI-H2452,100016,6.6405878618594985
OPM-2,135659046,2.7260896342727396
DK-MG,4378219,1.9835001762819475
OCI-Ly10,12003241,1.0181729921478868
TTC-709,11494412,1.1773331803884557
HCC44,11152667,-1.1903603696824805
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
RPMI-8226,selumetinib-vorinostat (8-1 mol-mol),2.271353218041498
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
NCI-H1792,11152667,1.4250094925446752
IGROV-1,9884685,-0.088911709267569
BT 187,11404337,1.604866987850638
L-540,9868037,1.7753670524076954
UACC-257,10322450,5.085942175181601
HGC-27,54618771,0.7122849148463839
HCC4006,54618771,1.138326772964569
OE33,12003241,0.2230817721074321
Li-7,selumetinib-GDC-0941 (4-1 mol-mol),0.6490035918823776
Mino,11494412,-0.5549437780850603
NCI-H647,54618771,1.14773606602027
HuG1-N,9926054,1.9171272639265269
SU.86.86,136227924,3.0459574781144014
LUDLU-1,71751553,4.8619324376076785
RKO,100016,5.817852214634293
IGROV-1,11152667,-1.4116509977729443
AGS,135421197,2.7162637897993123
KMS-20,9935249,1.026705986562312
SW948,10322450,3.138867511839475
AGS,54618305,4.485668809554542
NCI-H1666,1566236,1.9953376747700329
L-1236,9911463,2.598114748272053
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
SK-MEL-3,3854666,3.3514333338797697
SNU-C4,54618771,0.9535591955957128
MDA-MB-435S,73707386,3.113131049817223
Karpas-422,11152667,-1.1823612296931902
OAW42,JQ-1-carboplatin (1-1 mol-mol),4.198659850424817
IGROV-1,49836020,5.658436828096057
786-O,54618305,4.390272666676528
697,10296883,1.236413600919532
SNU-423,1566236,1.8226515664509473
IST-Mes1,71751553,5.350652566949457
Rh41,9911463,2.849226951569497
NCI-H1573,JQ-1-carboplatin (1-1 mol-mol),-0.275309697042944
HCC1806,9911463,4.318466961943044
KMBC-2,2746,3.623005517857566
GP2d,12003241,-2.636823152177336
NCI-H1373,selumetinib-vorinostat (8-1 mol-mol),2.652947864267465
SW620,3854666,2.758810632628281
MOLP-2,9926054,1.6077834745045567
Panc 10.05,12003241,0.2449442349226892
JHUEM-1,3465537,3.1283604264685403
BT 245,6918638,0.7917501577559235
SF268,135421197,1.2829440642017702
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
OV7,11152667,1.2259129508261295
DAN-G,12003241,-0.4522104330137063
NCI-H28,9926054,1.6125728317603996
KMRC-3,3854666,0.9965380576700774
MOLT-13,9926054,1.5657094756283445
K-562,11152667,-1.0937594737206502
RERF-LC-MS,1566236,3.687566928717542
Peer,44241473,3.9209775866085264
DLD-1,54618771,1.295500773429104
NCI-H2052,3854666,4.351538961130796
PK-45H,11404337,1.3434585990232362
TE-9,4378219,2.7093446251851243
Li-7,9935249,3.5726541001796734
NCI-H2342,54618305,3.816194262243341
TE-5,9926054,1.840497993611495
NCI-H1838,9884685,1.3772556691931654
F-36P,4378219,5.856796743395766
NCI-H1581,9915743,3.627185987098802
SUP-T11,1566236,1.3558207096631127
CAL-51,9926054,2.2227862000004577
LNCaP clone FGC,11152667,0.3595402317003787
NCI-H1651,54618305,4.375363168358667
KYSE-180,selumetinib-vorinostat (8-1 mol-mol),4.1823671735531835
ACC-MESO-1,9911463,4.148709224081578
Capan-1,4705,2.4129084207631943
SEM,9935249,-3.4494441375925153
A101D,11404337,-0.7377742007243514
HCC1954,135984461,4.275090239717432
NU-DHL-1,4705,3.159533609841756
MKN1,136227924,3.2741698595271025
WM88,6918638,-0.228247400007117
SYO-1,49836020,4.445841076102608
BT 498,3465537,2.67100305933086
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
Hs 940.T,11404337,-0.6222132136822929
EBC-1,24779724,-4.464226757719938
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
MFE-296,selumetinib-vorinostat (8-1 mol-mol),3.5111137224314626
WM793,65628,5.352978394453619
HEL 92.1.7,2746,1.730022792287867
DAN-G,3854666,2.9021314616259435
SNU-407,135984461,4.363892494969776
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
HCT 116,9911463,4.389845100856259
OVCAR-4,24771867,3.2555155226127264
RPMI-7951,9911463,4.017661136446782
COLO 668,10322450,3.302091291225127
U-251MG,selumetinib-GDC-0941 (4-1 mol-mol),1.876710388033308
COV434,6918638,0.3564723109557184
SJSA-1,4378219,5.8426903496195965
KMH-2,100016,3.8705403745512017
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
HCC1588,3854666,1.0629541303090142
CAL-78,2742550,4.1823102450441505
NCI-H2110,1566236,3.9517659227404263
TCC-Pan2,2746,3.0854386111148333
JHUEM-7,71751553,3.8993350668195874
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
BT 422,9926054,2.139061359959833
MFE-319,135984461,4.655775210040696
BT 359,2742550,3.7696896418502432
BT 286,71751553,4.3381123592050015
NCI-H1944,3854666,1.9975132180667243
H-STS,11404337,-0.7903033287308603
ALL-SIL,135984461,1.7193250250744925
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
SNU-1,4705,2.948044298069726
Kelly,JQ-1-carboplatin (1-1 mol-mol),1.229495862558611
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
HuH-1,12003241,0.2926250163716364
JeKo-1,9935249,0.8594033037358069
SK-MEL-31,9915743,2.191298837926563
JM-1,135421197,0.410328587733175
Mel Ho,135984461,4.333479355055791
A-204,135659046,3.450205324523238
GDM-1,44241473,4.586747806569252
MFE-319,6918638,0.7924367103155517
OV56,11494412,4.390651682494516
OC 314,11404337,-1.3108205145467993
HH [Human lymphoma],24779724,4.755180644839901
OVTOKO,11152667,-0.2633474356550239
SW1710,9915743,1.0949390608186476
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
SCC-25,44487872,4.502394555510824
Mono-Mac-6,9935249,1.9756983103736592
SK-N-BE(2),10296883,3.8653649395268896
AU565,136227924,2.2371309282915184
PF-382,136227924,2.0859082008018084
OVTOKO,4378219,2.100236908434064
BT-16,10296883,4.008579102599456
HT-1376,54618771,1.723140489486428
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
SEM,54618305,4.259603919662889
IST-Mes1,9915743,1.0557522455188102
GA-10,9926054,1.7130115486469382
BT-20,10322450,4.517270992352955
MIA PaCa-2,10296883,4.037005331930825
P-STS,selumetinib-GDC-0941 (4-1 mol-mol),4.834100084681968
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
U266B1,selumetinib-GDC-0941 (4-1 mol-mol),1.5301935614482745
Calu-1,selumetinib-vorinostat (8-1 mol-mol),3.8564467382040304
NCI-H522,136227331,5.948504593030567
PC-14,2746,2.459398202696394
COLO 800,135398744,6.478150217692287
NCI-H1339,71751553,4.829519613793705
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715
WM793,4378219,1.9547593472491875
ESS-1,10322450,4.730793151305824
NCI-H1734,selumetinib-vorinostat (8-1 mol-mol),0.4737362905842023
SK-MEL-1,135421197,3.405543423729856
IGR-39,11152667,-0.525623026371846
NCI-H2087,12003241,-2.8362492565909543
SEM,10296883,-0.6538100941325019
BICR 56,71751553,4.474191091785433
SNU-1077,9868037,3.077547755538649
HCC1500,11494412,1.8019649514762912
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
HGC-27,4705,3.374202647698771
OV56,135421197,2.071998378530058
MCAS,2746,3.159271623653468
A4/Fukuda,9935249,-4.132944592984893
SK-LMS-1,9926054,2.9005897081408833
U2OS,selumetinib-GDC-0941 (4-1 mol-mol),1.8236240565324096
NCI-H1792,135398744,6.377997167001959
RPMI-6666,11494412,0.7865449714736076
KHM-1B,12003241,-0.9345261470540068
JHH-5,11152667,-0.2906740707907462
NCI-H1869,9935249,4.228137987840005
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
COLO 792,10296883,3.769618463238052
KYSE-510,10296883,4.094303304653805
MDA-MB-231,9915743,4.40604807158467
HCT 15,10296883,4.151348683553031
SW1710,54618771,1.2075824947863512
G-361,135421197,1.3668023463515628
RPMI-7951,100016,4.945357769827656
U-937,4705,3.455929812371293
L-540,9911463,3.3305533835855528
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
HuG1-N,135421197,1.5338215255875798
OVCAR-4,9935249,3.584254547871848
BT 428,3465537,1.041948856740563
SUP-M2,71751553,4.246289721019636
SNU-878,9926054,2.3591129664276194
SK-MEL-24,4378219,1.9801794171781064
KNS-62,1566236,3.420118878937147
NUGC-3,9935249,3.7836037686670543
SK-N-MC,10296883,3.751405483484442
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
MDA-MB-157,135421197,1.265960780615991
NCI-H810,136227331,3.856341284870196
COR-L279,135421197,1.2327200147457915
A-498,4705,4.1964696083385595
SNU-5,11152667,-1.9781629384593116
SNU-308,100016,6.582722131637771
OC 314,54618771,0.7264278872863676
CAL-85-1,135659046,3.2911060115493487
COLO 684,9935249,2.5534920000178816
A2780,2742550,2.799223861459344
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
Hs 940.T,9926054,2.0266998753682324
TC-71,3854666,1.5564077538227652
HuH-1,11404337,-0.1897413514588927
BT 482,11152667,0.8832813821321016
SK-N-SH,9911463,3.4426003417788618
SK-BR-3,54618771,0.9510207607432342
HuP-T4,JQ-1-carboplatin (1-1 mol-mol),-0.0362149836695267
MeWo,12003241,-1.7569732997280945
HuH-6,44241473,4.289282436830392
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
HuT 78,24771867,-2.8492074914531407
HCC15,2742550,3.2685764522673972
JeKo-1,6918638,-1.1344735337684004
KO52,11494412,-1.6308846276697513
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
SNU-869,11152667,0.3812635199782596
SNU-387,2746,4.374506555334325
KMRC-3,4378219,1.7853002850063464
HCC202,2746,3.341807216301485
Hs 578Bst,136227331,4.283595415699579
FTC-133,135984461,4.350998124633342
HT-1197,24771867,4.03094674128079
LS1034,54618305,4.642113072115868
HT,12003241,2.790793152125299
SW579,9911463,4.038751545861884
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
MHH-NB-11,2742550,4.089431061262103
SK-MEL-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.2410221738936931
SK-ES-1,11494412,-0.0621130910981748
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
CL-11,100016,6.945803371228119
SW1573,1566236,3.3872191513469025
TE-1,selumetinib-GDC-0941 (4-1 mol-mol),3.018112465414828
T24,selumetinib-GDC-0941 (4-1 mol-mol),2.57595628877945
OUMS-23,136227924,2.42742246798026
RVH-421,selumetinib-GDC-0941 (4-1 mol-mol),0.2332916793846582
KATO III,9926054,1.9057208307143456
NCI-H1869,9915743,-0.6149308552384661
HD-MY-Z,11404337,-0.4126072630667986
NCI-H1838,54618771,1.6121528318079854
JHUEM-3,12003241,-2.0090653802187197
LOX-IMVI,24771867,2.089263700134128
LP-1,136227924,2.2350423658008416
BT 147,65628,5.5152381073160655
OAW42,3465537,3.409740302129575
LN-229,11152667,-1.783834293697264
SK-MES-1,136227924,2.193847007439744
NCI-H647,71751553,4.622172981641497
Calu-3,11152667,-0.8542233160115779
BT 228,1566236,1.8075699945716677
OAW28,9926054,1.976123345191561
COR-L88,JQ-1-carboplatin (1-1 mol-mol),1.7692891259412051
NCI-H650,136227924,4.852289363773007
NCI-H1339,10296883,3.881669394748239
COR-L95,9884685,1.274087436172542
OV-90,100016,6.511633470460193
Sq-1,1566236,2.0721352118450276
TE-9,3854666,0.8638769923044404
BxPC-3,136227924,2.62858882862477
ACHN,11494412,3.503130086985654
NCI-H660,136227331,5.940989847463471
RL95-2,9911463,3.5456378999337077
GaMG,2746,4.055581358402891
BV-173,135398744,4.1083578998819945
P3HR-1,9935249,4.307909434108789
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
IMR-32,6918638,-2.6640844779638244
SW1271,4378219,1.9495591217614856
WM266-4,12003241,-2.6604387870862745
RERF-LC-A1,4378219,1.8089871114360447
NALM-6,JQ-1-carboplatin (1-1 mol-mol),-1.4954941357174671
DV-90,3465537,1.1955098369709305
NCI-H1395,100016,6.569605836811141
TE-14,2746,3.3749666856765304
HCC38,136227924,2.8991930932960983
Hs 822.T,10296883,4.102512563950569
PE/CA-PJ41 (clone D2),selumetinib-vorinostat (8-1 mol-mol),2.0198593804037475
COV434,11152667,-2.1073866587536583
MDA-MB-435S,54618771,0.9964394209064932
NCI-H727,12003241,-0.657143782776601
U-937,11152667,-1.7473082418218258
M059K,9911463,4.34253595851811
BT-12,10296883,3.911493297930768
TE-8,1566236,1.7989435705839352
SNU-407,135421197,1.3307309137808745
HCC1195,44241473,5.227815780172388
SNU-1077,9911463,3.723863128468891
SW948,2746,1.2183078272507333
SNB-75,71751553,4.563743784479649
PLC/PRF/5,12003241,0.8244509806325866
JHH-5,40482356,6.541104674056933
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
KMH-2,135984461,4.570908568849745
PK-59,9911463,3.8863333115764416
SUIT-2,135421197,1.9421505415119584
SNU-5,12003241,2.4960585201420247
DMS 273,11494412,0.2734180035919979
OC 314,9911463,3.7977277680710393
NCI-H1581,selumetinib-GDC-0941 (4-1 mol-mol),1.7228993365162983
KMS-11,9911463,3.370246429208364
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163
SNU-620,11404337,0.4407908814780362
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
EJM,44487872,4.364141533871357
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
SU.86.86,54618771,0.7552640390383902
SHP-77,12003241,2.3628262056689384
LS411N,135984461,5.061110843141604
MOLT-3,1566236,0.8792744178265615
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
WM793,9911463,3.794379463406426
SNU-175,44505237,4.300100197754533
SHP-77,11404337,-0.9564004867270302
SaOS-2,11152667,-0.1732170298835725
NCI-H889,10322450,4.7831613013187
PaTu 8988s,selumetinib-vorinostat (8-1 mol-mol),2.3854275000826592
BDCM,selumetinib-GDC-0941 (4-1 mol-mol),0.2374601063606183
NCI-H2122,135398744,6.485849720689022
COLO 684,9926054,1.5779304975312065
Kasumi-2,24771867,-3.1023362721742607
KMRC-20,selumetinib-vorinostat (8-1 mol-mol),2.4254013680145663
OCI-Ly10,2746,1.6714722565073843
PE/CA-PJ49,12003241,-1.496755728928347
BT 328,11404337,1.5843001055688009
Rh41,selumetinib-GDC-0941 (4-1 mol-mol),-0.3258971504305004
SK-N-FI,9915743,0.2439816221510078
MCF-7,selumetinib-vorinostat (8-1 mol-mol),2.344882073871156
SNU-410,9915743,1.505425413193383
SNU-1066,selumetinib-vorinostat (8-1 mol-mol),3.1459365881963293
SNU-475,24771867,2.8085195596563524
TE 441.T,12003241,-1.1939319008466374
BT 172,9911463,2.9844378000407543
WM115,54618771,0.9043395114740442
BHY,selumetinib-vorinostat (8-1 mol-mol),1.471907668838586
OE33,4378219,2.1039345864440433
U-BLC1,3854666,3.2538263988952534
MDA-MB-157,100016,3.517936084480814
NCI-H322,71751553,4.705668316435038
AsPC-1,135984461,3.722049898583642
PaTu 8988t,10296883,3.999790485906541
NCI-H2196,136227924,2.7386742576768643
NCI-H1581,65628,4.285371471418109
BT 330,9868037,3.503197969188101
HGC-27,9868037,2.329533656521022
HT-55,11152667,0.1150286371338621
EFO-27,9884685,1.4230112837032636
BHY,135421197,2.210170489791885
KO52,9935249,-1.4350246650055785
WM115,9926054,3.0880179510914454
Hs 895.T,136227331,4.438273380824898
SNU-1196,11152667,-0.7933973738301417
BT 112,selumetinib-vorinostat (8-1 mol-mol),2.3775465177087063
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
T-47D,1566236,2.191762088104109
SNU-308,3854666,3.849126427296356
LS411N,9915743,2.8294092926119028
SNB-75,54618771,2.061985596678881
SNU-C5,44241473,4.742782219975071
SNU-478,100016,6.124719500368946
KP-4,4378219,5.374060110087321
MEC-1,71751553,4.055455710580445
BT 131,71751553,4.311619191931445
MOLT-3,24771867,-4.288298222643625
HCC1954,136227924,3.208934620428715
SNU-387,JQ-1-carboplatin (1-1 mol-mol),2.560433008803645
NCI-H1105,135659046,3.0265793516175536
HEC-1-A,135659046,3.907670889087363
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
DMS 53,9935249,2.2286580352978858
NCI-H23,2742550,5.761822709981514
NCI-H1793,9884685,-0.7653178122103681
WSU-DLCL2,12003241,-3.4791532779073373
SCaBER,135421197,2.9143213088501794
KMS-34,11404337,-2.4295348311340375
SUP-B15,9935249,2.106568222732024
Hs 578T,9911463,4.370366906905746
NCI-H727,54618305,5.896457883643312
BT 145,9884685,-0.6373719469605073
SK-BR-3,54618305,4.3856791246446365
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
NCI-H1299,9935249,3.5547957097116143
Hs 944.T,136227924,3.55320847384718
AM-38,11152667,-1.321239615811224
OV7,71751553,5.024310013233452
KYM-1,10322450,3.05782537023932
SW1990,9911463,4.278474352365717
CAL-51,136227924,2.079284078064279
NCI-H2029,9926054,1.852947583651784
SK-BR-3,9915743,-3.880272444164353
ACHN,9915743,1.4221547150387026
ME-1 [Human leukemia],9915743,0.9546590301314803
DEL,12003241,1.2715450206031036
TE-5,54618305,4.248872316076633
Capan-2,9911463,3.916008821715387
PC-3,selumetinib-vorinostat (8-1 mol-mol),4.9380309221831755
NUGC-3,11404337,-0.7682490419788565
SET-2,3854666,1.160822920042355
NCI-H522,2742550,2.7952007563166203
Tm87-16,49836020,-0.9947449056575012
TF-1,11152667,-0.9808185437399498
NCI-H1155,54618771,1.281458310238897
THP-1,3854666,-0.2277266329399054
SK-MEL-1,54618771,1.3594910944295866
NCI-H1339,11494412,1.0306883056063765
J82,3854666,3.07601629027796
OAW28,11152667,0.0990704789630026
KYO-1,54618771,-0.1196374796023553
Karpas-422,selumetinib-vorinostat (8-1 mol-mol),1.6918556367520698
EFO-21,10296883,4.412303624074482
NCI-H446,2742550,3.416612314830542
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
NCI-H1299,136227924,3.5346618762414392
SNU-C4,9935249,3.203269653737987
BT 444,4378219,1.9498849500623192
HDLM-2,selumetinib-vorinostat (8-1 mol-mol),2.3904496984026884
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
HD-MY-Z,9926054,1.8885520747906608
NCI-H1573,3854666,0.891504736627984
TCCSUP,136227924,3.28330337763218
NCI-H1666,44241473,4.303441498942035
LS1034,6918638,1.0848877258969036
HT,135984461,4.608558257937864
RPMI-8226,9915743,0.7773898345283005
Tm87-16,54618305,4.358739868911079
SU-DHL-10,2746,2.3013930855347877
HCT 116,12003241,-0.2623292503702257
HCC1833,9935249,3.7916141061990305
Hs 940.T,4705,3.481010414742296
Calu-6,136227924,5.658776934081175
OCI-Ly19,11404337,-3.477649976578423
NCI-H1694,10296883,3.5236508455835116
Daoy,136227924,3.329647267316264
A-549,12003241,-1.903076073453771
SNU-8,selumetinib-vorinostat (8-1 mol-mol),1.098702489226645
UACC-62,9884685,1.2635848184496714
Hs 822.T,11152667,2.6413007405228703
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
EFE-184,10296883,3.6509562081155167
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
8505C,136227924,3.0385484032115215
PE/CA-PJ34 (clone C12),11494412,-0.047975107536018
Hs 852.T,9911463,3.443003634084564
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
A-549,3854666,3.2699518455850964
SiMa,selumetinib-vorinostat (8-1 mol-mol),0.6254332670939313
KYSE-450,12003241,-0.0119879221972118
SNU-478,9884685,-1.5309712705157508
PaTu 8988t,11152667,-0.7220641758089987
DV-90,2742550,2.9708942896917625
SUP-M2,135421197,0.9814934118096088
HEC-59,11404337,-0.8184180849969249
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
UM-UC-3,1566236,1.790793058046746
SNU-1272,11404337,1.107901220459772
HCC4006,12003241,-2.6394477245029355
JeKo-1,1566236,1.2971928286160908
ME-1 [Human leukemia],11152667,-1.6733344626685482
BT-20,4705,3.454921322809781
SK-MES-1,54618771,-0.0773843626642112
HuH-1,10296883,4.280217513091765
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
MOLP-8,10296883,2.725727750190508
HEC-151,9926054,1.821769205783168
JJN-3,9884685,0.2310380370022593
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
SR,9926054,1.591402599592269
KO52,2746,2.0900422497447906
COR-L51,10296883,3.6257769468740166
K-562,1566236,1.8179642124055264
RKN,11404337,0.6786980557761386
BHT-101,54618305,6.415368122447373
NB1,136227924,2.7984479768491335
BT 498,54618771,3.343910197755889
U-118MG,9935249,3.6479372422776266
MEC-1,135421197,0.4740815920241465
HCC15,54618771,1.6567762934530044
HCC1806,11404337,0.4604274664094434
PE/CA-PJ49,3854666,0.40608223824848
KYM-1,1566236,1.0824430309271504
KNS-42,135421197,1.7884636185596865
IST-Mes1,2746,3.2096433183027604
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
BT 164,11404337,-0.5496255890882706
BICR 6,9926054,1.8719413430769756
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
BT 333,4378219,1.8266001874312183
SW1783,10296883,3.940377993774996
KMS-18,3854666,1.9037855185817367
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
A-549,3854666,3.2699518455850964
Hs 944.T,136227331,3.8800196533098847
IGROV-1,12003241,-2.0122972114546904
TT,3854666,3.3139239024984586
CFPAC-1,76446078,4.3199096836628685
SNU-620,135421197,2.4250401955395984
SF539,11404337,-0.0923032150573938
RERF-LC-Ad2,135398744,6.529632870190649
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
EPLC-272H,2746,3.4040670746589523
CA46,4705,3.1649236354970154
LS180,54618771,0.643112685351952
BT 504,9868037,3.967723190943412
LC-1/sq-SF,11494412,2.9399811715980633
SNU-387,selumetinib-vorinostat (8-1 mol-mol),1.7181520026261925
LP-1,100016,3.986438392754067
BT 216,selumetinib-vorinostat (8-1 mol-mol),3.701652605226817
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
KYM-1,selumetinib-vorinostat (8-1 mol-mol),2.38379411541386
NCI-H2452,44241473,5.273016525632626
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
HuP-T3,135421197,1.625440100707307
CJM [Human melanoma],54618771,1.1195989916695683
SR,24771867,3.033042374975761
WT2-iPS,11494412,4.82247788096836
HEC-108,100016,6.393272881400893
CAL-12T,9915743,-1.8110199185247196
BT 231,11494412,-1.440888792525865
NCI-H522,11494412,-0.7022253688217924
TT2609-C02,9911463,4.397605537094769
JHOM-1,9926054,2.608228459897926
SNU-C5,9884685,0.2599835482766612
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
G-401,24771867,0.701574094296253
GCT,9911463,3.61026772748382
BT 172,11494412,2.393309931030472
TE-11,54618771,1.216683446725779
Karpas-422,JQ-1-carboplatin (1-1 mol-mol),-0.5867346052444206
Hep 3B2.1-7,selumetinib-vorinostat (8-1 mol-mol),2.071849268804795
KMS-12-BM,1566236,0.5726482736694104
Li-7,100016,6.9157107863456915
NCI-H2081,135984461,4.3718384438901285
AsPC-1,9926054,1.8957621767397328
BICR 18,135421197,2.040633770246715
G-361,54618771,0.3816147000987149
A3/Kawakami,54618771,0.7801439877237109
HCT 8,11494412,3.7529349259758114
OE21,44487872,4.4115983844674185
BT 271,3854666,0.015916515144646
CCF-STTG1,4705,3.7462462996550534
Hs 611.T,136227924,1.5120677878583844
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
VM-CUB-1,9915743,0.0251855246366983
A2058,selumetinib-GDC-0941 (4-1 mol-mol),0.6721412852797596
SK-ES-1,24771867,-2.850374927044578
SK-MEL-30,9926054,2.6578574468285434
LP-1,71751553,3.851521724606858
HCT 15,3854666,0.492639302454022
BT-549,49836020,-1.94641857460656
SUP-B15,11404337,-2.134584192149202
HDLM-2,135421197,3.3057353966925613
MDA-MB-468,40482356,6.906745828481074
NCI-H1623,4705,0.0935418442786881
KE-37,selumetinib-GDC-0941 (4-1 mol-mol),2.002060120469268
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033
SK-MM-2,selumetinib-vorinostat (8-1 mol-mol),-0.2857263715636989
BT 147,135421197,1.4134853513564778
SNU-175,selumetinib-vorinostat (8-1 mol-mol),1.1144482658649129
SET-2,24771867,3.532138745646488
MDA-MB-453,9911463,3.8683390626627454
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
OE19,10296883,4.248743663804576
L-540,135659046,3.3513489819639837
OAW28,9915743,2.8675584787684456
KMH-2,73707386,2.2684707650817453
NUGC-4,136227924,2.1432448607030308
NCI-H1755,9926054,2.18101646942672
G-361,9926054,2.5235638278884687
NCI-H1373,3854666,3.2037739453809233
HuG1-N,11152667,-1.176066330134098
SK-N-MC,6918638,-1.6031189268800108
MM1.S,54618771,0.954891721558104
MG-63,65628,4.3545217389034425
Detroit 562,9911463,2.662493501158816
NU-DHL-1,9915743,0.5782531397120328
SNU-466,135421197,3.5326251478471877
DLD-1,9935249,3.699749001194777
SK-N-AS,9884685,0.5788482092816835
VMRC-LCD,JQ-1-carboplatin (1-1 mol-mol),0.5789512547654533
T98G,11152667,-0.8592432480151526
NCI-H23,9911463,3.868491646866135
SJSA-1,9884685,1.785229116734418
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
UACC-812,11494412,1.976870257251046
WT2-iPS,9935249,2.882456991655045
G-401,24779724,6.361263224396382
MCAS,40482356,5.123729097421837
NCC-StC-K140,10322450,2.306971577556796
DB,1566236,1.3179912110212906
NCI-H69,selumetinib-GDC-0941 (4-1 mol-mol),3.077666934797567
647V,12003241,-0.2300893498058843
A2058,9926054,1.7529225868456957
COV644,6918638,0.0395517386882894
KNS-81,54618771,0.6221036403024617
PF-382,selumetinib-vorinostat (8-1 mol-mol),2.136528432975779
SNU-8,JQ-1-carboplatin (1-1 mol-mol),1.6259891864743636
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
WSU-DLCL2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2724910625039847
SW1417,71751553,4.180023380180108
UO-31,9915743,-0.5228341735607687
SW620,11404337,-0.8120361907901654
OCI-M1,9935249,3.0060343171338624
SNU-685,1566236,1.7579222323884358
Karpas-299,135421197,1.2662606482255232
SK-MEL-24,54618305,5.4405077428340345
Hs 729.T,1566236,2.2356986776894736
L-540,selumetinib-vorinostat (8-1 mol-mol),2.5583527619421123
COLO 699,44241473,5.105446071992325
Ri-1,54639665,5.943871116773062
NCI-H1650,selumetinib-GDC-0941 (4-1 mol-mol),2.5973614834330965
MOLP-2,65628,-0.7445574295939409
GP2d,4705,2.380546540309972
Daoy,9935249,3.744593484818124
SW1271,24771867,3.777194428597206
ZR-75-30,10296883,3.903831871588827
COR-L88,12003241,-0.20090693258686
HT-144,24771867,4.057365679118102
KP-N-YN,11494412,3.870145712967313
EC-GI-10,9935249,3.8979806422622905
SW1116,9935249,3.7478471232466464
SW1990,1566236,1.8608127009436903
DMS 454,54618305,4.403504439808318
Hs 839.T,76446078,4.18660099517859
SNU-503,135421197,3.1341230661682125
JJN-3,100016,3.8434142095984303
Ri-1,selumetinib-vorinostat (8-1 mol-mol),1.7453072919465344
DoHH2,9935249,1.4071678940232923
LN-18,100016,6.511039950794577
MDA-MB-231,11404337,0.2282829933143647
ESS-1,135421197,2.603718676668537
Caov-3,2746,3.7712035722232304
Yamato-SS,10296883,4.303641626861945
U266B1,3854666,0.4975147801712618
MFE-319,2746,3.158531328998989
BT 232,4378219,2.0204698564843144
WM983B,9915743,1.863557730328146
MHH-CALL-4,9884685,-0.3839194515587534
A-375,9915743,2.060034252561476
NCI-H2081,10322450,4.110472568642291
MOLP-2,selumetinib-GDC-0941 (4-1 mol-mol),2.6485727489944555
SNU-478,9926054,1.8304489551937344
JL-1,24771867,5.069917661322182
OCI-Ly19,11152667,-2.422275512682942
KMRC-1,10296883,4.079927671527966
JHOM-1,11152667,0.3930850023562942
HCC2218,4705,1.2825749224447869
Kuramochi,9935249,4.025943917149305
DU145,9884685,1.2239638281476493
BC-3C,3465537,3.2940431181911447
YKG-1,10322450,5.46076367923885
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
HH [Human lymphoma],24771867,-0.4655388870509639
VMRC-RCW,3854666,3.082282497439221
KYM-1,9884685,-0.7131682804521101
LP-1,54618305,3.83678249468376
GB-1,9926054,2.832614445271179
HCT 15,24771867,3.1019491924915488
Kasumi-1,24771867,-2.017794395483198
NCI-H358,11152667,-1.164579912523402
NCI-H524,135421197,1.1654489956873584
HDLM-2,136227924,3.1256787357030937
NCO2,9868037,0.9893364674462136
8305C,9884685,-0.6545120065048111
Namalwa,2742550,3.645148069005769
PaTu 8988s,136227924,2.43354349220747
MOLM-13,12003241,-3.578107028375036
SF268,24771867,2.8847603116755742
JMSU-1,135984461,4.473893168113172
L-363,9915743,1.0748185712665137
IGROV-1,54618771,1.2456991772210466
SNU-478,selumetinib-GDC-0941 (4-1 mol-mol),-0.9905008638696244
Panc 10.05,11152667,0.4061024027057239
OVK18,73707386,3.069858343080502
KE-37,2742550,3.1393906639463
D283 Med,9935249,1.011376298828927
CJM [Human melanoma],9926054,2.54173081148122
HT-144,2746,3.166634323430978
HuCC-T1,3854666,2.02774458559481
Sq-1,9911463,3.467859950121971
SUP-HD1,135984461,4.187192866644665
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
PaTu 8902,11152667,1.2355675895718252
CML-T1,9926054,1.696565612874625
JeKo-1,24771867,-4.008363796837406
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
NCI-H2052,selumetinib-vorinostat (8-1 mol-mol),0.3758764732322367
MDA-MB-453,9884685,-1.4419247946131482
CAS-1,136227924,2.284810237581045
NU-DUL-1,100016,4.060799847781438
NCI-H2030,12003241,-1.1383124397984303
GP2d,24771867,-2.9334511642290906
OAW42,3854666,1.601770174817354
JHH-6,11152667,1.750975958865048
Aska-SS,4378219,4.576786984257773
KYSE-30,9935249,3.1154683324094368
Daudi,9915743,0.3665260221427978
SNU-601,135421197,1.035367817666236
OE33,2746,2.7393344543249443
COV434,11494412,0.9260092674058792
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
KU-19-19,11404337,0.0275069311149896
ECC10,136227924,2.5549710603978366
SW1783,10322450,4.230470764848986
C2BBe1,3465537,1.3268482843439444
U2OS,100016,5.485609538675787
KCL-22,136227924,2.6502010503693016
HCC1171,136227924,3.688896594319452
MEC-1,JQ-1-carboplatin (1-1 mol-mol),-0.5603049112570107
HCT 8,1566236,3.3602911761309375
LOU-NH91,9926054,3.1176474597994908
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
DB,136227331,5.354479486577142
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
NCI-H1355,9935249,2.9372219822756658
253J,JQ-1-carboplatin (1-1 mol-mol),2.6243340273130733
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
TTC-709,44241473,4.118831638383191
YKG-1,6918638,1.332910318202703
SNU-1214,selumetinib-vorinostat (8-1 mol-mol),1.1139893258531253
PLC/PRF/5,24771867,3.823478811331514
SU-DHL-8,73707386,1.513049090975232
A-375,3854666,2.66860299543091
SK-UT-1,9926054,1.807396230777958
COV644,136227924,2.3380958896938147
JHH-6,10296883,4.397827548560224
8305C,9911463,3.96844449411402
HCC1806,JQ-1-carboplatin (1-1 mol-mol),3.517828248057606
SNU-C5,24771867,4.157645693337039
NCI-H508,12003241,-0.6008293317473488
DBTRG-05MG,135398744,6.409074750923468
Raji,12003241,2.533123505917396
Hep-G2,9915743,2.3547256655946542
Detroit 562,44241473,5.339477600392362
RCH-ACV,9868037,2.145537179112383
EHEB,12003241,-2.0597430880681062
LC-1F,selumetinib-vorinostat (8-1 mol-mol),0.4234700662281405
COLO 201,9911463,3.786354581854646
OAW28,2746,2.637952220594215
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
CAL-85-1,3465537,3.465433741890866
KU-19-19,9911463,4.338553857034003
RERF-LC-Ad1,selumetinib-vorinostat (8-1 mol-mol),4.734189741537759
U-118MG,136227924,3.3662867602003006
U-937,11404337,-0.2465746995884755
HEC-108,54618305,5.558551802909847
NCI-H211,9926054,1.5085991120248008
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
HuG1-N,54618771,1.617121666996059
SW1417,6918638,0.2566537635355694
HPAC,9926054,1.8309217170446392
HEC-1-A,10296883,3.968185450063831
SNU-466,JQ-1-carboplatin (1-1 mol-mol),1.650577111038187
HCC15,9935249,4.091947122155354
Ki-JK,JQ-1-carboplatin (1-1 mol-mol),-0.8899338497944629
LN-18,11404337,-1.073662299758218
HDQ-P1,selumetinib-vorinostat (8-1 mol-mol),3.932774068428703
NCI-H647,2746,3.2477313608093143
DMS 273,54618305,4.272082763698834
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
NCI-H661,11404337,-0.0954545894437525
NCI-H2085,135421197,1.1751521107550191
SW982,71751553,4.266101673204756
Hs 611.T,9884685,-2.4852647330534383
SET-2,9884685,0.7877386877892533
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188
Ci-1,9911463,3.2890552525793395
KMBC-2,9868037,4.318288154925569
K029AX,11404337,1.217288155718472
23132/87,24771867,3.071153874274406
CAL-33,2746,4.008172318733893
KMS-28BM,11152667,-2.3327327995014224
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
LMSU,4705,3.840410851100799
VMRC-RCZ,54618771,3.963095950994299
SCC-9,54618771,0.4910288003516506
SUIT-2,9911463,4.378510442631056
EM-2,73707386,5.173636041104296
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
HPB-ALL,1566236,1.32802974463896
TE-15,135984461,4.740662203651603
SW1990,11494412,3.8548639457314184
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
NCI-H1869,10296883,4.447785026459559
JHUEM-7,9911463,3.659236793496393
Hs 822.T,6918638,4.296934000106513
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
RD,71751553,4.447029966270882
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
Karpas-620,135984461,2.8856459263707213
SK-HEP-1,6918638,1.490993863020431
NCI-H292,135421197,1.1571557888211337
HCC202,54618305,4.256678019929169
PSN1,24771867,4.167644606554913
NCI-H1975,54639665,4.272009655983378
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
LOX-IMVI,136227924,2.635687863612288
HH [Human lymphoma],JQ-1-carboplatin (1-1 mol-mol),-1.6749963255545115
NCI-H1092,selumetinib-vorinostat (8-1 mol-mol),2.4548144613596885
NCI-H1355,9911463,3.4182526352072458
TE 617.T,71751553,3.9067894428896928
FaDu,54618305,4.56300350667308
K-562,65628,4.517417686157834
SR,136227924,2.657612515566446
HCC1428,11404337,-0.7676967113695158
KMRC-3,71751553,3.7430804034732783
OCI-Ly19,1566236,1.0614433704498352
PK-45H,136227924,2.93841309707887
HSC-4,65628,3.12205826618997
NALM-6,9884685,-1.9004731956493823
A4/Fukuda,1566236,1.4071330472860828
A-375,9915743,2.060034252561476
SH-10-TC,1566236,3.879679185733888
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
KCL-22,135421197,1.194260119901322
LS513,9868037,2.665917193045876
KM12,54618305,-4.709576860439217
JHUEM-1,4705,3.281034175975557
YD-8,9935249,3.870405994417823
KNS-42,10296883,4.193671249081411
HOP-62,9926054,1.899267170249981
8505C,9935249,3.565227289409523
SNU-899,selumetinib-GDC-0941 (4-1 mol-mol),0.9114020833269496
253J,selumetinib-vorinostat (8-1 mol-mol),2.385104279160593
WT2-iPS,9926054,1.80219025961501
KP-2,10296883,4.2919996415348125
HCC827,54618771,-0.2286942378672794
647V,9911463,4.409219514766685
T3M-10,54618771,0.7014662357085544
JJN-3,4378219,5.58269559509905
SF126,selumetinib-vorinostat (8-1 mol-mol),2.6989526919187012
KE-37,JQ-1-carboplatin (1-1 mol-mol),-0.7652010802718352
T84,135421197,1.1926800486380174
SK-MEL-1,9926054,2.8910201246716403
Mono-Mac-6,73707386,1.6241068743605291
KP-2,11494412,2.702664786817325
NCI-H810,135984461,4.558480725303822
HCC1428,24771867,4.311681326860514
C2BBe1,10322450,3.982412687303459
SK-MM-2,54618305,4.453861549537744
TC-71,6918638,-0.2365825415632411
KYSE-30,3854666,4.258040109077401
BT 440,100016,6.480442369798277
MDST8,4378219,1.9480435949418269
CAL-78,12003241,-1.8526248382085972
NCI-H2126,54618771,2.112004674949257
DEL,73707386,2.3391393619741416
NUGC-3,100016,7.160996607387645
RS4;11,65628,2.763130092940229
TTC-709,12003241,-2.491438610606954
SK-MEL-24,9926054,2.7611591641517323
ESS-1,135984461,4.427051677708814
YKG-1,11494412,2.049778246411874
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
HCC4006,9915743,-2.0110769744346824
KYSE-520,selumetinib-vorinostat (8-1 mol-mol),3.2709887922226555
SNU-C1,2746,1.4154378520046618
NCI-H2170,54618771,1.1991545038550235
SUP-HD1,9926054,1.7829346209502994
HCT 8,71751553,4.527245038842783
PE/CA-PJ49,3465537,2.6771043941056254
GMS-10,136227924,3.0615637003217433
DB,11152667,-0.1181623714214869
NCI-H1299,9926054,1.7323284970245385
BT 228,24771867,4.536409167426945
NCI-H2106,9868037,1.1316953676895871
786-O,11152667,-0.8998458405595287
CMK,9915743,0.8633678445268913
U-251MG,JQ-1-carboplatin (1-1 mol-mol),3.361706194293166
EFM-192A,135659046,3.6859856473219175
CMK,selumetinib-vorinostat (8-1 mol-mol),1.8342196975016083
A4/Fukuda,54618305,3.964460418875751
EoL-1,9935249,-2.654152668854086
ECC12,selumetinib-GDC-0941 (4-1 mol-mol),2.781694050737888
SNU-216,135984461,4.361470667524811
T-47D,54618305,4.335856862288139
DLD-1,11152667,1.1045398350406073
BL-70,54618305,3.7838693082643977
A-204,71751553,3.978264694616455
SW1417,9884685,0.1615844377536893
MFE-296,3854666,1.1807177077248874
KMS-26,44241473,4.230627074244854
BC-3C,1566236,3.5939971161988367
NCI-H810,24779724,4.409374552120998
MES-SA,11494412,0.938409593954222
JHH-4,71751553,4.2835287364171055
BT 232,136227924,3.5495643934514223
Hs 888.T,11152667,-1.0648621263802394
HMCB,54618771,0.8772324111806863
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
NCI-H1395,24771867,4.164021178387528
JHH-5,24771867,2.843990808767394
SCC-25,2742550,3.0640378690909023
RT-4,65628,4.4679434201664945
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
A4/Fukuda,4378219,1.9024946719152895
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
EPLC-272H,9915743,-3.018922536526067
NCI-H2228,136227331,3.956978031272767
FaDu,44241473,4.306530268234286
EKVX,10322450,4.528299789057068
KYO-1,2742550,3.984579842487294
UO-31,135984461,0.7514155990157345
PE/CA-PJ49,135421197,1.7245990786454344
SK-ES-1,12003241,-1.52997414629941
F-36P,12003241,-0.4333234421592413
EPLC-272H,selumetinib-vorinostat (8-1 mol-mol),0.8736900112568272
U-118MG,4378219,2.132978521018862
GB-1,JQ-1-carboplatin (1-1 mol-mol),3.1926244646475
PSN1,4705,3.10830122261482
NCI-H2228,selumetinib-GDC-0941 (4-1 mol-mol),1.1807966887528696
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
SNB-75,11404337,0.4228386005556312
COLO 800,2746,2.915316687123913
HCC1438,2746,3.591868126146154
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477
NCI-H322,2742550,4.207154778137866
Panc 08.13,9868037,4.03637116886627
T3M-10,1566236,4.194013409938231
Toledo,54618305,4.370635560016167
ACC-MESO-1,135984461,6.029797163877839
Peer,9915743,-0.353266525071404
HEC-265,9935249,3.718501307594467
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
Daoy,54618771,2.692188489844714
SNG-M,2746,3.2265366784113914
SNU-719,4378219,6.704358439762523
D283 Med,6918638,-2.490498776882626
BT 271,9935249,1.8959027291266075
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
LS123,selumetinib-GDC-0941 (4-1 mol-mol),1.252033053606901
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
TE-14,135421197,1.7423329869648043
SNU-C1,3854666,3.2898007773487223
RT-112,24771867,-0.1899405194194727
HCC2935,4378219,1.4432895448448082
SNU-1076,9915743,-3.1891763584227775
MPP 89,11494412,1.787151667463632
OE33,10296883,3.414380068882816
COR-L88,9911463,3.307213706947891
JHOC-5,9911463,4.507364247607918
BICR 31,9915743,-0.3251640044425866
HD-MY-Z,JQ-1-carboplatin (1-1 mol-mol),1.7743689460569436
HCC4006,71751553,3.746393975050998
H-STS,9915743,1.4562053378516668
CCK-81,11404337,-0.4332164579586651
OAW28,11494412,4.413959214794941
BT 224,3854666,2.1377597986560315
UM-UC-1,3854666,1.8827049614808689
Hep-G2,2746,2.5421699123058383
PSN1,11404337,-0.8573645663798306
CAL-54,1566236,1.9405181909145055
L-540,11404337,-2.0629027797963664
G-402,9926054,1.7683002714551472
CHP-212,3854666,-0.8182055422302374
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
SNG-M,9926054,2.579798992981947
BT 231,JQ-1-carboplatin (1-1 mol-mol),2.3175217406535156
NCI-H1155,selumetinib-GDC-0941 (4-1 mol-mol),2.5268470929641964
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
EoL-1,3854666,-0.2024908872180563
EFO-27,9935249,3.352272124535396
TE-9,11152667,-0.2283406603078907
SUP-M2,11404337,-2.6173632126758313
L-363,9935249,3.3152136583481893
WSU-DLCL2,54618771,1.0658572900197
MHH-CALL-4,1566236,1.2228321668732802
SF295,9911463,4.265275017996558
NCI-H2452,11152667,-1.2581393219211725
HMCB,10296883,4.337758420607625
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
NCI-H1155,10322450,3.1814270570709766
GSS,54639665,4.407333409116942
COV644,11404337,-1.0337314183791615
Caov-3,11404337,1.105594084873841
NCI-H1792,136227331,4.237356132647452
FTC-133,71751553,4.47121108066688
NCI-H2029,136227924,2.308767464525173
JHH-2,9926054,3.1999514592679508
HEC-151,44241473,4.57695213454535
TF-1,54618771,1.249031073864191
SW1088,selumetinib-vorinostat (8-1 mol-mol),3.839668411135048
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992
HGC-27,136227331,3.820430594188932
JHH-5,65628,4.074084523836835
T98G,11494412,3.010368499943237
NCI-H810,135398744,5.260119762115652
SW620,11152667,-0.0002133218220567
KMS-34,9935249,1.539915970001855
MDA-MB-361,9926054,1.9315814680305097
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
SNU-407,9915743,0.256973573653406
SNU-719,selumetinib-vorinostat (8-1 mol-mol),0.3154855809643748
Panc 10.05,54618305,4.6350576039907265
HSC-2,9911463,4.049895427785984
BT 328,4705,3.594890989297502
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
NCI-H1703,54639665,4.494588545198389
TE 617.T,12003241,-2.151805000440827
NUGC-4,11404337,-1.0911037435760411
Caov-3,9911463,3.58522921506602
MHH-CALL-4,24771867,-2.8040386715982746
NCI-H727,9926054,2.0492739470784445
Jurkat,9868037,1.5278313323124582
MHH-CALL-4,3854666,1.9842302826736613
JVM-2,11152667,-2.7222121764526372
JMSU-1,24771867,1.173328055781772
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
KNS-81,selumetinib-GDC-0941 (4-1 mol-mol),3.534657473122144
Mono-Mac-1,10322450,2.242206847932455
OC 314,4378219,1.809018493372473
NCI-H446,9884685,-0.3047801458707657
SH-10-TC,2746,4.061240756381498
MHH-NB-11,9911463,3.881225823923783
Peer,135984461,1.6438359963470832
HEC-59,136227924,4.443118393205084
IM95,6918638,0.7344376580151405
CAL-33,135659046,3.957573500074978
MFE-296,65628,4.330181236318155
OS-RC-2,54618771,2.9628716823736334
U-937,9926054,1.4281376565753103
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
SNU-410,73707386,2.4851962355672956
SNU-1066,44241473,5.23528345900378
A101D,6918638,2.125640820969418
IGROV-1,4705,3.3098412390054603
HCC78,9911463,4.271642559456931
CAL-27,12003241,-1.271388336497811
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
COLO 205,9911463,3.950435193023514
DBTRG-05MG,11152667,-0.3425807079935632
697,10322450,2.5214685909488037
G-292 clone A141B1,136227924,3.074698527992838
MDA-MB-453,10296883,4.2989687155614735
TF-1,10296883,3.653157078260328
OE21,6918638,0.1632098658801684
NCI-H1869,11152667,0.433153558661154
NCI-H1573,9884685,-0.054986717819308
HuT 78,6918638,-1.8650927856269544
TALL-1 [Human adult T-ALL],49836020,4.412561834618748
NCI-H2171,9915743,0.832341910278816
MOLM-13,9935249,2.7939558009041283
NCI-H146,2746,0.8652413173737366
NCI-H647,JQ-1-carboplatin (1-1 mol-mol),2.369977920664563
PaTu 8988s,1566236,3.825164305906747
NCI-H2228,1566236,2.805458510432221
COV434,54618305,4.486199329327327
NCI-H1734,selumetinib-GDC-0941 (4-1 mol-mol),-0.5700124177299448
SNU-182,10322450,3.100358710746125
Toledo,71751553,4.116950576345889
OE19,11404337,2.1559744659791975
Namalwa,3854666,0.1539435938538964
SKM-1,12003241,-1.1629643414911237
COLO 829,3854666,2.075808913393435
LAMA-84,44241473,4.323168795816793
Yamato-SS,1566236,3.4847720151894395
NALM-6,136227924,1.937403591420271
TE-10,136227924,2.8479301717793435
KP-4,54618771,2.957585816818264
HuP-T3,9911463,3.677427040789425
MOLP-2,3854666,0.6548902093634233
NCI-H716,54618771,0.9147566577185032
NU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),0.3575264561509241
Malme-3M,9868037,3.7927874033279703
WM266-4,4705,3.3453038415665652
HL-60,9915743,0.8108920758640651
SU.86.86,1566236,3.226684285708377
NCI-H841,9911463,3.5951842135342145
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
253J,9911463,2.6444907494378476
RPMI-8226,10296883,3.535123167046786
DMS 53,135659046,3.734074928791185
SK-HEP-1,9926054,1.934364320328667
OVK18,selumetinib-vorinostat (8-1 mol-mol),1.7946932468084609
G-361,1566236,1.6393005665211553
NCI-H716,12003241,-5.132639925352329
MKN74,9926054,2.8513802079001844
HT,selumetinib-GDC-0941 (4-1 mol-mol),2.035866243674196
A-673,54618771,0.7910545462175201
NCI-H1341,9911463,2.510960457156186
NCI-H1869,135984461,4.367577543921494
NCI-H1105,11152667,-0.3234910570642634
SF268,2742550,4.301402217118159
HuP-T3,10296883,4.266239948990751
HEC-151,9884685,0.5854860158758856
MM1.S,12003241,-0.8577985614667851
ST486,4378219,2.040688019208728
EoL-1,10322450,2.2148801830684097
OCI-Ly3,135984461,1.8190519261994496
SNU-738,selumetinib-vorinostat (8-1 mol-mol),3.5433152247780892
OC 314,11152667,0.476340993676233
NCI-H2122,9926054,1.7352659466482192
BT 112,136227924,2.645928432247734
ESS-1,49836020,-4.193111027878734
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
SNU-182,24771867,1.7909371153803624
KYM-1,9935249,2.52533764683477
GaMG,9911463,3.671296703751626
JeKo-1,10296883,3.632586939598192
MOLM-6,135421197,0.9867364446858986
SUP-T11,54618771,1.250827086156436
KMS-26,9935249,-0.1717529790774238
HMC-1-8,54618305,5.430829922421115
Hs 936.T,100016,5.806135174623166
MG-63,100016,6.791496028485962
PF-382,54618771,-0.2642287573533248
TM-31,selumetinib-vorinostat (8-1 mol-mol),3.0229766520782095
22Rv1,12003241,-0.1253815141985464
ME-1 [Human leukemia],2746,2.1142830069466467
M-07e,11404337,-0.615837130994534
EJM,4705,3.167336091742425
NCI-H2228,3465537,5.100002381629012
NCI-H1105,selumetinib-GDC-0941 (4-1 mol-mol),2.7215813635503165
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
SNU-466,selumetinib-GDC-0941 (4-1 mol-mol),2.355398867195719
PE/CA-PJ41 (clone D2),9915743,0.2241511570918921
TUHR10TKB,24771867,4.053542648429772
Hs 940.T,4378219,1.939176067532295
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
HuP-T4,11152667,-0.7857084329923945
Caki-1,10322450,6.689578466604137
Panc 10.05,135659046,4.933394914057929
TE 617.T,135659046,3.676706194159886
NCI-H1355,54618305,4.816261952475267
SIG-M5,9926054,1.755465184389032
BT 187,selumetinib-vorinostat (8-1 mol-mol),4.40135270594373
CJM [Human melanoma],11152667,0.0216601684739394
TT2609-C02,135421197,3.994443505891966
SW1116,135984461,2.388083333366143
BT 333,selumetinib-GDC-0941 (4-1 mol-mol),3.256611594261358
RPMI-8226,selumetinib-GDC-0941 (4-1 mol-mol),1.6638240545531544
HMCB,9926054,1.939305093595803
8305C,12003241,-1.8647493707838596
769-P,selumetinib-vorinostat (8-1 mol-mol),3.2147834954252734
SW1271,2746,3.8382249001906814
NCI-H508,4705,1.5778147513769882
NCI-H2126,135421197,2.0437497253057137
COLO 699,9911463,3.7196306171977183
BxPC-3,9935249,3.9268263105803727
HCC95,3854666,3.6849865416308303
UACC-257,selumetinib-vorinostat (8-1 mol-mol),0.0439995598921686
SNU-216,71751553,4.1520368918370965
Caki-1,135984461,1.2044683879292255
SK-LMS-1,6918638,1.135857739605079
EoL-1,135984461,1.5166332685892363
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
JVM-3,73707386,3.3946866816247168
HCC38,9911463,3.9831039186193022
OV7,1566236,2.0738454479215087
TTC-709,135984461,4.327447366032638
SK-MEL-5,2746,2.5702716912932337
A101D,54618771,1.2420685416826056
Namalwa,54618771,0.6847017954935718
HMC-1-8,9868037,2.3858174570633848
NCI-H2122,2746,3.68558209467045
Mel Ho,54618771,0.7088013166832736
G-361,11152667,-0.4231393311970948
P12-Ichikawa,54618771,-0.5432908489240523
C2BBe1,54618771,1.7187966275352082
Hs 895.T,44241473,5.605664067092928
A3/Kawakami,135421197,1.197973904783629
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
Mel Ho,136227924,2.792099034627563
BT 328,9884685,2.9316032553217166
HL-60,JQ-1-carboplatin (1-1 mol-mol),0.4804402451119697
OE33,1566236,1.7756816603120642
YD-8,1566236,1.8146289426775175
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
NCI-H69,3854666,0.6814839685498992
HCC1419,selumetinib-GDC-0941 (4-1 mol-mol),1.9715069787616553
Mino,11152667,-1.4239628293556983
Ku812,135984461,1.927355885078453
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
COV362,24771867,4.672069630767738
CMK,65628,4.289383545384549
NCI-H446,2746,2.3498670428559807
697,2742550,2.4843478572758357
KP-N-YN,9926054,3.360231389536055
NCI-H2029,JQ-1-carboplatin (1-1 mol-mol),2.876722869032902
Li-7,11404337,-1.093112923264353
Ku812,selumetinib-vorinostat (8-1 mol-mol),-1.7038187664037243
SW1417,135659046,3.701977348188013
D283 Med,11404337,-0.900512184015852
SNU-601,65628,4.852093885842574
CAL-54,11404337,-0.6827741736439762
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552
MHH-CALL-4,135984461,1.796074414413381
VMRC-RCW,135398744,6.359457324257638
Hs 729.T,2742550,3.942286133248854
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
IA-LM,11152667,1.0642318645878492
DMS 53,4378219,1.8704094813009713
SUP-HD1,54618771,-0.1374288926012433
KMS-11,9884685,-2.516546134244935
NU-DUL-1,135659046,3.4749068685188176
SaOS-2,1566236,1.7620742085681662
MDA-MB-468,135421197,1.1227139239966792
EFE-184,11152667,2.2340596962566703
KMS-18,136227924,4.439422503928272
BT 131,JQ-1-carboplatin (1-1 mol-mol),5.021524376247219
BT 330,9911463,3.351892794022171
EB1,54639665,4.325181348836959
Rh41,JQ-1-carboplatin (1-1 mol-mol),-0.6167510986440503
COLO 201,10296883,3.948039741906064
CAL-120,9868037,3.5025734894646656
KP-2,9926054,2.0579312242664645
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
NCI-H358,9868037,2.709462311550209
PaTu 8902,54639665,4.483683562011812
SiMa,11152667,-1.8318254504900469
SR,135984461,3.8485164299114714
HCC2218,136227924,2.978872567688762
SK-MEL-3,54618305,4.885800889564964
RD,136227924,2.2627633289805424
HCC15,9884685,1.2743229964902805
SNU-407,11152667,-0.0617753170704596
BT 340,selumetinib-vorinostat (8-1 mol-mol),2.9565277200818048
TE-14,3854666,0.9160893400358509
SNU-601,1566236,3.2761403052312534
COLO 201,11152667,0.3098381642234148
HEC-151,135984461,3.687449100902744
OPM-2,4705,3.10353547990691
SNU-899,9868037,2.9097531186900536
SUP-T1,9868037,1.5835878510828882
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
LN-18,9926054,0.598983976680667
OCI-Ly10,11152667,-2.5286147720755943
A-253,11494412,2.4238653146886
L-1236,54618771,1.349542879439561
DB,9911463,2.6003327839693244
8305C,11404337,-0.9530165105805044
Hs 822.T,11404337,0.2632617923039199
SNU-61,11152667,-1.0116802565381595
A-172,9915743,0.9354288818920024
TUHR10TKB,9935249,3.5999871902501357
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
HPB-ALL,2742550,3.552331603688017
HEY A8,65628,4.133816964756257
Rh18,4705,2.954039930023468
HCC1428,2746,2.7120939724972444
MDA-MB-231,selumetinib-vorinostat (8-1 mol-mol),2.4295694079712433
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
KMRC-20,9935249,4.274093683443108
EC-GI-10,12003241,-1.9756752078564588
CAL-51,4705,2.903463840875761
G-402,6918638,0.7835735464626096
T84,24771867,-3.1514285711428487
SH-10-TC,3854666,3.043135915172001
DAN-G,11404337,0.1874495042654069
BT-16,11404337,-1.376831419013344
BT 248,65628,4.438815715072134
5637,JQ-1-carboplatin (1-1 mol-mol),0.0353131764923719
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
DV-90,4378219,2.0060701137998698
Ci-1,9935249,3.4134945639154526
Lu-99,100016,4.341210602126273
NB1,2746,2.341012333124764
HCC4006,selumetinib-vorinostat (8-1 mol-mol),1.7233637217176108
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
NCI-H1666,3854666,2.4849019558472047
NCI-H1792,1566236,3.2685479943945857
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
NCI-H1563,10322450,4.527770702811014
PLC/PRF/5,3854666,0.918467942921984
CAL-33,6918638,1.6029165317197565
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
RL95-2,54618305,4.622487640245331
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
KYSE-510,135421197,2.241265348212864
YD-10B,12003241,-3.1216797421568847
Fu97,12003241,-1.5366115434948442
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
NCI-H226,136227924,3.4351319272724585
B-CPAP,11152667,-0.1979921497288642
PLC/PRF/5,JQ-1-carboplatin (1-1 mol-mol),5.5351057973107505
NCI-H2228,135659046,3.319323346147118
Hs 294T,71751553,5.047281655304285
Lu-65,135421197,2.266142941564523
NCI-H1373,135659046,5.766842578733638
697,9911463,2.5551719944155016
KNS-60,4378219,0.8607292349530608
NCI-H1623,136227924,2.959018127447204
DMS 53,12003241,-1.7395700319118894
SK-MEL-30,10296883,3.708722133804856
HuH-1,54618771,1.0275459281807533
HuH-28,65628,4.297810748025056
NH-6,2746,1.9017163102404129
LOU-NH91,100016,8.416108067142021
HSC-3,135984461,4.3923039521515985
HCC202,9911463,4.016113462481005
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
BT 440,4378219,1.9559827950979
OUMS-23,11404337,-1.4377112711513047
NCI-H838,4705,3.3276720699815563
JHUEM-7,11404337,0.6000529311141187
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
JHH-2,6918638,0.332827130243307
NCI-H1915,136227331,4.393848466029563
HD-MY-Z,selumetinib-vorinostat (8-1 mol-mol),2.8123718664727773
BT-12,136227924,2.3126118312621404
RT-4,135984461,3.767018649492271
T24,24771867,3.9672488207624306
JHH-5,4378219,5.594947711280743
CGTH-W-1,12003241,-0.9249574155092228
OCI-AML-5,11152667,-1.4309616874651
NCI-H661,9868037,2.6835007144938032
OVK18,9911463,3.86173311118799
Capan-1,9884685,3.5003951132484485
RS4;11,1566236,0.9422336167179756
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
NCI-H211,10322450,3.046049170762013
SET-2,136227331,4.340141921453115
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
HSC-2,selumetinib-vorinostat (8-1 mol-mol),4.145527332979143
HCC1195,9926054,3.439884423988142
OV7,selumetinib-GDC-0941 (4-1 mol-mol),2.168494345054348
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
MOTN-1,11152667,-1.6889217949973774
MOLP-8,24779724,4.381900106399647
NCI-H661,9926054,1.7811448977738318
NCI-H929,9884685,-3.111418876103824
NCI-H2286,3854666,0.7538606981908345
SW1271,54618305,4.440463475812739
NCI-H1650,11152667,-1.7139939862640134
BT 112,1566236,1.551499234243426
K029AX,11494412,2.307806821374703
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
RPMI-7951,3465537,-0.2413225331247042
SW1116,2742550,3.2977805707201675
SNU-761,135659046,3.552687853164843
KHM-1B,54618771,-0.6219515555388266
NCI-H522,2746,2.8917767436803414
SNU-1196,136227924,2.95634276982207
NCI-H446,11152667,-1.5976182081930357
Caki-2,11404337,2.178214779259819
NCI-H2023,11152667,-0.1011481552792021
RCC10RGB,136227924,3.611686331312014
U-BLC1,selumetinib-vorinostat (8-1 mol-mol),-1.468805400461474
EPLC-272H,49836020,-3.920805882597204
KYM-1,49836020,-6.165786834710826
2004,100016,6.70935199674954
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
JHOC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1101820766966832
HPAF-II,9911463,4.010750287703811
BT 131,11152667,0.986821674709279
OAW42,11152667,-1.0580201050498812
SW1710,11152667,-0.6686415545105019
KE-39,54618305,4.948156947347383
COR-L51,6918638,-0.9148184553572968
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
NCI-H647,selumetinib-vorinostat (8-1 mol-mol),3.465801087956738
LK-2,10322450,2.8029884793598177
CCF-STTG1,9915743,3.2198509615239024
HCC-56,9926054,1.8387784948097223
SNU-61,44241473,4.262106100814371
Hs 888.Lu,2742550,4.401570476814638
NU-DUL-1,11404337,-3.806861406156987
MJ,11404337,2.657052353931515
DU145,9915743,3.139044524773344
CAMA-1,73707386,3.5601870738851997
ALL-SIL,54618305,4.365324809283883
EFO-21,9911463,4.46100095082043
ONCO-DG-1,44241473,4.483853064372171
SNU-475,9926054,2.638013601993947
JHOS-2,9884685,1.5653765415471337
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
CAL-54,4705,3.029255173670364
L3.3,11404337,0.7171912876466348
SNU-489,76446078,4.137942909746443
639V,9926054,0.5445384370060099
RPMI-8402,9868037,1.5465007663482742
23132/87,selumetinib-vorinostat (8-1 mol-mol),2.218713845544177
BC-3C,71751553,4.284434035767574
SNU-16,9926054,1.81351744877406
JeKo-1,65628,2.9302336616000417
NCI-H1915,3854666,3.460087345196579
SET-2,JQ-1-carboplatin (1-1 mol-mol),-0.9059473366978348
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
SW1573,9884685,-1.2788581073527363
SW1710,24779724,4.364171366545052
TM-31,9926054,1.8520077619388624
HCC1395,9926054,1.865398038154908
NCI-H1341,3854666,0.1266388074278771
LCLC-103H,9926054,2.81223402195442
DAN-G,selumetinib-GDC-0941 (4-1 mol-mol),0.9464172392973902
JHH-4,2746,2.8564345574200685
TT,11152667,-0.1087658009608058
LNCaP clone FGC,3854666,0.694335956852511
NCI-H810,10296883,3.337359136658117
KP-2,71751553,5.326076847809721
NCI-H929,9926054,0.4409605375156073
MOTN-1,49836020,2.722382817781131
COLO 684,100016,6.373471933627605
L-540,136227331,3.8428800907354983
RKN,24771867,0.8860225124393014
COV644,11152667,0.0100466059649179
EB1,100016,6.112181525197604
MOLM-6,135984461,3.5601883048539635
MKN74,135421197,1.917095385489804
HCC1438,9935249,3.1241914241248905
OCUM-1,1566236,1.275292241534932
CAL-85-1,9915743,-0.3969926925010483
TM-31,12003241,-1.3961411648113156
WM983B,11494412,2.4978869334252143
NCI-H28,10322450,4.072990606284223
KMRC-1,9926054,1.768451409600443
NCI-H1703,71751553,4.134415829550765
DU145,11152667,0.2266180408489874
KMBC-2,71751553,4.649110275042704
COLO 205,54618771,0.9873734762739949
HuP-T4,selumetinib-vorinostat (8-1 mol-mol),-2.420119488886567
BV-173,12003241,-5.971697113356734
KYSE-150,4705,4.321978699991397
OUMS-23,4378219,2.1508481292425627
F-36P,9926054,1.445748070072179
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
JK-1,65628,2.528699450938154
HEL,9926054,1.596813412273358
TE-11,11152667,-0.8173606825709024
PK-1,136227924,2.8943441164421633
NCI-H2110,3854666,1.2202267080403588
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
DU145,3854666,2.445661849899651
LOX-IMVI,9911463,3.8715849180913633
SKM-1,11404337,-1.0204518416697923
T3M-10,4378219,4.311042676598848
KMS-27,3854666,0.5713663154579435
L-540,9926054,1.766103135672326
CCF-STTG1,11152667,0.6516582666822289
BT 330,2742550,3.720607437110895
A101D,4378219,1.955713754678415
SK-MM-2,9915743,1.9327552948519848
23132/87,4378219,2.010482966046333
BHT-101,100016,6.007811941047966
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724
MOLT-3,49836020,4.359982480668932
HDLM-2,10322450,3.293303215923486
OE21,136227924,2.0991161235844404
PSN1,3465537,3.294093255917581
SHP-77,selumetinib-vorinostat (8-1 mol-mol),2.4257473125745275
NCI-H358,54618771,2.9972263013300955
NCI-H1105,10296883,2.7167194577249947
RERF-LC-MS,10296883,4.230661493555322
CJM [Human melanoma],12003241,-0.9609981142913676
Mono-Mac-1,9884685,-0.2142901784268321
BT 179,9926054,2.969670240545962
Granta-519,11152667,-3.975154363660797
MOLT-16,54618771,-1.933148337810649
KP-2,135984461,4.592059766741548
PK-59,11404337,0.8851709837592256
JHUEM-3,9935249,3.4231296114502068
MDA-MB-435S,11404337,0.4937179544357896
HCC2218,9926054,1.6047846197702569
CGTH-W-1,65628,5.036961777585174
CAL-62,9915743,0.6528059847635581
GB-1,9911463,4.167195991638194
JHUEM-3,6918638,0.235039867332202
K-562,9915743,1.457381054045144
SK-MM-2,JQ-1-carboplatin (1-1 mol-mol),-2.35535314984042
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
Daoy,selumetinib-GDC-0941 (4-1 mol-mol),2.0496212726424914
OAW42,54618771,1.2241554078015442
Hs 294T,9935249,3.17037121804739
Panc 10.05,54618771,0.7242321681283157
Hs 729.T,9915743,2.696415858684256
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
SNU-61,4378219,2.193359587578685
ES-2,4378219,1.9762325092315076
HCC202,11494412,2.145306314869007
NCI-H1666,54639665,4.462050745406922
TE-5,65628,4.1265200072069455
Mino,11404337,-2.29299189538819
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
BV-173,9926054,1.6102872074476016
KNS-60,650361,2.902836062071098
DMS 273,3854666,0.530051590236263
DB,11404337,-1.658875879170345
LCLC-103H,11152667,0.8142627496272367
LS123,100016,6.571994849278421
OC 314,65628,3.7936421143756145
Caki-1,9884685,4.271295455862672
HCC1500,4378219,1.8377088226049565
MHH-CALL-4,65628,1.9162335341820356
VMRC-RCW,9911463,3.519354422119686
KYSE-180,9911463,4.116935332494812
TALL-1 [Human adult T-ALL],135984461,3.024733387854321
DMS 114,136227924,2.8316140416519664
EC-GI-10,9926054,1.9054317321627203
LS123,4705,2.777266406946489
AML-193,9911463,2.567392494652272
NCI-H716,6918638,0.7980253522475573
NOMO-1,9911463,3.1879476164010243
NCI-H1793,10322450,3.1720779233297405
Mono-Mac-1,selumetinib-vorinostat (8-1 mol-mol),2.0513617036591323
TC-71,54618305,4.321118108161562
Karpas-620,135421197,3.2232508043122587
SNU-61,73707386,3.625444775073466
HCC1438,135421197,2.9315312537575124
FaDu,selumetinib-GDC-0941 (4-1 mol-mol),1.0128048472171496
KNS-60,3854666,0.0716701028086042
NCI-H226,9926054,2.2620908490117526
OE21,135984461,4.867121216346128
HLF,3854666,1.0114410413454975
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
MOTN-1,135398744,7.842138367791958
CCK-81,selumetinib-GDC-0941 (4-1 mol-mol),1.1249387686067662
MEC-1,3854666,0.5961187704066611
AsPC-1,2746,3.619198032462304
A-204,2742550,3.2354852525519577
NCI-H520,135421197,1.6066426721545042
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
DU145,54618771,3.337458824494602
KMS-34,4378219,1.7831996548730944
CL-11,1566236,1.7101379821681366
GCT,135659046,3.4332962928318893
TE-6,11152667,-1.5406626235215035
VMRC-RCZ,6918638,0.7764115752639781
EB1,11152667,-2.271733256733806
SNU-719,136227924,2.577096412948206
ChaGo-K-1,12003241,1.029111103028103
COLO 320,71751553,4.409375162477877
COR-L88,2742550,3.917514421187428
Hs 940.T,selumetinib-vorinostat (8-1 mol-mol),3.949639758307315
NCI-H1944,24771867,3.493574071943943
CAL-27,24771867,-0.9789859091186196
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
NCI-H1299,12003241,-0.9760038754339474
TE 441.T,10322450,2.5137861182837207
KNS-81,11152667,0.7126411736718126
TE-6,11404337,-2.253854386513332
MOTN-1,54618771,0.6090768126034483
A-172,24771867,4.102264903855083
A101D,1566236,2.4335097410517914
GCT,136227924,3.024645180957839
BT 498,1566236,3.668153571841636
42-MG-BA,9884685,-1.3551185166012014
NCI-H2081,10296883,3.746053952557345
ECC10,54618305,3.9917932371163696
NCI-H2291,selumetinib-vorinostat (8-1 mol-mol),1.0028755905319455
JHUEM-2,9926054,1.5571026590008097
Rh41,selumetinib-vorinostat (8-1 mol-mol),2.07145353240202
TOV-112D,54618771,0.882664692368087
CAL-148,12003241,2.7249507328526015
HCC2218,135984461,4.242222575016064
RVH-421,54618771,0.9846410856532696
NH-6,9911463,4.337318302270048
HMCB,100016,6.123582467992384
TOV-112D,135659046,3.4067984131913938
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
SBC-5,54618771,0.9612938071948806
Mino,2746,0.8044795617412364
NCI-H1299,2742550,4.427150184712593
CHP-126,135421197,1.2464718397024956
FTC-133,9911463,4.36756965003986
SK-BR-3,3854666,0.6288211894501958
A2780,24779724,4.3340331177123765
BICR 31,4378219,2.049792351388142
BC-3C,4378219,3.95059564857708
NCI-H1703,selumetinib-GDC-0941 (4-1 mol-mol),1.0120925414359212
MDA-MB-157,9926054,2.0716850398098368
Hs 940.T,136227924,0.9830608526546036
HCC1500,9935249,2.2800833668468266
639V,11152667,0.5009160292642465
OVISE,2742550,5.280611289386831
GMS-10,49836020,0.0918808601925
NCI-H716,3854666,1.816337211721982
MOLT-3,54618305,3.785701581176766
NCI-H1395,9926054,1.836702615994444
SNU-1196,JQ-1-carboplatin (1-1 mol-mol),5.1757669603807015
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012
FTC-238,9911463,4.0725433031762694
MEC-1,54618771,0.2642234138424628
G-402,11404337,-0.2966965164109829
GaMG,9926054,2.873858460522757
MOLT-16,24771867,-2.876686026982402
P-STS,11152667,-0.9281446368525446
RKO,9935249,5.020114551473781
NCI-H2029,12003241,2.5373322791001636
SNU-213,9911463,3.827165589896959
BT-549,54618771,1.4883156908959423
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
SNU-478,135984461,4.6270303617123165
NCI-H841,11152667,-0.143998376497437
ChaGo-K-1,6918638,0.8510727110172542
WM88,135659046,3.481693995509175
A-253,2742550,3.4379925560978406
SW579,selumetinib-GDC-0941 (4-1 mol-mol),1.5749080758485403
KMS-18,2746,2.154567509155723
SK-LU-1,54618771,0.3237862890103595
EKVX,11494412,2.903225819111975
OCI-AML-3,11494412,-0.6961081339076156
NCI-H69,11404337,-0.840898512834909
KE-37,54618771,-2.6599690790186425
CML-T1,54618305,-5.881736901302383
SW1417,11494412,2.7620074844216345
DMS 53,11494412,1.0144009801512948
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
OCI-Ly19,10296883,3.222057904422062
Rh18,3854666,3.614341837202171
SCC-4,6918638,-0.3136358743623781
HCC202,4378219,2.022121550401258
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
NCI-H446,65628,4.365743972833802
BT-549,11404337,-0.1293922368150601
SYO-1,100016,3.831378840669671
CAL-51,135421197,1.6266864976107616
NCI-H2087,3465537,1.2179436522568818
CHP-212,135984461,1.9564066999314385
NCI-H2172,54618771,2.767787208774524
HuP-T3,136227924,2.888640375816574
NCI-H1792,9911463,4.29249161845891
F-36P,24779724,4.9138855829975565
CL-11,11152667,-2.0837700149013725
MV4-11,9935249,1.024868546026966
GDM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.4015630537734989
KP-4,JQ-1-carboplatin (1-1 mol-mol),3.935772405145619
Hs 766T,11404337,0.6729236116595668
NCI-H1915,6918638,-0.1155536778195901
SU-DHL-10,135984461,3.8302995434103138
CAMA-1,9935249,4.786232529876141
BT 333,6918638,1.7862101251077225
JHOS-2,11404337,1.6734890105758244
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
LS513,9911463,3.8575108406588705
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
OCUM-1,11152667,-4.397219169137368
Karpas-422,1566236,1.018431355816045
LNCaP clone FGC,100016,6.505127339133147
BT 333,2746,4.493584993819337
SEM,11152667,-6.712483327053162
G-402,9915743,1.3194896557677194
SW1088,3465537,2.9925231341209964
Granta-519,11494412,-1.422706675432074
COLO 201,9926054,1.9430022433891496
SNU-899,9935249,3.658894921708273
TCC-Pan2,selumetinib-vorinostat (8-1 mol-mol),4.508948185921673
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
OUMS-23,54618771,-0.8110473327008938
Reh,44241473,5.846369290867164
Kelly,11404337,-0.935685652893764
NCI-H460,3854666,3.1385110084048065
RERF-LC-Ad2,4378219,2.030697080387384
Aska-SS,JQ-1-carboplatin (1-1 mol-mol),-0.8718657257645913
U-CH1,2746,3.3579143403808995
HuP-T3,2746,4.662800576379415
LOU-NH91,24771867,3.0978851297923895
Capan-1,24771867,4.358241115555216
SU-DHL-6,11152667,-4.5064226702829
BV-173,9911463,2.9939973484009608
BICR 6,selumetinib-vorinostat (8-1 mol-mol),2.3950298084345545
GB-1,selumetinib-GDC-0941 (4-1 mol-mol),1.0997063493321384
VMRC-LCD,11404337,0.4104249926978496
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
RMG-I,3854666,2.558829585712286
IM95,11152667,-0.330952579269037
KE-37,11404337,-3.142013141834162
647V,135984461,4.277931256809204
8-MG-BA,49836020,-4.019161217996327
EC-GI-10,135421197,2.6554260651885944
SCC-9,11404337,-1.771041191231111
NCI-H526,65628,3.508124639606281
SNU-16,54618771,0.522197701958757
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
MFE-319,9884685,0.756895604366277
NCI-H2291,11152667,2.770715957693989
M-07e,4705,3.81547426285279
OVTOKO,selumetinib-GDC-0941 (4-1 mol-mol),2.323282098150216
SU-DHL-10,9911463,2.7102339081267948
SW48,136227924,1.7122170056378203
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
NCI-H2087,11152667,-1.020172453854182
CAL-148,65628,4.514684852840301
SUIT-2,11152667,1.417612600480328
HCC1833,54618305,4.412472871081104
FTC-238,9926054,1.7889944253526169
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
H-STS,135421197,1.21674084203813
NCI-H522,135659046,3.4944475458884012
HCT 15,9935249,2.820339042692745
PC-3,9926054,2.02880432108919
Ki-JK,9926054,1.4842884582556586
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
OVK18,135421197,1.6539511410681966
YD-38,11404337,-1.21391516825444
KMS-12-BM,65628,3.1283199596989624
SNU-119,24779724,4.340610631668066
TE-8,9868037,2.984578465657965
T84,9868037,2.575833887310964
SW1573,3854666,2.927116287337192
HT115,9915743,-3.7208520870958286
EFO-27,3465537,3.52414234339403
KYSE-510,2746,3.665067942472177
HDLM-2,9911463,3.4490026877809674
HT-1080,11152667,-0.5358883400554086
NCI-H522,136227924,2.2034936459857506
Hs 688(A).T,selumetinib-GDC-0941 (4-1 mol-mol),3.4396417778201305
CAL-27,9926054,1.784787570446616
5637,9915743,-2.6589939523871347
MIA PaCa-2,3854666,0.8531836291018433
A-549,44241473,4.768992901407106
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
PE/CA-PJ34 (clone C12),3854666,0.7943523247128464
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
UACC-257,135421197,1.9290983247334992
Daudi,24771867,-1.2539165255857252
MFE-296,11494412,0.9022675907017478
HuH-1,11152667,-1.0247289501781058
NCI-H1651,11152667,-0.8885478586200989
MDA-MB-435S,135984461,3.5983225133232795
NOMO-1,136227331,3.913043208951298
GP2d,selumetinib-vorinostat (8-1 mol-mol),0.6453511281872317
BT 228,135421197,1.0231801193279042
AML-193,4705,3.164558666224438
BICR 56,24771867,2.0042147669406236
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
TE-4,9868037,3.2663312680184227
COR-L51,2742550,3.971917509503878
YD-38,9926054,1.970357209117647
SNU-C4,11494412,1.7480299860261157
NCI-H2228,136227924,2.998313400459559
SNU-1,2746,3.00506247553621
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
JeKo-1,3854666,0.6806935772544002
PaTu 8902,54618771,-1.3103145579416535
Fu97,9935249,3.520902332325934
AN3-CA,135421197,1.808403236431818
JHUEM-1,135421197,1.216827050882974
AML-193,1566236,0.9779280105236772
COLO 680N,11404337,-0.1735930732643658
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
Jurkat,selumetinib-vorinostat (8-1 mol-mol),2.341506614269864
LXF 289,54618305,4.64176895308047
SK-N-DZ,2742550,3.9747270585724577
BT 147,2742550,3.5945516662037846
Hs 895.T,11404337,0.3575168130913553
EFE-184,2746,3.7272239224015697
NCI-H1944,2742550,2.9262336519999903
SK-N-FI,100016,6.445734787344034
REC-1,9935249,3.294492382049569
NCI-H1184,9911463,3.5599804039419225
AU565,9868037,3.1053436778875843
ALL-SIL,49836020,-3.56746653346715
SW982,9926054,1.795372121114862
KMS-27,100016,3.811410813700335
HT-1080,JQ-1-carboplatin (1-1 mol-mol),3.260374124157549
SNU-601,3854666,2.8190052907424996
YH-13,9926054,1.834128888426512
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
Caov-3,12003241,-2.5094220970195136
GMS-10,2746,4.267808418736884
JHH-4,40482356,5.781711046627208
Sq-1,10296883,4.026329905742616
SNU-668,11404337,0.2383012933548859
CAL-27,selumetinib-vorinostat (8-1 mol-mol),0.7309790077712324
EB1,71751553,2.2286483741209593
NCI-N87,136227924,3.040461203265333
IM95,24771867,6.24452570548908
MOR/CPR,9935249,3.5674307926017415
CL-34,JQ-1-carboplatin (1-1 mol-mol),-1.7099551390648522
EFE-184,3854666,3.747321393651702
HCT 8,3854666,3.4092895535150083
TYK-nu,10322450,3.7591527396933895
TE-8,135659046,3.4515439367981435
SF268,9911463,3.2093311468755843
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
Calu-6,2746,5.003270781401264
RKO,54618771,2.3159310195777985
COR-L51,135421197,2.6598803683271965
SNU-620,49836020,5.484424750861699
JMSU-1,9926054,1.0458929376132455
VMRC-RCW,135421197,2.019130008458573
NCI-H520,1566236,1.8490403312922712
JHH-5,3854666,3.08058465542435
MDA-MB-361,11494412,4.099226139153975
SW948,6918638,-0.8188756331889222
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
BT-16,11152667,-1.4424120868288224
NCI-H1651,136227924,3.2782738852919966
BICR 56,9911463,4.962922659402967
WM115,11404337,-2.7813606850874595
KMS-27,9926054,0.4648817543416692
A-549,11152667,0.4045052003861268
TE 441.T,135984461,4.21306533466607
MOR/CPR,11404337,-0.964531919151295
LS513,9926054,1.5640640769912204
ST486,selumetinib-vorinostat (8-1 mol-mol),1.5457849466336735
SNU-C1,136227924,2.406947195401098
Granta-519,2746,3.996696473436098
NCI-H810,9935249,2.010109308551092
HCC2218,11152667,3.74490271643498
BC-3C,2742550,3.812502027917897
GI-1,2746,3.841206202688264
NB1,3854666,0.2195348196747777
MDA-MB-361,3465537,1.4227411882949614
NCI-H1869,2746,3.565752906078767
DND-41,1566236,0.8938432244307261
BT 271,JQ-1-carboplatin (1-1 mol-mol),4.042067647182753
LS180,135984461,4.839780886141452
KE-39,12003241,0.559414259019648
AsPC-1,76446078,5.483716778202627
MEC-1,9915743,0.3780873784747607
SNU-899,9911463,4.136676393958991
HCC78,54618771,0.9247891976251188
HEC-1-A,6918638,0.4637384706031703
HGC-27,65628,4.265310037500784
LP-1,9911463,2.6220620880442773
UO-31,2742550,2.8360287699975943
SK-ES-1,2742550,3.875609520275834
BT 286,136227924,1.3356746395497436
CCK-81,100016,4.4296308435579554
HCC1195,10296883,4.230054584219755
SK-N-AS,135659046,4.543052332569712
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
SK-N-FI,9884685,0.5794007214682347
Hs 611.T,1566236,1.2731219518363013
BT 359,4705,3.8493251509059
A-549,54618771,0.0374822867627876
SNU-869,12003241,1.357086277670327
HuH-28,11404337,0.2716572522655043
8-MG-BA,54618771,3.7934452714384954
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
SNU-216,11152667,-0.1857708456890594
OCI-Ly10,3854666,2.717312719982327
Hs 936.T,11152667,-0.982911765278613
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
MKN1,9911463,4.154655732863371
CAL-51,136227924,2.079284078064279
LAMA-84,136227924,2.847754951874779
NCI-H889,136227924,2.7199111384597447
NCI-H2228,49836020,2.091075397258879
SU-DHL-6,9868037,3.231553190440303
A-253,135659046,3.360976512621253
TE-10,54618305,4.872996569288002
Mino,10322450,2.499731281895077
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
NCI-H2170,136227331,4.269339943775955
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
HCC1588,selumetinib-GDC-0941 (4-1 mol-mol),-0.6693543343840518
PL-21,3854666,0.4528352950899395
LS1034,24771867,5.7908371524264215
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
769-P,100016,6.594067506922387
NCI-N87,11152667,-0.2953714197447944
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
Hs 766T,100016,6.453782329995662
SNU-398,3854666,1.3633746323858775
COLO 320,100016,4.196375737127383
HEC-108,44241473,4.4856951268247585
BT 216,1566236,2.9702648671976757
Fu97,9926054,1.5136567302830126
Namalwa,24771867,-1.506492255683234
HCC2218,2742550,3.114607696672168
BV-173,1566236,1.4234045213430984
SNU-1077,selumetinib-vorinostat (8-1 mol-mol),2.452404658166729
DMS 79,136227924,2.929954381299975
HGC-27,54618305,4.217377303978183
253J,9884685,-1.1911858764968464
IM95,9926054,1.717853214717972
AM-38,54639665,-6.281262655351625
BT 147,6918638,2.7935207721855764
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
SF268,136227924,2.8034077121566967
LS513,3854666,1.2742578609019837
NCI-H1341,9884685,-0.5514971191572201
SK-ES-1,1566236,1.3455371740590636
8505C,selumetinib-GDC-0941 (4-1 mol-mol),0.125719667045265
COLO 668,135398744,8.327897360354253
CAL-33,54618771,-0.7874087703723603
SW982,3854666,1.1307369870989918
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
ECC10,9926054,1.849592705301639
NCI-H2009,100016,6.24887408197215
KATO III,24771867,1.472155912376193
COV644,49836020,0.1306983764226103
NCI-H1339,2746,3.2710965804253633
U-251MG,selumetinib-vorinostat (8-1 mol-mol),3.4594447583943757
COR-L105,3854666,3.5309487733662923
GaMG,24771867,3.523992397039573
CL-11,135421197,1.4144894380219903
HEY A8,49836020,5.6501572313244885
WT2-iPS,1566236,1.6707145987469252
253J,54618305,3.985513491818871
TE-1,9911463,4.060857496316997
BICR 6,12003241,-1.5069556465481264
SNU-C4,9868037,3.980442058485963
Daudi,10296883,2.545577320776033
NCI-H1755,12003241,-1.003418586049609
OVCAR-4,11404337,-0.6423478354429553
MIA PaCa-2,2746,3.119583352790748
MIA PaCa-2,9935249,2.549119041340402
KYSE-520,10296883,4.455912187683782
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
Hs 294T,9926054,1.7844528476619044
Aska-SS,9915743,4.6132993472825765
HCC1937,54618771,3.213475189198509
MOLP-2,136227924,2.531478892468582
OE33,11404337,0.6160671156841868
MDA-MB-415,9884685,-0.7698340401064314
HT-55,selumetinib-vorinostat (8-1 mol-mol),1.1562866602293844
IGR-1,3854666,0.8648150741140344
KYSE-450,24771867,3.24164368139856
BT 164,11494412,1.7024726353165465
PL-21,selumetinib-vorinostat (8-1 mol-mol),-0.1981312398958528
J82,11494412,3.499670592008664
HCT 15,11404337,-1.6671544641516778
NCI-H196,9868037,4.869553170308075
ChaGo-K-1,9884685,1.4931363766033252
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
TF-1,1566236,1.641325483030065
HT-1376,24771867,3.215322136386946
P-STS,135421197,0.9430476955578664
OVTOKO,65628,5.039210953905471
DAN-G,24771867,3.4695069177838795
KM12,selumetinib-vorinostat (8-1 mol-mol),2.525570037198844
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
SNU-182,11152667,-1.401202030451144
EFO-27,1566236,1.9834366009012432
U-937,24771867,2.85401731592862
NCI-H1838,selumetinib-vorinostat (8-1 mol-mol),-0.3496961442903177
A2780,54618771,-0.248592168161829
NCI-H810,4378219,2.1606055747393724
L-363,4705,4.264725490975614
A2058,4705,3.593116670395646
SNU-61,10322450,3.828611192492266
NCI-H520,11152667,-0.8111617843564765
IMR-32,1566236,1.2008370083057098
MCAS,1566236,2.0523817086491296
KYSE-510,9884685,1.452172872973614
KMS-12-BM,4705,2.431122737655679
SK-N-FI,11404337,-1.561187150233845
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
SNU-685,24771867,3.676317857473756
PSN1,9915743,2.9916709267911084
PK-1,1566236,1.9563055032628711
SET-2,9926054,1.6776501813643687
A-204,11404337,-1.0491261061944723
RL95-2,12003241,-0.4521887729146946
NCI-H1355,11404337,-0.5901548623910822
Kuramochi,54618771,2.421317406339968
Yamato-SS,11404337,-0.7201649864225125
SCC-4,135659046,3.853752534308609
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
AN3-CA,2746,4.007834108220286
LCLC-97TM1,9926054,1.7367616025320842
Raji,135421197,1.3656726509446273
LNCaP clone FGC,136227924,2.6855023326383387
OE21,12003241,-2.4283256435660205
NCI-H2122,9935249,3.63066345559963
BT-16,100016,4.275534033025709
BL-70,9915743,2.1180817838790658
LoVo,4378219,2.040258922351895
MeWo,71751553,4.508451230000785
NCI-H1838,135421197,3.0892223680095077
UM-UC-1,9935249,3.1268439830894854
769-P,11152667,-1.1976521797110848
TOV-112D,11404337,0.1450388001924293
YD-10B,44241473,4.39672434740099
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
KYSE-30,12003241,-0.1095696990749684
DMS 454,24771867,3.8612369973518783
Hs 611.T,135421197,0.2639365806220374
SW1783,4705,3.473081250569121
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
SU-DHL-1,135421197,1.1384736779813156
KYSE-510,4705,3.5266968051066856
NMC-G1,54618771,1.359129875373881
CAS-1,4378219,5.402855075046525
SW1783,136227924,2.7676121780420364
HuH-6,54618771,-1.3988584380495144
A-673,11494412,0.2373053627626316
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
NCI-H520,136227924,2.065702540466464
SW1417,1566236,1.950642609595583
KYSE-70,2746,2.8005709054024224
OVCAR-5,2746,2.6087959831645433
SNU-719,9926054,1.5286214740335768
PLC/PRF/5,11152667,1.7058073401634024
SNU-738,73707386,3.659830894488395
SU-DHL-1,11404337,-0.9851913382580488
SUIT-2,selumetinib-vorinostat (8-1 mol-mol),2.64771661765404
HCC2279,54618305,4.381528297963885
NCI-H1573,10322450,3.3091904926766835
RERF-LC-MS,12003241,-0.3897829713203344
SaOS-2,12003241,-0.699813042979073
HuNS1,136227924,1.7771734051898846
NCI-H2196,9935249,1.3463658676393593
BT-16,9911463,3.6213577746189514
Toledo,2742550,4.189693729696579
22Rv1,65628,3.6974933806561214
MHH-CALL-3,selumetinib-GDC-0941 (4-1 mol-mol),3.01666713959806
RCH-ACV,11404337,-3.4886710255299516
COLO 684,6918638,0.5443329565313224
CMK,54618771,0.9710170961013548
AsPC-1,135421197,1.8824248695595285
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
SNU-685,selumetinib-vorinostat (8-1 mol-mol),2.4986183869313696
SNU-1,12003241,-2.3799966933109262
OCI-AML-3,10296883,3.1586909460466455
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
Rh41,100016,7.167579216403683
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
EB1,10322450,2.387875240843174
BT 179,135421197,2.7508543391500875
EN,selumetinib-vorinostat (8-1 mol-mol),2.3844723548226336
AM-38,10322450,-5.137257783739551
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142
NCI-H810,3854666,1.3321102661413062
HCC1395,54618305,4.96091768508178
Karpas-299,11404337,-0.9739899309482728
P-STS,1566236,0.9528688802089575
SR,selumetinib-vorinostat (8-1 mol-mol),2.722566868305421
HCC-56,11494412,1.5604105617758193
Rh41,10322450,3.0581399607102773
FTC-133,2746,3.487652314498242
CHP-212,11404337,-1.6031269960117245
Panc 04.03,11404337,1.3784278741672673
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
NCI-H1373,12003241,-0.7849764131433078
MFE-319,1566236,3.6446257988507
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
U-251MG,2742550,4.085614396741507
BT-20,54618771,4.093139907883374
BHY,100016,6.773898116669002
SNU-16,11494412,-1.5668452585582169
GCT,136227331,4.154263248782668
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
COLO 678,9884685,1.636173828507052
LXF 289,9935249,3.315625346230847
NCI-H2029,6918638,-0.2360985045568938
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
Rh30,9935249,3.355243286720757
SNU-308,JQ-1-carboplatin (1-1 mol-mol),5.335805605025179
BHT-101,9868037,3.7978715471358218
SEM,11494412,-0.8044371012013913
BT 159,65628,6.014934419792849
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
Pfeiffer,3465537,1.0799742381514623
YD-10B,3854666,0.8759037420312452
SW1271,9868037,2.9396003878324857
TYK-nu,1566236,1.811771162812953
HCC827,54639665,5.801355339134406
LXF 289,54618771,-0.5375230222620658
TYK-nu,135659046,3.766078033019111
LUDLU-1,9935249,3.4988429310109264
SK-MM-2,10322450,5.033500984762851
QGP-1,12003241,-0.3742156649429844
CCF-STTG1,9915743,3.2198509615239024
HDQ-P1,54618771,4.6079698372057605
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
WM1799,11404337,0.7575845894663391
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
SW48,12003241,-0.9746028071684796
NUGC-4,9926054,2.05156938319837
KE-97,selumetinib-vorinostat (8-1 mol-mol),2.0582156479057176
MCF-7,JQ-1-carboplatin (1-1 mol-mol),-0.3789372065214004
KNS-62,9926054,2.478814606658306
CCF-STTG1,136227924,3.7108552267199504
22Rv1,11152667,1.3271929435007497
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
MEC-1,4705,3.2350662901156264
YH-13,44241473,5.475816552188209
FTC-133,1566236,2.958331107997485
MV4-11,100016,3.584878230644963
DEL,4378219,1.328244846384661
ONS-76,44241473,4.684511997660941
ES-2,selumetinib-vorinostat (8-1 mol-mol),2.4176750496579524
WM88,135421197,2.6537583925781054
NALM-6,selumetinib-GDC-0941 (4-1 mol-mol),-0.5223211713783823
SUP-HD1,49836020,4.390823916389519
OVCAR-8,3854666,2.8229286254274624
BT 239,JQ-1-carboplatin (1-1 mol-mol),2.368101123229976
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
BT 271,135659046,3.5809922662045137
COR-L105,12003241,-1.8759508779616432
NU-DUL-1,11152667,-4.730563211126392
BT 422,9935249,1.3442145971797932
IGR-39,2742550,5.0272104945587035
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
A-673,4705,3.2416788332737454
HuP-T4,135984461,3.493927750187572
NCI-H1915,54618771,0.2887330377515757
Karpas-299,11152667,-4.530059155107273
BT 482,3465537,3.495136029701583
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
COLO 684,selumetinib-GDC-0941 (4-1 mol-mol),1.3698128792946012
CHP-212,1566236,1.526376682720088
TE-15,11152667,-0.8942963388788865
NCI-H524,12003241,-3.023793196266873
Hs 895.T,12003241,-1.2157135831587602
NCI-H1563,9935249,3.0845372381099923
MFE-296,24771867,2.7154919688453494
ESS-1,24779724,4.457445117995274
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
HD-MY-Z,11152667,-1.450671407688362
NCI-H446,selumetinib-vorinostat (8-1 mol-mol),2.5724030712671904
SW620,selumetinib-GDC-0941 (4-1 mol-mol),-0.6864895325025141
HT-1376,1566236,2.1181506136413635
OCI-Ly19,65628,1.529458135947593
T3M-10,9884685,1.5536647474926049
GMS-10,9915743,1.3582856861071526
DV-90,49836020,4.269422045712615
GI-1,100016,6.475829804009189
Kasumi-2,11494412,-0.1140662522158316
TUHR10TKB,136227331,3.9944328984652975
WT2-iPS,9911463,4.390053474560322
DEL,135421197,2.352546042439028
BHY,54618771,-0.7807984758131394
JHUEM-7,11152667,-1.617539087588013
CHP-126,selumetinib-vorinostat (8-1 mol-mol),2.379492910294905
THP-1,4378219,1.8740488485055216
NCI-H1734,44241473,4.326721690860974
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
BT-16,6918638,2.124835074302428
ZR-75-30,100016,8.126082181881081
IGR-37,136227331,4.32939216676153
A-204,12003241,-1.8688427044932845
TE-10,11404337,-0.3956055748669924
Mono-Mac-1,650361,3.717997934004441
DMS 114,selumetinib-GDC-0941 (4-1 mol-mol),1.847196257351989
BICR 18,selumetinib-vorinostat (8-1 mol-mol),3.62095054613652
EN,selumetinib-GDC-0941 (4-1 mol-mol),3.4742194134426168
BICR 18,2742550,4.119213346419039
EM-2,4378219,1.33062111232141
NCI-H2291,54618771,2.606874288662127
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
HT-1197,136227331,4.1686832896523685
NCI-H520,9911463,3.6961325383043007
KMS-18,selumetinib-vorinostat (8-1 mol-mol),2.400685931534778
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
VMRC-RCW,24771867,3.7770265583840734
NCI-H1568,11152667,-1.392140833696634
SK-MEL-31,65628,4.422520079013974
Li-7,9915743,1.173340818103225
RKN,3854666,2.132003481112045
EFO-21,100016,8.032262329904976
SNU-475,100016,7.606290519099935
SNU-503,10296883,4.26792397433306
SCC-9,6918638,0.4192666549800527
TYK-nu,24771867,3.5192943352295476
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
M-07e,3854666,0.4503079747875654
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
SK-N-FI,136227924,2.3066593011882084
JMSU-1,12003241,-3.06340831413481
NCI-H2052,135984461,5.580046564229557
OVCAR-8,9935249,3.7854627498334343
UACC-257,136227331,4.461620315172803
PK-45H,selumetinib-vorinostat (8-1 mol-mol),1.281652325813519
MOLT-3,9911463,4.579256279183223
SEM,71751553,4.239243086655999
Hs 683,135984461,3.956952055268157
RT-4,12003241,-1.8542714118634884
NCI-H2081,9884685,-0.1678318744759171
SET-2,4705,3.0557910229077554
JHUEM-3,4378219,2.140768713132357
HEY A8,100016,6.30003295297675
MDA-MB-453,24771867,4.091824937074987
WM793,136227924,4.7819042035619255
NCI-H196,9911463,4.433350594042992
MDA-MB-468,11494412,0.2824609467328579
EC-GI-10,11152667,-1.025242413755307
K029AX,9911463,4.292366302219474
Pfeiffer,9915743,-1.0333729924514143
TE-1,12003241,-0.9529252226933594
NCI-H1703,10296883,3.9122809054247054
MOLT-13,11404337,-0.8509497692060022
IGR-37,3854666,0.7173312278766348
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
ONCO-DG-1,9935249,3.554031601583604
SU-DHL-1,12003241,0.0778318253848937
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
SU-DHL-8,135984461,2.059848227553284
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
JURL-MK1,9868037,1.498600945744401
KE-39,11152667,0.74958800909379
HOP-62,11404337,-1.0489074115392232
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
JJN-3,135421197,1.2672654970884558
BT 482,6918638,6.285533973123243
BxPC-3,135984461,1.8776729747018608
G-402,9935249,2.789116740198665
A4/Fukuda,2746,1.0000278581130588
SUP-T11,2742550,3.0787021809680044
P31/FUJ,135398744,5.7727848933678
KE-39,44487872,4.457727251314366
JVM-2,selumetinib-vorinostat (8-1 mol-mol),-0.8355948375109636
BT 172,1566236,1.9782936054266065
P31/FUJ,135984461,4.1454221372139894
KCL-22,12003241,-4.05956124354109
IGR-1,135984461,4.582629731672088
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
HL-60,9926054,1.793392077078212
CAL-85-1,54618305,4.262319524380244
JeKo-1,9915743,1.243422351043917
KMS-11,selumetinib-vorinostat (8-1 mol-mol),2.399749533932205
NCI-H1563,9926054,1.9605295654487136
SW1353,9911463,4.226440696401509
Granta-519,11404337,-2.8078628280004048
WSU-DLCL2,9935249,2.5426806019846864
OCI-Ly3,11404337,-1.6616072452432793
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
TUHR14TKB,6918638,1.3183057311971391
DOV13,54618771,0.905613637796649
G-402,136227924,2.8538202085088185
MDA-MB-361,11404337,1.0134082132616506
ONCO-DG-1,9915743,0.2840854953845789
SW48,24771867,-3.897611921368264
NCI-H28,65628,4.1820759324242776
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
NCI-H2087,9911463,3.2205698375383935
HEL 92.1.7,9926054,1.77080435305732
DMS 53,selumetinib-vorinostat (8-1 mol-mol),2.453431663164935
OAW42,12003241,1.2884936123543242
VMRC-RCW,1566236,3.1837632909467497
HPAF-II,selumetinib-GDC-0941 (4-1 mol-mol),0.3156523393039555
SNU-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1369641916187444
NCI-H650,11404337,0.16531704112611
IPC-298,54618305,4.557481113357753
NCI-H747,71751553,4.209240380331091
HT,9911463,3.44376520524061
NCI-H1355,2746,3.638121411384877
HEL 92.1.7,12003241,-0.5838184983387604
NCI-H322,1566236,4.003179609874178
J82,11404337,-0.1967629252441953
NCI-H841,2746,3.2973731643311193
CCF-STTG1,12003241,0.9586959919868534
SNU-C1,4378219,1.9935084471521043
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
SaOS-2,9911463,4.168030006572111
ZR-75-1,135421197,1.3077773564492
MOLM-13,11152667,-8.249378694414048
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
HCC1937,selumetinib-GDC-0941 (4-1 mol-mol),1.9717867215396572
MV4-11,selumetinib-GDC-0941 (4-1 mol-mol),-2.1623049126826372
SNU-5,11404337,-1.177028079516049
UM-UC-3,12003241,-0.2552051516294621
SK-MES-1,2746,3.092337082097677
KMRC-20,76446078,4.8666377437919985
HuG1-N,6918638,0.9009310032915192
CA46,3854666,0.2733202158609283
RT-4,9926054,1.7601963161522494
639V,3854666,3.290280806070441
EFO-27,4378219,5.419366677908557
QGP-1,selumetinib-vorinostat (8-1 mol-mol),2.506831901126706
KATO III,10322450,4.372347394636034
SNU-81,49836020,-3.195484765979539
TUHR10TKB,135421197,3.595491301203154
MOR/CPR,selumetinib-GDC-0941 (4-1 mol-mol),2.600932232406458
LS513,24771867,0.3716933986959717
UACC-257,9926054,1.800588068202944
NCI-H2029,1566236,1.632401955287535
SW48,3854666,0.5343434371102147
NCI-H292,9884685,1.805947993429832
OCI-AML-2,9935249,1.831954757010996
CAL-51,12003241,-1.2189714227076325
MOTN-1,1566236,1.466029037834187
TE-5,135659046,3.5312451731544887
BT 422,54618305,4.804608461276929
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
G-401,10322450,4.220475308231234
TE-5,9884685,1.3127368947926776
Hs 944.T,4378219,1.8673330290514083
SNU-1,9935249,2.5676508314094866
MOLT-13,3854666,0.8628721884474523
HEC-151,136227924,2.850288220591168
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
Hs 839.T,1566236,4.086954474692148
SNB-75,9911463,3.761177145867038
SNU-407,2742550,3.2176632042347255
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
BT 328,136227331,5.061934875267611
PF-382,65628,3.430221294092043
NCI-H1299,136227924,3.5346618762414392
HCC2935,9911463,4.226502617966516
JHUEM-2,100016,5.904304927611702
HCC4006,JQ-1-carboplatin (1-1 mol-mol),4.481735519200737
GDM-1,9935249,1.7678028451687384
Sq-1,49836020,-1.2584721229421645
BT 139,4378219,1.2549106486924078
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
Lu-65,9911463,3.1807959522129905
MEC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4728620848599026
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
OCI-AML-5,9868037,3.637294932872617
BT-12,135421197,1.7013160656627575
WSU-DLCL2,54618305,4.290605558681752
OCI-AML-5,2746,1.486809354456374
BT 504,65628,4.716972580704197
BT 422,12003241,1.9442582460098417
Panc 04.03,9884685,1.6842032304446288
NCI-H358,135984461,4.245060558791378
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
COLO 680N,9926054,2.740733080202674
Tm87-16,9926054,1.142722518421256
Jurkat,54618305,4.560601689877131
WM1799,136227924,5.317137472440357
SK-N-FI,135421197,0.4390653325388048
UO-31,1566236,1.6794024876094742
TE-4,12003241,-0.733911012282654
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
FaDu,135421197,1.369051763273762
SNU-C2A,100016,6.499335908465164
SEM,65628,2.5869900174043647
KMRC-20,100016,7.210629640241846
BCP-1,JQ-1-carboplatin (1-1 mol-mol),0.3849655191585445
RCC10RGB,135421197,4.393109316582631
JHH-4,10296883,4.085569000531024
SNU-201,11404337,0.8622736318146181
HMCB,9911463,4.262652850494811
BT 440,4705,3.213211271406504
DU145,71751553,4.612532696139562
HCT 116,3854666,3.4772433391395827
KYSE-520,9915743,1.755136902967863
KMH-2,11152667,-1.1792266264119935
HSC-3,11152667,0.7686574426782067
Hs 611.T,65628,3.4812835817833183
CHP-212,2742550,3.525103629838529
NU-DHL-1,9868037,1.5827566273106026
Pfeiffer,10322450,2.3368906147857693
Capan-1,2742550,4.040805186459864
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
NB1,12003241,1.4891548799263434
BICR 16,135984461,4.382455604132067
L-363,11404337,-0.847854507325903
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
T84,11404337,-0.6580973567556256
G-361,73707386,3.203260265102939
MOLM-6,9926054,1.5702726782081282
YH-13,1566236,1.6600939078751014
BT 231,9935249,0.8788796020104754
KMRC-2,2742550,3.727908257312414
BFTC-909,9868037,3.24226767674478
NCI-H69,65628,4.288655327852399
SK-MEL-30,54618771,0.8383532620392692
786-O,135421197,1.9891121265690648
TC-71,9884685,0.722756540979205
NCI-H1105,3465537,1.3223684650477756
NCI-H841,11494412,-0.8697727818940187
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
SK-LU-1,JQ-1-carboplatin (1-1 mol-mol),2.4628830674055933
HEC-1-B,54618771,2.2656883390933342
HCC202,136227924,3.1235993915196723
HH [Human lymphoma],2746,1.0745261144361813
BT 216,selumetinib-GDC-0941 (4-1 mol-mol),3.6929291774805177
PE/CA-PJ49,11494412,-0.4920931569097222
SNU-213,136227924,3.1812992174761696
U266B1,6918638,-0.6016513516102697
NCI-H2087,9884685,1.9812992127779516
HL-60,10296883,3.84878644864352
Hs 294T,9915743,2.0387924348275734
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
TT2609-C02,9884685,3.4868790724366425
Kasumi-1,9935249,-0.4567187201555336
BT 112,11404337,-0.2767075951827175
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
OE21,49836020,4.665936469802933
Daudi,6918638,-1.8107043721369585
HCC1428,71751553,5.401847453673522
NCI-H838,1566236,2.1277007205357275
CAL-12T,selumetinib-vorinostat (8-1 mol-mol),3.341411110328655
KMBC-2,49836020,0.1766293750985906
BICR 31,54618771,0.3365869204450262
MES-SA,9915743,3.475302692532233
Mino,9915743,-0.1014414753917248
CAL-148,9926054,1.1690943917504333
NCI-H727,9935249,3.73205967923935
BT-20,44241473,4.955734709190799
BICR 56,4705,0.1068986630843261
Hs 729.T,136227331,4.519931514074803
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
MOR/CPR,9911463,3.708088966162912
LS180,100016,6.005443229591697
SNU-1033,9935249,2.812235160690358
BT 482,selumetinib-GDC-0941 (4-1 mol-mol),-0.4370874918517858
M059K,JQ-1-carboplatin (1-1 mol-mol),1.2153984105475986
TCCSUP,9935249,4.183000192911627
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312
SNU-878,selumetinib-GDC-0941 (4-1 mol-mol),0.5330473997899833
T-47D,135421197,1.1997772280694294
SK-ES-1,JQ-1-carboplatin (1-1 mol-mol),1.3011647537174793
G-361,9911463,3.257776789856645
Caki-1,selumetinib-vorinostat (8-1 mol-mol),3.758908188315328
NALM-6,24779724,4.859133768812742
EBC-1,JQ-1-carboplatin (1-1 mol-mol),0.4045548074723116
BICR 16,71751553,4.300063763079023
HCT 8,9868037,4.173444279573331
NCI-H1341,71751553,3.937953220570689
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
Panc 08.13,9915743,2.266213209948084
EJM,54618771,0.5366367501744294
TOV-112D,136227331,4.785922428339521
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
NB4,9868037,2.03614451589969
HCC1171,11404337,-0.0693231628102016
KP-N-SI9s,3854666,0.8601282293978239
GI-1,11494412,0.5016309927416697
HEC-251,135421197,1.306349279370071
SCC-25,136227924,2.958495944269512
LC-1/sq-SF,54618771,0.7298922583446973
OS-RC-2,136227924,4.587923384885118
DMS 114,2742550,4.758631670542552
MOLT-3,9926054,1.73923619089024
WT2-iPS,selumetinib-GDC-0941 (4-1 mol-mol),0.0160943327982104
MOLP-8,136227924,1.5113872866650588
GP2d,JQ-1-carboplatin (1-1 mol-mol),1.3751792778879013
C2BBe1,136227924,2.0906474270390656
IGROV-1,24771867,1.9944882740161016
BT-549,9926054,1.9687680834705423
CAL-62,9926054,1.583748031587333
SNU-1033,9915743,1.252454153580825
TT2609-C02,9926054,1.870565341301735
SNU-489,650361,3.775081020904096
IGROV-1,24771867,1.9944882740161016
Hs 578T,11494412,1.776688404069291
HCT 8,9926054,1.7590637787808916
BT 179,9935249,3.0053860414976135
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
BT-12,71751553,4.308313811110702
PE/CA-PJ49,6918638,-0.873109094603626
HuT 78,10296883,2.429678266579514
MIA PaCa-2,54618771,1.4864580952045414
TF-1,100016,6.442708110888471
NCI-H2141,9926054,1.978492871362738
HuNS1,11494412,-0.2614588159632262
JM-1,9926054,1.6867956204893688
PaTu 8988s,135659046,3.7225208809385073
Ri-1,9926054,1.5974379061435915
KO52,6918638,-1.0658834160946808
A2780,100016,4.757543521992015
NCI-H1915,10296883,3.8603336548286498
ALL-SIL,24771867,-3.516684419884963
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
NCI-H661,9911463,3.595935737335879
MOLP-8,6918638,-1.572747132532541
DLD-1,9926054,3.0182242883731516
ChaGo-K-1,54618771,2.4705381408155183
BV-173,9935249,1.1911732484782378
TT2609-C02,2742550,4.340338597954281
LN-229,9926054,2.0012507920531206
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822
TOV-21G,selumetinib-GDC-0941 (4-1 mol-mol),3.592857274356158
NB4,135984461,4.636533285990447
LUDLU-1,54618771,1.3669770958947776
HEL 92.1.7,54618771,1.044267286847691
HDQ-P1,9926054,2.660031643800519
NCI-H1568,12003241,-1.4870303892505918
JIMT-1,9926054,3.6367846725262543
Hs 888.T,9911463,4.2898422169426285
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
PK-59,9915743,1.423625885080464
G-401,135659046,3.5574575455214608
LN-18,12003241,2.3352832275998927
NCI-H1341,12003241,-1.9101542939935303
Hs 888.T,12003241,-1.970204906844497
TE-5,136227331,4.141551967030233
KMM-1,73707386,2.6585902947393216
LS123,10296883,3.5438428207771495
SCC-25,49836020,1.4878182873068626
Aska-SS,54618771,0.6758112733038071
RKO,136227924,3.256787131627037
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
G-361,44241473,4.869528897645944
AML-193,11494412,-0.7844966821773789
TE-15,JQ-1-carboplatin (1-1 mol-mol),0.1114942232553469
Capan-1,54618771,1.2966911040963736
LoVo,65628,4.171555925906434
ALL-SIL,100016,4.099229681419155
UACC-257,136227924,2.920939130155667
GDM-1,54618771,1.3683939355818997
LN-18,135421197,2.222908154028884
JeKo-1,2746,1.6598198436915612
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
Hs 746.T,100016,6.2249168538435
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
OV-90,selumetinib-vorinostat (8-1 mol-mol),0.8269808058743753
ST486,9884685,0.3011062845226507
SNU-1079,JQ-1-carboplatin (1-1 mol-mol),-1.464930217070614
DOV13,11404337,1.060894937445875
LS1034,12003241,0.7423322156732435
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
SET-2,selumetinib-vorinostat (8-1 mol-mol),0.6611589487965128
NU-DUL-1,JQ-1-carboplatin (1-1 mol-mol),-0.6986861691391648
ST486,135659046,3.2413267660830316
KMRC-2,54618305,4.826508920504646
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
MHH-CALL-3,selumetinib-vorinostat (8-1 mol-mol),2.880180263090181
LK-2,11152667,1.1499971917861662
SET-2,3465537,3.762273356710905
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
SNU-475,10296883,4.244707148014393
HCC2279,JQ-1-carboplatin (1-1 mol-mol),3.2942402482720707
SH-4,54618305,4.155942321597448
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
TCCSUP,65628,5.421928358435332
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
Rh30,136227924,4.165333500464175
HCC1419,11494412,3.802636442485394
EFM-192A,11404337,1.8904479261466252
Mono-Mac-1,3854666,0.6969728274023116
SJSA-1,9868037,3.601599013312942
OE19,6918638,0.8601306195335003
SK-MM-2,9884685,0.3555545930345702
HCC4006,1566236,2.9393966315563076
T84,11152667,-1.571698746124204
SET-2,11152667,-2.526707061700353
NCI-H810,selumetinib-GDC-0941 (4-1 mol-mol),2.904538887533327
NB4,9926054,1.6278742802322663
OPM-2,9935249,1.874633336412032
HCT 15,JQ-1-carboplatin (1-1 mol-mol),0.2733719637316636
HCC2279,135421197,3.588174017039921
KM12,9926054,1.9213576714139085
NCI-H2172,11152667,1.0620592795126853
CCK-81,136227924,2.050553135971544
JL-1,9911463,4.108881360453434
KMS-20,40482356,4.999111533237927
Hs 746.T,24771867,4.231120208949857
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
BT 416,136227924,3.4255307271180726
KE-37,10322450,3.174319565832949
HCC44,49836020,-1.9143926504163185
CCF-STTG1,54618771,4.049347271840678
U-251MG,136227331,3.886496175618068
MDA-MB-157,24771867,-2.9284017086321197
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206
CCF-STTG1,10296883,4.282837475963798
Pfeiffer,136227331,3.814394552258677
KG-1-C,54618771,0.7082793216949752
OUMS-23,selumetinib-vorinostat (8-1 mol-mol),2.421949754069272
NCI-H1869,4378219,1.9871738842268776
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
NCI-H1341,49836020,4.324192381476246
RT-4,11152667,0.7569607325973031
MOLP-8,2742550,3.824247044326815
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
CHP-126,54618771,-1.2207824703172212
A4/Fukuda,24771867,-3.7385177445932585
JHUEM-1,9935249,3.046679227327208
NCI-H211,9884685,-0.7968734906992008
Kasumi-1,135984461,1.8896899929854232
BT 498,11494412,3.6640895055137017
A-172,9884685,3.4220600168976008
HMC-1-8,9926054,1.7153047636867798
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
LP-1,65628,4.349583792779986
SW48,9915743,2.691515978939234
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
BICR 22,6918638,0.0558003797401064
NCI-H889,11152667,2.2627288939831214
HCC1833,9926054,1.8132192248663452
NCI-H2081,4705,3.121794828383862
HeLa,54618771,0.9271666044907572
SR,9915743,2.3691370724807985
SUP-T1,9911463,3.1631435618556827
BT 112,9926054,1.759668872476805
ST486,100016,6.384120256869386
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
MDA-MB-231,24771867,3.614905857257698
NCI-H2196,4705,3.044507714028595
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
DMS 454,JQ-1-carboplatin (1-1 mol-mol),3.538784914005209
U-BLC1,135659046,3.900294549540867
TE-11,100016,3.880053912311749
HCT 15,9884685,1.036755619748056
A3/Kawakami,9915743,1.8122427094959257
SF268,54618305,6.182660593063807
QGP-1,9911463,4.188188217183116
LUDLU-1,24771867,3.754802815691078
Panc 02.03,9935249,3.920507280118285
SU.86.86,10322450,5.077156891369805
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
TE 441.T,2742550,3.688066908856028
Kelly,2746,1.4763853988158775
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
SNU-201,136227924,3.0451171975506903
JHH-4,1566236,1.7106073845324858
LN-18,11152667,-1.441877874591565
COLO 678,135421197,1.7545986410246563
SK-MEL-5,11152667,1.6641946386501631
Lu-65,9884685,0.6868572515984375
SW1990,135421197,2.4673652362446887
NCI-H647,135421197,2.605948730624533
HT-1376,9926054,2.913590047827676
HT-55,10296883,3.42762863324558
MOR/CPR,selumetinib-vorinostat (8-1 mol-mol),2.4234354673770317
COLO 792,10322450,2.61287912809147
KP-N-SI9s,136227924,1.797924144791439
SF126,9911463,4.3238091091620525
NCI-H1299,135421197,1.297843636132371
Hs 822.T,selumetinib-GDC-0941 (4-1 mol-mol),4.199779090816491
HCC202,54618771,2.3790685785467964
HOP-62,54618305,4.329207399796136
ST486,136227924,1.8715049257554837
LOX-IMVI,100016,4.319089113839007
Kasumi-2,54618771,-0.6876381814105375
A4/Fukuda,3854666,-0.0838776105349313
JURL-MK1,10322450,3.220647204131025
IPC-298,54618771,-0.94588727453768
SNU-5,65628,4.310461356065421
NCI-H2122,9911463,3.941857850856705
GCT,2742550,3.4044184901576124
BT-20,168313307,4.416530392456532
769-P,135984461,1.7373161428714323
SNU-C5,54618771,0.8135546853425193
HCC95,44241473,5.218917018825289
Hs 578Bst,11404337,-1.6472861367813505
MV4-11,65628,2.0068612845632137
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
EKVX,6918638,2.279509875261518
TE-15,selumetinib-vorinostat (8-1 mol-mol),2.423276654507223
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
JHOC-5,135421197,3.377612264303829
BT 245,12003241,-0.4272477548788383
RD,1566236,1.443604472261318
KYSE-30,24779724,4.458734114330223
G-401,3854666,0.6606077023561356
KNS-62,9884685,1.806452906595739
Panc 03.27,6918638,1.3027265452400043
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
P12-Ichikawa,11152667,-2.1243820214829925
Lu-65,71751553,4.665406208764287
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
HCC44,selumetinib-GDC-0941 (4-1 mol-mol),-1.5745455752339166
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
NCI-H522,9915743,1.083108246388964
OAW28,9884685,1.3567472374362477
Hs 611.T,9911463,2.4472090052981104
SNU-216,9884685,-1.507922407291845
BT 248,11404337,-1.3909400551472375
NCI-H460,9926054,2.081701465030928
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
NU-DUL-1,selumetinib-vorinostat (8-1 mol-mol),-0.8061860485308271
Tm87-16,6918638,1.685877377601704
NCI-H650,9915743,1.7401502562987152
EFO-21,10322450,5.02193128329613
EKVX,4378219,6.123152451297636
NCI-H889,JQ-1-carboplatin (1-1 mol-mol),5.709235070199913
42-MG-BA,9926054,1.7568260355296932
TYK-nu,12003241,-2.574649573149326
BT 139,4705,1.2736947517063846
LOX-IMVI,71751553,4.503158231702006
HCC1419,4705,1.9049721189242583
DOV13,9911463,3.6581619709101383
HT-1080,3465537,3.2149756579803404
PC-3,2742550,4.163134998379986
AN3-CA,12003241,-2.637522524679412
L-540,11152667,-1.9469048056861156
A-253,9915743,1.8509292893724236
PC-14,12003241,-2.6584563263219203
MPP 89,11152667,-2.4400346442017833
JMSU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3740828564312233
HCC202,135421197,1.3435596040644655
NCC-StC-K140,24779724,4.87573915744582
ZR-75-30,9911463,4.362849921974398
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
BT 271,12003241,-0.5875601678545488
PE/CA-PJ49,135984461,4.387949775407799
SaOS-2,65628,4.208345318362158
MHH-CALL-4,2746,0.6611792988086074
Hs 839.T,100016,7.045878686884313
CAL-29,12003241,-0.9586511485623302
RPMI-7951,2742550,3.350018850838408
CCK-81,135421197,1.1239650919721589
WM983B,54618771,1.7213296960323683
SW48,11404337,-1.6842588085779022
GA-10,4705,2.180825520695711
EC-GI-10,selumetinib-GDC-0941 (4-1 mol-mol),2.251648827392905
BT 422,135659046,4.905108449533952
BT 147,71751553,4.775890846508256
TUHR4TKB,selumetinib-vorinostat (8-1 mol-mol),2.39126332276638
KMS-18,9911463,3.17333222126381
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
MDA-MB-468,136227924,1.762243520931147
A-172,11494412,1.9795109251160852
NCI-H1341,44241473,3.201366495333106
KNS-60,11404337,-0.460790888098764
OVK18,11152667,-0.6962973198109103
NUGC-3,9915743,-0.9717204559547163
Kelly,135398744,7.079466503802849
Panc 08.13,135984461,4.38718124814828
JeKo-1,9926054,1.771855949205148
BT 482,12003241,-1.3288470463834767
IGR-39,10296883,4.067420766140578
TE 441.T,3465537,1.109247742302779
SNU-466,65628,3.880758058928387
BFTC-905,9926054,1.624797844745876
Lu-65,9926054,1.7186862089776234
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
Panc 05.04,selumetinib-GDC-0941 (4-1 mol-mol),0.8434992349336349
SF539,136227924,2.8154987155907905
MDA-MB-157,135984461,1.8807242402896556
SNU-245,54618305,4.280035674003469
SNU-449,1566236,1.8764566240908545
COR-L95,11494412,1.7619372096243109
KMS-11,24779724,4.338886383407692
DBTRG-05MG,11404337,1.1943390639472689
NCI-N87,9926054,1.7069639615174013
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
KE-39,71751553,4.448067406832394
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
CAL-54,9926054,1.984720179187459
SNU-878,135421197,4.562979063002288
RPMI-7951,selumetinib-vorinostat (8-1 mol-mol),2.1108488039083775
GaMG,54618305,5.206463564133868
C2BBe1,selumetinib-GDC-0941 (4-1 mol-mol),0.2357334763777015
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
D283 Med,9884685,0.4652080192462777
NCI-H526,73707386,2.1101105290421485
TT,9935249,3.4910310127288073
Ki-JK,54618305,4.056978478089845
HLF,10296883,4.080114065573622
TE 441.T,10296883,4.028933328577424
NU-DUL-1,10322450,3.4880509453639763
NCI-H1869,9911463,4.397307517913515
JK-1,135984461,2.6256690501392717
SNU-503,9935249,5.308308259709731
K-562,11404337,1.5978316825317844
A-172,11404337,0.9074451848226016
U-937,9911463,3.0033248654394944
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
UM-UC-1,6918638,0.4127396353013411
VCaP,10296883,3.8501012850712137
HCT 15,selumetinib-GDC-0941 (4-1 mol-mol),0.3162595465665505
HCC4006,10296883,4.182376901779113
SUP-M2,9884685,-0.7258224085380136
Ci-1,12003241,-0.8991759784993727
DK-MG,3854666,0.8707231532991512
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
DU145,9935249,3.749003876346386
HEC-6,135421197,3.631820052963688
JJN-3,1566236,1.40984776427009
KHM-1B,11152667,-2.085888250346346
Hs 888.Lu,4705,3.630552951351385
KMBC-2,9884685,1.520589448798377
CAL-54,9911463,4.0925396787823685
GSU,136227924,3.064976264970486
YD-10B,136227924,2.2440881554064105
KM12,4705,2.9738555795227093
NCI-H838,9911463,3.605104029249328
NCI-H1581,44241473,4.3098222458352256
QGP-1,3854666,3.072510284410307
UACC-257,3465537,2.953755053311969
EKVX,3854666,3.2297546672389243
JM-1,71751553,4.311473922741218
DV-90,9884685,0.8758663515713847
A-253,3854666,2.445612996132141
BT 164,10296883,4.081572415093264
NCI-H929,65628,3.950811987229233
SK-N-SH,9884685,0.674262884402922
NCI-H1694,100016,6.457618599357896
FaDu,136227331,3.76397674876245
EN,9911463,4.4052301302232415
Hs 852.T,JQ-1-carboplatin (1-1 mol-mol),1.014033031882682
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
JHH-1,100016,6.434861287132587
SK-BR-3,11152667,-3.133407190107384
2004,2742550,3.45905626352143
NH-6,54618771,1.535066774557613
HEC-6,selumetinib-GDC-0941 (4-1 mol-mol),2.6580781853062887
KMS-12-BM,49836020,4.363885927749537
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
NCC-StC-K140,136227924,1.8113931494957989
Aska-SS,9911463,4.275261976243402
SNU-387,1566236,3.889303411236744
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
WSU-DLCL2,49836020,-5.951866834778445
GaMG,135421197,1.593389235572815
HT-1080,136227331,3.9777239464002223
Kasumi-1,11152667,-6.314892495387823
GSS,135984461,1.9439618887139551
CCF-STTG1,2746,3.7135967128071385
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
HCC2218,65628,6.436563943794135
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
J82,10296883,4.03825923249178
Hs 688(A).T,9926054,3.3187342382489255
HGC-27,6918638,0.210335220598235
CW-2,10296883,4.166950774210748
EKVX,54618771,-0.0209843896322389
Hs 746.T,9884685,-0.72643676564829
BT-549,6918638,1.3825585614023566
IST-Mes1,54618771,0.8929247318821524
ECC10,1566236,1.6584200154088518
BT 139,selumetinib-vorinostat (8-1 mol-mol),4.048057418215767
HCC1195,24771867,2.893257889986404
KP-N-SI9s,9911463,3.657189132130691
SNU-503,9911463,4.508813956754841
AML-193,54618771,0.4173774880605814
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
SaOS-2,4378219,3.572923749570723
SNU-1077,9926054,3.1436307505327123
Hs 822.T,9868037,5.178466658447283
BL-70,49836020,4.386780315181427
SNU-C4,11152667,-0.8356210085556769
HPAF-II,54618305,4.6332328382766255
CAL-148,136227924,1.0972662327382037
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
Panc 10.05,11404337,0.4030412000723416
IGR-37,24779724,4.966607724183206
KU-19-19,3854666,3.1161318305167995
BT 245,3465537,3.867182511877691
DB,12003241,-2.5818700415802107
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
NOMO-1,9935249,2.770043096032674
OE33,11152667,-0.6577753900315373
YD-38,65628,4.316413155478777
Namalwa,135984461,4.336205571620734
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
HuH-28,9911463,4.067632897122288
SK-N-BE(2),12003241,-2.145069511983118
LoVo,9911463,2.8816718818913176
SNU-1105,11404337,0.7156656202798479
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
TE 441.T,2746,2.0767838467856654
ACHN,6918638,1.020041941526732
Kasumi-2,135398744,8.02054113805855
NCI-H1792,3854666,0.9694263265646962
IA-LM,71751553,4.579394980470846
HCC2935,135659046,3.704118522372791
HEY A8,1566236,2.198789562474832
NCI-H2122,24771867,4.015433571715332
M059K,10296883,4.043900698661033
KE-39,9935249,3.082096285966509
SNU-840,1566236,3.632634266236844
786-O,11494412,1.5315586966264776
MDA-MB-435S,11152667,-0.6282120536011198
MV4-11,54618305,3.9427264192697304
TM-31,11404337,0.421952078244741
RL,selumetinib-vorinostat (8-1 mol-mol),2.3848455335656347
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
A2780,65628,0.1843862993724733
OVK18,9935249,3.263802932433917
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
IM95,100016,6.474511795509729
LoVo,49836020,1.6927786584323
A-375,9935249,3.760967262961611
CAL-33,selumetinib-GDC-0941 (4-1 mol-mol),-0.2245005212599697
NCI-H23,JQ-1-carboplatin (1-1 mol-mol),0.4166506199838714
Caki-2,71751553,5.140065557527163
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
MM1.S,65628,3.725915125304722
EHEB,9911463,3.619047359567488
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416
LN-229,11404337,0.1730765836405472
TE-8,24771867,1.884227890488137
KMRC-3,selumetinib-vorinostat (8-1 mol-mol),3.1024559431165937
Ku812,11152667,-2.1041122356576127
HCC202,selumetinib-vorinostat (8-1 mol-mol),2.578552961022298
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
OUMS-23,49836020,3.7624735721332736
KMS-18,9935249,3.004576680840286
HSC-4,9884685,0.6492053944574516
L-428,10296883,3.2610580713690944
JHH-5,9915743,-1.119406504769704
A-673,2746,1.857945511282164
NCI-H1693,9911463,3.5933449659927477
769-P,JQ-1-carboplatin (1-1 mol-mol),2.198713761096946
BT 245,selumetinib-vorinostat (8-1 mol-mol),2.5548993263736235
KYSE-30,10296883,3.7447664313518767
UO-31,11494412,-0.0705899636432608
NCI-H2106,4378219,1.2446438227684664
WM266-4,65628,3.9802354121666794
SK-ES-1,135659046,3.743123640282263
LK-2,1566236,3.949906628051727
GB-1,135984461,4.369160227652603
BT 231,12003241,-1.271590527231957
SUP-T11,100016,5.673603064365157
HuH-1,100016,6.427674645277276
Mino,9935249,1.3209410835927553
A3/Kawakami,9911463,3.9596615304001745
NCI-H661,9884685,0.1767392095869446
KP-3,12003241,-0.3092638329597765
SKM-1,135421197,1.6359213938027426
NCI-H2452,9915743,1.4140850498548845
JHOM-1,9915743,4.157597716548686
A-375,11404337,-0.2038231220320669
EoL-1,76446078,1.114225331427788
Namalwa,4705,3.621778373883038
Panc 03.27,10322450,4.4639775206651295
NCI-H2171,135421197,2.0026019926205185
A-673,10322450,2.1969870036583323
OE21,11152667,-1.518661040860189
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
ESS-1,4378219,1.976133617597145
KU-19-19,11152667,0.8748891502312
NCI-H2023,9935249,3.058599334588111
OCI-AML-5,65628,3.584711118460752
PL-21,100016,4.334695208074886
HCT 15,4705,3.822514103379746
TCCSUP,54618305,5.536232511374765
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
Toledo,9926054,4.027631226191203
SNU-16,11152667,-1.4150266390059103
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
OCI-M1,4705,3.4843889260435215
YD-8,3854666,3.395603852355968
SaOS-2,71751553,4.337892909522829
JHUEM-7,100016,7.782886537779513
SNU-620,54618771,0.0782224190169237
SNU-398,9915743,1.0980624705271882
NCI-H716,24771867,-0.0340246669047214
KATO III,4705,2.4067147037992696
NUGC-4,135421197,0.9656923984345016
Rh41,4378219,2.4726350884495836
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
SU-DHL-8,selumetinib-vorinostat (8-1 mol-mol),2.6193351578085164
HGC-27,11404337,-1.4323340614808602
D283 Med,71751553,4.245405525851178
SNU-C1,100016,6.347812039507436
YH-13,136227924,2.93381240838723
786-O,11404337,-0.5189034557080271
CW-2,9911463,3.3999880147048795
HGC-27,10322450,3.112046430554876
HEL 92.1.7,135984461,3.406492111199009
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
WM1799,selumetinib-GDC-0941 (4-1 mol-mol),0.0731579232599876
DMS 53,24771867,2.2893106691874308
OPM-2,9884685,-0.7869928949425254
647V,9915743,0.3723955679086398
VM-CUB-1,3854666,0.7459181413886853
BT 159,1566236,1.632057569895571
8505C,9868037,2.6963732773492572
RERF-LC-MS,2746,3.2731211053052647
OVCAR-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.7048742493039822
AN3-CA,9926054,1.8039265956503063
U266B1,9868037,3.3366436031438034
LS513,135421197,1.126111149798444
JHUEM-3,135659046,3.4797526976334003
HL-60,9935249,1.0070236847489953
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
TE-4,11152667,-0.0224679138001448
HCC1954,9911463,3.8607019439121046
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
THP-1,54618771,0.1282958307593316
ALL-SIL,3854666,-1.067048731148745
HD-MY-Z,44241473,4.531432746353987
CW-2,4705,1.5406950136134017
RVH-421,1566236,2.764859572776919
Panc 10.05,10322450,4.07148015639342
KCL-22,65628,4.308150173969958
NCI-H2342,11152667,1.6588542110928108
MOLM-13,49836020,-0.1965532240483963
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
Reh,9868037,2.2106606169750824
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
SH-4,selumetinib-GDC-0941 (4-1 mol-mol),-0.2287581368829222
Calu-3,JQ-1-carboplatin (1-1 mol-mol),2.436391578693632
CAL-148,11152667,-0.6834238334432461
786-O,1566236,2.88270736752961
MFE-319,54618771,1.5027851162197383
MKN1,24771867,2.464440877621751
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
BT 145,selumetinib-vorinostat (8-1 mol-mol),0.8536258280861712
BT 224,11404337,0.3604838347782244
PK-1,12003241,-0.8622642153841519
SNU-668,3854666,3.728623982687201
CAL-120,selumetinib-vorinostat (8-1 mol-mol),2.2507147717347737
639V,selumetinib-vorinostat (8-1 mol-mol),4.333825603918846
HCC1143,10296883,4.463772522749199
MKN7,11494412,4.037198779666313
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
SNU-423,24771867,3.564101413967203
HPB-ALL,9915743,0.6969273375453205
NCI-H1339,54618771,2.498525802737919
GP2d,54618771,1.3284936518837778
KYSE-180,54618771,0.8276624799970426
NCO2,9911463,2.9393398457743163
COLO 678,1566236,2.5936141595100173
DEL,9926054,1.477463428719593
SUP-M2,135659046,2.724730541134964
NCI-H1666,JQ-1-carboplatin (1-1 mol-mol),-1.0019835803629806
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758
IM95,65628,5.771975961367952
NCI-H508,11152667,-1.4790798242730578
A-549,4705,3.61311120139633
JHOM-1,9911463,3.982223760363972
MDA-MB-435S,12003241,-1.2560113103811834
LS1034,49836020,4.406866434657065
UM-UC-3,100016,5.625806405184742
FU-OV-1,44487872,4.488734888040304
JHH-4,135421197,2.467716742231404
SNU-119,9926054,2.3608984923700036
Hs 895.T,54618771,2.243323536930484
G-401,71751553,4.092007605377758
Hs 934.T,11494412,1.867105540829516
42-MG-BA,71751553,4.358509915414978
WM115,4378219,1.986798403927216
MCF-7,135421197,1.272552449753212
C2BBe1,135984461,4.331505253640542
ZR-75-30,135421197,0.9431769837232008
BFTC-905,2742550,3.4288613566145356
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
HEC-59,selumetinib-vorinostat (8-1 mol-mol),2.380555243275298
HH [Human lymphoma],6918638,-1.7974497688929272
PaTu 8988s,9884685,3.7069578425529257
SF539,11494412,-0.7610024681264586
OCI-Ly10,54639665,5.195826059453437
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
SEM,9926054,1.3281424685311425
UACC-812,135421197,0.8848266315498433
JHUEM-3,1566236,1.872999267753902
NCI-H2342,JQ-1-carboplatin (1-1 mol-mol),1.5439939655053172
SEM,2746,-0.0565030951113346
BHY,9911463,3.455291934456847
OV-90,1566236,2.845542775636685
SNU-8,4378219,2.1792585601727468
NCI-H1341,76446078,4.166684786032972
HD-MY-Z,100016,6.5820470291511555
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
P12-Ichikawa,2742550,3.252408328818169
VM-CUB-1,9884685,0.5597863495737894
MM1.S,100016,6.180279624553647
ALL-SIL,11152667,-2.075218964097288
DU4475,3854666,-0.0986482056543338
NCI-H650,9926054,2.0416939641657175
HEC-265,11152667,1.5972160577959365
KNS-81,9926054,3.3411524859237196
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
UM-UC-3,2742550,4.216415771783444
BT 340,9926054,4.031759543162761
HEL,54618771,0.7283869495698151
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
SBC-5,9926054,3.0567796435466628
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
VMRC-LCD,54618771,1.8324078419915515
JHUEM-2,136227924,1.8669676160402808
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
GI-1,11404337,-1.291312367049636
HCC1954,54618305,4.294285323035425
JJN-3,10322450,3.7003001259189903
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
ECC10,2746,0.8272304201141983
Fu97,selumetinib-GDC-0941 (4-1 mol-mol),0.7041233813460074
KU-19-19,135421197,1.2163789616721166
SBC-5,9911463,4.310936662946409
HOP-92,9884685,-0.9123746680711942
BT 232,11152667,1.540463264489362
FaDu,71751553,4.416066442268583
DOV13,11152667,-1.0068890418824286
MPP 89,JQ-1-carboplatin (1-1 mol-mol),2.0529863800316
Panc 03.27,9911463,4.350526382797422
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
PE/CA-PJ15,3465537,1.6564118127840195
BT 428,9935249,1.746513548919668
HCT 8,9911463,3.550140199778626
TF-1,135659046,3.556796547128311
SNU-478,9915743,-2.1915037699834863
LOU-NH91,9915743,1.51930479588737
GDM-1,9926054,1.958570414824769
PK-45H,54639665,4.450076753179179
RD,49836020,4.595069513532316
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
SUIT-2,135421197,1.9421505415119584
Ci-1,3854666,0.556588581107643
RVH-421,10322450,7.0717457529323875
Panc 03.27,9926054,1.7808185952102251
HOP-62,4705,3.552280933872326
NCI-H2087,44487872,5.468068577588152
BT 112,54618305,3.877432993303292
BT 131,6918638,1.6036373067765148
FaDu,11494412,4.222913714689007
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
EoL-1,4378219,2.030770464720386
COLO 320,9884685,-1.3641958570159751
SIG-M5,9884685,0.6191669126899408
HCC78,9935249,4.286479592386118
LS123,54618771,1.1296400370948565
Lu-99,11404337,-1.2042664696883392
KMS-11,11404337,-0.8094185492018079
GP2d,3854666,0.4643191826857844
PaTu 8988t,135421197,1.788370067257354
VM-CUB-1,136227924,2.7643713240945016
NCI-H2172,9911463,3.8994270098936745
A2058,2746,3.220065264010931
COLO 792,11152667,2.5246510568234193
Detroit 562,12003241,-1.0092858141729106
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
SW1573,65628,4.136448104244246
Panc 04.03,9911463,4.4327726522455855
23132/87,11152667,-0.9756712768346428
MFE-319,10296883,4.228563171543355
NCI-H889,2746,2.2836430328377997
AsPC-1,54618771,1.0442216511349782
FTC-133,4705,5.547028107549284
BICR 56,2746,2.65605235072967
HCC-56,71751553,4.790643666333034
BV-173,selumetinib-GDC-0941 (4-1 mol-mol),0.1025224911363418
AU565,4705,1.275846161151896
MKN74,selumetinib-vorinostat (8-1 mol-mol),2.9891343546894267
DEL,9911463,3.5570893591949932
SNU-601,6918638,1.0757828818218795
SBC-5,65628,3.417870630997437
HLF,4705,3.4184924882313372
SF295,9926054,3.0771086967152845
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865
SUP-M2,9926054,1.703022301763295
Mono-Mac-1,44241473,4.325172344907564
NCI-H1563,3854666,3.3782655568775932
BT 359,9935249,2.952600079781156
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
TYK-nu,65628,3.6002403051970733
DB,9915743,0.3856668875763299
8305C,JQ-1-carboplatin (1-1 mol-mol),-0.8214093043098781
HT-1197,10322450,2.509794666751626
BT 131,9926054,2.1358376599970397
KMS-28BM,24771867,0.8477060619723921
NCI-H23,49836020,3.049554437236292
NCI-H2081,3854666,0.2078847774714705
SCC-9,12003241,-1.125345709331217
HCC2279,11404337,1.1407968347244497
42-MG-BA,24779724,4.9915900210245105
KMRC-2,6918638,2.530608433892335
TOV-21G,3854666,2.2368280986346387
MFE-296,1566236,1.6615174208061805
T24,9915743,2.484963977138841
LUDLU-1,6918638,0.1404084517596252
VCaP,54618771,1.0243470535164156
NCI-H2228,12003241,-0.7511130172017173
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
JJN-3,2746,1.639686724346065
A-498,135421197,2.4500558267656873
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
SW1353,44241473,4.4186959651454565
SW948,9935249,-1.8483271913214137
A-172,136227924,1.9508876589720905
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
SK-LMS-1,4378219,1.9539135587059129
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
OAW28,11404337,-1.5682838378564492
THP-1,2746,1.8092224588916963
SIG-M5,135659046,3.608194247499591
HCC4006,9884685,1.1563651228927987
MES-SA,10296883,3.8748644308488864
KYSE-150,9935249,3.2107723044305185
KMH-2,3854666,0.5486625704198924
FaDu,9915743,0.0595730562348672
BT 320,6918638,3.210777195522013
HOP-62,1566236,4.388769459301917
Capan-1,2746,3.367877422922766
A-549,11152667,0.4045052003861268
NCI-H69,JQ-1-carboplatin (1-1 mol-mol),4.253677409086092
LS123,135984461,1.5979297518000015
Hs 683,11152667,-1.390521313969312
MDA-MB-361,12003241,-1.091645986643679
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
TYK-nu,selumetinib-vorinostat (8-1 mol-mol),2.6103059793632246
SUP-T11,73707386,1.4307849373586292
Granta-519,3854666,0.1662242620713641
LOX-IMVI,9915743,1.7866984805438202
MOLT-3,4705,3.045598390925212
NCI-H1869,54618771,2.934235316942264
CAL-85-1,10296883,4.0142951898227155
EJM,1566236,1.0332712944799087
TALL-1 [Human adult T-ALL],73707386,2.325158531134017
HCT 116,9868037,2.1391599474791394
5637,12003241,-2.3897344760826775
A-204,9868037,2.4016455234321694
EFO-21,6918638,1.430978330266965
LS513,selumetinib-vorinostat (8-1 mol-mol),-1.1646642615707117
HT,11152667,-2.196108970099486
CAL-54,135984461,1.524237172079529
Hs 746.T,6918638,0.8539034237562276
K-562,10296883,3.719487542859837
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
Granta-519,135659046,3.900512348834848
RCH-ACV,135984461,1.5871533406295049
A-253,10296883,4.076083585934383
OCI-Ly19,136227924,2.004549918496879
SW579,44487872,4.882887167101439
PK-45H,12003241,-0.6609061403409452
C2BBe1,2746,3.6409486434648706
BT 147,135659046,3.464945185211132
SNU-878,2742550,3.061498936852825
BV-173,9915743,0.6416286379608698
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
RPMI-7951,135421197,2.3107830834906324
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
BICR 18,9911463,4.416579979715041
JHUEM-3,54618771,0.1338872502491787
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
B-CPAP,selumetinib-vorinostat (8-1 mol-mol),2.3348701814890904
YKG-1,4705,3.5798209595137247
HCC366,9911463,4.244130983157471
JM-1,49836020,4.6064946369246025
NCI-H358,10322450,3.5952188723285436
MKN7,12003241,0.0513011107794011
Kasumi-1,65628,4.818728513509837
SNU-398,54618771,-4.947778172038554
23132/87,9915743,3.213624563446712
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
NCI-H28,9911463,4.1891652273823015
Ku812,24771867,-1.2789053732108495
HEC-151,11152667,0.2545196919023241
T98G,54618771,1.1759260656480666
DMS 53,10322450,3.0772263685237062
JeKo-1,12003241,-2.1711036059300963
DB,3854666,-0.3666218398057528
SW1088,9935249,3.794327561663299
SK-UT-1,11404337,0.3155392200884543
Capan-1,10296883,4.201537501236006
A-204,136227331,3.914790015372966
DU145,9884685,1.2239638281476493
MM1.S,135984461,3.1063926235928703
RPMI-8402,9911463,3.009293370203492
MHH-NB-11,24771867,-3.972481943200715
KMS-20,selumetinib-vorinostat (8-1 mol-mol),-0.0574541449020858
NUGC-3,11152667,-0.5905276129747937
MOLT-16,135984461,1.926751672348732
HCC1428,11152667,2.498506650796191
SK-BR-3,9911463,3.827340075959426
CAL-85-1,JQ-1-carboplatin (1-1 mol-mol),0.6697793962766999
EoL-1,6918638,-2.889280053807362
COR-L95,9911463,4.18924595414168
JVM-3,135984461,4.680195748314229
NCI-H2170,71751553,4.39124421441993
NCI-H2087,54618771,-0.2190788311634532
SNU-878,54618771,0.5665140825302253
LAMA-84,54618305,4.386276896438661
HCC2279,9926054,2.352300509177514
TE-10,9926054,2.0362558072853827
MeWo,100016,6.619977613887792
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
DLD-1,selumetinib-vorinostat (8-1 mol-mol),2.6727552723054755
KMS-18,JQ-1-carboplatin (1-1 mol-mol),0.042136194628161
OVISE,54618771,1.319775250733869
NCI-H841,54618771,1.7073628985349325
EFO-21,11152667,0.2535336606337931
KP-2,11404337,1.570112378340211
BT 228,9915743,2.3964891014052943
NCI-H446,JQ-1-carboplatin (1-1 mol-mol),0.8362654932665712
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
NCI-H322,3465537,3.325986658577423
LP-1,11404337,-1.552804364872206
Toledo,9911463,4.445021234029437
HuH-1,selumetinib-GDC-0941 (4-1 mol-mol),1.7373904451201925
A-375,3854666,2.66860299543091
SNU-1214,11152667,-0.0787501334473708
Hs 729.T,4705,3.584127080125275
GCT,24771867,2.4290598695439853
MG-63,12003241,-0.4675070550973023
B-CPAP,76446078,4.324455702979326
T84,1566236,1.6536979341568203
NCI-H2444,9915743,2.889982162911787
Daudi,49836020,3.49644839546437
KMRC-3,11404337,1.0527621044793514
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
Kuramochi,selumetinib-vorinostat (8-1 mol-mol),4.455240431430057
NCI-H1568,136227924,3.032081072579533
EFO-21,1566236,2.973739256167703
MHH-ES-1,100016,6.165620846351705
MM1.S,9926054,1.5897504862532963
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
SCC-4,11494412,-1.2435861209633752
LOX-IMVI,136227924,2.635687863612288
PE/CA-PJ34 (clone C12),71751553,4.188621560003168
L-540,136227924,2.3931383545900524
HEC-265,11404337,-1.185290223880338
LS513,136227924,2.4637797835127793
NCI-H524,3854666,0.1377442015623311
BT 482,9911463,4.164033493319952
YD-8,9915743,1.4308611377432014
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
JHH-2,24771867,1.9700923170902591
RS4;11,11404337,-3.5879317876288956
Hs 895.T,selumetinib-GDC-0941 (4-1 mol-mol),2.3327892844393374
NCI-H1944,6918638,0.6118472454485641
Mino,JQ-1-carboplatin (1-1 mol-mol),-0.9180856967211396
KMS-12-BM,2746,1.2802142564618226
U-87MG ATCC,11152667,2.583459941503649
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
NCI-H2110,9884685,0.5868574340900204
SH-4,100016,6.480724052638794
NCI-H69,9926054,1.6669613133383836
CAL-148,9911463,3.7959797988422226
WM115,136227331,3.7917327546536983
KMS-27,135984461,4.260058247162953
Aska-SS,6918638,1.1582390446838242
Reh,135984461,1.6180740266430926
NCI-H2444,10322450,5.0413898485773
NCI-H322,24771867,4.2399100060797945
SiMa,JQ-1-carboplatin (1-1 mol-mol),1.754117349948639
Mel JuSo,11152667,-1.5047268130647675
U-87MG ATCC,selumetinib-vorinostat (8-1 mol-mol),4.060549041627366
HOP-92,6918638,0.7630598951940987
Kasumi-2,6918638,-1.1951505869280743
NCI-H2342,selumetinib-vorinostat (8-1 mol-mol),3.3714966194337745
ONCO-DG-1,54618771,2.377307525963503
ONCO-DG-1,9911463,3.9906358040746417
Hs 578Bst,9935249,3.016320926718586
KP-3,136227924,3.03068470875373
UO-31,9911463,3.1211940874261623
SNU-620,9935249,-0.059115681236359
NCI-H446,73707386,2.6989989368624476
HCC44,24779724,5.2401806586282085
SU-DHL-10,136227924,2.6642941314249327
PE/CA-PJ34 (clone C12),65628,4.231511653332105
Caov-3,135984461,4.111460769399049
SNU-869,4378219,2.01095059265839
NCI-H146,40482356,6.02837292181762
NCI-H1694,54618771,0.8096670876443307
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
WM115,71751553,4.133313051647094
NCI-H1915,136227924,2.449863082820113
AU565,9884685,0.3686008824574254
CAL-51,54618771,0.0049145289548569
MOLT-3,JQ-1-carboplatin (1-1 mol-mol),-0.167608830947713
CCK-81,54618771,1.3252136057849369
SNU-C1,9935249,3.148720594073001
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
KE-37,4378219,6.502959732904179
HCC1171,9935249,4.44081832650938
HEC-265,9868037,1.4639639907135185
AsPC-1,1566236,2.844580785967763
SNU-C1,9911463,2.5734182022274763
SW579,76446078,4.963577165566617
ChaGo-K-1,135659046,3.4410165185967743
KMRC-3,6918638,1.2491038866653728
BV-173,24779724,4.291946466896556
Pfeiffer,12003241,-4.957665380544675
Caov-3,100016,5.7781449283056645
NCI-H2122,11152667,-1.4729705548083307
MDA-MB-453,1566236,2.5975650319928434
BT-20,6918638,1.2073069769548774
KATO III,71751553,3.9676851594161304
MDA-MB-415,44241473,-5.271702170747327
OPM-2,9911463,3.091122447781221
MPP 89,9884685,1.0647805860804536
NCI-H2342,135421197,1.9083443664668167
DMS 114,9911463,4.412610597961803
SW1990,11404337,0.292005149466272
Granta-519,10296883,3.749738066673353
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
SNU-869,9926054,1.9894355639340104
EBC-1,11152667,-0.3627843771120927
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062
FaDu,10322450,3.9560507258071422
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
SUP-B15,100016,6.907261874504965
Rh30,JQ-1-carboplatin (1-1 mol-mol),0.2476583684107503
BT 232,4705,3.775264883664604
SNU-1272,24779724,4.452113053156204
BT 422,6918638,3.528900316043955
HGC-27,3465537,1.8864187021975392
COLO 800,54618305,4.447513462605581
NCI-H1155,2742550,3.5148462774904368
BT 164,4378219,2.002940552188762
SW1783,2746,4.238030101530504
BT 228,65628,4.442361591085553
LOU-NH91,12003241,-1.4006618643370652
REC-1,1566236,3.018034053127421
HEL 92.1.7,11404337,-1.5262741770805954
NCI-H2452,9926054,2.7849990975548726
Karpas-299,100016,4.52969889794102
Mono-Mac-1,2742550,3.3470269848726004
RT-112,9911463,3.6857409910721337
MHH-NB-11,11152667,-1.8020603345616932
AN3-CA,1566236,1.2128002285671464
YAPC,135398744,6.484368053683043
HCC202,12003241,0.4259304556953664
HCC1195,9911463,4.371247220655063
SU-DHL-1,9926054,1.6936537424309908
NCI-H1563,9911463,4.06391181051362
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
JeKo-1,135984461,1.9350471702678365
HCC1419,selumetinib-vorinostat (8-1 mol-mol),2.8318655126254986
HPB-ALL,selumetinib-vorinostat (8-1 mol-mol),2.369639737776143
A4/Fukuda,10322450,2.3588003127389277
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
HEL 92.1.7,JQ-1-carboplatin (1-1 mol-mol),0.0305344247994576
VM-CUB-1,12003241,-0.6809659848466374
NUGC-4,9915743,-4.1416967256258275
DMS 114,135398744,6.443015881513616
SK-N-MC,9884685,-1.1337198062003164
U-87MG ATCC,3854666,3.5140340927241267
LS123,JQ-1-carboplatin (1-1 mol-mol),4.3726195228270175
COLO 678,135984461,4.384387771979114
GDM-1,136227924,3.363011715884638
UACC-62,11152667,2.4715685672767465
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
BT 422,4705,3.053482831247426
NCI-H1755,135398744,6.361982871837632
Panc 05.04,11404337,1.2043196407136412
HSC-2,11404337,-1.7488575927200145
RL95-2,3854666,0.9415814942039398
TE-5,1566236,1.810150930428808
MSTO-211H,100016,4.243846732059744
DV-90,135659046,3.4000463050083582
NCI-H322,11404337,0.5054322511135948
COR-L47,9926054,1.681825446292649
SNU-1,1566236,1.7318278950694468
Becker,71751553,4.672382658610356
HuH-1,135421197,1.8778683670700504
BT 286,9915743,1.1038828678808648
NCI-H23,24771867,0.1110003974420956
P31/FUJ,136227924,2.3905530687579497
RCH-ACV,9911463,3.0164495694829903
NCI-H522,10322450,3.5945001970925787
A-549,2746,4.106748757541722
MKN74,12003241,-0.9650452844715884
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249
HuT 78,135421197,0.0616295171222303
KMS-21-BM,9911463,2.539829104515626
FTC-238,54618771,3.2424899672946195
A-673,10296883,3.758044639987347
NCI-H2170,4378219,6.495671400395324
MKN7,3854666,3.49207359928349
U-937,selumetinib-GDC-0941 (4-1 mol-mol),2.5351871004530713
TE-14,6918638,0.7581256744070354
SUP-T1,JQ-1-carboplatin (1-1 mol-mol),-0.4695857122816443
NCI-H1944,9926054,1.887577830316648
GP2d,135984461,3.863711386365813
OVCAR-4,9911463,3.705471110886421
SW1271,12003241,-1.4062779923685875
RCH-ACV,49836020,-2.2684832321475774
KYM-1,54618771,0.695388101268428
VCaP,2746,1.3458949391757813
SNU-601,9868037,3.788839029413147
TE-1,9935249,3.915142612487917
BT 482,selumetinib-vorinostat (8-1 mol-mol),1.0923581719220932
SK-N-DZ,selumetinib-vorinostat (8-1 mol-mol),1.2861910244827397
NCI-H2110,9926054,1.839297705521365
DEL,9884685,0.9674911622434976
COLO 678,136227924,3.6500617296173288
TF-1,9935249,1.174824623802912
UACC-257,135659046,3.626518059791559
KMRC-3,10322450,5.943320377485073
C2BBe1,11152667,0.0079172533868618
BICR 22,10296883,3.888864516393213
OE21,11494412,-0.1422694910703912
AN3-CA,10296883,3.730893077527662
OCI-Ly10,1566236,3.348368105621456
F-36P,2746,1.451851668810028
MKN7,6918638,1.0804402687871355
NCI-H1341,136227924,2.213362476241057
GMS-10,4378219,1.971646344070652
KYSE-510,136227924,3.267869272747249
SaOS-2,135421197,3.6760992974277817
HMC-1-8,selumetinib-GDC-0941 (4-1 mol-mol),-0.1007905970017958
JL-1,100016,8.572446789328106
Ki-JK,selumetinib-GDC-0941 (4-1 mol-mol),1.348149232454661
SaOS-2,136227924,4.496792726095474
HuP-T4,24779724,6.099439934888711
HEC-108,136227924,3.134071919213167
2004,3854666,0.9594440338227248
HCC38,9926054,1.7712684565891563
A-172,49836020,6.443724072404216
8305C,135984461,1.979761055337833
Hs 294T,10296883,4.084911728329476
MOLT-16,49836020,4.026167262908274
EPLC-272H,4378219,1.9089225807496908
CCK-81,9926054,1.6277365454540644
TCCSUP,2742550,3.882646249663198
THP-1,2742550,3.28458957438955
WM115,11152667,0.9737214532192616
U-118MG,24771867,6.335242847488958
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
UO-31,135659046,3.3569813740472267
VMRC-LCD,1566236,2.051225388786631
CCK-81,4705,0.3214356139711527
NCI-H2286,selumetinib-GDC-0941 (4-1 mol-mol),2.0876737367962495
MCAS,135421197,1.955288267695935
COLO 680N,11152667,0.9012324673098332
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
K-562,49836020,4.414855158615189
CL-34,3854666,0.1027491710141273
MDA-MB-453,3465537,1.8912554302439897
TCCSUP,9926054,2.5470676869748763
TE-10,44241473,5.586280691717314
NCI-H1693,3465537,1.3413238246383017
CHP-126,11404337,-0.8425306912863763
OE19,12003241,0.3915460727280876
HEC-1-A,9868037,3.1210515206348246
FTC-238,100016,6.441740826290021
AN3-CA,11494412,0.238688631284878
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
HT-29,selumetinib-GDC-0941 (4-1 mol-mol),2.4520768151927976
BT 164,6918638,0.5981127471787415
PE/CA-PJ49,9935249,3.146155709540263
SIG-M5,3854666,0.6952699424052499
KYSE-520,54618771,1.6405254882986982
VMRC-RCZ,selumetinib-vorinostat (8-1 mol-mol),3.888432832731119
G-402,71751553,4.275452856729738
COLO 699,11404337,1.232943062942203
BT 239,65628,2.367518289741246
JHOS-2,10296883,4.146882384876985
BT 187,12003241,-0.5243066739913107
BICR 6,100016,5.983099357165641
T98G,JQ-1-carboplatin (1-1 mol-mol),2.716924678196497
G-361,11404337,-0.7972280561087973
NU-DUL-1,2742550,3.078844862941076
KE-39,9868037,3.621529869698051
NCI-H841,1566236,1.6695329258140523
JURL-MK1,selumetinib-vorinostat (8-1 mol-mol),-1.5392481517810297
NCI-H2196,2746,3.7981769416630193
HL-60,44487872,5.591140774264588
Peer,135421197,0.5765613346520675
KMS-27,73707386,3.821733041812712
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
NCI-H1651,9868037,4.401411250995596
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
CAS-1,9915743,1.3093689847422858
TALL-1 [Human adult T-ALL],3854666,1.0059352605145684
JJN-3,44487872,5.329764604860554
SW1573,135421197,1.3915330004591782
OCI-Ly3,9926054,1.7075624586647575
CGTH-W-1,9884685,1.4891158923193792
LMSU,1566236,2.090789851327695
COR-L105,11404337,0.9270352493146456
HT-1080,3854666,0.7314496106684282
J82,54618771,2.0781543911386264
NCI-H322,9911463,4.3692718252233895
NCI-H322,10322450,4.379144140600869
JHUEM-2,JQ-1-carboplatin (1-1 mol-mol),1.384634873843588
JHH-5,54618771,-0.2658300379563106
Hs 766T,2746,3.89842644202364
Hs 852.T,selumetinib-GDC-0941 (4-1 mol-mol),1.139310291685008
SNU-620,JQ-1-carboplatin (1-1 mol-mol),-0.5250735139206945
KMBC-2,135659046,3.5104960306219155
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
EM-2,100016,3.5566389909433913
NCI-H1734,3854666,0.8618341531909581
MKN7,11152667,-0.2915307424688416
LUDLU-1,JQ-1-carboplatin (1-1 mol-mol),0.2520834188708127
NCI-H810,2746,1.0986608343124125
NCI-H2009,44241473,6.22803294537171
NB1,54618771,1.1360692536684358
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177
KO52,135421197,1.227280721989531
ST486,135398744,6.173673764709001
MFE-296,4705,3.3548297681801387
T84,9915743,0.6360721322539938
Mel JuSo,11404337,-0.8493423015678001
MOLT-16,10296883,2.3695958656227782
HCC1833,9911463,3.7741336364868943
SNU-387,100016,7.682207014450764
Daoy,135984461,2.2950744051926497
SK-MEL-31,9911463,4.28610993232139
BFTC-909,11152667,-0.3524603871752078
GCT,135398744,7.690422491741855
NCI-H838,selumetinib-vorinostat (8-1 mol-mol),3.9701798301910873
NCI-H2087,650361,4.093890124173705
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
K-562,135984461,3.2548026411837787
2004,10296883,3.635468664105464
Calu-1,1566236,3.658841194975484
P12-Ichikawa,11404337,-1.993052837563161
SW1417,4378219,2.099486886259409
HCC1395,selumetinib-vorinostat (8-1 mol-mol),3.6842342409301305
OE33,3854666,4.486907351479266
LUDLU-1,11494412,1.2447977541494917
KG-1-C,6918638,1.2884838473807014
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
WM115,10296883,3.9273376390568138
RPMI-6666,24771867,-2.220255222659602
BT 444,9911463,3.786370986996904
8305C,9935249,3.4966518610298833
TTC-709,9935249,1.8024072456954583
TE-4,11404337,-1.2952896861413017
KMS-26,44487872,4.333552536617936
SW982,1566236,3.274409185853836
NCI-H2291,selumetinib-GDC-0941 (4-1 mol-mol),-0.2991032125390215
BT 498,4705,4.208148450276773
DMS 53,9911463,2.8139915060011766
KMS-18,100016,3.3973864073508864
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
HOP-62,selumetinib-vorinostat (8-1 mol-mol),1.8094917487163475
Hs 888.Lu,65628,4.350003437777803
8-MG-BA,9911463,4.3776650964828985
SYO-1,9911463,4.053570521016679
Mono-Mac-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3199178680358683
Jurkat,135984461,1.8556253442912225
SNU-1079,44241473,3.793438088949652
SUP-B15,10296883,2.342173612428345
L-540,9935249,3.0305830105986
BT 482,24771867,3.9004503435640983
CAL-27,135984461,4.281831870560516
ACHN,11404337,1.842611884457436
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
U-937,135421197,1.66797552132573
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
NCI-H1385,9868037,2.914000161841284
NCI-H747,2742550,3.088890414220319
647V,49836020,-1.4541135312501283
SNU-387,9926054,2.4528482629879655
U-CH1,4705,-0.5183454701294119
G-292 clone A141B1,135984461,1.9916208334171763
SNB-75,11152667,0.9716304572958736
NCI-H929,9915743,0.0759555072139175
SNU-1,54618771,0.7827346323778329
SW579,2746,2.8077894693149017
P31/FUJ,54618771,-0.1557090961755644
NCI-H1395,54618771,3.4411900765558125
SIG-M5,2746,2.071797250841479
CAL-27,3854666,0.635835630985428
WSU-DLCL2,10322450,2.94948924271478
DU145,136227331,5.067250261949365
SJSA-1,11152667,-1.6734619502857082
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
KYSE-30,6918638,1.557418868446986
SNU-423,136227924,3.242018782370702
YKG-1,3465537,3.622087306802616
BT 147,54618771,0.8857496125783197
BT 172,11152667,0.6586522998064477
SNU-216,10322450,3.800791101615317
HCC15,12003241,-1.0460858766179792
SNB-75,selumetinib-GDC-0941 (4-1 mol-mol),0.9916175958844948
BT 231,3854666,-0.8969243562437486
SNU-719,9911463,3.4585682156791555
SKM-1,selumetinib-vorinostat (8-1 mol-mol),-1.297292884672553
MHH-CALL-4,9935249,3.1368744392379555
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
BT 504,6918638,2.3418262484979593
LUDLU-1,4705,2.2241864664767013
MKN1,9915743,2.5735660173658323
KMS-20,9911463,2.8485967740948284
CAL-51,11404337,-1.4033364127444676
NALM-6,9868037,2.034741540026143
OAW28,54618771,1.1011370240470315
MDA-MB-157,9915743,0.9957990206413116
SCC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.2085595072680022
KYM-1,9926054,1.655871413890737
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
SNU-1079,9915743,-4.016291754559019
COV362,71751553,4.353596116077162
SEM,6918638,-1.2521894984782256
UM-UC-1,10322450,4.765411515490737
ECC10,JQ-1-carboplatin (1-1 mol-mol),0.0523843610498873
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
NCI-H1355,136227331,3.624687432922337
HuH-28,24771867,1.7711464010048796
OCI-Ly10,9915743,3.628362232198514
MEC-1,selumetinib-vorinostat (8-1 mol-mol),2.147486249621255
NCI-H292,54618771,0.019803014891406
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
HT-144,9926054,1.741901669011513
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
TUHR14TKB,2746,3.3342973091296506
Becker,11404337,1.8814700373648592
SNU-489,11152667,0.659808026568522
KATO III,3465537,3.500965141259956
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
MOLP-2,135984461,5.292222187732742
Calu-3,44241473,5.665231234171089
SNU-216,10296883,4.064330575642344
COV644,135984461,4.368014985644984
Pfeiffer,44487872,4.230977727945689
L-540,9915743,0.3390225663294273
EJM,65628,4.064740748344536
G-402,2742550,3.748755543521402
HMC-1-8,136227924,3.367197210687835
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
HuH-1,selumetinib-vorinostat (8-1 mol-mol),2.367798014443328
Hs 944.T,selumetinib-GDC-0941 (4-1 mol-mol),0.0800181936999451
RPMI-8402,135421197,0.8834932639167268
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
NCI-H226,3854666,3.7383883228891746
T24,6918638,1.5098375019739547
COLO 320,135659046,3.560187032006994
OAW28,12003241,-0.542287488877267
HPAC,10296883,3.470080354686621
HT,136227924,2.3517784191427613
A-673,3465537,3.0102553460613626
BT 228,9868037,3.723299534994555
SaOS-2,2742550,4.001711578380083
MHH-CALL-3,9915743,1.3835239256634295
LOU-NH91,9884685,4.047485572984955
KNS-81,9911463,4.180814120115767
CML-T1,135421197,0.9317392273651705
KMS-28BM,JQ-1-carboplatin (1-1 mol-mol),-0.0604179663950409
OCI-M1,11494412,-0.1293133865918841
EFO-27,9915743,1.432055126276498
TOV-112D,1566236,1.6561224717543024
TE-5,2742550,3.747517930078368
SK-MEL-28,1566236,1.6963201581644038
BL-70,6918638,-1.5969799068966968
SK-CO-1,9915743,2.0474134916136184
HSC-4,10322450,4.749470049467763
Karpas-422,65628,4.69981691134154
LK-2,54618305,-5.911740174807013
NUGC-3,1566236,1.9302798040984224
DU4475,71751553,4.242765792802766
BT 328,24771867,5.867133384354764
YD-8,9868037,3.0733964994503244
PaTu 8988s,11404337,-0.6739371473320328
SUP-B15,24771867,-2.317203984498759
NCI-H196,4378219,2.689374955193756
KMRC-1,136227924,2.9529226708788734
HT115,9935249,2.785249692793322
RL95-2,11152667,-0.8669097015904319
HCC1438,10296883,4.228487573080105
KYSE-150,3854666,3.0365911002629553
CAL-78,selumetinib-vorinostat (8-1 mol-mol),2.749764405209418
BT 428,54618305,4.316661671711245
KP-3,9911463,3.5465517511972173
BT 131,12003241,0.8855020405936681
NCI-H1693,selumetinib-GDC-0941 (4-1 mol-mol),1.7777896818074843
JVM-3,65628,3.2582906367483857
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
NCI-H520,2742550,4.31238635720589
A101D,3854666,3.889882258102607
EFO-27,10296883,4.235346466258499
CAL-85-1,11494412,-0.0950460839554517
TC-71,135659046,3.771711324789507
Mono-Mac-1,9868037,1.9108517803242744
J82,selumetinib-GDC-0941 (4-1 mol-mol),2.8384419330971147
Caov-3,4378219,2.205040679536802
COLO 678,100016,6.808142270815235
TALL-1 [Human adult T-ALL],1566236,1.195576285789708
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
SNU-840,2742550,6.426027402701062
NCI-H2196,JQ-1-carboplatin (1-1 mol-mol),4.258041583976656
ECC12,12003241,-0.4991552447723122
NB1,100016,5.984902151942781
TE-5,JQ-1-carboplatin (1-1 mol-mol),0.6958191987342512
LS411N,136227924,3.1900427132689724
Capan-1,1566236,1.8786990481071677
ChaGo-K-1,9915743,2.151950733066917
ESS-1,4705,3.449305158476875
HCC1954,3854666,1.898706418770946
HLF,11404337,-1.3063321678597395
NCI-H929,54618771,0.737310556758401
MCAS,10296883,3.979435703813419
SF539,1566236,1.697367188486211
BT 224,10296883,4.270908833872631
MOLM-6,12003241,-5.9234672860619995
MOR/CPR,2742550,4.462061009820355
DMS 454,6918638,-0.5364847082053857
KE-37,136227924,2.0912429237758796
NCI-H1339,9935249,3.107250994389658
G-292 clone A141B1,11152667,0.2395732211281228
BT 179,4378219,1.984680392180732
HPB-ALL,3854666,0.8658225320961793
KMS-11,2746,1.943011072949534
Hs 578Bst,6918638,3.629464164319933
HT-1080,2746,2.8042774445835397
KYSE-510,JQ-1-carboplatin (1-1 mol-mol),4.538673492010493
BT 147,10296883,4.22717301234077
DMS 53,1566236,1.4544984078076502
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
SUP-T11,136227924,2.659905722722051
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
NCI-H446,3854666,-0.7214547473284718
MDA-MB-361,1566236,2.7545211526059643
SW1088,1566236,3.5418738685813542
COLO 792,2742550,3.342402133589489
NCI-H520,4705,3.58444135118044
KMS-20,100016,6.235059528000449
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
HEC-1-A,71751553,4.403700885127046
Hs 888.Lu,76446078,4.24840207369825
BT 179,10296883,4.29112387952489
EJM,100016,6.634092198961092
SW1271,65628,4.408026608161547
GA-10,136227331,3.9402947188121793
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
AML-193,4378219,1.2402464882131368
G-401,4705,3.1032512954578415
BT 416,11152667,0.4556152500975832
KM12,24771867,0.4549025927501815
TUHR4TKB,12003241,-0.5778416487283387
BT 216,6918638,1.5591874228981395
Hs 888.Lu,9926054,2.118592716385535
SNU-1,44241473,4.451095216051789
CAL-85-1,9935249,3.1583698268143157
NCI-H1563,9884685,1.788333404380603
KYSE-450,3854666,3.622949827534998
IGR-1,JQ-1-carboplatin (1-1 mol-mol),-0.2178346273954091
RL,6918638,-0.8458065739236997
KE-39,100016,6.665188081944046
KYO-1,10322450,3.690990391858763
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711
SK-MEL-24,9915743,1.6776285599749
COLO 792,135984461,4.281305530768826
GaMG,2742550,3.1284657448768054
BICR 22,54618305,4.315554591509874
U266B1,4705,3.88133298077809
T84,selumetinib-vorinostat (8-1 mol-mol),0.4047942108328854
LS513,9884685,0.8647679809690252
Daudi,2746,0.9195319579001202
HuH-28,JQ-1-carboplatin (1-1 mol-mol),1.577793116101398
Pfeiffer,54618771,-1.2193011849050512
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
BT-12,9911463,4.073120813742317
Lu-65,3854666,0.9157071351936018
PK-1,11152667,1.060142887302552
NCI-H1581,10322450,2.9109511498380485
TALL-1 [Human adult T-ALL],10296883,3.2857162294996933
HL-60,6918638,-0.8041494190093976
SNU-840,3465537,3.512409198925668
U2OS,9915743,-1.5669717520878548
TUHR4TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.368524394039708
BT 504,4378219,1.4407405746143198
NCI-H1581,JQ-1-carboplatin (1-1 mol-mol),3.147849134537928
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
2004,9911463,3.209931377747237
TM-31,54618771,1.840176176931743
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
NCI-H322,3854666,1.2832764839171569
P3HR-1,9926054,1.7849212389607798
MFE-296,12003241,-1.246731028560956
NCI-H841,9868037,4.373708012827469
SK-HEP-1,11404337,1.0852289139958715
NCI-H1944,100016,8.062523558454052
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
NU-DHL-1,3854666,0.0415857497138207
M059K,11494412,1.974522837526778
ST486,40482356,6.907176194464358
MSTO-211H,4705,2.457156821386339
NCI-H2291,9911463,4.278294670111937
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
SNU-8,136227924,2.992589463119238
NCI-H1693,3854666,2.669312044507388
JK-1,1566236,1.2840602067740463
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
42-MG-BA,54618771,0.7266363256889177
TE-4,4378219,5.168467235694335
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
NU-DHL-1,135984461,1.11873859248707
RMG-I,9935249,3.733298041701348
OC 314,3854666,-0.6017079238350578
BxPC-3,4378219,2.0321108717651426
COLO 668,9915743,2.0243501166827924
HEC-6,3854666,2.6571461904309723
MCF-7,54618771,-0.7262011969078179
COLO 829,6918638,1.0233016863586175
AsPC-1,12003241,0.1897400127907629
SK-N-MC,168313307,4.3685059701661215
OVSAHO,3854666,3.3934113413340663
CAL-78,selumetinib-GDC-0941 (4-1 mol-mol),2.58322288214442
JHH-5,9926054,1.852888607063122
HuCC-T1,9926054,1.7884670483643574
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
HCC1806,135421197,3.3559114199150697
OCI-Ly19,9915743,-0.208935572268568
KNS-42,11404337,1.3884544485554386
CAL-78,4378219,2.017292953212585
SW1990,71751553,4.1573307972574485
NCI-H2009,135421197,1.5480281661357902
CAL-12T,11404337,-1.0513453542481006
MHH-CALL-4,9926054,1.817922343737897
NCI-H1651,11404337,0.2113643612214112
JHH-4,selumetinib-vorinostat (8-1 mol-mol),2.0641916826842963
GB-1,24771867,2.4836469105583703
G-361,4705,3.3559681127377936
IMR-32,24771867,-4.867128838340709
Reh,3854666,0.867730782820825
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
HeLa,11152667,-1.1066196767080478
MHH-ES-1,54618305,4.636026356107167
SW948,2742550,2.6149964231270166
MHH-NB-11,65628,2.292899242166229
HEY A8,9926054,2.010020919181283
SK-LU-1,3465537,3.809052717752696
RL95-2,54639665,4.517806910494635
A-204,65628,4.317611163757104
KYSE-510,54618771,0.5023256188939713
MOR/CPR,11152667,-1.366558612447239
VMRC-RCW,selumetinib-GDC-0941 (4-1 mol-mol),3.3415688059991537
CGTH-W-1,54618771,1.2189927241974945
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
MPP 89,100016,6.902779011713528
TT,54618305,5.02275363611129
MHH-ES-1,9868037,2.631225103410452
SW1116,11404337,-1.048062477762995
KMS-11,54618771,1.142705350534528
EPLC-272H,11152667,-0.8972804727996353
NCI-H1650,9911463,3.9017952806831313
MDA-MB-453,9935249,2.561550169446695
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
DK-MG,9911463,4.35158589399959
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324
SH-4,2742550,2.9279609499951222
SK-LMS-1,11494412,2.2164540785451106
HCC202,6918638,0.9094073905237152
JHH-4,54618305,5.480642450312855
NCI-H322,54618771,1.4640514819881318
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
NCI-H747,12003241,-1.9291719472544329
MOLT-3,10296883,3.393769807045215
OVCAR-5,24771867,3.106604045536207
SW48,9935249,1.3330175828473068
HuG1-N,136227924,2.3836679865505332
DLD-1,JQ-1-carboplatin (1-1 mol-mol),2.485770842488409
NCC-StC-K140,54618771,0.2055366704850876
JMSU-1,100016,3.921608363156487
TF-1,12003241,-0.8942649772523563
NCI-H2170,11152667,-1.0107802099537535
WM1799,selumetinib-vorinostat (8-1 mol-mol),-0.9356643897041474
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
Karpas-422,49836020,3.572840137931533
SK-MEL-30,selumetinib-vorinostat (8-1 mol-mol),-1.2228200130489273
BT 444,3465537,1.7178503845935178
YD-15,11152667,-1.1817729874123373
BT 139,11494412,3.8637696290948815
CAL-78,54618771,1.2758318023633108
NCI-H1105,2742550,3.8038005756853575
WM793,11152667,-0.0685864179324616
COLO 800,135421197,2.3295817527143243
Rh41,9935249,2.1844071013981377
DND-41,65628,2.868103877059646
BT 271,11152667,0.7182560535051697
SNU-626,selumetinib-vorinostat (8-1 mol-mol),4.212223566347579
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
Hep 3B2.1-7,12003241,-1.3373877223864783
Yamato-SS,selumetinib-vorinostat (8-1 mol-mol),2.5138780111787424
Karpas-299,54618771,-0.1406101617053584
LMSU,10322450,5.4992145641719095
U266B1,100016,6.458228016262307
MDA-MB-468,JQ-1-carboplatin (1-1 mol-mol),3.305072238295291
KYSE-510,24771867,2.9455668420955736
P-STS,54618771,0.5747646300183281
HOP-92,9911463,3.5299931958283093
Kasumi-1,135398744,7.461687299190896
BV-173,3854666,0.5295371069760887
SNU-601,JQ-1-carboplatin (1-1 mol-mol),1.969115182185286
VMRC-RCZ,selumetinib-GDC-0941 (4-1 mol-mol),2.964733367482892
Reh,9911463,2.887324979980584
SCaBER,JQ-1-carboplatin (1-1 mol-mol),1.2535925980177334
MOLM-6,selumetinib-vorinostat (8-1 mol-mol),-0.0456049176618857
HCC1395,11152667,-2.038239333441405
GP2d,9926054,2.6461987815751096
SNU-C4,4378219,4.434167640590076
BICR 22,1566236,3.7080344976190434
PSN1,6918638,0.0567405704969879
ME-1 [Human leukemia],10296883,3.2444666645650675
THP-1,135421197,0.9721009186640236
HL-60,selumetinib-vorinostat (8-1 mol-mol),-1.0995278309678689
NCI-H1693,65628,6.204473532146459
Pfeiffer,54639665,4.400648169756794
EJM,9884685,0.026997005394607
NCI-H1915,9935249,3.246288044473248
JHUEM-1,9926054,1.7870789981263362
SW620,selumetinib-vorinostat (8-1 mol-mol),2.4747661815342306
NCI-H1155,12003241,0.5053452290511842
A-253,65628,4.217567213450775
GA-10,10322450,2.465288440600798
SH-4,54618771,-1.4714653388751002
REC-1,selumetinib-vorinostat (8-1 mol-mol),5.79386517083513
Hs 729.T,10296883,3.893392968394133
NU-DUL-1,9935249,2.5570443888862737
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152
BHY,136227924,2.366046867351899
GDM-1,24771867,-2.0800495035690925
NMC-G1,135421197,2.4402756951086477
KYSE-30,9884685,1.4164675900937749
SBC-5,135421197,2.079587314097717
Kuramochi,3854666,3.353903240141939
HLF,49836020,3.6461336560985087
NCI-H2342,11404337,1.4757013589007744
COV434,11404337,-1.4918185868147884
KYM-1,135659046,3.425924566474854
CAL-29,54618771,1.1722146209139084
SNU-C1,54618771,0.8389876741679191
SNU-620,11152667,-0.9787695629039372
EM-2,12003241,-5.8745734353402534
697,71751553,3.5236027453781404
RPMI-6666,3854666,0.6368398839729822
OAW28,9884685,1.3567472374362477
DMS 273,9926054,1.8030373867492464
Hs 852.T,11152667,-1.6035219297014784
COLO 320,11152667,1.0063426184228563
PF-382,9935249,1.8009635209130423
NCI-H727,3854666,3.6466691501950512
SNU-16,40482356,6.270567146975274
LP-1,1566236,1.2090017249909242
SHP-77,44241473,5.867209011270152
Ki-JK,54618771,0.0695093081370742
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
EM-2,44241473,5.57361084178171
DB,9926054,1.795775748692003
NCI-H28,JQ-1-carboplatin (1-1 mol-mol),0.6583342429642598
SK-N-DZ,JQ-1-carboplatin (1-1 mol-mol),0.6864490875129473
VMRC-LCD,9911463,3.586787073438602
Panc 04.03,9935249,3.3873751996630177
OVCAR-8,135398744,6.524120777237468
Ki-JK,4378219,1.333685282806329
SEM,2742550,2.6060865780770293
BT 482,9884685,0.8554628610116185
TE-11,24771867,1.9890571621725943
SNU-886,9911463,3.862708319776098
LS1034,136227924,1.69162800732405
BFTC-909,3854666,1.1654585644167257
L-428,9911463,3.1303248719612093
DMS 114,71751553,4.87881133729169
SK-MEL-24,11152667,1.2067542330034051
TUHR10TKB,10296883,3.708176518593342
P12-Ichikawa,73707386,3.4499084060111445
SNU-8,3854666,0.7475509647190202
HOP-92,3465537,1.2768665307356584
COR-L105,9911463,4.222864246171191
LXF 289,11404337,0.1273620702572638
SKM-1,9911463,3.5328203832136276
THP-1,10322450,3.145062676752804
NUGC-4,11152667,-1.113957335382959
HuP-T4,44241473,4.5225401007756005
Mono-Mac-1,100016,3.734497226962008
COLO 678,10296883,4.183536343390627
DV-90,1566236,1.716628899153487
GA-10,3465537,2.6293508447683376
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
OAW42,2746,4.654777781524689
DND-41,9911463,3.037480492878027
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
KMM-1,JQ-1-carboplatin (1-1 mol-mol),5.732885286738059
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
BL-41,1566236,1.0273686221427951
HCC38,6918638,0.6464158254242791
NCI-H1623,9915743,-1.6977137550638366
HEC-1-B,135984461,4.439754583263078
NCI-H1373,JQ-1-carboplatin (1-1 mol-mol),1.2259768292567783
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
HLF,9935249,3.066009874384815
CCK-81,9911463,3.2040299523214304
Lu-99,9935249,3.4193801310758105
RKN,11152667,0.0617927102225113
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
MDA-MB-453,44241473,4.685974466458818
NCI-H520,9926054,1.793691213544428
SCC-4,11404337,0.119875077583324
LS123,1566236,1.625300036443469
MOLP-8,9935249,-5.983061984872936
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
NCI-H716,9911463,3.7061520966996033
SW948,9915743,1.1952390119197474
NCI-H1373,9935249,3.3287555686276504
SBC-5,11404337,1.1992857421773124
SNU-C1,71751553,3.9915077218774506
SUP-HD1,selumetinib-vorinostat (8-1 mol-mol),1.5115268098946817
OS-RC-2,135984461,1.5869411346906208
MeWo,2742550,3.6892292088743086
SNU-5,54618305,4.931285968596896
NCI-H226,9911463,4.360420570038796
Hs 940.T,12003241,-1.8353600585061816
VMRC-RCZ,JQ-1-carboplatin (1-1 mol-mol),3.747713311192417
HOS,24771867,3.6159639550893856
OCI-AML-5,11494412,0.989113534938917
OCI-Ly3,JQ-1-carboplatin (1-1 mol-mol),0.1227368323293568
COLO 201,54618771,0.4783318937698353
PE/CA-PJ41 (clone D2),2746,3.71543902732957
BT 428,135398744,8.121810698450407
LOX-IMVI,3854666,2.4185877249013368
MHH-ES-1,135421197,0.9821303635644922
G-402,9884685,-1.1274637875769815
A-204,4378219,4.648885174302636
NH-6,24771867,-3.735265138330838
C2BBe1,11404337,-0.9784657174077572
MG-63,54618771,1.3665941956425405
Kasumi-1,3854666,0.6053881674524748
T84,3854666,0.9881989979716492
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
IGROV-1,9911463,4.195269991960018
EBC-1,4705,2.4186429670201153
TE-1,3854666,3.3218697538076296
SUP-HD1,54618305,4.039800109038852
PaTu 8902,135421197,2.3024316473658004
LS180,135421197,1.2375553911833763
SU.86.86,11404337,0.6097421920639037
NCI-H2087,54618305,4.263137730985128
EFO-27,3854666,3.6632128701571194
PE/CA-PJ41 (clone D2),11404337,1.298340763398175
SW1710,11404337,0.2062189220113439
YD-38,9915743,-2.811758020987732
NOMO-1,9926054,1.6113291347040215
BFTC-905,11404337,-1.6179925215678757
HT-1376,11404337,0.7952974713578591
Mono-Mac-1,10296883,2.780550097818586
SF126,11404337,-0.0225096476236154
KMRC-3,54618771,0.1504826951638593
A2058,11152667,-0.8357318584187301
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
COLO 699,3854666,0.677728842403528
HuH-6,9915743,1.4192862158653652
KE-39,135421197,0.9510973278490732
HT-144,100016,6.638904024373049
UM-UC-1,4705,3.153349109118703
BT 504,10296883,3.915758265808419
PC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.4972652387658174
SF268,selumetinib-vorinostat (8-1 mol-mol),2.7475433476572872
BT 328,12003241,0.43959296828198
NCI-H2029,9935249,3.1466708658016223
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
NCI-H1568,54618305,4.1006341963066255
LS123,9915743,1.0126339899264374
NCI-H2342,1566236,3.0828221386653314
WT2-iPS,selumetinib-vorinostat (8-1 mol-mol),-0.2809222958468133
NCI-H322,12003241,-0.9727084564838948
NCI-H1869,1566236,2.8728790566593747
SNU-119,11152667,-1.7505046185564503
TYK-nu,9915743,1.635959733436141
YD-10B,9926054,1.7388994338775816
MHH-CALL-3,11404337,0.3136523516674954
SJSA-1,selumetinib-vorinostat (8-1 mol-mol),4.163879643350655
JHOC-5,JQ-1-carboplatin (1-1 mol-mol),1.4333459148204122
SK-HEP-1,9911463,4.3683168964450125
SW1710,3854666,1.210332525594085
HT115,100016,5.804685245268015
P12-Ichikawa,9915743,0.5856133039095079
F-36P,135984461,3.5381976593553444
SNU-407,9911463,3.2824377830352818
BT 216,135398744,6.476974321326381
HCC38,10296883,4.206787389129117
UACC-62,136227331,3.8337503750077175
A2780,136227924,2.141563547945887
NCI-H460,54618771,1.6853262233131374
WM266-4,11404337,0.1712081153064202
LP-1,selumetinib-vorinostat (8-1 mol-mol),2.1103342223953243
BT-20,9935249,3.213936920036377
SU.86.86,11152667,-1.681749243998976
SNU-308,12003241,0.0879961923245038
COLO 680N,12003241,-0.3137141462022448
BT 164,100016,6.2228733531949505
JHH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.7984148033328824
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
Tm87-16,selumetinib-GDC-0941 (4-1 mol-mol),0.1421801276665628
SCaBER,9935249,3.150717155032017
BHY,76446078,4.286785779255522
PK-45H,9911463,4.054004002243204
PLC/PRF/5,9915743,4.0648434850392
COLO 205,9935249,3.504893004849407
SK-MEL-24,2742550,3.6014189128850216
LC-1/sq-SF,9926054,1.8795702077099137
Li-7,54618771,0.3416557888944573
KHM-1B,9926054,1.3720275885206477
HPB-ALL,54618771,-0.7909644269662123
RERF-LC-A1,9935249,3.663083529492861
MG-63,6918638,1.818394000557256
PaTu 8988s,12003241,-0.9111494781164662
AU565,11494412,-0.7938994603064
Panc 03.27,selumetinib-vorinostat (8-1 mol-mol),3.66722901648523
SNU-601,selumetinib-vorinostat (8-1 mol-mol),2.1558363641207574
BT 239,6918638,2.260003296695808
SNU-C1,11152667,-1.3604211574664309
EPLC-272H,9884685,-1.556981990897552
NH-6,136227331,4.3480381735805365
ChaGo-K-1,10322450,2.8130717345361336
MOLM-6,11404337,-1.8876803787246543
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
SK-N-AS,71751553,4.378274889288709
RD,11494412,1.018514928419539
NCI-H747,100016,6.898929440027426
SCC-9,11152667,-0.1233430086603879
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
SNU-449,135398744,6.632733291537939
WM88,24771867,4.963554195247929
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
Panc 02.03,9911463,4.953148943637795
OS-RC-2,3854666,3.742004616856006
CAL-27,9884685,0.5318876769597282
Hs 683,10296883,3.967060059444981
HT,9868037,1.9905523234994904
RPMI-8402,11152667,-1.9551493741804535
TE 441.T,4705,3.429293976923017
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
BT 239,11152667,1.551234478397614
EKVX,71751553,4.292154921521479
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
A-172,135421197,2.0454281917849357
BICR 6,11404337,-0.1935615710602951
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
RKO,24771867,6.323343540042099
OAW42,10296883,4.103500664094552
Mino,135421197,1.5483687621841111
EBC-1,1566236,2.360259919551262
OCI-Ly19,71751553,4.646570444939478
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
HPAC,11404337,1.5796437577977354
A3/Kawakami,65628,3.260470610713876
NCI-H2110,9935249,3.1608776626158432
MDST8,2746,2.514425635914287
DK-MG,71751553,4.329180053945678
MOLT-3,135984461,3.930713176256541
LS513,54618771,0.3815245482334266
NCI-H2023,selumetinib-GDC-0941 (4-1 mol-mol),2.6884050561180253
KM12,135421197,2.2620714252127336
SK-MEL-28,73707386,4.4832416514767335
Panc 04.03,3854666,3.6180263181428622
TUHR14TKB,9915743,0.9798821424990548
SET-2,11404337,0.2728842638306079
VMRC-RCW,54618771,0.4533300000402974
HuT 78,3854666,0.8787104419208177
Hs 888.Lu,6918638,1.6527379036504295
MDA-MB-453,11404337,-0.3002498088297632
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
DEL,9868037,2.284164309985857
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
LNCaP clone FGC,54639665,5.111125595868773
SF268,9935249,2.638287761328334
8-MG-BA,135984461,4.363641187325639
Kasumi-2,11404337,-1.9658161518336
PK-1,selumetinib-vorinostat (8-1 mol-mol),2.9485876327218077
BT 147,11494412,1.94524902376892
JVM-2,11404337,0.0691580331258648
SCC-9,71751553,4.89059631642312
CL-34,selumetinib-vorinostat (8-1 mol-mol),-1.1139178490326602
JVM-2,9884685,-4.167138100754272
LCLC-97TM1,136227331,4.3740550996774745
SNU-869,4705,4.285651078954769
NCI-H1793,9911463,3.76780025503232
HOP-62,9935249,3.1113084784743
SK-N-AS,54618771,1.0154959522530718
KE-97,9911463,3.4009628133959713
JJN-3,9868037,2.860227740471185
KALS-1,10296883,4.367875954814542
SUP-HD1,2746,2.2026290919231055
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
SF539,65628,3.9792533711127582
WSU-DLCL2,selumetinib-vorinostat (8-1 mol-mol),1.9937136864187064
KYM-1,24771867,5.118561428198421
RPMI-8226,54618305,-4.544324517561474
RL,1566236,1.5616385715057797
MDA-MB-468,100016,5.725845417349072
KG-1-C,selumetinib-vorinostat (8-1 mol-mol),2.5432622641170908
SNU-899,selumetinib-vorinostat (8-1 mol-mol),2.6583170354453047
OCI-Ly10,71751553,4.3682069656519324
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
BT 286,4705,3.0604993750879834
SCC-25,9884685,0.9824143256806416
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
SET-2,71751553,3.975724095102093
HCC2935,selumetinib-GDC-0941 (4-1 mol-mol),0.0464684942355828
NCI-H1105,12003241,2.305570238632079
JIMT-1,JQ-1-carboplatin (1-1 mol-mol),6.316159128553351
SK-HEP-1,10296883,4.4971190241998835
NCI-H1734,11404337,-1.6493245767646154
CGTH-W-1,9935249,4.1803974090658
TE-8,12003241,-1.9101664586501004
T24,135659046,4.4485705776291935
CL-11,selumetinib-vorinostat (8-1 mol-mol),-1.2741368590150106
OCI-AML-3,9884685,-1.3985823695443076
SNU-5,100016,6.769356825304223
TE-11,135984461,4.268125230338474
SET-2,4378219,5.019702964288066
JHH-1,4705,3.6727549882245634
Kasumi-2,3465537,0.5812514796989715
MDST8,65628,4.39024768664476
JHOS-2,11494412,3.6714396856764857
P12-Ichikawa,135421197,0.8700527660051071
OCI-AML-2,44487872,4.166036259077145
COLO 800,100016,6.663651406564157
OE33,selumetinib-vorinostat (8-1 mol-mol),1.9103124902448312
SNU-423,selumetinib-vorinostat (8-1 mol-mol),2.465169855614971
G-401,9926054,1.744192331951833
THP-1,JQ-1-carboplatin (1-1 mol-mol),-1.7291574226431643
SW1116,JQ-1-carboplatin (1-1 mol-mol),-0.0144510957041741
IGR-37,9915743,1.4211592255405934
NCI-H508,9915743,-3.0595011879146967
ME-1 [Human leukemia],135984461,2.3168305015054793
Namalwa,11494412,-0.23219160030294
Capan-2,11494412,4.291482697999069
42-MG-BA,54618305,4.3821225148917335
LMSU,135398744,6.91211293627059
BT 286,11404337,-1.6660130116300145
WM266-4,71751553,4.434367335384286
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
BT 145,54618771,1.0324414673710869
DND-41,6918638,-0.9223144661019224
NCI-H1734,136227924,2.5893506458509634
22Rv1,selumetinib-GDC-0941 (4-1 mol-mol),-0.8202887961023889
CAS-1,9911463,4.201825913266076
LS411N,9926054,1.9376785020428349
AML-193,136227331,3.928096776967208
Capan-1,135421197,1.617926303344926
DMS 53,71751553,3.942952237428104
UACC-257,1566236,2.0742825046781963
Ishikawa (Heraklio) 02 ER-,9911463,4.4894975893783435
BICR 6,1566236,1.9670842482993127
SK-N-SH,2746,2.865356656524813
COLO 800,136227924,2.9949932078985437
F-36P,100016,3.924028764616067
JHUEM-7,24771867,-0.3037567272373623
NCO2,JQ-1-carboplatin (1-1 mol-mol),-0.8378761962661548
A101D,selumetinib-GDC-0941 (4-1 mol-mol),0.5924729203046659
NCI-H69,136227924,3.1937315471147443
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
DND-41,12003241,-0.2098098510645495
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
SK-BR-3,136227924,2.8779705448471975
RKO,11152667,-2.010180339323448
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237
OVCAR-8,2746,3.926071578453057
IGR-1,2742550,3.6164330021426503
MeWo,9935249,3.0187575448972854
OAW42,135984461,3.763630222707139
HCC1438,selumetinib-GDC-0941 (4-1 mol-mol),1.8999757097381424
Tm87-16,1566236,3.2749985953055893
BT-20,2742550,3.667982838644888
YD-8,11152667,-1.506864416830652
MCAS,3854666,1.0662273712961947
BT 416,6918638,-2.563404601621211e-06
TUHR4TKB,135421197,2.8220761476999665
NCI-H226,54618771,1.8675416009470285
Rh30,12003241,-2.0054573943466876
Kuramochi,11404337,-0.4054139611353435
Hs 746.T,9911463,4.2317998219247785
TOV-112D,selumetinib-vorinostat (8-1 mol-mol),4.502433725059984
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
NCI-H1435,2746,2.5897217485668222
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
TC-71,54618771,1.220599365734416
C2BBe1,3854666,2.885406461282777
ONS-76,10322450,3.321198163736043
Capan-2,12003241,-1.76044802004158
NCI-H1155,JQ-1-carboplatin (1-1 mol-mol),0.0214289604046408
MKN1,3465537,2.2988612958925656
LS513,11152667,-0.1030849983220042
NCI-H1568,11494412,0.631822071405162
SU-DHL-4,11152667,-3.818519597612646
NCI-H1568,49836020,3.1231470101883336
KM12,selumetinib-GDC-0941 (4-1 mol-mol),1.4045070472454428
NCI-H23,2746,2.7818216168279526
COLO 741,44241473,4.3686200073997785
VMRC-LCD,135421197,1.103585656826272
TE-14,12003241,-0.291419040743519
PaTu 8988s,100016,6.475282567189534
Hs 729.T,136227924,2.3598946894515014
Hs 822.T,71751553,4.5741055393957515
NCI-H889,9926054,1.840125789909785
OS-RC-2,9911463,4.41077585460665
KMS-27,54618771,0.0520641396166809
G-402,76446078,4.331457699559396
SK-MEL-5,9915743,2.239295477459583
BT 271,3465537,1.4031174390930885
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
NCI-H889,10296883,3.661891434193148
KMS-20,11152667,-1.0661904813825076
Tm87-16,selumetinib-vorinostat (8-1 mol-mol),2.472623169855902
KYSE-410,4705,2.1516675380518953
SK-N-MC,11494412,-0.6115742998674478
TE-15,49836020,0.684840592082847
JL-1,9926054,1.8045722808491491
IM95,9915743,-0.1388033573785565
Mono-Mac-1,4378219,0.2241292373980127
NCI-H508,135984461,1.3950567746266993
OCI-AML-3,9911463,2.5081471019206014
Hs 746.T,4705,3.427191561764603
JHUEM-3,10322450,4.4054488453060525
P12-Ichikawa,9926054,1.82657661814102
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
H-STS,2746,2.861217997075228
Pfeiffer,selumetinib-GDC-0941 (4-1 mol-mol),-0.3312571594037772
TT2609-C02,10322450,4.933026976290495
Caki-2,10296883,3.9921303819788574
HSC-4,3854666,2.969420021692798
HCC1428,selumetinib-GDC-0941 (4-1 mol-mol),5.009115635429041
Daudi,1566236,1.0534301581716357
TE 441.T,11494412,0.8893803866671172
U-251MG,9911463,4.11693061123882
BT 231,2746,2.74381286555369
Ri-1,10296883,1.1182456491009578
KYSE-150,12003241,-0.8115897611031261
Granta-519,9911463,3.5000933341892733
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
NCI-H747,4378219,2.0364303735871836
BT 145,11494412,0.0535331415657337
A4/Fukuda,71751553,4.0599050322296995
BICR 16,11152667,-0.4064565156133361
LC-1/sq-SF,JQ-1-carboplatin (1-1 mol-mol),2.338357576071754
NCO2,24771867,-1.6535896052577994
SCC-9,2746,3.644005246156997
OCI-M1,135421197,1.730627187910493
HuH-1,9926054,1.861851059546876
MV4-11,9868037,1.3692321377880616
A-549,44241473,4.768992901407106
EM-2,24779724,4.869730500223735
SNU-410,2746,4.749931599758568
SK-UT-1,11152667,-1.0251821128308043
SNU-423,11494412,1.245479972676825
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
NCI-H2023,54618771,0.8725356592337147
Granta-519,6918638,-1.0102021398050984
CAS-1,9868037,3.4810587934023363
SW948,136227924,2.9576701343794145
COLO 684,3854666,0.6969509433091737
Hs 888.Lu,10296883,4.303649203246193
IA-LM,9915743,1.455667571666015
T-47D,65628,5.946495806512569
NCI-H1838,100016,6.459213557236613
U-CH1,selumetinib-GDC-0941 (4-1 mol-mol),2.4998386609630834
BT 164,selumetinib-vorinostat (8-1 mol-mol),2.2572837583830068
DV-90,54618771,-0.717052278919437
KMS-18,24771867,3.2181710472351246
NCI-H1341,2746,1.640350418119998
IGR-37,selumetinib-vorinostat (8-1 mol-mol),0.5095178470220681
ECC12,11152667,1.0156466397145238
SNU-245,JQ-1-carboplatin (1-1 mol-mol),1.4160097038546082
HCC2279,9868037,3.3429801008899833
SNU-1033,11152667,-1.2864641909035752
OE21,100016,6.577886119924336
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
A-549,11404337,-0.2898707579606809
COR-L51,9884685,0.271374180223106
Karpas-620,1566236,2.834005518083698
WM1799,4705,4.447302669477667
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
DV-90,24771867,-3.155082674121724
NCI-H810,1566236,1.1113162433781687
RPMI-8226,9911463,3.1535934695934538
HCC1833,selumetinib-vorinostat (8-1 mol-mol),2.3317673316592753
OCI-AML-5,12003241,0.3941324977706439
DMS 114,9868037,3.4094491088437633
ONCO-DG-1,3465537,3.928768905260986
NCI-H929,136227924,1.899057841083653
IST-Mes1,1566236,1.9315527075511711
HSC-2,12003241,-2.7433654243875214
WM88,54618771,1.141068520778182
DMS 114,54618771,0.497932875253643
SK-LU-1,11404337,-0.1113986286493255
BT 286,9868037,4.125737289056318
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
DMS 53,4705,3.2924346460856015
HCC38,11152667,-0.905518740650514
NCI-H1563,11494412,4.208131510093767
OAW42,10322450,4.813249082593069
ECC10,73707386,2.488909979454374
JHUEM-2,9935249,3.290906411802745
NCO2,2742550,2.371256887035148
SK-ES-1,4705,2.9772656086028
HT115,54618305,4.118965494777058
SNU-308,44241473,4.357724828152583
BT 428,1566236,1.6245492383600229
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
HuNS1,9915743,0.7777068121651658
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
Daoy,9868037,3.1554114600396725
TE-6,9926054,1.628264374651606
NCI-H2342,11494412,3.810299583777443
G-361,135398744,6.4148171061967645
IGROV-1,9911463,4.195269991960018
KMS-21-BM,54618771,-0.9009155156599936
MOLT-3,9915743,2.149590681460773
NCI-H1944,4378219,4.5801202621882915
RVH-421,11152667,0.9057369680302438
HCC1195,selumetinib-vorinostat (8-1 mol-mol),1.6123669197012191
T98G,9926054,1.93846990860498
SUP-HD1,9935249,0.0380094941240227
PC-14,24771867,-2.59629099527772
Raji,9935249,3.258166700499432
PE/CA-PJ15,2746,3.741230111498992
OCI-AML-3,9926054,1.7279388216590237
IGR-1,9915743,1.9511711316311544
ONCO-DG-1,100016,7.582922943410799
YD-8,54618771,-1.0700457769979232
SYO-1,135421197,1.7778335849280964
HSC-2,9926054,1.7452128350759892
Kelly,54618771,0.9246671147478912
PSN1,65628,4.215557225147028
JHH-5,3465537,2.9573193940502
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
DEL,3854666,-0.1483525975905523
DK-MG,12003241,0.4512209867473665
WM793,12003241,-0.659721194491695
SK-OV-3,9926054,2.1800400954819716
EoL-1,54618771,-1.3490437314976569
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
T98G,10296883,3.86323730718366
HeLa,11404337,0.8471506482049684
HEC-265,100016,5.251492285111922
A2780,73707386,2.710080958425795
Hs 683,9911463,3.853379830397607
M-07e,10322450,3.3333673801284944
MES-SA,6918638,1.1340225754768447
SNU-878,JQ-1-carboplatin (1-1 mol-mol),0.3987725595760565
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
Sq-1,11152667,-1.3140921047356755
SH-4,2746,3.3582559523336024
TE-5,4378219,1.986871468742584
253J,BRD-K16130065,4.180822895879859
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
JVM-3,4378219,1.7761830599039734
HOP-92,11152667,0.0194334457460503
PL-21,9884685,-0.9848433807049898
LMSU,24771867,2.7605292141618945
SK-MEL-2,1566236,1.8049776049740816
PC-14,9926054,2.1919524814380846
MOLT-16,44487872,4.467679467136648
BT 228,54618771,0.9979024036150752
ST486,44241473,3.631824742432312
HCC1143,54618771,1.714955024233068
UACC-257,12003241,-1.8114895383547025
Granta-519,54618771,-0.1786557603441652
BT 333,selumetinib-vorinostat (8-1 mol-mol),3.1081878072417015
COLO 800,selumetinib-GDC-0941 (4-1 mol-mol),-0.6648524830772472
SUP-B15,11152667,-1.17456524958868
SCC-25,10296883,3.5302402637637145
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
NCI-H2405,12003241,-1.91851712943585
SK-N-FI,4705,2.5887830768874993
PSN1,54618771,1.0833304445253575
SNU-182,12003241,-2.036673656339672
KMRC-2,71751553,4.728116551648532
SNU-C5,11152667,-1.1058691080077447
ESS-1,2746,2.6118901158900423
BxPC-3,100016,6.453363473458683
NCI-H1693,24771867,2.82905957425596
BT-12,selumetinib-vorinostat (8-1 mol-mol),3.455129054550989
KNS-62,44241473,4.482234474578089
Capan-2,9935249,3.196012622928356
Rh18,2746,2.848745725372627
NCI-H1373,9926054,1.8231885221159896
SW1271,9926054,1.9992649208496855
K029AX,54618305,4.3314388492322955
SW620,135421197,1.4472362766412623
GaMG,9884685,0.6197999278572434
LOX-IMVI,selumetinib-vorinostat (8-1 mol-mol),2.269667540856765
NCI-H292,54618305,4.4370648491662195
Mino,3465537,1.332066458036503
U-BLC1,9935249,1.956441197069186
NCI-H1581,12003241,-3.141909657100737
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
SH-10-TC,54618771,0.3960881038412169
NCI-H661,24771867,2.8989054210712784
Namalwa,9884685,-0.9006349124358586
GOS-3,10296883,4.354871301885758
HCC-56,2742550,3.74024214406613
SW1573,9935249,2.8664920450292852
LOX-IMVI,11152667,-0.6802335307199879
PSN1,1566236,1.7739634802573778
A101D,9915743,1.230916500554605
HuH-28,11152667,0.3540574012859301
FaDu,6918638,1.0818433355899586
SNU-387,54618771,3.696671727532153
MOLT-16,65628,2.3092388368184937
769-P,9915743,0.5554140720620152
SW579,54618771,0.7719470301120797
Mel Ho,selumetinib-vorinostat (8-1 mol-mol),-1.2703640044537123
WM115,12003241,-3.303596686294694
BT 239,9915743,1.0912084303287637
HCC1588,11152667,-0.4007938807614604
BT 187,2746,4.1078549912417355
SNU-407,3465537,1.295339761164929
DU145,135421197,3.2080942542888056
Caov-3,54618771,0.7751702842643667
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
SW1990,135984461,4.558882799669272
YH-13,9911463,4.412003433189975
LXF 289,9915743,1.5678711489122208
Hs 944.T,135421197,1.7444427011785306
KMS-21-BM,44241473,4.497358254483185
SK-N-DZ,2746,1.2350474359899652
Reh,136227924,1.9009503552795357
L-428,44241473,5.81945312497994
JHUEM-7,135421197,2.2083604774336973
NB4,3854666,-0.3062621244403906
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
WT2-iPS,11152667,-1.4090250835135414
ES-2,24771867,1.680683877003192
Caki-1,24771867,3.0527341139439264
YD-15,65628,3.895219828692723
UO-31,24771867,0.58932998670591
SNU-5,44494148,4.421256906479104
NCI-H1650,24771867,1.8651401071514455
BT 359,9926054,3.2726911092773223
SNU-C4,1566236,1.7829044756286356
HOS,9884685,2.221888063930838
MV4-11,49836020,2.655795655295622
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
SK-N-MC,54618305,4.415419037379575
SK-MEL-31,2746,3.1579151966275343
OV-90,54618305,4.337650139847183
SNU-398,11404337,-0.6882395076793462
SNU-489,9926054,2.706160270050288
NCI-H1793,9935249,3.0315194479133276
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144
LoVo,12003241,-2.8621949377385465
DU145,10322450,6.851968050616261
TE-5,selumetinib-vorinostat (8-1 mol-mol),2.572123660917941
HOP-92,10296883,4.19032829919567
Kasumi-2,100016,5.973936097539331
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
SUIT-2,9911463,4.378510442631056
NCI-H2087,9935249,2.1855057709444092
SW1088,selumetinib-GDC-0941 (4-1 mol-mol),3.0866822201862374
MOTN-1,24771867,-3.540991568105158
BT-20,4378219,4.276971805341904
BT 231,9884685,-1.167030956523576
Karpas-299,4705,2.3837874770371816
D283 Med,11152667,-1.23900039901842
MHH-CALL-4,JQ-1-carboplatin (1-1 mol-mol),-0.223161875024046
PSN1,JQ-1-carboplatin (1-1 mol-mol),4.6221791431053845
EFO-21,9935249,3.4290046574242843
8505C,11404337,-1.4016142280742767
MKN74,24771867,3.715312508081128
BICR 18,2746,3.306459207135074
WT2-iPS,135659046,3.296193945470927
JHOS-2,selumetinib-vorinostat (8-1 mol-mol),5.50185776695037
SNU-840,selumetinib-GDC-0941 (4-1 mol-mol),1.257752895410429
JHH-2,selumetinib-vorinostat (8-1 mol-mol),2.324010173009433
MDA-MB-361,9935249,3.141937087605061
LUDLU-1,selumetinib-vorinostat (8-1 mol-mol),2.8227543135070157
PLC/PRF/5,9926054,1.9278694567430317
Mono-Mac-1,11152667,-4.583124026355614
LP-1,9915743,0.8947745693738212
SCC-4,4378219,4.575700344955467
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
SNU-216,4378219,1.8378393827834911
NCI-H358,selumetinib-vorinostat (8-1 mol-mol),0.0207617613285498
ECC12,3854666,0.9162836881070394
CJM [Human melanoma],10296883,4.108453768620905
RL,49836020,3.855414326561088
BT 147,3465537,1.2508282611469033
SK-CO-1,2742550,3.074063089907043
NCI-H810,2742550,2.3856132718749197
HEL 92.1.7,54618305,4.735432222315623
BT 147,4378219,1.8467077225806037
SNU-119,9935249,3.2348685245924726
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
KMS-11,selumetinib-GDC-0941 (4-1 mol-mol),1.0292581351367205
U266B1,2742550,4.53274163038269
KMS-12-BM,44241473,4.1211159216828035
OAW42,6918638,1.325262653338047
CJM [Human melanoma],24771867,4.547748868082027
HCC44,100016,5.500199899639815
HuNS1,selumetinib-vorinostat (8-1 mol-mol),2.3159502101358225
HPAF-II,136227924,3.1547615754637
CCF-STTG1,6918638,2.2635117256438835
M059K,1566236,1.7750147325704222
Rh18,10296883,3.770152183649725
RERF-LC-MS,54618771,0.9955970244631366
UO-31,9935249,0.1849232731406093
HPB-ALL,24771867,-2.647164355158826
BT 286,9884685,0.8858351843955082
PaTu 8902,11404337,0.5155229173062875
Karpas-299,9911463,3.0084205212852724
KNS-60,10322450,5.014085797692543
SK-CO-1,9911463,3.850014047184169
KHM-1B,9911463,3.1729521589558125
ES-2,136227924,4.099714373678264
Hs 746.T,3465537,2.483002821893036
TE 617.T,9915743,-4.6063841978227
HCC78,selumetinib-GDC-0941 (4-1 mol-mol),2.9308548857555303
HOP-92,JQ-1-carboplatin (1-1 mol-mol),4.25217637860204
SNU-475,12003241,0.1195420556659512
COR-L88,24771867,3.5924715813690633
SNU-1076,3854666,0.6976917906829407
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
K-562,9935249,0.8993678101188762
Li-7,24771867,0.3080363702758987
PLC/PRF/5,1566236,1.8943301700866575
BT 248,4378219,1.4454405763629643
MSTO-211H,9935249,0.534197831206919
DMS 79,9915743,0.1053493686109965
MCF-7,11404337,-0.4787544229741591
CAL-33,11494412,0.5999793453593346
Jurkat,135421197,1.0042206438045034
KMH-2,9868037,1.8367202409128176
HCC202,1566236,1.9965281595401527
MCF-7,136227924,2.325387172028071
NCI-H2081,9915743,0.926591953046768
SW982,2742550,4.283669241388704
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
RPMI-8402,135398744,6.9217830210823434
TE 617.T,JQ-1-carboplatin (1-1 mol-mol),1.6979959142929375
MOLT-3,10322450,4.054866374407206
PL-21,44241473,4.839124245542347
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
IGROV-1,9884685,-0.088911709267569
PSN1,11152667,0.7920097543928998
Hs 852.T,73707386,3.700283239805054
IGROV-1,135421197,1.96820638017286
Pfeiffer,135421197,0.665786429706454
MKN74,1566236,3.387752601691297
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
Mel Ho,11404337,-0.9675830815963552
SW1088,650361,3.877818258700098
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
BT 147,136227331,3.829920256470893
OCI-AML-5,3854666,0.9845193843983524
EFO-21,11404337,0.1948042890750945
HT-144,9935249,2.150553590588431
Lu-65,2742550,4.528880941958593
COR-L279,11152667,-0.9089545810902804
NCI-H1355,135659046,3.71812862658832
SW982,11494412,0.9362353205677216
NCI-H650,3854666,2.944937467815792
MeWo,3854666,0.739672925768373
PE/CA-PJ41 (clone D2),2742550,5.692172963582456
Panc 05.04,9926054,1.8029787074876424
IGR-1,136227924,2.467918205864833
KMS-11,9935249,2.0287121726728783
Sq-1,4705,2.78304746157314
AN3-CA,71751553,3.9967289000483097
SW1116,9915743,-1.8123899004443464
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
T24,54618771,1.5069365622547568
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
Hep 3B2.1-7,3854666,3.158608075491721
DMS 273,2746,1.8465116882146249
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
EM-2,9915743,0.5726352403116545
RKO,4705,3.750134101835121
HMC-1-8,11404337,-0.9366100909278564
HCT 8,54618771,0.896470905316868
SNU-398,135984461,5.493775428408586
Hs 852.T,49836020,3.510211812103559
THP-1,100016,3.892329450898836
IMR-32,3854666,-0.9157783750736912
TE-6,1566236,4.012567975048785
PaTu 8988s,4378219,1.968690646273728
NCI-H358,12003241,-1.009244775405437
SCC-25,54618771,-1.4085770807185976
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
Peer,65628,4.247857610781868
JHH-1,2746,1.382928885813351
MDA-MB-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.5607130395634891
NCI-H211,12003241,-0.3344728899219033
NCI-H520,65628,4.358434508292663
SNU-C1,135659046,3.6498249144750656
RPMI-7951,44505237,4.378502916493453
SNU-899,44241473,6.2980101013111245
NALM-6,49836020,4.594148282336944
JMSU-1,3854666,1.2672758634513397
TE-5,54618771,0.4798060513951584
WM115,3854666,2.6196721416111024
DMS 454,71751553,2.689876856029613
HOS,4705,3.554341392933483
SNU-626,135421197,2.600343807362106
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225
GA-10,9911463,2.3483289589885135
CCF-STTG1,11404337,1.400188980811807
G-402,11494412,0.8196805103807205
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
NCI-H2081,76446078,4.17311881830217
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
BT 428,12003241,-1.1639537703903158
Hs 888.Lu,9911463,4.373380817731519
ECC10,9868037,1.7411053203163678
KNS-60,136227331,3.7348276766396986
SUP-M2,3465537,1.2171909076225451
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JURL-MK1,9915743,0.946381424496901
HCC2935,11494412,6.077431072444395
CFPAC-1,3854666,3.9218760682690545
EFM-192A,24771867,3.883388653593596
G-361,3854666,0.7332994055275925
DU4475,11152667,0.3173121741310821
Kasumi-1,54618771,-0.5933473150200181
SNU-1079,136227924,2.5648904820695693
EC-GI-10,44241473,5.7620226988842065
IGROV-1,3854666,2.3355254440561137
IST-Mes1,49836020,4.276541253138442
SIG-M5,24771867,-2.220706789767579
BT 172,3854666,1.4651755366799823
SEM,49836020,0.2207243584754971
COLO 678,9915743,-1.0812060080075532
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
TM-31,selumetinib-GDC-0941 (4-1 mol-mol),1.793600027043238
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
KYSE-450,11494412,3.783526385415406
BT 340,9868037,4.513244290019421
PSN1,100016,3.987578982943132
KYSE-510,6918638,1.620078603816946
RERF-LC-Ad2,65628,4.3888994667995815
GCT,9926054,1.6553855879894792
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
MKN74,11494412,3.198332306822972
ZR-75-30,6918638,0.8461701725499111
THP-1,9935249,2.0469656741900955
MHH-CALL-3,24779724,4.5671029590732894
NCI-H716,11404337,0.1274429986614186
KMS-20,71751553,3.937106268474675
LCLC-97TM1,3465537,1.1142431298706064
Hs 766T,11152667,-1.5545196561885208
647V,54618771,-0.1034366562319205
SK-LMS-1,9911463,4.31771461226135
GDM-1,11152667,-2.8208505664126435
TALL-1 [Human adult T-ALL],54618771,-0.8815186258752705
HD-MY-Z,10296883,3.8983586745084033
Hs 766T,12003241,-1.434019858151168
NCI-H446,4705,3.0322510190148795
KO52,9884685,2.8647583667584553
TE-11,10296883,3.918560367292528
NCI-H889,selumetinib-GDC-0941 (4-1 mol-mol),5.471466100727687
NCI-H2106,44494148,4.415574771245799
SH-10-TC,135421197,2.8631167309091556
WM983B,136227924,4.383113443662036
Pfeiffer,3854666,-0.3763392240874574
L-363,49836020,4.471751893617592
OCI-Ly3,selumetinib-GDC-0941 (4-1 mol-mol),1.725768146081181
PaTu 8988s,9911463,3.6809927178566855
MOR/CPR,3854666,0.693887275502914
YD-38,9935249,3.800527323611882
IGR-37,24771867,4.593816018133968
P31/FUJ,24771867,-2.604308550432203
WSU-DLCL2,73707386,1.5634460794946006
PANC-1,135659046,3.591022095575617
SNU-1,10322450,2.9825136311356055
TM-31,71751553,4.644454824252927
H-STS,135984461,1.3384437031548353
TT,9911463,3.632649980547299
SUP-HD1,3854666,0.4718894570556139
SUP-T11,65628,3.35493935784814
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
NCI-H2291,136227924,3.7471032532575457
Peer,JQ-1-carboplatin (1-1 mol-mol),-0.0564533853445443
A-673,65628,3.827084992759042
Peer,selumetinib-GDC-0941 (4-1 mol-mol),3.981609189515586
NCI-H522,40482356,5.076444098213918
HT-1197,11152667,1.4681222423137998
HeLa,100016,5.8653655502295
HSC-3,44241473,4.97517832627678
SK-MEL-5,selumetinib-vorinostat (8-1 mol-mol),1.478441576802813
SNU-886,12003241,-3.694795257520175
CAL-29,135421197,2.48018015495381
OCI-AML-5,JQ-1-carboplatin (1-1 mol-mol),0.5116033389333992
Panc 03.27,9915743,1.9150966993651488
OV7,11404337,1.1254553955818216
HH [Human lymphoma],selumetinib-GDC-0941 (4-1 mol-mol),-1.1427111457994747
NCI-H526,9926054,1.8580444014969677
NCI-H508,3854666,3.6716452946739313
Hs 852.T,54618771,3.3539274587451935
Hs 746.T,135421197,2.8198811275725206
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
RPMI-8402,11404337,-1.8259507324161124
OCI-Ly10,9884685,-0.5960730002236428
KYM-1,11494412,0.4173722915158559
NCI-H1793,100016,7.252403961124031
NCC-StC-K140,9884685,-1.2435361669128766
Becker,10296883,4.31752254310815
KE-97,65628,3.692213431422058
253J,11152667,-1.7218129506088469
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
LS123,2746,2.8702857681070064
JJN-3,9915743,0.8433303744027496
Hs 578Bst,9926054,3.786469361001098
Calu-6,selumetinib-vorinostat (8-1 mol-mol),1.6602418601614706
NUGC-4,100016,6.130178573368833
TCCSUP,24771867,2.435510206237169
OVK18,11404337,-0.9122714237451722
ChaGo-K-1,135421197,1.864105940411698
A-204,3465537,1.456370701568416
DV-90,135421197,0.8587381868219376
647V,136227924,2.038450233147295
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
Lu-65,10296883,3.98979643435714
SNU-119,12003241,-0.7435067493629696
ZR-75-30,11494412,3.375465721476885
BICR 22,4705,3.4365696424802477
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
SNU-761,3854666,2.764365196176534
MG-63,24771867,1.908460951729608
EKVX,12003241,-0.995524269330736
HPB-ALL,11152667,-1.8112650513454247
786-O,9926054,1.9189583630988831
BT 139,136227924,3.476406727957654
SNU-1105,selumetinib-vorinostat (8-1 mol-mol),2.6742538037072854
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
EN,135984461,4.3188637411869255
OV-90,11152667,1.1297317130055462
RD,44487872,5.83185828502989
Lu-65,9915743,2.050551276197927
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
HCC827,9926054,1.8610804670039272
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323
EFE-184,selumetinib-GDC-0941 (4-1 mol-mol),4.957759622991816
KNS-62,11494412,3.2232509119756245
ECC10,10296883,3.344976615043335
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
HCC366,11152667,1.1664557661226933
ECC10,9915743,-1.3646312579395177
TUHR10TKB,11404337,0.4722597238806724
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302
NCI-H23,12003241,-0.7384604538146603
BHT-101,65628,4.438959852267732
BHT-101,9935249,5.00813048060855
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
HCC1428,9915743,2.613420698751445
NCI-H838,JQ-1-carboplatin (1-1 mol-mol),6.320973453370018
CAL-54,6918638,-0.089811229970637
BT 239,10322450,3.395640435178443
SEM,3854666,0.6904434014299387
HCC44,9935249,3.223427936251387
PSN1,3854666,1.2146416795166468
PE/CA-PJ15,9884685,0.3729589706560922
GP2d,65628,4.475000453671442
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
WM266-4,3465537,1.2286223371431932
NCI-H1184,10296883,3.900599246219188
SR,9935249,3.2977617807698127
KYM-1,2742550,4.241157390185703
KNS-42,9926054,3.077818601925372
MOLT-3,3465537,3.351210335156386
Hs 683,11404337,-0.8094527425397864
LCLC-97TM1,2742550,3.525188493197443
GI-1,9911463,4.305477844403804
YD-15,54639665,4.469393901086846
OCI-AML-2,3854666,0.7636875666723406
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
DV-90,10296883,3.593064780015178
SU-DHL-8,2746,1.0938758310486527
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
BT 444,24771867,4.597208374840628
U-118MG,10322450,5.196465804540769
SYO-1,1566236,3.1317024897927364
LXF 289,135984461,4.539632657840611
HMC-1-8,54618771,0.1355198199402433
HOP-92,100016,6.879559613863246
KYM-1,2746,1.273696140003964
SK-LU-1,9911463,4.212038568288349
697,JQ-1-carboplatin (1-1 mol-mol),-0.9101343627046008
KYO-1,11152667,-1.6457051301162502
T84,11494412,-0.7217837675976604
KMS-21-BM,65628,3.740044409654922
Hs 895.T,1566236,3.875495749699162
HuCC-T1,54618771,0.1107160240770854
NCI-H322,11152667,-0.4802050567162326
SIG-M5,4705,3.652896158282669
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
U-BLC1,2742550,3.0998896662106676
SW48,2742550,3.28553671385033
HuCC-T1,9911463,3.575644452957985
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
JHOS-2,11152667,0.4249087048745091
CAL-85-1,54618771,1.8439388085147956
HuP-T3,1566236,2.433067651410228
ACC-MESO-1,2742550,5.050370416732392
SW1417,4705,3.4268309691018377
AN3-CA,44241473,5.120578762393663
NCI-H2141,54618771,0.6862443380441183
HCC1395,136227924,3.3223803208690135
CL-11,JQ-1-carboplatin (1-1 mol-mol),-0.9371463412040694
SK-N-DZ,6918638,-2.181446020930978
BT 248,2742550,4.585670765822412
NCI-H2452,9911463,3.657985193851277
CML-T1,65628,2.7154825762494057
HCC95,JQ-1-carboplatin (1-1 mol-mol),-0.3599763977581854
MKN7,9884685,1.546576208419255
SNU-119,selumetinib-vorinostat (8-1 mol-mol),2.4531148017097726
D283 Med,135984461,1.545115225409391
TT,44241473,4.828241178509976
GP2d,11152667,-1.1349019914223002
CJM [Human melanoma],9911463,3.8597474778035217
Mel Ho,9911463,3.195934345244136
MOLT-16,2746,1.4936688600740762
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
NCI-H2126,11152667,0.7845952457095523
WM266-4,10296883,3.7855589365633584
HT,3854666,0.7093323572382654
SNU-387,24771867,5.153283639518161
GSS,JQ-1-carboplatin (1-1 mol-mol),0.1875541485462026
TALL-1 [Human adult T-ALL],9926054,2.0252828062199257
Peer,9926054,0.3844122788400798
BT 416,4705,1.1449833696295684
BT 286,12003241,-0.6969940125697452
Li-7,136227924,3.3307357238068818
LK-2,24771867,2.587311537636826
OV56,24771867,4.0801862654804495
CAS-1,54618771,0.3007933924780016
SK-N-SH,4705,2.8516151129930396
CAL-85-1,24771867,3.9272965541235103
JHUEM-1,65628,4.833015195333772
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
Hs 934.T,selumetinib-vorinostat (8-1 mol-mol),5.598638890689216
KALS-1,12003241,-0.678278256964916
Ki-JK,49836020,-3.31096865556518
Hs 578T,9926054,1.6885826482167057
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467
OCUM-1,10296883,3.433101608728151
SNU-81,9926054,1.3093723678717843
Hs 852.T,12003241,-1.871479503201469
OCI-Ly19,JQ-1-carboplatin (1-1 mol-mol),0.1428825624230537
CAL-148,selumetinib-GDC-0941 (4-1 mol-mol),1.314198336751646
Hs 294T,136227924,2.369017342053728
NCI-H1355,9884685,0.765717776543527
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
NU-DHL-1,100016,6.7557445252971355
NCI-H1623,9926054,1.7409203229588674
HOP-92,24779724,4.387185953628773
RL,10322450,3.279088357497389
WM793,44241473,6.43700199521037
BICR 22,12003241,-0.4808187565312439
IPC-298,135421197,1.9910993623388888
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
OE21,9935249,1.7053577449970625
HCC1569,135984461,4.511721689442577
BT 340,136227331,4.417429547624524
HEC-151,2746,2.893075641123897
TE-11,9911463,3.3577728460138414
SK-LU-1,135984461,4.3992720133799725
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
KE-39,3465537,4.350124533164427
BT-549,11152667,-0.4620191787747055
HEL,9911463,3.4775133545177774
SR,10296883,3.1802245137675533
MHH-NB-11,9915743,1.606610900960874
UACC-62,2742550,3.809853081967923
Becker,1566236,1.7807841622280378
KYSE-510,11152667,1.4867272406888024
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
KYSE-520,1566236,3.7886958488528832
DV-90,9935249,1.6068796550141815
LNCaP clone FGC,12003241,-1.977151768552247
SUP-B15,135398744,6.752582090660733
OCI-AML-2,135984461,3.686177545558833
LS180,9926054,2.059729849775666
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
HCT 8,6918638,0.8681641222033742
MPP 89,3465537,1.30185737748147
SJSA-1,10296883,3.777259880045869
MDA-MB-435S,9935249,3.4809324238867863
MHH-CALL-4,73707386,0.2000268022047914
U-CH1,11404337,0.9399047306468424
CAL-27,9911463,3.9808339840731537
AU565,54618305,4.305835133395234
QGP-1,100016,6.909688760762285
DK-MG,9915743,1.7937332394851484
NCI-H1755,44241473,4.2914614337175
A-204,9911463,3.1571313791441407
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
RCH-ACV,3854666,1.1311620148963422
MPP 89,6918638,0.8493258123756348
CJM [Human melanoma],24779724,4.49881872320391
KE-37,9935249,1.5126551967808797
SIG-M5,136227924,2.112174988724855
ZR-75-30,2742550,4.106554973592453
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
PE/CA-PJ49,2742550,3.734489746257058
VMRC-RCZ,3465537,3.509493141901576
HGC-27,selumetinib-vorinostat (8-1 mol-mol),2.872290349693273
TCC-Pan2,12003241,-0.2350019856779653
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226
MV4-11,9911463,2.299906972293434
NU-DUL-1,10296883,3.165126973502135
SK-MEL-5,4705,2.45435106083484
HEC-251,9911463,4.214524932841787
BT 139,76446078,5.753374932108957
U-251MG,3854666,2.7881952029693657
SW1088,9926054,2.0788174328581515
SW48,11152667,-1.5089069748808788
CCF-STTG1,12003241,0.9586959919868534
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
COLO 741,selumetinib-vorinostat (8-1 mol-mol),2.423544405127772
NCI-H1623,11494412,1.2552972437851018
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
CAL-51,12003241,-1.2189714227076325
KMS-12-BM,9915743,-0.3780298011492129
ACHN,1566236,1.6353428003471475
JHOM-1,10296883,4.346647898166674
SIG-M5,54618305,4.363479672443714
SW48,9868037,2.459515994210572
BT-12,11404337,-1.312123383148081
MDA-MB-468,4378219,2.0452282433447233
NCI-H1703,24771867,1.971765847032719
NCI-H929,selumetinib-vorinostat (8-1 mol-mol),1.6351341952434315
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
JHH-4,9911463,3.8474740585863785
C2BBe1,9911463,3.464782033118563
ES-2,44241473,4.753442252855421
BT 187,9911463,2.9501767294250607
KNS-60,54618771,0.379873149864298
OCI-AML-5,135421197,2.371407792163204
Ci-1,136227924,2.861978373437932
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
ACC-MESO-1,9935249,4.592258833593908
EKVX,136227924,3.396888883126824
Mino,4378219,3.5909916747536976
DMS 454,9935249,1.8638785090695316
TE-11,4705,1.37332661199947
A2058,6918638,1.2547310541014554
HCC202,10296883,4.070733059674107
RL,11152667,-0.9516536352115936
SHP-77,100016,6.499498313563913
SNU-201,9926054,3.435558365800804
Pfeiffer,2746,2.517649488872207
SNU-899,9926054,2.026075556253581
UO-31,12003241,-2.005680138773524
UACC-62,71751553,5.228907111872232
KYSE-140,9935249,3.7147808884364473
HCT 116,54618771,0.4629468645075349
HCC44,54618305,5.3306637356323705
NCI-H1703,9915743,0.7424925656484964
CAL-33,11152667,-1.543751172579295
CAL-12T,9868037,3.211288861847722
SNU-489,9884685,2.750537044283334
TE 617.T,2746,2.7076097617545276
RERF-LC-MS,71751553,4.213964581210796
TE 441.T,11404337,-0.8068289898007032
BT 444,10296883,4.263096612755244
COLO 205,3854666,3.737938865903665
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
RERF-LC-Ad2,1566236,1.925261747039256
SK-ES-1,11152667,-1.0313660438121697
Ki-JK,100016,3.514869011895543
MFE-296,10296883,4.050843841946721
NCI-H1155,9926054,2.490439813838108
SNU-475,6918638,2.175803719234096
EB1,9911463,2.50745807911791
Granta-519,2742550,3.255820788990773
WM1799,54618771,2.4607401092815677
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909
BICR 16,11494412,1.740743547951069
NALM-6,100016,5.173644166821544
VCaP,135984461,3.022939486158339
HuT 78,11152667,-1.8885306635916228
KMS-12-BM,9884685,-1.5036404450716507
GSS,9926054,1.4316065343869406
L3.3,9935249,4.2075706542966955
RS4;11,JQ-1-carboplatin (1-1 mol-mol),-0.1933675643740757
Panc 08.13,6918638,1.0573629526558566
COLO 678,24771867,4.853821302552722
RVH-421,4705,3.3547577531124175
Hs 688(A).T,3465537,3.232721194822597
NCI-H446,1566236,1.4112475546908474
BICR 16,9868037,4.084276624251401
BT 139,2742550,2.665128125190364
HSC-2,54618771,1.8867567266847771
HCC1395,9915743,2.6383057789400746
NCI-H1650,4378219,4.936228712668145
ES-2,9935249,3.3722887493761857
NCO2,selumetinib-vorinostat (8-1 mol-mol),0.8624505474898547
THP-1,9911463,2.82598855830453
JHOM-1,100016,6.419236010839144
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
TE-8,9926054,1.8785619758496184
Mino,54618771,0.6228570132231963
SNU-668,76446078,4.336971954700678
COV362,9935249,3.245525383557066
RD,10296883,3.864434451204585
COV362,54618771,1.3077362978490088
BT 172,2742550,3.366341904499679
FaDu,11152667,-0.3109618737618113
LOX-IMVI,11494412,1.902525347361519
NCI-H1793,11404337,1.9243754153186607
G-361,10296883,3.484714996081857
Hep-G2,selumetinib-vorinostat (8-1 mol-mol),-0.2891046147054946
SUP-B15,9926054,1.7233676505424833
PL-21,11404337,-0.8522775208697388
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187
SEM,136227924,1.2424830449991908
BT 131,136227924,1.4796003986288269
K029AX,9915743,0.8984841793104903
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
SHP-77,54618771,1.054053584588012
NCI-H524,9915743,-0.1513844458241534
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
PK-59,136227924,3.43326158684526
PL-21,4705,2.342779269332656
SNU-869,24771867,4.453470568354372
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
SYO-1,selumetinib-vorinostat (8-1 mol-mol),2.478385861383767
CA46,65628,4.372814936384242
NCI-H2405,9935249,3.7987191129461673
KMBC-2,3854666,3.5091352093149455
HCC2935,11404337,1.520718137800647
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
MIA PaCa-2,3465537,1.2213186133491942
TE-8,11404337,-0.0552230225351692
Hs 683,3854666,0.633440254190545
IGR-1,54618771,0.8622245008505476
NCI-H2106,65628,5.651858118902885
SNU-C2A,11152667,-1.3590856917202871
EB1,4378219,2.0850158870725304
Calu-3,9911463,3.153404929849599
VCaP,136227924,2.2790218879563255
NCI-H2286,54618771,-1.3554512222972157
KP-4,11152667,0.9201986867468503
AsPC-1,9926054,1.8957621767397328
Hs 940.T,136227331,4.452644003789645
OVCAR-4,54618771,1.8457330551632656
NCI-H1694,9884685,0.2353151314762636
LNCaP clone FGC,4705,3.099970805518314
MG-63,1566236,1.8094317598532976
KMS-26,9868037,2.2608372373619035
SET-2,135421197,1.735218850040683
Calu-3,100016,7.471917827082483
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
GB-1,11152667,0.7961300588467334
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
253J-BV,JQ-1-carboplatin (1-1 mol-mol),2.2786098419782403
MEC-1,9926054,1.8123305243841612
T3M-10,135984461,4.376961457869337
KATO III,1566236,3.1364594748652666
KNS-62,11404337,0.0351027480224998
CMK,3854666,0.1868583071129725
Calu-1,11152667,1.3026694822022318
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
HOP-92,2742550,6.370201560373045
SNU-899,135421197,3.636870006524017
JHUEM-7,136227924,2.4332957155572688
DV-90,selumetinib-GDC-0941 (4-1 mol-mol),-0.7506307924929138
Hs 839.T,54618771,1.980967408775539
COV362,9911463,4.09854826662349
KMRC-2,9935249,5.014843219573403
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
GSS,44241473,4.323404466734721
NCI-H2087,24771867,2.194969943963046
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
EC-GI-10,3854666,1.1347089817031333
PaTu 8988s,2746,3.571987596167747
HPAF-II,2742550,5.057683204128017
NCI-H1650,54618305,4.618622661976623
OC 314,9915743,0.9289282136331763
OPM-2,11152667,-1.3080541002664456
HCC1500,3854666,1.4433352503078565
BICR 31,135421197,2.236076370585341
MEC-1,49836020,4.363121412189612
JHOM-1,selumetinib-GDC-0941 (4-1 mol-mol),2.18755430310554
DOV13,selumetinib-GDC-0941 (4-1 mol-mol),3.389057426499923
WM983B,9926054,1.9818225106954688
KP-2,24771867,3.86975788694378
U-87MG ATCC,selumetinib-GDC-0941 (4-1 mol-mol),3.2770460011243308
SUP-B15,44487872,6.366307642327811
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
NCI-H1341,11494412,-0.562249331475485
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108
U-251MG,24771867,4.142511051443775
Daoy,44241473,4.8278731665228465
CMK,2746,1.105123942963827
SNU-308,54618305,4.365090105355177
DMS 114,2746,3.518384680762127
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
HOP-62,135421197,0.8812919220198131
NCI-H2023,11404337,1.2221631791218432
HuNS1,49836020,4.176817793282971
D283 Med,9915743,1.368920834577302
DMS 273,135421197,2.3407622077730035
HH [Human lymphoma],71751553,2.3299764959766107
RPMI-7951,11404337,-1.491748801484046
NCI-H446,11404337,-1.699168171743611
HEC-108,11404337,0.7883165010808656
COV362,2742550,4.118954550351592
DMS 53,136227331,3.826104197881878
NCI-H226,9868037,3.726769382585606
HEY A8,9935249,3.4696021143903333
MKN7,135984461,4.326296832547204
RERF-LC-A1,12003241,-0.839480669213789
KYSE-520,2746,5.1336312613599295
F-36P,71751553,4.682679613514395
SEM,10322450,3.0556839954997685
Hs 729.T,135984461,4.562955987712422
NCI-H2228,54618771,2.218595953642778
OCI-AML-3,11404337,-2.717957747989526
LUDLU-1,100016,6.796390484470128
D283 Med,4705,3.1008912872866325
LP-1,44241473,4.281218782455272
MeWo,11404337,-0.4455476930760103
TT,136227924,2.992692937715844
SW1573,10322450,3.835483834832597
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
HEL 92.1.7,24771867,3.4217183277492036
A101D,135984461,2.9923151826586474
OVISE,9911463,4.4041109725525525
CHP-126,10296883,3.566759468815065
SH-10-TC,selumetinib-vorinostat (8-1 mol-mol),3.8714348747997978
NCI-H2081,12003241,2.480414390654569
IGR-39,selumetinib-vorinostat (8-1 mol-mol),2.363486431650059
VM-CUB-1,54618771,0.9006396829235269
PF-382,54618305,4.182237982253296
LS513,10322450,3.234062312565812
L-428,11152667,-0.972054324518145
IA-LM,49836020,4.225846480888235
Panc 10.05,24771867,4.726809867550207
IGROV-1,11152667,-1.4116509977729443
COLO 699,JQ-1-carboplatin (1-1 mol-mol),5.401700421556877
SK-LMS-1,3854666,1.8023710888832385
HCC1569,10322450,3.661738408949136
VMRC-LCD,9926054,1.8620502952585032
WSU-DLCL2,100016,5.8333868406138585
SK-MEL-28,9926054,3.4888277398466765
EBC-1,135398744,6.3334705093468235
KYSE-30,24771867,3.210346701902163
LUDLU-1,1566236,4.083550355743597
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
HCC44,9911463,3.3099390770105748
BT 271,selumetinib-GDC-0941 (4-1 mol-mol),1.6032684287566925
Sq-1,JQ-1-carboplatin (1-1 mol-mol),0.7735005611319609
HGC-27,100016,3.78981980973908
HEC-108,9868037,3.1019775097215554
Mono-Mac-6,9911463,2.1674354406749914
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
HCC1428,54618305,4.446486653284686
U-CH1,9915743,-0.5689803305661224
A-253,650361,3.561835185419963
COR-L279,54618771,0.9541573251908244
BT-474,11152667,2.684788398514369
Hs 683,136227924,2.524769704566026
CHP-212,24771867,-4.650090613035068
TTC-709,71751553,4.330479823321924
697,11494412,-1.3326007243857068
Hs 944.T,9911463,3.7196895176851608
BT 444,9935249,2.9286697760241176
U-251MG,11152667,1.4499699740293923
U2OS,11404337,1.5271724700309952
HEL 92.1.7,135421197,1.9345150408297491
Panc 05.04,2746,3.125163927586484
PE/CA-PJ41 (clone D2),11152667,0.8748020996772465
SNU-61,4705,2.600761934037586
DEL,2742550,3.398292456577154
SK-N-MC,136227924,2.70298794492574
COR-L105,136227924,2.729950058152846
Hep-G2,3854666,3.2360339128212554
HGC-27,9884685,-2.183204546291056
KP-3,9868037,3.7824186326212494
F-36P,4705,3.5916410235221914
TT,9915743,-0.2506861046068376
OCI-AML-3,3854666,0.3450933416643372
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
BT 340,4705,3.3902514957212153
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282
COR-L105,4705,0.5312031062005766
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
CAL-85-1,11152667,-0.0969922195386295
WM1799,65628,6.439328359215507
Mono-Mac-1,12003241,-3.167077714646063
KO52,9915743,1.1549502462375985
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
HT-1080,11494412,0.5637126058812378
SUP-T1,10296883,3.2156381873423725
SNU-1033,4705,2.6216736811916044
KYSE-140,selumetinib-vorinostat (8-1 mol-mol),3.686519594509002
KLE,135984461,1.6662233005465323
UM-UC-3,11152667,0.5303159770829485
HeLa,3854666,0.8309069429521455
SNU-899,9915743,1.4111818856730072
PE/CA-PJ41 (clone D2),3854666,3.9258785658494166
NCI-H526,3854666,0.5432695443885891
EM-2,54618771,-0.9805043805831684
EB1,9926054,1.6799735914328415
Hs 746.T,24779724,-3.709642201579214
BT 444,54618771,3.3386759439235267
G-402,54618771,0.638636579266015
SNU-503,9926054,1.9244850158263864
D283 Med,3854666,0.4329488785955893
BICR 31,24771867,6.325583215176513
KYSE-520,135984461,4.658716640693311
Aska-SS,24779724,-1.025302849370559
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
ZR-75-1,73707386,2.6324611831301192
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
HEC-265,54618305,4.392591602622262
COR-L88,54618771,0.6942100062595253
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
SNU-626,9926054,2.31791428562488
SK-MES-1,3465537,2.1833251870865595
Mino,2742550,2.804646277870024
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079
NCI-H358,9884685,0.3952053274664801
Capan-1,24779724,4.377169410070466
KP-4,9911463,4.220672229227994
Hs 944.T,54618771,2.424765430874906
HPAC,9915743,0.7621805259187995
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
RL,9911463,3.2834076821465525
SNU-216,100016,6.2010021575017085
BT 320,9935249,2.6939509810826294
OCI-Ly3,4705,3.087724315846988
RD,9926054,1.756104923287422
BL-70,44241473,3.571507575113122
MHH-ES-1,9926054,1.555405413320919
SU-DHL-8,12003241,-0.8632235676270862
NCI-H747,135984461,2.203794550549454
SNU-46,11152667,0.3589036654746563
HH [Human lymphoma],11404337,-1.3544677406632493
NCI-H2342,9911463,3.680960249446254
BT 216,54618305,4.343548232440738
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
KCL-22,selumetinib-vorinostat (8-1 mol-mol),1.6515891446083002
G-361,selumetinib-vorinostat (8-1 mol-mol),-0.6405428240281378
SNU-489,3465537,3.741170628687715
NOMO-1,54618771,-0.7336388686704796
BT 131,9911463,3.3950142124992113
L-540,9884685,0.8390068676478399
NOMO-1,100016,4.546215242968586
HT-1080,24771867,3.524730973031447
L-363,135421197,1.89182184034138
HOP-92,4705,3.0147714927694387
SU.86.86,4378219,3.8427528223693033
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
BT 504,136227331,4.427068433279088
NCI-H1666,24771867,1.7228005580346388
GA-10,100016,3.803284916821312
NCO2,11404337,-0.941549986556875
U-251MG,11404337,1.3506850952063736
HeLa,12003241,1.4760559160729645
CGTH-W-1,100016,5.226111530095554
HOS,4378219,4.903872265267583
TUHR14TKB,136227924,3.4575547117836836
SK-N-BE(2),9935249,2.6019280874439543
SK-N-DZ,10296883,0.393447388652097
SNU-C2A,2742550,4.524601558141107
NCI-H810,6918638,-1.4946550265349503
EPLC-272H,11404337,-0.7906068386477291
MDA-MB-157,9868037,3.2071579521245823
ONS-76,24771867,4.286887453999452
OC 314,6918638,1.2645256695778866
NCI-H446,9915743,1.175250953167702
KYM-1,135421197,2.2292481943308906
HOP-62,135659046,3.835086594204883
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
EFO-21,4705,3.5117788930279037
ONCO-DG-1,49836020,4.455184005808947
BT 330,65628,3.9363187212664488
KYO-1,9926054,1.8377950360183533
BT 333,135421197,2.652327815352438
WM983B,JQ-1-carboplatin (1-1 mol-mol),2.7485302033318084
NCI-H2291,JQ-1-carboplatin (1-1 mol-mol),4.431893565977406
SiMa,24771867,-3.54097045756652
JHH-2,11494412,1.3748169332763898
TOV-112D,2742550,4.171017848046487
HCC1419,2742550,4.650611377955487
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
Panc 08.13,12003241,-0.6066963298008116
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
UACC-62,9935249,3.01689471253563
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
MOR/CPR,100016,6.350482300205422
L-428,12003241,-0.2572573546541544
CAL-33,3854666,0.8364949890662897
CML-T1,10322450,3.1347292789416934
D283 Med,9911463,2.6227366888943986
UO-31,136227924,2.530889708332206
DU145,6918638,0.5820093502251232
SF268,3465537,1.4623363787062609
Rh41,12003241,-2.564539347057637
KNS-60,9915743,0.9849454355481576
NCI-H810,3465537,1.1562872459305875
253J-BV,12003241,-1.283652626050959
YD-15,12003241,-1.418070390851184
IMR-32,11494412,-1.4286694328738665
SF268,selumetinib-GDC-0941 (4-1 mol-mol),2.7601032387039433
SU-DHL-1,11152667,-1.9410189761528236
NH-6,JQ-1-carboplatin (1-1 mol-mol),3.51966216446804
KHM-1B,2742550,3.1994406451662045
8505C,65628,4.25039511481597
ZR-75-1,11404337,1.062777047801886
KM12,44487872,4.22383894781136
PF-382,9884685,-1.5269409733501682
JK-1,24771867,-2.666375708809898
HEY A8,4378219,1.952253599184279
JMSU-1,9884685,0.9431200811659592
H-STS,1566236,1.8552051664221092
A2780,135659046,3.385733838662662
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
VMRC-RCZ,10296883,4.271473325203521
TM-31,11494412,2.439889324117589
RERF-LC-Ad2,135984461,4.955680046889378
NCI-H1373,1566236,3.9226527359425702
A-673,2742550,4.033526638201744
KYSE-520,54618305,3.9456365566574543
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
TE-6,24771867,2.8736447286878057
OV7,49836020,5.356073606057271
CGTH-W-1,4378219,5.066960459759232
HMCB,11404337,-1.2429546984634874
HuT 78,9868037,2.4738144029909908
NCI-H1650,4705,4.261347716805476
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
BT 498,11152667,1.974918691110967
NCI-H1869,100016,6.8338343579730285
L-363,135984461,2.740673882414865
NCI-H1395,9911463,3.814426972193391
BT 131,4705,3.217253929262008
NCI-H211,54618771,-0.4464011185148343
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
Reh,100016,6.483959173055827
HCC1395,44241473,5.106557721006339
BT 286,1566236,1.6712159772486277
MEC-1,11152667,-1.5556986034524167
SK-N-DZ,4705,3.245242705626778
KYSE-140,9868037,2.3848747025475343
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236
NCI-H2141,135421197,1.2037655567537868
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276
KMRC-1,9915743,1.4003501061845525
IGR-37,11152667,-1.3185458372175074
JK-1,9868037,1.2248431410806535
HLF,71751553,4.640978665963766
MDST8,3854666,1.4298592595361392
HLF,selumetinib-vorinostat (8-1 mol-mol),3.5615159911942267
KATO III,9915743,3.5253109145888013
Hs 578T,11152667,-3.116369263954623
MPP 89,11404337,-0.8971916884586333
SNU-16,49836020,4.5096990404507125
SK-MEL-31,3854666,3.574297358855384
DMS 53,11404337,-2.5635745994207677
TE-1,135984461,4.283297519816261
BT 330,135421197,3.0606427160011433
Hs 683,71751553,4.288998179151866
A-253,71751553,5.043913374031373
JeKo-1,135659046,3.5634335603711995
J82,65628,4.2082293918109706
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
LS1034,71751553,4.24322040850765
DEL,selumetinib-vorinostat (8-1 mol-mol),2.397935480215318
EFE-184,11404337,0.1091235831071998
SNU-601,9935249,3.074055139432478
WSU-DLCL2,65628,3.2794423535209947
HuH-6,12003241,-0.3879852820159472
NCI-H1299,9911463,4.155040762407167
NCI-H1666,2742550,2.8978231696200547
Granta-519,3465537,1.1430845598370274
Hs 611.T,54618771,-1.6189149218844685
SR,49836020,-3.5786730229489603
DU145,9926054,1.942219630113699
CAS-1,24771867,4.836580541150291
SNU-407,1566236,1.7858742258512093
Hs 895.T,71751553,4.840538175613458
Pfeiffer,71751553,2.2277672851720647
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
SW1710,9911463,3.971766424444902
Hs 936.T,selumetinib-vorinostat (8-1 mol-mol),0.3450165973720776
BC-3C,11152667,-0.9624710260076396
COLO 678,54618305,4.289136510205439
DU4475,4378219,1.9891275498597476
TE-14,71751553,4.6389654689543205
A2058,136227924,2.613575897416718
BT 228,9926054,2.418157139092261
COR-L105,135984461,4.336047626093702
Hs 766T,24779724,5.962768678879229
SNU-423,3854666,1.5881763460824465
Panc 10.05,4705,4.9433650756166685
G-401,54618305,4.431468655886698
NCO2,73707386,2.320986142131463
RKO,1566236,3.4833841973625725
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
CAL-27,4705,0.9855510405669268
A-172,selumetinib-GDC-0941 (4-1 mol-mol),2.629230075004273
BC-3C,9926054,1.793966289929591
JVM-3,54618305,4.207755520219925
MOTN-1,135984461,3.8565361151501585
HEL 92.1.7,selumetinib-vorinostat (8-1 mol-mol),2.302657261163946
BEN,54618771,1.4690006980639003
U-BLC1,9868037,3.998089604427344
SNU-685,JQ-1-carboplatin (1-1 mol-mol),2.807780609987689
SU-DHL-8,1566236,1.835793020693765
LS1034,selumetinib-GDC-0941 (4-1 mol-mol),-0.3273277386123449
BICR 56,selumetinib-GDC-0941 (4-1 mol-mol),-1.0561550719087085
SR,135421197,1.9567356952392363
NCI-H716,2746,2.8210994981095556
CAL-51,9911463,4.251278022142156
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
L-540,65628,2.916098116617406
OVCAR-5,135659046,3.4462487776762303
OCI-AML-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.789265040727208
Calu-3,9868037,2.901548984515766
SUP-T11,11404337,-1.4432067175867065
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
OVCAR-5,12003241,-2.4332289606556903
OV-90,4378219,2.1499232510348807
G-401,11494412,0.2825252149996007
KMS-12-BM,9926054,1.301975129823355
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
KYSE-450,136227924,3.5350495950730645
TT2609-C02,135984461,4.527681424871781
PE/CA-PJ49,9884685,0.5185977592735194
GP2d,44241473,3.7158482344549153
FTC-238,135421197,2.4336090665615115
COV362,135659046,4.956551237170632
SW1417,selumetinib-vorinostat (8-1 mol-mol),1.0525400374551923
NCI-H647,135659046,3.6743271693589854
NB1,54618305,-4.477531236870953
U-BLC1,135421197,1.4306901409483936
PLC/PRF/5,9884685,0.8097728854232519
SW579,3854666,0.6717110182568982
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
KMRC-3,2746,3.925965159660651
Granta-519,9935249,0.0212855082517002
U-BLC1,24779724,5.444020620154264
Hs 611.T,136227331,5.417316134562269
CCK-81,11152667,-1.7483684618349902
KLE,9868037,3.52213609317776
SiMa,136227924,1.9858625956320377
MIA PaCa-2,12003241,-0.7993036743010778
COV434,9911463,3.0126718428319905
SUP-T11,24771867,-1.2217891109870544
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
SW620,135398744,6.387116600988426
SNU-410,2742550,3.711358313306516
RPMI-8226,3854666,0.1565872953150206
PE/CA-PJ15,54618305,4.31153259720802
L-428,2746,2.35147790863918
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
TUHR14TKB,11404337,-1.071885756009756
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
TC-71,135421197,1.432077175902578
BT 164,9884685,0.1084711288481639
BT 440,12003241,-2.6320772698218793
A3/Kawakami,11404337,-1.3571350042405983
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
NCI-H209,9915743,-2.0620663235985797
BT 164,9915743,0.6934008137449594
JHH-6,10322450,6.3752081259808415
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
TOV-21G,2746,4.617945270091336
TF-1,65628,4.208115912164116
NCI-H2110,10296883,4.192584749950301
NCI-H1568,2746,2.7741418395417163
ACC-MESO-1,100016,6.4652465436588775
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
NCI-H1299,44241473,4.35326709675966
EM-2,selumetinib-vorinostat (8-1 mol-mol),-1.2351306123509636
LMSU,6918638,1.4149573073550044
HuT 78,2742550,1.9478816710996465
KO52,10322450,3.562187913985661
Yamato-SS,54618771,0.3737524907753581
SNU-449,11494412,2.814472666417892
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
BT 416,135659046,3.716005987498819
T3M-10,135421197,3.6176522796441546
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
Panc 04.03,2742550,4.347188786942969
A-549,11404337,-0.2898707579606809
A4/Fukuda,12003241,-4.192136354440014
EB1,3854666,0.1328331375955075
SNU-16,1566236,1.6760978918576763
NCI-H1869,71751553,5.160002179984854
HDQ-P1,650361,3.658442619133936
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
NCI-H1694,11494412,0.349051552710581
NCI-H1944,135659046,3.626487516875678
SNU-668,136227924,2.8591825047695925
HCT 8,136227924,3.7452024891634785
NCI-H196,54618305,5.68839138137451
LP-1,135984461,3.5540732743417665
LP-1,11494412,0.682179564781432
SNU-685,9926054,1.8961816645578051
Daoy,9926054,2.457854765834399
K-562,2742550,1.8061055262772656
HEC-251,9926054,2.414490090670839
T3M-10,selumetinib-GDC-0941 (4-1 mol-mol),0.2338392597437749
EFO-21,40482356,5.811915559046589
HMC-1-8,3854666,1.172285232162034
NCI-H1568,9911463,2.564901149372131
SNU-213,11404337,0.895138111314107
SH-4,6918638,2.256041037231368
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
JHUEM-7,1566236,1.715043210679705
L-428,135984461,4.314670254949914
KO52,12003241,-1.0632598943321483
Rh41,136227924,2.134040377876842
SNU-601,11494412,1.3592671808376295
UM-UC-1,71751553,4.283600193961869
RL,selumetinib-GDC-0941 (4-1 mol-mol),2.248792439261428
Hs 888.T,71751553,4.666696298230253
OC 314,9935249,2.41512675276784
OVCAR-4,9926054,2.3051007827251095
HCC2218,9915743,-6.199285187365854
MIA PaCa-2,49836020,4.16350045307359
HCC1954,54618771,-0.9668163478355224
NCI-H838,11404337,0.7986935268513927
TYK-nu,49836020,4.345378886251337
SNU-46,9935249,3.0603122105068445
BT-474,4378219,-0.527763479928482
42-MG-BA,24771867,4.531889451521487
WM266-4,6918638,0.8919001534334414
JVM-3,44241473,6.369222560813174
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
KNS-42,4705,5.099780843040584
HL-60,54618771,-0.823810735668653
BT 328,135659046,3.8583019402961343
BT 428,11404337,-0.9400136442546092
MFE-319,10322450,5.941485697503465
EN,11404337,1.8995795363110224
MCAS,24779724,4.433406171067244
BT-12,49836020,2.972579306483729
MOLT-3,6918638,-1.6571682023232988
NCI-H716,136227924,3.096712149885638
M-07e,135421197,0.940164437961766
HOP-92,3854666,3.1115994029267413
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
GB-1,136227924,3.951727784027331
Ci-1,54618771,0.8239917117342518
SEM,1566236,0.4832736150587708
HCC38,71751553,6.251019673223731
CAL-62,3465537,1.3103085266470418
Kasumi-2,10322450,3.5434418993684114
CW-2,54618771,-1.320149123720888
LK-2,9884685,0.5793401438981376
MOLT-3,11152667,-1.3348646255930374
RT-4,11404337,1.401838262846579
SK-MEL-24,11404337,-2.842069291243037
ESS-1,3854666,1.0692309253016814
SCC-4,3465537,2.011653473536215
BT-474,54618771,0.7682511511531626
JHH-6,3854666,4.002777094361515
L-428,9868037,2.0739066262106265
SNU-761,1566236,1.6191563733264562
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
Caov-3,49836020,-0.0609342715049496
SK-MEL-30,24771867,5.520405854692791
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
SF539,6918638,1.218816827551867
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
GDM-1,54618305,-2.5154618566340323
RCH-ACV,9935249,2.7024850725527165
BL-70,JQ-1-carboplatin (1-1 mol-mol),0.8530226058768635
BFTC-905,9911463,3.2243947261734114
MDA-MB-231,54618771,1.2900163685753538
WM266-4,135659046,3.439590672760098
8-MG-BA,65628,4.1211650686240615
SaOS-2,135984461,4.8186429168984475
TOV-21G,54618771,2.0367745651121867
L-540,selumetinib-GDC-0941 (4-1 mol-mol),4.246283194196457
MOLM-13,136227924,1.704251401840426
BT 164,9911463,2.6939037161672617
OPM-2,11494412,0.3054873199299708
Mel Ho,3854666,0.8589361448710405
NCI-H1355,10322450,3.720862951663928
MOTN-1,54618305,4.123984854180418
HSC-4,9935249,3.700870290975298
NCI-H1944,44241473,4.248526254827086
ZR-75-30,136227924,3.5756469644058613
COV434,9915743,-0.2434354150711091
LS1034,65628,4.320188837845099
NCI-H1623,10296883,4.489600285768525
SNU-C5,54618305,4.2620968898118665
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
AU565,135659046,3.967998335471068
TE 617.T,9926054,1.7506239081922086
M059K,135421197,3.1464794228942488
SNU-886,11404337,1.5055907567781088
LOX-IMVI,2746,2.55877549764083
SUP-B15,11494412,0.7807550096042158
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
IM95,71751553,4.314578700875926
CAL-62,11152667,-0.846495362159148
KYSE-520,100016,6.554858217735662
KP-2,selumetinib-GDC-0941 (4-1 mol-mol),0.2413129500799869
KATO III,selumetinib-GDC-0941 (4-1 mol-mol),2.4282234364089863
LNCaP clone FGC,9935249,1.606284127709269
KMRC-3,1566236,1.699322098754536
U-251MG,10296883,4.141522340635607
SCC-4,71751553,4.298955474315719
Kasumi-2,9926054,1.3771704127752784
NCI-H2106,12003241,4.508121614525734
Calu-3,136227924,3.506459850502243
DU145,136227924,5.593457102459236
BT 328,11152667,1.7027658226426858
U-BLC1,4705,-2.296462105953433
TE-15,9935249,2.05768814929574
VMRC-RCW,9926054,3.031512586509183
SNU-423,11404337,0.0022687984612849
DMS 454,9868037,2.022820925899878
HOP-92,65628,6.008725293872382
SNU-C5,1566236,1.7369222481964657
EFE-184,9911463,4.31832221914332
NCI-H929,3854666,0.9590353539059504
BT 245,1566236,1.7422793804281065
HCC366,selumetinib-vorinostat (8-1 mol-mol),2.631541890513729
A-549,12003241,-1.903076073453771
A-204,24779724,4.583598164298229
NCI-H650,11152667,-0.0238050356920854
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
UACC-62,selumetinib-GDC-0941 (4-1 mol-mol),-0.701178032611257
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596
NCI-H1666,9915743,-2.9000343533744353
LS411N,11152667,-0.1489697958567156
MDA-MB-361,JQ-1-carboplatin (1-1 mol-mol),1.1182697854337842
HCC1195,12003241,-0.4871999069137717
HT-144,10322450,4.703374814219381
NCI-H1694,9911463,3.249384626336109
SET-2,10296883,3.6220267482667943
OV56,54618771,2.692220458386417
5637,24771867,-2.219917934519628
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
L-428,9926054,1.7396260856582195
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
OAW42,11494412,1.718292738866412
JK-1,136227924,1.8733417156502243
HT-1197,2742550,3.6280622418897743
BT 498,selumetinib-vorinostat (8-1 mol-mol),4.296908663159793
DU145,11152667,0.2266180408489874
CAL-54,54618771,-0.0146618789918735
KYSE-70,11404337,0.2060464556058333
HLF,100016,6.001250521147636
KMS-20,10322450,3.2597318465423353
SK-MM-2,2742550,4.185293113762589
NCI-H1838,49836020,4.844484842212348
BT 179,71751553,4.552917707943204
ME-1 [Human leukemia],24771867,0.1893276377910557
NCI-H1666,12003241,-2.860788946487449
SK-MM-2,3465537,0.5878825614670627
A-549,44241473,4.768992901407106
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
KMS-11,136227924,2.4847849493179406
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
SK-N-FI,11152667,-1.0361820542951687
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
JHH-1,9911463,5.178733241899389
EKVX,24771867,3.0893222984130797
2004,9935249,1.9457637987820169
LK-2,12003241,-1.6123297720888603
Hs 683,9884685,-0.0613437771219763
CL-11,11404337,-0.8805356384482084
NCI-H1869,9935249,4.228137987840005
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
Rh30,44241473,4.682131674115786
WM88,11494412,0.914272881101828
KYSE-30,11494412,4.405043553296497
NCI-H1666,135659046,3.3700367762048877
KO52,65628,3.991598666523216
DLD-1,9911463,4.0801300312150115
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
T98G,9911463,4.1746073665153105
NCI-H23,selumetinib-GDC-0941 (4-1 mol-mol),-0.1629435385383226
RCH-ACV,135421197,1.024054023197644
Caki-2,3854666,4.077354495139288
DU4475,9935249,-0.972287605705258
OV56,2746,5.269655177673237
Kelly,9884685,-0.5846979087196816
IPC-298,11404337,-0.8384519836472744
DEL,100016,3.851368536137221
JHH-2,44241473,5.589939993003952
OAW42,9926054,1.8927643653266228
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
NCI-H1092,4705,2.99261822421246
Karpas-299,3854666,0.1554068619507315
NCI-H146,54618771,0.1782763900918093
Panc 02.03,11404337,1.528571500956484
NCI-H1435,3854666,3.178817498087244
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
DV-90,11494412,-1.43146933490536
RERF-LC-Ad2,9915743,1.500109019763864
SK-CO-1,11152667,-1.1935109806009474
HEL 92.1.7,9884685,1.1070075347275754
MFE-319,11404337,1.7191748497396555
NCI-H1568,9915743,-0.8427224057935273
OV-90,11494412,2.6360991056690053
NCI-H2444,selumetinib-GDC-0941 (4-1 mol-mol),3.5798793535857625
FTC-238,136227924,2.431059366258334
MOR/CPR,12003241,1.56456971518695
LAMA-84,12003241,-5.010316876482206
TE-9,44241473,4.8498549368791934
LMSU,9926054,1.9493229998791417
HDLM-2,3854666,1.016562395835814
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
HSC-4,12003241,-0.0373048915881231
Namalwa,9926054,1.683884099727144
OVCAR-5,9868037,3.692137842921165
Mono-Mac-1,JQ-1-carboplatin (1-1 mol-mol),-0.3034213126939502
JHUEM-7,2746,3.3298840403754153
SK-LMS-1,10296883,4.497007332627828
SH-10-TC,44241473,4.426083440248119
NCI-H1105,136227924,3.5995085606393955
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
BT-474,9868037,4.006182036110513
UM-UC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.98446738693651
YH-13,11152667,0.725065654418547
SW1271,9911463,3.695583497273472
Hs 294T,135421197,2.57319967501113
42-MG-BA,4378219,2.0206302095661988
DU145,2746,3.3697589984535528
SNU-1272,11152667,1.552242826912863
LNCaP clone FGC,2746,2.220031738697338
T3M-10,9935249,3.366318489883339
COLO 668,135421197,1.2477515484477224
NCI-H838,selumetinib-GDC-0941 (4-1 mol-mol),1.9940738428957552
SNU-869,10322450,4.162727619764448
786-O,100016,5.342252836782742
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
BT 245,11494412,1.2412391063444357
VMRC-RCZ,136227331,4.757387304339598
A-498,9935249,3.347418171794467
OE21,9915743,-2.7713034399639
EBC-1,9935249,3.3043470601843885
WSU-DLCL2,9884685,-2.0768912685811056
UO-31,11404337,-1.2748998268508818
HSC-2,6918638,1.1394559383012468
KE-39,9911463,3.415693188275342
BT 147,selumetinib-vorinostat (8-1 mol-mol),2.9014977587834374
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
NCI-H1915,12003241,-2.138789855422618
JHH-4,100016,6.356907567320683
NCI-H2110,100016,6.079052375839209
H-STS,54618771,0.7523066402016166
M-07e,9915743,1.0767758822983564
KATO III,JQ-1-carboplatin (1-1 mol-mol),1.5255725604391266
SNU-466,9926054,2.420216987024882
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
EBC-1,9915743,1.337451785479007
SK-N-FI,54618305,4.445177677039758
Panc 08.13,9935249,3.22505822571949
SNU-738,9884685,3.081994636813429
SIG-M5,12003241,-2.3044245068014826
G-292 clone A141B1,11494412,1.715634331094443
Calu-1,4705,3.5470871536142563
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
QGP-1,11404337,0.7683818583115465
CAL-29,3465537,1.8717239313692025
KPL-1,4378219,2.1677219133521404
MOLM-6,1566236,0.8087277514740788
NCI-H1869,2746,3.565752906078767
HEC-1-A,9935249,2.849198991074919
CAL-78,JQ-1-carboplatin (1-1 mol-mol),0.9735097666189562
IGROV-1,2746,2.8413672686351212
SNU-886,9884685,0.7167053677402274
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
M-07e,12003241,-1.0456216878354962
NCI-H2081,135421197,1.057518505455496
NCI-H1666,selumetinib-GDC-0941 (4-1 mol-mol),-1.4234011879049815
Aska-SS,9926054,1.7306138768842658
OVSAHO,9911463,3.940240147394606
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044
WT2-iPS,6918638,1.254016270163871
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779
BT 286,9935249,1.1744552926242438
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
BT 498,9926054,3.200560952387037
Hs 688(A).T,11404337,0.289109562279099
SET-2,6918638,-1.854101300935
SCC-9,10296883,4.238304408621306
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
WSU-DLCL2,9915743,0.1660660253888135
KP-4,136227924,3.1314573836961235
JVM-3,9926054,1.6493371537606276
NCI-H650,9911463,4.297971078148598
NCI-H460,135421197,3.2510260026522233
JHH-5,2746,3.1730265714990047
NCI-H2110,135984461,4.3368706411004325
SNU-489,12003241,-0.3449149032803904
VMRC-RCZ,12003241,-1.8843773680512867
NCI-H146,9935249,1.0600603569941576
HuT 78,71751553,4.273670469751914
MFE-296,2746,4.362260792624359
Calu-1,100016,7.639038839177244
EBC-1,10296883,3.5123553698394336
MeWo,4705,3.307515593807436
KMM-1,selumetinib-GDC-0941 (4-1 mol-mol),3.455450229836309
KMRC-2,selumetinib-vorinostat (8-1 mol-mol),3.246916366131707
SU-DHL-1,9911463,3.067527187401269
JHUEM-2,54618305,4.313629109650022
KMS-11,100016,4.183673123455152
LMSU,11404337,0.046862413597458
MDA-MB-361,6918638,0.2584524690871702
NCI-H2081,2742550,2.443856607923171
A4/Fukuda,54618771,0.259551202975953
Hs 611.T,10296883,2.1070249605904574
L3.3,135398744,6.452563021638662
Ishikawa (Heraklio) 02 ER-,9868037,3.205963776347529
CJM [Human melanoma],100016,5.681499096329984
MIA PaCa-2,6918638,-0.2858557386208528
SF539,9935249,2.423475425325452
HL-60,2746,1.7934505084154275
SNU-61,9915743,-0.5579526190142376
SNU-449,9911463,3.778924364931394
BT 416,12003241,-2.2907483254938774
A-549,9911463,3.875766071211208
NCI-H747,9884685,-1.1997486818556398
SNU-182,selumetinib-GDC-0941 (4-1 mol-mol),-0.56211795944893
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
SaOS-2,4705,3.668938036329027
NCI-H2444,1566236,3.679443534316406
NCI-H2081,9926054,1.7325996665522785
A-172,3854666,2.6125463077827664
SNB-75,136227924,3.131186635449868
TE 441.T,71751553,4.471943805545609
CAMA-1,selumetinib-vorinostat (8-1 mol-mol),2.4457892828715746
SCC-25,JQ-1-carboplatin (1-1 mol-mol),0.0141568039533375
WSU-DLCL2,24771867,-0.6006173323124957
NCI-H524,10296883,3.65691401974992
NCI-H460,11404337,1.7201854837770862
BT 320,24771867,4.382883452747231
ONCO-DG-1,54618305,4.684283592340112
NCI-H1694,4705,3.5318874612096924
Kasumi-1,selumetinib-vorinostat (8-1 mol-mol),1.0640333870614955
HEC-251,135984461,5.040099547557525
JHH-2,135421197,1.6322230690261417
Hs 294T,11494412,1.2087769391494103
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
NCI-H1341,24771867,-0.7901827861087273
Kasumi-1,71751553,3.614972495109249
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
SH-4,49836020,4.187960947372796
HPB-ALL,12003241,-0.6872291231969794
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
OCI-Ly19,4705,3.3718260967656715
KE-97,9868037,2.0832362410238736
HCC827,12003241,-4.000089472829944
OVCAR-4,11152667,-1.393586523711413
NCI-H1694,11152667,-1.6159587435744196
PL-21,135398744,6.318867550173511
KMRC-2,12003241,-1.7913952791170802
LN-229,9935249,3.4182081996918794
U-118MG,9915743,2.4267236248915753
FU-OV-1,9926054,2.079351745951841
JHOS-2,9926054,1.95390752128008
HCC1806,44241473,4.547530745149975
TE-9,12003241,-0.5375086976849406
YD-8,9926054,2.068126295394322
MDST8,9926054,1.8075400364112937
RS4;11,4705,2.710513990501979
DB,49836020,4.238014398783195
NCI-H2291,9935249,4.011307681542379
Panc 10.05,2746,4.189917582449672
SNU-16,9911463,2.3292898367461823
VCaP,9915743,0.8539213695890696
SNU-C2A,12003241,-1.200287436461147
NCI-H1693,10296883,3.9815475003033143
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
Pfeiffer,9884685,-2.975976494157007
LN-18,9911463,3.9395482508876714
JHUEM-3,4705,2.325459550435627
EFO-27,136227924,3.515702384882397
BT 440,selumetinib-vorinostat (8-1 mol-mol),2.9296723538082543
BT 286,11494412,1.6157020309527923
NCI-H358,135421197,3.655226783621308
NCI-H1155,9884685,-0.5170479452111597
SUP-B15,4705,3.3539496545861542
LN-229,136227924,2.284287102346984
AU565,4378219,1.7809295710052302
SNG-M,135421197,2.4480650600360705
OE21,10322450,4.259055597018236
VMRC-RCZ,54618305,4.302419161500339
OVK18,2746,3.0954313714228316
P12-Ichikawa,9935249,2.689969364287355
NCI-H1693,49836020,4.720041053935088
Rh18,JQ-1-carboplatin (1-1 mol-mol),2.2033827405363087
UM-UC-1,11494412,0.969963404603011
SNU-1033,71751553,4.333449645170772
SaOS-2,9926054,1.5065280757428428
SUP-HD1,11404337,-0.4036873763873929
SK-MEL-3,9926054,1.7891311822278144
Ku812,9868037,1.2688072678140785
SKM-1,24771867,-3.0651139758567068
HOS,135421197,1.1481730372475163
SK-LMS-1,1566236,1.8712285641000048
ESS-1,9926054,1.828443058535804
HuH-28,9935249,3.1558005109772376
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
HEC-251,3854666,0.8388050556715588
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
RL,12003241,-0.503691110401914
LoVo,44241473,4.10673515965005
Caov-3,11152667,-4.560027237060856
AU565,2746,2.9112036552039737
ESS-1,11152667,-1.1144895141014577
REC-1,2742550,3.767979931246989
M059K,12003241,-0.3753342750649466
HCC95,2742550,2.964424160692779
SNU-387,9935249,4.473593036706646
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
SF268,1566236,3.2619426521234343
Caki-1,1566236,4.675917153008097
BHT-101,3854666,1.5142603567930877
HOP-62,11152667,-0.1983015993822777
SNU-1077,3854666,3.1308724985393255
DU4475,9915743,0.8769529722012402
UACC-257,11152667,1.927303386211879
BCP-1,11152667,-1.2520018158393194
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
HOP-62,10296883,4.184861943544038
TE-5,10296883,3.820447093434926
TE-8,selumetinib-vorinostat (8-1 mol-mol),1.8671517519131735
DMS 454,9926054,2.735237319148254
IGR-37,9935249,3.174032242283855
HCC1954,9868037,6.210309136598162
OCI-AML-2,135398744,6.3440072866172965
Hs 895.T,76446078,4.247583921980978
VMRC-RCW,selumetinib-vorinostat (8-1 mol-mol),2.6578648618984526
SNU-761,9915743,0.9081807401116692
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
K029AX,54618771,0.9903222324801182
MDA-MB-157,136227331,3.870321503168366
SNU-1033,11404337,-1.419235655385228
DK-MG,135398744,6.3715043377255665
G-401,2746,2.560873344661061
EFE-184,selumetinib-vorinostat (8-1 mol-mol),2.9021971847254893
Hs 839.T,11152667,0.795668591768864
SW1783,24779724,3.9128595943603544
SW948,9926054,1.8406028662949705
JHUEM-1,71751553,4.152599364438323
MOLM-6,9911463,2.9457292800178605
MDST8,135421197,2.23565927197073
U266B1,54618771,0.5848544182666181
NCI-H28,9868037,2.6779673338971826
BICR 16,selumetinib-GDC-0941 (4-1 mol-mol),2.023123629912069
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
BT 330,54618771,1.126600316617638
JIMT-1,selumetinib-vorinostat (8-1 mol-mol),2.6253101469518136
BT 172,136227924,2.3975770198101545
SK-N-SH,1566236,1.1494040104220686
SW1710,54618305,-4.785600787088483
NUGC-4,135984461,2.7361037757189184
HSC-2,9915743,-1.4415795953156172
COR-L51,2746,1.8698991434806345
KYSE-30,136227924,3.298083829392356
RL,9884685,-0.1858015850473789
TC-71,9935249,1.560837001432667
HEC-59,9911463,4.219022102468233
2004,71751553,3.819859094471768
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
ECC10,10322450,3.1238725703849988
DV-90,9911463,2.614812777882286
NCI-H1975,12003241,-2.295585009641022
COLO 320,9911463,3.3012856335719096
G-401,135984461,4.271777659576195
MDA-MB-435S,10296883,4.225013123345449
LN-229,135984461,0.9798021343059176
GMS-10,9911463,4.363409531102835
JMSU-1,9915743,-1.579364390846883
T98G,135421197,2.3831918060045663
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
P3HR-1,1566236,2.3415442579386987
HCC2935,9884685,0.4654305165451881
KMRC-20,11404337,0.8151706043014814
RERF-LC-Ad2,6918638,1.8472690467547748
SNU-C5,selumetinib-GDC-0941 (4-1 mol-mol),1.7590235463431136
L-363,selumetinib-GDC-0941 (4-1 mol-mol),2.240470367275986
SNU-C5,136227924,3.8791329718590264
HT,9915743,0.0669624214071764
COV644,9915743,2.089583867030486
Hs 944.T,100016,5.802201252997301
NCI-H1373,135984461,4.3853156416266
OVCAR-8,11404337,-0.7516792511202276
NCI-H460,135421197,3.2510260026522233
BICR 18,6918638,-0.187981376082111
Hs 888.Lu,1566236,4.1191371889760475
WM115,6918638,1.2765614986990457
SW1353,selumetinib-vorinostat (8-1 mol-mol),2.5043308707131673
JJN-3,135984461,3.369618368566917
KYSE-180,12003241,-0.805265861116592
MOLT-16,73707386,2.2080155946135007
NCI-H889,1566236,1.5127666053152062
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
KNS-60,selumetinib-GDC-0941 (4-1 mol-mol),3.6071015552128873
MV4-11,54618771,-0.7918947949340449
KP-3,JQ-1-carboplatin (1-1 mol-mol),5.58247855672367
NCI-H841,12003241,-1.6250883775981226
SK-MES-1,136227331,4.390258592428933
MHH-CALL-3,136227924,2.519521666896543
SF539,10296883,3.7658288303305976
RS4;11,54618771,-1.3838955198533192
HuCC-T1,44241473,5.882941541358504
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
HSC-2,44241473,4.575397695274467
AU565,135421197,1.4743648854968991
F-36P,9884685,0.0275163434096536
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
BT 504,11152667,1.2887357418273375
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
MV4-11,9884685,-1.1493564195895725
OV-90,9911463,4.122087400059479
LXF 289,2746,3.190299829163617
Hs 936.T,11404337,0.4334403969580954
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053
Mono-Mac-1,65628,3.8711624211456215
NB1,11152667,-1.640539309256127
FTC-238,71751553,4.356328665274234
KYSE-520,selumetinib-GDC-0941 (4-1 mol-mol),2.0690481757247037
MDA-MB-157,54618771,3.1146330047846877
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
NCI-H522,3465537,1.2201304719285595
NOMO-1,4705,2.5023829157060926
NCI-H446,24771867,-1.307584402439545
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
NCI-H1915,9911463,4.383927524299923
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876
IGR-1,9926054,1.7421331192656782
LoVo,54618771,0.7060685526757626
OE33,6918638,-0.1523417231642655
LN-18,54618771,-0.903169975136804
BT 333,9926054,3.6254500020575366
Hs 729.T,24771867,6.1288796035686515
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
LCLC-103H,3854666,3.318934857088878
NCI-H1703,1566236,1.934428397387429
BV-173,135984461,2.039918751992627
LP-1,49836020,4.554043159133258
HuG1-N,9915743,3.4035980439406432
NCI-H1915,135659046,3.854368010615629
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
HuH-6,JQ-1-carboplatin (1-1 mol-mol),1.9936450141574449
OCI-Ly3,65628,2.4701870047236696
SK-MEL-2,9926054,1.8796163413954976
SK-MEL-24,9935249,2.8085259534778246
Granta-519,49836020,3.8229564713378057
SK-ES-1,9915743,-1.1737874171427145
SK-HEP-1,136227924,3.6301481247272287
A3/Kawakami,9926054,1.6582602288279693
Mel Ho,9926054,2.124486503190193
697,12003241,-3.737782369602395
PE/CA-PJ15,9935249,2.936045396377626
CML-T1,24771867,0.0964586614823225
NCI-H23,4705,3.013128646573162
BC-3C,24771867,3.611120049755405
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
DMS 454,136227924,3.2899111891910424
SNU-1,6918638,0.043682815737195
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
Daudi,135421197,0.2989842149032058
MeWo,24771867,3.098464965711784
OCUM-1,selumetinib-vorinostat (8-1 mol-mol),-0.881751433026724
SCC-25,12003241,-2.271238083973026
SNU-216,9915743,-0.7074992417120266
G-402,2746,4.175584503802389
KMS-34,9911463,2.3879833599840934
Hs 936.T,54618305,4.362446334432475
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
SCC-9,2742550,4.1692460597635135
KATO III,9911463,4.145072857900557
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
KMH-2,11404337,-1.9075326301634037
CHP-212,12003241,-2.3110623292084695
SW1088,4378219,4.119513755940814
HSC-4,2746,3.845189406581069
LoVo,3854666,1.417426416420887
Hs 294T,4378219,2.0077448006250465
NCI-H1568,9884685,-0.6579514975056241
697,9926054,1.6701290934346382
SK-MEL-5,3854666,2.922871568885423
MHH-CALL-3,9935249,3.71823055651671
TE-1,54618771,1.3906017960660586
PE/CA-PJ49,71751553,4.17175921879406
BFTC-909,24771867,4.730369684143592
VCaP,11494412,1.610321577610624
A101D,2746,3.2076862054046877
SNU-899,136227924,3.189426259363562
HCC38,9915743,2.4807170857977865
HuG1-N,10296883,3.840828409406213
CML-T1,9911463,2.5893115421622737
Hs 888.Lu,9915743,1.135469165316104
SYO-1,11494412,0.2771607459161898
CHP-126,9868037,2.7962624557740385
TT2609-C02,1566236,4.89299711958549
TCCSUP,135421197,2.510598154952076
Detroit 562,9926054,1.947776964101976
JHOM-1,11404337,0.0884008871371316
OCI-Ly10,2742550,6.051416351700485
NCI-H322,9884685,1.1030205864116356
SNU-423,10322450,4.431866174300737
BT 359,9884685,1.2132482277376444
MOLT-3,9884685,-1.4743376865802589
SK-N-DZ,12003241,-0.5399118336559388
SNU-407,9935249,2.8918359205304984
Lu-65,12003241,0.1595843887204832
EFM-192A,44241473,5.222534563675172
RPMI-7951,9868037,2.673802488787611
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
SH-10-TC,100016,6.555483038363527
HT-29,9911463,4.192139664463844
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
BT 428,100016,4.306836909333982
HCC44,136227924,2.988750330313465
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
HCC1954,9915743,-1.9238050645061189
MCAS,9926054,1.882674367902201
OE33,54618771,0.6463967742027482
RS4;11,4378219,1.298247552754701
Kelly,9926054,1.469291049176786
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
OUMS-23,selumetinib-GDC-0941 (4-1 mol-mol),1.2093335289094016
SNU-C5,24779724,4.378944664444423
SNU-685,9915743,3.119233801889696
NCI-H1299,100016,6.953805951258825
DU4475,24771867,-3.2695638279373993
BT 333,9884685,4.2715186714197815
U-251MG,6918638,1.4300554442043
TE-11,136227924,3.028335758763499
RPMI-8402,65628,2.821796268032044
HCT 116,135984461,4.355158085376645
NCI-H1915,135421197,1.7136891979004163
NB1,9926054,1.7584183979270531
SK-N-AS,10322450,4.76025598295129
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
RS4;11,100016,4.815282587104974
OV56,11404337,1.1969378200934953
KO52,1566236,1.4428264325400242
MOR/CPR,54618771,0.4872515527398967
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
RCC10RGB,4378219,3.5112219508307017
ALL-SIL,12003241,-5.746631994241774
DU145,9926054,1.942219630113699
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
SNU-503,4705,4.54925442873891
BT 224,100016,6.546386559669457
SW1116,54618771,-0.9904180488449444
TYK-nu,3465537,1.2645774096433158
697,135659046,2.7406453886964837
OE21,4705,-2.1528136210817324
EKVX,11404337,-1.1482953673467733
SK-N-MC,71751553,4.671564506916946
Hs 683,12003241,0.8693905406704602
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
EBC-1,selumetinib-vorinostat (8-1 mol-mol),0.7518479217217616
TE-9,9926054,2.1843594630677674
Kelly,12003241,2.7454811269637145
TYK-nu,54618771,0.511557548457066
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
A-673,9926054,1.7717409858597033
KP-N-SI9s,11404337,-0.8140726577630073
LN-18,135984461,4.397956692211827
OAW28,9926054,1.976123345191561
BICR 22,9884685,0.2149660223226223
DV-90,4705,1.8434366903908024
L-1236,100016,5.644363792904431
Hs 839.T,selumetinib-GDC-0941 (4-1 mol-mol),3.521332428924413
Granta-519,1566236,1.1036082649410253
NCI-H1563,12003241,-2.3981612742304614
C2BBe1,71751553,3.745740113359517
NB4,49836020,-4.1463475414292
HEC-151,2742550,3.8773994743488966
RL95-2,100016,4.898266673475204
COLO 792,12003241,-1.2493881793514412
AML-193,135984461,4.549999355322756
NCI-H716,135421197,1.426114705682071
MDST8,9911463,4.372295154952754
Hs 888.T,9926054,3.017509441424242
SNU-840,44241473,5.119759475600114
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
SK-UT-1,6918638,1.3984076220807655
SNU-478,9935249,3.458613578481264
NCI-H2291,100016,7.4079580735543695
Hs 839.T,selumetinib-vorinostat (8-1 mol-mol),5.039190007116338
HCC1438,selumetinib-vorinostat (8-1 mol-mol),2.8249795691061736
NCI-H1573,9935249,2.8036192050574336
NMC-G1,9911463,4.44969477965095
BICR 16,1566236,3.7013157010931743
HeLa,6918638,0.9489193596088062
Hs 578Bst,9884685,1.886380711190355
NCI-H1694,selumetinib-GDC-0941 (4-1 mol-mol),2.084938486650406
BT 271,2742550,3.149966758396329
SK-N-BE(2),1566236,1.702802410845402
OCI-Ly3,9911463,2.5217077768511635
PSN1,10296883,4.046781040996588
SW982,2746,3.3231218148802144
TE-1,135421197,1.2529610572902146
OCI-Ly3,9884685,-0.2062933199760503
JHUEM-7,selumetinib-vorinostat (8-1 mol-mol),2.3580216719117284
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
COLO 684,135659046,3.00478194293248
NCI-H1395,10322450,2.951434286433811
EoL-1,9911463,2.487921562669019
JL-1,3854666,3.213509564597454
Kasumi-1,12003241,-2.8903721425855284
TE-11,135421197,3.0798207714757906
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
Hs 888.Lu,24771867,3.944772564320003
DB,6918638,-1.1770450338568663
WM793,9935249,4.106686148008307
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
BT 131,9935249,1.565696008817727
VMRC-LCD,6918638,-0.8957275762534151
HL-60,1566236,1.591886995939466
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
CA46,71751553,4.222934016329145
HCT 8,2746,2.9621933110100103
SK-ES-1,135421197,0.934110711885636
P31/FUJ,9911463,3.6551866379259743
OV7,135984461,1.9074868372682827
GCT,9935249,2.2487886001651263
DU4475,12003241,-2.262419788533744
P12-Ichikawa,3854666,0.4880959044456195
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
TF-1,9911463,2.560339190284904
G-402,selumetinib-GDC-0941 (4-1 mol-mol),1.3603902664341745
GB-1,44241473,6.049185625129691
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
KYSE-30,2746,4.052809859815596
HT115,selumetinib-GDC-0941 (4-1 mol-mol),-0.4177192932655061
SNU-5,3854666,0.8939164456438955
MV4-11,10322450,2.830685267799283
KNS-42,9935249,5.700998341787269
SK-N-DZ,54618771,1.6513533063720298
TUHR14TKB,24771867,1.7918957767024009
SK-LU-1,12003241,-2.6616586719339725
HT,JQ-1-carboplatin (1-1 mol-mol),-0.8971683298362426
SNU-503,9884685,0.6988570756468532
KMS-11,4705,3.23194213568903
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
MOLM-13,9926054,0.378361077880871
COLO 678,9911463,3.776615868788405
NCI-H446,9911463,3.3081231442060304
SNU-840,9911463,4.425436668411372
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
BT 428,4378219,1.777728517709583
EN,2746,3.955257118996246
NCI-H647,24779724,4.284354116768243
OAW28,12003241,-0.542287488877267
NCI-H650,100016,5.632760623979546
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
SNU-761,10296883,3.572250767719841
BEN,9911463,4.573978563534662
MDA-MB-468,71751553,4.192901853519086
SNU-620,9868037,3.01129610064575
OE21,135659046,3.360946677017383
BT 422,3465537,1.4684918107788285
Calu-6,9926054,1.940861811750295
COR-L105,9935249,3.5389604716579175
NCI-H2009,11404337,-0.0657811746758558
DLD-1,2742550,3.451094792104627
JVM-3,9911463,2.5369754211947217
HEL 92.1.7,11152667,-1.275650454905527
KYSE-410,9911463,3.4542799068802696
COLO 320,10296883,4.10892826768056
ECC10,65628,3.692288785501721
OCI-Ly3,2746,1.9886775425138576
SK-MEL-31,76446078,4.655203492782105
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
Caov-3,2742550,5.8507463294718605
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
SK-LU-1,24771867,2.357886269602111
KYSE-510,135984461,4.447866088850815
A2058,11494412,0.9278027425359372
KNS-62,11152667,0.7144620946918225
COLO 800,11494412,3.09129887824684
HPB-ALL,9868037,2.0330145425513044
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549
HCC1833,76446078,4.238919706292637
NCI-H661,9915743,-0.8538809858854721
SNU-410,9935249,3.802389634291995
OV-90,JQ-1-carboplatin (1-1 mol-mol),2.6498991971281702
VCaP,9926054,1.7541172082533985
SNU-387,6918638,0.7332887261776959
BT 498,135659046,3.899086642972748
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
HPB-ALL,136227924,2.35435467065409
SNG-M,24771867,3.433465674779685
KATO III,9935249,3.1862227458693475
SU-DHL-8,selumetinib-GDC-0941 (4-1 mol-mol),1.9311696765253152
BT 159,9911463,2.981994023267703
MOLM-13,11404337,-1.791363376051536
TTC-709,1566236,1.4753512072750776
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088
HT-1080,54618305,4.346285801076027
BT 328,9935249,3.0923830009934843
Calu-1,6918638,2.4930739459862936
L-428,2742550,2.838625484982941
TT2609-C02,4705,3.2623564948908106
COV434,12003241,-2.0451557846060537
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
TCC-Pan2,JQ-1-carboplatin (1-1 mol-mol),1.852597236843256
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
SW48,100016,6.031440310304127
T24,11404337,0.0422226925382746
WM115,10322450,3.651827454662003
A-498,54618771,1.1394352833671273
SR,54618305,-4.49006394356538
EM-2,9926054,0.5147420382885298
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
SNU-423,65628,4.328235834084208
SNU-16,9915743,0.7177446910868589
ES-2,JQ-1-carboplatin (1-1 mol-mol),4.854592360478168
Hs 895.T,11494412,4.004820419756853
M059K,11404337,1.3426444842625342
SNU-878,73707386,3.9073553748318672
TE-1,10296883,4.161455110097264
LK-2,54618771,0.9625218695691432
MDA-MB-157,11494412,-1.4760508995443156
NCI-H1623,6918638,-0.0742651507067239
AML-193,10322450,2.9754304486857
SK-MEL-2,11494412,4.029789291760362
NCI-H460,11152667,1.2005763717636435
SW1088,135659046,4.039700337753171
KLE,9935249,5.162792026951856
SUIT-2,selumetinib-vorinostat (8-1 mol-mol),2.64771661765404
LAMA-84,9935249,3.1340525693570167
NCI-H1666,136227924,2.19834773760599
NU-DHL-1,9884685,-1.1010004281847865
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
MDA-MB-415,selumetinib-GDC-0941 (4-1 mol-mol),-0.0962287719038293
SNG-M,JQ-1-carboplatin (1-1 mol-mol),1.0442661112179723
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
M-07e,2746,0.8814107880911471
HSC-2,65628,4.197445162801139
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
SNU-620,12003241,1.204190065135074
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
NCI-H661,3854666,2.0669995151297633
NCI-H1299,44241473,4.35326709675966
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
Li-7,11152667,-0.8164153978529881
Karpas-422,11494412,1.1821757343676855
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
HEY A8,54618771,0.8975201265586629
L-363,136227924,2.122664399399679
42-MG-BA,11404337,0.5565192143599668
MM1.S,10296883,3.0108141042121246
IGROV-1,4378219,2.016502068118561
D283 Med,54618305,4.176148849074149
TT,2742550,5.320745361223404
CFPAC-1,9911463,4.23074803596426
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
OE21,9884685,-0.6560236160170761
OCI-M1,10322450,4.213723369205614
UM-UC-3,3854666,2.11257703860495
NCI-H2085,3854666,3.930659800096944
SK-MM-2,100016,6.381158442456996
JHH-4,11152667,0.8928711048040257
NCI-H1650,9926054,2.506807917571585
EFE-184,2742550,4.5004666344414765
KYSE-30,2742550,3.649677885996823
VM-CUB-1,24771867,2.536989745779381
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
MHH-CALL-4,49836020,-0.2445846673370129
HCC4006,11152667,-0.7682912604310446
CML-T1,9868037,1.2045012402986977
NCI-H1869,9926054,1.781753958996035
GCT,11494412,0.2192094321151819
KP-3,11152667,-0.1171632623198148
SF126,54618771,1.1174524755985609
BT 216,65628,5.58909901665688
SNU-1,135659046,4.075705949169052
KMS-21-BM,4378219,1.5147595639547715
HGC-27,10296883,3.371644583045061
NCI-H1568,4378219,1.8995328874154
LAMA-84,9915743,0.3935059145962964
MIA PaCa-2,136227331,4.243512473772355
K029AX,100016,6.8355789955685395
CAL-120,9926054,3.430797555245233
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
NCI-H1755,54618305,5.372984260776961
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
NCI-H1395,9884685,-0.0679636269907438
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
Sq-1,9884685,5.552272252484493
BT 224,11494412,3.1147296058379483
BT 172,12003241,-0.4866452668331515
BT-12,3854666,3.044277454915718
AGS,54618771,0.8602025015707093
TOV-112D,24771867,-3.821264829263794
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
HeLa,9911463,4.222129751403694
U-937,9935249,2.745882291823877
Hs 940.T,24771867,5.33700266311788
WSU-DLCL2,9911463,3.171565801022685
SW1417,2746,3.073421161812704
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765
BT 245,11404337,-1.7449999203479594
NCI-H2110,9911463,4.283441783130732
COR-L51,54618771,1.1553419440915085
OE19,71751553,5.043181894493393
Ki-JK,9911463,2.4210836276003755
MOTN-1,6918638,-1.3378384389105569
DMS 273,54618771,0.8675837195237585
OE21,71751553,4.442993146906493
CAL-29,9911463,3.8262240253801623
253J-BV,76446078,4.136916816277146
SaOS-2,9935249,3.097116977919543
Karpas-422,135421197,2.168063446429243
TALL-1 [Human adult T-ALL],10322450,3.187962745096946
Granta-519,135421197,0.2234065586927925
MEC-1,10322450,2.616136352285943
HuNS1,JQ-1-carboplatin (1-1 mol-mol),1.1759253044065412
ZR-75-30,selumetinib-GDC-0941 (4-1 mol-mol),2.2960611598253178
COV434,135421197,0.3873638415100381
Hs 940.T,9915743,0.0875879000353744
CL-11,9884685,0.1443876486447486
NCI-H508,24771867,-1.5105076118527037
MOLT-16,9926054,1.655760518642202
Hs 729.T,6918638,2.1064288612965205
U-BLC1,12003241,-2.3919609664555543
MM1.S,136227924,2.5395832269167027
MHH-CALL-3,24771867,-2.5672102166578163
SW1783,9911463,3.515685844560525
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765
SW1417,135421197,1.3555171655865843
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374
Daoy,JQ-1-carboplatin (1-1 mol-mol),4.339760854193934
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
PE/CA-PJ15,135421197,1.0415253026449975
AML-193,6918638,-1.1768920136459526
SIG-M5,1566236,1.4914390289257415
T24,9911463,4.359537886200324
BT 187,4705,4.226067351518777
YD-8,136227924,3.733712180219105
JHUEM-3,9884685,0.8743192311633359
Hs 729.T,4378219,1.983246998890038
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
OCI-AML-3,3465537,1.1544662524916731
HT-144,11152667,0.9785925094290924
NCI-H196,9926054,2.525003076989932
Ki-JK,135984461,3.4417965783615414
JIMT-1,24771867,4.00022735533514
AsPC-1,76446078,5.483716778202627
T84,100016,6.649554415164183
L-540,1566236,1.6540096701346272
SNU-119,9868037,3.103417825493656
TT2609-C02,10296883,5.629000446872017
SK-N-MC,100016,6.319948334432407
HCC1954,12003241,-0.7991546925756471
BT 224,6918638,1.2404651093328147
SNU-1105,54618771,1.067302549999792
HeLa,3854666,0.8309069429521455
YAPC,135984461,4.395865755985396
NCC-StC-K140,4378219,1.8621812382845468
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
DND-41,136227924,1.87568318170164
SU-DHL-10,11152667,-1.8313784682506988
SW1088,136227331,5.532811982625497
A-375,54618771,0.2489032260565352
JHH-5,1566236,3.0867040268076793
Hs 683,136227331,4.5546400151434066
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
SW1088,10296883,3.7456002290694954
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
SNU-685,9911463,4.245246526228465
BT 245,100016,6.42627295768896
REC-1,54618305,4.3771111696641185
U-118MG,9884685,0.538617237870011
RERF-LC-MS,4705,3.292681011259135
BT 286,3854666,0.3675459578647432
BT 159,9868037,4.039671954943351
RPMI-6666,10296883,3.884924501065409
Lu-99,54618771,-0.746886748911533
MKN7,9926054,2.9968312406373574
MDA-MB-157,49836020,-4.4611089332084335
NCI-H2110,6918638,0.2299759669474582
BHT-101,9926054,1.1931762912946844
HCC2108,selumetinib-vorinostat (8-1 mol-mol),2.476774013379894
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
NCI-H1623,11404337,1.3417738865788873
COV362,136227331,5.836047268415018
SK-UT-1,54618771,2.629062811355061
SF268,JQ-1-carboplatin (1-1 mol-mol),2.4555584209908923
OVK18,9926054,1.8068809708246223
Panc 04.03,6918638,0.956445062850862
NCI-H1355,10296883,4.3250704024764115
NUGC-3,selumetinib-vorinostat (8-1 mol-mol),2.91278989567709
NCI-H292,12003241,-1.027467238096921
NCI-H1184,3854666,1.1815941086455106
NCI-H2110,12003241,-0.2811614102315782
LMSU,65628,4.981021352317802
DU145,136227331,5.067250261949365
BL-70,135659046,3.3949027184182707
PE/CA-PJ34 (clone C12),2742550,3.898499868649933
QGP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3136510607151746
HT-1197,3465537,3.2276782151604877
YAPC,135421197,1.6415717791988456
MOLT-3,100016,3.7727587478901734
MKN74,650361,3.7860453637514953
KYO-1,24771867,0.5849608625942118
LK-2,6918638,-0.400750886877545
Calu-6,9915743,-0.5707645596602849
JJN-3,JQ-1-carboplatin (1-1 mol-mol),-0.9961051054382296
SCC-25,4378219,2.5143805183117864
Sq-1,2742550,3.759213633183168
U-BLC1,2746,2.5365215352469175
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
NCI-N87,3854666,1.2679317332294615
KP-4,selumetinib-vorinostat (8-1 mol-mol),2.6285521395824527
GA-10,12003241,-5.009664542431325
TE-5,3854666,2.975196514311936
BT 271,1566236,1.8489883376842131
KM12,2742550,3.4783528342792103
BL-70,2746,1.4659724026992842
OVTOKO,136227924,4.392974848141837
JHUEM-3,71751553,3.8384920336488384
SNU-449,4705,3.898593282840832
Rh18,12003241,-2.237967131461188
HGC-27,71751553,3.896602890461538
RPMI-8402,100016,6.7779334067701145
COLO 829,54618771,1.3486725115535303
HOS,11152667,-0.1843365091194761
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
DMS 53,9884685,0.3261238173015792
SEM,9868037,2.0923686689232137
OV56,10296883,4.933118307038668
SF268,11404337,-1.2777642443849726
NCI-H69,9915743,1.0136854730638705
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
SK-MEL-24,3465537,1.2407688925018412
RPMI-6666,6918638,-0.5773375343735736
ECC12,24771867,2.682045437393948
HCC1806,3854666,3.691005549955363
GaMG,selumetinib-vorinostat (8-1 mol-mol),3.41853760080223
TE-4,10322450,4.2386221838106835
SK-UT-1,selumetinib-vorinostat (8-1 mol-mol),3.855507066103229
KMS-21-BM,73707386,2.971597915568964
EJM,10296883,2.9448984253361057
SNG-M,49836020,6.278284295689695
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
JK-1,9911463,2.3192555000733197
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
T84,136227924,2.5199027398538707
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
KYSE-510,12003241,-0.1961434673469709
MJ,24779724,5.157647123549832
COLO 320,135398744,6.463011253269961
VMRC-RCZ,9935249,3.784816906466892
SF295,selumetinib-vorinostat (8-1 mol-mol),2.6390667810596624
KO52,10296883,3.770873498157397
SH-10-TC,4705,3.0238585653901655
Lu-65,4705,2.2628868276979404
HSC-2,54639665,4.488674454832704
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
NCI-H2023,9926054,1.8656368845898197
MV4-11,24771867,-3.612221476953712
BT 164,11152667,1.258456029067334
KYSE-410,9935249,4.016740976439891
Panc 05.04,10296883,5.097523984239884
HGC-27,12003241,-2.439316929165163
LCLC-97TM1,135421197,1.517750954289076
Hs 683,4378219,5.423312148170216
SNU-423,JQ-1-carboplatin (1-1 mol-mol),4.402018355533478
BT 444,selumetinib-GDC-0941 (4-1 mol-mol),1.0784151115799612
NCI-H2110,4378219,2.2471941094410752
JJN-3,9911463,4.059977429957208
IM95,136227924,1.5571875137371276
SK-CO-1,135421197,1.070123520764916
TUHR10TKB,2746,4.350875917891638
Panc 04.03,4378219,5.53220646065493
RCH-ACV,9884685,-0.7829826614387396
GI-1,selumetinib-vorinostat (8-1 mol-mol),2.2740495965317624
KYM-1,11152667,-1.7906769013264132
Ki-JK,65628,3.9116740915216894
ACHN,12003241,-1.5952093864502457
Pfeiffer,135984461,1.4360263209874906
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
SK-N-MC,4705,3.836161182771402
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
MKN74,9926054,2.8513802079001844
CAL-27,1566236,1.710103727952198
SNU-C1,11494412,1.7066036750459093
BV-173,11404337,-1.6839007353956104
HPB-ALL,135984461,3.5745681488529693
K029AX,10296883,4.016071874543954
PK-45H,54618305,4.240243799773472
K029AX,71751553,4.553165888029419
DU4475,selumetinib-vorinostat (8-1 mol-mol),-2.7823531761956257
IA-LM,24771867,1.1290385026114922
JHUEM-1,12003241,-0.7244634318456832
KG-1-C,4705,4.10841801715904
NCI-H1944,135421197,1.84181744698867
HeLa,9915743,4.03760238390019
WM1799,11152667,-0.0315249727126408
SK-MEL-30,9935249,5.245383940669338
SKM-1,10296883,3.074274434558128
HCC1569,12003241,1.6977916939082411
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
HT-55,3854666,3.4559567246974305
5637,3854666,0.5695697267835587
HCC1588,9868037,2.925382992818106
NCI-H1694,135421197,1.1346758741878853
TE 441.T,135421197,0.4096443090762519
COLO 741,49836020,-1.8257608892409716
LoVo,11152667,-3.1828514843907967
EKVX,49836020,5.428301745137177
RERF-LC-A1,9868037,1.4970424039127654
SH-4,136227924,2.5718168505003693
KHM-1B,10322450,2.734741066135324
MKN1,135421197,0.9793646210495068
Kasumi-2,9915743,-0.5759730647314978
NCI-H1650,9935249,3.669332383907399
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
SK-MES-1,24771867,3.6484623093531066
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
MJ,9935249,-0.0346265394865933
Kasumi-2,49836020,6.151495097204233
CA46,9926054,1.6892727173627182
DMS 273,10296883,4.130929131041443
CW-2,10322450,3.213941293379877
KMH-2,9915743,0.5597932998699471
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
Toledo,11494412,2.936313599866626
COLO 320,24771867,2.413353240121045
KYO-1,136227924,2.5889716651569614
KYSE-150,2746,3.6554538134101255
SW948,11494412,0.3616963479580831
PE/CA-PJ15,11494412,-0.2051245265419709
U-BLC1,65628,6.23836675001552
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
MSTO-211H,9868037,1.9157833543052896
NCI-H1341,135421197,1.8518080327886164
RKO,11404337,-0.3534280477619294
BT 231,71751553,4.584826391566352
5637,54618305,4.243965384291741
ONS-76,9911463,3.87028315643254
NCI-H1573,11404337,-0.6417516749678569
IM95,selumetinib-GDC-0941 (4-1 mol-mol),-0.8100536248662729
NCI-H508,44241473,4.549961408590122
LCLC-97TM1,73707386,3.587652793939767
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
EPLC-272H,10322450,3.877521478432198
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
LMSU,9911463,4.298553287365515
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
G-401,136227924,2.3105932180874365
COLO 800,3854666,3.110464063654363
NCI-H1651,135421197,1.3042680543887686
BT 330,12003241,-0.9920089469814386
KMS-21-BM,24779724,5.254342909571376
BT 231,11404337,-1.7001463923522222
LOX-IMVI,11404337,-0.9085197853802874
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
Hs 294T,12003241,-1.502620378279095
ACHN,selumetinib-GDC-0941 (4-1 mol-mol),3.1627804075909727
HMCB,9915743,1.6080279846600372
OE33,9926054,1.932041644306032
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
SK-N-FI,6918638,-0.1979002452406887
TM-31,136227924,2.988827636595516
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
TE-8,11152667,-1.9127933488083488
HT-144,11494412,2.967267605483665
SIG-M5,135984461,4.131261553814095
MFE-296,135659046,3.966575901006911
NCI-H1092,11152667,0.3392565176972865
NCI-H520,3854666,-0.551991556599842
SCaBER,6918638,-0.2327063934194413
SNU-1033,54618771,0.4334411730243536
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
PC-3,6918638,2.0608196100088336
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
OCI-M1,selumetinib-vorinostat (8-1 mol-mol),1.952041230338225
HuT 78,9884685,0.1724524998439705
TE-11,JQ-1-carboplatin (1-1 mol-mol),3.4932129749903984
HDLM-2,JQ-1-carboplatin (1-1 mol-mol),4.397812362748352
KYSE-450,100016,6.589468110151047
MKN1,9935249,3.838267685606268
OV7,54618771,3.08705703189789
CAL-12T,49836020,4.6523718910669745
HCC1588,54618771,0.4261259622820442
NCI-H810,135421197,1.5773346723196464
PK-45H,6918638,1.185943066859981
MDA-MB-468,11152667,-0.5073124090955701
CHP-212,65628,3.7734320584498744
Karpas-620,3465537,3.7195040450487986
BT 328,1566236,2.4214904059930156
FTC-238,11404337,1.3350239521780074
M-07e,54618771,0.3587170705521248
DMS 273,135659046,3.477426326571923
SNU-308,11152667,0.4634525960285107
NCC-StC-K140,selumetinib-vorinostat (8-1 mol-mol),0.7044083601205671
JHH-5,JQ-1-carboplatin (1-1 mol-mol),1.839630269464315
BT 216,2746,3.994166924580774
FTC-238,4705,3.281251392763017
U266B1,10322450,4.335564928351158
OCI-AML-3,11152667,-2.175996552901593
KCL-22,selumetinib-GDC-0941 (4-1 mol-mol),1.6879768271667388
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
JHH-4,12003241,-1.7562385090138668
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
D283 Med,65628,4.590969471061447
GA-10,6918638,-2.7044389235712187
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
COLO 678,12003241,-1.07618054300688
TT2609-C02,9935249,3.1187203148031566
Mel Ho,12003241,-1.328246141696159
KMRC-2,44241473,4.436801876335884
NCI-H1694,9935249,1.6639617864003344
SK-LU-1,3854666,3.216847376167724
NCI-H1435,9935249,2.948577558546625
TC-71,136227924,2.205314859996721
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
UACC-812,9926054,1.7122964049751828
BEN,11404337,0.9203658173456966
SK-LMS-1,24771867,4.309064190513273
MOLM-13,44241473,6.124350775268443
BT 164,selumetinib-GDC-0941 (4-1 mol-mol),1.5214027789841535
NCI-H508,9935249,3.1772334043452237
PC-14,selumetinib-vorinostat (8-1 mol-mol),1.2532439157087734
EoL-1,4705,0.6699610598370959
HL-60,11494412,0.7668465686912257
KYM-1,9911463,3.4885377293018154
CAL-33,24779724,5.532658892433513
NCI-H1651,65628,6.210976092474593
Ri-1,11404337,-1.810959317313917
BT 482,2746,5.533000175403538
SK-MEL-31,54618771,1.4879835427229802
ESS-1,1566236,1.5560500313895365
KMS-11,3465537,1.1905372585392755
CAL-120,selumetinib-GDC-0941 (4-1 mol-mol),2.9364136017139932
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
HD-MY-Z,4378219,1.959213460816033
SK-MEL-1,9911463,4.223226979936513
SNU-182,9915743,-0.6528575435960152
HCC-56,2746,2.5868502665085615
HuH-6,1566236,2.9155001663313542
Hs 683,3465537,3.213284685402938
NU-DUL-1,24771867,-2.817643909580504
NCI-H1693,2742550,3.606618769057063
VM-CUB-1,9911463,3.9957694448680265
NCI-H1563,11152667,1.175264521222522
Panc 02.03,3854666,5.373190444337423
A-549,1566236,4.271699172517002
REC-1,9926054,3.5400616992055847
SIG-M5,9915743,0.6121664403334032
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
SCaBER,2746,3.471134652471349
BT 248,12003241,-0.5635987052840526
SET-2,168313307,4.480873522233062
GA-10,2742550,2.2253737438129564
OCI-Ly3,71751553,4.255231078422555
DK-MG,100016,7.056187444773538
HT-1376,135421197,1.3113029615588312
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
KE-39,135659046,4.845551344520264
A-549,3465537,3.857188765779011
JHUEM-1,9884685,-1.0339537431528274
HEC-151,9868037,0.6566472366149405
HEC-108,135421197,3.884784600125324
SNU-C5,12003241,-1.9279387541899935
HEC-108,9911463,4.37199271437254
COV434,100016,6.159872289007743
BICR 16,3854666,1.3467812594658026
SNU-626,11152667,0.4022575570601642
MKN45,JQ-1-carboplatin (1-1 mol-mol),5.954362231550531
HPB-ALL,2746,1.2086783297242478
NCI-H2052,selumetinib-GDC-0941 (4-1 mol-mol),-0.0438612547991499
HT-55,JQ-1-carboplatin (1-1 mol-mol),3.678098211673295
Kasumi-2,9868037,2.67651294484719
SNU-685,136227924,3.487679457544809
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
TE-9,54618771,0.2399637036570816
TALL-1 [Human adult T-ALL],11404337,-1.3736940548636651
GI-1,135421197,1.6519040465788966
BT 131,10296883,4.294985704877121
CCF-STTG1,4705,3.7462462996550534
JJN-3,54618305,4.325120216222494
TT2609-C02,selumetinib-GDC-0941 (4-1 mol-mol),0.2335990554024833
HMCB,6918638,0.939566819440244
NCI-H2126,135984461,4.348748825653974
PK-45H,2746,3.885970840485544
SCC-25,3854666,1.9347031057126212
A101D,9935249,3.2332188881135147
RCC10RGB,11404337,1.763382313076518
EPLC-272H,10296883,4.153935511243516
T84,12003241,-0.2889439900128532
HT115,54618771,0.5275869701844733
NCI-H2228,4705,2.420157544814273
NCI-H1339,1566236,2.281112121085828
BICR 56,135421197,3.0441014153106893
JHUEM-3,10296883,4.22416361613302
TE-5,24779724,4.3731418653710445
SET-2,2742550,3.6204915074122814
SNU-1105,selumetinib-GDC-0941 (4-1 mol-mol),2.42350207909939
DU145,3854666,2.445661849899651
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
Hs 688(A).T,9935249,3.392605669419124
HLF,11494412,1.078147161015815
Ri-1,1566236,0.746437074488416
MHH-CALL-4,11152667,-1.953186727917395
BICR 18,54618771,1.6226277377850309
UM-UC-3,9911463,4.051295962185813
PK-59,selumetinib-vorinostat (8-1 mol-mol),2.306892423893395
647V,2746,2.8879721375680214
COV362,12003241,-1.5516185540299623
RVH-421,3465537,3.326597966026809
C2BBe1,4705,2.8323844421338324
ZR-75-30,11404337,1.0158794681512644
JHUEM-1,11152667,-1.2363443703261163
YD-10B,JQ-1-carboplatin (1-1 mol-mol),1.656184810616646
OVCAR-5,135421197,1.110544860283993
8-MG-BA,selumetinib-vorinostat (8-1 mol-mol),4.658007883531654
BT 428,selumetinib-vorinostat (8-1 mol-mol),0.9101675495588571
SK-N-MC,49836020,5.673841333096494
MOLM-6,24771867,-2.5891704531153192
KP-N-SI9s,54618771,1.0229229118908414
GMS-10,71751553,5.377338497621535
HCC1419,54618305,4.91442381429649
RL,135984461,2.130872276325595
KMS-26,54618771,-0.1721472849955331
SCC-9,9884685,0.522968392230544
KYO-1,4705,2.8597279175992925
SNU-C4,2746,3.564383627090603
HPB-ALL,10296883,3.0547886036343663
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459
KMS-12-BM,11152667,-2.0033121328533054
CHP-126,9884685,0.6738089560085174
BT 224,selumetinib-vorinostat (8-1 mol-mol),3.8876839551876174
L-428,71751553,4.538965099068746
KMBC-2,10296883,4.242347433736866
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
REC-1,24771867,5.565042494395041
HEC-1-A,135421197,1.5855088638754589
Hs 683,100016,6.526692615081327
GB-1,9935249,3.420618097201761
COLO 792,11404337,-0.504163589197378
SIG-M5,9911463,2.49992979660486
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
TE-10,65628,4.400493664627162
BT 245,JQ-1-carboplatin (1-1 mol-mol),4.46215850472978
SNU-C5,4705,2.835396064750649
SNU-601,4705,3.2115549185604757
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648
NCI-H810,9926054,1.762118845212232
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
Rh41,44487872,5.324428070047643
CGTH-W-1,selumetinib-vorinostat (8-1 mol-mol),2.294733258472385
IA-LM,11494412,5.732457488131999
MDA-MB-453,6918638,-1.2403270134347248
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
NCI-H2196,selumetinib-vorinostat (8-1 mol-mol),2.7260788817347965
JHH-5,135984461,6.19105959090805
SH-4,10296883,3.644987847906302
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
SW948,24771867,-2.1331828785420166
Hs 888.T,135421197,-0.1341748338568028
EFO-27,12003241,-1.7336155023360622
LMSU,12003241,-1.0531077396215482
NCI-H1944,11494412,1.0398128267017497
TT,54618771,0.4529536382950971
MOLP-8,135984461,3.690365922940533
HOS,1566236,3.95322165315026
PK-45H,71751553,4.624328155960912
RERF-LC-MS,6918638,0.4520678244574614
SK-LMS-1,10322450,5.260294901094195
WM266-4,11152667,0.6640088083236647
TF-1,10322450,2.6855110570299696
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
BT 231,1566236,1.681485280274636
RPMI-6666,2746,2.3385323995154033
VMRC-RCW,JQ-1-carboplatin (1-1 mol-mol),1.9272630806826467
KNS-60,9868037,3.077370485876798
Mel JuSo,selumetinib-GDC-0941 (4-1 mol-mol),1.489805359284141
SK-N-SH,9935249,0.7535155935236955
NCI-H2122,1566236,4.547369215315693
SK-N-SH,JQ-1-carboplatin (1-1 mol-mol),2.4267481661369734
COLO 829,76446078,4.189431555803559
SNU-16,135421197,0.9463670972041712
RL,2746,2.394974113272841
NU-DUL-1,73707386,2.96968071129634
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
MFE-319,3854666,1.5302957515422178
SNU-620,selumetinib-GDC-0941 (4-1 mol-mol),-2.4786489689796554
PC-3,3465537,3.386652661841469
P12-Ichikawa,9868037,1.7340437958552062
RPMI-8402,3854666,0.737448430208504
MDA-MB-435S,9911463,3.9126633903128143
HPAF-II,selumetinib-vorinostat (8-1 mol-mol),3.0881046895318325
SW579,selumetinib-vorinostat (8-1 mol-mol),2.4107277098290782
Lu-65,44241473,4.745952871370416
AML-193,136227924,2.0129973822753735
KMS-18,44241473,5.07291620705629
SK-ES-1,44241473,6.159760732743632
Hs 895.T,6918638,1.92517171748629
CW-2,9926054,2.0798492458785978
KMRC-2,2746,4.010185211314044
HCC827,11152667,-1.8909743220158417
RERF-LC-MS,135421197,1.554065103888189
HL-60,9884685,-0.1505385847488882
WM1799,135421197,2.490323876838408
SUIT-2,54618771,1.0369427055295135
Pfeiffer,24771867,-0.0752821740648467
EBC-1,3854666,0.7076213009699341
EFM-192A,71751553,5.63854540907664
JHOS-2,135984461,4.415400974704629
EM-2,3854666,1.1863120866897956
SNU-213,9915743,1.2181447895342674
SNU-869,2742550,3.985788589548601
NCO2,135984461,1.9525292456009808
TE-8,9915743,1.7914899736385264
SK-MEL-2,54618771,2.1400716929659045
KP-3,selumetinib-vorinostat (8-1 mol-mol),2.7675803183632155
IGR-39,9915743,0.9113402553932568
MDA-MB-231,135421197,1.4675791065879262
GCT,12003241,-2.363961173456096
NCI-H838,9926054,1.8305885270474245
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
NCI-H838,3854666,0.8537044590791573
Hs 683,9935249,2.3161488384728575
MDA-MB-361,24771867,4.150765983025328
TUHR10TKB,73707386,3.2234831136980464
PaTu 8988s,9926054,1.8956430403525124
KYSE-410,9915743,-1.3205440456701116
CAL-62,JQ-1-carboplatin (1-1 mol-mol),1.017398941700892
NCI-H1975,24771867,-0.6490002518891199
Jurkat,9911463,3.146935995662798
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
NCI-H2122,11404337,0.2982247321371532
Caov-3,135421197,1.5167281474841918
BT 139,11152667,1.692404589023897
WM88,9926054,1.794473369640358
NCI-H1869,24771867,4.056145825527395
GOS-3,6918638,1.663921744527482
COLO 699,54618771,0.7648431477044199
253J-BV,11404337,0.2786580160895149
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
HT115,9911463,3.084067678745635
KNS-81,11404337,0.4763039315570028
NCI-H1693,135659046,3.507522004254733
Kuramochi,44241473,5.070294664962983
HCC2108,9926054,2.5765466804926445
Kelly,selumetinib-GDC-0941 (4-1 mol-mol),2.978588327990176
SF126,135398744,7.810596319596066
CW-2,9915743,-2.027282933968592
SK-BR-3,9935249,2.056401078503904
JHUEM-3,24771867,1.4074983371644816
SNB-75,JQ-1-carboplatin (1-1 mol-mol),6.178448608970183
HCC1419,24771867,4.4430055874325705
LS1034,selumetinib-vorinostat (8-1 mol-mol),0.4760250390753199
NCI-H69,54618771,1.222543289082317
JHH-5,54618305,4.218748186690721
BT 145,10322450,2.778545625329855
RS4;11,10296883,2.9468024036762483
NCI-H1092,9935249,2.293612828813301
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
Aska-SS,3854666,3.7773042948558726
OV56,135984461,4.418964616172034
SNU-C5,3854666,1.9958774012372615
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
SNU-719,135984461,4.329152044939095
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
BT 147,selumetinib-GDC-0941 (4-1 mol-mol),1.4700877243858868
NCI-H2029,9915743,1.4952182425439322
EN,1566236,4.189994188152843
MJ,2746,3.266657890633373
SK-N-SH,9915743,1.1616840064565594
GMS-10,12003241,-0.439124949180571
Toledo,10296883,3.728204772396323
SUP-M2,24771867,-4.460270779180961
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
JeKo-1,11152667,-3.245778632504348
SCaBER,3854666,0.3065476859554776
ECC10,9935249,2.455654324483876
SU.86.86,54618305,4.404788411078512
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
TE-14,11404337,-0.8774681002045693
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
GDM-1,100016,5.649529454604957
Kasumi-2,2742550,3.256021563602066
NCI-H1355,24771867,2.307791034332925
ST486,4705,3.1106371129539325
SK-MM-2,9935249,3.5161188228318987
TE-8,10296883,3.8933893456121984
NCI-H292,9935249,3.8808310590786
MSTO-211H,136227924,2.717505566177341
NCI-H747,24779724,5.142586038492887
HCC1833,11152667,2.1146320609656426
OE19,1566236,2.960522722455562
NCI-H647,4705,2.403903221755703
NCI-H146,11494412,-1.136229477240518
BT 131,135421197,1.356520545497568
WM115,2746,3.2273654457979957
Yamato-SS,JQ-1-carboplatin (1-1 mol-mol),0.686256399915639
SR,135398744,6.424256669199728
FaDu,3465537,2.9926809640711456
SCaBER,9884685,-0.0878392335196988
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
HT-1197,3854666,2.5073606400565143
NCI-H660,9935249,1.6293188334591442
ACC-MESO-1,9926054,4.037988480167424
TE 441.T,selumetinib-vorinostat (8-1 mol-mol),3.7277184259028378
SK-MEL-1,100016,6.470813601542051
CAL-148,73707386,2.7699850376563075
MeWo,6918638,-0.7125250805485809
MV4-11,JQ-1-carboplatin (1-1 mol-mol),-1.9845172656852084
HuH-28,54618771,1.3880976899184387
F-36P,2742550,3.2568507775815525
SR,9884685,0.4372930980383124
JMSU-1,49836020,6.465700185404903
SK-MEL-3,135659046,3.5354638551340756
KATO III,135421197,1.1737614873683315
HuT 78,selumetinib-vorinostat (8-1 mol-mol),-4.277294994055841
F-36P,11404337,-0.3828282129667895
NCI-H1341,24779724,6.355175868035526
BT 232,11404337,-0.4479930144977115
SKM-1,3854666,-0.271294085602593
SW1271,49836020,-1.4027167140646708
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
THP-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.4555480818826622
UO-31,24779724,5.276933608870132
NCI-H1568,65628,3.926137474064237
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
BT 330,11494412,3.1533604427813833
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
SK-N-SH,135421197,1.303640254483224
NH-6,11494412,0.0442527385928499
OCI-M1,1566236,1.1491839821612235
MES-SA,11404337,-4.5203474212928265
MEC-1,1566236,1.1632689835014047
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344
BT 147,11404337,-1.2546311246387
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457
SUP-B15,135984461,1.5774458339349344
EJM,136227924,2.8681258655198367
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
FaDu,54618771,1.2079595597502673
BT 216,9935249,2.905393144849144
PC-14,1566236,4.058624946663528
KP-2,135398744,6.663666573534304
HOP-92,9868037,3.341339504436607
5637,9868037,3.3749998871313127
MV4-11,3854666,0.6291218486966372
GSU,12003241,-0.2864311193180854
SJSA-1,3854666,2.6670180544231914
Detroit 562,100016,6.391000104824681
DU4475,1566236,1.1054290653888534
RPMI-6666,40482356,5.401236859279798
BT 359,12003241,0.8363622600991807
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
CML-T1,135984461,1.8956927240773784
LN-18,9935249,3.1873954770146486
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
Hs 822.T,9926054,3.800948674297046
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
HCC366,24771867,3.067940154374148
SNU-1079,9926054,1.5049009904469195
SIG-M5,54618771,-0.4946927468469176
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
SW579,4378219,2.0428499295271942
SK-MEL-24,1566236,2.137151818303078
SNU-1079,135984461,-0.6651362104222878
Panc 08.13,136227924,2.4171431229910265
SNU-466,54618771,0.431904700089911
UM-UC-1,12003241,-2.5301689860244534
NCI-H2029,76446078,4.175128641560328
BT 172,selumetinib-vorinostat (8-1 mol-mol),1.8698207880631204
GB-1,selumetinib-vorinostat (8-1 mol-mol),3.3033356812645
HCC2218,12003241,-0.1021817446699859
SNU-1033,6918638,0.9929294920003592
Jurkat,100016,5.920987823967134
OAW28,9935249,3.684332158484572
SEM,12003241,-3.075217153076431
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
DMS 53,24779724,4.53912068548046
5637,136227924,2.876940542257041
Rh41,11152667,-1.370946283647722
GaMG,9915743,4.602253717337043
NCI-H2405,9868037,0.0658407711920554
CAL-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.559817490656083
SK-MEL-2,2746,3.33396317139844
OCI-AML-3,71751553,4.438951947729107
MOLM-6,9868037,1.47878958691074
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
SUP-T11,11152667,-4.45703936760011
NCI-H1341,selumetinib-GDC-0941 (4-1 mol-mol),0.3827497304694547
KMS-28BM,3854666,0.5367322792808957
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
COV362,136227924,2.2847413829349947
COLO 320,136227331,6.064515235330745
PE/CA-PJ15,2742550,4.3930090361473155
MOLP-8,44487872,4.385798937588512
COLO 668,2742550,3.5349511926835255
Hs 688(A).T,24771867,4.110673655791937
Ci-1,6918638,-0.1267659134210231
BT 239,11494412,1.0989545703534742
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
MOLT-13,3465537,3.8394867045029217
RERF-LC-Ad2,10296883,4.240676300513298
MDA-MB-231,3854666,4.122425724106694
HCC1195,9868037,3.635348829335935
SNG-M,4705,3.157780900696135
JMSU-1,4378219,2.1572889505442117
KALS-1,9926054,2.3431755062482487
NCI-H2172,10296883,3.8919469305692256
BT 428,2742550,3.051967949404776
KE-39,1566236,2.837512341107075
KHM-1B,54618305,4.409714485426553
EFO-27,10322450,4.618987367546035
AU565,9915743,-3.6885201415408098
CGTH-W-1,11152667,-1.852976314266698
FU-OV-1,12003241,-1.039273875540509
BDCM,9915743,-0.0089573294150241
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
SNU-1066,9911463,4.257839675478274
SNU-410,9926054,3.256884508245376
RL95-2,135984461,4.241681706125587
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
KMS-18,135984461,4.3135759037232635
HT-55,135984461,4.061265813784957
SNU-1079,2742550,1.6275760819084113
GSS,65628,5.281644335437836
TUHR14TKB,54618771,1.495898324291793
HOS,11494412,1.9544385789907803
HEC-251,selumetinib-vorinostat (8-1 mol-mol),2.5885002243488153
NCI-H2081,11494412,-0.0076516448343769
Calu-3,4378219,2.3780392078454025
HCC1588,9915743,-0.589938249140678
LOX-IMVI,2746,2.55877549764083
JL-1,11494412,3.122839444279875
GOS-3,9926054,2.0544356724695776
SNU-C4,4705,2.69481257913417
22Rv1,136227924,2.1207718843699
TF-1,3854666,0.2073598853175925
SJSA-1,65628,4.421860734175966
HCC2935,9935249,3.0627293798034563
HEC-251,JQ-1-carboplatin (1-1 mol-mol),0.3625171381701316
DMS 53,selumetinib-GDC-0941 (4-1 mol-mol),1.3170486781657051
WM1799,54639665,4.532721587133595
IST-Mes1,9926054,1.778703370274458
SU-DHL-8,9868037,2.223027391830787
IGR-39,11404337,1.3258536421281484
Panc 02.03,136227924,3.0839082623333387
KMS-34,9926054,1.6315221733896668
TE-4,9884685,0.7383489542895525
BT 147,9884685,1.61150148213557
LN-229,selumetinib-vorinostat (8-1 mol-mol),2.9963776796611015
COLO 792,11494412,2.516630089039559
NCI-H838,9884685,2.0145389854866345
NCI-H526,11152667,0.4389339837373306
IA-LM,10296883,4.25848729020474
23132/87,54618771,0.9253043807120772
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
Sq-1,9935249,4.030130164184431
HuCC-T1,11152667,0.3942846705957664
A-375,65628,4.4466647793828855
SK-UT-1,10296883,3.957718672541511
NCI-H747,9911463,3.270591530161213
OCI-AML-3,12003241,-2.086986892339566
NCI-H1755,1566236,3.4537013601829525
IGROV-1,49836020,5.658436828096057
SNU-475,136227924,3.0898415955820715
YD-8,24771867,2.3430098767377263
GSS,4378219,1.891542644264269
LP-1,44487872,5.2384234330551385
NALM-6,135421197,0.6704764022840549
B-CPAP,9926054,2.1103473685311043
BT 216,4705,2.9949115895470704
KE-97,JQ-1-carboplatin (1-1 mol-mol),-0.8780333698313584
VCaP,4378219,2.0117835493270313
B-CPAP,100016,6.506572981316216
NU-DHL-1,136227924,1.2519389073848997
TUHR14TKB,JQ-1-carboplatin (1-1 mol-mol),-0.4661242690765318
NCI-H522,12003241,-1.5672925136718587
T3M-10,10296883,4.278304655632823
A-204,10296883,3.4330765827623617
CCF-STTG1,selumetinib-vorinostat (8-1 mol-mol),4.379403579151937
HCC1428,3854666,3.671770908312049
BT 330,9915743,0.5029117023680005
NCI-H1693,54618771,1.322684232768969
U-CH1,71751553,4.767713851069639
MDA-MB-468,2746,3.461391528245753
NCI-H1299,11404337,0.8410914432786373
SNU-216,49836020,4.392080781330326
JHH-5,4705,1.264083267323837
HuP-T4,9911463,3.108892921619022
NCI-H1568,9935249,0.3822057580098375
Karpas-299,49836020,-1.2149928929897504
BT 416,2742550,2.5913413615570087
COV644,135421197,2.2912269565469936
SNU-46,136227924,3.2751090842747637
HT-55,9926054,1.864291830267701
MOLT-16,3854666,0.1998287701213994
MDA-MB-415,3854666,2.669945376708198
OCI-Ly3,1566236,1.0416509518508918
NCI-H2171,11152667,-0.915095731247344
A-549,24771867,2.4933733383815206
NCI-H2126,9915743,3.640256854727969
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
Capan-2,4378219,4.670648119351669
Mel JuSo,selumetinib-vorinostat (8-1 mol-mol),2.3900440309733804
Hep-G2,9911463,3.8113421260686735
SK-MES-1,9935249,2.2482629589570804
KYSE-70,3854666,1.6457032232411275
BT 271,9926054,1.6411198648288656
ME-1 [Human leukemia],3854666,1.822762737344071
OAW28,135421197,1.4901490212875883
HeLa,9926054,1.7615972318293558
Hs 729.T,3465537,3.210090205188344
SNU-61,24771867,2.3194270269791772
JHOC-5,9915743,-0.591005693368505
ST486,10322450,2.677792904621428
JHUEM-3,11404337,-0.7844272598135029
8305C,selumetinib-GDC-0941 (4-1 mol-mol),-0.5953379888353332
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
SNU-620,44241473,4.296583129671868
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978
DU145,12003241,-2.0135691280208876
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
PaTu 8988t,11494412,2.1257430484232525
RCH-ACV,135659046,3.4161353826802783
Calu-6,JQ-1-carboplatin (1-1 mol-mol),5.26702992417303
BT-12,11152667,2.0016495749496137
LC-1/sq-SF,136227924,3.5583860131764835
KP-N-YN,11404337,1.502474208515668
IST-Mes1,135421197,1.925463420817299
SU-DHL-8,44241473,4.387725877495194
NCI-H1435,11404337,-0.2240916752478429
K029AX,1566236,1.7525838021386102
HL-60,100016,6.415560767920564
PLC/PRF/5,135421197,1.8500736721187756
769-P,54618771,0.1291484559700657
SUP-T11,JQ-1-carboplatin (1-1 mol-mol),1.338159132216547
YH-13,135421197,2.4430977346174165
NCI-H2087,3854666,1.5016469134351038
JIMT-1,9935249,3.6195859739992544
NCI-H1755,2742550,4.204893958331653
NCI-H2081,11404337,-2.077246389622244
OV7,44241473,4.390252256895913
JM-1,135659046,3.550517545140938
MDA-MB-435S,9926054,2.269822503715403
NU-DUL-1,2746,1.0800469209102068
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
HCC-56,100016,6.404810900486153
NCI-H1155,54639665,4.4838841081587555
SCC-4,11152667,-1.3827031006544217
FaDu,11404337,0.6518309370028597
G-361,100016,5.501390716782531
Hep 3B2.1-7,9926054,2.8753203525792026
FaDu,2746,3.60931245556166
MDA-MB-453,71751553,4.5545018888168185
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
L-428,9935249,1.854395336163708
DK-MG,11404337,-0.0389749694048802
DAN-G,selumetinib-vorinostat (8-1 mol-mol),3.226437568677093
COR-L95,65628,4.016533332946612
BT 228,JQ-1-carboplatin (1-1 mol-mol),4.047543030971835
EJM,9935249,2.9209217117855903
JHUEM-2,54618771,-0.9670015993235072
CCK-81,10296883,3.3537849250565244
Granta-519,136227924,1.3333863896282263
Hs 746.T,49836020,5.866178883912361
MKN74,11152667,-0.1995571526819112
JHH-2,135659046,3.3681644336140284
OCI-Ly3,10296883,3.058188630852339
ONCO-DG-1,selumetinib-vorinostat (8-1 mol-mol),2.407796834998747
MG-63,3854666,1.0280422807059248
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
ST486,12003241,-0.1204499968223502
BT 145,49836020,5.352704973250576
BT-16,54618771,-1.2134331946377312
SNU-16,100016,4.136425652163891
BC-3C,11404337,0.8699913882296267
OCI-Ly19,11494412,-0.1179063664940395
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
PE/CA-PJ15,136227331,4.888188791536357
L3.3,65628,4.284850303510067
IM95,54618771,0.6089600215622465
A-375,9935249,3.760967262961611
COLO 678,9926054,1.8882856749448629
JHUEM-7,135398744,6.411220982649173
LOU-NH91,9868037,3.6278868560603574
BT 179,54618771,0.9924128093703488
NCI-H1355,3465537,1.4614911488650857
DU4475,100016,3.3182611876021157
Peer,11152667,-2.098459258101671
Pfeiffer,9935249,-1.9078957429829817
Calu-6,12003241,-0.728129558300084
HCC2279,12003241,-1.0560673565017786
DND-41,44241473,4.581035180233111
TE-4,1566236,3.823533230768045
PK-59,2746,3.5698867833367585
HDLM-2,11152667,-0.0982473466118714
NCI-H1299,12003241,-0.9760038754339474
CAL-33,135421197,1.5184759141231294
NCI-H1944,1566236,4.110727011027785
MOLT-16,selumetinib-vorinostat (8-1 mol-mol),2.410769382861759
NCI-H2087,9915743,0.7035169318123878
Detroit 562,3854666,0.8163843049251128
KMS-26,12003241,-3.93647753580664
CA46,2742550,3.5037926309603944
SNU-878,10322450,4.398776492188379
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
SK-HEP-1,11152667,2.375581084403437
WM983B,135659046,3.887851853089627
UM-UC-3,selumetinib-vorinostat (8-1 mol-mol),4.277445444212211
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
SK-N-DZ,9911463,3.9970399765376423
HuNS1,71751553,4.7444430749787445
TUHR14TKB,136227331,4.279193413134127
BT 504,135659046,3.5842907457354376
NCI-H716,10296883,2.894605704782392
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
DMS 114,135421197,1.272483451000873
PE/CA-PJ41 (clone D2),9911463,4.289796480511007
VM-CUB-1,JQ-1-carboplatin (1-1 mol-mol),1.087386470094272
SBC-5,9868037,1.591902673624677
OPM-2,2742550,2.8639715022070713
Hs 729.T,9884685,0.8131307080900988
COR-L95,100016,6.620829555802918
THP-1,10296883,3.2356206516906765
ST486,11152667,-1.2094487766375612
EoL-1,1566236,0.4316252370968399
SK-N-AS,3854666,0.6008769130221079
BT 428,136227331,3.9646009077151456
SNB-75,10322450,5.848985655680984
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
SNU-1079,3854666,1.692119471543111
SNU-C5,2746,3.0959467324138346
MM1.S,9935249,3.6617301245150498
JHOM-1,12003241,-1.2744243269669069
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516
JHUEM-2,selumetinib-vorinostat (8-1 mol-mol),2.576668042411364
LXF 289,44241473,4.688676931788039
COLO 684,4705,3.605341252393416
NCI-H1694,4378219,1.5781470551715766
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
NCI-H1944,11152667,-0.9331821189018308
HSC-4,3465537,2.7025414883497443
BT 232,40482356,5.459130936961733
SK-LMS-1,71751553,5.37247176250955
IM95,11404337,-0.2020778805418927
MDA-MB-453,2746,1.6853152695376463
MDA-MB-361,9884685,-0.7513711106213427
EoL-1,44487872,4.166402657118513
NCI-H2087,11404337,-3.0287738757732585
NCI-H2196,9911463,3.768579820818315
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
PL-21,9868037,2.018011914645477
Panc 03.27,135421197,1.6982326506072338
F-36P,JQ-1-carboplatin (1-1 mol-mol),-0.2067996802850356
NCI-H810,9884685,0.0292455778048883
KMRC-1,24771867,5.5206603877823275
PE/CA-PJ15,24771867,2.507049112145433
NCI-H1435,JQ-1-carboplatin (1-1 mol-mol),2.9022740526211765
YD-10B,9935249,3.5260896085305773
SNU-1214,12003241,-2.886982661469118
SNU-899,4378219,2.6009436227988862
HuH-6,4378219,2.0621045138260823
SK-MEL-24,6918638,1.430971742186676
BT 416,9911463,2.4624621217887457
GCT,9868037,3.729944078778933
JHOM-1,135421197,1.641458342897405
MHH-NB-11,136227924,1.3020282745517038
NCI-H727,9911463,4.409308573364914
L-540,54618771,-0.836764308956379
2004,135398744,6.587609936981218
LC-1/sq-SF,12003241,1.312627912595186
MeWo,3465537,2.2989787553206806
L-428,135659046,3.7649753981582137
DU4475,135421197,0.912129000759155
HT-1080,6918638,0.2598453428268436
BEN,selumetinib-vorinostat (8-1 mol-mol),4.272191912190305
HT-1376,selumetinib-vorinostat (8-1 mol-mol),2.644964050552289
MSTO-211H,73707386,2.8647689708389943
TCC-Pan2,9935249,3.899374521003951
JM-1,12003241,0.2073989775302392
JeKo-1,JQ-1-carboplatin (1-1 mol-mol),1.2993795236120171
647V,135421197,1.6081071378201617
BT 224,168313307,4.4908402152924785
BT-16,135421197,1.2495545603041716
KO52,9911463,3.5355164060453004
MDA-MB-435S,JQ-1-carboplatin (1-1 mol-mol),5.894688800138277
NCI-H1694,9926054,1.45656685953477
Rh18,135421197,3.2073141034499577
JIMT-1,136227924,4.112902711551938
TE-5,135421197,1.4018767750008558
VMRC-RCZ,71751553,4.4517301361944694
MHH-ES-1,3854666,0.6560806360047275
OCI-Ly19,6918638,-1.0527387975754474
KO52,24771867,-3.917806210376699
NCI-H146,9915743,-0.2957101551438801
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
SiMa,selumetinib-GDC-0941 (4-1 mol-mol),0.1893088365447134
NCI-H2228,65628,5.022227644787099
U-251MG,9915743,2.5124314599198407
MOLP-2,selumetinib-vorinostat (8-1 mol-mol),2.2725522139570447
BT 145,11152667,1.0829552728349376
BFTC-905,54618771,-0.6913922246342757
Sq-1,11404337,0.5164739159658084
TYK-nu,4705,3.3824774754373
KLE,12003241,-1.9975693903430911
SNU-C1,10296883,2.645859922334997
NCI-H1105,11404337,-1.3453817375837114
SK-N-SH,12003241,-0.1782836435040178
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
697,135984461,1.702307522694506
JHOC-5,100016,4.009706795291197
L-1236,11152667,0.9711871425868174
KYO-1,JQ-1-carboplatin (1-1 mol-mol),0.7001099842135994
HCC1171,9911463,4.341484075283008
HT-1197,135421197,1.673772932436652
OCUM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2423134599079573
SYO-1,2746,1.3641867767791351
GCT,24779724,4.780911773379765
HMCB,11494412,1.1725416400884527
BT 286,10296883,4.151589590813863
NCI-H747,136227924,2.5739387589966265
HSC-2,11494412,0.0401305850858842
HMCB,selumetinib-vorinostat (8-1 mol-mol),3.744114804484371
HOP-62,54618771,0.1660184306238314
KP-2,9935249,3.768117101530522
IM95,49836020,4.204800354439791
NUGC-3,9911463,3.217932170312211
NCI-H2141,11494412,0.5114354173300891
T84,2746,3.6506002682923926
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
HT-29,54618771,-0.2374080700541868
Panc 03.27,12003241,-0.3666669100111787
MOTN-1,9915743,0.6517075840543033
J82,2746,4.586638058567165
JJN-3,24779724,5.7356283726242
SK-N-AS,65628,4.296687684289776
KE-39,11152667,0.74958800909379
BT 187,65628,4.295313885744154
OV-90,135421197,1.209947389883954
C2BBe1,9935249,3.1734347371744036
NALM-6,11152667,-2.6312917838320877
NCI-H716,9926054,1.9023068554939984
LNCaP clone FGC,1566236,3.496775804541155
SNU-869,10296883,4.255396033988242
NCI-H647,9884685,1.1799984991000132
HCC1419,10296883,3.973664807604541
SH-10-TC,9884685,3.631476367936063
CAL-29,11152667,-1.4112558222688478
MG-63,4378219,4.0528629596402705
SNU-869,JQ-1-carboplatin (1-1 mol-mol),5.110674906782879
L-1236,73707386,1.6833815514075816
EBC-1,135984461,4.240736230766537
TE 441.T,11152667,-1.20408962070059
8505C,9911463,3.9204213231071527
OCI-Ly10,54618771,1.2684517844951826
YKG-1,11404337,0.7038073229533129
HDQ-P1,9915743,0.2716921146551485
SW1271,3854666,4.252835819462087
BT 333,71751553,4.321215757704447
JHOS-2,4705,4.289779797821904
BT 428,3854666,1.1222123532361343
GP2d,100016,6.428285689025714
LS1034,135421197,0.962643417558857
C2BBe1,11494412,2.98786476035404
BICR 22,136227924,2.105383482893856
PK-59,135421197,1.5554330287724354
IGROV-1,11404337,-0.7659238947812715
H-STS,11152667,-1.2361022970372575
SNU-C5,9915743,1.1022150159535518
SEM,3465537,0.8371255640679629
NB4,54618771,-1.2377399281525494
HT-55,54618305,4.362307873110049
VMRC-LCD,9915743,2.4183813584018616
CAL-51,9868037,3.5441777448678615
CAL-54,2742550,3.412395936689071
T24,9884685,3.0703903022477643
NCI-H510A,1566236,1.6103804489942135
HT-55,2746,2.9467453757111848
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
Hs 611.T,11152667,-4.000300813330283
KG-1-C,9935249,3.19520490423661
P31/FUJ,11152667,-2.5755274762926095
PLC/PRF/5,100016,6.529147023700783
UM-UC-3,135659046,4.064951020836241
CAL-33,136227924,2.366373998099427
CCK-81,135984461,3.9266881520309247
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
KE-39,10296883,3.8123665461282545
KMRC-3,12003241,-2.293511180564156
KMBC-2,9935249,2.7698221479828726
UACC-812,9935249,3.1921366544842
RMG-I,9911463,3.4639746242491545
NCI-H1568,6918638,-0.3782949656582497
COLO 829,11494412,4.564162529405607
OV56,2742550,6.393989194319079
BT 416,11494412,-1.7443510359170835
BT 159,9915743,2.235896124208317
NCI-H661,1566236,3.2299922345410006
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
PC-3,54618771,1.1708182294918184
SK-N-MC,selumetinib-vorinostat (8-1 mol-mol),2.156046762999695
VCaP,9884685,-1.1282350078658885
RERF-LC-MS,11494412,1.0302757077826894
RERF-LC-MS,136227924,4.560045704487339
SW1271,24779724,6.290779023739936
HD-MY-Z,135421197,1.63491304477545
SiMa,12003241,-0.7003588791224504
OV7,12003241,-1.6318982026296969
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
HCC78,11404337,1.202138123239975
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
BICR 22,9915743,0.3047863731286212
BT 131,3465537,1.252065876496985
U-BLC1,9915743,-4.280634530876826
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756
SNU-1076,9884685,-1.5611558865711956
SNG-M,9911463,4.222801467969213
EKVX,JQ-1-carboplatin (1-1 mol-mol),5.826710016487848
U-118MG,54618771,1.5788983669789174
NCI-H1373,selumetinib-GDC-0941 (4-1 mol-mol),2.438730896518944
L-363,54618305,-2.6619495669373383
NCI-H727,136227924,3.2179651731130585
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
DMS 114,9884685,-0.6854409679622795
HEC-1-A,3854666,1.770805804146439
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
P31/FUJ,12003241,-0.93015536828776
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
BT 112,71751553,4.665557673334606
DK-MG,JQ-1-carboplatin (1-1 mol-mol),1.3379136622287715
WM983B,2746,3.5652531947368495
647V,1566236,1.696707922435322
OVK18,65628,4.603637756279064
SIG-M5,JQ-1-carboplatin (1-1 mol-mol),-0.4990095627989978
BT 340,10322450,6.150676634502763
NCI-H747,54618771,0.1335600477139397
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
SNU-878,BRD-K16130065,4.3857850176988125
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
HuP-T4,12003241,-2.8459442311528154
ONS-76,135421197,2.4329108516652775
U-BLC1,24771867,1.193236570951232
SNU-489,selumetinib-GDC-0941 (4-1 mol-mol),2.3199148187504592
EFM-192A,3854666,0.9755146763983704
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
TOV-112D,12003241,-0.8504182456561812
BT 330,9884685,0.2489393167095227
SU.86.86,9911463,4.35911979104002
KP-N-YN,9911463,4.355119869591486
FU-OV-1,11152667,-0.9879051128837576
BV-173,24771867,-2.98212322307884
MDA-MB-157,136227924,3.402219650297347
IGROV-1,9926054,1.8111808945519428
Panc 10.05,selumetinib-vorinostat (8-1 mol-mol),2.182952448913038
KE-39,12003241,0.559414259019648
OCI-AML-2,9926054,1.545607447345451
SIG-M5,11152667,-1.411056546270547
BT 224,2746,4.512164577407842
Caki-2,54618771,1.2625964957313875
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
Mono-Mac-6,100016,3.84240036835353
Mel Ho,65628,4.368881393126495
Yamato-SS,11152667,-1.320791776573827
NCI-H446,54618305,4.329529638985389
NCI-H2196,54618305,4.391453781837025
NCI-H1623,71751553,5.091527890142487
COR-L105,11152667,-0.3968124554752262
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
JM-1,135984461,1.552881480804892
HPB-ALL,9884685,0.51403657851557
HCC1806,9915743,1.1947371643854778
ZR-75-30,71751553,4.500324132162376
SK-UT-1,71751553,5.981983562576585
Mel JuSo,3854666,2.774880128423634
SK-MES-1,9915743,0.4302153441445988
NCI-H2452,2742550,5.209305166760603
BT-549,9911463,4.268645247281358
Kasumi-2,9884685,-1.7492969798518767
697,4705,2.278672622564821
EoL-1,136227331,3.409385468978638
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
EB1,2742550,2.859851248001829
OCI-AML-3,136227331,4.0355343672890935
KMS-18,10322450,4.373704561545144
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
NCI-H1105,9935249,0.0872849260187398
NCI-H810,100016,4.22640705156995
RD,6918638,0.5242831454740873
HCC1428,10296883,4.338608751562579
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866
DV-90,54639665,4.358893407876041
NCI-H146,11152667,-0.8780602169524299
TE-8,2746,1.7722164747559497
NCI-H1755,9915743,0.4239600926886341
RL95-2,selumetinib-GDC-0941 (4-1 mol-mol),-1.0392511344110156
SNG-M,1566236,1.975586698228256
MOLP-2,135421197,1.9402190230236491
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
Peer,2742550,3.1352268495567244
OCI-AML-3,135659046,3.507210713812752
MOLM-6,3854666,0.1170601989372903
BICR 16,9935249,3.515936718867687
Calu-3,24771867,2.9270730892519174
NCI-H1385,4378219,1.5408822959755366
NCI-H2196,135984461,4.343785074544861
JHH-5,2742550,3.699420936679788
HCC38,3854666,0.590612515412198
BICR 56,11404337,1.611918044632369
YD-15,selumetinib-vorinostat (8-1 mol-mol),3.259964348594559
NCI-H1573,100016,4.561614919470221
SK-MEL-24,3854666,5.129098369298213
U-BLC1,1566236,1.8337532039015736
RPMI-8402,9926054,1.3971414667672897
NCI-H2126,12003241,2.692479485403981
BT 498,4378219,1.6877979414326845
Mono-Mac-1,54618771,1.1455775902832934
K-562,9926054,1.8612748023096723
NCI-H1092,2746,3.1114505923007583
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
A2780,9935249,1.4583070792637778
Hs 688(A).T,selumetinib-vorinostat (8-1 mol-mol),4.759563761908848
SU-DHL-1,100016,4.0163007651424945
JHOC-5,136227924,3.178485175637893
TCC-Pan2,11152667,-1.5312652033075302
NCI-H211,136227924,1.9167606171360705
Hs 852.T,10296883,3.5270090388531883
RVH-421,24771867,4.996835194110274
CAL-12T,100016,6.470654025405006
OAW28,1566236,3.486252592676433
MOLM-13,3854666,0.5101644656521153
BT-474,9911463,4.372266907871184
Namalwa,9935249,0.8927496794896076
LN-229,12003241,-0.983315383516156
PK-59,9935249,3.732455742727782
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
PK-1,2746,4.301846105037093
RERF-LC-MS,100016,6.56071523320666
NCI-H1734,JQ-1-carboplatin (1-1 mol-mol),1.68501877850312
NCI-H322,10296883,3.9806006473812
ST486,1566236,0.5405681794856062
NCI-H1869,3854666,4.318290699876198
TUHR14TKB,11494412,4.3199141466237805
COLO 699,selumetinib-vorinostat (8-1 mol-mol),3.340743888549838
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
HCC2218,44241473,4.43561890592857
HEC-108,65628,4.442011228839073
EFO-21,65628,4.296622507427161
KATO III,11404337,-0.4970359765575001
P-STS,11404337,-0.4703645434055084
EB1,24771867,1.441441734129046
GI-1,6918638,0.0741451008048908
HCC1428,4378219,1.996488874546088
Panc 08.13,4705,3.2768687691723395
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
BICR 6,24771867,4.062233890475674
A4/Fukuda,9884685,-2.10728676228506
HEC-265,9926054,2.077081644507314
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
SUIT-2,12003241,-0.3419407469483631
HCC1937,11152667,0.4358352072628013
DMS 79,3854666,3.294297622052333
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
MM1.S,73707386,0.9217883452214084
B-CPAP,11404337,-1.1633647036433346
SH-4,135421197,1.5292272501013058
KHM-1B,136227924,1.9174951940989704
YD-15,9926054,1.8520578861045605
JJN-3,6918638,-0.7413603432623325
GMS-10,selumetinib-GDC-0941 (4-1 mol-mol),1.7760805254050829
SUP-HD1,selumetinib-GDC-0941 (4-1 mol-mol),2.188403523917611
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647
HPAF-II,44241473,4.345766693300401
SNU-C5,65628,5.533856982258314
PLC/PRF/5,2746,3.4483774015176447
KMS-26,9915743,-1.9616830637475051
Tm87-16,12003241,-0.0978800802816917
SW1271,2742550,3.530952260660614
OV-90,11404337,1.6888356686840926
J82,44241473,4.581557491308484
NCI-H146,6918638,-1.4860665745363582
CAL-148,10322450,5.795817783172109
SNU-119,9911463,2.8532899111041385
BT 245,11152667,0.6307471035808881
ESS-1,71751553,4.681072103352448
DV-90,136227924,1.3959750608222408
KMS-20,1566236,0.9059478778030634
RPMI-8226,11152667,-1.9312828713071295
NCI-H647,9915743,2.3861555081982035
HEL 92.1.7,1566236,1.5970537122155075
YD-15,9911463,3.7436865426032786
NCI-H1793,selumetinib-vorinostat (8-1 mol-mol),2.6768979006350184
KMS-11,JQ-1-carboplatin (1-1 mol-mol),-1.3337682684641334
KMS-34,11152667,-1.7848864383845235
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289
SR,44241473,4.8441308052614485
SW620,9915743,1.1918924065742125
A-172,135984461,4.014453553183264
AsPC-1,6918638,0.7071735542476161
CHP-212,54618771,1.2694957147058317
SU.86.86,3465537,2.251677692666755
SK-HEP-1,1566236,1.7725788045776691
ZR-75-30,9884685,3.5597047060324445
TE-14,11152667,0.6332718687769578
NCI-H650,73707386,3.7981145791895705
YKG-1,71751553,4.894394979371257
EPLC-272H,2742550,3.751744166545609
WSU-DLCL2,44241473,4.822037535076557
BxPC-3,54618771,0.182098153600537
LCLC-97TM1,49836020,1.9924259842665932
BT 359,100016,6.547217450499836
HCT 15,3465537,2.265148035694417
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
PC-3,11152667,2.8272133206200087
AN3-CA,3854666,0.7881289812333258
SNU-C5,9935249,3.152183771231709
PaTu 8988s,6918638,1.3708196410669105
PSN1,9911463,4.382520563111527
Karpas-422,2746,1.689970111701259
CAL-51,10322450,3.881825194853649
BT 131,135659046,3.687491752801227
KP-2,11152667,0.1770667572692464
L-363,selumetinib-vorinostat (8-1 mol-mol),2.56044642347113
Kasumi-1,54618305,3.79646106226917
TCCSUP,44241473,5.1111150240253975
BICR 56,selumetinib-vorinostat (8-1 mol-mol),1.34351766962856
COR-L105,2746,3.1035280268076217
NCI-H1341,1566236,1.499019730270858
Ishikawa (Heraklio) 02 ER-,3854666,1.1543280454894709
SNU-C4,selumetinib-GDC-0941 (4-1 mol-mol),1.401600163987786
BHT-101,136227924,2.4401355841785173
TE-6,9868037,2.429153883082853
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
NCI-H810,11404337,-1.324114158027616
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
KMS-18,11152667,-0.8948965427332419
LN-18,JQ-1-carboplatin (1-1 mol-mol),2.2157134511008927
CHP-212,71751553,4.254165776093673
MES-SA,9935249,3.0678180432463873
KLE,9911463,3.5004519168580828
SW948,11152667,-0.307089718187717
KG-1-C,11404337,-1.389816436065637
WM266-4,9926054,1.9241350180859695
NCI-H441,12003241,-0.5712831750055372
KMS-18,4705,2.900796291419513
LS1034,9884685,0.8754277449757942
KP-N-SI9s,4705,2.458330533365605
Mino,71751553,3.961570534496015
JHOS-2,100016,8.119351788295337
SNG-M,12003241,-1.3269427590967688
HCC4006,135421197,1.321900660308596
HT-144,4705,3.2699315895586127
SNU-C5,136227331,4.384397979730017
G-401,9915743,0.7240748800691799
A3/Kawakami,9884685,0.5438529954210741
NU-DHL-1,6918638,-1.28362156468715
VMRC-RCZ,2746,3.717022138974909
OCI-M1,11152667,-1.18912794450191
MEC-1,24771867,1.4163434494066525
Granta-519,9926054,1.8135939424605243
T3M-10,11152667,-0.370129452740934
HOS,9911463,3.9584214760624
BT 231,9926054,1.8669465776815437
MOLM-16,11152667,-1.9263651409287528
MM1.S,11404337,0.2422934532029092
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803
A-549,100016,7.181380121169662
COLO 668,11404337,-0.9260086161567648
NCI-H520,11494412,0.2940036385814875
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
Malme-3M,135421197,3.050817856383808
TT2609-C02,71751553,4.283700752409424
KLE,11152667,-1.6090314572433455
Hs 839.T,10296883,4.248587708803948
U-118MG,2746,3.48796975848492
NCI-H1581,9911463,2.8150360294016927
Hs 888.T,11404337,-1.3976008238381223
NCI-H1915,24771867,4.054924664071392
BICR 16,100016,8.634217681257812
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
COR-L95,9926054,2.0133423062539726
KP-N-SI9s,11152667,-1.205697383084552
SK-MEL-31,selumetinib-GDC-0941 (4-1 mol-mol),3.550007018724769
RMG-I,selumetinib-vorinostat (8-1 mol-mol),1.624672886728396
SUP-M2,3854666,-1.0118736970987623
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
PK-45H,135984461,4.36472213501135
Capan-1,11152667,-0.5862513866914233
MHH-ES-1,136227924,2.293763722118734
786-O,65628,4.397983863237757
JHUEM-7,9926054,1.641999407547345
Panc 05.04,selumetinib-vorinostat (8-1 mol-mol),1.2713698550685717
MHH-ES-1,49836020,5.438630069429388
BT 440,135421197,3.1509992040487074
NCI-H1341,100016,3.8327529210726903
SNU-16,135659046,3.4263831246491367
BT 112,100016,6.504213631006025
PE/CA-PJ15,100016,6.230779358531284
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278
NCI-H1299,135421197,1.297843636132371
NCI-H292,65628,4.3235700442832625
JHH-1,10296883,4.130591139989607
Hs 839.T,24771867,4.879420947352755
Mono-Mac-1,9911463,2.4863663707883723
HOP-92,10322450,5.279706344713567
ZR-75-30,9935249,3.534829888991848
NUGC-3,54618771,-0.8642995608201182
KE-37,11152667,-3.2630425463199884
Hs 683,135421197,1.945110581550152
KMS-26,JQ-1-carboplatin (1-1 mol-mol),-2.004743944030579
NCI-H929,11152667,-0.508669926836867
NCI-H522,135421197,1.9700795220087195
EoL-1,135659046,2.6902533100653785
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
DLD-1,12003241,-0.215038024432674
U-251MG,24779724,5.1714808067165
SW1271,4705,3.86061099620112
SW1783,2742550,4.177993888768022
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
IGR-39,12003241,-1.2962824425712205
T-47D,6918638,0.9017402025049926
TE-9,11404337,-0.8200746499862688
SK-N-SH,54618771,1.3194145394853296
Rh18,9926054,2.105597282648335
MSTO-211H,44241473,3.911097970359605
IPC-298,11152667,-1.5670594784434084
KYO-1,136227331,5.147481927043426
SCC-9,24771867,5.065268858490301
BT 232,9868037,4.279293873867471
DEL,24771867,-0.9003292713485972
LN-229,3854666,3.037583320137183
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
KYSE-30,9926054,2.699990284064641
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
BT 164,3854666,0.922367981820593
22Rv1,100016,5.084356097831624
HSC-2,100016,6.282703144403752
HuG1-N,135984461,3.7113703806960054
HMC-1-8,135421197,3.069266594691258
NCI-H1869,9926054,1.781753958996035
HeLa,selumetinib-vorinostat (8-1 mol-mol),2.818630942725572
COLO 792,54618305,4.394702528877574
SK-CO-1,65628,3.554197618459022
LS123,4378219,1.895917583227428
TE 617.T,65628,4.20520230930191
SNU-899,54618771,0.9144402364445118
RMG-I,11152667,0.0642721521014258
NCI-H1792,24771867,3.876297551331772
RCH-ACV,9915743,0.3296075403381741
TE-14,4378219,4.491971036424627
TE-14,9915743,-2.4468727006504483
HCC78,12003241,-1.0292430450952663
NCI-H1869,selumetinib-vorinostat (8-1 mol-mol),2.952305626055488
Hs 766T,11494412,4.28391436408153
GaMG,selumetinib-GDC-0941 (4-1 mol-mol),2.5044066808337644
JL-1,11152667,0.7661061138281205
COLO 792,71751553,4.132027532829227
23132/87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1204952013387844
TCCSUP,650361,4.871702860557827
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
SNU-119,9884685,1.7075636021097025
SNU-1214,3854666,1.2717797575016767
NCI-H660,71751553,3.85779920922312
OV-90,3854666,3.230215800724518
BC-3C,11494412,2.054977599436637
CL-11,136227924,2.4405671689998027
SUP-HD1,168313307,4.639616266105548
EFM-192A,9884685,1.0219370503063232
Calu-6,54618305,6.226054590267507
NCI-H1341,135984461,3.1611856157713607
BT 340,selumetinib-GDC-0941 (4-1 mol-mol),2.751381864792414
UO-31,2746,3.591448305166117
HDQ-P1,24771867,4.1240968944837295
KMS-27,9911463,4.115013696687494
BICR 6,2746,3.4354439873980143
A3/Kawakami,100016,3.999978023882096
MKN7,1566236,1.7135584287859864
SNU-119,4378219,1.466515976267717
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
GP2d,1566236,1.660029832907994
MDA-MB-453,135421197,0.8806711164351635
SK-MEL-31,9926054,3.613636907383419
NCI-H841,JQ-1-carboplatin (1-1 mol-mol),4.388076170034027
GCT,6918638,0.9621268988100647
JVM-3,JQ-1-carboplatin (1-1 mol-mol),-1.4584140934293672
Calu-1,11404337,1.1287217214353569
SF126,24771867,2.01602585342232
Kasumi-1,9884685,-1.171230132839738
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
A-204,9915743,1.0041843523053866
NCI-H460,100016,5.855223104671776
BT 147,9915743,2.5746757141413887
NOMO-1,12003241,-0.5951695723430065
MOTN-1,11404337,-2.499451139937234
U-937,44241473,5.163507287721795
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984
647V,selumetinib-GDC-0941 (4-1 mol-mol),1.2881187017164255
CMK,100016,5.771362707779288
HOP-92,11404337,-0.857854163470874
SNU-466,9915743,-0.0842203347342703
LS513,73707386,4.571028126982481
PC-14,4705,-3.029150478382576
BT 248,71751553,4.279070264679743
OE21,9911463,3.2233291636106727
NUGC-4,54618305,4.338411628407715
COLO 829,10296883,3.971671939086983
COV362,100016,7.994124175315401
UO-31,9868037,3.0642898749383627
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
Kasumi-2,135984461,1.6284116850001094
PLC/PRF/5,4705,2.7931521546735243
MOLT-3,11404337,-3.211450754750083
NB4,9935249,1.5205044198931177
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
COLO 205,12003241,-1.1256209046349093
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
HuH-1,2746,2.931726924620674
SK-MM-2,9868037,2.838791027261754
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
22Rv1,selumetinib-vorinostat (8-1 mol-mol),2.372409172383956
HCC1500,71751553,4.671922723370954
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
LCLC-97TM1,54618771,0.7707104681824843
JHUEM-3,selumetinib-vorinostat (8-1 mol-mol),1.9362671719924216
Detroit 562,selumetinib-GDC-0941 (4-1 mol-mol),2.228637480790017
NCI-H526,135421197,1.27710242642961
NCI-H520,9926054,1.793691213544428
RERF-LC-A1,24771867,3.1832932078828335
SNU-C4,136227924,2.9928621999202467
AU565,54618771,1.1954147839624212
Hs 729.T,65628,4.328856822619668
U266B1,4378219,4.677212924718182
P3HR-1,2746,2.544135667971718
NCI-H2405,54618771,0.0947860267625534
DMS 114,10296883,4.0850638557883165
MeWo,10296883,4.224617443246128
MOLM-13,24771867,-2.755307399303063
G-292 clone A141B1,9915743,4.37083604289579
SNU-16,3854666,1.7329468911720929
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
FTC-238,6918638,0.6994122204113324
HCC202,selumetinib-GDC-0941 (4-1 mol-mol),2.1279074309941413
CAL-33,9935249,2.6612309023726723
SK-MEL-24,54618771,0.9964231192757652
SK-N-FI,3854666,-0.1881636838326112
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
SK-LMS-1,54618771,1.3800871170557885
DMS 273,11152667,-1.0918930552191226
KNS-42,2742550,4.472356160469779
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
IST-Mes1,9884685,0.6527999920478087
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
SNU-16,9884685,2.9055473229469015
SNU-840,24779724,5.873236558361466
DMS 273,10322450,3.6367733537116167
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
SaOS-2,6918638,1.2055090485954645
SF268,9915743,0.6317459379603247
G-401,11404337,0.5096427987118028
COLO 741,selumetinib-GDC-0941 (4-1 mol-mol),3.828549424884254
G-402,4705,2.98367942972675
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617
KM12,100016,6.486077549174115
DMS 79,9911463,3.344915999400502
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
SNU-478,136227924,2.019778672481118
KU-19-19,9926054,2.3371072555508445
KMS-21-BM,3854666,0.4771292097987486
HCC1588,selumetinib-vorinostat (8-1 mol-mol),-0.2694546594396645
KNS-60,4705,3.2659251845873425
DU4475,136227331,3.920684597845916
MOLT-16,100016,4.920795787487072
Panc 10.05,9935249,2.6158504828973626
SNU-1077,9935249,3.485135676518772
SNU-216,3854666,1.5615804262646893
Hs 729.T,12003241,-0.5985537077535523
BICR 31,12003241,-1.4237270953299652
LOX-IMVI,135421197,1.985626548385356
SNU-5,9911463,3.488493689315011
BICR 31,9911463,4.617619725588035
OCI-M1,54618771,0.2801133336374899
SH-10-TC,10322450,5.299988243449435
OAW28,11404337,-1.5682838378564492
GaMG,135659046,4.983259743883316
G-292 clone A141B1,selumetinib-GDC-0941 (4-1 mol-mol),0.4997156895846377
GDM-1,135984461,4.082680160500648
Caki-2,9935249,3.2046131890205243
SW1353,11404337,0.8555790619059997
SNU-601,4378219,4.57452982901372
NCI-H716,11152667,-0.7087449737081221
BT 228,12003241,-1.6653206714884845
OAW28,54618771,1.1011370240470315
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
DLD-1,4378219,2.3905672314053388
A3/Kawakami,1566236,1.0129797315712863
BT 245,65628,4.476006410833118
KCL-22,3854666,0.7303027216654703
BC-3C,10322450,3.9889152923020537
SK-N-DZ,135984461,1.5493461602233345
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
SNU-840,9935249,4.258063861319956
NCI-H647,10296883,4.213615092820639
DMS 454,135421197,0.7906856651766786
BICR 6,selumetinib-GDC-0941 (4-1 mol-mol),1.9156863537341864
U266B1,selumetinib-vorinostat (8-1 mol-mol),1.5567800488837416
L-363,100016,4.553463106890726
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
B-CPAP,44241473,5.575826833143993
SUP-M2,65628,1.971543612334658
SUP-M2,JQ-1-carboplatin (1-1 mol-mol),-0.9276851107158648
HuP-T4,9935249,3.6458180171980223
A2058,selumetinib-vorinostat (8-1 mol-mol),2.9812584938386273
Hs 578Bst,3854666,3.703046177176273
ZR-75-30,selumetinib-vorinostat (8-1 mol-mol),4.024339554516039
KALS-1,JQ-1-carboplatin (1-1 mol-mol),0.9205030835960966
EHEB,9926054,1.8810570858595552
LXF 289,3854666,2.0847029854583377
786-O,135984461,4.712417821590371
SBC-5,135398744,6.447254342428179
OVK18,24771867,3.547144392461473
NCI-H2081,selumetinib-vorinostat (8-1 mol-mol),1.9423097889386416
HCC1500,2742550,3.2494473825713026
REC-1,11404337,-2.3807065169464336
MHH-CALL-3,9926054,1.9964305651779948
SK-LMS-1,2742550,3.9277163858782913
SF539,9884685,-0.5281104713803977
LCLC-103H,12003241,-0.4608233539243975
BT 179,selumetinib-vorinostat (8-1 mol-mol),3.4704732436334296
NCI-H460,11152667,1.2005763717636435
MOLP-8,24771867,-5.187641849515016
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
ACC-MESO-1,selumetinib-vorinostat (8-1 mol-mol),3.6513542751877313
Hs 944.T,11152667,-3.1279512985211264
Becker,65628,4.34244809682726
BICR 18,3854666,1.5659435461984097
SNU-878,3854666,1.275422306167658
HCC1588,136227924,2.6333776491111585
CCF-STTG1,2746,3.7135967128071385
TE-4,9911463,3.1897003979431093
BT 248,135421197,1.5349499708791383
JHOS-2,24771867,4.188551763626288
Mono-Mac-1,1566236,1.6378087380099338
GSS,9868037,1.8794585438915803
D283 Med,135659046,3.420100505846104
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544
OPM-2,11404337,-1.9830798838769188
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
HLF,9926054,1.9113272674317217
NCI-H841,9935249,1.8463416409566311
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
SNU-620,selumetinib-vorinostat (8-1 mol-mol),-2.832370500615607
CAL-51,1566236,2.769525954778687
EBC-1,9911463,2.6275230759379933
EFO-27,24771867,3.839082818590537
A-253,49836020,4.493346426084629
SNU-C5,JQ-1-carboplatin (1-1 mol-mol),5.5029017516630345
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
CAL-85-1,71751553,4.145949269472578
COLO 684,1566236,1.5720461197639393
UACC-62,11404337,0.3177271897074518
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
2004,6918638,1.2985206929345292
JHOC-5,11404337,-0.7952540156360246
HuP-T3,54618771,0.8132197250487964
KMS-11,2742550,3.0552231561161447
U2OS,54618771,2.9736494040757924
Daudi,3465537,3.6729414318228697
KYM-1,65628,2.1252254904247656
NCI-H2085,54618771,-1.2353665657353068
EJM,24771867,4.483722434089688
Reh,11404337,2.5289524412183964
BT 232,10296883,4.252681745204764
JHH-5,10296883,4.145444689794886
MDA-MB-361,2746,1.2909021690228906
KALS-1,650361,4.294663890793572
KMRC-3,2742550,3.5464542059960653
WT2-iPS,10296883,3.9536732530855647
CAL-27,9935249,3.0508585770185817
KPL-1,11152667,3.5133536124099387
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
Panc 02.03,54618771,1.0884531427161812
DU145,11404337,1.4411442495527176
U-BLC1,9926054,1.6248687315541563
SCC-4,24771867,3.188216971666832
A2780,10322450,2.9165978660974545
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
SCC-4,9926054,1.835519091908301
SK-N-BE(2),11494412,1.3144229317777725
Hs 940.T,2746,3.6289293164152614
HLF,12003241,-1.5273612308967348
SK-BR-3,4705,1.1013734177792738
SNU-449,71751553,4.402646349497825
OCI-AML-5,9911463,4.375280736441336
COR-L95,1566236,1.7351682171374878
NCI-H520,9935249,3.10400998228373
KMRC-1,4378219,2.060133570967863
KMRC-3,135984461,3.851943021545312
SF126,selumetinib-GDC-0941 (4-1 mol-mol),2.749668996319385
RCH-ACV,selumetinib-vorinostat (8-1 mol-mol),1.2774108337481205
HGC-27,9911463,2.724483471079002
SK-N-MC,136227331,5.402807013617019
OCI-AML-5,24771867,-1.900109207004394
NCI-H1385,24771867,2.3172494601759417
MES-SA,12003241,-0.7503338761579216
U-CH1,9911463,3.7817201694123432
EFM-192A,selumetinib-vorinostat (8-1 mol-mol),2.534370375575117
TE-1,73707386,3.78694357461448
TE-15,9915743,-3.4156269103241605
639V,selumetinib-GDC-0941 (4-1 mol-mol),4.596668684568556
639V,54618771,0.9699506907820744
8305C,136227924,2.5381850582467913
ACHN,54618305,4.302999530390601
NCI-H1734,9926054,1.950289426848977
SW620,100016,5.873144490676751
SF539,135421197,1.037431947377599
KYSE-450,9926054,1.8553044985655331
LXF 289,100016,7.121965810949268
RPMI-8226,136227924,2.992898649350054
Hs 944.T,11404337,-1.616812668410186
BT 286,selumetinib-vorinostat (8-1 mol-mol),-2.316984046450598
NCI-H2110,4705,2.9559067422385494
SNU-869,65628,5.2914896740347785
RVH-421,11404337,-0.9304733374413466
VCaP,JQ-1-carboplatin (1-1 mol-mol),-0.2826597777645429
AU565,12003241,-0.6235660341918571
697,3465537,3.3295432366949895
KMS-27,10322450,3.3921429038631707
SNU-61,100016,6.106397388471953
Capan-1,9935249,3.692856081858843
BICR 16,12003241,-0.754422743943259
DMS 79,73707386,2.699728745482677
A-172,9911463,3.965281913049293
NCI-H2405,135421197,1.0087242199460646
MKN74,3854666,2.1744767713942905
BT 147,1566236,1.8849884587533212
NCI-H520,9915743,1.4167224147327635
COLO 680N,100016,6.604594090356929
OE19,2746,3.0430549573559036
NCI-H196,11404337,0.5983725190796483
MHH-CALL-4,9911463,4.039768304149654
TE-15,10296883,4.422841947508094
JURL-MK1,135421197,2.4135031491286285
SU-DHL-8,9935249,1.218820963316766
NCI-H28,135421197,1.3178315366428714
COLO 829,135421197,3.0893974148285466
Becker,3854666,0.4017122764286526
EB1,24779724,4.283325009913098
DV-90,54618305,4.068440382040456
TOV-112D,3854666,1.2404915095556075
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
Hs 944.T,12003241,-1.584632945920027
PC-14,100016,6.551425062945198
NCI-H2126,11404337,1.7929049534978918
KG-1-C,3854666,4.168870008885518
MEC-1,136227924,1.9415739350117864
MeWo,selumetinib-vorinostat (8-1 mol-mol),0.3610205668495764
SK-N-AS,1566236,2.45590112845104
LCLC-103H,54618771,0.2983505798341654
NCI-H2110,9915743,1.734073577383887
253J,136227924,2.473625062581448
Hs 578T,9884685,-0.940364062265686
NCI-H2141,9915743,0.5832119024567368
SH-4,3854666,5.025906872043464
OUMS-23,9926054,1.8521308155808696
U-118MG,1566236,1.829120516017912
MDA-MB-453,100016,6.0730906594859215
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
JHUEM-2,44241473,4.3199413160415645
MHH-ES-1,24771867,-3.5252517950001097
SNU-878,11152667,-1.7105164771196346
OVTOKO,54618771,1.1892418619446876
OCI-Ly3,9915743,0.6097478926104294
P31/FUJ,76446078,4.256026108364254
NCI-H508,135421197,1.875184072500521
DMS 114,11404337,-0.5972709505558575
NCI-H1568,135984461,4.216726883570129
U-937,54618771,0.4735715356031699
U2OS,136227924,2.232158663555595
DMS 79,135421197,1.224509473614064
COLO 320,10322450,3.382399386681384
HEC-108,selumetinib-vorinostat (8-1 mol-mol),3.960684910603258
HOP-92,9935249,3.096811050653779
KMS-28BM,selumetinib-GDC-0941 (4-1 mol-mol),1.2761888843371896
SUP-T11,10322450,3.259585661278822
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
NCI-H1568,4705,2.022283964907955
HOP-92,11494412,3.5967755894760645
G-402,135421197,2.1545147661375275
CGTH-W-1,136227924,3.107802787848976
SNU-1041,12003241,-1.3076188477929267
NCI-H1944,3465537,3.2781251694419677
COR-L105,6918638,0.8528151020185122
NCI-H28,11404337,-2.031510536668559
RPMI-6666,4378219,1.938131119067339
LOX-IMVI,3854666,2.4185877249013368
ChaGo-K-1,9926054,1.8139091606673228
G-292 clone A141B1,9926054,1.742102063355914
NH-6,9926054,1.9034563361062868
FTC-238,9915743,0.6345085116820538
NMC-G1,4378219,4.65762217703462
JHUEM-1,136227331,3.9088223702445526
NCI-H1650,1566236,2.485076362735835
NCI-H2452,9868037,3.199558399493599
Detroit 562,135984461,4.371525738638509
GCT,10296883,3.718708218585829
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
OCI-Ly3,54618771,0.9426860423184806
SK-MEL-30,1566236,3.2801192467549836
HCC202,9915743,-1.8631873030547408
MSTO-211H,12003241,-2.79016034960529
SJSA-1,9911463,4.067531678479842
A-549,100016,7.181380121169662
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
AsPC-1,11152667,-0.9426796832875202
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
SK-LMS-1,136227924,4.704854352606181
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
KYSE-70,9926054,2.326174845830733
U266B1,135421197,2.0671733343036247
RMG-I,selumetinib-GDC-0941 (4-1 mol-mol),3.743143666757181
NH-6,9884685,0.8141539195615259
DEL,136227924,2.1995562608544494
UACC-257,9935249,3.33799622234966
NCI-H2087,9926054,1.8666936138192145
HCC1419,6918638,0.6452864183541364
NCI-H1184,135984461,3.671317509665682
TOV-21G,9935249,3.3191148876859824
NCI-H747,1566236,1.766438037166322
LMSU,11152667,0.2226803323304874
NCI-H28,136227924,2.9733016664554155
RKN,54618771,1.93479648501244
T24,9926054,1.988465622132668
JHH-1,12003241,2.181152294070196
Hs 688(A).T,12003241,-0.4220829795676687
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
NOMO-1,3854666,1.0231806307237967
CHP-126,9911463,3.8708790519739593
MOLT-3,135659046,2.7195018879588995
MOLP-8,4705,2.7848528520877727
COLO 320,2746,2.553177448203693
GSU,selumetinib-vorinostat (8-1 mol-mol),1.9525647465582676
MV4-11,76446078,5.40812202570981
DND-41,9915743,1.2658570457354406
NCI-H1755,9911463,3.444248819442768
TE 441.T,1566236,2.5728062109815335
NCI-H838,24771867,3.0246279665643874
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
SU-DHL-8,100016,4.106875584244309
OAW42,9935249,3.0438491704796076
SaOS-2,135659046,3.828911922642458
BT-474,3854666,3.675072420225406
Raji,100016,6.465762715187829
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
A-673,49836020,4.096681472773702
MDA-MB-231,12003241,-1.774974219486486
BT 245,9911463,3.0517796790400173
JM-1,6918638,-1.945896791217812
KNS-62,3854666,3.1302523533571014
NCI-H2196,11404337,1.3261557854884771
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
SNU-1033,135984461,1.7836640453843908
ZR-75-30,11152667,3.770951125825099
OCI-Ly19,selumetinib-vorinostat (8-1 mol-mol),0.6945020606262625
MHH-CALL-3,135984461,3.2485861141409975
Calu-6,10296883,3.629960277454761
NCI-H1435,9911463,2.965679998241422
8505C,54618305,4.737027632312438
NCI-H2228,9868037,2.633347793828571
KMS-12-BM,100016,3.5545657198194873
PE/CA-PJ15,4705,2.241412647888812
SF539,135659046,3.181821233210504
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
KYSE-140,9915743,-1.963321476047282
NCI-H358,JQ-1-carboplatin (1-1 mol-mol),-0.0841702060243808
Hep 3B2.1-7,11152667,0.7681962822393275
PaTu 8988s,11494412,1.3671050203889736
VMRC-RCZ,9915743,2.338225361528291
NCI-H520,135659046,3.9949277821053704
SW982,11404337,-0.6290614073029407
MHH-CALL-3,10322450,4.0007371010331045
COLO 320,6918638,-0.2537054006659544
SEM,650361,3.800745597928697
P12-Ichikawa,12003241,0.1281153302005317
BT 416,71751553,3.5669452232202317
KYSE-140,11152667,-1.9920193440846787
SW1353,136227924,3.029116785491403
HEC-1-A,11494412,2.510528357240151
OS-RC-2,11404337,1.5898749393998126
MOTN-1,135659046,3.5203350268102978
PL-21,4378219,1.9173931358029312
JL-1,71751553,5.12535964256515
BT 504,9935249,2.8901634129680764
SU-DHL-8,JQ-1-carboplatin (1-1 mol-mol),0.1071137470507251
LS1034,11494412,1.9461067942011936
SNU-1077,100016,6.64200464659652
Caki-1,12003241,-1.8863162536101896
Panc 08.13,135421197,2.5362535902354932
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
OCUM-1,4705,2.5400266776319067
HeLa,2746,3.522514487554161
CAL-51,10296883,4.0377332681132305
Hs 895.T,3854666,3.5289829664502568
NCI-H2286,9911463,4.284933717494527
KMS-27,135421197,2.249002810195298
U-BLC1,10296883,3.798592374745875
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
J82,9911463,4.397317703164105
SEM,4378219,1.9889519046071171
EM-2,JQ-1-carboplatin (1-1 mol-mol),-1.2961188335461022
D283 Med,2742550,3.5680258108109975
NCI-H520,1566236,1.8490403312922712
JIMT-1,11404337,1.30553025443882
KMS-28BM,12003241,-1.6881209255451883
TE-11,6918638,1.4188732058945317
Panc 03.27,10296883,3.962678998629819
NCI-H889,12003241,4.506379405890452
8-MG-BA,1566236,2.0324035604559554
RCH-ACV,JQ-1-carboplatin (1-1 mol-mol),-0.5668300449210979
Peer,10322450,2.772201791811034
Hs 944.T,9935249,3.2171969585361846
SNG-M,54618771,1.0542976852091588
HPAF-II,11152667,0.3961380987480721
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
MDA-MB-468,selumetinib-GDC-0941 (4-1 mol-mol),2.2484170521033437
RL95-2,9926054,1.9942568161623715
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
ONCO-DG-1,136227924,3.186548860778023
HuG1-N,11494412,1.1145937703232094
BT 159,100016,7.101052412805122
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
TT,selumetinib-GDC-0941 (4-1 mol-mol),2.303935736572117
COR-L47,11152667,-0.7609778276005695
NCI-H1793,selumetinib-GDC-0941 (4-1 mol-mol),1.778228229757508
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
MKN74,4705,5.009866699561135
MEC-1,9884685,-0.5815283881591208
MDA-MB-361,2742550,4.4584287487827945
LXF 289,12003241,-2.348837864712453
OPM-2,24771867,-0.0082042750480303
MSTO-211H,10296883,3.6762481855456985
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
EFE-184,135421197,2.5178551703046277
MHH-ES-1,9911463,3.923380979166965
AML-193,selumetinib-vorinostat (8-1 mol-mol),0.1935247845364687
HCC78,4378219,2.0252083323548993
EJM,11152667,-2.5425383772209393
JHH-2,9935249,4.674458161367072
NCI-H1869,100016,6.8338343579730285
NCI-H838,71751553,4.290826471669843
A-204,44487872,4.615233082071892
OCI-AML-3,2742550,2.8792511739592728
BT 245,135421197,1.3239460835535384
A-375,selumetinib-vorinostat (8-1 mol-mol),1.9790131702817335
IGROV-1,54618771,1.2456991772210466
SK-N-DZ,136227924,0.9645463461515836
TE-4,9926054,1.7320967547040995
TE-10,9915743,-1.7671163693014442
KMBC-2,6918638,1.17976161020614
Yamato-SS,40482356,5.141017205612628
HCC2108,135984461,3.878993075429708
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
T98G,71751553,5.013882600728961
DND-41,9935249,1.6830323290551856
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
AsPC-1,10296883,4.32215490848641
T3M-10,24771867,3.214240677067828
HCC1954,selumetinib-GDC-0941 (4-1 mol-mol),0.8258284821582321
Ri-1,9868037,1.6681879870423917
G-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.129609857983409
HEC-265,136227924,3.2525592636436405
Li-7,JQ-1-carboplatin (1-1 mol-mol),-0.1092601408867035
PK-1,6918638,1.0537426259825138
THP-1,1566236,1.6784142154407886
ES-2,3854666,3.173981203722866
BT-16,3854666,1.5084254792866438
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
BT 440,54618771,0.7745514333639397
GA-10,49836020,3.868484173874789
JHH-4,76446078,4.3456789152422335
NCI-H520,71751553,4.213251672590111
A-204,135398744,7.3650683487349236
NCI-H1755,54618771,-0.2834105943747247
NCI-H2444,136227924,3.2293818919988153
FTC-133,6918638,0.7173410835371117
MOTN-1,9911463,3.133435605539891
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
MOLT-3,2746,1.7836701533013988
GCT,selumetinib-vorinostat (8-1 mol-mol),3.339752225403805
KMH-2,12003241,-0.520398442259763
MOLM-13,10322450,2.9930800125873045
Hs 746.T,9915743,2.055973723979153
BICR 16,11404337,-0.0303488744380645
SUP-B15,9911463,4.29291953210489
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
M059K,9884685,0.2325695956853431
NB1,11404337,-0.8321448133483081
22Rv1,9911463,3.7822745291397646
MOTN-1,40482356,5.009265328360243
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
D283 Med,136227924,2.613464686393682
23132/87,9911463,3.696162581982579
769-P,136227924,4.180099818093012
HL-60,11152667,-0.8354420378718092
SNU-398,10296883,3.408276810721882
BT 320,44241473,4.3699389688619945
CAL-51,9915743,1.1260994347217144
UM-UC-3,65628,5.657575837936911
RCC10RGB,11152667,2.8531679730856268
8505C,12003241,-1.423942083306862
TE 617.T,9884685,-0.3777668305269445
SNU-175,24771867,-1.8998752396068417
TOV-21G,1566236,1.9185710355129983
NCI-H2141,3854666,2.106417752865544
NCI-H1105,9884685,1.2486660328700614
GSU,100016,6.3262103117900805
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
HCC1171,24771867,3.049721329255735
MKN74,71751553,4.911455575935293
JHH-5,44241473,5.268622149378289
CAL-27,71751553,4.275579019580937
SHP-77,135421197,1.1078063098339157
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
BT 139,10322450,4.915425697373417
SNU-C5,73707386,4.781379809316252
J82,JQ-1-carboplatin (1-1 mol-mol),4.923162890410876
SK-N-FI,2746,2.6055222437505248
LOX-IMVI,44241473,5.900540062527418
HuNS1,24771867,-2.3585506573330988
T24,1566236,1.9228008753437764
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
A-549,9926054,1.8971220341716168
LC-1/sq-SF,10296883,4.166838405657319
NCI-H1666,9926054,1.8501166706396857
ECC12,100016,5.969737428755433
T98G,9884685,2.6740995473938467
Hs 611.T,49836020,3.6507368971801983
HEC-1-A,24771867,3.2633708160358132
Panc 04.03,54618305,4.994656380487723
PE/CA-PJ41 (clone D2),4378219,4.605247392620583
CAL-78,9926054,2.780134265811309
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
SNU-5,136227924,2.8950932658181876
DB,9935249,0.9788795503419736
SK-MEL-2,2742550,4.157489560725976
MES-SA,135421197,2.6547553279335543
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
MCAS,selumetinib-vorinostat (8-1 mol-mol),1.2956109897166193
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
Hs 895.T,9926054,3.037300507007888
Hs 936.T,9926054,1.615791858991988
Karpas-422,9935249,3.5194679685123695
EPLC-272H,12003241,-2.3102763219954867
LXF 289,11152667,-0.4789950074309144
SF539,3854666,0.2673517991428248
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759
SCC-4,12003241,-1.1287847624263156
KE-39,2746,3.4287978126101337
NCI-H1184,73707386,2.391798435242647
GB-1,9868037,4.836422813626047
NCI-H2196,54618771,3.689475396494767
SU-DHL-10,73707386,3.373609446995838
A-204,9935249,1.7999718511664184
22Rv1,4378219,1.7995710439872756
Hs 766T,9915743,-0.5263602870781319
OV-90,135984461,4.4198301628710475
JJN-3,selumetinib-GDC-0941 (4-1 mol-mol),1.20099577342293
A3/Kawakami,54618305,4.415479239877224
MOTN-1,9935249,2.4236669844767755
YH-13,71751553,4.865573337264169
COR-L95,135421197,1.4504202802892363
Kelly,11152667,-4.572350734135745
SUP-HD1,135421197,1.0608859931865553
A-498,6918638,1.620608219340894
BT 216,12003241,2.6409098560740243
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
KNS-60,3465537,2.201526829680429
SK-MES-1,135659046,3.5561232881246805
NCI-H1666,selumetinib-vorinostat (8-1 mol-mol),-1.7632853469855017
C2BBe1,54618305,4.283741235825971
LCLC-97TM1,9915743,-0.0836077976930932
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644
HuH-1,136227924,2.959438331398248
BT 216,135984461,5.695741813463895
BT 440,10296883,3.8375846267667777
SNU-1,65628,4.167785493547138
SK-ES-1,65628,2.5290006136482868
A2058,54618771,1.1536818044190116
JIMT-1,9884685,2.6126732364530487
NCI-H226,4705,3.419610218683655
TOV-112D,10322450,4.283005252404589
Hs 888.Lu,12003241,-2.029150250693523
TYK-nu,2746,4.272425827953672
HD-MY-Z,3854666,0.9362531303701136
YAPC,9911463,3.901904463732921
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
BT 147,3854666,0.1621960582737569
HDLM-2,12003241,-2.9289857152710344
Hs 888.T,2742550,3.10434655175039
PaTu 8902,9911463,4.390925153080421
BT 239,11404337,-1.7707193107124473
Hs 940.T,9935249,3.1065250184638673
FTC-238,9884685,3.0053387857331963
HT-1080,100016,6.676268064255503
ZR-75-1,selumetinib-GDC-0941 (4-1 mol-mol),1.5981380020167046
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
NCI-H2122,12003241,-0.1228144224546952
FTC-238,11152667,-1.371306432474619
P3HR-1,11152667,-1.7804635987572712
JHH-2,2742550,4.034353519220002
SEM,24771867,-2.7357477254631744
Hs 936.T,2746,2.6919045473185284
RERF-LC-A1,54618305,5.82239682454832
SW1417,9911463,3.860832052888163
SNU-216,9926054,1.7628487898715297
SNU-182,54618771,-1.075104843594332
NCI-H1341,54618771,1.0375359960566886
M059K,6918638,0.417143769995747
HOP-62,9915743,2.3333223593469947
HEL 92.1.7,4705,5.773447886671419
BT 328,54618771,1.300712581347958
BT 159,10322450,4.663429189765849
RMG-I,54618771,1.320928613305781
SNU-1041,9911463,4.300045729883578
SF126,44241473,5.470477003060317
KHM-1B,65628,3.60559222842334
LS180,9911463,3.681535048080384
AN3-CA,JQ-1-carboplatin (1-1 mol-mol),4.617910971387189
HCC1195,100016,5.060252338886612
JHOS-2,6918638,1.6953141096129207
SNU-1077,54618771,3.2500418975361347
PE/CA-PJ34 (clone C12),54618305,4.348682714943588
BV-173,9868037,2.047976501818227
WM115,4705,2.3860154683324897
NCI-H1944,136227924,3.273500409836235
NCI-H2087,10296883,3.767340744960793
HSC-3,100016,6.558832951826536
ChaGo-K-1,9935249,2.017228734725955
KMS-12-BM,9935249,1.0143045497874623
MHH-CALL-3,11152667,-4.433514521858705
BICR 18,11152667,-1.4287836453350045
NCI-H1184,2746,1.0703875331333406
HCC44,54618771,-0.1525308444748626
MeWo,54618771,2.702523015833562
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
U-BLC1,9911463,3.7218159913620887
IGR-1,1566236,1.9029402037211105
SK-UT-1,9884685,5.1525602917749875
YH-13,11404337,1.1602704800571209
MOLT-16,4705,2.727533313346627
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
U-937,3465537,2.9406919869890378
CL-11,136227331,4.347611231682629
EM-2,65628,3.859788884791103
EB1,3465537,1.4429875061757191
GSS,9915743,0.3423445319525382
BT 187,100016,7.76208292164505
K-562,3854666,0.2872946014041473
COLO 792,3854666,2.1804770549972514
SNU-878,9868037,3.069026942604855
HCC1806,12003241,-0.1866891199802881
SUP-T1,4705,3.362457199926275
BT 320,11152667,2.8584362453350427
SK-N-SH,6918638,-0.7450895378891518
DMS 53,10296883,3.680097664762246
LOU-NH91,2746,5.002248002286792
BxPC-3,9868037,2.7194108471732243
BT-549,136227924,3.266068806496957
HSC-3,selumetinib-vorinostat (8-1 mol-mol),1.9164073521640128
BFTC-905,136227924,2.194418567728585
BDCM,11152667,-2.033195724638313
KP-N-YN,24771867,4.285082318015032
SH-4,11152667,0.2445827338007607
HSC-2,10296883,3.989480591678073
OCI-M1,11404337,-0.1677571096937809
JURL-MK1,65628,4.134392418722166
OVCAR-5,9884685,1.3438944937186146
WM266-4,2746,2.9939940640061495
Daudi,76446078,6.274042769130843
L3.3,100016,6.042484334243821
UM-UC-3,4705,3.0900844559148632
HOP-62,3465537,2.2363453693957536
LAMA-84,135984461,1.7013411112248076
SNB-75,selumetinib-vorinostat (8-1 mol-mol),3.46881104269872
ST486,71751553,4.101372984675863
Rh18,9884685,-0.3844851965964752
COR-L95,12003241,2.921570030601445
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
BT 359,9868037,4.109229289751441
SNU-216,136227924,2.452598137182288
MCAS,JQ-1-carboplatin (1-1 mol-mol),0.8866425431722468
MDA-MB-453,24779724,5.606505141806212
HCC1428,9935249,3.209642355584571
SK-BR-3,71751553,4.291196523141903
COLO 792,136227924,2.7402829929938908
SU-DHL-8,136227924,2.244700910858823
COLO 829,12003241,-1.833925982592443
HuH-6,4705,2.6985150624088967
NMC-G1,11152667,1.2131729378595566
SW948,3854666,3.050289300885683
647V,3854666,1.0737576185285356
EC-GI-10,1566236,3.222129437181103
G-361,JQ-1-carboplatin (1-1 mol-mol),0.286360842929743
KMS-11,9915743,0.4869298751458265
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
SW982,100016,3.947877721573723
HDLM-2,9915743,-1.1010684043189596
RT-112,10296883,4.279082989999429
TUHR10TKB,49836020,-1.137446729131538
ME-1 [Human leukemia],JQ-1-carboplatin (1-1 mol-mol),0.2037061432721303
NUGC-3,12003241,-0.6366922027749422
GMS-10,9935249,3.247903389257114
Mono-Mac-6,135421197,1.2337860408769474
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
KE-37,65628,2.521719302882167
SNU-216,4705,1.5383436923122542
OCI-AML-5,9884685,0.3245592636969091
NCI-H1703,136227924,2.979921585365296
MOLM-6,54618771,-1.125250361131471
SR,JQ-1-carboplatin (1-1 mol-mol),1.1771203251260662
Hep 3B2.1-7,136227924,5.40641673036814
NCI-H841,71751553,4.669276949969767
RCC10RGB,135659046,5.776465120313546
KM12,9935249,3.2460042952821024
TE-14,9884685,0.211407416382201
CHP-126,JQ-1-carboplatin (1-1 mol-mol),1.0753028994481633
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
SNU-1079,selumetinib-vorinostat (8-1 mol-mol),4.808622110594304
IPC-298,9915743,1.3514375802174825
SNU-475,2746,3.808468111093762
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
SUP-T1,136227924,2.470227214750311
A-549,11152667,0.4045052003861268
DAN-G,4378219,2.0311977892738757
L-428,6918638,-0.3138373301557662
TE 441.T,9915743,0.2395120621423657
Hs 766T,2742550,4.638958882709758
GSU,11152667,1.006110243453895
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
EFM-192A,11494412,1.6268317124247755
PaTu 8988t,54618771,0.599962301527202
SW1353,54618771,0.8265365902772687
SK-MEL-30,3854666,4.201898778622083
NCI-H211,44241473,4.458294883692226
Panc 08.13,9884685,0.2056896463643182
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
SNG-M,2742550,4.721521036243505
KCL-22,9911463,3.4603287312388415
HCC1195,11404337,1.6211275323325096
TE-1,9926054,2.343374218225638
BT 239,selumetinib-vorinostat (8-1 mol-mol),0.2511204621924663
YH-13,9935249,4.648604322917456
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
NCI-H1651,selumetinib-vorinostat (8-1 mol-mol),2.389055853752904
Peer,54618771,-0.6256151799638473
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
Capan-2,9868037,4.081009798039869
PC-14,11404337,-0.86699452338107
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
NCI-H146,54618305,4.054654997899016
ACC-MESO-1,11404337,0.4174226395883805
SK-ES-1,135984461,2.1821823459422
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
HLF,135421197,1.600730736912683
G-401,11152667,0.9519757620011424
8-MG-BA,12003241,-0.0474192028844215
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368
NCI-H2126,2746,2.4286105170144587
NCI-H841,10296883,4.212542527018102
MHH-CALL-4,136227924,1.8406000029443903
SW1990,24771867,2.961729646695687
DEL,11404337,-1.8098726855093707
BICR 16,4378219,5.0102490985910375
HCC1195,2746,3.3067232318452895
OCI-AML-2,100016,4.069849166636085
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
CAL-51,2746,3.539110169106334
VMRC-RCW,12003241,-1.0941298808716429
Hs 729.T,9935249,2.8329935941223567
HL-60,9911463,4.3879479306105535
HCC2279,selumetinib-GDC-0941 (4-1 mol-mol),1.829926030012146
Rh30,11404337,-0.0362683068466765
SK-N-MC,24771867,-2.3691388989269155
Panc 04.03,12003241,0.3752932920389255
RPMI-6666,selumetinib-vorinostat (8-1 mol-mol),2.222116520325129
K029AX,6918638,0.9688280539035616
NB1,9911463,3.710884488807899
Rh30,9911463,3.4097101365925786
NCI-H1105,9915743,0.8862915101567481
PF-382,9868037,2.2881920680680756
JHH-1,3854666,1.0749390724727717
SNU-398,9926054,1.6383550213348652
KMS-34,1566236,1.5122865114095023
KATO III,11152667,-1.077676049163545
TE 441.T,9935249,2.3228197055940556
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
DV-90,12003241,-1.148500998331207
AU565,9926054,0.9817648939808896
SK-MEL-24,12003241,-2.7585414015303424
SHP-77,9915743,3.2387614248812984
NCI-H1694,135984461,1.8368991431523527
HuT 78,9926054,1.4431118641564118
SK-MEL-5,2742550,3.3094903780657368
LC-1/sq-SF,6918638,0.3702997456121862
NB1,10296883,3.4933227717672337
MHH-CALL-3,135421197,1.4359965769543697
SK-N-BE(2),54618771,0.9594673871894048
BT 330,selumetinib-vorinostat (8-1 mol-mol),2.5092548953484184
LP-1,135421197,1.2171511840038625
SNU-182,9868037,2.968787964623164
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
SK-MEL-30,11404337,-1.0604812670426378
NU-DHL-1,135421197,0.761695548293036
HDQ-P1,12003241,-0.8789475866858393
KP-4,65628,4.537508539882641
JHH-1,9935249,3.114168862925099
PaTu 8988t,9935249,3.4642640806067897
NU-DHL-1,24771867,-3.1166811668070844
SW620,24771867,1.8155800761192495
HOP-62,11494412,2.9227878689679105
Rh41,54618771,-0.2470499473038629
HCC1143,135421197,0.8918606552263807
MOLT-13,12003241,-0.6419644689091649
Ki-JK,11152667,-2.3089641882656977
A-673,11404337,-2.7698937773977033
Hs 578Bst,54618771,0.4145984361233129
HPAC,100016,6.325474069382135
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
LS513,49836020,4.383197758831643
COLO 699,9884685,-1.6553137427056115
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
SK-MEL-31,24771867,5.8356221722760715
42-MG-BA,136227924,3.1509029182486845
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
COLO 829,9911463,4.4284990844241126
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
NCI-H838,54618305,4.350780627784178
SW48,65628,3.988389614478155
HDQ-P1,9884685,3.380052821161662
HT-1080,9935249,3.0025121843193525
HEC-59,9868037,3.1649055297895483
YD-10B,54618771,-0.547775158029887
EFO-21,54618771,1.150184773372703
SW1088,4705,3.635040472252734
EoL-1,65628,1.668421818220866
OCI-Ly3,9935249,-2.03534792120864
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
MDA-MB-453,12003241,-0.9610578830621354
Pfeiffer,2742550,2.1700000700098445
SNU-182,49836020,5.156218287298631
Daoy,selumetinib-vorinostat (8-1 mol-mol),2.406498201434062
Daudi,11494412,-0.3802447608890573
UACC-62,1566236,3.0141386967262687
SNU-407,JQ-1-carboplatin (1-1 mol-mol),0.2520834241289693
RERF-LC-Ad2,54618771,1.6045253072760792
SF126,11152667,0.4115032346348637
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
Hs 888.Lu,3854666,2.6256598468811903
SiMa,9868037,1.987643785401739
BT 286,4378219,1.3689305744165488
CFPAC-1,54618771,0.7086931491389132
CAL-78,73707386,4.03423025283393
JHOC-5,135984461,1.694493037424127
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
SK-N-AS,11404337,-1.03684068328029
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231
HCC2279,9935249,4.25110367005722
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
NCI-H1693,4705,2.4450047758451054
SNU-C4,71751553,6.158441410572784
SF126,3854666,2.652504864422733
HCC1588,135421197,1.0846790192354827
NCI-H747,9935249,2.157652912221255
UACC-62,135421197,3.0810150127011773
TE-4,4705,1.41757349828419
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
KMS-27,54618305,4.755877459713762
PC-3,10296883,5.2902434892598365
HH [Human lymphoma],2742550,2.063067793366252
BICR 18,24771867,2.6553102017934496
SNU-761,9868037,3.0815059044101822
UM-UC-1,10296883,4.123728630230191
SK-N-BE(2),135659046,3.712639827240539
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
A-549,135421197,2.4799819746704075
RL95-2,136227924,2.901366933043705
BT 359,54618771,0.98089237051643
Caki-1,6918638,0.9504524779019108
LP-1,76446078,4.724451228444263
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
HSC-2,2746,4.285336510819298
KNS-62,6918638,1.7300620365189876
DU145,135659046,3.5568052359419604
NCI-H2170,3854666,1.5230641106876586
NCI-H441,11152667,0.8838707075861002
U-937,10322450,3.569133925539397
LMSU,44487872,4.479427716264116
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
HCC1171,12003241,-1.936475523579036
CAL-51,9935249,3.84795648434564
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
DAN-G,9884685,-0.0367634949535886
SNU-216,9935249,2.9187421404972165
HD-MY-Z,10322450,2.950696163732152
KNS-62,12003241,3.5800547148534165
RPMI-8402,9935249,1.248313969132739
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
JHUEM-1,JQ-1-carboplatin (1-1 mol-mol),1.8045893002317055
Li-7,44241473,5.250482842287072
SW1710,73707386,-5.927041257386023
SNU-119,2742550,2.8976089932934883
RERF-LC-A1,44241473,5.145911228951114
Hs 895.T,11152667,0.141102349832315
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
NU-DHL-1,2746,0.9771874808438498
NCI-H889,4705,2.395490274803622
LOX-IMVI,12003241,-2.813518393614124
HT115,136227924,1.4968152830691424
JIMT-1,9911463,4.046723460616858
Lu-99,11152667,-1.4137916127487686
NCI-H69,9868037,3.2675827879881556
SNU-1214,JQ-1-carboplatin (1-1 mol-mol),3.0225618728899675
AGS,9911463,3.955796960522849
BT 172,4705,2.221362713741292
KMS-12-BM,10322450,2.7501974340219575
SNU-1214,135984461,4.331180195663339
BV-173,49836020,4.1850611213091105
TF-1,6918638,-0.802877327266543
HCT 116,11152667,1.3675862061051176
SCC-25,24771867,0.3246558759824934
SNU-761,2742550,3.6477900911436967
639V,11404337,-0.9671981800309744
SNU-1033,49836020,1.7840304926095434
LN-229,9915743,-0.4123038394428829
NALM-6,9911463,2.9275320549499613
HCC2218,135421197,0.9685735875874713
RERF-LC-Ad1,12003241,-0.821513059069255
KMS-11,73707386,2.003938683847614
Caki-1,54618771,1.6306245872023055
DLD-1,136227924,3.626313463652563
BT 498,6918638,3.833356013639187
P-STS,9915743,0.8915414353493989
HSC-4,24771867,2.9499855440491243
HuP-T4,135421197,1.5998853236041033
EKVX,9926054,2.0075425899751513
SNU-213,11152667,-0.7142929754084242
BT 416,9926054,1.8827513028201357
CCF-STTG1,9926054,1.9394922490252933
PC-14,24779724,4.4167236388652364
Ki-JK,3854666,-0.1739211329910635
SNU-601,2742550,3.064615106373439
GA-10,71751553,3.203587324288507
LC-1/sq-SF,135421197,3.695638130955798
PK-1,10296883,4.277974392891681
SET-2,2746,0.8916395455775363
U-251MG,9884685,5.8675878787053035
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883
PLC/PRF/5,135659046,3.5172360380546084
HEC-108,11152667,0.9436637108805932
OVISE,11404337,1.793635825025173
NB4,10296883,3.07920263263956
HuH-1,9935249,3.147472490702491
HCC2218,11494412,1.7192366491368396
TE-14,11494412,0.7185329040944464
NCI-H2228,54639665,4.4666627207641065
EN,11152667,-1.326887253790568
BT 320,9911463,3.706038906545982
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
SUP-B15,1566236,1.4989304787624995
SaOS-2,11404337,-0.7935370479535776
SW579,6918638,0.7272456776623913
8305C,selumetinib-vorinostat (8-1 mol-mol),1.151504245037868
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
NCI-H838,44241473,4.831040111148448
SNU-C5,10296883,3.7798832653502727
VCaP,3854666,0.8856034047599067
SNU-478,54618305,4.7061307072475405
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
SNU-685,135421197,3.6677204832747976
TE-11,40482356,5.141321459746869
TE-15,12003241,-1.6215722433150963
MIA PaCa-2,9884685,0.7084207681532095
RD,selumetinib-vorinostat (8-1 mol-mol),1.6803258761619044
RT-112,3854666,1.0623619754138416
Panc 10.05,4378219,2.3758207235974846
BC-3C,54618771,1.3234339265863326
COR-L105,71751553,4.255827287979035
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708
NCI-H522,9926054,1.815484319665427
NCI-H460,54618771,1.6853262233131374
HCC1833,11404337,0.2409381121234374
CCF-STTG1,1566236,4.223986774063583
LNCaP clone FGC,24771867,3.412877398053759
HOP-92,54618771,0.6588876018328178
KP-3,54618771,0.4281141975114925
HEC-265,9911463,4.29184324369936
BT 216,3854666,3.6586729763480337
JHOS-2,12003241,-0.473680569939606
Ishikawa (Heraklio) 02 ER-,135984461,4.462174661404989
NH-6,9935249,2.624855508560777
KATO III,2742550,3.7878556797124254
U-937,JQ-1-carboplatin (1-1 mol-mol),3.049803202040864
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
SUP-HD1,100016,7.0046366432620735
RCH-ACV,136227924,2.5365542828193957
JHH-1,JQ-1-carboplatin (1-1 mol-mol),3.3935500836468764
A-673,1566236,1.6605846703776754
SNU-387,71751553,5.286582011756761
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
Daudi,4705,2.565440722309658
SK-CO-1,24771867,2.6665073598645086
Hs 746.T,11494412,3.539724142394036
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818
Li-7,9926054,2.073130645224697
Ishikawa (Heraklio) 02 ER-,11404337,-0.8066309120452816
SK-MES-1,4705,1.78363684998227
MDA-MB-231,9911463,3.910290396938666
NCI-H2009,11152667,-0.3244172236423036
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
CA46,2746,0.9501634288999758
SU-DHL-10,100016,5.73425222116556
EC-GI-10,2746,3.3454005249386243
T-47D,2746,3.323386211929572
U266B1,135398744,6.53135676756175
BT 159,9926054,3.0118614770860286
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
DV-90,10322450,2.5684087153895447
Rh18,11404337,-0.8453979019724388
ChaGo-K-1,JQ-1-carboplatin (1-1 mol-mol),3.068818553236091
NCI-H1793,49836020,4.8036601506688275
TUHR10TKB,135984461,5.527226516832142
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
TUHR4TKB,9911463,4.0914884316210145
NCC-StC-K140,9915743,-4.061475008678285
BT 504,9911463,3.2688065154654287
LOX-IMVI,9935249,3.870791681758961
CML-T1,100016,5.302267949835527
MeWo,1566236,1.7978340466809355
HCC366,12003241,-0.2149977364985454
TE-6,136227924,2.9118612520968803
SW1116,12003241,0.0582707461824652
RMG-I,2746,2.7034933006437023
BT 428,9926054,1.9432227600739695
UO-31,9884685,-1.8965253629059915
HD-MY-Z,136227924,3.0737298330446103
SNU-1076,9935249,5.6817063643724826
IGROV-1,135398744,6.402844237905131
Hs 895.T,9884685,1.2058829180471424
YD-38,11152667,-0.8447422607526522
FaDu,2742550,3.976628077260584
TE-11,11494412,-0.2865529339214188
BT 159,4378219,1.5068978364726322
SNU-475,44241473,4.900861278488291
RL,9935249,1.1595020386945936
Raji,9868037,1.949547656703084
BT 320,1566236,4.371560124605876
GCT,65628,3.937581767993038
SiMa,9911463,2.7480230825613488
NCI-H292,11404337,-1.5117614396305947
ONS-76,54618305,5.4771970245541866
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
BT 147,2746,4.827192237439561
NCI-H1563,71751553,4.037519551970505
MCAS,135398744,6.37399282177603
NCO2,54618771,-0.1705151191723565
U266B1,9884685,0.3768710353905473
JM-1,9911463,2.675259516581914
HDQ-P1,9911463,4.421902621869527
SR,54618771,1.0757630585056626
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
RERF-LC-MS,3854666,0.8294073497518095
HCC827,selumetinib-vorinostat (8-1 mol-mol),2.3127534557071474
OVCAR-4,136227924,3.1468518699477097
MDA-MB-453,135659046,3.699316020945489
KO52,11152667,-1.2056266729151108
OVCAR-5,JQ-1-carboplatin (1-1 mol-mol),2.2287915879849116
UO-31,54618771,0.667805712786254
SF539,3465537,2.1777468091875125
GA-10,10296883,2.032033381288912
NB1,4705,2.5823945012160214
HCC1419,3854666,2.9721540619689972
NCI-H292,11152667,0.5464898224488388
HCC1419,9915743,-4.40313771987628
KE-97,54618771,-0.8035636826323382
MDA-MB-468,135984461,4.286487577540472
SW579,135659046,3.634666498260953
NCI-H1339,6918638,0.2750671891608724
ESS-1,54618305,4.255754792589274
SK-LMS-1,9935249,3.6088412338145366
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
SK-ES-1,10322450,3.263279499807968
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
CAL-27,135421197,2.124038194027939
Hs 895.T,9935249,4.499234655323106
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
WM983B,135398744,6.927047773444745
SNU-407,4378219,2.0140383575583805
OE19,136227924,3.1692952710595557
OAW42,135659046,3.5713429692189447
HCC366,9915743,1.377762778734198
MSTO-211H,135421197,0.8053711662366769
PaTu 8988t,1566236,2.792784501487116
COLO 678,4705,2.6344609779467603
GaMG,9935249,4.235528927004279
KE-39,135984461,4.3782777468955745
BT 428,65628,3.929247019179895
NCI-H2405,selumetinib-GDC-0941 (4-1 mol-mol),-1.6328323472989523
SNU-1214,9915743,-3.00050567913294
HuP-T3,9935249,3.692881062494191
IST-Mes1,11152667,-0.1137559634255308
Karpas-620,selumetinib-vorinostat (8-1 mol-mol),4.853039642331254
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
SUP-M2,2742550,3.7062792287011175
LC-1/sq-SF,1566236,4.426287640720265
LOU-NH91,1566236,3.241690914019502
SNU-16,selumetinib-vorinostat (8-1 mol-mol),1.7213135683170462
NCI-H1385,135421197,0.1924120036443515
A-375,2746,3.0738136393469393
HEC-151,54618305,4.2925699084671525
M-07e,44241473,5.146938802474246
TE-15,2746,3.020954904357082
SNU-387,9911463,4.312383544863764
Ci-1,10322450,2.8273692765810643
Hs 888.T,4378219,0.8463528830369604
RERF-LC-Ad2,11494412,5.090684169686155
OVCAR-8,44241473,5.484953118673612
8-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),3.0365797378883843
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
EFO-21,12003241,-0.6894261883426276
DV-90,6918638,-0.7904486688735644
KMS-12-BM,10296883,2.976049270226853
A3/Kawakami,4378219,4.275687766465954
THP-1,135659046,3.5163432758648256
OVTOKO,selumetinib-vorinostat (8-1 mol-mol),4.272915839484638
TF-1,71751553,4.25440409334611
NCI-H1581,3854666,1.054316312368188
KNS-81,49836020,5.788020143086265
SK-BR-3,100016,6.79119351825136
Peer,12003241,-2.4634872028083015
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
SNU-1079,11152667,-0.9238055167208472
SNU-878,54618305,4.855908979136769
NCI-H1915,JQ-1-carboplatin (1-1 mol-mol),0.8785852564094064
BT 145,135421197,2.030859989245954
SNU-489,11404337,0.8809237890954298
HPB-ALL,selumetinib-GDC-0941 (4-1 mol-mol),3.2361225802608593
OE21,2742550,3.7946471320286568
OC 314,selumetinib-vorinostat (8-1 mol-mol),2.4307033935801505
NCI-H716,JQ-1-carboplatin (1-1 mol-mol),0.4768639572382123
NCI-H211,24771867,-3.1618026330644273
LP-1,6918638,-1.2002393899697523
CGTH-W-1,24771867,1.9573781276583488
NCI-H2081,24771867,-2.330318084024509
SK-MM-2,4378219,3.420987153458004
BT 416,135398744,7.827037669937473
HCC366,9935249,3.9678422341456665
KO52,4705,3.2027960620979576
OVTOKO,9911463,4.1019339858754025
DOV13,135421197,2.464750540362873
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
KYSE-510,9911463,4.240688148771923
Malme-3M,3854666,2.9636380835575498
CGTH-W-1,135421197,2.895305047489035
IGR-37,9868037,4.196529232004268
ONS-76,9935249,3.5330143946083874
SNU-C2A,135421197,5.231431749442163
G-402,12003241,-1.3833657940583168
THP-1,selumetinib-vorinostat (8-1 mol-mol),-2.0234656075147037
VCaP,2742550,4.205604430030452
CMK,135421197,2.3308084532247935
OC 314,10296883,4.120910871567529
CCF-STTG1,100016,6.985278157575169
OCI-AML-3,2746,0.9833779922081392
HOP-92,136227924,3.2563886907656725
SCC-9,4705,2.492131143046821
GOS-3,11404337,1.2142789078350222
NCI-H2110,71751553,4.36348548213894
SNU-1214,44241473,4.767389445416476
MKN1,10322450,5.563545254073129
SNU-503,1566236,3.964267180277688
PE/CA-PJ15,3854666,0.5733431717297748
TYK-nu,selumetinib-GDC-0941 (4-1 mol-mol),1.6731134624767203
SNU-1066,54618771,0.6033249887552533
SF268,40482356,6.272456244990514
COLO 792,9935249,1.9723606797901485
MKN45,11152667,4.066950092294402
WM88,11404337,0.2884415241135956
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
MOLT-13,100016,6.122983577816604
Kasumi-2,9935249,-0.6704419087402653
COV434,selumetinib-GDC-0941 (4-1 mol-mol),1.0563079487833569
SK-N-BE(2),11404337,-0.1394184505793084
A-375,135398744,6.486116496095493
RL,JQ-1-carboplatin (1-1 mol-mol),-0.1816781364388249
8-MG-BA,9926054,2.058364924251872
NCI-H441,selumetinib-GDC-0941 (4-1 mol-mol),1.6335298040025916
WT2-iPS,9884685,1.6129793208812115
Malme-3M,11404337,-1.1089721048886994
Karpas-620,135659046,3.5237997077765275
CL-11,3854666,1.3042610376736252
TE-5,selumetinib-GDC-0941 (4-1 mol-mol),0.92004648470689
NCI-H1184,65628,3.2450245277105867
Rh41,65628,4.1511023714523025
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
LP-1,3854666,0.8576356397095183
CAL-29,44487872,4.282164596032457
SR,73707386,3.571733863738371
NCI-H2170,9884685,0.3769031267544711
DoHH2,65628,2.6605879457823627
SK-MEL-28,11404337,1.5828408993005263
OCI-Ly19,2742550,4.517507112855574
Kasumi-1,9926054,1.808732421420859
KMS-28BM,54618771,-1.095324315742339
KE-39,100016,6.665188081944046
BHT-101,135421197,3.464281402199008
NCI-H1581,24771867,-0.0456312451614995
PSN1,135659046,3.366359260152028
QGP-1,9926054,1.84722301836143
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987
DU145,11494412,1.9147313694004515
KYSE-180,3854666,2.7659153089015898
NCI-H1355,54618771,0.7096344074223282
Hs 944.T,4705,3.126834538989372
SNU-869,135421197,2.4475958723974944
JIMT-1,135984461,4.835908287513633
DMS 114,4705,3.4227674177619187
NCI-H2286,10296883,4.1413309005393755
OVCAR-5,136227331,3.878676395565833
JHUEM-7,9884685,-1.60078111934439
NCI-H1703,135421197,2.2444093773538043
NCI-H211,54618305,4.463856903344854
HT,44241473,4.503211700520401
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
SNU-C4,3854666,3.1013249794927846
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
KMS-20,9926054,1.4765400556600523
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
OAW42,135421197,2.0874020814941643
SNU-1041,44241473,4.422105933247079
SNU-685,71751553,4.38772919784633
NCI-H1341,10322450,2.409871050091722
SK-MEL-28,11152667,4.172027715871216
SNU-216,11404337,-0.7436610925810526
SNU-398,4378219,1.8739330437483992
HuNS1,9935249,0.4549731816761326
NCI-H1915,selumetinib-vorinostat (8-1 mol-mol),2.1526268159946156
CA46,9915743,0.7447060154867644
HSC-4,54618771,2.9865797342969564
JVM-3,10322450,3.1045130110101335
LOU-NH91,44241473,5.33179348194517
KE-97,73707386,3.3259864219274897
Caov-3,9935249,4.3792566326143385
KYSE-140,9926054,1.9800704230635255
ZR-75-1,54618305,4.65018258042655
SNU-C2A,9935249,3.886157846226495
SUP-T1,3854666,-0.1009501914586207
VCaP,44487872,4.231150871019104
SNU-1196,54618305,4.430886852006675
WM266-4,selumetinib-GDC-0941 (4-1 mol-mol),-1.002003549431085
ECC10,selumetinib-vorinostat (8-1 mol-mol),1.623685100455314
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
SW1417,2742550,4.242431031209741
EoL-1,44241473,3.8558981906070695
SK-N-AS,10296883,4.111462357552098
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
DMS 79,9935249,2.9784415958919848
HSC-2,selumetinib-GDC-0941 (4-1 mol-mol),0.8174688254253049
KMS-11,10322450,3.512225559181566
HSC-4,1566236,1.9723291328750472
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
HSC-2,9884685,0.5039874094801778
FTC-238,11494412,0.3673314774517735
WM793,2746,3.494212158504219
G-402,135984461,1.930732604318706
Hs 822.T,9911463,4.380200456677196
MOLM-13,2742550,3.0943449980031845
NCI-H929,54618305,4.349731057515986
KYSE-410,135984461,4.6292418393207235
PC-3,71751553,4.3090170557564145
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
NCI-H2170,12003241,-0.7011198558518746
HEC-1-A,24779724,4.728392002883349
EM-2,11404337,-1.9269330473502917
KMRC-3,135421197,4.3103204050054345
BT 328,4378219,2.241353375973062
KYSE-70,11152667,0.5949086715112851
MeWo,selumetinib-GDC-0941 (4-1 mol-mol),-0.6155502943571556
LCLC-97TM1,12003241,-0.8351557307101188
KE-97,11152667,-1.8456942642384448
NCI-H2170,135421197,1.5856670633650565
KALS-1,selumetinib-vorinostat (8-1 mol-mol),3.138531968281592
SNU-46,selumetinib-GDC-0941 (4-1 mol-mol),1.1203054933058916
Calu-1,3854666,3.7215465603538727
JHH-5,12003241,-2.221894796534897
AsPC-1,10296883,4.32215490848641
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
JURL-MK1,3854666,0.543256648206117
MOLP-2,JQ-1-carboplatin (1-1 mol-mol),1.3158368386628676
KO52,100016,6.24417827042609
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
LoVo,2746,2.3133613771451524
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
PE/CA-PJ15,11404337,-2.320439466084731
DND-41,71751553,4.317305171023822
TT2609-C02,54618771,3.852922772730834
CAL-85-1,100016,6.683113656599713
SNU-1,11494412,1.5103919119470426
HT-144,selumetinib-vorinostat (8-1 mol-mol),0.5530422914319657
Sq-1,9926054,2.1337916564135906
Capan-1,9915743,1.7686030457629929
HOP-62,3854666,3.243198417563859
SNU-C4,9911463,4.273087904874907
HCC1419,4378219,1.9741792268051543
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
KYSE-150,1566236,1.943778647833198
JVM-3,3854666,0.3289813551665968
MOTN-1,4378219,6.509206118776753
DAN-G,54618771,0.722967916386815
SNU-423,6918638,0.4106402962761268
Caov-3,selumetinib-vorinostat (8-1 mol-mol),2.3601771455204226
TOV-112D,65628,4.105671540915195
VMRC-LCD,10296883,4.114131577263389
PLC/PRF/5,9911463,3.7898292588985862
SNU-1033,JQ-1-carboplatin (1-1 mol-mol),1.515968870431384
FTC-238,24771867,-0.0877505596872641
CW-2,100016,4.445901991176778
M-07e,1566236,1.062564677028791
KYSE-150,24771867,3.205810745205018
SCC-25,9935249,3.4774309357547413
COV434,24779724,4.28393897361134
DMS 454,135659046,3.663027273300578
786-O,9911463,4.177709508458616
GA-10,135659046,2.94673518989487
AML-193,2742550,2.301530395833896
NCI-H23,54618771,-0.0460259250887816
BDCM,9911463,2.647772913572023
FaDu,135659046,3.4851599686971544
CAL-33,selumetinib-vorinostat (8-1 mol-mol),3.0707076397558204
Hs 934.T,3465537,2.411494715947719
NCI-H1341,9935249,-1.1000276739958554
BT 239,9926054,3.266360841464617
NCI-H1693,9935249,1.052551842926199
NCI-H2170,11404337,0.5827033431431107
Panc 02.03,10296883,4.297264305827386
SNU-761,selumetinib-GDC-0941 (4-1 mol-mol),3.4718208794514167
T84,JQ-1-carboplatin (1-1 mol-mol),2.264364679539306
NCI-H2087,JQ-1-carboplatin (1-1 mol-mol),-1.3930122272626189
EC-GI-10,24771867,-2.569573977991323
SET-2,135984461,1.767736462015104
NCI-H1395,10296883,4.692616973111803
NCI-H2444,24771867,4.140417584680654
IMR-32,selumetinib-vorinostat (8-1 mol-mol),0.9204615438259656
MKN74,9911463,3.772186916904206
YH-13,9884685,0.7618617096747208
ECC10,54618771,0.89322852305294
NCI-N87,11404337,-0.8803091706648726
VMRC-LCD,24771867,-3.7563289324747737
DMS 273,11404337,-1.7233190830375906
BT 444,11404337,0.6214326786633448
NCI-H446,10296883,3.7190585184043337
Hs 294T,3854666,1.2484666832223503
SNU-620,24771867,-1.804657683486662
FTC-133,11152667,-0.4786534736280033
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
LNCaP clone FGC,9915743,0.7205657109253502
Ri-1,2746,1.8815592761229076
HuT 78,1566236,0.8672075486868017
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
RPMI-8226,4378219,1.9850032148269143
SNB-75,6918638,2.2878300521074246
HH [Human lymphoma],11152667,-0.6696779635320641
Rh41,24771867,0.2215293112128568
COR-L105,1566236,2.352597865521479
BICR 18,1566236,3.8333699769110026
DND-41,selumetinib-GDC-0941 (4-1 mol-mol),0.5695513725916952
COV644,4705,3.798670959115779
HT-29,136227924,3.5079295938152706
SNU-407,9884685,0.5059737152516742
LUDLU-1,2746,3.195399638512964
BT 428,9915743,0.3842410251142636
SW1990,6918638,1.2411625887645945
MV4-11,9915743,-1.3857936300638058
G-292 clone A141B1,9868037,4.069169616789992
HCC1143,100016,7.122041956726765
253J,2742550,3.1297466195096537
NCI-H1105,49836020,4.351413850540497
Ki-JK,selumetinib-vorinostat (8-1 mol-mol),1.702696595732736
Hs 852.T,9926054,1.891936574698373
TE-6,9915743,1.0725683226021352
CL-11,9911463,4.035953193106903
UO-31,9926054,1.6709527378064972
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
BT 320,11404337,0.6966185269279856
HEL 92.1.7,selumetinib-GDC-0941 (4-1 mol-mol),3.657513004741347
P3HR-1,9915743,1.4210240305197754
NCI-H1563,1566236,3.3573548741774224
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
Capan-1,4378219,3.5285591243290715
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
HCC1806,54618771,-0.2864222176978986
RPMI-6666,12003241,-3.2897330659592705
Rh41,9868037,1.7289800807892195
BT 228,4378219,1.3498100312418253
JHH-1,selumetinib-vorinostat (8-1 mol-mol),1.767604008553774
TE-11,1566236,3.9613648784907625
CAS-1,11404337,-0.7290961346307245
697,65628,2.1818307162762154
UM-UC-3,135421197,1.7291544564806811
TE-5,76446078,4.227786871169325
COV362,10296883,3.813835962370156
TF-1,JQ-1-carboplatin (1-1 mol-mol),-0.0928028716388946
BFTC-909,9911463,4.114346930944119
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
U-937,9915743,1.290945765650766
RPMI-8402,JQ-1-carboplatin (1-1 mol-mol),0.3952055511625851
TF-1,54618305,4.224640520612506
253J,76446078,4.141142107103818
BICR 31,2742550,4.742856926113666
Tm87-16,9911463,3.8938855092804454
769-P,3854666,3.5697954228742543
KCL-22,54618771,-0.0982742970998633
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
SW1088,24771867,2.9287380097368025
Calu-3,54618771,0.5501561277635466
OVCAR-8,12003241,-0.599857829959187
HL-60,3854666,0.8436991056497039
SNU-1033,24771867,4.258069767516097
EFE-184,54618771,1.5466528492822589
NCI-H322,2746,3.8367481879313305
HCT 8,11404337,0.7757331501446172
NCI-H1568,54618771,0.8004506686595156
OCI-Ly3,24771867,-4.709074636592981
PK-59,1566236,1.7362298213190046
JK-1,135421197,1.447193045378296
TT,JQ-1-carboplatin (1-1 mol-mol),3.4641930949375572
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
MIA PaCa-2,71751553,4.303479284138883
HL-60,selumetinib-GDC-0941 (4-1 mol-mol),-2.2086507819126213
NCI-H1341,6918638,-0.9178094299381953
NCI-H1184,49836020,5.907287846852096
YD-15,3854666,0.780361863126364
NCI-H1184,11404337,-0.3594338062101045
JM-1,54618771,-0.5043757930015165
SNU-1272,9926054,2.4790221898932283
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884
SK-LU-1,11152667,-2.9662561957508906
SCC-9,11494412,1.4365999648395638
SUP-T11,9915743,0.5825260386012178
Ri-1,4705,2.754354482473573
SNU-449,11404337,-0.5921655065432572
MKN1,9926054,3.700935468951971
JMSU-1,54618305,4.2290636516001285
BxPC-3,2742550,6.208235416241253
LOU-NH91,11152667,-0.304989451834292
BT 444,136227924,3.5279486847576886
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
MES-SA,JQ-1-carboplatin (1-1 mol-mol),4.437075394990418
CMK,selumetinib-GDC-0941 (4-1 mol-mol),2.84334284857712
SCaBER,selumetinib-GDC-0941 (4-1 mol-mol),-0.4937512054243923
GA-10,54618771,-2.458628793316373
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
NCI-H1651,11494412,1.3542824137592235
BT 330,10296883,4.249787142782667
EN,9926054,1.746243630057145
Karpas-620,3854666,3.775426831161984
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
A-673,9915743,0.6829950735134661
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
JJN-3,3854666,0.7254434498430801
Caki-2,selumetinib-GDC-0941 (4-1 mol-mol),1.5536102429563667
SNU-8,73707386,4.786793714978147
SNU-620,100016,4.241219903285237
BT 504,54618771,0.7999313784166654
MOLP-2,12003241,0.9753237716846912
SNU-878,24771867,-3.394257882767643
RERF-LC-MS,65628,5.693639897620667
L3.3,1566236,3.261153981033622
NCI-H2170,3465537,3.4509317418058383
NCI-H1792,10296883,4.349504038438606
HPAF-II,11404337,1.4025289203850997
M-07e,9935249,0.4541689416973374
OVCAR-5,6918638,0.1206125609110546
22Rv1,JQ-1-carboplatin (1-1 mol-mol),6.088896276058885
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
JIMT-1,100016,6.5721980857327935
SR,100016,4.130694890660373
U266B1,136227924,2.814695997301776
HCC1419,9911463,4.378443603359897
Detroit 562,54618771,-0.8917291521267056
MOLP-2,1566236,1.5712857054768314
MOR/CPR,9926054,1.7872025764961004
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
NCI-H23,11404337,-2.5552294487119664
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
BICR 6,65628,4.292883800732888
LNCaP clone FGC,10322450,2.7673995360058954
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
SNU-407,100016,6.489561303898527
SNU-1033,11494412,3.797369316086489
CAL-51,9911463,4.251278022142156
PaTu 8902,2746,3.932313359375791
GaMG,11404337,0.0335653022418154
253J,100016,6.267948749211356
MKN45,136227924,3.646033724215572
NCI-H1650,54618771,3.34176248194117
NCI-H727,54618771,2.7901712320729333
JHH-1,6918638,-1.2691376417044395
EJM,2746,1.455612839065016
WM1799,9935249,3.982916233384913
HuG1-N,12003241,-0.7398422629882291
HCC2935,11152667,0.3516453142040726
Calu-3,selumetinib-vorinostat (8-1 mol-mol),0.3086361684190137
SNU-1066,12003241,-0.4993915951512702
A2780,4705,2.567744201920244
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
HEC-1-A,10322450,3.4172941541878705
JeKo-1,10322450,3.378353270661745
G-292 clone A141B1,76446078,4.53605293758809
OCI-Ly19,9926054,1.6873576988098775
SW982,11152667,-1.020934919327518
SNU-201,9935249,4.988925782011606
IGROV-1,4705,3.3098412390054603
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
SNU-216,9911463,4.000497828097352
LNCaP clone FGC,selumetinib-vorinostat (8-1 mol-mol),3.5283733311441208
BL-70,71751553,4.162810725567264
U266B1,1566236,1.3827832543916845
COLO 800,1566236,1.997001649617786
CAL-120,3854666,3.5869013773786573
MOLP-8,9915743,0.5160575940701332
KLE,65628,4.416189153864011
BT 482,11404337,-1.3517535636718878
Kasumi-1,1566236,1.005917996817539
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
HCC366,9884685,2.0785174453269937
Jurkat,73707386,3.139054608217693
SW982,9911463,4.45911198153204
REC-1,24779724,3.0011490046538407
COV644,71751553,4.45251512796569
TF-1,11494412,-0.2484952250511907
MFE-296,2742550,4.910167263419947
TF-1,135984461,1.7189308198167896
BT 228,2742550,2.4792885987707605
FaDu,9911463,4.044046112259449
T98G,2746,4.022730778919953
SNU-1066,135421197,3.020792561550821
SK-N-AS,6918638,-0.3067046964839828
NCI-H522,6918638,0.2628749411775776
A2780,9868037,1.6123332444026346
EN,12003241,3.248318270429482
BT 245,54618771,0.8318467537608688
JHUEM-2,3854666,-1.0160197071128136
NCI-H747,9915743,-0.7315863736844913
Kelly,44241473,4.37084095424835
NCI-H1703,11404337,0.332581718456744
HCC1500,9926054,1.7367797854287812
NCI-H810,54618771,0.890127008742605
A-172,12003241,-1.0086398080644707
HEC-1-A,selumetinib-vorinostat (8-1 mol-mol),2.344183978160483
VCaP,1566236,2.9014070046824143
NCO2,4378219,2.896409854144592
FTC-238,1566236,1.6472945299152564
SW1353,54618305,5.761463956285616
NCI-H1563,9868037,3.932153442928962
Hs 766T,4705,3.67943819927122
HuH-28,selumetinib-vorinostat (8-1 mol-mol),2.5161900130942176
HSC-2,11152667,0.3676430135282471
A-673,136227331,4.241984110268528
SU-DHL-10,135421197,2.145200655725533
BICR 18,9926054,1.7755527669372533
CAL-27,11494412,-0.2612711655416662
CHP-212,54618305,4.169241448375394
SK-N-MC,selumetinib-GDC-0941 (4-1 mol-mol),1.42335889342789
Panc 04.03,71751553,4.683117627568525
NCI-H1915,1566236,2.5492075643485532
NCI-H520,2746,2.5300013032729556
VMRC-RCW,135984461,3.0066717091132182
NCI-H1651,2746,3.195891738830615
JJN-3,12003241,-0.0138977078234466
LK-2,136227924,2.893153940116167
Panc 04.03,11152667,-0.1106415062306802
A-204,selumetinib-vorinostat (8-1 mol-mol),2.356272602694142
EC-GI-10,10296883,4.124587788483945
LNCaP clone FGC,54618771,1.2210181091381391
U-CH1,54618771,1.7714870299819865
NCI-H2052,9911463,3.999991108260545
PE/CA-PJ41 (clone D2),135659046,4.325865774807889
U-118MG,10296883,4.307423912677154
OCI-Ly19,9911463,4.156908261510834
HCC15,136227924,3.0147456858017923
SNU-1077,135984461,3.620374859792411
HCC1500,24771867,4.066345817331682
IA-LM,11404337,0.4340662777154989
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
BT 330,11152667,1.4109610692427392
SU-DHL-8,11404337,-3.4588929056554245
BT 504,3854666,0.6653491549199024
NCI-H2172,135421197,1.3346129669572484
Sq-1,54618771,1.1991492698184876
OVCAR-5,136227924,3.2070295394145782
KYSE-30,135659046,3.903698290168812
MKN74,11404337,-0.8129110599609928
EM-2,11152667,-2.11262389342865
AsPC-1,6918638,0.7071735542476161
AN3-CA,9884685,-1.0076208994656373
NCI-H1623,12003241,-0.4868602659209724
MDA-MB-435S,4378219,1.2808946662799707
SU.86.86,9926054,1.8736072532544432
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
KLE,136227924,3.154327848580928
SNU-81,73707386,1.6277005390789234
SNU-1196,9911463,4.32461924704032
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
KHM-1B,11404337,0.2779693874185021
Sq-1,100016,4.274424361552861
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
SK-OV-3,11152667,-0.6824217491873509
RT-4,3854666,3.7100044962154506
EB1,9884685,-2.5216345274961585
ALL-SIL,2742550,3.1857763586562577
HT115,135984461,1.7227419077735964
MEC-1,4378219,3.506057400941654
NCI-H508,11404337,0.8891896977969643
NCI-H1755,11404337,-0.8825666312095473
Lu-99,3854666,0.8555462935732805
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366
T-47D,54618771,0.7815754342030017
Ki-JK,44241473,4.627069906707717
8305C,9926054,1.435515250555218
JVM-3,54618771,-1.0453450586020971
KYSE-140,54618305,4.517279868327929
MOLM-13,9868037,0.9756233042827712
DMS 53,54618305,4.135188182610859
L-1236,selumetinib-GDC-0941 (4-1 mol-mol),3.573145022328455
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
HCC1833,65628,4.511213018881878
BHY,12003241,-1.9102935005607824
NCI-H2110,24771867,3.185032011648231
HEL 92.1.7,9935249,1.0850600770193293
NCI-H841,135421197,2.4797318977451095
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
NCI-H1793,6918638,1.6746912031469072
UACC-257,3854666,3.66425519078933
WM115,135984461,4.094268409164816
SNU-503,11152667,-0.4742332423584474
NCI-H28,76446078,4.728160805740167
SiMa,2742550,3.1231022749996917
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
U-CH1,11152667,0.6955238528116828
NCI-H1694,2742550,3.4313593701801732
HT,9926054,1.610418759813605
HCC78,selumetinib-vorinostat (8-1 mol-mol),2.477042525751606
KYSE-410,selumetinib-vorinostat (8-1 mol-mol),2.854769391791397
BT 333,65628,4.53575381255774
Hs 766T,selumetinib-vorinostat (8-1 mol-mol),-1.4002604234783536
KMS-21-BM,100016,3.297202365361246
TCC-Pan2,135421197,1.46026769574307
SUP-T1,135421197,0.9840092633419462
KYSE-520,12003241,-1.836986739794001
U-937,100016,4.26159584690163
NCI-H1581,11404337,-0.7792985838470738
HPAC,135421197,1.2085727097221448
CAL-12T,9926054,1.6569209752811729
COLO 699,73707386,3.740137690108706
CAL-51,11152667,-1.203722258692511
KMS-20,4705,2.611307391977677
786-O,9915743,1.0501009752042196
SNG-M,24779724,4.480201208969766
OPM-2,54618771,0.7318105179081044
HCC15,44241473,5.510013950441446
NCI-H1341,JQ-1-carboplatin (1-1 mol-mol),1.5093857547528675
DV-90,71751553,4.251894226569197
SJSA-1,2742550,5.0115207110356295
SNU-308,9915743,-2.1849760358615296
JVM-3,100016,3.63486720200834
OCI-M1,2742550,3.075796712533082
KP-3,11404337,-0.3315209931001077
EFM-192A,10296883,4.154655152723566
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
PE/CA-PJ34 (clone C12),9884685,0.3333327844016708
KMS-11,9926054,1.1489638287123365
BT 231,9868037,3.3180720809611137
OV7,2742550,5.380934224392059
LS123,11404337,0.6660636167955499
A-375,11404337,-0.2038231220320669
TALL-1 [Human adult T-ALL],65628,2.43503143696304
NCI-H1869,11494412,4.466275600700225
Peer,9911463,2.710753746966499
HEC-1-B,136227924,3.6469104939920154
IGR-37,135659046,4.488769216179786
SNU-1079,11404337,-1.3798089381866616
COLO 678,6918638,0.5482139794843425
CAL-33,9911463,3.5337307884792213
HuP-T4,3854666,3.1047417632515986
OV-90,10296883,4.385218547099001
SNU-886,9915743,1.7822621128192635
SW1783,54618771,3.657201070811366
HT-1197,11404337,0.4511848825128766
SU.86.86,4705,2.6337462408918846
MKN7,44241473,4.793248029329902
RERF-LC-MS,44241473,4.536869636330491
NOMO-1,11152667,-1.8753376491976492
NCI-H1299,54618771,0.5506920644788533
SNU-878,9911463,2.819735999013875
NCI-H1755,2746,2.93988031593663
TCCSUP,12003241,-0.9458347981681208
CAL-85-1,3854666,0.5613093984627853
SKM-1,9915743,-0.8868720134451151
Li-7,54618305,4.449202899028902
L-540,4705,2.669607218607157
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
HDLM-2,65628,5.287608845235475
GCT,100016,6.941224948418202
CAL-12T,9911463,4.058144807952839
HEY A8,3854666,2.567651740863786
HCC1937,44494148,4.424262012108153
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
MEC-1,135659046,3.430654530654597
RKO,9911463,3.963116579454927
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654
SK-N-BE(2),6918638,-0.1264166594674796
TUHR4TKB,11404337,-1.470690034731614
ESS-1,136227924,3.049003867547222
NCI-H647,11152667,-0.8858853545948763
MES-SA,2742550,4.347572570535663
DMS 53,44241473,6.276450604721429
OV-90,2746,3.04639214002508
BT 440,11404337,-1.269417175966202
HEY A8,11404337,-0.225254822272347
HEL,9868037,2.50949616555346
OVISE,12003241,-0.8183931153803442
BT 216,9926054,2.3183160666654783
HCC1438,54618771,1.468368103137055
SNU-1272,10322450,4.07877256776116
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
WM115,44241473,4.443917717257507
HuT 78,4705,4.420154035532244
HDQ-P1,4378219,5.63468602821412
KATO III,4378219,3.939378606499176
TE 441.T,9926054,1.7722508105545176
BT-16,selumetinib-GDC-0941 (4-1 mol-mol),1.0815618001864344
COLO 205,135421197,2.4843493589992125
NH-6,1566236,2.178701901681321
MDA-MB-157,9884685,1.398372779004129
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
639V,135421197,3.226794865257896
SNU-16,71751553,1.7407385044241688
NCI-H1155,65628,3.3222312629678776
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
Hs 611.T,11404337,-3.0246332650270777
BHT-101,11404337,-0.8780725416326395
HD-MY-Z,9915743,1.384717362630253
HPB-ALL,9911463,3.8574243217658215
AsPC-1,11494412,3.580103428724827
IGROV-1,11404337,-0.7659238947812715
SF539,24771867,1.191281674737788
KYO-1,9935249,3.63147495537084
P-STS,selumetinib-vorinostat (8-1 mol-mol),2.362145867213819
RS4;11,9911463,2.865814362111231
BT 482,10296883,4.136673129402408
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
Hs 936.T,9935249,4.288072369675604
P12-Ichikawa,10322450,3.1626592716679376
SEM,selumetinib-vorinostat (8-1 mol-mol),0.5449202862000408
HCC1438,1566236,3.420942312784018
L-428,136227924,2.9759698761374795
OCI-Ly3,135659046,3.630790427153339
COR-L105,10322450,4.112392966182136
786-O,3854666,2.4233058508969414
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
SNU-899,11152667,0.5219214178176714
CAMA-1,11152667,3.9116421057380193
RPMI-6666,11404337,0.2298054354312977
NCI-H747,24771867,3.381605104077559
COLO 668,2746,3.082307436589746
IPC-298,4378219,2.0011234258094723
NCI-H1373,135398744,6.356905852078599
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
HEC-6,12003241,-1.1839534104512932
MHH-CALL-3,54618305,-2.6032617939923672
KYSE-410,11404337,-0.5095483106694066
KMS-27,JQ-1-carboplatin (1-1 mol-mol),2.20932469874721
CAL-148,9915743,1.3006857721800915
NCI-H1975,3854666,0.3706009095573263
PaTu 8988s,54618771,-1.1165982816182902
SK-MES-1,12003241,-1.463616091527542
NCI-H1703,6918638,1.6559021523664152
SNU-489,9911463,4.33052136373557
CAL-54,9915743,0.6596692010948818
JK-1,3854666,1.8994532314964685
Aska-SS,136227924,2.71481465035111
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
SEM,9915743,-2.2587042117517284
NCI-H28,3854666,0.2888629492877926
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
DAN-G,2742550,4.03196202986672
MOLP-2,9884685,1.3188927269907686
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
HEC-6,135984461,4.376035832446469
COLO 829,4378219,3.638456848241486
BT 245,9926054,2.9422912383021393
SK-LMS-1,135421197,1.8226321341170344
EFE-184,12003241,-0.5797348651994826
MeWo,135659046,3.600051172308168
NU-DUL-1,136227924,1.961051427269065
COV434,4705,5.401407376455341
LoVo,136227924,4.6796674015936075
MOLM-13,9911463,2.5287579203643986
NCI-H1666,9935249,2.383353166083433
JHUEM-3,135984461,1.6896934055741442
MOLT-16,135421197,0.9266017011835492
OCI-Ly19,135421197,1.1485789152916004
BICR 18,9884685,0.4785445469171743
SNU-1041,11404337,0.704382749568953
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
SK-N-BE(2),4705,3.5810026533743793
MHH-ES-1,JQ-1-carboplatin (1-1 mol-mol),0.9828156633335828
VMRC-RCW,11152667,-0.2135397069324333
OV7,135421197,2.579158372442756
SK-N-AS,135421197,2.9463042299637645
U-CH1,10296883,4.147142232028317
ECC10,12003241,-2.873030940363692
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
DLD-1,9915743,3.4458544437920784
SF268,136227331,3.2043124531473945
TE-15,4705,1.329912019407035
OV7,9884685,0.1253380741957696
SNU-449,10322450,2.7236273289045942
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
COR-L105,4378219,1.9356703916494296
HT-1376,9915743,2.2155128053194777
IGR-39,49836020,4.439074954514643
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
Panc 05.04,73707386,3.515667776304821
Namalwa,JQ-1-carboplatin (1-1 mol-mol),-0.7629380597950661
SNG-M,135398744,7.8429611595155055
MG-63,11404337,1.2234517903826516
SNU-61,135421197,1.1046098427392648
MDA-MB-231,10296883,3.96898040107769
SK-N-DZ,9884685,-0.9050200773000474
HCC1954,10322450,3.841021204455557
SET-2,65628,4.139593667952883
KMS-12-BM,136227924,1.841540408480291
NCI-H2196,1566236,1.8128230891442871
KMS-21-BM,10322450,3.0637099399177936
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
DAN-G,1566236,4.031993556597769
OCI-AML-2,135421197,1.0650932399576858
OCI-AML-5,9935249,3.1801154078434584
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
MSTO-211H,3854666,2.1662920246080963
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
HT-1197,136227924,5.329383648142769
L-540,135984461,3.746123506346987
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
SW1417,JQ-1-carboplatin (1-1 mol-mol),0.7027994901214438
Kelly,135984461,4.326005791878528
SUP-T1,12003241,-2.125139255884817
OVTOKO,3854666,3.283000762867778
NCI-H1703,3854666,0.3793069520255608
SU-DHL-8,54618305,3.6427143953976593
MOLP-2,73707386,3.154347724998132
BT 216,9884685,3.718234384299296
HEC-1-B,selumetinib-GDC-0941 (4-1 mol-mol),1.120792302253412
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
HCT 8,12003241,1.3953140594908418
NCI-H1563,2742550,3.3220396656862
BT 416,selumetinib-vorinostat (8-1 mol-mol),2.2892282073971737
G-361,12003241,-2.5867066735550623
HCT 15,71751553,3.9981225717046858
Hs 895.T,24771867,5.91633120446611
Calu-3,2742550,3.0539698835079863
T84,54618771,0.5762306711501146
OCI-Ly19,3854666,0.5741249589427668
NCI-H747,selumetinib-GDC-0941 (4-1 mol-mol),-3.828774406071909
ChaGo-K-1,4705,3.918553629962962
Hs 944.T,selumetinib-vorinostat (8-1 mol-mol),-0.0424227791856705
KG-1-C,2742550,3.940460773716529
P3HR-1,9935249,4.307909434108789
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
Panc 02.03,71751553,4.925944110140211
IGR-37,11494412,1.023778204341386
U-937,24779724,4.361169405698901
Raji,9911463,2.729188500459454
DU4475,10296883,3.4957672338374204
NCI-H2196,9926054,1.658766361497933
KYSE-70,10296883,3.691258417269261
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
GA-10,135421197,0.1177808721156358
CAL-85-1,2742550,3.495700065332706
BT 444,3854666,3.4712886438660417
EoL-1,9926054,1.828019217783983
HuH-1,6918638,1.1599636412838177
SW948,135421197,1.7477185084776832
Rh41,9926054,1.5140566326622644
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
KNS-60,9926054,1.3283551370415152
SCaBER,136227924,3.000538162090115
SF268,9884685,0.6614241142301136
JHUEM-7,11494412,0.4868890434989014
Lu-65,selumetinib-vorinostat (8-1 mol-mol),0.948619360922771
SUP-M2,9915743,1.8223517486811256
PE/CA-PJ49,136227924,2.4190721025981987
KP-4,24771867,0.2854190310309647
LC-1/sq-SF,9911463,4.2961748372048465
OE33,135421197,1.9963159792783505
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425
OS-RC-2,135421197,5.318093622175408
SNU-626,11404337,1.6916289336018857
SUP-B15,71751553,5.338056707616089
NCI-H460,9911463,4.421747687015995
HOP-62,9911463,3.8769302944036266
AsPC-1,2742550,5.133078791264603
MHH-CALL-4,selumetinib-vorinostat (8-1 mol-mol),1.0890030142935403
HH [Human lymphoma],12003241,0.3736289232405389
Tm87-16,136227924,1.7990989939748585
HEL 92.1.7,100016,4.201358504841771
WM88,100016,6.2407728308576
Karpas-422,9926054,1.7787061620357676
GP2d,135421197,2.1727622250503607
DMS 53,11152667,-0.3155259461808404
SH-4,9926054,1.7270263084889954
LS180,54618305,4.3130332958468385
NCI-H2196,11494412,3.593697279450839
MDA-MB-453,4705,2.8938913201458583
SK-MES-1,135421197,1.0053632050719472
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
NCI-H28,selumetinib-vorinostat (8-1 mol-mol),2.3549234517364512
LNCaP clone FGC,9926054,1.750086860049474
Hs 895.T,9911463,4.380073854320694
SNU-719,65628,4.730492639805566
Kasumi-1,2746,0.7375663953189775
Karpas-422,10296883,3.4516705884612704
BHY,54618305,5.6036447645776315
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
SNU-308,11404337,1.2327957985917497
KHM-1B,135421197,0.982032972009238
TE 441.T,3854666,0.9289040865316472
ONCO-DG-1,2742550,5.6054605972439875
SF126,54618305,5.7910239418696
ONS-76,136227924,2.542073211711186
HCC44,selumetinib-vorinostat (8-1 mol-mol),0.804624946321419
8305C,4378219,1.8423800736639109
P31/FUJ,73707386,2.311695228129917
NCI-H1666,136227331,3.5475542812047873
PL-21,135984461,4.312224560924431
T-47D,9868037,4.066424821107803
NCI-H520,11404337,-0.911000559838952
KMM-1,3854666,4.082078961009132
TE-5,11494412,1.6145960929630034
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
CAL-54,135421197,1.5931766951689923
Kuramochi,10322450,3.6258037590655383
L-428,100016,6.045371287660442
EoL-1,135421197,0.8401357676850814
BT 145,JQ-1-carboplatin (1-1 mol-mol),4.281045912366545
Hs 839.T,136227924,4.248389123686858
NCI-H1838,65628,4.38525152721343
MDA-MB-361,135421197,1.0665899538152213
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
DMS 273,4705,3.496116762813734
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
VMRC-RCW,54618305,5.1504502435726005
VMRC-RCZ,4378219,5.043011480001355
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
LK-2,3854666,0.2625984273437197
NCI-H526,JQ-1-carboplatin (1-1 mol-mol),2.899547040421834
HGC-27,1566236,2.3802027184021037
CAL-33,9926054,1.6426139792956471
Panc 10.05,100016,7.2735240015579645
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
HT-55,11404337,0.898087242487133
U-118MG,11152667,0.4804391951353036
NCI-H2172,44241473,5.356586155091817
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
RCH-ACV,10296883,2.7404232752674273
MOLM-6,4705,2.310096856528744
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
KG-1-C,136227924,2.6958486075351944
DMS 273,9935249,1.448801275140577
KMS-20,2746,0.7437630311682376
IGROV-1,3854666,2.3355254440561137
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
BHY,11152667,-1.171892891477289
HD-MY-Z,135659046,3.544790983777307
ESS-1,11494412,1.0604335653802026
CAL-29,2742550,2.973881350945423
RL,11494412,0.0299021136601704
HuG1-N,3854666,3.578012994225317
SK-BR-3,135984461,4.752422329058812
Rh18,selumetinib-vorinostat (8-1 mol-mol),2.37781269725146
KMS-12-BM,3854666,-0.1079800642722917
OCI-Ly3,54618305,3.9282315260489766
COLO 792,54618771,0.4942463473126465
Hs 294T,9911463,4.3958964450734594
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
A4/Fukuda,9911463,2.417745886609146
Hs 766T,9911463,4.174180963053701
KMS-34,100016,4.459610626448404
MDA-MB-453,9926054,1.6596725660557576
P12-Ichikawa,54618305,-5.897174424976468
SNU-182,JQ-1-carboplatin (1-1 mol-mol),2.6048292871272865
FaDu,12003241,-1.459997114195287
MFE-296,9884685,1.1807568276780505
HT-1197,54618771,2.611053325854013
FU-OV-1,24771867,2.3744516407985485
A3/Kawakami,9935249,1.5690106286668166
AsPC-1,135421197,1.8824248695595285
SUP-T11,selumetinib-vorinostat (8-1 mol-mol),2.479374773758299
TE 617.T,11404337,-2.8418150062947487
NCI-H1944,9911463,2.563983379964603
KYSE-30,54618771,0.4265256767943792
KYM-1,9868037,3.127577125862836
Daudi,135659046,3.1156448500687923
IGROV-1,135984461,4.285945029851472
EFO-27,9911463,4.361076045114702
SU-DHL-8,11152667,-4.648221806130362
NCI-H1838,9915743,0.3872640032202238
PK-1,71751553,5.428390787076589
22Rv1,2742550,3.8751655229026674
TT,12003241,-1.2151389854631975
MDA-MB-468,54618305,4.506986368363062
HD-MY-Z,3465537,2.9850007343449003
COLO 680N,24771867,3.568864783291443
NCI-H1869,10296883,4.447785026459559
FaDu,selumetinib-vorinostat (8-1 mol-mol),3.771184293371853
SUIT-2,54618771,1.0369427055295135
BICR 56,54618771,-1.9015282957289323
SUP-T11,2746,2.7508028515684457
OAW28,135421197,1.4901490212875883
L-428,9915743,0.0978026688985125
NCI-H1581,9884685,0.1991439741532774
CAL-51,9868037,3.5441777448678615
Capan-2,135659046,4.498205375540461
NCC-StC-K140,11494412,-0.839248093029438
HCC1500,65628,4.452955395596753
Panc 03.27,2746,4.351064714114301
HSC-4,9915743,0.765957034876682
BT 330,44241473,4.196358562733664
Karpas-299,136227924,2.4546473500331576
SU-DHL-1,136227924,2.1802521862386395
NCI-H23,71751553,4.365548247441621
MES-SA,4705,2.820968448326189
HCC1806,11152667,-1.845858422637801
NCI-H1339,3854666,1.1163933455881117
SK-MEL-28,9911463,4.538912500786334
Calu-3,135421197,0.9816420613117603
MDST8,9915743,3.1722151191536607
NCI-H1703,44241473,4.584630638969769
TALL-1 [Human adult T-ALL],12003241,-0.6623785293924347
MKN7,9915743,1.455342343306638
SU-DHL-8,9911463,2.7396964773709764
CL-11,54618771,0.9971438816591957
Jurkat,11404337,-1.079312367340039
Hs 688(A).T,9884685,-1.0348609535352993
M-07e,2742550,2.9985200083609014
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
SH-4,11494412,4.155864270127312
BT-549,10296883,4.161421407524775
SU-DHL-10,9868037,2.3348220475042343
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
NCI-H520,3854666,-0.551991556599842
MSTO-211H,9884685,-1.5007126123703023
NCI-H841,24771867,-2.2199550687686114
BFTC-909,12003241,-0.8371396827795129
SNU-878,selumetinib-vorinostat (8-1 mol-mol),2.250653624443524
KP-3,9926054,1.9542215923866435
K029AX,2746,3.0884726506960805
MKN74,54618771,1.3558742291917982
Namalwa,71751553,4.989934392817737
DU4475,selumetinib-GDC-0941 (4-1 mol-mol),-4.053577940845995
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
GDM-1,3854666,0.7201378614035356
ME-1 [Human leukemia],selumetinib-vorinostat (8-1 mol-mol),0.9847489523071804
A-253,9911463,3.7937497344775815
MDA-MB-453,10322450,5.853812101119735
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
MFE-296,11404337,-0.7207303053792228
NCI-H1703,selumetinib-vorinostat (8-1 mol-mol),4.45362073786032
NCI-H1694,65628,2.2458505354729854
NCI-H2029,4378219,2.006881528865792
A-375,11152667,-0.6556318193430793
PC-3,9915743,3.040450489306842
SK-MEL-3,6918638,0.5772610172488114
HCC2935,12003241,-0.8324751754872037
P-STS,10296883,3.777775874485648
HEC-251,136227924,4.831338089277502
NCI-H2087,10322450,3.569680650808545
SNU-503,JQ-1-carboplatin (1-1 mol-mol),0.9047504626214904
Ci-1,9926054,1.7408061846273166
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687
Kasumi-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1995459699844852
KMRC-1,12003241,-1.418239320082467
Panc 04.03,24771867,4.398084543376112
JHH-5,135659046,3.6151990449321705
HuP-T3,6918638,1.0959798369911515
SNU-1,24771867,3.612227968637844
TE-10,73707386,-4.3328999275948314
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
253J,3854666,0.8471444686993981
AGS,11404337,0.6854213320992603
OPM-2,1566236,0.7571858740606694
MPP 89,4378219,2.1056277411264728
NCI-H1395,2742550,4.633125791317317
253J,9935249,3.7967052414935223
BT 139,3854666,3.266069647715192
BT 228,3854666,1.688749434997188
A-549,136227924,3.1395144761786486
M-07e,9926054,1.1111810240373077
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094
KYSE-510,2742550,4.37690819597459
OVCAR-5,11152667,-0.1360191619178498
OE33,65628,4.337074317818266
SU.86.86,selumetinib-vorinostat (8-1 mol-mol),2.278542875052656
SNU-398,54639665,-0.6353401826184709
SK-N-AS,49836020,4.951261339623108
IGROV-1,1566236,2.765820903157784
HuH-6,24779724,4.249580878490073
MHH-ES-1,11152667,-1.0440831311792091
Kasumi-2,3854666,0.5999676074569762
HCC1195,4705,3.3009207230647952
Kasumi-2,10296883,1.6134498936175832
VCaP,11152667,-0.5682983840571335
SNU-1,49836020,4.400146563188995
EBC-1,54618305,4.408004821032484
Kasumi-2,136227924,1.9658135956042504
SCC-9,100016,6.423023301160456
Hs 729.T,9926054,1.9199617191316192
HCC1500,135659046,2.9858139057826905
BT 504,11404337,-1.134155028298889
HMC-1-8,11152667,0.5419777398264091
KE-37,100016,3.280443906920473
SaOS-2,3465537,1.5281169625539155
EKVX,4705,1.6368061530799292
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
NCI-H1703,9911463,3.2274875516011257
REC-1,44241473,4.8692289567308675
SU-DHL-1,9935249,2.376788737359572
T24,11152667,0.7065000488555848
MSTO-211H,9911463,2.6842905920893108
BT 328,100016,6.778172011931934
BT 145,selumetinib-GDC-0941 (4-1 mol-mol),0.1649490649734122
647V,6918638,0.3753177333233063
SYO-1,54618771,-0.0439888220829119
LOX-IMVI,65628,4.323385700869822
ECC10,11152667,0.6554196221982307
NB1,9884685,-0.4292622986017718
AGS,100016,6.525427767108566
NCI-H2126,selumetinib-GDC-0941 (4-1 mol-mol),2.896687453534691
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
MKN74,4705,5.009866699561135
Hs 683,2746,3.210764654839646
GB-1,54618771,2.0040836599793077
SK-CO-1,9926054,2.0008566323964576
DMS 454,3465537,1.238616523221781
KMH-2,44241473,4.307492980589522
A-375,135984461,4.563596493696721
YH-13,11494412,0.8602319711686647
HCT 15,135421197,1.319827384864071
HT,9935249,2.103185333162581
NCI-H1755,JQ-1-carboplatin (1-1 mol-mol),0.9057830308904904
COR-L279,6918638,-1.2783041826308352
CA46,11404337,-2.4021967063511434
BT 498,9911463,3.937995526968798
BT 239,2742550,2.277540170314908
NCI-H441,9935249,4.015307304312089
HCC1419,9935249,3.389124149949876
SNU-C5,3465537,1.1156127237454885
HH [Human lymphoma],11494412,0.1412103893601752
EC-GI-10,136227924,3.398194138185936
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
G-361,54618305,4.649093637663993
TM-31,9911463,4.397855159833588
OVCAR-5,3854666,3.3204773535647916
NCI-H1793,4705,3.730029638704029
GDM-1,12003241,-2.0828988572069487
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
Lu-99,136227924,2.52697800854745
KYSE-410,54618771,1.043731623373752
DK-MG,selumetinib-GDC-0941 (4-1 mol-mol),2.430443160394254
DU145,9935249,3.749003876346386
LP-1,9884685,-1.812472682789282
F-36P,44241473,6.465065982538859
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
HOP-92,49836020,5.403656238129832
TUHR4TKB,11152667,-1.5326893310023182
OE33,135984461,4.2867065871619445
Hs 294T,135984461,3.742416066345508
CW-2,136227924,3.283467391951437
Mino,9926054,1.8004792382140618
MEC-1,135984461,4.143438780946002
A4/Fukuda,136227924,1.9204852137512072
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
NCI-H2228,9911463,3.8620959723614474
Hs 611.T,9915743,-0.4075331774048215
ST486,9911463,2.5005951178615775
LOX-IMVI,12003241,-2.813518393614124
NU-DHL-1,4378219,5.179201062544345
Namalwa,11404337,-2.5348333703062575
EB1,9935249,-0.4672615921444373
EB1,135421197,0.2915543489276729
NCI-H1975,JQ-1-carboplatin (1-1 mol-mol),1.6464051642952602
CCF-STTG1,100016,6.985278157575169
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
MES-SA,10322450,4.209540173303182
BT 286,10322450,5.184244057340175
NCI-H2106,9915743,2.062061101089789
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
NCI-H1693,71751553,6.177840358634376
SH-10-TC,11494412,1.409264522589107
OE21,1566236,3.330797910783387
SR,12003241,1.5749280257994038
SW579,65628,4.401264893837287
IPC-298,9911463,3.847943729471794
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
OCI-AML-5,9926054,1.291118063021603
SK-MEL-24,71751553,5.203403695597485
A-253,1566236,1.9034646060389304
ST486,10296883,2.054791984575977
U-118MG,9911463,4.435757923179886
SET-2,1566236,1.327292849582041
HCC2218,100016,5.089450081937329
KMBC-2,135421197,1.90199423292403
WM266-4,9915743,5.517914495108045
WM88,136227924,2.639448330236639
Panc 03.27,136227924,3.110606575361216
CAL-54,9935249,2.6795394357960145
A-673,135421197,0.3124298336996849
CAL-51,10322450,3.881825194853649
SNU-668,9911463,3.9434734903909976
HDLM-2,9935249,2.6630480358330657
A-204,9926054,1.5825801354867326
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
Aska-SS,selumetinib-vorinostat (8-1 mol-mol),2.5241370498286373
KNS-62,135659046,4.2739779007754
SUP-B15,135421197,1.049763554342806
IGR-1,9911463,4.350306132693756
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
M059K,11152667,0.916806350052847
T84,4378219,3.51511491389043
Lu-65,11494412,0.9324583231494612
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
Jurkat,selumetinib-GDC-0941 (4-1 mol-mol),2.512422287113006
HH [Human lymphoma],135421197,1.0671301978035626
Li-7,9911463,2.7835624344387924
BT 271,4378219,1.6547833007779609
SK-N-AS,135984461,4.344661124927598
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
BICR 56,9915743,-1.8480051060237024
BT 172,3465537,1.5223639043000616
MCF-7,9926054,1.7310317924725227
TUHR10TKB,JQ-1-carboplatin (1-1 mol-mol),4.175841940785285
HEL,11152667,-1.5416892011653274
ESS-1,2742550,4.194579887734085
Granta-519,12003241,-2.1147517064841925
MOLT-3,11494412,-1.4900582448150606
BT 340,9911463,3.653234979635605
VM-CUB-1,9935249,3.9687808377617855
COLO 699,135421197,0.9619259452362175
BICR 16,9884685,0.7876467739980545
HCC1195,54618771,3.4499455256162475
CHP-212,3465537,1.2207374723965898
PE/CA-PJ15,6918638,0.9363103788474072
SUP-B15,9915743,0.9578532779585308
JHH-1,1566236,3.07431641585211
SNU-407,136227924,2.9703344519672785
NCI-H1355,2742550,3.68494332628851
BT 172,9935249,2.02669963846525
Calu-1,9868037,4.36020250982657
CCF-STTG1,1566236,4.223986774063583
ZR-75-30,24771867,4.272666461213065
RPMI-8226,73707386,3.162899044408619
HT115,selumetinib-vorinostat (8-1 mol-mol),0.9982252810504696
PaTu 8902,3465537,3.540732953494624
NCI-H1105,9911463,3.5192324604951533
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
SK-N-BE(2),9915743,0.2330456921975308
WT2-iPS,135421197,2.4533231744799235
Kuramochi,24771867,4.433141016178507
Hs 683,9926054,1.7064216062537565
TE 441.T,54639665,4.381195082349918
COR-L105,54618771,2.0419110046350135
KCL-22,44241473,4.808701951314744
Mino,136227924,1.7493984310197022
HSC-4,10296883,4.12801319058873
KALS-1,135659046,3.8631943181286
Ki-JK,135421197,1.017420564830507
HCC1438,136227924,3.0530124683265725
HT-1197,9935249,1.8352479707891152
OVISE,11152667,1.81896217810704
BT 231,4378219,1.1996674528146534
SCC-9,9911463,4.4493328300482995
CJM [Human melanoma],135421197,2.95523092671823
IM95,135984461,1.6793347325377754
NCI-H522,54618771,1.252244709003548
SNU-1076,9926054,2.0143618167190493
EC-GI-10,9911463,4.066814548265045
HEC-151,1566236,1.8834874590606951
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
CAL-148,JQ-1-carboplatin (1-1 mol-mol),1.5060433709656682
TC-71,11404337,-2.7316229346528145
C2BBe1,6918638,0.4020582532011564
KMS-34,4705,2.7646110447825647
TE-6,9935249,3.4314047332936264
HOP-92,135659046,3.870872238104053
SUP-T11,10296883,3.5958048269755114
HCC1143,9911463,3.749174224015704
TE-5,6918638,0.0730063512653744
OV56,9935249,3.246105804019043
SCC-4,selumetinib-vorinostat (8-1 mol-mol),1.0043202724846296
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843
Caov-3,selumetinib-GDC-0941 (4-1 mol-mol),3.787884726335324
KMS-26,135984461,1.0857498172669495
RL,136227924,2.481613482211788
SF268,65628,4.3659613726729685
JHOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.3752490539264866
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
Rh41,9884685,-2.3204125045611264
HOS,6918638,1.052559651861536
PC-3,24771867,4.319166760544565
IST-Mes1,44487872,4.402175961022997
KLE,49836020,-2.0520357560351714
NCI-H1373,24771867,3.8378937409417
Jurkat,65628,3.880362964919709
BT-16,12003241,-1.8198494997272787
TE-8,2742550,4.06449029872564
JHH-1,11404337,-0.8045754581071476
HT115,JQ-1-carboplatin (1-1 mol-mol),2.098973716553155
Mono-Mac-1,136227331,4.247854438913471
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
DBTRG-05MG,135421197,2.57791349467794
Hs 729.T,selumetinib-GDC-0941 (4-1 mol-mol),3.0623228913945684
Panc 10.05,9926054,2.010421160581402
MIA PaCa-2,4378219,1.989659969490472
HCC1588,100016,6.591658390404969
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
A-673,135984461,3.9402009784769745
HT-1376,11152667,-0.1959046835831934
NH-6,135421197,0.8889429247891555
DU145,65628,4.2291081704038325
Rh30,73707386,2.7421591744749745
HEC-59,12003241,-0.4049011737939335
JIMT-1,11152667,0.2510787979057463
HuP-T3,4378219,2.0668857590794767
ACC-MESO-1,3854666,3.6033422587717854
HPAF-II,135421197,2.4273877762947933
YH-13,6918638,0.7209706519949683
COV644,JQ-1-carboplatin (1-1 mol-mol),1.9465163410913973
JURL-MK1,44241473,4.883252200068975
OCI-AML-2,9868037,1.5356230496639076
T98G,1566236,4.934328741372893
NCI-H1944,10296883,4.093574875483821
BC-3C,12003241,-1.7584420473179934
BT-20,9926054,1.9620105743223175
SW1783,24771867,4.842203084909567
EN,54618771,2.591553593247422
JHH-2,9911463,4.025209032029127
B-CPAP,135421197,1.178862358485884
OCI-M1,10296883,3.5292915322873255
HSC-4,650361,3.951915492066197
NCI-H2405,100016,6.531050125500204
KMS-34,136227924,2.5847633588950147
Lu-99,24771867,1.9574239853284192
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
SR,11404337,-0.9358789780848294
TE-14,9926054,1.5943832140078456
SaOS-2,24779724,4.377738848523283
CW-2,JQ-1-carboplatin (1-1 mol-mol),0.838354754464334
HCC4006,11494412,-0.4064620911690372
UO-31,71751553,3.4066570222974466
OV7,135659046,3.534077236182633
CAL-27,49836020,4.376742607272952
NCI-H1693,9915743,0.8308025375292787
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
NCI-H1944,136227331,3.877742239943195
SU-DHL-1,73707386,2.8817783064824773
Daudi,135984461,3.9990978127252728
PK-59,135984461,4.560793597848683
Kelly,3854666,0.4283162780328328
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
OC 314,12003241,-2.177807668538587
SF539,9911463,3.3415175792660854
BT 159,54618771,0.7710223588064036
DND-41,11152667,-2.545797429507851
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
SCC-25,135421197,1.688972609410465
BL-70,4705,3.4398242170879723
NCO2,3854666,-0.3022721957151304
VMRC-RCW,10296883,3.756986073264271
HT-1376,49836020,5.287165459832521
OVCAR-5,9935249,2.5949281328886316
BICR 22,100016,6.157225392196351
SH-10-TC,JQ-1-carboplatin (1-1 mol-mol),1.9237782728423225
BL-70,11494412,-1.22344895039541
HCC2935,9915743,-3.080711335255353
SK-UT-1,135421197,2.4956722116312813
SNU-761,9935249,3.1228430287660354
NCI-H1793,4378219,1.948584660455076
Hs 888.Lu,4378219,1.8969136462809248
SU-DHL-1,54618771,0.3433661921186922
SK-MEL-24,9884685,1.802642811189954
A3/Kawakami,11152667,-1.367626298154913
Karpas-422,135984461,4.3057747311374746
A-172,54618771,1.0559368295396556
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
A-253,12003241,0.3953648973902781
MKN1,JQ-1-carboplatin (1-1 mol-mol),4.3566594896883934
RPMI-6666,9915743,0.6394902381719043
SU.86.86,135659046,3.4966511693155637
Hs 888.T,10322450,3.2748281083496114
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
DB,71751553,4.024428323991343
EBC-1,49836020,4.041761576127936
JHUEM-1,135984461,4.231451308328731
SUP-HD1,11152667,-1.1328719651576526
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
RKN,9935249,4.428036529076262
HCC366,11404337,0.8660876212905556
NCI-H841,2742550,3.727846047428191
A101D,10296883,3.721128272051271
HEC-1-A,12003241,-1.9132267433224897
OCI-AML-2,10322450,2.967388898319709
NCI-H1693,11404337,-1.060288608943807
RT-4,9935249,3.446453833049965
KYO-1,100016,4.086276175586104
NCI-H522,4705,3.8595388748644375
NCI-H1944,11404337,1.0777396024830528
DU145,54618305,4.450294310090801
T84,24779724,4.300698841519802
JMSU-1,65628,4.470977639866145
CAL-78,135984461,4.031920307936069
COV644,10296883,4.09466699132534
NCI-H1355,4705,2.565459964061863
U2OS,4378219,5.0189948345612585
KATO III,9884685,3.32909591420453
SF539,100016,5.965471494853995
U-937,1566236,1.2304884719985758
Hs 294T,11404337,-1.3657699869791882
BT 145,71751553,4.949668908284117
SF268,2746,2.880766016506668
SW1990,65628,4.249281655519801
D283 Med,12003241,-3.4539176227720794
MDA-MB-415,54618771,1.363110492584667
HuP-T4,100016,6.7159168289197915
PLC/PRF/5,44241473,3.926194550962254
LCLC-97TM1,4705,3.0319662392534057
L-540,10296883,2.97370959547478
DLD-1,9868037,3.074628293738507
NCI-H1650,9915743,2.357354883780035
HLF,11152667,-0.0932620413517799
HCC1438,100016,5.852637802531623
Hs 683,11494412,0.4021600423895013
PF-382,3854666,0.8290647153929614
MHH-CALL-3,135398744,6.205129646453742
MKN74,9884685,2.0469611247981625
BT 422,4378219,1.5041109408264797
KP-2,6918638,1.246532088214889
LS123,9926054,2.1967740903619934
SNU-1214,3465537,5.236709132299774
T-47D,4378219,1.870672130476483
T98G,11404337,0.3579674680524426
SNU-213,54618771,0.1807958320323681
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
8-MG-BA,9935249,5.559500366284677
SNU-878,9915743,3.52259328044215
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
NCI-H1568,11404337,-0.63897934294681
NCI-H2110,10322450,4.394668434370401
DAN-G,135421197,3.0058015912267475
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
NCI-H2110,135659046,4.755266203031495
M059K,54618771,3.2179449616328775
EoL-1,11494412,-1.5028659812721048
HCC1500,54618771,1.4039271563223086
CAL-148,3854666,0.9870114885277602
NU-DHL-1,10322450,3.582925513183909
NCI-H211,9915743,0.3286661494354852
SNU-466,11152667,1.6720712603186765
K029AX,136227924,2.929460109593454
HuT 78,12003241,-1.0527217193191982
SNU-626,12003241,0.7059762795421864
MHH-ES-1,selumetinib-vorinostat (8-1 mol-mol),2.4304170716272813
NCI-H446,9868037,2.387486859676029
Hep-G2,11404337,0.9907256098180968
JURL-MK1,100016,3.373338788856286
NCI-H1395,3854666,3.0219534193280637
EFM-192A,6918638,-0.4995491162684927
NU-DUL-1,135421197,1.0938833376467747
JJN-3,54618771,-0.9152585642725306
WM983B,6918638,0.63474278918499
SK-ES-1,11404337,-1.5843384891531491
OAW28,2746,2.637952220594215
MOLT-16,9915743,-0.2771679442099183
SW48,9884685,-1.5395746259931604
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
UACC-62,2746,3.149907742936544
AML-193,65628,3.6139480198766822
JHH-4,3854666,2.756856566368671
GSS,9911463,2.6255650357234797
COLO 680N,3854666,4.154438593941972
HT-144,10296883,4.023256164305908
L-428,selumetinib-vorinostat (8-1 mol-mol),2.5510918509363876
ChaGo-K-1,44241473,4.641604791111675
Capan-2,24771867,2.913513449565644
JHUEM-3,650361,3.6848753876902767
CJM [Human melanoma],11404337,-0.6079802482567472
IGR-39,136227924,2.6355333557661167
SK-MEL-3,135984461,4.369065349705821
PE/CA-PJ15,10296883,4.07189179930938
COLO 829,71751553,4.323103675248641
JHH-2,100016,7.043022520962564
NCI-H2286,100016,5.552985583261177
SK-N-SH,9926054,1.7311235151913027
PC-3,4378219,2.181875059346443
ZR-75-30,10322450,4.312003120067809
647V,JQ-1-carboplatin (1-1 mol-mol),0.8897727111065127
BT 164,54618771,1.1636109320756167
COR-L105,100016,7.1590039780101895
C2BBe1,4378219,5.7328477959434245
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
Hs 888.Lu,selumetinib-GDC-0941 (4-1 mol-mol),2.177806274579951
LCLC-97TM1,2746,2.92478275020961
U-118MG,2742550,3.858663232806478
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
TE-1,selumetinib-vorinostat (8-1 mol-mol),2.3565359063634133
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
SU-DHL-1,65628,3.0805404655500843
BT 147,4705,1.580019140366276
FU-OV-1,9911463,4.1305925074662575
RS4;11,2746,2.038871596243954
BICR 16,6918638,2.6722716810347205
SW1710,12003241,-1.2750404815852618
KMS-12-BM,12003241,-2.27657533610394
A3/Kawakami,JQ-1-carboplatin (1-1 mol-mol),-1.0104542056691184
KLE,11404337,-0.1549034777249487
SK-N-BE(2),9911463,3.2648033538854517
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
NU-DHL-1,2742550,3.0949121408680886
KM12,9915743,2.3506580045121948
BT 172,100016,6.450201924949107
TE-6,4705,1.909603555694431
KMS-11,44487872,4.082164397360745
TE-5,12003241,-1.2234174090075007
SNU-1,136227924,2.7041604085298205
COLO 684,135421197,1.6241995142011054
BT 444,9884685,1.6676673594353697
HCC15,54618305,4.644823264977023
HLF,1566236,1.6568268509267354
G-401,1566236,1.5621622205700352
KYSE-180,11152667,-0.8702132503194517
JHH-6,9911463,4.586704502262201
A101D,selumetinib-vorinostat (8-1 mol-mol),3.608310140298691
LXF 289,135421197,2.6553019911408056
Kasumi-2,12003241,-2.245419673861097
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
CAL-51,11404337,-1.4033364127444676
OV56,11152667,0.7027706335700444
U-CH1,11494412,5.678083341070562
CA46,135421197,1.13174100448049
OCUM-1,12003241,-0.8918432074998596
DU145,71751553,4.612532696139562
ChaGo-K-1,136227331,4.028131370047934
MOLP-8,135398744,7.476327693514706
NCI-H1573,9911463,3.324628771870272
LS513,2742550,3.7446705767698494
JM-1,136227924,1.2038413750130548
HEL 92.1.7,9911463,3.2489228387503486
OC 314,24771867,2.6444001779908226
RL95-2,11404337,0.2119113216403357
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
Calu-6,11152667,-1.6386205302726315
COLO 320,9926054,1.5350415050718291
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
NCI-H1573,11152667,0.2094466733684726
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
L3.3,12003241,-0.3315333583144895
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
NCI-H69,11152667,0.8165842886713589
BT-20,9911463,4.1322446502045285
TYK-nu,9935249,3.27204815047351
WM88,9911463,3.783818746196605
EPLC-272H,JQ-1-carboplatin (1-1 mol-mol),0.1127668354525981
NCI-H2291,3854666,3.6740826337304022
A2780,135421197,1.3895584306244824
HMCB,135421197,2.011360494635396
KMS-12-BM,9868037,1.5063019992906226
BT 359,1566236,3.822998836032952
BT 330,1566236,2.4105147195149694
Hs 888.Lu,650361,3.8028163824947967
RERF-LC-Ad1,136227924,3.427007002266959
CHP-126,9926054,1.6835442403825218
KG-1-C,12003241,-2.4512871070373476
BT-12,135398744,6.373256605371206
Rh30,1566236,1.5669773851253712
HCC95,9926054,2.566209783667777
NCI-H1944,9884685,1.1029349994643696
HCC4006,11404337,0.6477756071897834
BT-16,4705,1.941125757653359
KE-39,11404337,-0.6939323202576905
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
SW1990,selumetinib-vorinostat (8-1 mol-mol),3.2800234723001016
42-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),0.6620658581773345
SK-LMS-1,11404337,0.6927873506119244
HH [Human lymphoma],10322450,2.565345423842302
NCI-H810,9915743,0.7242422490458518
Namalwa,12003241,-3.0032452893334596
BT-474,135421197,1.065092434126716
CAL-85-1,9926054,1.875240534371988
EFM-192A,1566236,1.7365732775368694
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
LS180,44241473,4.435457667187811
COLO 320,44241473,6.1474610184816685
BT 159,11152667,0.5411121048326067
DMS 114,6918638,1.3129980903302014
KNS-42,11152667,1.7002195185356743
GaMG,136227924,2.741790754216058
KYM-1,12003241,1.54362271248318
NH-6,65628,3.5010382729298133
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
T24,3465537,3.175784055433204
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
Hs 852.T,9935249,3.48401275666249
MOLP-8,11404337,-0.9705317414577028
639V,54639665,5.761167112647425
BT 239,1566236,1.2451641316505642
SNU-1041,9926054,2.2828270152060623
HT-29,11152667,1.0220849180343163
HCT 15,11152667,0.0648633497352948
BT-16,136227924,2.1772162484418924
5637,135421197,1.1694761088255747
OCI-M1,12003241,0.3090538594406519
JHH-2,11152667,-0.679570545513591
ST486,135984461,1.4882803556489697
RS4;11,selumetinib-GDC-0941 (4-1 mol-mol),0.8544814441739125
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
UACC-62,9926054,3.2338645061682914
HCC2108,9911463,3.889332679655138
Hs 578T,6918638,0.545294838071351
JHUEM-2,135421197,0.9907591998948792
COR-L95,4705,3.007858501345706
SK-BR-3,1566236,2.316860466268058
TTC-709,65628,4.616344803397528
MES-SA,9911463,4.310178106628171
NCI-H2106,9926054,3.0044250532123735
SKM-1,100016,4.336407790429152
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
A-549,4705,3.61311120139633
HEC-6,selumetinib-vorinostat (8-1 mol-mol),1.2683644389849238
SNU-423,9915743,2.488155909988838
Becker,2746,3.675450807498904
NCI-H1623,65628,4.265717950525356
NCI-H1105,54618771,0.6246243373087411
NH-6,10296883,3.372603292906397
BT 145,12003241,-0.8369227670207208
TYK-nu,54618305,4.312286550254365
HCC827,9915743,-2.5410079672049446
NCI-H508,9911463,3.6080758528024055
SCC-25,100016,6.900174579464034
G-402,135659046,3.518784307973502
NCI-H2023,2746,4.105485199258473
Hs 729.T,71751553,4.8113442822732155
NCI-H1105,3854666,0.1958522634475155
PE/CA-PJ15,9926054,1.7631963091393454
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
Yamato-SS,9926054,1.8348633448645275
DMS 273,1566236,1.8001113918747356
Rh41,11404337,-1.1237512240479817
NCI-H1623,2746,3.1722069840164533
COV434,10322450,3.177068710390827
Ri-1,11152667,-3.7285428023246943
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
OV-90,12003241,-0.4315626967505086
KG-1-C,9911463,4.124800665042544
OVCAR-4,135398744,7.790531663529689
P3HR-1,136227924,2.9304577514896466
HCT 15,11494412,0.4362890009933227
SIG-M5,100016,4.056618507771364
IM95,135421197,1.82803770659542
WM1799,3854666,2.78635889347835
PE/CA-PJ49,65628,4.299223683644022
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
HOS,9935249,3.318859677592704
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
NCI-H1341,11152667,-1.02440592323998
BICR 6,11152667,-2.1819410522068083
MOLP-2,9915743,1.124715317065168
KMS-34,54618305,3.5477903418914214
NCI-H2196,11152667,0.1681584585599158
TE-10,3854666,1.0043229420232422
K-562,135421197,2.032823128578147
Rh41,9915743,0.4194124468243376
Calu-1,135984461,1.7273977102248494
HCC44,2742550,4.03995268983579
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
SW982,49836020,1.3794416609441722
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
Hs 688(A).T,71751553,4.068289679020872
NCI-H2170,9926054,1.935868452223027
BT 239,136227924,1.4188260158561712
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
697,100016,3.656696343596264
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
MDA-MB-435S,selumetinib-GDC-0941 (4-1 mol-mol),0.7675119040231712
BT 216,100016,6.740671439747835
NCI-H810,11152667,-1.104847529984581
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
CAL-54,9884685,-0.6877334329271488
Hep-G2,9926054,1.3870503906392218
WM793,9915743,2.18814480431127
IGR-1,9935249,3.4531896518082745
KYM-1,71751553,4.9624941614458935
Ri-1,135421197,1.0934360104975305
KMBC-2,11404337,0.8852156711792197
HT-144,4378219,2.014593668444455
BT 504,136227924,2.4961671253802957
SCC-4,9935249,3.0407089317538167
CW-2,44241473,5.020335156949289
Kasumi-1,11404337,-1.4406380230714082
NCI-H1581,9935249,3.181386202860213
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
LAMA-84,JQ-1-carboplatin (1-1 mol-mol),0.9812608136784076
PaTu 8988t,9926054,1.9241127892750265
SK-MES-1,11152667,-3.0245097367815172
LOU-NH91,9911463,4.226439837654448
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
OCI-M1,4378219,1.9933418249078871
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
MKN74,2746,3.2220393473660973
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
SNU-620,135984461,2.973595726933627
Panc 03.27,4705,3.85101081283364
AsPC-1,9911463,3.4970941612274693
LoVo,9926054,1.9069881185353632
OCI-Ly10,135421197,1.9634913874205968
OCI-Ly3,100016,3.877117461004623
HCC1500,136227924,2.675203690625814
TYK-nu,9911463,3.540996784535568
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
Mel Ho,9935249,3.5260132794046597
DMS 53,100016,7.1608088069035185
RERF-LC-Ad1,11404337,1.7320849295693297
HD-MY-Z,1566236,1.7825991347956482
RPMI-8226,JQ-1-carboplatin (1-1 mol-mol),-0.0653783177632561
HSC-2,3465537,3.4081587801176574
CAL-12T,136227924,2.605918242540546
SF268,54618771,0.7113827759626075
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
RERF-LC-Ad2,136227924,3.207411157267862
SNU-886,9868037,2.869419012431549
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
MKN74,24771867,3.715312508081128
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
TOV-112D,10296883,4.52965667337078
CML-T1,12003241,-4.650247315633356
SNU-16,6918638,-0.935817634094486
SKM-1,136227924,2.5339244468963407
COLO 668,11152667,-0.8544795692513644
NCI-H1694,24779724,5.057231476341762
JHUEM-1,10322450,3.3656679927658213
SCaBER,71751553,4.44084569502903
GB-1,3854666,2.326131738518675
Rh41,54618305,3.8818848297915665
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842
HT-1376,9935249,3.971188542533541
OE33,11494412,2.705114225479706
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194
Becker,9911463,4.366530732677302
NCI-H2030,selumetinib-vorinostat (8-1 mol-mol),2.944898179545911
ONS-76,11152667,-0.1692604119623072
HEC-265,54639665,4.667688857990006
NCI-H1792,selumetinib-vorinostat (8-1 mol-mol),2.4401728283589694
SNB-75,12003241,-1.444419761785008
IPC-298,9926054,2.387739594101664
LUDLU-1,11404337,0.8726842724577241
SW1353,135984461,3.620259529955406
OC 314,136227924,3.246361398875885
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
MOLP-2,11404337,-2.275467470037822
BT 216,3465537,3.501074047645802
CAL-51,9884685,-0.2528326244590672
MEC-1,12003241,-2.6195126554486223
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
HOP-92,71751553,4.539782001552626
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
SNU-C2A,54618771,1.0947392287826
SNU-620,9915743,2.3587879241072227
Hs 766T,9926054,1.7033769922015074
Reh,135421197,0.7565283422785475
SNU-16,2746,1.5955901549759912
EFM-192A,54618305,4.273726836942187
HeLa,2746,3.522514487554161
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
MOTN-1,11494412,0.1932398209475109
RS4;11,9915743,-0.3402304070794544
MOLT-3,3854666,-0.0527429362820416
VM-CUB-1,11404337,-0.7362908779657769
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
Ku812,136227924,2.6493599225721742
CW-2,2746,2.3288495510322087
MOLP-8,2746,0.9128995235322724
HCC827,9911463,4.568230901721179
A-204,10322450,3.769962101678964
MHH-CALL-3,1566236,1.809290756960591
MIA PaCa-2,76446078,4.284259753564461
OVCAR-8,selumetinib-vorinostat (8-1 mol-mol),2.9059684430944133
CAL-33,12003241,-0.8317301463564554
SK-MEL-3,4378219,4.648611006826355
42-MG-BA,9911463,3.88998551993186
KHM-1B,3854666,1.0178761505547558
NCI-H1944,10322450,4.686726867812177
KE-97,9926054,0.8495096752282992
Calu-1,136227924,3.5665542391568774
HCC1954,11404337,0.9656290265602768
NCI-H1184,JQ-1-carboplatin (1-1 mol-mol),-0.5864173330660996
HCC1937,selumetinib-vorinostat (8-1 mol-mol),3.3139482335722787
NCI-H1395,9915743,5.704472879097531
JHUEM-2,9868037,1.1428293531660954
KP-N-YN,2746,2.243582059323954
BT 248,54618771,0.8718785044821341
Capan-1,135984461,4.359340050025923
ECC12,136227924,3.114580380384796
MOLT-13,136227331,4.740160343609143
Fu97,54639665,-0.9928942554758008
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
23132/87,JQ-1-carboplatin (1-1 mol-mol),1.651339324624301
HCC4006,76446078,4.251276403130331
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
Caki-1,selumetinib-GDC-0941 (4-1 mol-mol),2.159609795753867
BL-70,11152667,-0.9992900741194192
SNU-387,3854666,3.852007749514328
A-549,12003241,-1.903076073453771
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
Calu-6,135398744,6.4194279820254465
OPM-2,100016,3.804278037815123
KE-39,54618771,0.8543301924142261
Hs 746.T,11152667,-0.4528987545325829
Hs 888.T,10296883,3.7100072063785534
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
T84,10322450,3.7674280785024976
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
NCI-H23,1566236,1.1335950409984874
HL-60,136227924,2.3594265520512447
RERF-LC-MS,11404337,1.609147033115388
Hs 688(A).T,54618771,0.2687022491152004
Capan-2,71751553,4.720349798394505
SK-MEL-2,3854666,3.3106573281169664
TE 617.T,10296883,3.758267174754907
SW48,44505237,4.455085659285412
MOLM-6,9884685,0.1809773777392092
SF268,9868037,3.0654827755113203
Becker,9884685,-0.0960658377350512
A2058,12003241,1.9511247747481215
TE-6,54618771,1.015505758549108
JHUEM-7,9915743,2.288162918918336
HCC1143,2746,1.9419289545652112
HCC44,9915743,1.8487357867630132
JHH-2,9884685,3.029241450708335
BT 333,9911463,3.323400968043226
SNU-398,3465537,3.876042527546671
SK-N-MC,65628,2.481985889078365
Hs 294T,JQ-1-carboplatin (1-1 mol-mol),4.214438557750139
BICR 18,4705,4.076520014659249
HT-55,1566236,3.1458064864445197
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
HCC2935,136227924,3.4382607017764473
BT 147,11152667,1.0893077431707785
EJM,6918638,-1.326291213724497
TE-5,9935249,1.6516778855408267
T98G,selumetinib-vorinostat (8-1 mol-mol),4.3337419760383
Hs 934.T,11404337,-0.0491167451592997
ChaGo-K-1,24771867,3.5582145966940697
KMS-26,24771867,-3.579078717742708
SK-MEL-24,135421197,2.6941455652105852
SW1990,9884685,1.028509429358882
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
SF126,9926054,2.7905707570317686
NCI-H1650,136227924,4.84526698521074
GSS,12003241,-1.231369265985878
HCC1833,100016,6.427561679501585
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
U2OS,3854666,0.8117112929653146
DV-90,3854666,0.9061659566144276
NCI-H28,9915743,1.3436778069227204
NCI-H2286,135421197,1.3585015224229091
SYO-1,11404337,-1.0421940088856276
SW1990,9926054,1.8053433824091036
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
T3M-10,10322450,3.511254114346124
KO52,136227924,2.4006650771153923
MES-SA,9884685,1.4540909419303651
KMS-21-BM,11404337,-1.2049963736057572
NCI-H1155,136227924,2.9905910988633653
NCI-H2170,2746,3.369366607476525
OS-RC-2,12003241,-1.2099466565873536
NCI-H1373,54618771,1.0971026728505908
LUDLU-1,4378219,3.714991068984281
OAW42,1566236,3.718309855470026
D283 Med,54618771,1.215604089870786
OCI-AML-5,1566236,1.6568370935553676
KMS-11,3854666,0.0996052694394281
COLO 800,9926054,1.9844303127825855
SF268,44241473,5.7201557668181895
IGR-1,4705,3.3965723543512647
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073
MOLT-16,10322450,3.2788415570807
NCI-H1915,9926054,1.8603630934731663
NCI-H929,9868037,2.724281418576466
BT 159,12003241,-1.7931625060077818
SCC-25,2746,2.621805832840377
Pfeiffer,136227924,1.7936916860357504
NCI-H209,11404337,0.938734555574242
BT 232,71751553,4.301675554416272
KYSE-150,11152667,1.0905080839242076
OCI-M1,2746,2.0288899582402165
NCO2,11152667,-1.862283935437442
697,9915743,-1.2877511169277274
EFO-21,11494412,3.1959267599217047
KP-N-SI9s,100016,6.171993249574907
OVCAR-4,49836020,-3.3998329005368833
SNU-16,10296883,1.9530696041557936
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
BT-474,9926054,2.0382536553726207
MM1.S,9911463,3.396498541948332
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
BT-16,71751553,4.230204942204508
LK-2,11494412,1.1417367850098237
SF539,4378219,1.830086902499326
HCC1143,11404337,-0.7051632820466462
VMRC-RCW,11404337,-0.70484816503425
NCI-H2170,11494412,1.250336821961045
SNU-1033,selumetinib-vorinostat (8-1 mol-mol),2.0856562296145187
Hs 888.T,100016,7.920695284419831
SK-MES-1,71751553,4.12788922702423
GA-10,136227924,1.4612725021832749
BT 228,11152667,1.5826836079285618
SK-MES-1,3854666,1.8711540273812308
NCI-H2452,136227331,4.192235498443636
COV644,selumetinib-GDC-0941 (4-1 mol-mol),0.580143851486064
647V,9884685,0.1816455497455283
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
MPP 89,9935249,3.288216820516572
A2780,10296883,3.5268945611299927
JVM-2,3465537,3.696111807069497
P12-Ichikawa,100016,6.391056060940552
U266B1,71751553,4.293573976078506
UM-UC-3,9935249,4.580111467121929
HCC1143,12003241,-0.0421467164139253
MDA-MB-468,168313307,4.437587557581034
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
RPMI-8226,11404337,-0.8965265864586413
COV644,selumetinib-vorinostat (8-1 mol-mol),1.2714620480734766
Panc 05.04,12003241,-1.2094626899686458
Panc 03.27,100016,6.730276002902577
Hs 688(A).T,4378219,1.869537278848524
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
CAL-78,2746,3.5103539544732745
KMS-27,9884685,-0.4174100202309531
SNU-81,11152667,-1.3658791794225291
A2780,9915743,1.3754925129164983
Daudi,136227331,3.813653547789358
OVK18,54618771,0.5319615878172647
BT 216,9868037,4.409348845364788
Caki-2,135984461,3.6867665044524025
PC-3,9935249,3.435899400354577
KMBC-2,2742550,4.819576117265504
YKG-1,11152667,0.85211892000732
Raji,136227924,2.5188827267380116
SNU-478,9911463,3.926310960218254
NCI-H1734,54618771,0.2470181202194854
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
SIG-M5,4378219,1.9811797818384451
VCaP,49836020,3.7297112197262337
HCC827,100016,4.431453048958875
NCI-H2029,54618771,1.4933886789628814
Panc 08.13,2746,3.457516363442077
EBC-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.174699743525061
DMS 53,6918638,-0.2331882953997054
KM12,9911463,3.8225148805957465
BT 112,6918638,0.7933014260092189
BT 145,11404337,-1.106330552835472
WM793,3854666,3.254480086465336
B-CPAP,12003241,-1.7111954205398938
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
KMS-12-BM,54618771,-0.8802136937205215
ECC10,4378219,1.4134664456324193
EFO-27,135659046,3.7618075322397297
KNS-42,9911463,4.405771521475071
COV644,24771867,4.713908780717303
Becker,11152667,-0.0638370344727879
MKN1,11152667,-0.4741120582989742
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
NCI-H2023,3854666,3.016095382213318
MEC-1,6918638,-1.2393643982661684
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
U-937,2746,2.8216172923240825
KATO III,2746,3.141354246007229
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
PC-3,135421197,2.1784840639419154
Mel Ho,9868037,3.9124116875783654
SNU-503,100016,6.601678520618542
HT-1197,10296883,4.022509724629416
SNU-668,135421197,2.8470371844107274
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
K029AX,3854666,2.8456781664653845
YAPC,54618771,0.5686030675412354
HCC1428,11494412,5.984030575865442
BxPC-3,135421197,1.4419000032460958
SK-MM-2,136227924,3.42367167276636
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483
KMRC-2,4705,3.2105980144700004
KNS-62,24771867,4.844988107236873
TUHR14TKB,1566236,3.406104899548504
NU-DHL-1,65628,2.3268847474457317
OCI-Ly10,49836020,3.5902164250425503
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
NCI-H716,1566236,2.5544710796905044
BT 228,selumetinib-vorinostat (8-1 mol-mol),3.923422561678695
KYSE-410,54618305,4.463720756901811
BT 159,10296883,4.294831220705457
SK-N-DZ,11494412,-0.9568858878968056
HT-144,49836020,4.351286347642034
NCI-H1105,1566236,0.7862780744513477
NALM-6,selumetinib-vorinostat (8-1 mol-mol),1.444675581802376
BICR 31,49836020,4.313223650735915
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
TCC-Pan2,135984461,4.348420574958303
J82,11152667,-0.0912735424219637
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
GMS-10,9926054,1.955397909013321
OVK18,136227924,2.593591625928113
COLO 678,11152667,1.0419437000778482
HSC-3,9911463,3.6821530137729983
KMRC-3,65628,6.285670036063726
EFM-192A,136227924,3.313769329286525
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
JURL-MK1,selumetinib-GDC-0941 (4-1 mol-mol),-1.4981298966453434
SUP-HD1,65628,3.5504679742815792
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
KMRC-2,11404337,1.481375710238033
TUHR14TKB,135421197,2.206090635498825
BT 159,136227924,3.541986211057949
SNU-738,9911463,3.7270128558697664
NCI-H520,9915743,1.4167224147327635
NCI-H1623,11152667,-0.7587975819891684
U266B1,135984461,4.925134147369508
OV56,6918638,2.271106971688871
SK-N-SH,selumetinib-vorinostat (8-1 mol-mol),2.237833901076091
SUP-T1,9935249,2.0968505860065156
NCI-H1623,3854666,1.505587442259218
DMS 454,136227331,4.3527556098556275
HT,135421197,1.8590236680580152
HT115,9926054,3.740593425047279
SNU-738,54639665,4.332725290413926
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
ST486,54618771,-1.8169523642360077
SUP-B15,9884685,2.0642771767960726
RPMI-6666,1566236,1.297677417550993
SW1271,136227924,3.2074421772411372
Pfeiffer,76446078,5.826400257253173
SNU-899,44494148,4.523585952097628
Kelly,9868037,2.3025407636761197
KMM-1,11404337,0.5617812148360622
DB,2746,2.552003566153149
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
WM266-4,44241473,4.2631163978898154
OE33,100016,6.493432597771833
CAL-78,9935249,4.073656052732806
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
HOS,9926054,1.8874056753100945
HCC1143,9935249,3.8757786370374303
NCI-H1105,4378219,1.8462979779877584
NCI-H2196,6918638,0.6945006285388182
HEC-1-A,JQ-1-carboplatin (1-1 mol-mol),2.5106263332941308
WM88,1566236,1.820047619843189
Panc 10.05,9868037,3.845487816364076
LOX-IMVI,73707386,2.553135353706567
BICR 22,71751553,4.276876209585518
NCI-H1693,135421197,1.2995160865472135
GCT,49836020,-4.509787849566978
NCI-H1568,135421197,1.29303587511011
GCT,3854666,0.8803972511425264
NCI-H226,selumetinib-GDC-0941 (4-1 mol-mol),3.612309653965627
NCI-H292,9926054,1.8794077191249725
CL-34,24771867,-2.6715455127481342
NCI-H1975,9911463,3.169797897462341
SNU-761,54618771,-1.251470969575028
NCI-H2452,12003241,-1.7557808561862691
EJM,650361,3.796410138993618
HDQ-P1,136227924,3.063540067223108
NCI-H2228,11404337,1.3876441913514168
Hs 940.T,71751553,4.30632511382116
Hs 852.T,3854666,1.6640156687386156
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485
IGR-1,12003241,0.2975109917194724
MDA-MB-435S,100016,6.42664314163943
KMS-20,135398744,7.132407790781497
COR-L51,JQ-1-carboplatin (1-1 mol-mol),0.8526356625711052
OCI-M1,135659046,3.73314659306938
KE-39,54618771,0.8543301924142261
SW1710,2742550,4.744380514553192
MG-63,9911463,4.367195765244299
NCI-H2009,24771867,-1.6305331500245923
OVK18,9915743,2.5814540538306012
Namalwa,65628,3.512710693266535
LS1034,54618771,0.9023023463820332
BT 172,135421197,1.393069790953409
SNU-423,4705,3.684586446624816
SNU-423,9911463,4.2882741176819446
JHH-6,9926054,3.460826847853425
RERF-LC-A1,65628,4.427259211867234
SW948,4378219,2.7444419460246716
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
NOMO-1,10296883,3.647443685498321
Hs 934.T,9868037,4.303687473486903
SNU-719,11152667,2.1367048146797294
JHUEM-7,54618771,2.242796216513649
SNU-466,12003241,-1.792822949683991
AsPC-1,11404337,0.3809720735493328
CAL-120,54618771,-0.541329282057163
SK-N-AS,3465537,3.1460094304770387
KMRC-2,10296883,4.145802538683136
SHP-77,3854666,0.6540211692983887
VMRC-LCD,100016,6.5149453048399515
BV-173,11152667,-2.8644264072030623
DB,11494412,-1.392713123619272
HuG1-N,1566236,2.07821046362843
ECC12,54618771,2.554935234255265
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
Karpas-620,4705,3.7367070326716982
SNU-387,135421197,2.3985099297623815
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403
NCI-H2030,135984461,5.0269440888877135
SUP-M2,49836020,-3.0340639982218898
COV434,selumetinib-vorinostat (8-1 mol-mol),1.8163098139826408
KMS-26,100016,3.884140356330727
SUP-B15,3854666,0.959316947307526
UO-31,44241473,4.484556076599968
EC-GI-10,6918638,0.7617636190742709
MDA-MB-468,11404337,1.423282205986455
MDA-MB-157,11404337,0.0143481506183785
MDA-MB-361,136227924,3.324084435927791
NCI-H2087,2746,2.6080456190013632
Hs 852.T,11404337,0.7011610270367453
TE-1,2746,2.3035924875170997
OC 314,4705,3.18423368229223
LXF 289,10296883,3.609856485747645
EHEB,3854666,0.7564347377790305
WM983B,12003241,-2.729936813041864
MKN1,selumetinib-vorinostat (8-1 mol-mol),3.560075936672011
Panc 10.05,65628,4.812367305175919
AU565,10296883,3.47614106437246
NCI-H226,4378219,4.066238522648304
TE-4,10296883,4.159951408110945
Panc 03.27,2742550,3.7369111271801234
A101D,11152667,0.6218248204283258
RL,10296883,3.466522300927401
BICR 16,9926054,1.5790536370066437
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
ST486,54618305,3.679577166214843
NCI-H1944,54618771,0.5378192056232364
FaDu,136227924,3.658135500280057
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
LOU-NH91,136227331,3.865245001267085
Hs 766T,JQ-1-carboplatin (1-1 mol-mol),-0.2736789980960341
SNU-1077,11404337,-0.4720370259421129
SNU-387,11404337,1.3618084362793803
Lu-99,9868037,3.2143966099709655
SW1353,9926054,2.273911586274605
NCI-H1184,11152667,-1.0488387695368542
NCI-H1694,JQ-1-carboplatin (1-1 mol-mol),-0.7317263485639335
JHH-2,4378219,1.9275106836639475
BHY,9926054,1.5277493877995152
WSU-DLCL2,3854666,0.519326937779907
CML-T1,3854666,0.73725489161191
Hs 746.T,54618771,0.5763857654673513
HD-MY-Z,2742550,3.521539986674307
BV-173,10296883,3.0067160543994045
YAPC,12003241,-0.7644111057992425
HuH-28,12003241,-1.746609784805712
BT 444,11152667,1.5346821618799644
OAW42,9884685,1.2574804791084064
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
SNU-61,10296883,3.559313583941647
SNU-466,9935249,3.051741222660739
A-375,12003241,-1.2978704743837648
NCI-H322,4705,1.051415284541447
MPP 89,9915743,2.161327298254378
NCI-H1755,3854666,2.659558570060276
EHEB,136227924,2.586993854279513
HPAF-II,54618771,2.4967516753926216
SJSA-1,11404337,-1.5700525200999282
Lu-65,24771867,3.5458119260189194
JMSU-1,9911463,3.337278506693628
NCI-H1568,24771867,2.7621066837370156
T84,9911463,2.866030218571942
IMR-32,135421197,0.1202799185207932
NCI-H1581,73707386,3.3103978289770692
OVCAR-5,selumetinib-vorinostat (8-1 mol-mol),0.2015701638150661
LN-229,9911463,4.132714937024961
EFE-184,54618305,4.669753195753842
JIMT-1,3854666,1.22286835521865
HEC-251,12003241,0.0135079560064688
MM1.S,9884685,-0.9027319630033926
HCC2279,3854666,0.8378749167236459
KMH-2,54618771,-0.6611868525273566
DMS 273,100016,5.677769516399485
MPP 89,4705,3.4869840360057855
KNS-81,selumetinib-vorinostat (8-1 mol-mol),3.903810781537335
Raji,10296883,3.544688579045074
SNU-668,selumetinib-vorinostat (8-1 mol-mol),2.4332575717888303
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
SNU-719,JQ-1-carboplatin (1-1 mol-mol),0.748518031379031
Mel JuSo,9915743,2.4580846898357547
COLO 792,selumetinib-vorinostat (8-1 mol-mol),-0.2959640740097565
HCC1419,11404337,0.8171144747312442
KYSE-410,136227924,3.831866760516254
RPMI-6666,JQ-1-carboplatin (1-1 mol-mol),0.5557739670518063
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
Lu-99,12003241,-1.7463019078510122
UACC-257,11404337,0.2193965048118893
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
KMS-21-BM,24771867,-3.5658839764452623
RVH-421,2746,3.1689695044320056
NCI-H1299,54618305,4.3112203505981554
IGROV-1,9935249,3.330117761231163
DoHH2,9915743,0.0778019212938174
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
NCI-H1755,135421197,1.7196206530846876
Panc 08.13,11404337,-0.6282112311194213
OC 314,10322450,5.7270020231574446
SCC-25,11152667,-0.6154723920828342
HuP-T3,12003241,-0.2833744856936582
JMSU-1,136227924,3.0914793862161747
NB4,11404337,-1.1437955432104374
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
8505C,54618771,0.8247832120162748
ChaGo-K-1,11494412,-1.211362160076409
ST486,11494412,-0.4970972218954756
HCC366,9868037,6.006558205006566
BT 286,JQ-1-carboplatin (1-1 mol-mol),3.0626602949719226
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
MFE-319,9926054,1.8492827713698956
YKG-1,4378219,2.059610902750737
DU4475,11404337,-2.480961012408467
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234
NCI-H1341,9926054,1.7553356281022332
A-204,136227924,2.1384474587970113
A3/Kawakami,3465537,1.3050221927736254
GI-1,9884685,-0.1673991964560569
Capan-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.340534390124913
G-402,selumetinib-vorinostat (8-1 mol-mol),3.748451645687271
NCI-H2196,3854666,0.3982979522037077
ME-1 [Human leukemia],44487872,4.314288172726458
COLO 668,JQ-1-carboplatin (1-1 mol-mol),3.106273678335465
SIG-M5,135421197,1.947558909075972
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
Calu-6,135984461,4.796785128617679
8-MG-BA,11494412,3.720947721009423
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
RCH-ACV,1566236,1.4143282835015505
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
KMS-18,9926054,1.804034237605838
HuH-1,9911463,4.24697261954459
COR-L88,10322450,4.2439806030503915
SHP-77,9911463,3.880568712678563
Reh,10296883,2.990424165005631
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
KYM-1,JQ-1-carboplatin (1-1 mol-mol),-0.1526503740959246
KYSE-520,11152667,-0.2788738018769383
BT 187,9926054,3.0457893099703197
BT-20,10296883,4.2664147255542
Mono-Mac-1,9926054,3.1061890381784187
MKN74,11152667,-0.1995571526819112
HMC-1-8,9935249,3.5115160925085047
HEC-1-A,selumetinib-GDC-0941 (4-1 mol-mol),0.8454811422727944
CAL-78,24779724,4.391845429611093
GOS-3,100016,7.242262816552233
WM1799,9911463,3.918930617108345
NCI-H1755,24771867,2.3151605974345455
PF-382,24771867,-1.6533655868224757
KMS-34,10322450,2.8971491774933553
BxPC-3,9915743,0.4274244099837221
AGS,11152667,0.9910903722220584
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
WM115,100016,7.477930972064711
CMK,71751553,4.313223146712625
CHP-212,11152667,-1.2052121008957308
HCC-56,135421197,2.032560895215065
M-07e,49836020,-3.7990494796960337
GMS-10,11152667,0.1694535094272809
SNU-1214,135421197,1.3172671598461234
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
SNU-16,3465537,1.2882089943863808
HuH-6,2742550,3.1145719555139126
HEC-108,3854666,0.9548518440486092
VMRC-RCZ,2742550,4.506974409997668
ECC10,4705,2.6842412149864012
DBTRG-05MG,3854666,3.12566617937735
RL95-2,9935249,2.412741265710608
BT-16,9926054,1.298876500503981
KYO-1,selumetinib-vorinostat (8-1 mol-mol),2.230088152579139
Hs 294T,6918638,1.5500466074402643
COR-L95,54618305,4.5292428127427575
DBTRG-05MG,1566236,3.403448822293681
HEL 92.1.7,11494412,0.9504313755002392
RCC10RGB,2746,4.042085650474663
EJM,9911463,3.809334952263978
KP-2,selumetinib-vorinostat (8-1 mol-mol),0.7110863342407049
Rh41,135984461,3.8957403720163177
Rh18,24771867,2.064683552483523
JMSU-1,135421197,1.367458661118936
RPMI-6666,9911463,2.703428779423556
CAMA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.627092897381015
NCI-H524,JQ-1-carboplatin (1-1 mol-mol),1.4939916755553018
KMS-20,49836020,5.970121389426133
BT 248,9911463,2.7908107916357436
BT 428,135421197,1.0281432833092603
OS-RC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8729257102095325
SW579,54618305,4.4190036596404925
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
T24,12003241,-0.6434481559725229
PSN1,selumetinib-vorinostat (8-1 mol-mol),2.2163429397624133
NCI-H660,6918638,-0.1001418926217168
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
SNU-175,100016,4.815284438481943
Panc 08.13,11152667,-0.3273337674105917
Fu97,54618771,-4.808914794700833
COR-L51,9935249,1.489900132842433
OV-90,44241473,4.729192324527891
IMR-32,9884685,-1.1306444874275756
Caki-1,2746,3.5868220629550858
RERF-LC-MS,11152667,0.0782441689403026
GA-10,9884685,-2.5713880970623397
JHUEM-7,6918638,0.5834631364682521
OCI-AML-3,54618771,-1.4994430738546511
NCI-H1694,24771867,-1.2277818228174942
MDA-MB-453,136227924,2.410345496671846
HCC1195,136227924,3.859466477996048
Ri-1,100016,4.838113149785687
8305C,24771867,3.743655105127469
NUGC-3,65628,4.4498634773511725
SUP-HD1,9884685,0.1146842786809414
COLO 320,54618771,1.0088130808392026
MHH-CALL-4,12003241,-1.7117307202040182
PF-382,11404337,-1.5613133934389778
DBTRG-05MG,9911463,4.332332359679133
HCC2935,4705,1.0369145434655835
BT 428,10322450,4.171296655818114
TYK-nu,11404337,-1.0316748871481556
T98G,6918638,1.4380012949673455
SNU-1,selumetinib-vorinostat (8-1 mol-mol),2.376035951172743
Li-7,3854666,1.2438113999786788
BFTC-909,9915743,2.0959000942543025
BT 416,135421197,2.461654603646364
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
Calu-6,11404337,-0.8915888703545986
LUDLU-1,2742550,2.041048832535319
PaTu 8988t,3854666,2.839522644305469
NCI-H1694,11404337,-1.0250746048431445
TUHR4TKB,2742550,6.429098286465402
SK-MES-1,9884685,-0.7643025392616056
SCC-4,54618771,3.088112117698249
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
HCT 116,11404337,-1.072028422937356
NCI-H929,12003241,-1.2414676879861424
CAL-27,54618771,1.1214145254285035
OCI-Ly10,44487872,5.449648812232099
TOV-112D,6918638,-0.2708686651634265
SW982,135421197,2.997806489210206
MEC-1,2746,2.441084907474043
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
A-253,135421197,1.6531350819497892
BICR 31,6918638,1.4401869695378149
NCI-H2122,selumetinib-vorinostat (8-1 mol-mol),2.447368686339531
MDA-MB-361,9911463,4.323497130466389
U2OS,12003241,-1.2814871357228934
MOLT-3,12003241,0.5652275410160802
ACC-MESO-1,24771867,3.511510808680287
KMS-34,9915743,0.841267495899617
KP-N-SI9s,9935249,3.2907228390265084
BT 320,71751553,4.331550413851084
Hs 852.T,100016,3.86747930561629
KCL-22,JQ-1-carboplatin (1-1 mol-mol),0.9961294088187655
JeKo-1,54639665,4.459417646835938
HuG1-N,10322450,2.6791795001351355
F-36P,49836020,5.768901368593018
T3M-10,selumetinib-vorinostat (8-1 mol-mol),1.7080840266936326
ES-2,11404337,1.4427511575724656
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
DMS 273,4378219,3.0463884183789336
SNU-182,2742550,3.101242383691764
NUGC-3,54618305,4.228237436999806
GCT,11404337,-0.3437943087587521
697,11152667,-2.390714900309964
A-204,49836020,-1.292663609986573
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276
LS180,11152667,-1.0678137233062412
ZR-75-30,4378219,2.3774532546634877
22Rv1,9915743,0.4549229080465418
MDA-MB-453,54618305,5.448966988850886
NCI-H1694,2746,1.1698970904386303
SaOS-2,100016,6.565789067704999
SW1088,11152667,-1.4774805215910087
HL-60,11404337,-0.9575342155378792
HOP-62,71751553,4.571888658933869
SW620,1566236,2.632666707678549
MDA-MB-468,54618771,2.476122879099443
Hs 729.T,11494412,2.5231914609190667
NCI-H1563,selumetinib-GDC-0941 (4-1 mol-mol),0.8971079477843085
PE/CA-PJ15,71751553,4.310591125974167
ALL-SIL,54618771,-0.3818526805852408
HeLa,100016,5.8653655502295
BT-20,9884685,0.8317755642556006
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
NCI-H358,44241473,5.313859789947056
JHH-2,4705,4.1476073277063445
BxPC-3,24771867,1.9124988819938955
BT 232,12003241,0.7689860927775146
JHH-2,10296883,4.160944892429831
MOTN-1,136227924,2.565430053126423
NCI-H2110,2742550,3.917163865497912
RS4;11,54618305,4.215230625357053
Li-7,selumetinib-vorinostat (8-1 mol-mol),2.389251395528668
Calu-3,9935249,3.4211545663410585
SNU-182,3854666,0.8744500130786221
FTC-238,selumetinib-GDC-0941 (4-1 mol-mol),2.3347122521245396
SU-DHL-10,24771867,0.6570286816848907
Tm87-16,2742550,4.403843434069264
NCI-H838,11152667,-0.3515468004130501
BT 145,10296883,3.987169762001794
Karpas-620,JQ-1-carboplatin (1-1 mol-mol),4.330604154257919
SEM,135659046,3.5193041881341087
ESS-1,10296883,4.371449070908232
JL-1,6918638,1.5598435396772805
CAL-62,3854666,0.7777912107790768
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
Caov-3,24771867,-2.69525002962801
C2BBe1,12003241,-0.6014753337621667
GSS,10322450,2.8723971217143824
SNU-407,3854666,1.54781446028366
BT 422,9911463,3.7605478097150704
COLO 829,selumetinib-GDC-0941 (4-1 mol-mol),-1.0343545456738177
TE-11,11404337,-0.8497822409936865
U-BLC1,11404337,-1.495782153452068
EoL-1,100016,3.3783759894754795
BT 145,9926054,1.693307076625488
SNU-387,9915743,2.531778656004573
BHT-101,54618771,-0.9032414416493152
COLO 668,136227924,2.7222662640570356
HuNS1,6918638,-1.0677458393848085
SNU-840,135421197,1.1283252272940862
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
HCC827,selumetinib-GDC-0941 (4-1 mol-mol),0.5704009597174646
RPMI-8226,135398744,6.232374281438443
NCI-H2110,136227924,4.625762146403413
RERF-LC-Ad2,71751553,4.725836068423468
8505C,135984461,1.800698479354495
CAL-120,11152667,0.6693554019859562
PE/CA-PJ49,selumetinib-vorinostat (8-1 mol-mol),1.4585612568832638
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
SW1463,11152667,-0.1903484351781526
Hs 895.T,135659046,5.409831657927163
KP-N-SI9s,135398744,6.4391278360731246
CCF-STTG1,9911463,4.668972921835481
JHH-2,2746,3.041008676294123
Detroit 562,JQ-1-carboplatin (1-1 mol-mol),0.26349976511481
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
KMRC-1,11404337,1.3121470144090095
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
BT 248,24779724,5.957496049021181
TE-14,135984461,4.3356196573929
SCaBER,11404337,0.8251582568604987
COLO 678,11404337,1.0934047446888793
Panc 04.03,54618771,1.7180394725494992
A2058,11404337,-0.7992092997258325
RCC10RGB,71751553,5.18764953581067
Hep-G2,54618771,-1.2901934533941846
AM-38,9926054,1.7644212109272557
DLD-1,24771867,2.7180274798431947
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
KP-N-YN,650361,3.8016345293446743
BICR 56,136227924,3.153782585129781
LUDLU-1,136227924,3.2639698653649254
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
EoL-1,10296883,0.2540444549811657
SK-N-AS,9911463,3.98556434214228
WM266-4,24771867,4.1533413715441085
OAW28,9915743,2.8675584787684456
Kasumi-1,10296883,1.6176834941349487
BL-70,9884685,-1.719750861009791
NCI-H211,9911463,2.7267014601738575
KHM-1B,9915743,0.5787442773030028
SK-N-AS,12003241,-1.4595382352216486
TC-71,9926054,1.5758673536433587
HGC-27,2742550,2.8025291770000846
ChaGo-K-1,2742550,3.263905661793297
DAN-G,71751553,4.949444751940985
VMRC-LCD,76446078,4.226793178448001
HH [Human lymphoma],100016,3.957825935624259
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
MOLT-16,9911463,3.124866313552043
L-428,65628,4.3161887010588655
RT-4,135421197,2.4643711937197756
RKO,12003241,-0.2410566552434749
BT 164,136227924,2.714674644422482
SCC-9,9935249,4.690276947265519
Namalwa,135421197,0.8963594643304925
NCI-H209,54618771,0.4504113944457773
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
HCC44,3854666,0.5435532196199894
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
Caki-2,136227924,3.8399348879900854
NCI-N87,76446078,4.157863043796239
LNCaP clone FGC,44241473,4.6222925565590085
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
SNU-423,2742550,3.778188563180187
A-204,9884685,-1.0926459148305512
SK-N-SH,11152667,0.0675911998351618
RS4;11,10322450,3.4392008344478895
A4/Fukuda,65628,3.8428022223998366
KLE,73707386,3.2783445744557307
ST486,9915743,0.8352161269515779
Ci-1,54618305,4.280250718208194
HCC38,54618771,2.492060866479401
OVISE,3854666,4.260793298508907
A-549,9911463,3.875766071211208
SNU-C2A,11404337,1.3290101789179258
BICR 56,9884685,-0.7491894375183117
Caki-2,12003241,-1.799336945217181
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
SW620,54618305,4.6897742902806625
TE 441.T,9884685,0.7848536864337075
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
RS4;11,3854666,-0.0769207651889505
WM88,12003241,-2.725037582616198
NCI-H2087,136227924,2.807670387816286
HCC2935,selumetinib-vorinostat (8-1 mol-mol),2.9225347430042503
NH-6,3854666,-0.2101261717672276
Daudi,54618305,3.9105424608095847
OE33,54618305,4.272506927413016
TE-1,65628,4.452520498092532
KE-37,12003241,-1.2024354482149269
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
COR-L279,11404337,-2.7299136771765102
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
SYO-1,12003241,-0.4468506697584958
TUHR10TKB,9926054,2.161946529406516
Jurkat,54618771,-0.5483098658584711
TE 441.T,6918638,0.7814615450050921
SK-LU-1,65628,4.370272148908934
AsPC-1,1566236,2.844580785967763
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
NCI-H1299,73707386,3.9485300681626625
NCI-H322,135659046,3.4659012632221695
MSTO-211H,24771867,-1.256499005348058
Panc 10.05,135421197,2.5618075811816277
SIG-M5,6918638,-0.9320116161211188
EN,6918638,1.0700608344727125
MHH-NB-11,selumetinib-GDC-0941 (4-1 mol-mol),0.4891965075201672
LS123,12003241,0.0406446748290718
SUP-T1,9926054,1.5313307080964844
NCI-H1435,9915743,-1.162246321840318
NCI-H2052,9926054,2.624833706657142
SNU-1079,9911463,2.811910172991152
KALS-1,73707386,3.625166654480883
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876
MDA-MB-468,6918638,1.4750739327280944
MG-63,9926054,3.1754047574180815
CML-T1,11152667,-2.6898641024331584
SK-ES-1,136227924,2.7143313352480143
BT 179,11404337,-0.0288044782393938
HGC-27,24779724,5.013063083172612
NCI-H1703,4705,3.628855745395659
Mino,135984461,1.4657661855370687
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484
BT 228,6918638,2.21176132394779
HCC2108,11404337,0.8287580393905775
SK-HEP-1,11494412,3.332434654266433
TTC-709,135421197,1.6212603414567397
OCI-M1,24771867,-0.1913251805688479
TE-10,11152667,-1.9561905553634344
B-CPAP,3854666,1.7042245826351512
SK-LMS-1,2746,4.054624823156548
SK-LU-1,49836020,-1.7403396635124715
CAL-120,136227924,2.519967645750226
HCC1588,49836020,4.436779912961811
8305C,3854666,0.2716677714836975
NCI-H1693,2746,3.264827301273958
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
SW1783,3854666,3.296513769962362
RT-112,11152667,0.0286911001185177
OC 314,JQ-1-carboplatin (1-1 mol-mol),-0.0943346801193366
KO52,2742550,3.525067743551677
WSU-DLCL2,JQ-1-carboplatin (1-1 mol-mol),-0.9568070052125086
KYSE-510,selumetinib-vorinostat (8-1 mol-mol),3.1641046161129376
COV434,9868037,3.5790100972586867
LN-229,selumetinib-GDC-0941 (4-1 mol-mol),1.343707265826647
VM-CUB-1,100016,6.234028822794693
UM-UC-1,65628,4.132094852649124
KYSE-30,11152667,0.7148136552213618
253J-BV,11152667,0.0104193756827245
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
MKN1,135984461,5.649993285948901
RPMI-8226,54639665,6.381219990706471
HuG1-N,JQ-1-carboplatin (1-1 mol-mol),3.9513233413995983
NCI-H2106,11152667,0.9326509304786484
RERF-LC-A1,9926054,2.5963235420247965
GaMG,10296883,3.750929990698749
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
MDA-MB-361,11152667,2.2451523747224114
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
HSC-3,9935249,4.975494741872852
OVCAR-5,71751553,4.553409828903415
Tm87-16,11494412,2.181680767540109
BT 224,54618305,4.648547319057684
COLO 699,12003241,-1.6460659518938752
HT,54618771,1.085769963879092
HSC-3,9926054,2.205728912393848
Rh30,9926054,2.2159405572329143
COR-L105,9926054,1.7310748902984938
LMSU,11494412,2.9419044574604554
TE-15,65628,4.191504747725539
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637
DMS 114,11494412,1.119929591096694
TE-9,9935249,3.618595502089871
HT-144,135984461,4.033555973965414
OPM-2,9926054,1.8132463747821628
HOS,71751553,4.86028944300483
Caov-3,65628,3.782061082694565
RERF-LC-A1,3854666,0.6720221481756725
DND-41,24779724,6.0388973137341155
KP-2,12003241,-1.0131753515014823
BxPC-3,12003241,-1.7282705692868598
42-MG-BA,9868037,4.648919905548912
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
ECC10,9911463,2.6804416943678917
MeWo,9926054,1.733945316459816
SYO-1,136227924,1.0009147925604558
RPMI-8402,136227924,2.2526718879349694
EC-GI-10,54618771,2.241833399474009
BT 444,12003241,-0.4351069615199688
TOV-21G,11404337,1.0752571237200843
JHOS-2,71751553,4.578795631337799
OCI-AML-3,54618305,-5.913694317144885
KE-39,54618305,4.948156947347383
JK-1,100016,6.141145240463154
Tm87-16,135421197,2.3570280625350057
LS123,135421197,1.188222873463802
2004,11494412,0.904379471293079
BT 179,selumetinib-GDC-0941 (4-1 mol-mol),2.518966795971957
IGR-39,9911463,4.324644624489837
HCC4006,2746,3.5545517621317586
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
T84,6918638,0.2315605213048026
SW948,12003241,-1.7903806895013192
HuH-6,135659046,4.749269186947959
Kelly,136227924,2.280835674454857
COLO 205,11152667,-0.0947339237953433
SK-MEL-24,135659046,3.636205861193986
MKN74,136227331,4.503917554589063
BT 440,71751553,6.044533690123534
SK-HEP-1,135421197,3.339831791709741
NCI-H1694,135659046,3.770401283474136
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
NCI-H526,11404337,-0.7565430519554945
YKG-1,3854666,1.2272418792594904
CCF-STTG1,136227924,3.7108552267199504
OCI-AML-2,136227331,6.356124272356354
NCI-H1975,4378219,1.734925090079542
SF539,4705,3.4621418210440296
HuP-T4,65628,4.410726137782856
UM-UC-3,9926054,2.187616038354346
Hs 839.T,9911463,4.51823555869199
EFO-27,136227331,4.702115323060179
NCI-H520,54618771,1.0653077757718592
DMS 114,9915743,2.4307544773783465
PANC-1,1566236,1.9012203857252232
SK-BR-3,12003241,-1.7425302549890949
OC 314,1566236,1.3422457845436446
BT 112,11494412,1.153463963183282
BFTC-909,136227924,2.3418993883842134
Kasumi-2,2746,1.0036072682129122
NCI-H1793,3465537,3.669471583064163
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
NCI-H1155,9911463,3.422756009393138
JL-1,12003241,-1.4801638152381718
GI-1,65628,5.000190036806228
KYSE-30,4705,4.659105063071051
ST486,9935249,0.774563781013363
SUP-HD1,10296883,3.4620113901204927
MOLP-2,2742550,4.186750588427236
BT-549,100016,6.139281322747303
LS180,136227924,2.415770069388299
NCI-H520,65628,4.358434508292663
NCI-H2196,24771867,4.181085401739465
TE 441.T,4378219,2.137715670751678
NCI-H747,6918638,-0.0618345557686977
OV-90,6918638,0.8312701026022422
TE-9,9911463,3.937916951140395
Li-7,2742550,3.2014821761988244
Fu97,11152667,-0.4985838721886936
CCF-STTG1,9926054,1.9394922490252933
WM88,9935249,1.762742740497851
KU-19-19,44241473,5.030815161961597
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
PSN1,12003241,-0.8593243794123258
COV362,135421197,3.17227725861234
22Rv1,135421197,1.1830541259797036
NCI-H2171,136227924,2.167829841056951
639V,136227924,2.8924456476929605
SNU-601,54618771,0.1352260287728254
NCI-H1869,4378219,1.9871738842268776
BL-41,135421197,4.0056146501146195
COLO 800,65628,4.173360308807501
MOLT-16,135659046,3.348397173147883
AsPC-1,9935249,3.639166614114404
OCI-Ly3,12003241,-1.5890645032871102
KMBC-2,4705,2.3520992205272395
Hs 746.T,2746,3.181547233706405
SiMa,11404337,-1.9067460076304843
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
CAL-33,9868037,3.732658877947959
SF295,49836020,5.953375339581455
HH [Human lymphoma],54618771,0.4732630552220457
IGROV-1,135984461,4.285945029851472
HCC38,135421197,1.646244202411993
NCI-H1694,3854666,0.1968088036326413
BT 239,2746,2.5478715326116252
OCI-AML-3,9935249,-0.327940311351079
OE21,54618771,-0.7908986466721764
SW1088,9911463,3.760639555360148
SH-4,11404337,0.8208570932203854
NCI-H747,11404337,-0.8176088644523414
BICR 18,136227924,3.2249717702756486
JHH-5,9911463,2.4505780103780563
CMK,1566236,1.14506767841984
RT-112,9926054,1.990332375678948
Hs 852.T,135984461,4.050524376376727
RCH-ACV,54618771,-1.6129004186602771
MHH-ES-1,12003241,-1.3957716684214538
SIG-M5,2742550,3.8599440330266432
Hs 944.T,2746,3.0349004525827583
OUMS-23,135421197,2.711287517534292
YH-13,135984461,4.0881390777757245
ACHN,11152667,-1.1903462602323582
BT 224,selumetinib-GDC-0941 (4-1 mol-mol),3.286346759744933
MFE-296,9868037,3.862165464380283
HSC-2,3854666,1.2957927638907802
KMS-18,12003241,-1.9143210957947092
JURL-MK1,JQ-1-carboplatin (1-1 mol-mol),0.6722664514176999
SNU-1076,100016,6.986031941643801
SW948,9911463,3.099005262739027
DB,135984461,3.626527837681527
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
JURL-MK1,24771867,-0.8719020110266327
HCC1500,6918638,0.5709126385335386
SNU-1077,44241473,4.729716696280308
TE-6,JQ-1-carboplatin (1-1 mol-mol),3.92725328436462
LS411N,3854666,3.592971008902542
KE-39,11404337,-0.6939323202576905
SW579,9884685,-0.5742606085453624
Kasumi-2,1566236,1.00471674851072
NCI-H1838,136227924,4.034071845409975
VMRC-RCZ,9911463,4.022790104530676
PE/CA-PJ15,9911463,4.11474968197752
SH-10-TC,6918638,1.0653110676660122
HEC-151,selumetinib-vorinostat (8-1 mol-mol),2.0752491992861537
HEC-6,9926054,1.6312694597986903
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
VMRC-RCZ,11404337,1.035796097984766
TCC-Pan2,73707386,4.107129131333133
SEM,11404337,-1.9668178292815095
DU145,54618771,3.337458824494602
LUDLU-1,9926054,1.8617120828735427
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
Mel Ho,JQ-1-carboplatin (1-1 mol-mol),1.3630461698598746
NCI-H2052,1566236,2.9608656869976424
AN3-CA,54618771,2.457771155909442
SK-MEL-3,10296883,3.7969706070865423
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
HCC2935,71751553,3.94725782245623
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
NCI-H1703,168313307,4.427466714189447
OVK18,selumetinib-GDC-0941 (4-1 mol-mol),1.2512103740452307
NCI-H292,136227924,3.1886204590132654
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
NUGC-4,54618771,0.2838784179231751
SNU-878,100016,5.516104284834857
BICR 18,9915743,1.102775446718332
COLO 205,100016,5.963233409359241
COLO 829,65628,4.575219924330789
HCC2935,1566236,1.7440828651971758
KMS-20,12003241,-1.6984779188581272
HCC1171,selumetinib-GDC-0941 (4-1 mol-mol),-0.4155569356036221
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
EFE-184,1566236,1.7539601989723244
T24,4705,3.5984863118556065
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
MOR/CPR,9868037,3.699217434711235
OC 314,24779724,5.172782111531357
NCI-H716,selumetinib-vorinostat (8-1 mol-mol),1.3365473974528714
RL95-2,9915743,-0.1806547920270402
MHH-ES-1,9935249,3.1458992380926616
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
FaDu,65628,3.984705708438991
SNU-1196,3854666,3.3332348606215376
U-BLC1,71751553,4.056877782229039
NCI-H2170,24771867,2.952345884142027
Calu-6,49836020,4.336137767537177
VMRC-RCZ,135659046,3.396736562465423
JVM-3,12003241,-2.550977818363364
MIA PaCa-2,11404337,-1.8965485173920145
Panc 08.13,JQ-1-carboplatin (1-1 mol-mol),-0.4380500096287519
PL-21,54618771,-1.4027013448904684
PSN1,2742550,4.257797435139967
HT-1197,135659046,3.3219776451446923
SNU-869,3465537,3.3177024921498575
SUIT-2,11404337,0.4217329969696077
OPM-2,2746,0.9082445461467812
RERF-LC-Ad1,54618771,3.6047591405088673
G-401,9911463,2.712760379614347
LMSU,3854666,2.6863801842781863
HH [Human lymphoma],49836020,3.7105679750249663
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
ME-1 [Human leukemia],9926054,1.888180715398536
PL-21,9926054,1.453737550570679
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
NCI-H1563,136227924,3.549094897051017
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
KYSE-180,9926054,1.7654325832877988
Hs 944.T,3854666,2.005774542899694
BT 239,9911463,2.823437133731174
SNB-75,9884685,-0.3913631936872798
CAL-12T,11152667,-2.142354911883577
JHOS-2,44241473,5.074985608199619
NCI-H2029,selumetinib-vorinostat (8-1 mol-mol),2.618172827263168
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673
RL,9926054,1.8760180722442283
U-118MG,4705,3.313386331825358
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
OCI-AML-2,11404337,-1.0891062211328033
D283 Med,24771867,-2.2450737191486883
BT 245,136227331,4.251360717375094
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
OS-RC-2,9935249,5.541714857295115
KYSE-140,44241473,4.686527931868355
NCI-H2009,3854666,0.912328636385412
KYSE-180,54618305,5.290256883782679
KP-N-SI9s,9915743,0.2181439527436794
JM-1,24771867,-4.48997165682624
EHEB,9915743,0.5785876427148751
MPP 89,9926054,1.8831902537321672
FTC-238,2746,3.1491636542411605
SU-DHL-10,9926054,1.7621581525939023
COLO 800,10296883,3.791440473177963
IM95,54618305,4.19219470828467
MOLT-16,9868037,1.8123148849264936
NCI-H747,54618305,5.694022652224505
NCI-H2009,9926054,2.181635437582939
SNU-1105,11152667,0.3397625589018838
SNU-119,54618305,4.480526935824261
BT 330,135659046,3.618868703955065
Peer,54618305,3.921049020117824
Peer,selumetinib-vorinostat (8-1 mol-mol),1.7833552737931586
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
MJ,11152667,-1.2121300476072767
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
Mel JuSo,9911463,4.248107858199516
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
TE-4,3854666,0.4344815210505751
COLO 678,2746,3.5639277993349254
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
MDST8,11152667,-1.6082048518025778
FTC-133,4378219,2.0024564120700874
Yamato-SS,2746,2.81924703396879
P3HR-1,136227924,2.9304577514896466
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
SNU-1033,9868037,4.1632978097237014
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
KYSE-30,selumetinib-vorinostat (8-1 mol-mol),0.7250547393630876
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
WT2-iPS,3854666,3.293035472406592
LP-1,11152667,-1.0091547787337771
GB-1,12003241,-0.733058723008687
Reh,12003241,0.0982187894519585
HuT 78,65628,5.4520261644264165
HT-1080,2742550,3.555929471473571
U-BLC1,11494412,1.2654808753679463
SUP-M2,4705,3.1560884673066765
NCI-H358,11404337,-0.2316736333548727
PC-3,11404337,1.6869548437610449
Hs 746.T,135659046,3.4161599287064925
NCI-H1650,9868037,3.338275078682257
Hs 578T,136227924,2.600789152961688
U266B1,11152667,-1.464396016979744
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
KALS-1,54618771,1.5195853448840246
HT-1080,selumetinib-GDC-0941 (4-1 mol-mol),1.1211488481166476
RD,12003241,-0.8502341845781216
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
WM115,9935249,2.3950107716018465
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
OV7,9926054,1.9278544510999935
HCC366,100016,6.086233690393214
SK-N-BE(2),9884685,-0.3835133513232162
BL-70,4378219,1.987736854074977
HSC-4,135659046,3.804399419736421
KE-97,135984461,3.5565388757369014
ST486,24771867,-2.404185708949454
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
NCI-H358,9911463,4.09003122269505
NCI-H520,12003241,-2.710304641181941
L-540,2746,2.2201981774781383
Caki-2,11152667,1.5240540155219149
Caki-1,44241473,5.460166003385121
KNS-60,49836020,-2.408070727278554
KMS-20,9868037,2.1280335543005293
KYSE-450,135421197,2.3081928088852774
Rh18,2742550,3.0219531402353565
KMRC-1,100016,6.458679548763862
A-204,11152667,-2.7777919264690505
SK-N-DZ,49836020,4.282357500475809
M-07e,9884685,-1.2688501325272783
JHH-1,9926054,1.7588254192067414
SNU-1033,3854666,3.138218307419996
GSS,136227924,2.0459518542117983
Li-7,135421197,2.8637872744317763
Daudi,12003241,-4.903510386182724
YD-15,54618305,4.368712757775692
SNU-1066,136227924,3.4679855479635644
SK-N-FI,24771867,0.1969766043414688
SNU-478,11404337,-0.3528320268789623
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
RL,2742550,3.1981240154048134
NCI-H2081,136227924,2.7498424735477913
SNU-5,135421197,2.4308176065595672
CFPAC-1,100016,6.545938487461667
Panc 02.03,6918638,1.5939476449475074
MHH-CALL-3,2746,2.3163095915542224
WM793,54618771,0.892561932009902
MOLP-2,3465537,2.360381635863911
SNU-761,selumetinib-vorinostat (8-1 mol-mol),0.7909854295550836
SK-UT-1,3854666,2.1786369520498283
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321
NCI-H2228,10296883,4.1270071752314275
SNU-423,11152667,0.7300251820386706
LOX-IMVI,9926054,1.7031980960413209
RS4;11,11152667,-1.893444270216278
CAL-51,9884685,-0.2528326244590672
CL-11,12003241,-0.9595086367475664
NCI-H1793,24771867,4.645722307240471
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
RPMI-8226,54618771,0.103524211569064
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
SNU-407,54618305,4.292854914169787
KG-1-C,4378219,1.9946711061325484
COLO 668,9926054,1.8652250146590224
SK-N-MC,3854666,0.4857062806503081
NMC-G1,3854666,4.917265347218566
SNU-738,24771867,2.826866643740335
NCI-H2023,100016,7.201065180404722
NCI-H526,9915743,2.0217278226524606
TOV-112D,2746,3.3421101516838445
NCI-H460,40482356,5.06381124686115
DV-90,11404337,-2.4511468256703908
KO52,selumetinib-vorinostat (8-1 mol-mol),-0.9100667251350252
MOLP-8,11152667,-1.9226575172330305
CA46,10296883,3.259152671675197
HCT 15,1566236,1.8792685821972948
TF-1,135421197,2.0817745254871216
MDST8,54618771,1.2096098448968695
MOR/CPR,135421197,2.970176340421023
BT 159,selumetinib-GDC-0941 (4-1 mol-mol),1.265249520396083
TC-71,10322450,2.6904194400167207
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
SNU-216,24771867,2.909916707277168
LoVo,135398744,6.330186357549225
MOLP-8,100016,7.090961588333011
KYSE-30,100016,6.190453384433256
COLO 201,11404337,-0.0610215360634596
RS4;11,136227924,1.742872720779967
KMS-28BM,9915743,0.6729564679567067
KP-N-YN,3854666,3.696443980357986
NCI-H1703,11494412,-0.6929236113536564
BT 482,135659046,5.385969156386867
K-562,24771867,1.7261535062160185
NCI-H2172,54618305,4.356498397814067
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
TT2609-C02,selumetinib-vorinostat (8-1 mol-mol),3.0555400293407313
NCI-H460,9926054,2.081701465030928
BT 139,1566236,2.5894214641501345
Kasumi-1,135421197,1.491198054618576
WM266-4,11494412,3.195977931192662
SK-N-BE(2),JQ-1-carboplatin (1-1 mol-mol),-0.9274219312218726
A-253,11152667,0.6040839569955214
OPM-2,6918638,-1.573449675489913
NCI-H2342,selumetinib-GDC-0941 (4-1 mol-mol),3.1490507666269307
UM-UC-3,3465537,2.695798094049334
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
NU-DUL-1,9868037,0.9018542361543456
BT 231,9911463,2.979244544193708
PaTu 8988t,11404337,-0.5897258437911538
SUIT-2,12003241,-0.3419407469483631
HEL 92.1.7,71751553,4.617723136603169
Reh,9915743,0.535170068043037
SBC-5,11152667,-0.3838978082878119
HuT 78,54618771,-0.2261201753145263
EBC-1,9884685,-0.5072112125161227
CHP-212,10322450,3.626434944218361
F-36P,10322450,3.2432615470800883
DMS 454,11404337,1.0460109741609804
BICR 22,9935249,5.2884064452137585
SNU-878,12003241,-0.6657900217683382
GDM-1,9915743,-0.2522404028033351
BT 482,4705,3.30831403068686
CAL-120,4378219,4.553686294190054
IMR-32,JQ-1-carboplatin (1-1 mol-mol),0.0356823782644729
23132/87,44241473,4.418945497953935
HPB-ALL,11404337,-2.5207664268075676
639V,12003241,3.941533367074586
NCI-H460,9911463,4.421747687015995
SYO-1,JQ-1-carboplatin (1-1 mol-mol),-0.7857384720647894
CMK,135984461,1.8069857121104629
A-673,4378219,1.9880690032317576
HuH-1,11494412,1.5429179145787622
CAL-51,9915743,1.1260994347217144
Peer,135398744,6.7016638444522325
KALS-1,9911463,4.316842396735623
NCI-H211,49836020,0.8643825091547783
Hs 888.Lu,selumetinib-vorinostat (8-1 mol-mol),3.0889826196747685
Detroit 562,11152667,-0.9771031381633576
Mino,3854666,0.1564706607141011
P3HR-1,9911463,4.040866432648006
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
SNU-761,11152667,0.2423844419785793
BT 440,11152667,0.0173379430865997
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
CHP-212,10296883,3.383005137854127
SUP-B15,12003241,-3.8836552178144848
KMRC-20,44241473,4.734926633770504
BT 179,54618305,4.626740556100955
SNB-75,4705,4.116486299784252
Capan-2,4705,4.948104259721338
U-251MG,11494412,3.5194531484174822
HCC38,1566236,1.6073129295205384
SNU-719,12003241,0.0299382028109862
SNU-761,24771867,3.999020995480087
MIA PaCa-2,100016,4.223400842588871
KMRC-1,11152667,-0.0604913513883814
Hs 688(A).T,9911463,4.549351986100886
UACC-62,12003241,-2.2941993438250865
SNU-668,12003241,-0.9113554646183494
SET-2,9915743,0.156310507538352
COLO 792,9911463,3.3724671090253793
SK-CO-1,12003241,-0.9578793579943758
RPMI-6666,selumetinib-GDC-0941 (4-1 mol-mol),0.4507229369642581
253J-BV,9911463,3.300090280409142
MKN7,10322450,4.432955441296817
NCI-H1299,11152667,0.5765175859368963
BT 422,11152667,1.7355049120029544
BT 172,9868037,4.137588031447499
647V,10296883,3.904352101938312
L-1236,9915743,1.4582710578381164
OV56,1566236,1.8628278563698883
NCI-H2405,selumetinib-vorinostat (8-1 mol-mol),0.4232908864831333
GP2d,10296883,2.4344246529088163
Hs 822.T,11494412,5.061407284482217
KMRC-2,1566236,2.2234157510538832
MFE-296,71751553,4.455327794268508
SK-UT-1,2746,4.836098417840603
CA46,9884685,-1.0270691788705264
697,2746,0.8778149651277364
HCC2935,9926054,1.9348902152341665
NH-6,11404337,-1.1373922103777243
NCI-H1563,9915743,0.028314904661926
JHOC-5,9935249,3.6862671571619225
BICR 6,49836020,4.408429630205201
ECC10,3854666,0.7424887644114392
RPMI-7951,54618771,0.8844591471525661
CHP-126,1566236,1.4388100369243024
COLO 829,1566236,3.7680524824386135
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
SNU-1,9926054,1.7218155896190992
MIA PaCa-2,54618305,4.257702417709433
MEC-1,10296883,3.7478105751485646
HT-144,selumetinib-GDC-0941 (4-1 mol-mol),0.3357004293629391
2004,65628,4.602327136017835
MOLM-6,136227924,2.6719988051227386
P3HR-1,135421197,1.4692220072432751
DV-90,11152667,-1.263843057681376
BT 416,10296883,4.010101282848487
AML-193,3465537,0.6863913104025677
HCC1954,selumetinib-vorinostat (8-1 mol-mol),2.207566293158473
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
SNU-182,100016,8.076902029611453
Daoy,11404337,-0.8590348859055235
NALM-6,65628,2.4464188338602355
MHH-CALL-3,73707386,1.7975631964986447
COV434,71751553,4.197696410536109
Mono-Mac-1,4705,2.1526940159262593
SF268,11494412,0.8419965889075506
KYSE-450,54618771,1.2705031609145587
SW948,11404337,1.0073661261070797
Karpas-620,136227331,4.429067996401553
SNU-182,selumetinib-vorinostat (8-1 mol-mol),1.2344831556208138
TUHR10TKB,54618771,-1.4225066809641267
COLO 800,selumetinib-vorinostat (8-1 mol-mol),-0.4443681516533044
SNU-449,9884685,0.40134732620175
AsPC-1,3854666,3.565227366628202
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
TM-31,3854666,2.1009694082153105
WM983B,9884685,2.1138858450656937
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
Capan-2,9884685,1.4728915431544811
NCI-H647,135984461,5.580010344943138
ESS-1,12003241,-1.211695248693708
SK-MEL-5,9926054,2.75949424585879
WSU-DLCL2,11404337,-1.1416325362941906
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398
SK-N-BE(2),3854666,0.893693804231817
BICR 31,11404337,-0.6318210319309021
KMRC-3,11494412,0.9425287375632188
BT 187,11152667,2.627435911702914
GSS,49836020,4.0402801556040036
OC 314,71751553,4.2935684369934
SNU-407,2746,2.5870056952714777
SK-N-MC,9926054,1.7404893912673354
A4/Fukuda,4705,2.104501352907832
U-937,135659046,3.9710319401622063
NCI-H661,2746,2.7828270451310786
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
CJM [Human melanoma],65628,3.795572451400352
BFTC-905,9935249,3.626324338446925
OVCAR-5,11404337,-1.1267721710555685
Pfeiffer,6918638,-1.780695741068461
JM-1,100016,5.094244415703564
YD-10B,100016,5.941622042216757
KMRC-1,11494412,2.978505743964039
A-549,3854666,3.2699518455850964
SNU-1196,12003241,-1.2616769402260497
NB4,100016,6.294523599868374
CAL-54,2746,3.3346441526791306
BT 232,9935249,2.6697754129604183
NCI-H1299,selumetinib-vorinostat (8-1 mol-mol),3.816207733314422
Reh,9935249,1.2522485980978375
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
KYSE-410,2742550,3.0781954877880797
Hs 822.T,4378219,1.5948079131002726
Mono-Mac-1,9915743,-1.5760754079944657
DB,136227924,2.1225886217744376
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
Karpas-620,76446078,3.908543900726376
NCI-H1581,54618305,4.300256508666718
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
Karpas-422,9915743,0.8862360651040179
NCI-H1703,9935249,1.5289979919056798
Kuramochi,9915743,0.8375201089369183
BT 248,9868037,3.916296675967623
NCI-H1355,12003241,-2.4294292569102436
JVM-2,9926054,1.9901106639385144
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
COV362,9915743,1.8157277713688496
SNU-1196,9926054,2.598124573780665
VMRC-LCD,135398744,6.4569642970049
HCC1954,135421197,1.006556252272656
OCI-AML-3,49836020,4.587745933093821
COLO 829,9935249,3.01817640679569
JHOS-2,136227924,2.6850771580880783
SCC-4,650361,3.7059662115412
DEL,selumetinib-GDC-0941 (4-1 mol-mol),2.6612594732504475
NCI-H1299,73707386,3.9485300681626625
NCI-H2141,2746,2.383841945459931
IGR-39,71751553,5.513684955203546
QGP-1,136227924,3.0535414774537424
MDA-MB-468,10296883,4.0590713051476115
Kuramochi,11152667,1.7895542205335806
SW1353,135421197,2.4746920364366813
BT 359,136227924,4.313964424354799
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
KMS-20,65628,3.828249966077918
MKN7,65628,4.295843593821497
IGR-1,6918638,-0.5793236649070632
MHH-CALL-3,9911463,4.211712369373876
NCI-H2081,2746,1.7876165118995768
COLO 800,4378219,1.987702491162245
SNU-503,selumetinib-GDC-0941 (4-1 mol-mol),1.4877260570474324
SK-MEL-24,9911463,3.297368561955771
CW-2,73707386,2.405296299062749
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
F-36P,9911463,3.056113876518826
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
BT 224,12003241,-0.3430722292852487
SUP-M2,4378219,4.1242889852881515
SW48,3465537,3.829258919586145
UACC-62,3854666,2.8561673070888034
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
G-402,11152667,-1.9802758600685508
WM983B,10296883,3.9280678477622857
DMS 53,2742550,2.93982953242082
OCI-AML-5,11404337,0.1912186748994763
JHH-2,54618771,-0.1274840314711515
P12-Ichikawa,136227924,2.6176590952299477
VMRC-RCZ,3854666,3.325804998432433
KYSE-510,135659046,4.68799289750423
COLO 678,selumetinib-vorinostat (8-1 mol-mol),0.9502383991002584
JM-1,3854666,0.4999957819555636
Rh18,9915743,1.1636262664119963
KP-3,135421197,0.5862918255078794
KMRC-2,136227924,3.1141635996197183
Mino,54618305,3.884266825894896
RVH-421,2742550,4.124489101542342
CGTH-W-1,selumetinib-GDC-0941 (4-1 mol-mol),1.204610504332706
YKG-1,9915743,1.478165176900873
BFTC-909,11404337,0.4468911705694049
MKN45,11404337,2.918608562534022
BT 422,136227331,4.344086098247262
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
Karpas-422,9884685,-1.8579964706591168
RT-4,selumetinib-vorinostat (8-1 mol-mol),2.4962461169474084
SNU-213,9926054,2.110529432598139
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
REC-1,136227924,3.1866861789415855
HCC1500,44241473,4.374636754710865
HEY A8,135421197,2.419965019315952
JHUEM-7,10296883,3.9492602271456065
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
NU-DHL-1,9926054,1.5745053582273782
BT 440,9935249,2.494987882874959
HMCB,11152667,-0.8228544828189237
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
5637,9926054,2.1895240062195396
HSC-3,11404337,-0.7786873247989411
Caov-3,73707386,3.637986514762385
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
MDA-MB-453,9868037,1.568237926564538
OE21,JQ-1-carboplatin (1-1 mol-mol),0.5069290847889931
GI-1,11152667,-1.419511602006618
NCC-StC-K140,6918638,1.6255556223865495
IGROV-1,9915743,-0.4757488934941289
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
MCAS,9911463,3.99734234256231
DAN-G,9935249,3.199039509516943
RD,JQ-1-carboplatin (1-1 mol-mol),1.5252268474537996
SNU-81,11404337,-1.7380856142345846
OCI-AML-5,4705,4.476386157060081
BT 330,4705,1.8638133419743137
JHUEM-2,65628,2.577248815747806
BT 328,135398744,6.520469371663204
COLO 668,1566236,2.0753956808057072
KALS-1,135984461,4.764345529991705
A2058,9935249,3.321967887008341
KMS-34,10296883,3.0941719737889515
CAL-54,JQ-1-carboplatin (1-1 mol-mol),-0.1626654882984976
HT-1197,JQ-1-carboplatin (1-1 mol-mol),3.4670046988259675
TE-10,9935249,3.642626385966905
MES-SA,54639665,-0.0179563616855297
COLO 699,65628,4.39005504290011
NCI-H2081,9935249,2.3780454134873263
HT-1080,9915743,2.579690358518253
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
DB,10322450,2.48234404234163
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
KYO-1,2746,2.1757976930185854
DAN-G,4705,3.464155926779532
42-MG-BA,3854666,2.0337567414641184
ES-2,9911463,4.341533806603841
OAW42,9911463,4.338639640842429
A-498,9926054,1.5026788619071982
L-540,24771867,-1.0038960018751442
DAN-G,9926054,1.747482520890968
Fu97,2746,1.9781372466422251
UACC-257,2746,2.6143707562443135
KPL-1,9911463,4.601591010161613
JVM-3,135421197,0.8439957558117435
COV362,65628,4.318237963578557
YD-15,136227924,2.6934840054154834
LUDLU-1,10296883,3.7997906540073623
KMRC-1,6918638,1.621172594092556
HGC-27,135398744,6.47323705988127
HDQ-P1,selumetinib-GDC-0941 (4-1 mol-mol),1.336429644847675
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
JHOM-1,1566236,3.808049799944417
SK-N-AS,11152667,-2.6826642832146126
Hs 888.Lu,11494412,3.655029348626413
KYO-1,9915743,0.2540895185471781
HEC-151,135659046,3.7740160846468
SW1990,9915743,2.956888864284862
HCC1195,54618305,4.470862582727534
A-375,9926054,2.393426871996004
TE-11,selumetinib-GDC-0941 (4-1 mol-mol),0.8389295990054343
SW1783,9926054,2.85460969526429
AMO1,11152667,-1.6304517231581788
SNU-398,135421197,1.394943523979563
NCI-H841,selumetinib-GDC-0941 (4-1 mol-mol),1.7546401329299928
SNU-685,10296883,4.374649581801884
NCI-H810,11494412,-1.110991109290378
KMS-12-BM,73707386,2.349774634710614
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
NCI-H23,9884685,-0.0842435854190503
U-87MG ATCC,9926054,2.857820648476152
769-P,9911463,4.323897233798415
HCC1438,135659046,3.8563158871978342
Panc 04.03,135659046,3.760242578723066
MKN74,9911463,3.772186916904206
MOLM-13,9915743,0.7456385275428815
VCaP,11404337,1.1855429552753238
CAL-27,136227924,2.2169431722835324
Kasumi-1,136227924,1.874085610777816
DB,4705,3.0475659193893296
MOTN-1,JQ-1-carboplatin (1-1 mol-mol),-0.1739413245124559
NCI-H522,9911463,3.273817127322074
HuP-T4,2742550,4.819776074763647
TM-31,1566236,1.750364202680973
SUP-B15,2746,1.2299523793541935
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
Ku812,9926054,1.5145588468111315
AN3-CA,11404337,1.5621280335523782
LOX-IMVI,9935249,3.870791681758961
Hs 578T,2746,2.072712678704015
8-MG-BA,136227924,3.3968176736472446
H-STS,11494412,-0.8730313423515421
NCI-H747,11152667,-0.5062893189459198
MKN1,9868037,3.4608837590202746
BT 498,9935249,2.416260478208693
HeLa,selumetinib-vorinostat (8-1 mol-mol),2.818630942725572
SNU-1041,54618771,3.2318145292931195
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153
LAMA-84,3465537,3.920493576455389
Reh,11152667,-1.6622100649738478
CAL-85-1,selumetinib-vorinostat (8-1 mol-mol),2.332419733999627
TYK-nu,135984461,4.470061724636727
BL-41,9911463,3.564176203754708
HEY A8,9911463,4.0239951836348595
SK-MEL-3,135421197,1.515093492040075
BL-70,3854666,0.0420244539233536
BT 216,10296883,4.1939688234140435
IST-Mes1,9935249,3.876611894197404
SW948,1566236,2.0550116218076235
NCI-H929,49836020,2.30560189930029
EB1,136227331,3.874508283981952
DMS 53,65628,4.630893368202044
EoL-1,24771867,-3.753621458977194
MKN74,9884685,2.0469611247981625
MDA-MB-157,10322450,5.067042624032479
SK-MEL-28,3854666,3.183656457854027
EC-GI-10,9915743,-1.6990033620090657
SET-2,9935249,0.876527985665801
697,54618771,-1.411266128730911
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
KLE,9915743,0.4681181116614699
L-363,24771867,2.9285273728601613
YD-10B,11152667,-0.8619602748650732
BT 112,2746,3.687274706255036
KMS-26,3854666,0.369015191618214
BT 164,12003241,-0.888203268787868
L-540,12003241,-2.1812715398766844
42-MG-BA,selumetinib-vorinostat (8-1 mol-mol),3.737674590470835
NCI-H146,11404337,-1.5914515878545687
Hs 746.T,9926054,1.836274642391939
WM115,9884685,-1.925323313513864
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
SH-10-TC,71751553,4.325355534508399
BFTC-909,3465537,1.8561429441463555
SNU-1033,12003241,-0.6294445516416565
DK-MG,10296883,4.218475231126156
PE/CA-PJ41 (clone D2),1566236,3.025698807379891
MeWo,9884685,0.7659797455120133
KNS-60,65628,4.405089731015004
SK-N-AS,4705,3.5227875242438103
KMH-2,JQ-1-carboplatin (1-1 mol-mol),1.5982474569998335
MOTN-1,selumetinib-vorinostat (8-1 mol-mol),2.375951826808806
MEC-1,9935249,1.043041648413363
SF295,3854666,4.284983950639361
Hs 888.T,selumetinib-vorinostat (8-1 mol-mol),3.55147943154118
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
HDLM-2,9868037,2.9118865294279943
OAW42,100016,6.607597097790758
NCI-H647,65628,4.301198610868103
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
NCI-H810,12003241,1.7210077749227564
Hs 729.T,49836020,4.229774154263897
NCI-H460,3854666,3.1385110084048065
HSC-3,49836020,-1.9036219787804456
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
LS411N,54618771,1.0517408544895162
COLO 684,11494412,0.8693565994616046
CAL-85-1,1566236,1.6913877607653736
A2780,11152667,-1.0749204847082217
YAPC,11404337,0.4717703732171429
JHUEM-1,54618305,4.244696493525863
WM983B,11404337,0.2030951424899205
BICR 6,71751553,4.217345085718347
LAMA-84,135421197,2.406961444006632
SK-HEP-1,2746,4.04921422913523
NCI-H522,100016,6.692385014202011
TT,11404337,-1.240692607165932
KYSE-70,9911463,3.4914249269651307
SK-MES-1,1566236,3.8724426148603706
UO-31,10296883,3.111389314005664
G-292 clone A141B1,4378219,2.1250658674267835
COR-L95,11152667,-1.0192155235937173
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
RPMI-8226,44241473,4.641771314897712
G-401,2742550,4.179048555325354
Ku812,11404337,-0.6784609129861706
8-MG-BA,71751553,5.547191078335952
RERF-LC-Ad1,3854666,3.753707482876592
TM-31,2746,3.629695868471985
HSC-2,2742550,4.322545974924492
HEC-151,12003241,-1.83751972949174
NCI-H2228,JQ-1-carboplatin (1-1 mol-mol),3.687353697289914
NCI-H441,9911463,4.313275778321212
SNU-601,100016,6.491707225104745
HT115,11404337,-1.1807464120641065
BT 498,136227924,4.389685115045935
Ci-1,11152667,-1.2211092701119557
DK-MG,136227924,2.9692161266572707
EFO-27,11494412,4.723849828867172
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
NCI-H1341,4705,2.9971891882923485
KMRC-20,136227924,3.298573049161518
TE-5,2746,3.896227334745537
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
UACC-62,4705,3.53935768937283
SU.86.86,2746,2.8574990792137234
OVCAR-5,54618771,0.5295799029989672
SW1271,1566236,1.9677070098040983
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
TYK-nu,100016,5.6630271022409495
SNU-46,12003241,-0.9132341104689335
A-172,9926054,1.9975239370798743
HeLa,11404337,0.8471506482049684
BICR 22,11404337,-1.5250786338229352
BICR 16,54618771,0.7733031407883998
MHH-CALL-4,9915743,0.0855702351312573
CAL-51,65628,4.560195683913681
VMRC-LCD,54618305,4.210523394539639
SK-HEP-1,9915743,2.4580731883892293
PaTu 8988s,10296883,3.673245902839484
WM1799,1566236,1.692158319345263
EPLC-272H,9926054,1.8633723849420136
LCLC-103H,136227924,3.302464114309801
HSC-2,24771867,1.979935720904249
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
Hs 766T,selumetinib-GDC-0941 (4-1 mol-mol),-2.707404573640349
Hs 729.T,54618305,4.441548296188891
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
BxPC-3,11152667,-1.4400195695513092
MOTN-1,10296883,2.890144008228283
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
BL-70,54618771,0.7229646502566096
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
SH-10-TC,11404337,0.4880521649819775
LNCaP clone FGC,JQ-1-carboplatin (1-1 mol-mol),-0.8145893926012049
BT-20,1566236,3.9435008592905247
HEC-1-A,11152667,-0.468005866747532
RKO,135421197,1.472175761257966
EB1,selumetinib-vorinostat (8-1 mol-mol),1.9651507627888476
Hs 822.T,9884685,2.2881978726594028
U266B1,2746,1.1489280814220546
LS1034,11152667,0.8780645856082363
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372
RD,135984461,3.5201159395246293
HCC78,54618305,4.419168434433716
DEL,11152667,-1.9938024204279712
NCI-H2452,24779724,6.409137734448782
CMK,136227924,3.317343215770968
Caov-3,10296883,4.16431215306168
NCI-H526,135984461,1.6602336964556588
L3.3,54618771,1.1558037208399272
MM1.S,44241473,4.365495360199436
DV-90,2746,1.1630599878188876
OAW28,9935249,3.684332158484572
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
MDA-MB-453,9915743,0.2126089191242519
MES-SA,3465537,3.3813308976048706
BT 428,9884685,1.1692312726776757
NCI-H524,11152667,-1.4634752762077046
UACC-62,135659046,3.5566231675799123
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
KYO-1,selumetinib-GDC-0941 (4-1 mol-mol),1.8614571416094257
COLO 668,9935249,1.1947973712890914
JURL-MK1,9911463,3.2271794119199293
BICR 22,2746,3.5358057095338404
HuH-6,10322450,3.486001071319901
SNU-478,11152667,-1.2324145231760475
NCI-H292,9911463,4.207043029649759
OVSAHO,54618305,4.336452781819542
HEL,3854666,0.8085723321900852
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
NCI-H211,24779724,4.306409832686191
GMS-10,6918638,1.6892515574733475
NCI-H526,selumetinib-GDC-0941 (4-1 mol-mol),3.379534287031186
KE-37,24771867,-1.8638849065260303
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
IPC-298,2746,3.067568930900854
BT 333,9935249,3.0763319445074124
SNU-8,9915743,2.7412552085538326
GSU,11404337,1.2682774414342974
DU145,9915743,3.139044524773344
T-47D,136227924,3.374798567013006
KU-19-19,9935249,4.318045076797651
EHEB,9868037,2.9297052804513934
Daudi,9935249,-0.0031627785077317
ONCO-DG-1,11404337,-0.4359581165609131
HCC1806,selumetinib-vorinostat (8-1 mol-mol),4.002360886332026
RPMI-6666,136227924,2.5880592922669097
J82,24771867,3.846047406369192
Panc 05.04,54618771,3.033977458741074
NCI-H211,11152667,-1.0917449852638887
Ki-JK,136227924,2.2053195341815424
BICR 16,9915743,1.7576705506596324
SW1990,JQ-1-carboplatin (1-1 mol-mol),4.363911496200424
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
SK-N-BE(2),44241473,4.33447839790992
SW1353,9935249,5.005901458565512
NCI-H1299,54618305,4.3112203505981554
SNB-75,10296883,4.213369443684623
SUP-M2,10296883,3.1259811098442176
JMSU-1,selumetinib-vorinostat (8-1 mol-mol),2.3406904931318566
NCI-H1944,9935249,2.9934786320739772
BICR 18,71751553,4.372978120712914
BT 172,136227331,3.9802920608276886
WSU-DLCL2,9926054,0.3298976492900614
MSTO-211H,1566236,2.167071233614174
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
NCI-H2444,9935249,3.5288049405628437
OE19,100016,6.21408400033578
U-118MG,6918638,1.3922699547909616
SK-HEP-1,71751553,4.559763777433237
SEM,54618771,-1.6874791122177024
TE-4,9915743,-1.938588144911124
LOX-IMVI,54618771,-0.8031507578309087
Ri-1,JQ-1-carboplatin (1-1 mol-mol),-0.4957222903174305
SNU-119,10322450,3.771322180088625
BICR 22,9926054,1.8271931211135617
EM-2,2742550,3.298238405542188
HPAC,9911463,2.695255349587433
SNU-1077,12003241,-1.4220834787906382
NCI-H1395,1566236,2.7287407900944056
COLO 684,10322450,3.614358100313302
TE-15,2742550,3.96805077868976
2004,9868037,3.4947449671991735
NCI-H1703,2746,3.536107682516814
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
HCC2108,100016,5.291323338255078
NCI-H810,49836020,4.546134729481912
SK-MEL-3,11404337,-1.6693959250085673
A101D,9926054,1.713643305346107
Daudi,54618771,-0.114332288085178
BT 504,2746,4.403785985788142
SU-DHL-4,9868037,3.0850955865320695
DK-MG,11152667,1.484854643077864
NCI-H1666,9911463,2.79017781981442
HD-MY-Z,24771867,3.876330004015234
DND-41,3854666,0.757997992407008
Hs 895.T,9915743,1.4498545473897326
LMSU,4378219,1.9748882526366265
BT 224,1566236,3.339343318797912
SW1417,54618771,0.6384319893864374
HCC1833,136227924,3.0159379881399895
EKVX,24779724,5.209041273813266
T-47D,44241473,5.836551614886669
IST-Mes1,12003241,-1.7187710036837192
HEC-50B,11152667,-1.6153760473992984
MPP 89,12003241,-0.4822573033051652
OV-90,49836020,4.456425733691278
A-549,9926054,1.8971220341716168
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
NCI-H810,4705,3.09227910852851
NOMO-1,9915743,0.4758643096003905
SNU-398,JQ-1-carboplatin (1-1 mol-mol),3.701774883690344
M-07e,9868037,1.7477051770285184
KYM-1,4705,3.22823778940345
COLO 792,JQ-1-carboplatin (1-1 mol-mol),2.0014474236818183
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
SNU-1,9884685,-0.7770944312630863
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
SNU-1033,2742550,3.4354448610207555
LCLC-97TM1,10296883,3.762301074740285
HD-MY-Z,54618305,3.941215880627945
GI-1,71751553,5.7700397394120655
Jurkat,JQ-1-carboplatin (1-1 mol-mol),0.5557917412854158
OCI-AML-3,100016,6.665392900980702
HEC-59,73707386,3.788415137761945
NCI-H1299,3854666,3.0957339105974766
NCI-H441,44241473,4.431871911184584
H-STS,24771867,-2.0225510536358353
EHEB,selumetinib-vorinostat (8-1 mol-mol),1.837404923820544
CAL-120,135984461,5.818041384121715
8505C,73707386,3.3239741118236044
JHUEM-7,135984461,4.346774383555173
IGR-37,11404337,-0.93778882861888
HT-1197,11494412,3.79217525742206
NCI-H2141,11152667,0.4643269234046814
Caki-1,11152667,0.81941066368069
LCLC-97TM1,9884685,-0.6945268748645868
Hs 940.T,6918638,1.7343854780687948
HSC-2,135421197,2.289170573267479
Lu-99,9884685,-1.574037677667807
RERF-LC-Ad2,11404337,1.0614824386793822
MDST8,135984461,4.124255066625015
U-118MG,100016,6.712569444944465
KYO-1,9911463,3.8919177559591542
BFTC-909,100016,5.8134150302243865
Hs 683,2742550,3.2253237968684134
KYSE-510,10322450,3.90855044095945
SNU-886,2742550,3.913973677845718
NCI-H2171,11494412,-0.1110474347644453
BICR 16,9911463,4.5254282277171045
FaDu,9926054,1.9668207116492555
NCI-H810,10322450,2.3502016572001696
DMS 114,JQ-1-carboplatin (1-1 mol-mol),1.3957333814923674
OVCAR-8,selumetinib-GDC-0941 (4-1 mol-mol),3.698487260127977
PaTu 8988s,JQ-1-carboplatin (1-1 mol-mol),3.780889611052604
ESS-1,11404337,-0.7954778123034105
BT 271,136227924,1.335352033885486
SK-LMS-1,9884685,0.6915267736542438
HCC1143,9926054,1.808099247882512
SNU-601,11404337,-0.2592209107038837
Hs 746.T,10296883,4.016339774932521
BICR 6,3854666,0.6221366242380308
TE-8,9911463,3.6899987590816687
U-CH1,6918638,0.5704766963302896
NCI-H1435,135984461,4.625083763194788
Hs 683,54618771,0.8006472003548896
TTC-709,136227924,1.406309539576174
GI-1,1566236,1.393655472136886
BT 216,136227924,4.751796234635162
NCI-H1155,9935249,3.4085854139583507
TCCSUP,selumetinib-vorinostat (8-1 mol-mol),2.3847964981208305
MOLP-8,9926054,1.7939353525170396
Li-7,9868037,2.00817394504418
Mono-Mac-1,73707386,2.736178467367938
A-204,100016,6.602223097366851
TE-14,9868037,4.140324513825515
SUP-B15,136227924,1.2725004934322246
MFE-296,136227924,3.1639946768284672
Karpas-620,135398744,5.497457460597933
SET-2,9911463,3.8788092570896184
LOX-IMVI,24771867,2.089263700134128
Panc 04.03,44241473,4.425072929332434
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SK-OV-3,9911463,4.2249846626647125
YKG-1,9926054,2.005416681797869
PC-3,135398744,6.536880900821883
IGR-37,135421197,1.178661342091473
SCC-25,135984461,2.1535341859506776
BT 245,9868037,3.6125967873896543
Becker,6918638,0.8308628231051842
BT 271,selumetinib-vorinostat (8-1 mol-mol),2.2656019278803665
MOLP-8,12003241,-1.4499361325619826
BICR 22,54618771,-1.5156377594303725
RL,3854666,0.4036099146730044
TE-11,9926054,1.7898768600573436
ZR-75-1,44241473,6.015888529529037
NCI-H1105,6918638,-1.2664288249273916
NCI-H1651,1566236,3.5266167122475
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
DU4475,4705,3.033607783661443
JURL-MK1,54618771,0.584482701420473
AsPC-1,9915743,1.396378280260739
NCI-H446,24779724,5.6591005956111475
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
KP-N-YN,1566236,2.0598398462410215
HT-1080,54618771,1.2813621768338197
SNU-719,9935249,4.380712428445992
SW1417,9926054,1.9097255829508144
U-937,3854666,-0.0560330485174303
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087
Kelly,24771867,-2.8346980260572474
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
HuCC-T1,12003241,-1.0945393222434805
NCI-H1395,135421197,1.2810683988074232
LS411N,12003241,-0.0946051023392001
HCC366,135984461,4.314156466102652
KMS-27,3465537,3.890176803896576
NCI-H1355,44241473,5.680337710277207
VMRC-RCZ,9884685,3.905874897299475
MM1.S,11152667,-1.9350060885580451
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
Pfeiffer,JQ-1-carboplatin (1-1 mol-mol),-0.9123603269683516
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
UACC-257,9911463,4.265034719630062
HDLM-2,73707386,3.1146753521402712
KNS-62,selumetinib-GDC-0941 (4-1 mol-mol),0.6177155702395645
HCC4006,4378219,2.008992669388645
NCI-H1666,54618771,-1.5571959335462928
BT 248,11494412,3.557230805764516
GCT,9884685,2.068707809781696
NCI-H810,selumetinib-vorinostat (8-1 mol-mol),2.083433754987742
ACC-MESO-1,136227924,3.807440016829928
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236
SK-MEL-5,24771867,4.627335356714736
LS123,9911463,4.230374012673379
WM115,135659046,3.4373276092449667
NCI-H508,selumetinib-GDC-0941 (4-1 mol-mol),1.363383946626654
Fu97,1566236,3.693810032735882
OPM-2,135421197,1.341685947169011
OCI-Ly10,9911463,5.153566135827512
SK-ES-1,3465537,3.500986365111438
SNU-C5,9926054,1.8417265889744416
RT-112,54618771,0.4568083672151968
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
DEL,54618771,0.826392883586264
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
BL-41,11404337,-2.6110172879458244
LoVo,11404337,-0.8407014552816361
NCI-H23,11152667,-0.8798455367060118
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
697,selumetinib-GDC-0941 (4-1 mol-mol),0.5718014976116145
Panc 10.05,1566236,1.7597115131165313
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
BT 320,3854666,3.86904800273952
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915
SNU-761,3465537,0.6076384821970646
PE/CA-PJ41 (clone D2),9935249,3.298572074942043
JHUEM-3,JQ-1-carboplatin (1-1 mol-mol),0.1044516957131188
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
OV7,24771867,1.2318973241973454
Daudi,11152667,-2.9472151872913104
Daoy,12003241,1.232177667394707
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
SK-MEL-2,11152667,-0.6797547387468098
CHP-212,4705,3.1318410503879717
DMS 53,9926054,1.7188884438075969
OE21,selumetinib-vorinostat (8-1 mol-mol),1.753596194788317
HEC-6,11152667,-1.444625055884375
SU-DHL-8,3854666,2.010086978430689
647V,11404337,-2.8105111103232985
SNU-899,65628,4.4224431430468645
NCI-H1299,2742550,4.427150184712593
NCI-H2286,12003241,-2.840007028807547
OPM-2,9915743,0.7579871544404475
L-428,JQ-1-carboplatin (1-1 mol-mol),-0.0487798287789179
DK-MG,selumetinib-vorinostat (8-1 mol-mol),3.2742327803422757
NCI-H2196,9915743,2.494227946954125
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
UACC-62,44241473,5.546152776940529
NCI-H1703,11152667,-3.4809417543540873
NB4,selumetinib-GDC-0941 (4-1 mol-mol),-0.8849476640562556
YD-8,selumetinib-vorinostat (8-1 mol-mol),2.8906615427618982
U-CH1,selumetinib-vorinostat (8-1 mol-mol),3.4811968102545308
NUGC-4,73707386,4.27548765999553
BT 286,3465537,0.9211618438378432
OE19,3854666,3.0187887298383926
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
KMS-28BM,9926054,1.6939379684191658
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
CW-2,11152667,0.8041866836775025
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
UO-31,100016,6.129898752942045
M059K,selumetinib-GDC-0941 (4-1 mol-mol),1.9371226079768809
EC-GI-10,11494412,-0.3258090559677851
BT 504,selumetinib-vorinostat (8-1 mol-mol),3.416857931230803
T-47D,44487872,6.149738415961402
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
KMH-2,135421197,1.1476668863331456
OVCAR-8,JQ-1-carboplatin (1-1 mol-mol),4.213615448912052
DOV13,3854666,3.159620572325968
IST-Mes1,10296883,4.238957650390159
HEC-1-A,4378219,1.965640102582146
COLO 678,54618771,1.45327687843265
L-540,10322450,3.2951827838559895
VMRC-RCW,9915743,1.0689932165793572
SNU-738,9935249,3.575205918033142
OCI-Ly3,44241473,5.114038994982861
BHT-101,11152667,-0.0403503112468694
LUDLU-1,136227331,4.9346482061859875
HT115,3854666,1.4354847640217934
NU-DHL-1,54618771,-0.7819429035186433
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
8-MG-BA,11404337,1.0898140469965
COLO 829,136227924,3.354215786550203
KYO-1,10296883,3.465187781350624
TE 617.T,136227924,1.63601430884803
BT-549,135421197,3.4062158650675265
8-MG-BA,JQ-1-carboplatin (1-1 mol-mol),3.7753986930145658
NCI-H1869,11404337,1.2362831155289085
FTC-238,selumetinib-vorinostat (8-1 mol-mol),2.4763413555506677
JHUEM-1,9915743,0.9861539346224674
BV-173,selumetinib-vorinostat (8-1 mol-mol),2.207862220069229
Daoy,3854666,0.752712785298123
NCI-H747,JQ-1-carboplatin (1-1 mol-mol),-0.0686546754719674
RKN,9926054,2.8101544562472056
TE-14,135398744,6.394251875306054
NCI-H508,2746,2.9093324415745094
PL-21,9935249,2.29170119673888
RCH-ACV,65628,2.7817124037332435
SNG-M,135984461,3.667931124820979
Calu-1,4378219,2.1615496659266396
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
KHM-1B,4378219,1.8511847617722708
SIG-M5,11494412,0.6608906203269307
SU-DHL-1,4378219,1.8683369375684944
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
MOLT-3,65628,1.183850627818121
L-540,JQ-1-carboplatin (1-1 mol-mol),0.3906962491825653
NUGC-4,12003241,-1.4802161759010128
EFE-184,135659046,5.053439307588332
P31/FUJ,11404337,-0.879305702132212
NCI-H2286,9935249,3.5542516597696543
Kasumi-2,11152667,-1.6921100461719016
BICR 22,2742550,3.9616050819266326
NCO2,12003241,-5.3551857747003
K-562,44241473,4.342180714885996
G-402,10296883,4.070324886092359
NCI-H660,9884685,-1.4283332629152754
SK-MEL-31,selumetinib-vorinostat (8-1 mol-mol),4.169186584807818
SK-MES-1,JQ-1-carboplatin (1-1 mol-mol),2.3477622395388495
MKN1,11404337,1.138047347798436
KMRC-3,9868037,4.35268371291099
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
SNU-16,136227924,1.93853165721534
SNU-1214,100016,6.334633199659308
EB1,11494412,-0.5591011576932087
L-363,9884685,-0.4512111156416696
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
SW982,4378219,2.075343567766405
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034
FTC-238,JQ-1-carboplatin (1-1 mol-mol),3.2551841017728083
Lu-65,6918638,0.8216407628444748
SKM-1,4378219,1.146896788222022
MCAS,44241473,5.035889660055443
K-562,2746,2.4328857060914797
Mono-Mac-1,9935249,2.3948099372524965
BT 444,135421197,2.634348679178173
SK-N-BE(2),2746,1.332316139919228
NCI-H28,12003241,-0.6704965456124867
COR-L95,2746,2.78697970441755
COV362,11494412,2.0789814812325855
JHOM-1,6918638,0.1301206862216937
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
HOP-62,9868037,3.695700187533532
LNCaP clone FGC,4378219,3.8557648266649704
VMRC-RCZ,4705,5.276450440378561
MFE-319,11152667,-0.9823368330260248
HPAF-II,12003241,0.935672122739968
HEL 92.1.7,9915743,0.818697547230163
BICR 56,6918638,0.6328735578862519
OE19,54618305,4.519730581703255
Kelly,9915743,1.2517863913865832
NCI-H2405,9911463,3.94220055080447
SUP-B15,54618771,-0.7938935218437335
MFE-296,54618771,1.0202577840468772
23132/87,9884685,0.434965052776624
KMBC-2,9911463,3.851747430991294
ChaGo-K-1,3854666,1.588542463335614
KYSE-150,11404337,1.3102560246616723
MOLP-2,9911463,4.414943905167103
MES-SA,selumetinib-vorinostat (8-1 mol-mol),3.174242970755464
BT-12,11494412,1.7743294145971482
ONCO-DG-1,9926054,2.478958665773676
CAL-120,9935249,3.71206437331414
GCT,4705,3.1348509657034036
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
MOLT-16,9884685,-0.2563886004846691
C2BBe1,135659046,3.558851122632108
NCI-H2085,9911463,4.028733410205104
RMG-I,12003241,-2.7782598646997414
SNU-1076,9911463,3.975744841196654
SK-MEL-1,3854666,3.1088864044713747
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
MOTN-1,10322450,3.6897160275286343
JHUEM-2,12003241,-3.1995756847172108
23132/87,12003241,-0.6974968916735146
A-375,9911463,4.039687099931349
DU145,9911463,4.064467262158392
GSU,9926054,2.0753432463220065
NCI-H1755,49836020,-0.0301714782676706
NCI-H520,2746,2.5300013032729556
HCC15,24771867,-1.1106317715549263
Panc 08.13,4378219,2.1272088773778526
NCI-H1373,136227331,6.256455591315265
OCI-Ly3,2742550,3.803331365452129
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
NCI-H1395,12003241,1.698262392733821
RCC10RGB,9915743,0.9759946846108524
BHY,135984461,4.3306625702035575
Mino,135398744,6.764750512167438
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
OVSAHO,selumetinib-GDC-0941 (4-1 mol-mol),2.882517977180431
KE-39,11494412,5.804036993573256
CMK,24771867,-4.361208958320615
LUDLU-1,9911463,2.6555573112592494
NCI-H446,54618771,-1.076941007220397
P3HR-1,selumetinib-vorinostat (8-1 mol-mol),2.8609164673310907
SNU-216,135421197,1.0326096520006542
KYSE-510,9926054,1.8672783124576204
MCAS,49836020,4.94613909678053
MDST8,54618305,4.422279328619345
NCI-H1155,135421197,0.9372585927098024
COR-L51,10322450,3.875976126745678
SF295,11152667,-1.2215974796941085
A3/Kawakami,24771867,3.580892472047786
HMCB,2746,4.319833835287885
MOTN-1,9884685,4.168868767853732
YD-15,9935249,4.133669624082237
AN3-CA,6918638,0.8350174262489668
BICR 22,3854666,0.9977305103930704
BT 228,11404337,0.5365763312483942
TE 617.T,3465537,1.2174694198208424
LMSU,54618771,1.0017714306772694
SNU-878,11404337,-0.7245810711343122
HLF,24771867,3.9155745912341575
BFTC-905,11152667,-0.7894316986781663
786-O,54618771,1.0235126095922562
SK-MES-1,10296883,3.8789679823498178
SK-N-BE(2),135421197,1.0059955397340807
LXF 289,135398744,6.087135496005038
MOLT-13,11152667,-1.8178973770803584
ME-1 [Human leukemia],54639665,4.516656391788249
PE/CA-PJ34 (clone C12),11152667,0.0112826586729411
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
MHH-NB-11,135421197,1.028464988751559
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
NCI-H2029,135421197,1.9497380661453336
C2BBe1,9884685,-1.1193256567794436
AGS,selumetinib-GDC-0941 (4-1 mol-mol),0.9665370398813388
JHH-6,1566236,4.1223255495253115
HD-MY-Z,136227331,3.950603619388181
SR,4705,3.533585643751883
5637,9935249,3.304332904161991
SUP-M2,135984461,3.87048061577109
VCaP,100016,6.449384825808392
T84,9926054,1.9260026490734707
C2BBe1,10296883,3.913780393696494
NCI-H1666,3465537,1.89945588348698
BT 422,11494412,3.3460147450919338
OVCAR-4,selumetinib-vorinostat (8-1 mol-mol),3.885646865602492
BT 245,9935249,1.99402432106235
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
TUHR14TKB,11152667,0.3855019531264219
SNU-449,6918638,1.2557717528626495
SEM,100016,5.238818929389881
MHH-CALL-4,135421197,1.0493029833886585
SNU-C4,135659046,3.741001197926473
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
Panc 02.03,1566236,1.9322803720882225
SW579,9926054,1.761228342294705
NCI-H2087,135421197,1.3607762118240936
KYSE-180,136227924,3.113518519432139
JHUEM-3,135421197,1.4304571308518408
TE-15,11494412,-1.732621371792193
NCI-H23,65628,4.057192567331317
YKG-1,54618771,1.607640245193468
Hs 611.T,3854666,0.606015378482523
CCF-STTG1,selumetinib-vorinostat (8-1 mol-mol),4.379403579151937
Rh30,11152667,-1.7788269902081053
MOTN-1,135421197,1.3703744240022513
786-O,24771867,3.989531252229045
SK-MEL-3,136227924,3.573502388362414
NCI-H727,11152667,-1.354343634557878
COLO 668,selumetinib-GDC-0941 (4-1 mol-mol),1.3136339769423369
ZR-75-1,54618771,1.401899107302776
BICR 16,selumetinib-vorinostat (8-1 mol-mol),3.7038615941631305
CAL-12T,selumetinib-GDC-0941 (4-1 mol-mol),2.008414160334409
SEM,135398744,6.34358667151958
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
KMS-34,12003241,-3.0064029669480528
HL-60,65628,4.481571906059771
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
BT 416,100016,4.165407662771479
OVSAHO,9926054,2.353589005438
P3HR-1,9911463,4.040866432648006
MM1.S,4378219,2.139277509194807
G-361,9915743,0.2147475804393018
RPMI-8226,9926054,1.537898782638624
BT 112,11152667,1.095866512531577
KYSE-450,11152667,0.9209824146572594
DEL,9935249,3.169689797008309
IGR-1,11404337,-1.4130106945473468
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
Kelly,9911463,2.836372345977174
BT 145,1566236,1.6358239953164144
HCC2218,10322450,3.115665598848324
NCI-H441,11404337,1.4464911476472675
GCT,71751553,4.654227598204535
Daudi,3854666,0.3283534306514684
CHP-126,11152667,-3.0813157517767205
HCC4006,selumetinib-GDC-0941 (4-1 mol-mol),1.2371025715535526
MG-63,10296883,4.161966556004564
CGTH-W-1,44241473,5.444505098972642
HCC2279,9911463,3.61509749059407
HEY A8,44241473,5.321883796950796
NCI-H2126,54618305,4.7899642645933636
COR-L95,9915743,0.942320604231091
A-253,9926054,1.90575113373639
BT 440,135659046,3.614381775691437
U-118MG,11494412,3.4425661243736503
ChaGo-K-1,3465537,1.3270593672392677
OVCAR-8,4378219,2.2482607796278553
SNU-601,10322450,3.697276990394465
SNU-626,65628,4.324270511481314
TTC-709,9926054,1.3747627831999318
SK-N-FI,JQ-1-carboplatin (1-1 mol-mol),2.3302491289766825
OV56,100016,6.603582199202106
REC-1,9911463,3.153332853315619
RPMI-6666,54618305,4.308512579148535
LC-1/sq-SF,selumetinib-GDC-0941 (4-1 mol-mol),2.9597977830319935
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
EBC-1,2742550,2.785221228381935
OVK18,12003241,-0.5661348884613613
TE 441.T,54618305,3.9313540825452775
DU145,24771867,3.0403814394567283
RL,44241473,4.701643614739578
MOLP-8,9911463,4.2009596294807245
Hs 578T,4378219,1.7715862558235798
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
T-47D,selumetinib-vorinostat (8-1 mol-mol),3.20123924318934
RVH-421,3854666,2.5302343976603656
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
KE-39,44241473,4.750329858029805
COV434,1566236,1.6792163956062065
NCI-H841,9926054,1.733938420008062
OVCAR-8,9926054,3.028637084123283
MDA-MB-361,selumetinib-vorinostat (8-1 mol-mol),1.866211608168264
Hs 888.Lu,136227924,2.7652519196534304
Namalwa,9915743,0.490557645352366
SNU-1033,1566236,1.8581490134242764
L3.3,9911463,4.128757247123474
DB,54618771,1.151207273522801
LoVo,10296883,3.831816674357036
NCI-H1869,24771867,4.056145825527395
ME-1 [Human leukemia],9911463,3.822532388207368
Hs 766T,9935249,3.1459516171029924
NCI-H1734,49836020,-1.214582633360451
U-937,4378219,1.8449666280036168
RKO,24779724,5.847036108864024
Ku812,54618771,-0.0049031848150657
SUP-T11,9868037,1.5602991106462112
MEC-1,9911463,2.4578054116593555
NCI-H441,3854666,5.865964482686562
SIG-M5,9935249,-2.10947388119983
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
KMH-2,9926054,1.558336314725876
NCI-H23,9935249,1.5546274820807884
EBC-1,136227924,2.637152829802991
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
HCC827,44241473,4.843334893068553
NCI-H1693,9884685,-0.0882247449896871
JM-1,11404337,-2.1014875230304315
BT-12,9926054,1.4917142795883798
SNU-449,24771867,3.0453458349703793
DU145,2746,3.3697589984535528
NCI-H322,24779724,4.441371574711967
Panc 08.13,54618771,0.3340259245614503
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
MOLM-6,2746,1.449988915639522
NCI-H1355,selumetinib-vorinostat (8-1 mol-mol),2.6424962463643316
KMS-21-BM,54639665,5.788754853748425
HOP-62,2742550,5.0895590073246595
LXF 289,9911463,2.935801973679381
Sq-1,135421197,2.584547393194889
NCI-H1568,9926054,1.8156743035592564
Ri-1,135984461,2.0671055438536547
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
SNU-449,12003241,0.2005365129445947
RPMI-7951,12003241,-0.9511728924240472
SW1417,11152667,-0.9008177066075654
TE 441.T,54618771,1.354234974700439
TE 617.T,9911463,3.539966110266211
GI-1,4705,3.0771619650951214
UACC-62,9911463,4.3555610990342615
BT 164,71751553,4.849574531411229
UO-31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0895128254081629
2004,12003241,-2.052412032835344
TALL-1 [Human adult T-ALL],2746,0.9231868013667444
HT-1197,4705,3.093520040309316
CAL-85-1,135984461,4.357321132215755
NU-DUL-1,12003241,-3.7698079605480257
KE-39,3854666,4.449857131704124
SNU-245,selumetinib-vorinostat (8-1 mol-mol),0.3021660304268694
Mono-Mac-1,2746,1.2768381662660928
BT-20,11152667,0.257803129551301
ONS-76,54618771,0.5276024038238057
HPB-ALL,73707386,2.26309628791615
BT 428,9911463,3.0361887786890693
RPMI-8402,54618771,-0.5360819718373795
Hs 888.Lu,11404337,0.6569012069034585
RVH-421,9935249,2.635649117696883
LoVo,9915743,-0.8819018227786422
OC 314,selumetinib-GDC-0941 (4-1 mol-mol),0.5636308108859065
SNU-886,2746,2.8162256970394295
FaDu,49836020,4.381495172511739
JM-1,9915743,0.8499678141273637
Kelly,9935249,2.7785496119201807
LoVo,1566236,1.5203890875485482
HCC-56,9911463,4.275331241701339
SNU-840,11152667,0.6546651786480734
KE-39,135421197,0.9510973278490732
COLO 699,9935249,3.446924594700092
LK-2,100016,5.670732740144693
WM88,4705,3.410375599390418
HCC202,135398744,6.455993552330763
Hs 888.T,136227924,1.939793098771597
KMS-26,9926054,0.2958792952736858
BT 422,selumetinib-GDC-0941 (4-1 mol-mol),3.332699583710218
KALS-1,3465537,2.6305189862843155
HEC-265,54618771,0.9168316740799288
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
TF-1,24771867,3.967420274323183
GDM-1,10296883,3.3265560717041436
HCC1438,9926054,1.860816529304143
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
HSC-3,135421197,2.8710443540281756
SH-10-TC,135984461,4.500134355480999
TALL-1 [Human adult T-ALL],100016,4.020437007073488
NCI-H23,11494412,-0.4680789273941572
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
BICR 6,6918638,1.0635609098647931
CAS-1,2742550,3.0271705067193144
SW579,9935249,2.1247219818786776
PL-21,JQ-1-carboplatin (1-1 mol-mol),-0.1767086466705203
SNU-213,100016,6.954868306659309
BT 239,54618305,4.325444578852527
LOX-IMVI,1566236,1.766970310435897
OCI-AML-2,136227924,1.951984345015637
NCI-H1915,4378219,2.0198659829374597
TT,selumetinib-vorinostat (8-1 mol-mol),2.556499502295621
WM1799,2746,3.8578156417169542
CML-T1,73707386,2.9358077283853974
SNU-449,10296883,3.939630786750968
MHH-ES-1,54618771,0.4734030568205798
CHP-212,9911463,2.7015843726568005
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
TE-6,selumetinib-GDC-0941 (4-1 mol-mol),3.56930262529698
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
COLO 668,selumetinib-vorinostat (8-1 mol-mol),2.26627274162314
SNU-410,selumetinib-vorinostat (8-1 mol-mol),3.953798700676283
IST-Mes1,11404337,-0.5180157624887997
TTC-709,11152667,-0.5539552668889595
Hs 822.T,selumetinib-vorinostat (8-1 mol-mol),4.7546424855856175
CAL-54,135659046,3.5874305591890256
TALL-1 [Human adult T-ALL],9915743,0.282075897468642
JK-1,11152667,-3.7517663276424704
KP-N-YN,2742550,4.250403933342819
LoVo,4705,1.5085236639058903
PaTu 8988t,4378219,1.99751885903338
NCI-H661,12003241,-1.8871798966926587
Jurkat,9926054,1.8890918367446592
NU-DUL-1,65628,2.8411028717904734
BT 416,65628,3.396680033098099
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
SNU-1033,136227924,2.5540912421490387
JURL-MK1,9935249,2.8490147187785233
Hs 839.T,11404337,1.04111897538683
NCI-H660,9911463,3.200978092874424
HSC-3,9915743,0.268265478867946
LOU-NH91,54618771,2.8270991446030593
LS513,65628,4.8114828061247685
GP2d,2746,2.2157786787544023
A-673,9884685,0.1604809562987641
CCF-STTG1,54618771,4.049347271840678
Mono-Mac-1,136227924,2.2269797620359864
HT-144,2742550,3.8917870100143257
WSU-DLCL2,11152667,-1.6182237488430529
RCH-ACV,2746,0.9590882361015028
OCI-AML-3,24771867,-2.5790177528114695
DoHH2,4378219,4.427270397277719
CL-11,3465537,1.1526064329860466
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
BT 231,4705,1.5996652236036175
BT 416,11404337,-1.6662073764284366
NCI-H508,9926054,1.9520179071989003
769-P,selumetinib-GDC-0941 (4-1 mol-mol),2.2458256114397788
NCI-H1573,24771867,2.594882153684085
OVCAR-8,54618771,0.8925254662704427
OPM-2,54618305,3.930022905522119
BT-12,JQ-1-carboplatin (1-1 mol-mol),4.599252590032938
SNU-503,11404337,-0.7009485730992275
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
SW620,9935249,3.3377661554746956
NB1,JQ-1-carboplatin (1-1 mol-mol),2.7630745664593426
BT 245,2746,2.160904338087323
LNCaP clone FGC,11494412,0.5135445267768279
NCI-H1184,12003241,-1.9901297280698445
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SK-MEL-5,54618771,0.7093345512366925
GOS-3,54618771,2.751038853336045
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
NCI-H810,24771867,-0.3181195124828279
BHY,selumetinib-GDC-0941 (4-1 mol-mol),0.2537821037586068
LS180,4378219,2.066313424484697
PE/CA-PJ15,selumetinib-vorinostat (8-1 mol-mol),4.124369885528516
NU-DUL-1,135984461,1.2586249642588896
T-47D,71751553,4.80525405007375
RPMI-8226,12003241,-0.708602453849348
A-204,54618305,4.912767381988994
COLO 668,10296883,4.05500534274126
EHEB,9935249,3.177814055372344
MM1.S,54639665,4.38877596087519
GDM-1,9868037,0.3465772020912164
SNU-216,selumetinib-vorinostat (8-1 mol-mol),2.415634869676137
SNU-878,65628,4.1894016478203095
KMS-27,11152667,-0.6309596217329284
SUP-M2,2746,1.4359324283751405
NCI-H647,6918638,1.1619683266292729
NCI-H1666,2746,2.9810334185845617
Mel JuSo,54618771,-0.9101150768043303
SNG-M,10296883,3.727661706333134
KMS-18,9884685,-0.1468040785790071
HEC-151,3465537,1.222208329394757
NCI-H2087,135659046,3.4152304488602727
SNU-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.1592396564326592
SEM,4705,3.2789499070594816
SNU-1066,9915743,2.3115456271865664
MDST8,12003241,0.3559193403256231
NCI-H929,135984461,1.9075332391524664
SW579,4705,1.9687725092896824
HT-55,9935249,3.3600824224650836
BT-474,9935249,3.4097501700576016
GSU,54618771,1.7980525914601972
EFO-27,100016,6.711163327148508
SK-MM-2,4705,2.736644708232148
NCI-H2052,136227924,3.050038230910341
SNU-61,11404337,-0.7844361329588494
Mono-Mac-6,3854666,2.646035191331394
YH-13,3854666,0.9588236597385832
KU-19-19,12003241,-0.0608702413973226
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
Kasumi-2,135421197,0.8154486687594628
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
JURL-MK1,2742550,3.380705100447993
SNU-407,9926054,1.9660241476439948
CA46,9935249,0.2545497442771542
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
MOLT-3,135421197,0.6925394528870177
SK-N-MC,12003241,-1.5670005679110546
SW982,136227924,1.7454954285641082
SET-2,136227924,2.6175155289445646
AN3-CA,selumetinib-vorinostat (8-1 mol-mol),3.509818575986226
PL-21,2746,1.912238920638634
SBC-5,2742550,4.323082293816951
LS1034,9915743,2.2707321419893094
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
KE-97,54618305,4.294665496814293
Hs 934.T,11152667,0.4096473732828699
ECC10,136227331,5.843658104512461
TF-1,9915743,0.9371893849348516
NCI-H1755,selumetinib-GDC-0941 (4-1 mol-mol),0.8235666459967586
TE 441.T,135659046,3.3291028889346066
EKVX,9915743,0.527963418662055
JK-1,selumetinib-vorinostat (8-1 mol-mol),-0.0051710372018302
SET-2,100016,6.077577626399248
DMS 273,9884685,-1.1971048738595964
Panc 04.03,9926054,1.9560696374821285
COLO 205,11404337,1.3467239664016557
NCI-N87,73707386,2.4106113659233723
BT 179,4705,3.3464119205412697
23132/87,135421197,1.295481545457509
SW948,9884685,3.1398548031465525
KYSE-70,9935249,3.427959003246725
HuP-T3,11404337,1.0495167124251128
HEC-59,9926054,2.31296864465942
COLO 201,12003241,-1.3508897145637075
SW579,71751553,4.230632785990304
YD-38,3854666,0.4955683731799087
SNU-16,JQ-1-carboplatin (1-1 mol-mol),-0.5947193789750925
OCI-Ly10,JQ-1-carboplatin (1-1 mol-mol),0.3162452949317643
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
KMS-11,9868037,2.8057737885411855
SNU-886,3854666,1.448080837770843
NCI-H838,10296883,4.165878010219483
PLC/PRF/5,6918638,0.9074037907911854
TOV-112D,9935249,3.1679986881841384
NCI-H211,76446078,4.208571936143266
KMS-27,selumetinib-vorinostat (8-1 mol-mol),-1.5585431850605205
Caov-3,JQ-1-carboplatin (1-1 mol-mol),0.7058210563631089
CAL-33,11404337,-1.8217571970645148
ACC-MESO-1,11152667,1.137280520783936
Hep-G2,10296883,3.682570839684776
LOU-NH91,11404337,-0.9599092047687252
AU565,49836020,5.742264990221176
VMRC-LCD,12003241,3.8307047822357343
Karpas-299,9935249,2.202712445766307
Panc 04.03,10322450,4.721553837851545
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
NCI-H1155,4378219,1.4842518954586772
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
SNU-1196,100016,6.169672174830197
SNU-182,54618305,4.364644108861178
UACC-62,4378219,2.011551432591738
SNU-423,12003241,-1.4382544514663564
SW1271,11152667,-1.5987482479879582
Capan-1,3465537,2.9960206717772104
KMRC-2,11152667,0.1110471147886436
SCC-4,JQ-1-carboplatin (1-1 mol-mol),1.0548546410991495
PE/CA-PJ49,10296883,4.094155197512124
BFTC-909,650361,3.8112149600795706
MDA-MB-415,9935249,3.953903060274233
HCC2218,11404337,1.2593455770198374
SUP-B15,4378219,2.108886502039496
CAL-85-1,9884685,-0.6129731803090307
23132/87,9926054,1.8706773159839023
ALL-SIL,135421197,0.8278001934093618
NCI-H1581,136227924,2.9082899651974734
A-673,54618305,4.212251300263772
MDA-MB-468,12003241,1.1497525105309832
KYM-1,136227924,2.3887987595454594
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
Panc 03.27,49836020,2.722888568283256
SNB-75,24771867,2.476151060552252
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
SNU-1214,9911463,3.639683247778992
KMRC-3,9915743,1.1795230996835706
KYO-1,65628,4.687741125093448
HuP-T4,1566236,2.6794264754900325
BC-3C,9884685,2.9353156431975393
TE-8,54618305,4.365063234353354
H-STS,100016,5.985929376611731
UM-UC-1,11152667,-0.6873058456507053
A-673,3854666,0.8608139997201792
RCC10RGB,10296883,4.350673741830848
SK-CO-1,54618771,-0.118181134306818
U-251MG,135984461,4.456560738711495
UACC-812,11152667,2.562952126743398
SK-MEL-5,11404337,-0.86554047446545
KMS-28BM,9868037,2.7524179653938172
RERF-LC-A1,49836020,4.4326562717782005
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
U-251MG,4705,3.583212540247193
SNU-869,135659046,3.721754177816309
ESS-1,9935249,3.3777402733386617
NCI-H838,11494412,1.0155710484012703
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
NCI-H1385,11152667,0.7857053918396109
P31/FUJ,4378219,1.2412027933720209
BT 224,4378219,2.137537354607802
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
AML-193,9868037,1.69446413413849
KNS-60,2746,2.742254085521436
JHH-1,54618771,0.3940537570432531
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
SNU-407,11404337,-0.3690454337107759
Ri-1,9884685,-4.0721071535449065
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
SNU-1272,135421197,2.338787330458388
NCI-H661,11152667,-1.7022631730770723
OCI-M1,9915743,0.9472890233124052
BT 330,54618305,6.276995186966791
GA-10,24771867,-2.7425401258816104
B-CPAP,54618771,-0.888157328254987
DU4475,44241473,4.311789317033333
MOLM-13,24779724,4.7751629548446894
EoL-1,49836020,1.4161576765733714
GP2d,11404337,0.3964770765746153
NCI-H889,135421197,1.0362826511717604
A2058,135421197,3.1634124303989273
SF268,6918638,0.7896548541911668
U2OS,11152667,-1.813326658155893
CA46,135659046,2.986085914123542
BT 416,76446078,3.7973677296033985
Mino,12003241,-3.278689335869641
PE/CA-PJ34 (clone C12),40482356,5.160347507354427
NCI-H2291,11404337,0.0259813589502385
COLO 320,135421197,0.8671243277775497
TYK-nu,11152667,-1.4994661185688625
SK-N-DZ,9935249,1.2631361781648536
MG-63,136227924,3.2795436313273685
LoVo,100016,6.001395250082881
G-401,10296883,3.7583450228982342
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
WM266-4,selumetinib-vorinostat (8-1 mol-mol),0.5678434966492824
WM266-4,9911463,4.039840859111318
COR-L105,9915743,-1.8659407955600968
NUGC-3,135984461,5.20039455882723
MDA-MB-157,12003241,-1.4339892472843776
KP-2,9911463,4.372716241316865
UACC-62,11494412,3.786718982439659
Daudi,2742550,2.6022450411597764
AN3-CA,168313307,4.649989431692814
GA-10,9915743,0.398325607555859
KMS-34,2746,1.024640964168084
NCI-H1651,40482356,5.116507633981313
FTC-133,11404337,1.1811341910019733
JHH-5,10322450,3.916115158181419
BT-549,9915743,2.34179420613382
OC 314,9884685,-0.4241645607826622
RPMI-7951,3854666,0.7955375468414883
CAL-54,10322450,4.089763150244814
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
TE-8,JQ-1-carboplatin (1-1 mol-mol),3.3318874034400885
L-428,1566236,1.3847183242842775
OE19,11494412,2.655503410227205
IMR-32,11152667,-1.250307023414486
MHH-CALL-4,11404337,-1.4992681274735582
JURL-MK1,136227924,2.4264924164691135
CHP-212,6918638,-1.8920767869906776
Jurkat,11152667,-1.1847034322437038
KMRC-2,24771867,3.343574460922249
GB-1,11404337,-0.6005799825323985
OAW28,3854666,2.969576020962734
H-STS,12003241,-1.720451684377523
SNU-620,3854666,3.691648599475937
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
SNU-1076,11152667,0.2599051324779742
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
SUP-HD1,71751553,4.0712574517111
PK-59,3854666,3.1918550803858783
L-540,100016,3.9234848652304097
BC-3C,4705,2.713954554956948
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
COR-L279,9911463,3.362678282511464
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
NCI-H522,135984461,5.248212763135773
DMS 273,2742550,3.72774264414297
Ishikawa (Heraklio) 02 ER-,selumetinib-vorinostat (8-1 mol-mol),2.5379736482823625
BT 320,11494412,4.421767883618589
LAMA-84,100016,4.28644111913654
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
OVSAHO,selumetinib-vorinostat (8-1 mol-mol),4.369636445771919
NCI-H810,9911463,2.4681079610517394
Ci-1,10296883,4.053173965998694
KMRC-20,3854666,4.622266524166492
RS4;11,73707386,2.6897318309889577
TE-1,9915743,1.1903317834538285
Malme-3M,136227331,3.99929328678972
ACHN,9926054,1.8123369817060109
TE-14,selumetinib-vorinostat (8-1 mol-mol),2.42996649499285
J82,135421197,1.0520459695592828
HCC366,54618771,1.7092661743346285
SK-MEL-3,11152667,1.7453060671217775
HuNS1,11404337,-3.482184142703688
NCI-H508,selumetinib-vorinostat (8-1 mol-mol),2.379388447268019
KG-1-C,9868037,4.232023281385857
MDA-MB-468,selumetinib-vorinostat (8-1 mol-mol),2.32454994055681
DND-41,100016,5.882204784714585
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
SK-N-MC,135421197,1.0109878230238314
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
RPMI-6666,135659046,6.863233968439554
YD-38,12003241,-0.5056624439731239
SNU-46,54618771,3.9719869663653578
BT-20,selumetinib-vorinostat (8-1 mol-mol),4.571320043409551
THP-1,11404337,-1.5285516507486518
NCI-H1385,11404337,-0.5225028243847427
HSC-3,12003241,-1.4285198417789524
GSS,9935249,2.9109339589908374
BT 416,54618771,0.7344198776151593
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
EFO-27,11404337,1.0583908830182924
LUDLU-1,135421197,2.9427726224498274
SNU-1076,136227924,3.042119222699605
BT 286,9911463,3.0735360087935364
BT 416,9868037,3.6297803130488377
SNU-423,9884685,0.0513758273382596
SF539,9926054,1.722417855539817
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
Hs 611.T,135984461,2.1518456912790507
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
BT 179,12003241,-1.00247586074096
P31/FUJ,9868037,1.2869642230829814
BHY,24771867,4.455301160419176
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
ONS-76,11404337,-0.4259392266769182
ECC12,selumetinib-vorinostat (8-1 mol-mol),3.230210286741561
SW579,JQ-1-carboplatin (1-1 mol-mol),2.4764812172650905
COLO 668,9911463,2.6985000382715567
LMSU,100016,7.332455698517509
SK-MEL-3,9911463,3.4367416892485556
SUP-M2,54618771,0.2858718534698647
Hs 688(A).T,11152667,1.3458070732124674
G-401,65628,4.0909837295628275
HOS,100016,6.425173790511516
NCI-H2030,9911463,4.399921690700774
HCC-56,3854666,3.3654438500672423
BT 416,9915743,-0.2022944112216887
T98G,9915743,3.11701457310986
GCT,3465537,2.4303788835325895
SNU-213,selumetinib-vorinostat (8-1 mol-mol),1.4256342092692729
TC-71,11152667,-0.90552312132183
ES-2,135984461,1.833276143203305
SNU-C1,6918638,-0.1919705082946097
HD-MY-Z,9935249,2.519302012591236
PC-14,9915743,-2.4249555987147615
NCI-H2196,100016,7.101599749729703
JK-1,73707386,2.7182097499320874
MOLM-6,9915743,0.4708635426992801
HEL,9935249,3.1121102066484827
UM-UC-3,10322450,3.9081248739671945
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
AML-193,10296883,0.366102504312359
CL-11,2742550,3.86995660017133
ACC-MESO-1,135398744,5.83972457285084
A-549,135421197,2.4799819746704075
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
NCI-H211,selumetinib-GDC-0941 (4-1 mol-mol),1.1345350253302544
SEM,135984461,1.5883939694151252
KMS-21-BM,136227924,2.0166655260293487
YH-13,54618771,3.881155680896358
CHP-126,44241473,4.38473395288902
NCI-H2106,54618771,2.789728608480185
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
Hs 934.T,135659046,4.578054187652552
Hs 940.T,24779724,5.686708728443863
HCC1806,135984461,4.428357366686186
COR-L95,6918638,0.5429028056483723
AGS,9926054,2.4402585627733844
NCI-H522,1566236,1.6835491869847783
MKN74,12003241,-0.9650452844715884
BT 172,54618771,0.7743085294895093
BT 224,11152667,1.4221978666724842
TE-8,136227924,2.7469773037217715
SNU-407,10296883,3.619724008843853
COLO 320,9868037,3.042611566071044
5637,100016,5.253062593048346
OCI-AML-3,JQ-1-carboplatin (1-1 mol-mol),-1.7736109395797492
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
DMS 454,selumetinib-vorinostat (8-1 mol-mol),1.7522201936237716
CW-2,12003241,0.1847256343211754
SNU-761,4705,2.9442474881607676
BT 232,44241473,4.409909383747932
NCI-H1869,9915743,-0.6149308552384661
SW982,135984461,2.5678712779652364
M-07e,136227924,2.437184343955499
NCI-H1694,168313307,4.392519657750419
COLO 829,9884685,1.90207337330007
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609
DU145,12003241,-2.0135691280208876
SK-MEL-5,1566236,2.4643263629353576
TUHR14TKB,135659046,6.015555099108438
NCI-H2170,2742550,3.89101462979228
NCI-H1563,135421197,1.4749525017569085
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
Panc 02.03,100016,6.582809568040202
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
NCI-H2452,9884685,3.2183676658345868
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
RCH-ACV,136227331,3.661348982396994
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
BT 286,136227331,4.205096233968031
SK-MM-2,54618771,0.349796062936111
HuP-T4,11404337,-0.0710006834514767
DU145,136227924,5.593457102459236
HT-1376,2746,3.1690827101181736
SNU-C2A,65628,5.099663069206163
BT 330,3465537,1.066825715550645
DOV13,136227924,2.864785745195549
HCC1171,11152667,1.4462544365482133
HuG1-N,selumetinib-vorinostat (8-1 mol-mol),3.312476011895398
Hs 895.T,135984461,4.899016961012941
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
HEC-151,4705,2.9357366805195735
EKVX,selumetinib-vorinostat (8-1 mol-mol),2.797043783468325
BT 428,2746,2.3155764073240177
253J-BV,9935249,4.200094629242131
DK-MG,4705,2.3650435397254492
IM95,10296883,2.4504094731139676
Li-7,10322450,3.813696147876763
NCI-H520,2742550,4.31238635720589
JHH-4,6918638,0.0313135424356484
WM115,2742550,3.774256401917875
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
CAL-12T,3854666,1.7732900295256924
SK-MES-1,100016,6.467052003541006
MV4-11,135984461,1.5625386820387543
MKN1,4378219,2.0634079852484084
TUHR10TKB,4705,2.6546560293729677
SNU-C1,24771867,3.0919597709351994
BT 147,9926054,1.807277739033318
SUP-HD1,6918638,-1.2091323464126156
GI-1,12003241,0.5382171766517799
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
YD-15,135421197,2.516828006554414
MDA-MB-157,71751553,2.589623955944651
HCC1500,135421197,1.2704457907642457
SW1573,12003241,-0.6702221198842615
OCI-AML-3,selumetinib-vorinostat (8-1 mol-mol),-2.4724160390070775
Lu-65,54618305,4.948052353708299
NCI-H322,6918638,1.1027062108790242
OCI-AML-5,10322450,3.661053822054087
NCI-H1694,selumetinib-vorinostat (8-1 mol-mol),2.149311706676436
NCI-H1792,selumetinib-GDC-0941 (4-1 mol-mol),1.680387740806623
RVH-421,136227331,4.595276173623148
TTC-709,3854666,1.2966503099263071
DB,24771867,1.581482726056903
M-07e,135984461,4.142111283006845
HCC78,9926054,2.494370122209171
Granta-519,24771867,-1.6352261980607803
TYK-nu,3854666,2.0587210859588407
RPMI-7951,135984461,1.8350083594586524
TE-9,65628,4.309705001267168
SNU-387,selumetinib-GDC-0941 (4-1 mol-mol),1.4136760504697403
PaTu 8988s,9935249,3.279701271474824
CAL-85-1,136227331,4.603192424436066
PaTu 8988s,11152667,-2.740642733850453
BT 187,9915743,2.9672609424813
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
HCC1438,2742550,5.572019018738765
YAPC,9915743,1.8269757962027744
KMS-20,135421197,1.5361253797366796
TE 617.T,3854666,0.5346166749411773
HEC-59,11152667,0.382877882866184
SHP-77,JQ-1-carboplatin (1-1 mol-mol),1.995667602939756
SK-N-MC,54618771,0.9306599486262166
HuG1-N,2742550,3.170648842164322
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
CFPAC-1,12003241,-0.6323170147703681
CL-34,12003241,-1.25604782594079
NUGC-3,2746,2.5957810637319625
SNU-1077,11152667,0.5302678511241536
SK-MEL-31,11152667,2.6381894367137777
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
CADO-ES1,11404337,-1.7839684618435203
JURL-MK1,11404337,-0.8501595942866039
RT-112,selumetinib-GDC-0941 (4-1 mol-mol),2.1504291571764287
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
SNU-423,10296883,4.1095294295281795
KMH-2,65628,3.890017095144683
PK-45H,selumetinib-GDC-0941 (4-1 mol-mol),0.6996398674072702
CMK,9884685,0.94035273426848
TALL-1 [Human adult T-ALL],selumetinib-GDC-0941 (4-1 mol-mol),0.2604149322081276
DMS 454,11152667,1.0827498525791113
RMG-I,JQ-1-carboplatin (1-1 mol-mol),2.4287881260338584
WM983B,9935249,3.2390804243426876
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
COLO 201,selumetinib-GDC-0941 (4-1 mol-mol),0.0601925657233566
MM1.S,9915743,0.5251517896588939
UM-UC-1,9911463,3.4816748285227055
KALS-1,9884685,0.3630123980894349
EoL-1,2742550,1.6225337364075894
BT 248,3854666,2.6170510866367955
BDCM,3465537,1.2996187569558617
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
NCI-H1568,3854666,0.7326561551321923
NB1,24771867,1.0468768086284044
GI-1,136227924,2.879759291125734
MOLP-8,4378219,3.751203523477959
SK-N-FI,selumetinib-vorinostat (8-1 mol-mol),1.423109443377603
Calu-3,12003241,-0.8682368391192625
UO-31,4378219,2.1928320543955375
NCI-H2029,135984461,4.315213112140467
KMS-11,11152667,-1.7623955377212943
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
UACC-62,selumetinib-vorinostat (8-1 mol-mol),0.2264135589516406
LN-18,3854666,2.124963526883118
SNU-216,12003241,-2.3730818081536955
HCC1438,24771867,1.9294784321157563
MOLM-6,selumetinib-GDC-0941 (4-1 mol-mol),0.1291930510848496
LNCaP clone FGC,49836020,4.788899602776088
HGC-27,3854666,0.4310237545100587
JJN-3,11494412,0.8289116652067822
SNU-C1,9884685,1.2025701916659406
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
697,6918638,-1.9247711806790853
786-O,4378219,2.0388254450717453
OV-90,selumetinib-GDC-0941 (4-1 mol-mol),0.0279948147357564
PL-21,136227924,2.3397761554923413
NCI-H292,3854666,3.3764205876154074
BT 333,10296883,4.228869455795536
NCI-H647,135398744,6.542739498462596
NCI-H2029,selumetinib-GDC-0941 (4-1 mol-mol),3.389084232117775
22Rv1,11404337,0.9568158231901654
HuP-T4,9926054,2.1001790007483843
SU.86.86,selumetinib-GDC-0941 (4-1 mol-mol),2.756391846899265
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
Calu-6,9935249,2.2343949143207236
NCI-H2029,100016,6.638892611020326
OVTOKO,44241473,5.349589676955475
NCI-H841,136227924,2.950651455010232
SK-N-BE(2),24771867,-2.077961996305594
SNU-761,9926054,1.7039655374796845
CL-11,selumetinib-GDC-0941 (4-1 mol-mol),-0.9577137132947868
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
NCI-H196,selumetinib-vorinostat (8-1 mol-mol),2.502166357099755
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
KMS-28BM,9911463,2.9492767057904583
Capan-1,9911463,4.415677524412553
TE-14,136227924,3.1216716097465365
SET-2,54618771,0.9858111819135928
HCC-56,6918638,0.2361722846831457
TE-6,54618305,5.254782114960126
SK-MEL-31,1566236,2.849502480165651
WM266-4,136227331,3.760867873542347
BT 139,6918638,0.9412017663716644
HD-MY-Z,135984461,4.3982026911884455
HMC-1-8,selumetinib-vorinostat (8-1 mol-mol),2.4417596727205466
SK-MEL-31,11404337,-0.7650509670659701
SNU-201,12003241,-1.0113776062533857
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
COLO 320,JQ-1-carboplatin (1-1 mol-mol),2.160423517862895
KMS-21-BM,2742550,2.736475414851647
NCI-H1792,54618771,0.988608164360901
HEC-1-A,1566236,2.9371765308534594
BT 504,2742550,3.507515217857391
BT 444,6918638,3.2929194636283023
Hs 888.T,9915743,0.1139967508569927
MFE-296,JQ-1-carboplatin (1-1 mol-mol),2.681039150373503
CAL-62,136227924,2.2921842664772996
AGS,12003241,-0.4936842382500208
JeKo-1,71751553,4.358287051916344
IM95,9911463,3.6531576247852153
SET-2,11494412,0.7084758030554381
A-375,11152667,-0.6556318193430793
SW1990,100016,6.759971253936254
SaOS-2,3854666,0.6354016080385003
5637,11152667,-0.8505052650270252
OCI-Ly3,11152667,-1.1864108780291491
NCI-H2122,54618771,0.6219971058133998
BT 422,1566236,1.9031196665814163
MDA-MB-468,9911463,3.8192810544536058
NCI-H1155,100016,6.5684025185087505
G-292 clone A141B1,6918638,1.851561084162043
SNU-1196,54618771,1.539198282600217
LOX-IMVI,11152667,-0.6802335307199879
WM983B,4378219,2.293586704374939
2004,1566236,1.5535605371575574
COR-L51,9915743,1.408034977719198
BEN,135421197,5.032233949916212
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
ECC10,135984461,4.0726729521120975
REC-1,54618771,4.304155025574206
DEL,3465537,0.475159864785855
NCI-H1869,3854666,4.318290699876198
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
NCI-H2141,24771867,3.9346248515537448
HCC38,JQ-1-carboplatin (1-1 mol-mol),1.2340294143226358
HEC-251,11152667,0.8582943172462689
BT 444,135659046,3.767514231738307
MKN7,2746,3.491753391139794
SH-4,71751553,3.2437962454136016
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
OAW28,9911463,4.007690751229585
NCI-H1694,1566236,0.9563523099739728
NCI-H1650,2746,3.978561009929137
KYSE-410,3465537,2.783776931016741
MHH-CALL-3,44487872,5.322580782897121
P31/FUJ,135421197,1.0144502005310674
Hs 839.T,4705,4.001099763666499
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
WM1799,10296883,3.650999018677617
OV-90,65628,5.030482917460489
Hs 888.Lu,54618771,0.7485520203089981
IGR-37,10322450,5.040348991848962
G-401,54618771,0.8582285882331511
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
SK-N-SH,3854666,-0.6483541731368345
Daudi,44241473,5.233980827552566
8505C,9926054,2.4332368789969734
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
NCI-H2087,136227331,3.603331893484652
LK-2,135421197,2.2865264373163487
BT 164,135421197,1.9530013508190165
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
HCC2935,24771867,2.899558931808493
Caov-3,3854666,1.2394462987142651
HCC4006,136227331,3.713774396347732
NCI-H2085,1566236,1.816648295053065
